000005|N05AX0801|Risperdal|töflur|0,5|mg|20|stk|1|þpakki|þp|N05AX08|01.04.2000||R|A|2|0|0|*|0|JAS|0|1|0|100|SEK|1654|3140|lyfalmen|V1070|1887|00|20|0|2,0000|Vistor hf|Janssen-Cilag AB|Risperídón||1654||1654|3140| 000018|G01AF0501|Pevaryl|krem/sti|||15|g|1|sett|krem+3 stílar|G01AF05|01.05.1978||L|A|2|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||00|15|0|4,5000|Vistor hf|McNeil Sweden AB|Ekónazól|||||| 000054|B03XA0103|NeoRecormon|stl|4000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|37521|48971|lyfsjukr|||00|2|0|24,0000|Icepharma hf|Roche|Epóetín||37521||37521|48971| 000145|B03XA0103|NeoRecormon|stl|6000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|56602|72918|lyfsjukr|||00|2|0|36,0000|Icepharma hf|Roche|Epóetín||56602||56602|72918| 000153|A02BC0102|Losec|sh-tfl|20|mg|7|stk|1|þpakki||A02BC01|01.09.2009||L|A||0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||00|7|0|7,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól|||||| 000159|N05AH0302|Zyprexa Velotab|munndr.t|5|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|10211|14845|lyfalmen|||00|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||10211||10211|14845| 000184|N05AH0302|Zyprexa Velotab|munndr.t|15|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|30380|40406|lyfalmen|||00|28|0|42,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||30380||30380|40406| 000193|N05AH0302|Zyprexa Velotab|munnltfl|20|mg|28|stk|1|þpakki||N05AH03|01.12.2003||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|39510|51864|lyfalmen|||00|28|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||39510||39510|51864| 000198|N05AH0302|Zyprexa Velotab|munndr.t|10|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|19877|27225|lyfalmen|V0813|27223|00|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||19877||19877|27225| 000223|G02CX0101|Tractocile|stl|7,5|mg/ml|0,9|ml|1|hgl|lausn|G02CX01|01.12.2006||R|K|2|0|1|0|1|FER|0|0|0|100|DKK|5812|8388|lyfsjukr|||00|1|0|0,0400|Vistor hf|Ferring|Atosíban||5812||5812|8388| 000225|QM01AC0601|Metacam|mixtúra|1,5|mg/ml|100|ml|1|fl||QM01AC06|01.05.2004||R|A|3|0|0|0|0|BOI|0|0|0|100|DKK|7468|14512|vetalmen|||00|100|0|0,0000|Vistor hf|Boehringer Ingelheim|||7468||7468|14512| 000237|G02CX0101|Tractocile|irþ|7,5|mg/ml|5|ml|1|hgl|lausn|G02CX01|01.12.2006||R|K|2|0|1|0|1|FER|0|0|0|100|DKK|15983|21941|lyfsjukr|||00|5|0|0,2300|Vistor hf|Ferring|Atosíban||15983||15983|21941| 000290|G03GA0601|Puregon|stl|300|ae/rörly|0,36|ml|1|pakki||G03GA06|01.02.2002||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|19889|27240|lyfalmen|||00|0|0|4,0000|Vistor hf|N.V. Organon|Follitrópín beta||19889||19889|27240| 000316|G03GA0601|Puregon|stl|600|ae/rörly|0,72|ml|1|pakki||G03GA06|01.02.2002||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|39453|51793|lyfalmen|||00|1|0|8,0000|Vistor hf|N.V. Organon|Follitrópín beta||39453||39453|51793| 000373|N02CC0402|Maxalt Smelt|munnltfl|10|mg|6|stk|1|þpakki||N02CC04|01.03.1999||R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|5247|8055|lyfalmen|||00|6|0|6,0000|Icepharma hf|M.S.D.|Rizatriptan||5247||5247|8055| 000390|J01CR0202|Augmentin|sts|600|mg/hgl|10|hgl|1|pakki|500+100 mg|J01CR02|01.01.2000||R|A|2|0|0|0|1|GSK|0|0|0|100|IKR|2534|3657|lyfsjukr|||00|10|0|1,6700|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||2534||2534|3657| 000402|J01CR0202|Augmentin|sts|1200|mg/hgl|5|hgl|1|pakki|1000+200 mg|J01CR02|01.01.2000||R|A|2|0|0|0|1|GSK|0|0|0|100|IKR|2175|3139|lyfsjukr|||00|5|0|1,6700|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||2175||2175|3139| 000448|D07AC1301|Elocon|húðlausn|0,1|%|100|ml|1|glas||D07AC13|01.03.2009||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|3131|5160|lyfalmen|||0|100|0|100,0000|Vistor hf|Schering-Plough|Mómetasón||||3131|5160| 000530|J07BF0301|Imovax Polio|bóluefni|0| |0,5|ml|20|spr|án nála|J07BF03|01.06.2005||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|27526|36824|lyfalmen|||02|10|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Mænusótt, dauð veira||27526||27526|36824| 000548|S01GX0801|Zaditen|augndr|0,25|mg/ml|5|ml|1|glas||S01GX08|01.07.2001||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1925|3511|lyfalmen|||06|5|0|0,0000|Vistor hf|Novartis Healthcare A/S-|Ketotifen||1925||1925|3511| 000552|G04BE0105|Caverject Dual|sts|20|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|5107|7863|lyfalmen|||23|2|0|2,0000|Icepharma hf|Pfizer ApS|Alprostadíl||5107||5107|7863| 000555|N03AX1101|Topimax|hylki|15|mg|60|stk|1|plglas||N03AX11|01.05.2001||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|4912|7597|lyfalmen|||00|60|0|3,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||4912||4912|7597| 000565|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|20|sk-hyl||S01GX08|01.07.2001||L|A|2|0|0|0|0|NOH|0|0|0|100|IKR|||lyflausa|||00|8|0|0,0000|Vistor hf|Novartis Healthcare A/S-|Ketotifen|||||| 000573|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|60|sk-hyl||S01GX08|01.07.2001||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|5274|8092|lyfalmen|||00|24|0|0,0000|Vistor hf|Novartis Healthcare A/S-|Ketotifen||5274||5274|8092| 000641|B05BA0202|Intralipid 200 mg/ml|irl|200|mg/ml|100|ml|10|fl||B05BA02|01.04.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|14700|20331|lyfsjukr|||00|1000|0|1,0000|Icepharma hf|Fresenius Kabi|Fitusambönd||14700||14700|20331| 000646|C08CA0101|Norvasc|töflur|10|mg|30|stk|1|þpakki||C08CA01|01.01.1992||R|A|4|0|0|B|0|PER|0|0|0|100|DKK|4502|7036|lyfalmen|||00|30|0|60,0000|Icepharma hf|Pfizer ApS|Amlódipín||||4502|7036| 000784|G04BE0105|Caverject Dual|sts|10|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|3724|5971|lyfalmen|||23|2|0|1,0000|Icepharma hf|Pfizer ApS|Alprostadíl||3724||3724|5971| 000801|R06AA0201|Benylan|mixtúra|2,8|mg/ml|125|ml|1|glas||R06AA02|01.05.1999||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|125|0|1,7500|Vistor hf|McNeil Denmark ApS|Dífenhýdramín|||||| 000815|R06AA0201|Benylan|mixtúra|1,4|mg/ml|125|ml|1|glas||R06AA02|01.06.2001||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|125|0|0,8750|Vistor hf|McNeil Denmark ApS|Dífenhýdramín|||||| 000879|L03AB0702|Rebif|stl|44|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.01.2001||R|K|2|0|1|0|1|MSE|0|0|0|100|SEK|175180|221733|lyfsjukr|||00|6|0|122,7907|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||175180||175180|221733| 000957|H01AC0101|Genotropin|sts|5|mg|1|rörlyk|1|pakki|tvíhólfa|H01AC01|01.05.2001||R|K|3|0|1|0|1|PER|0|0|0|100|DKK|22063|29572|lyfsjukr|||02|1|0|7,4963|Icepharma hf|Pfizer ApS|Sómatrópín||22063||22063|29572| 001167|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|1|spr||H01CC01|01.05.2001||R|A|2|0|1|0|1|ORG|0|0|0|100|DKK|6213|8967|lyfsjukr|||02|0|0|1,0000|Vistor hf|N.V. Organon|Ganirelix||6213||6213|8967| 001194|M01AH0101|Celebra|hylki|200|mg|10|stk|1|þpakki||M01AH01|01.03.2003||R|A|3|0|0|E|0|PER|0|0|1|100|DKK|1686|3184|lyfalmen|||00|10|0|10,0000|Icepharma hf|Pfizer ApS|Celekoxíb||1686||1686|3184| 001225|C10AA0501|Zarator|töflur|80|mg|30|stk|1|þpakki||C10AA05|01.06.2002||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|11632|16789|lyfalmen|||00|30|0|120,0000|Icepharma hf|Pfizer ApS|Atorvastatín||11632||11632|16789| 001239|C10AA0501|Zarator|töflur|80|mg|100|stk|1|þpakki||C10AA05|01.06.2002||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|22259|30214|lyfalmen|||00|100|0|400,0000|Icepharma hf|Pfizer ApS|Atorvastatín||22259||22259|30214| 001291|C07AB0206|Seloken ZOC|forðatfl|23,75|mg|100|stk|1|plglas||C07AB02|01.05.2006||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2716|4593|lyfalmen|V0091|3694|43|100|0|15,8300|Vistor hf|AstraZeneca A/S DK|Metóprólól||2716||2716|4593| 001324|C09CA0201|Teveten|töflur|600|mg|98|stk|1|þpakki||C09CA02|01.08.2001||R|A|3|0|0|0|0|ABH|0|0|0|100|XEU|11573|16709|lyfalmen|||00|98|0|98,0000|Icepharma hf|Abbott Healthcare Products B.V.|Eprosartan||11573||11573|16709| 001337|V08CA0901|Gadovist|stl|1|mmol/ml|30|ml|10|hgl||V08CA09|01.12.2003||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|481768|606501|lyfsjukr|||02|300|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Gadóbútról||481768||481768|606501| 001399|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|5|spr||H01CC01|01.05.2001||R|A|2|0|1|0|1|ORG|0|0|0|100|DKK|31908|41927|lyfsjukr|||02|2|0|5,0000|Vistor hf|N.V. Organon|Ganirelix||31908||31908|41927| 001409|C10AA0102|Sivacor|töflur|20|mg|28|stk|1|glas||C10AA01|01.03.2000||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|928|2147|lyfalmen|||00|28|0|18,6667|Actavis Group hf|Actavis hf|Simvastatín||928||928|2147| 001431|C10AA0102|Sivacor|töflur|40|mg|28|stk|1|glas||C10AA01|01.03.2000||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|2700|4571|lyfalmen|||00|28|0|37,3400|Actavis Group hf|Actavis hf|Simvastatín||2700||2700|4571| 001490|A10AD0502|NovoMix 30 Penfill|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.08.2002||R|K|2|0|0|*|0|NON|0|0|0|100|DKK|6550|9837|lyfalmen|||02|15|0|37,5000|Vistor hf|Novo-Nordisk|Insulín aspart||6550||6550|9837| 001512|C04AD0301|Trental|forðatfl|400|mg|100|stk|1|þpakki||C04AD03|01.05.2002||R|A|5|0|0|E|0|SNO|0|0|0|100|NOK|4878|7550|lyfalmen|||10|100|0|40,0000|Vistor hf|Sanofi-aventis Norge AS|Pentoxífýllín||4878||4878|7550| 001517|N06AB0308|Fluoxetin Actavis|hylki|20|mg|30|stk|1|þpakki||N06AB03|01.03.2000||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|883|2085|lyfalmen|||10|30|0|30,0000|Actavis Group hf|Actavis hf|Flúoxetín||883||883|2085| 001528|N06AB0308|Fluoxetin Actavis|hylki|20|mg|100|stk|1|þpakki||N06AB03|01.03.2000||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|2456|4237|lyfalmen|||10|100|0|100,0000|Actavis Group hf|Actavis hf|Flúoxetín||2456||2456|4237| 001574|C09AA0209|Enalapril Mylan|töflur|2,5|mg|50|stk|1|þpakki||C09AA02|01.10.2009||R|A||0|0|B|0|PCO|0|0|0|100|SEK|558|1641|lyfalmen|||00|50|1|12,5000|Distica|Distica - óskráð lyf|Enalapríl||558||558|1641| 001588|B05BA1014|Kabiven|irl|900|kcal|1026|ml|4|pokar||B05BA10|01.08.2003||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|21695|29110|lyfsjukr|||00|4104|0|0,0000|Icepharma hf|Fresenius Kabi|Blöndur||21695||21695|29110| 001599|B03AC0201|Venofer|stl|20|mg/ml|5|ml|5|hgl||B03AC02|01.07.2005||R|A|3|0|0|E|0|VIF|0|0|1|100|CHF|15066|21187|lyfalmen|V0011|19474|00|25|0|5,0000|Vistor hf|Vifor France SA|Járnoxíð (sykurflétta)||15066||15066|21187| 001605|B05BA1014|Kabiven|irl|1400|kcal|1540|ml|4|pokar||B05BA10|01.08.2003||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|35664|46641|lyfsjukr|||00|6160|0|6,1600|Icepharma hf|Fresenius Kabi|Blöndur||35664||35664|46641| 001792|N02BA0109|Alka-Seltzer|freyðit|324|mg|20|stk|1|pakki||N02BA01|01.08.2004||L|A|3|0|0|0|0|BAI|0|0|1|100|IKR|||lyflausa|||00|20|0|2,1600|Icepharma hf|Bayer A/S|Acetýlsalicýlsýra|||||| 001874|G02AB0101|Methergin|stl|0,2|mg/ml|1|ml|10|lykjur||G02AB01|01.11.2001||R|K|3|0|0|0|1|NOH|0|0|0|100|DKK|1274|1839|lyfsjukr|||02|10|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Metýlergómetrín||1274||1274|1839| 001878|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|3|glös||S01EC04|01.11.2001||R|A|2|0|0|*|0|ALC|0|0|0|100|USD|3928|6251|lyfalmen|||06|15|0|75,0000|K.Pétursson hf|Alcon|Brinzólamíð||3928||3928|6251| 001889|A02BC0501|Nexium|sh-tfl|20|mg|7|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|1228|2557|lyfalmen|||00|7|0|4,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||1228||1228|2557| 001954|N05AX0802|Rison|töflur|1|mg|60|stk|1|glas||N05AX08|01.05.2000||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|2358|4103|lyfalmen|V0791|4103|00|60|0|12,0000|Actavis Group hf|Actavis hf|Risperídón||2358||2358|4103| 001957|N05AX0802|Rison|töflur|4|mg|60|stk|1|glas||N05AX08|01.05.2000||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|12969|18555|lyfalmen|V0795|18555|00|60|0|48,0000|Actavis Group hf|Actavis hf|Risperídón||12969||12969|18555| 001962|N01BX0401|Capsina|krem|0,75|mg/g|45|g|1|túpa||N01BX04|01.06.1998||R|A|3|0|0|0|0|BIG|0|0|0|100|SEK|5242|8048|lyfalmen|||00|45|0|45,0000|Icepharma hf|Bioglan AB|Capsaicin||5242||5242|8048| 001965|N05AX0802|Rison|töflur|2|mg|60|stk|1|glas||N05AX08|01.05.2000||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|4691|7294|lyfalmen|V0793|7294|00|60|0|24,0000|Actavis Group hf|Actavis hf|Risperídón||4691||4691|7294| 001974|J01CA0801|Selexid|töflur|200|mg|100|stk|1|glas||J01CA08|01.10.1990||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|8844|12975|lyfalmen|V0456|12862|43|100|0|33,3333|Vistor hf|LEO Pharma A/S|Pívmecillínam||8844||8844|12975| 001980|A02BC0501|Nexium|sh-tfl|20|mg|28|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|4432|6940|lyfalmen|V0084|6939|00|28|0|18,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||4432||4432|6940| 001986|N05AX0802|Rison|töflur|3|mg|60|stk|1|glas||N05AX08|01.05.2000||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|8009|11833|lyfalmen|V0794|11833|00|60|0|36,0000|Actavis Group hf|Actavis hf|Risperídón||8009||8009|11833| 001991|A02BC0501|Nexium|sh-tfl|20|mg|56|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|8662|12726|lyfalmen|||0|56|0|37,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||8662||8662|12726| 002011|A02BC0501|Nexium|sh-tfl|40|mg|7|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|1619|3092|lyfalmen|||00|7|0|9,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||1619||1619|3092| 002033|A02BC0501|Nexium|sh-tfl|40|mg|28|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|6064|9172|lyfalmen|V0085|8829|00|28|0|37,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||6064||6064|9172| 002071|A07EC0204|Asacol|sh-tfl|400|mg|100|stk|1|þpakki||A07EC02|01.01.2000||R|A|2|0|0|B|0|TIL|0|0|0|100|SEK|5553|8473|lyfalmen|||00|100|0|26,6667|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||5553||5553|8473| 002180|A02BC0501|Nexium|sh-tfl|20|mg|50|stk|1|þpakki|stakskammtar|A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|7412|11016|lyfalmen|||00|50|0|33,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||7412||7412|11016| 002194|B05BA1010|Kabiven Peripheral|irl|1000|kcal|1440|ml|4|pokar|fleyti|B05BA10|01.02.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|30756|40481|lyfsjukr|||00|5760|0|5,7600|Icepharma hf|Fresenius Kabi|Blöndur||30756||30756|40481| 002197|A02BC0501|Nexium|sh-tfl|20|mg|100|stk|1|glas||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|15248|21415|lyfalmen|V0087|21414|00|100|0|66,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||15248||15248|21415| 002205|A02BC0501|Nexium|sh-tfl|40|mg|50|stk|1|veski|stakskammtar|A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|9671|14107|lyfalmen|||00|50|0|66,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||9671||9671|14107| 002208|A10AB0504|NovoRapid|stl|100|ae/ml|10|ml|1|hgl||A10AB05|01.04.2006||R|K|2|0|0|*|0|NON|0|0|0|100|DKK|3087|5100|lyfalmen|||02|10|0|25,0000|Vistor hf|Novo-Nordisk|Insúlín aspart||3087||3087|5100| 002219|A02BC0501|Nexium|sh-tfl|40|mg|100|stk|1|glas||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|21614|29405|lyfalmen|||00|100|0|133,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||21614||21614|29405| 002265|D05AX0201|Daivonex|krem|50|mcg/g|120|g|1|túpa||D05AX02|01.06.2001||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|6994|10445|lyfalmen|V0092|10252|00|120|0|120,0000|Vistor hf|LEO Pharma A/S|Kalcípótríól||6994||6994|10445| 002276|D05AX0201|Daivonex|krem|50|mcg/g|60|g|1|túpa||D05AX02|01.06.2001||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|4071|6446|lyfalmen|||00|60|0|60,0000|Vistor hf|LEO Pharma A/S|Kalcípótríól||4071||4071|6446| 002312|D01AE1501|Lamisil|hlaup|10|mg/g|15|g|1|túpa||D01AE15|01.04.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|15|0|15,0000|Artasan ehf|Novartis Healthcare A/S-A|Terbínafín|||||| 002328|R03DC0301|Singulair|tuggutfl|4|mg|98|stk|1|þpakki||R03DC03|01.08.2002||R|A|2|0|0|B|0|MSD|0|0|0|100|XEU|16929|23525|lyfalmen|||00|98|0|39,2000|Icepharma hf|M.S.D.|Montelúkast||16929||16929|23525| 002342|B02BD0204|Helixate NexGen|sts|1000|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|K|1,9|0|0|0|1|BAY|0|0|0|100|SEK|109231|138967|lyfsjukr|||00|1|0|2,0000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuþáttur VIII||109231||109231|138967| 002356|B02BD0204|Helixate NexGen|sts|500|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|K|1,9|0|0|0|1|BAY|0|0|0|100|SEK|55676|71756|lyfsjukr|||00|1|0|1,0000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuþáttur VIII||55676||55676|71756| 002367|B02BD0204|Helixate NexGen|sts|250|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|K|1,9|0|0|0|1|BAY|0|0|0|100|SEK|34109|44689|lyfsjukr|||00|1|0|0,5000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuþáttur VIII||34109||34109|44689| 002391|G03AA1201|Yasmin|töflur|0||63|stk|1|þpakki|3+0,03 mg|G03AA12|01.02.2001||R|A|3|0|0|0|0|BAP|0|0|0|100|SEK|3181|5229|lyfalmen|||00|63|0|84,0000|Icepharma hf|Bayer Schering Pharma AG|Dróspírenón og östrógen||||3181|5229| 002413|G03AA1204|Yasmin 28|töflur|0| |84|stk|1|þpakki|3+0,03 mg|G03AA12|01.10.2007||R|A|3|0|0|0|0|BAP|0|0|0|100|SEK|3181|5229|lyfalmen|||00|84|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Dróspírenón og östrógen||3181||3181|5229| 002487|R06AX1304|Loritin|töflur|10|mg|10|stk|1|þpakki||R06AX13|01.10.2000||L|A|3|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|10|0|10,0000|Actavis Group hf|Actavis hf|Lóratadín|||||| 002499|R06AX1304|Loritin|töflur|10|mg|30|stk|1|þpakki||R06AX13|01.10.2000||L|A|3|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|30|0|30,0000|Actavis Group hf|Actavis hf|Lóratadín|||||| 002510|R06AX1304|Loritin|töflur|10|mg|100|stk|1|þpakki||R06AX13|01.10.2000||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|1679|3174|lyfalmen|V0984|3174|00|100|0|100,0000|Actavis Group hf|Actavis hf|Lóratadín||1679||1679|3174| 002616|S01LA0101|Visudyne|irs|15|mg/hgl|1|hgl|1|pakki||S01LA01|01.12.2000||R|A|4|0|1|0|1|NOO|0|0|0|100|DKK|194614|246123|lyfsjukr|||00|1|0|0,0000|Vistor hf|Novartis Ophthalmics Europe Ltd.|Verteporfin||194614||194614|246123| 002659|QP52AA0101|Droncit vet.|sts|57|mg/ml|10|ml|1|hgl|lausn|QP52AA01|01.03.2009||R|A|4|0|0|0|0|BAN|0|0|0|100|DKK|2825|4928|vetorma|||0|10|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||||2825|4928| 002754|N07BA0107|Nicotinell Mint|munnstfl|1|mg|204|stk|1|pakki||N07BA01|01.06.2002||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|204|0|6,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 002830|S01ED0106|Timosan Depot|augngel|1|mg/g|5|g|1|glas||S01ED01|01.08.2000||R|A|1,5|0|0|*|0|SAO|0|0|0|100|XEU|1246|2582|lyfalmen|||07|5|0|25,0000|Icepharma hf|Santen Oy|Tímólól||1246||1246|2582| 002853|M03AX0101|Botox|sts|100|ae/hgl|1|hgl|1|pakki||M03AX01|01.07.1994||R|K|3|0|1|0|1|ALL|0|0|0|100|SEK|33693|44167|lyfsjukr|||02|1|0|0,0000|Vistor hf|Allergan|Clostridium botulinum toxín-A||33693||33693|44167| 002966|G03GA0502|Gonal-f|sts|1050|ae|1|hgl|1|pakki|á 1,75 ml + leysir |G03GA05|01.02.2002||R|A|1|0|1|E|0|MSE|0|0|0|100|SEK|76175|97879|lyfalmen|||00|1|0|14,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||76175||76175|97879| 003023|C09DA0104|Cozaar Comp Forte|filmhtfl|125|mg|98|stk|1|þpakki|100+25 mg|C09DA01|01.06.2007||R|A|3|0|0|0|0|MSD|0|0|0|100|XEU|13991|15093|lyfalmen|V2220|4802|00|98|0|196,0000|Icepharma hf|M.S.D.|Lósartan og þvagræsilyf||10392||10392|15093| 003078|N03AX1401|Keppra|filmhtfl|250|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|A|3|0|0|0|0|UCB|0|0|0|100|DKK|10346|15030|lyfalmen|||00|100|0|16,6700|Vistor hf|U.C.B|Levetíracetam||10346||10346|15030| 003099|L01DB0104|Myocet|irl|50|mg|2|sett|1|pakki||L01DB01|01.07.2006||R|K|1,5|0|1|0|1|ZEP|0|0|0|100|DKK|273694|345368|lyfsjukr|||02|2|0|0,0000|Icepharma hf|Zeneus Pharma Limited-|Doxórúbicín||273694||273694|345368| 003112|N03AX1401|Keppra|filmhtfl|500|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|A|3|0|0|0|0|UCB|0|0|0|100|DKK|17862|24696|lyfalmen|||00|100|0|33,3300|Vistor hf|U.C.B|Levetíracetam||17862||17862|24696| 003158|N03AX1401|Keppra|filmhtfl|1000|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|A|3|0|0|0|0|UCB|0|0|0|100|DKK|34707|45836|lyfalmen|||00|100|0|66,6700|Vistor hf|U.C.B|Levetíracetam||34707||34707|45836| 003164|L01CA0401|Navelbine|hylki|20|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|K|3|0|1|*|0|PFP|0|0|0|100|SEK|10238|14882|lyfalmen|||00|1|0|0,0000|Vistor hf|Pierre Fabre Pharma|Vínorelbín||10238||10238|14882| 003175|L01CA0401|Navelbine|hylki|30|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|K|3|0|1|*|0|PFP|0|0|0|100|SEK|15273|21447|lyfalmen|||00|1|0|0,0000|Vistor hf|Pierre Fabre Pharma|Vínorelbín||15273||15273|21447| 003195|B03XA0201|Aranesp|stl|10|mcg/spr|0,4|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|18435|25018|lyfsjukr|||00|2|0|8,8900|Vistor hf|Amgen|Darbepóetín alfa||18435||18435|25018| 003208|B03XA0201|Aranesp|stl|15|mcg/spr|0,375|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|27463|36349|lyfsjukr|||00|2|0|13,3300|Vistor hf|Amgen|Darbepóetín alfa||27463||27463|36349| 003230|B03XA0201|Aranesp|stl|20|mcg/spr|0,5|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|26691|35380|lyfsjukr|||00|2|0|17,7800|Vistor hf|Amgen|Darbepóetín alfa||26691||26691|35380| 003238|J07AM0101|Tetavax|stl|40|ae|0,5|ml|1|lykja||J07AM01|01.03.2006||R|K||0|0|0|0|LDR|0|0|1|100|IKR|557|1639|lyfalmen|||00|0|1|0,0000|Parlogis hf|Parlogis - óskráð lyf|||557||557|1639| 003252|B03XA0201|Aranesp|stl|30|mcg/spr|0,3|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|39784|51811|lyfsjukr|||00|1|0|26,6700|Vistor hf|Amgen|Darbepóetín alfa||39784||39784|51811| 003274|B03XA0201|Aranesp|stl|40|mcg/spr|0,4|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|52385|67626|lyfsjukr|||00|2|0|35,5600|Vistor hf|Amgen|Darbepóetín alfa||52385||52385|67626| 003296|B03XA0201|Aranesp|stl|50|mcg/spr|0,5|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|64837|83253|lyfsjukr|||00|2|0|44,4400|Vistor hf|Amgen|Darbepóetín alfa||64837||64837|83253| 003298|V08CA0901|Gadovist|stl|1|mmol/ml|15|ml|10|hgl|lausn|V08CA09|01.04.2007||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|239221|302105|lyfsjukr|||02|150|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Gadóbútról||239221||239221|302105| 003310|R03AK0701|Symbicort Turbuhaler|innúðadu|164,5|mcg/sk|120|sk|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2001||R|A|2|0|0|0|0|AZD|0|0|0|100|SEK|9387|13718|lyfalmen|||0|120|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||9387||9387|13718| 003318|B03XA0201|Aranesp|stl|60|mcg/spr|0,3|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|77696|99391|lyfsjukr|||00|1|0|53,3300|Vistor hf|Amgen|Darbepóetín alfa||77696||77696|99391| 003325|R03AK0702|Symbicort mite Turbuhaler|innúðadu|84,5|mcg/sk|120|sk|1|pakki|80+4,5 mcg/sk|R03AK07|01.08.2002||R|A|2|0|0|0|0|AZD|0|0|0|100|SEK|8578|12612|lyfalmen|||00|120|0|15,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||8578||8578|12612| 003340|B03XA0201|Aranesp|stl|80|mcg/spr|0,4|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|103568|131860|lyfsjukr|||00|2|0|71,1100|Vistor hf|Amgen|Darbepóetín alfa||103568||103568|131860| 003353|L04AA1001|Rapamune|töflur|1|mg|100|stk|1|þpakki||L04AA10|01.04.2004||R|A|1,5|0|1|*|0|WTE|0|0|0|100|DKK|58800|76073|lyfalmen|||00|100|0|33,3300|Icepharma hf|Wyeth Europe|Sirolimus||58800||58800|76073| 003355|D01AE1501|Lamisil|úðalausn|10|mg/g|15|ml|1|fl|úðalausn á húð|D01AE15|01.04.2002|31.01.2011|L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|15|0|15,0000|Artasan ehf|Novartis Healthcare A/S-A|Terbínafín|||||| 003362|B03XA0201|Aranesp|stl|100|mcg/spr|0,5|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|128930|163690|lyfsjukr|||00|2|0|88,8900|Vistor hf|Amgen|Darbepóetín alfa||128930||128930|163690| 003386|B03XA0201|Aranesp|stl|150|mcg/spr|0,3|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|188072|237913|lyfsjukr|||00|1|0|133,3300|Vistor hf|Amgen|Darbepóetín alfa||188072||188072|237913| 003395|B03XA0201|Aranesp|stl|300|mcg/spr|0,6|ml|1|spr|áfyllt sprauta|B03XA02|01.12.2003||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|94012|119868|lyfsjukr|||00|1|0|66,6700|Vistor hf|Amgen|Darbepóetín alfa||94012||94012|119868| 003423|A10BG0301|Actos|töflur|15|mg|28|stk|1|þpakki||A10BG03|01.12.2000||R|A|3|0|0|*|0|TKE|0|0|0|100|SEK|4434|6943|lyfalmen|||00|28|0|14,0000|Eli Lilly Danmark A/S|Takeda Europe -|Píóglítazón||||4434|6943| 003455|A02BB0101|Cytotec|töflur|0,2|mg|60|stk|1|þpakki||A02BB01|01.08.2002||R|A|3|0|0|E|0|PER|0|0|0|100|DKK|3511|5680|lyfalmen|||00|60|0|15,0000|Icepharma hf|Pfizer ApS|Mísóprostól||3511||3511|5680| 003800|A10BG0301|Actos|töflur|15|mg|98|stk|1|þpakki||A10BG03|01.12.2000||R|A|3|0|0|*|0|TKE|0|0|0|100|SEK|15318|21503|lyfalmen|||00|98|0|49,0000|Eli Lilly Danmark A/S|Takeda Europe -|Píóglítazón||||15318|21503| 003809|A10BG0301|Actos|töflur|30|mg|28|stk|1|þpakki||A10BG03|01.12.2000||R|A|3|0|0|*|0|TKE|0|0|0|100|SEK|6704|10048|lyfalmen|||00|28|0|28,0000|Eli Lilly Danmark A/S|Takeda Europe -|Píóglítazón||||6704|10048| 003831|A10BG0301|Actos|töflur|30|mg|98|stk|1|þpakki||A10BG03|01.12.2000||R|A|3|0|0|*|0|TKE|0|0|0|100|SEK|22881|30995|lyfalmen|||00|98|0|98,0000|Eli Lilly Danmark A/S|Takeda Europe -|Píóglítazón||||22881|30995| 003869|R01BA5202|Clarinase|forðatfl|10|mg|10|stk|1|pakki|þp 10+240 mg|R01BA52|01.09.1998||R|A|3|0|0|E|0|SCP|0|0|1|100|DKK|867|2063|lyfalmen|||00|10|0|10,0000|Vistor hf|Schering-Plough|Pseudóefedrín í blöndum||867||867|2063| 003927|N06AB0602|Sertral|töflur|50|mg|28|stk|1|glas||N06AB06|01.11.2000||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|1017|1947|lyfalmen|V0931|1947|00|28|0|28,0000|Actavis Group hf|Actavis hf|Sertralín||782||782|1947| 003939|M01AB0505|Voltaren|sh-tfl|50|mg|20|stk|1|þpakki||M01AB05|01.03.1984||R|A|5|0|0|E|0|NOH|0|0|1|100|DKK|633|1743|lyfalmen|||67|20|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||633||633|1743| 003950|N06AB0602|Sertral|töflur|50|mg|98|stk|1|glas||N06AB06|01.11.2000||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|3016|5003|lyfalmen|V0933|5003|00|98|0|98,0000|Actavis Group hf|Actavis hf|Sertralín||3016||3016|5003| 003974|J05AE0601|Kaletra|mixtúra|100|mg/ml|60|ml|1|glas|80 + 20 mg/ml|J05AE06|01.08.2003||R|A|2|0|1|0|1|ABL|0|0|0|100|DKK|93453|119166|lyfsjukr|||00|60|0|7,5000|Vistor hf|Abbott Laboratories A/S|Lopinavír||93453||93453|119166| 003988|M01AB0505|Voltaren|sh-tfl|50|mg|100|stk|1|þpakki||M01AB05|01.03.1984||R|A|5|0|0|E|0|NOH|0|0|1|100|DKK|2115|3770|lyfalmen|V0608|2293|67|100|0|50,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||2115||2115|3770| 004002|L04AD0101|Sandimmun|irþ|50|mg/ml|5|ml|10|lykjur||L04AD01|01.10.1985||R|A|4|0|0|0|1|NOH|0|0|0|100|DKK|32957|43244|lyfsjukr|||00|50|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||32957||32957|43244| 004014|N03AF0201|Trileptal|mixtúra|60|mg/ml|250|ml|1|fl||N03AF02|01.01.2002||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|7872|11646|lyfalmen|||00|250|0|15,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||7872||7872|11646| 004028|A07DA0301|Imodium|mixtúra|0,2|mg/ml|100|ml|1|fl||A07DA03|01.01.1990||L|A|5|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||00|100|0|2,0000|Vistor hf|McNeil Sweden AB|Lóperamíð|||||| 004050|R03AK0601|Seretide|innúðal|75|mcg/sk|120|skammtar|1|pakki|25+50 mcg/sk|R03AK06|01.10.2002||R|A|1|0|0|B|0|GSK|0|0|0|100|GBP|4043|6408|lyfalmen|||23|120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||4043||4043|6408| 004086|N06AB0601|Zoloft|töflur|25|mg|7|stk|1|þpakki||N06AB06|01.05.2003||R|A|5|0|0|0|0|PER|0|1|0|100|DKK|589|1683|lyfalmen|||00|7|0|3,5000|Icepharma hf|Pfizer ApS|Sertralín||589||589|1683| 004111|N05CD0102|Dalmadorm medium|hylki|15|mg|30|stk|1|þpakki||N05CD01|01.12.2000||R|A|5|0|0|0|0|MAB|0|0|1|100|DKK|1054|2319|lyfalmen|||10|30|0|15,0000|Vistor hf|Meda AB|Flúrazepam||1054||1054|2319| 004259|N05AE0401|Zeldox|hylki|40|mg|14|stk|1|þpakki|hart hylki|N05AE04|01.03.2003||R|A|4|0|0|0|0|PER|0|1|0|100|DKK|6151|9292|lyfalmen|||00|14|0|7,0000|Icepharma hf|Pfizer ApS|Ziprasidon||6151||6151|9292| 004282|R03AK0601|Seretide|innúðal|150|mcg/sk|120|skammtar|1|pakki|25+125 mcg/sk|R03AK06|01.10.2002||R|A|2|0|0|0|0|GSK|0|0|0|100|GBP|6006|9093|lyfalmen|||23|120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||6006||6006|9093| 004293|R03AK0601|Seretide|innúðal|275|mcg/sk|120|skammtar|1|pakki|25+250 mcg/sk|R03AK06|01.10.2002||R|A|2|0|0|0|0|GSK|0|0|0|100|GBP|8360|12313|lyfalmen|||23|120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||8360||8360|12313| 004298|R06AX2701|Aerius|töflur|5|mg|10|stk|1|þpakki||R06AX27|01.05.2001||R|A|2|0|0|E|0|SCP|0|0|1|100|DKK|746|1898|lyfalmen|||00|10|0|10,0000|Vistor hf|Schering-Plough|Deslóratadín||746||746|1898| 004301|N06AX1101|Remeron|mixtúra|15|mg/ml|66|ml|1|fl|lausn|N06AX11|01.01.2003||R|A|2|0|0|0|0|ORG|0|1|0|100|DKK|5895|8941|lyfalmen|||00|66|0|33,0000|Vistor hf|N.V. Organon|Mirtazapín||5895||5895|8941| 004352|J02AC0301|Vfend|irs|200|mg|1|hgl|1|pakki||J02AC03|01.11.2002||R|A|2|0|0|0|1|PER|0|0|0|100|DKK|22128|29653|lyfsjukr|||00|1|0|0,5000|Icepharma hf|Pfizer ApS|Voricónazól||22128||22128|29653| 004370|R06AX2701|Aerius|töflur|5|mg|30|stk|1|þpakki||R06AX27|01.05.2001||R|A|2|0|0|E|0|SCP|0|0|1|100|DKK|1647|3130|lyfalmen|V1901|3129|00|30|0|30,0000|Vistor hf|Schering-Plough|Deslóratadín||1647||1647|3130| 004374|A04AA0101|Zofran|töflur|4|mg|10|stk|1|glas||A04AA01|01.01.2009||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|8366|12322|lyfalmen|||0|10|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||8366||8366|12322| 004378|R06AX2701|Aerius|töflur|5|mg|100|stk|1|þpakki||R06AX27|01.05.2001||R|A|2|0|0|E|0|SCP|0|0|1|100|DKK|4607|7179|lyfalmen|||00|100|0|100,0000|Vistor hf|Schering-Plough|Deslóratadín||4607||4607|7179| 004388|QJ51RC2501|Benestermycin, vet.|spenalyf|0| |5|ml|20|spr||QJ51RC25|01.12.1978||R|A|3|0|0|0|0|BOI|0|0|0|100|DKK|4542|8894|vetalmen|||16|100|0|0,0000|Vistor hf|Boehringer Ingelheim|||4542||4542|8894| 004455|N02AX0208|Zytram|forðatfl|75|mg|56|stk|1|glas||N02AX02|01.01.2001||R|A|3|0|0|E|0|NOP|0|0|1|100|DKK|3230|5296|lyfalmen|||00|56|0|14,0000|Icepharma hf|Norpharma |Tramadól||3230||3230|5296| 004465|C01DA0801|Sorbangil|töflur|5|mg|100|stk|1|þpakki||C01DA08|01.06.1980||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|748|1900|lyfalmen|||00|100|0|8,3333|Vistor hf|Recip AB|Ísósorbíð dínítrat||748||748|1900| 004468|J07BC0203|Vaqta|bóluefni|25|ein|0,5|ml|1|spr|áfyllt spr. án nálar|J07BC02|01.03.2001||R|K|2|0|0|0|0|SPM|0|0|0|100|XEU|3176|5222|lyfalmen|||51|0|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||3176||3176|5222| 004478|N02AX0208|Zytram|forðatfl|100|mg|56|stk|1|glas||N02AX02|01.01.2001||R|A|3|0|0|E|0|NOP|0|0|1|100|DKK|4307|6769|lyfalmen|||00|56|0|18,6667|Icepharma hf|Norpharma |Tramadól||4307||4307|6769| 004489|N02AX0208|Zytram|forðatfl|150|mg|56|stk|1|glas||N02AX02|01.01.2001||R|A|3|0|0|E|0|NOP|0|0|1|100|DKK|6084|9200|lyfalmen|||00|56|0|28,0000|Icepharma hf|Norpharma |Tramadól||6084||6084|9200| 004500|N02AX0208|Zytram|forðatfl|200|mg|56|stk|1|glas||N02AX02|01.01.2001||R|A|3|0|0|E|0|NOP|0|0|1|100|DKK|8098|11955|lyfalmen|||00|56|0|37,3333|Icepharma hf|Norpharma |Tramadól||8098||8098|11955| 004502|J07BC0101|Engerix-B|bóluefni|20|mcg/ml|0,5|ml|1|dæla|einnota dæla|J07BC01|01.01.1990||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|1990|3599|lyfalmen|||00|0|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-B, hreinsaðir mótefnavakar||1990||1990|3599| 004586|A10BB1201|Amaryl|töflur|4|mg|90|stk|1|þpakki||A10BB12|01.06.2005||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|4547|7097|lyfalmen|||00|90|0|180,0000|Vistor hf|Aventis Pharma |Glímepíríð||4547||4547|7097| 004589|N06AB0402|Oropram|töflur|20|mg|100|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|2556|4374|lyfalmen|V0926|4374|00|100|0|100,0000|Actavis Group hf|Actavis hf|Cítalópram||2556||2556|4374| 004611|H01AC0104|Saizen|sts|8|mg/hgl|1|hgl|1|pakki|+ leysir f.click easy|H01AC01|01.05.2002||R|A|3|0|1|0|1|EMA|0|0|0|100|SEK|43133|56014|lyfsjukr|||00|1|0|4,0000|Icepharma hf|E. Merck AB|Sómatrópín||43133||43133|56014| 004612|D06BX0105|Metronidazol Actavis|krem|10|mg/g|25|g|1|túpa||D06BX01|01.07.1987||R|A|2|0|0|0|0|AGT|0|0|1|100|DKK|1911|3491|lyfalmen|||20|25|0|25,0000|Actavis Group hf|Actavis Group hf|Metrónídazól||1911||1911|3491| 004613|J07BC0101|Engerix-B|bóluefni|20|mcg/ml|1|ml|1|dæla|einnotadæl|J07BC01|01.01.1990||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|2579|4405|lyfalmen|||00|1|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-B, hreinsaðir mótefnavakar||2579||2579|4405| 004623|J07BC0203|Vaqta|bóluefni|50|ein|1|ml|1|spr|áfyllt spr. án nálar|J07BC02|01.03.2001||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|4745|7368|lyfalmen|||51|1|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||4745||4745|7368| 004625|N06AB0402|Oropram|töflur|40|mg|28|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|1836|2062|lyfalmen|V0927|2062|00|28|0|56,0000|Actavis Group hf|Actavis hf|Cítalópram||866||866|2062| 004645|N06AB0402|Oropram|töflur|40|mg|100|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|5614|7316|lyfalmen|V0930|7316|00|100|0|200,0000|Actavis Group hf|Actavis hf|Cítalópram||4707||4707|7316| 004656|N06AB0402|Oropram|töflur|10|mg|28|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|776|1939|lyfalmen|V0921|1939|00|28|0|14,0000|Actavis Group hf|Actavis hf|Cítalópram||776||776|1939| 004667|N06AB0402|Oropram|töflur|10|mg|100|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|2703|4575|lyfalmen|V0922|4575|00|100|0|50,0000|Actavis Group hf|Actavis hf|Cítalópram||2703||2703|4575| 004678|N06AB0402|Oropram|töflur|20|mg|28|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|926|1820|lyfalmen|V0923|1820|00|28|0|28,0000|Actavis Group hf|Actavis hf|Cítalópram||689||689|1820| 004687|A02AA0403|Magnesia "medic"|filmhtfl|500|mg|100|stk|1|glas||A02AA04|01.02.2006||L|A|3|0|0|0|0|MET|0|0|0|100|DKK|||lyfalmen|||00|100|0|16,6700|Vistor hf|Medic Team|Magnesíum hýdroxíð|||||1656| 004688|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|7|spr||L04AC03|01.07.2002||R|K|2|0|1|0|1|BIA|0|0|0|100|DKK|42506|55228|lyfsjukr|||00|5|0|7,0000|Vistor hf|Biovitrum AB (publ)|Anakinra||42506||42506|55228| 004691|N06AB0402|Oropram|töflur|20|mg|56|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|1778|3309|lyfalmen|V0925|3309|00|56|0|56,0000|Actavis Group hf|Actavis hf|Cítalópram||1778||1778|3309| 004696|R05DA0901|Dexomet|mixtúra|3|mg/ml|150|ml|1|glas||R05DA09|01.06.2001||L|A|3|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|150|0|5,0000|Actavis Group hf|Actavis hf|Dextrómetorfan|||||| 004699|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|28|spr||L04AC03|01.04.2007||R|K|2|0|1|0|1|BIA|0|0|0|100|DKK|135024|171338|lyfsjukr|||00|19|0|28,0000|Vistor hf|Biovitrum AB (publ)|Anakinra||135024||135024|171338| 004733|H01AC0104|Saizen|sts|8|mg/hgl|5|hgl|1|pakki|+ leysir f.click easy|H01AC01|01.05.2002||R|A|3|0|1|0|1|EMA|0|0|0|100|SEK|215665|272542|lyfsjukr|||00|5|0|20,0000|Icepharma hf|E. Merck AB|Sómatrópín||215665||215665|272542| 004746|A10AE0405|Lantus [Clikstar]|stl|100|ein/ml|3|ml|5|rörlyk|rörlykjur fyrir Clikstar penna|A10AE04|01.06.2004||R|K|2|0|0|*|0|SDE|0|0|0|100|NOK|10620|15405|lyfalmen|||00|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||10620||10620|15405| 004834|N03AX1201|Neurontin|hylki|300|mg|100|stk|1|þpakki||N03AX12|01.03.2009||R|A|3|0|0|E|0|PER|0|0|0|100|DKK|8755|7311|lyfalmen|V0714|7311|0|100|0|16,6667|Icepharma hf|Pfizer ApS|Gabapentín||4703||4703|7311| 004845|N03AX1201|Neurontin|hylki|400|mg|100|stk|1|þpakki||N03AX12|01.03.2009||R|A|3|0|0|E|0|PER|0|0|0|100|DKK|11469|8528|lyfalmen|V0715|8528|10|100|0|22,2222|Icepharma hf|Pfizer ApS|Gabapentín||5593||5593|8528| 004855|P01AB0105|Metronidazol Actavis|töflur|250|mg|24|stk|1|þpakki||P01AB01|01.12.1972||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|646|1761|lyfalmen|||41|24|0|3,0000|Actavis Group hf|Actavis Group hf|Metrónídazól||646||646|1761| 004863|R03DX0501|Xolair|sts|150|mg|2|ml|1|hgl|+ leysir, lausn|R03DX05|01.01.2006||R|A|4|0|1|0|1|NOE|0|0|0|100|DKK|57091|73532|lyfsjukr|||00|2|0|9,3800|Vistor hf|Novartis Europharm Ltd|Omalizúmab||57091||57091|73532| 004880|J01FA1001|Zitromax|irs|500|mg/hgl|1|hgl|1|pakki||J01FA10|01.05.2003||R|A|3|0|0|0|1|PER|0|0|0|100|DKK|5387|7775|lyfsjukr|||00|1|0|1,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||5387||5387|7775| 004888|P01AB0105|Metronidazol Actavis|töflur|500|mg|8|stk|1|glas||P01AB01|01.03.1981||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|382|1400|lyfalmen|||41|8|0|2,0000|Actavis Group hf|Actavis Group hf|Metrónídazól||382||382|1400| 004921|P01AB0105|Metronidazol Actavis|töflur|500|mg|14|stk|1|glas||P01AB01|01.01.1988||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|652|1769|lyfalmen|||41|14|0|3,5000|Actavis Group hf|Actavis Group hf|Metrónídazól||652||652|1769| 004976|P01AB0105|Metronidazol Actavis|töflur|500|mg|30|stk|1|glas||P01AB01|01.01.1988||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|1235|2567|lyfalmen|||41|30|0|7,5000|Actavis Group hf|Actavis Group hf|Metrónídazól||1235||1235|2567| 005048|N07BA0107|Nicotinell Mint|munnstfl|2|mg|36|stk|1|pakki||N07BA01|01.04.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|36|0|2,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 005059|N07BA0107|Nicotinell Mint|munnstfl|2|mg|96|stk|1|pakki||N07BA01|01.04.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 005070|N07BA0107|Nicotinell Mint|munnstfl|2|mg|204|stk|1|pakki||N07BA01|01.04.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 005085|J07AJ5205|Boostrix|stl|0| |0,5|ml|1|spr|áfyllt, dreifa|J07AJ52|01.01.2007||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|1736|3252|lyfalmen|||00|0|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Kíghósti, í blöndum með öðrum toxóíðum||1736||1736|3252| 005089|J07AL0103|Pneumovax|stl|0||0,5|ml|1|hgl|lausn|J07AL01|01.11.2008||R|K|2|0|0|0|0|SPM|0|0|0|100|XEU|2306|4032|lyfalmen|||00|1|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Hreinsuð pneumococca poly­sakkaríð mótefnavakar||||2306|4032| 005108|G04CA0201|Omnic|forðahlk|0,4|mg|90|stk|1|þpakki||G04CA02|01.08.1998||R|A|4|0|0|E|0|YAM|0|0|0|100|XEU|8731|6958|lyfalmen|V0437|4760|00|90|0|90,0000|Vistor hf|Yamanouchi Europe|Tamsúlósín||4445||4445|6958| 005178|J01CF0102|Staklox|hylki|250|mg|30|stk|1|þpakki||J01CF01|01.05.2001||R|A|3|0|0|0|0|ACA|0|0|1|100|DKK|1101|2383|lyfalmen|||10|30|0|3,7500|Actavis Group hf|Actavis hf|Díkloxacillín||1101||1101|2383| 005189|J01CF0102|Staklox|hylki|500|mg|20|stk|1|þpakki||J01CF01|01.05.2001||R|A|3|0|0|0|0|ACA|0|0|1|100|DKK|1269|2613|lyfalmen|||10|20|0|5,0000|Actavis Group hf|Actavis hf|Díkloxacillín||1269||1269|2613| 005200|J01CF0102|Staklox|hylki|500|mg|30|stk|1|þpakki||J01CF01|01.05.2001||R|A|3|0|0|0|0|ACA|0|0|1|100|DKK|1735|3251|lyfalmen|||10|30|0|7,5000|Actavis Group hf|Actavis hf|Díkloxacillín||1735||1735|3251| 005241|R03AK0701|Symbicort Turbuhaler|innúðadu|164,5|mcg/sk|360|sk|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2001||R|A|2|0|0|0|0|AZD|0|0|0|100|SEK|28160|37620|lyfalmen|||00|360|0|90,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||28160||28160|37620| 005296|N05AH0401|Seroquel|filmhtfl|300|mg|100|stk|1|þpakki||N05AH04|01.12.2002||R|A|3|0|0|*|0|AZA|0|1|0|100|SEK|51007|66293|lyfalmen|||00|100|0|75,0000|Vistor hf|AstraZeneca AB|Quetíapín||51007||51007|66293| 005303|N02CC0303|Zomig Nasal|nefúði|5|mg/sk|5|mg|2|stauk||N02CC03|01.02.2003||R|A|2,5|0|0|E|0|ASZ|0|0|0|100|SEK|3365|5480|lyfalmen|||00|10|0|4,0000|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||3365||3365|5480| 005330|D08AG0201|Betadine|áburður|100|mg/ml|500|ml|1|fl|sprittl.|D08AG02|01.09.1982||L|A|3|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||00|500|0|500,0000|Icepharma hf|Norpharma a/s|Joð/pólývídón|||||| 005336|R01AA0704|Otrivin ukonserveret|nefúði|0,5|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.07.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||06|10|0|6,2500|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||| 005355|S01AA1301|Fucithalmic|augndr|10|mg/g|0,2|g|12|sk-hyl|2 mg/sk|S01AA13|01.04.1992||R|A|2|0|0|E|0|LEP|0|0|1|100|DKK|1120|2409|lyfalmen|||00|2|0|0,0000|Vistor hf|LEO Pharma A/S|Fúsidínsýra||1120||1120|2409| 005363|L02AE0301|Zoladex|vefjalyf|10,8|mg|1|stk|1|áf.spr|+ dæla|L02AE03|01.04.1996||R|A|3|0|1|*|0|AZA|0|0|0|100|SEK|70331|90544|lyfalmen|V0565|90542|00|1|0|83,7209|Vistor hf|AstraZeneca AB|Góserelín||70331||70331|90544| 005390|R03BB0101|Atrovent|innúðal|20|mcg/sk|200|skammtar|1|stauk||R03BB01|01.08.2004||R|A|2|0|0|B|0|BOI|0|0|0|100|DKK|1478|2899|lyfalmen|||24|200|0|33,3300|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíð||1478||1478|2899| 005503|N05AH0301|Zyprexa|húðuðtfl|15|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|A|2|0|0|*|0|ELD|0|1|0|100|XEU|29432|18086|lyfalmen|V0815|15238|00|28|0|42,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||12595||12595|18086| 005507|M05BA0403|Fosamax vikutafla 70 mg|töflur|70|mg|4|stk|1|þpakki||M05BA04|01.08.2001||R|A|3|0|0|0|0|MSD|0|0|0|100|XEU|5279|8099|lyfalmen|||00|4|0|28,0000|Icepharma hf|M.S.D.|Alendrónsýra||5279||5279|8099| 005526|N05AH0301|Zyprexa|húðuðtfl|20|mg|28|stk|1|þpakki||N05AH03|01.12.2003||R|A|2|0|0|*|0|ELD|0|1|0|100|XEU|37433|49257|lyfalmen|||00|28|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||37433||37433|49257| 005538|G03AA0702|Microgyn|töflur|0| |63|stk|1|þpakki||G03AA07|01.06.1977||R|A|5|0|0|0|0|BAP|0|0|0|100|SEK|1235|2567|lyfalmen|V2200|2532|23|63|0|84,0000|Icepharma hf|Bayer Schering Pharma AG|Levónorgestrel og östrógen||1235||1235|2567| 005565|M05BA0403|Fosamax vikutafla 70 mg|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.08.2001||R|A|3|0|0|0|0|MSD|0|0|0|100|XEU|13101|5516|lyfalmen|V0718|4780|00|12|0|84,0000|Icepharma hf|M.S.D.|Alendrónsýra||3391||3391|5516| 005576|R05CA1002|Tussol|mixtúra|0| |150|ml|1|glas||R05CA10|01.10.2001||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||01|150|0|0,0000|Actavis Group hf|Actavis hf|Blöndur|||||| 005588|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki|R03BB04|01.01.2003||R|A|2|0|0|0|0|BII|0|0|0|100|DKK|6223|9390|lyfalmen|||00|30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíð||6223||6223|9390| 005600|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki + Handihaler|R03BB04|01.01.2003||R|A|2|0|0|0|0|BII|0|0|0|100|DKK|6558|9848|lyfalmen|||0|30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíð||||6558|9848| 005606|J07AH0703|NeisVac-C|bóluefni|0| |0,5|ml|1|spr|áfyllt sprauta|J07AH07|01.09.2001||R|K|3,5|0|0|0|0|BAX|0|0|0|100|USD|3948|6278|lyfalmen|||00|0|0|0,0000|Icepharma hf|Baxter|Hreinsuð meningókokka C, poly­sakkaríð mótefnavakar||3948||3948|6278| 005624|A10BB0902|Diamicron Uno|töflur|30|mg|30|stk|1|þpakki||A10BB09|01.04.2002||R|A|3|0|0|*|0|SEV|0|0|0|100|DKK|1588|3050|lyfalmen|||00|30|0|15,0000|Icepharma hf|Servier|Glíklazíð||1588||1588|3050| 005641|A10BB0902|Diamicron Uno|töflur|30|mg|60|stk|1|þpakki||A10BB09|01.04.2002||R|A|3|0|0|*|0|SEV|0|0|0|100|DKK|2769|4665|lyfalmen|||00|60|0|30,0000|Icepharma hf|Servier|Glíklazíð||2769||2769|4665| 005672|A10BB0902|Diamicron Uno|töflur|30|mg|180|stk|1|þpakki||A10BB09|01.04.2002||R|A|3|0|0|*|0|SEV|0|0|0|100|DKK|7352|10934|lyfalmen|||00|180|0|90,0000|Icepharma hf|Servier|Glíklazíð||7352||7352|10934| 005674|A10BB0902|Diamicron Uno|töflur|30|mg|90|stk|1|þpakki||A10BB09|01.04.2002||R|A|3|0|0|*|0|SEV|0|0|0|100|DKK|4040|6404|lyfalmen|||00|90|0|45,0000|Icepharma hf|Servier|Glíklazíð||4040||4040|6404| 005689|B01AC0601|Hjartamagnyl|töflur|75|mg|100|stk|1|plglas||B01AC06|01.06.2007||L|A|2|0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa|||00|100|0|100,0000|Actavis Group hf|Actavis hf|Asetýlsalicýlsýra|||||| 005747|G03CA0317|Aerodiol|nefúði|150|mcg/sk|180|skammtar|1|pakki|60 skammtar x 3|G03CA03|01.01.2003||R|A|3|0|0|0|0|SEV|0|0|0|100|DKK|6116|9244|lyfalmen|||00|180|0|90,0000|Icepharma hf|Servier|Estradíól||6116||6116|9244| 005757|N06AB1001|Cipralex|töflur|5|mg|28|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|0|0|LBK|0|1|0|100|DKK|1777|3308|lyfalmen|||00|28|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||1777||1777|3308| 005782|L01BB0501|Fludara|filmhtfl|10|mg|15|stk|1|þpakki||L01BB05|01.11.2002||R|A|3|0|1|0|1|GZE|0|0|0|100|SEK|81376|104009|lyfsjukr|||00|15|0|0,0000|Vistor hf|Genzyme Europe B.V.|Flúdarabín||81376||81376|104009| 005790|N06AB1001|Cipralex|töflur|5|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|A|3|0|0|0|0|LBK|0|1|0|100|DKK|6607|8930|lyfalmen|V0940|6893|00|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||5887||5887|8930| 005812|N06AB1001|Cipralex|töflur|10|mg|28|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|0|0|LBK|0|1|0|100|DKK|3133|4833|lyfalmen|V0939|3524|00|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||2892||2892|4833| 005822|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|5|l|1|fl||QP54AA01|01.08.2001||R|A|3|0|0|0|0|MEF|0|0|0|100|XEU|17872|31177|vetorma|||16|5|0|0,0000|Vistor hf|Merial (MSD)|||17872||17872|31177| 005823|N06AB1001|Cipralex|töflur|10|mg|56|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|0|0|LBK|0|1|0|100|DKK|6382|9608|lyfalmen|||00|56|0|56,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||6382||6382|9608| 005836|L01BB0501|Fludara|filmhtfl|10|mg|20|stk|1|þpakki||L01BB05|01.11.2002||R|A|3|0|1|0|1|GZE|0|0|0|100|SEK|90728|115746|lyfsjukr|||00|20|0|0,0000|Vistor hf|Genzyme Europe B.V.|Flúdarabín||90728||90728|115746| 005845|N06AB1001|Cipralex|töflur|10|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|A|3|0|0|0|0|LBK|0|1|0|100|DKK|10507|14029|lyfalmen|V0938|7345|00|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||9614||9614|14029| 005867|N06AB1001|Cipralex|töflur|15|mg|28|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|0|0|LBK|0|1|0|100|DKK|5032|7342|lyfalmen|V0941|4024|00|28|0|42,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||4726||4726|7342| 005872|C09DA0701|MicardisPlus|töflur|52,5|mg|28|stk|1|þpakki|40 + 12,5 mg|C09DA07|01.02.2008||R|A|3|0|0|0|0|BII|0|0|0|100|DKK|3124|5151|lyfalmen|||00|28|0|28,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan og þvagræsilyf||3124||3124|5151| 005884|P01BC0201|Lariam|töflur|250|mg|8|stk|1|þpakki||P01BC02|01.01.1993||R|A|3|0|0|0|0|ROC|0|0|0|100|DKK|2966|4935|lyfalmen|||59|8|0|2,0000|Icepharma hf|Roche|Meflókvín||2966||2966|4935| 005885|N05AH0301|Zyprexa|sts|10|mg|1|hgl|1|pakki||N05AH03|01.02.2004||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|879|2080|lyfalmen|||00|1|0|1,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||879||879|2080| 005894|C09DA0701|MicardisPlus|töflur|52,5|mg|98|stk|1|þpakki|40 + 12,5 mg|C09DA07|01.02.2008||R|A|3|0|0|0|0|BII|0|0|0|100|DKK|10224|14863|lyfalmen|||00|98|0|98,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan og þvagræsilyf||10224||10224|14863| 005902|N06AB1001|Cipralex|töflur|15|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|A|3|0|0|0|0|LBK|0|1|0|100|DKK|16266|20499|lyfalmen|V0942|7345|00|100|0|150,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||14518||14518|20499| 005910|C09CA0301|Diovan|töflur|80|mg|28|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.01.2001||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|3658|5881|lyfalmen|||00|28|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||3658||3658|5881| 005922|N06AB1001|Cipralex|töflur|20|mg|28|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|0|0|LBK|0|1|0|100|DKK|6428|8618|lyfalmen|V0943|4392|00|28|0|56,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||5659||5659|8618| 005932|C09CA0301|Diovan|töflur|80|mg|98|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.01.2001||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|9388|12330|lyfalmen|V2209|3872|00|98|0|98,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||8372||8372|12330| 005933|N06AB1001|Cipralex|töflur|20|mg|56|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|0|0|LBK|0|1|0|100|DKK|12594|18085|lyfalmen|||00|56|0|112,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||12594||12594|18085| 005954|C09CA0301|Diovan|töflur|160|mg|28|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.01.2001||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|4664|7257|lyfalmen|||00|28|0|56,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||4664||4664|7257| 005976|C09CA0301|Diovan|töflur|160|mg|98|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.01.2001||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|12759|17481|lyfalmen|V2210|3915|00|98|0|196,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||12113||12113|17481| 006000|R07AA0201|Curosurf|innö.guf|80|mg/ml|1,5|ml|1|hgl||R07AA02|01.01.1995||R|K|1,5|0|1|0|1|NYG|0|0|0|100|SEK|90580|115560|lyfsjukr|||00|2|0|0,7500|Gróco ehf|Nycomed Danmark A/S|Náttúrulegir fosfólípíðar||90580||90580|115560| 006024|A10AD0501|NovoMix 30 FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.07.2002||R|K|2|0|0|*|0|NON|0|0|0|100|DKK|5748|8740|lyfalmen|||02|15|0|37,5000|Vistor hf|Novo-Nordisk|Insulín aspart||5748||5748|8740| 006079|J02AX0403|Cancidas|irþ|70|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|K|2|0|1|0|1|MSD|0|0|0|100|XEU|123190|156486|lyfsjukr|||00|1|0|1,4000|Icepharma hf|M.S.D.|Caspofungin||123190||123190|156486| 006102|A10AB0501|NovoRapid FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|einnota pennar|A10AB05|01.12.2001||R|K|2,5|0|0|*|0|NON|0|0|0|100|DKK|5576|8505|lyfalmen|||02|15|0|37,5000|Vistor hf|Novo-Nordisk|Insúlín aspart||5576||5576|8505| 006111|R07AA0201|Curosurf|innö.guf|80|mg/ml|3|ml|1|hgl||R07AA02|01.01.1995||R|K|1,5|0|1|0|1|NYG|0|0|0|100|SEK|161679|204790|lyfsjukr|||00|3|0|1,5000|Gróco ehf|Nycomed Danmark A/S|Náttúrulegir fosfólípíðar||161679||161679|204790| 006115|J02AX0403|Cancidas|irþ|50|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|K|2|0|1|0|1|MSD|0|0|0|100|XEU|79224|101309|lyfsjukr|||00|1|0|1,0000|Icepharma hf|M.S.D.|Caspofungin||79224||79224|101309| 006172|S01XA2007|Simplex|augnsm|0| |4|g|1|túpa|paraf+vasel án ullarf.|S01XA20|01.07.2003||R|A||0|0|E|0|LDR|0|0|0|100|IKR|1434|2839|lyfalmen|||00|4|1|0,0000|Parlogis hf|Parlogis - óskráð lyf|Gervitár og aðrar óvirkar sam­setningar||1434||1434|2839| 006178|A10AE0402|Lantus [Optiset]|stl|100|ein/ml|3|ml|5|pennar||A10AE04|01.11.2005|31.01.2011|R|K|2|0|0|*|0|SDE|0|0|0|100|NOK|8908|13063|lyfalmen|||00|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||8908||8908|13063| 006239|J01CF0501|Heracillin|töflur|500|mg|30|stk|1|glas||J01CF05|01.10.1995||R|A||0|0|0|0|REP|0|0|1|100|SEK|2867|4799|lyfalmen|||00|30|0|7,5000|Vistor hf|Recip AB|Flúkloxacillín||2867||2867|4799| 006346|N03AG0101|Depakine|sh-tfl|500|mg|40|stk|1|glas||N03AG01|01.04.1986||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|2661|4517|lyfalmen|||43|40|0|13,3333|Vistor hf|Sanofi-aventis Norge AS|Valpróínsýra||2661||2661|4517| 006443|QM01AC0601|Metacam|stl|20|mg/ml|50|ml|1|hgl||QM01AC06|01.05.2004||R|A|3|0|0|0|0|BOI|1|0|0|100|DKK|8765|17003|vetalmen|||00|50|0|0,0000|Vistor hf|Boehringer Ingelheim|||8765||8765|17003| 006558|B01AX0501|Arixtra|stl|2,5|mg/spr|0,5|ml|20|spr|áfyllt sprauta|B01AX05|01.03.2011||R|A|2|0|0|E|0|GGL|0|0|0|100|GBP|12746|18275|lyfalmen|||00|10|0|20,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||12746||12746|18275| 006579|D05AX5201|Daivobet|smyrsli|||60|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.04.2002||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|7255|10802|lyfalmen|||00|60|0|0,0000|Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||7255||7255|10802| 006637|D05AX5201|Daivobet|smyrsli|||120|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.04.2002||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|12301|17717|lyfalmen|V2001|17575|00|120|0|0,0000|Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||12301||12301|17717| 006681|N02BE0109|Panodil Hot|skammtar|500|mg|10|skammtar|1|pakki||N02BE01|01.05.2003||L|A|3|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||00|10|0|1,6700|Icepharma hf|GlaxoSmithKline CH A/S|Paracetamól|||||| 006785|G03AD0101|NorLevo|töflur|750|mcg|2|stk|1|þpakki||G03AD01|01.01.2005||L|A|3|0|0|0|0|LHP|0|0|0|100|IKR|||lyflausa|||23|2|0|0,0000|Gróco ehf|Laboratoire HRA Pharma|Levonorgestrel|||||| 006928|C09CA0101|Cozaar|töflur|100|mg|98|stk|1|þpakki||C09CA01|01.05.2002||R|A|3|0|0|0|0|MSD|0|0|0|100|XEU|14554|20544|lyfalmen|||00|98|0|196,0000|Icepharma hf|M.S.D.|Lósartan||14554||14554|20544| 007099|C10AA0701|Crestor|filmhtfl|10|mg|28|stk|1|þpakki||C10AA07|01.06.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|4557|7111|lyfalmen|||00|28|0|28,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||4557||4557|7111| 007104|N05AA0201|Nozinan|töflur|5|mg|100|stk|1|glas||N05AA02|01.10.1995||R|A|5|0|0|*|0|SNO|0|1|0|100|NOK|772|1933|lyfalmen|||00|100|0|1,6667|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||772||772|1933| 007123|V03AE0201|Renagel|filmhtfl|800|mg|180|stk|1|glas||V03AE02|01.01.2004||R|A|2|0|0|0|0|GZE|0|0|0|100|XEU|26926|36071|lyfalmen|||00|180|0|22,5000|Vistor hf|Genzyme Europe B.V.|Sevelamer||26926||26926|36071|31.01.2011 007126|QJ01CE9002|Mamyzin vet.|sts|10|millj ae|20|hgl|1|pakki|+ leysir|QJ01CE90|01.12.2002||R|A|3|0|0|0|0|BID|0|0|0|100|DKK|24060|46371|vetalmen|||27|20|0|0,0000|Vistor hf|Boehringer Ingelheim Danmark|||24060||24060|46371| 007133|C10AA0701|Crestor|filmhtfl|10|mg|98|stk|1|þpakki||C10AA07|01.07.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|14496|20472|lyfalmen|V2208|20471|00|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||14496||14496|20472| 007138|N05AA0201|Nozinan|töflur|25|mg|100|stk|1|glas||N05AA02|01.10.1995||R|A|5|0|0|*|0|SNO|0|1|0|100|NOK|2012|3630|lyfalmen|||00|100|0|8,3333|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||2012||2012|3630| 007144|C10AA0701|Crestor|filmhtfl|20|mg|28|stk|1|þpakki||C10AA07|01.06.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|6827|10216|lyfalmen|||00|28|0|56,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||6827||6827|10216| 007155|C10AA0701|Crestor|filmhtfl|20|mg|98|stk|1|þpakki||C10AA07|01.06.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|21723|29541|lyfalmen|V0341|29541|00|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||21723||21723|29541| 007161|N05AA0201|Nozinan|töflur|100|mg|100|stk|1|glas||N05AA02|01.10.1995||R|A|5|0|0|*|0|SNO|0|1|0|100|NOK|6510|9783|lyfalmen|||00|100|0|33,3333|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||6510||6510|9783| 007166|C10AA0701|Crestor|filmhtfl|40|mg|28|stk|1|þpakki||C10AA07|01.07.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|9063|13275|lyfalmen|||00|28|0|112,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||9063||9063|13275| 007186|C10AA0701|Crestor|filmhtfl|40|mg|98|stk|1|þpakki||C10AA07|01.07.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|28021|37445|lyfalmen|||00|98|0|392,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||28021||28021|37445| 007223|B01AD1201|Ceprotin|sts|500|ae/hgl|1|hgl|1|pakki|+ 5 ml leysir|B01AD12|01.02.2002||R|K|2|0|1|0|1|BAX|0|0|0|100|SEK|180756|228731|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Baxter|Prótein C||180756||180756|228731| 007268|B01AD1201|Ceprotin|sts|1000|ae/hgl|1|hgl|1|pakki|+ 10 ml leysir|B01AD12|01.02.2002||R|K|2|0|1|0|1|BAX|0|0|0|100|SEK|319297|402600|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Baxter|Prótein C||319297||319297|402600| 007278|C08CA0302|Lomir Retard|forðahlk|2,5|mg|30|stk|1|þpakki||C08CA03|01.04.1992||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|2096|3744|lyfalmen|||10|30|0|15,0000|Vistor hf|Novartis Healthcare A/S-|Ísradipín||2096||2096|3744| 007292|S01EE0301|Lumigan|augndr|0,3|mg/ml|3|ml|1|glös||S01EE03|01.04.2005||R|A|2|0|0|*|0|ALL|0|0|0|100|SEK|3191|5242|lyfalmen|||00|3|0|30,0000|Vistor hf|Allergan|Bimatóprost||3191||3191|5242| 007297|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.04.2002||L|A|2,5|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 007375|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.04.2002||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 007378|J01XX0801|Zyvoxid|irl|2|mg/ml|300|ml|10|pokar||J01XX08|01.12.2001||R|A|3|0|1|0|1|PER|0|0|0|100|DKK|129717|164677|lyfsjukr|||00|3000|0|5,0000|Icepharma hf|Pfizer ApS|Linezolíd||129717||129717|164677| 007385|A02BA0205|Zantac|töflur|150|mg|20|stk|1|þpakki||A02BA02|01.09.1983||L|A|5|0|0|0|0|GSK|0|0|0|100|IKR|||lyflausa|||00|20|0|10,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ranitidín|||||| 007424|J01XX0801|Zyvoxid|töflur|600|mg|30|stk|1|þpakki||J01XX08|01.12.2001||R|A|3|0|1|0|1|PER|0|0|0|100|DKK|314565|396662|lyfsjukr|||00|30|0|15,0000|Icepharma hf|Pfizer ApS|Linezolíd||314565||314565|396662| 007434|S01ED5106|Xalcom|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml |S01ED51|01.12.2001||R|K|2|0|0|*|0|PER|0|0|0|100|DKK|3211|5270|lyfalmen|V0988|5268|06|2|0|0,0000|Icepharma hf|Pfizer ApS|Tímólól í blöndum||3211||3211|5270| 007448|B05XC04|Cernevit|sts|0| |5|ml|10|hgl||B05XC|01.05.2002||R|A|3|0|0|0|1|CPS|0|0|0|100|SEK|8595|12405|lyfsjukr|||02|50|0|0,0000|Icepharma hf|Clintec parenteral SA|||8595||8595|12405| 007449|V03AB3401|Fomepizole OPi|irþ|5|mg/ml|20|ml|5|hgl||V03AB34|01.09.2003||R|A|2|0|0|0|1|OPO|0|0|0|100|XEU|120126|152641|lyfsjukr|||00|100|0|0,0000|Swedish Orphan International AB|OPi Orphan Pharma international (S)|||120126||120126|152641| 007462|N01AB0801|Sevorane|innönd.l|||250|ml|1|plastf||N01AB08|01.03.2002||R|A|3|0|0|0|1|ABS|0|0|0|100|DKK|23243|31052|lyfsjukr|||00|250|0|0,0000|Vistor hf|Abbott Scandinavia AB|Sevóflúran||23243||23243|31052| 007494|QP52AA0101|Droncit vet.|hlaup|9|%|6,67|g|1|dæla|til inntöku|QP52AA01|01.04.2002||L|A|2|0|0|0|0|BAN|0|0|0|100|DKK|1957|3414|vetorma|||16|7|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||||1957|3414| 007505|G04BD0702|Detrusitol Retard|forðahlk|1,4|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|A|2|0|0|E|0|PER|0|0|0|100|DKK|6209|9371|lyfalmen|||00|30|0|10,5000|Icepharma hf|Pfizer ApS|Tólteródín||6209||6209|9371| 007516|R03BA0701|Asmanex Twisthaler|innúðadu|200|mcg|60|skammtar|1|pakki||R03BA07|01.04.2003|31.01.2011|R|A|2|0|0|0|0|SPL|0|0|0|100|DKK|4751|7376|lyfalmen|||00|60|0|30,0000|Vistor hf|Schering-Plough Europe|Mometasón||4751||4751|7376| 007534|C09CA0601|Atacand|töflur|16|mg|28|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|3637|5852|lyfalmen|V2215|5852|00|28|0|56,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||3637||3637|5852| 007538|R03BA0701|Asmanex Twisthaler|innúðadu|400|mcg|30|skammtar|1|pakki||R03BA07|01.04.2003||R|A|2|0|0|0|0|SPL|0|0|0|100|DKK|4929|7620|lyfalmen|||00|30|0|30,0000|Vistor hf|Schering-Plough Europe|Mometasón||4929||4929|7620| 007540|N02BE0111|Perfalgan|irl|10|mg/ml|100|ml|12|hgl||N02BE01|01.08.2003||R|A|2|0|0|0|1|BRS|0|0|0|100|DKK|9046|13056|lyfsjukr|||00|1200|0|4,0000|Vistor hf|Bristol-Myers Squibb|Paracetamól||9046||9046|13056| 007541|J07BL0101|Stamaril|bóluefni|0| |0,5|ml|10|lykjur|+leysir|J07BL01|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|21396|29131|lyfalmen|||02|5|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Gulusótt, veikluð veira||21396||21396|29131| 007549|R03BA0701|Asmanex Twisthaler|innúðadu|400|mcg|60|skammtar|1|pakki||R03BA07|01.03.2003||R|A|2|0|0|0|0|SPL|0|0|0|100|DKK|9606|14018|lyfalmen|||00|60|0|60,0000|Vistor hf|Schering-Plough Europe|Mometasón||9606||9606|14018| 007559|C09CA0601|Atacand|töflur|16|mg|98|stk|1|þpakki||C09CA06|01.02.1998|31.01.2011|R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|10743|15573|lyfalmen|||00|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||10743||10743|15573| 007575|B05BB0213|Kalium-Natrium-Glucose "Fresenius Kabi"|irl|0| |1000|ml|9|plpok|Exel umbúðir|B05BB02|01.04.2005||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|2515|3630|lyfsjukr|||02|9000|0|0,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með kol­vetnum||2515||2515|3630| 007609|C09CA0601|Atacand|töflur|4|mg|28|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|2771|4668|lyfalmen|V2211|4668|00|28|0|14,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||2771||2771|4668| 007760|G04BD0702|Detrusitol Retard|forðahlk|2,8|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|A|2|0|0|E|0|PER|0|0|0|100|DKK|7141|10646|lyfalmen|||00|30|0|21,0000|Icepharma hf|Pfizer ApS|Tólteródín||7141||7141|10646| 007769|G04BD0702|Detrusitol Retard|forðahlk|2,8|mg|100|stk|1|plglas||G04BD07|01.01.2001||R|A|2|0|0|E|0|PER|0|0|0|100|DKK|21643|29441|lyfalmen|||00|100|0|70,0000|Icepharma hf|Pfizer ApS|Tólteródín||21643||21643|29441| 007778|N05AX0802|Rison|töflur|0,5|mg|60|stk|1|glas||N05AX08|01.10.2001||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|1728|3241|lyfalmen|V1075|3241|00|60|0|6,0000|Actavis Group hf|Actavis hf|Risperídón||1728||1728|3241| 007852|G02BB0101|NuvaRing|sk-hring|||3|stk|1|pakki|með forðaverkun|G02BB01|01.11.2002||R|A|3,3|0|0|0|0|ORG|0|0|0|100|DKK|3978|6319|lyfalmen|||00|3|0|84,0000|Vistor hf|N.V. Organon|Skeiðarinnleg með progestógeni og östrógeni||3978||3978|6319| 007878|V07AB0001|Sterilt vatten Baxter Viaflo|leysir|0| |50|ml|50|pokar|leysir f.stungulyf|V07AB00|01.08.2005||L|A|1,5|0|0|0|0|BAM|0|0|0|100|IKR|||lyflausa|||00|2500|0|0,0000|Icepharma hf|Baxter Medical AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||| 007889|V07AB0002|Sterilt Vand "Baxter" Viaflo|leysir|0| |100|ml|50|pokar|leysir f.stungulyf|V07AB00|01.02.2006||L|A|1,5|0|0|0|0|BAX|0|0|0|100|IKR|||lyflausa|||00|5000|0|0,0000|Icepharma hf|Baxter|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||| 007920|S01EE0401|Travatan|augndr|40|mcg/ml|2,5|ml|1|glas||S01EE04|01.02.2004||R|A|3|0|0|*|0|ALC|0|0|0|100|USD|2222|3917|lyfalmen|||00|2|0|0,0000|K.Pétursson hf|Alcon|||2222||2222|3917| 007921|S01GX0901|Opatanol|augndr|1|mg/ml|5|ml|1|glas||S01GX09|01.05.2004||R|A|3|0|0|0|0|ALC|0|0|0|100|USD|1255|2594|lyfalmen|||00|5|0|0,0000|K.Pétursson hf|Alcon|Ólópatadín||1255||1255|2594| 007978|B01AD1001|Xigris|irs|20|mg|1|hgl|1|pakki|lausn|B01AD10|01.11.2002||R|K|3|0|1|0|1|ELD|0|0|0|100|XEU|158525|200831|lyfsjukr|||00|1|0|0,5000|Icepharma hf|Eli Lilly Nederland B.V.|Drotrecogin alfa (virkjað)||158525||158525|200831| 007986|D07AA0208|Mildison Lipid|krem|10|mg/g|15|g|1|túpa|feitt|D07AA02|01.01.1990||L|A|3|0|0|0|0|ASP|0|0|1|100|IKR|||lyflausa|||20|15|0|15,0000|Vistor hf|Astellas Pharma A/S|Hýdrókortisón|||||| 007995|R07AX0101|INOmax|innö.gas|400|ppm|10|l|1|gashyl||R07AX01|01.01.2004||R|A|2|0|1|0|1|AGA|0|0|0|100|XEU|22141|29669|lyfsjukr|||00|10|0|0,0000|Ísaga ehf|AGA AB|Nituroxíð||22141||22141|29669| 007997|H02AB0104|Betapred|lausnart|0,5|mg|30|stk|1|glas||H02AB01|01.09.1998||R|A||0|0|E|0|LVE|0|0|1|100|IKR|729|1874|lyfalmen|||00|30|1|10,0000|Lyfjaver ehf|Lyfjaver - óskráð lyf|Betametasón||729||729|1874| 008010|B01AD1001|Xigris|irs|5|mg|1|hgl|1|pakki|lausn|B01AD10|01.11.2002||R|K|3|0|1|0|1|ELD|0|0|0|100|XEU|39944|52012|lyfsjukr|||00|1|0|0,1300|Icepharma hf|Eli Lilly Nederland B.V.|Drotrecogin alfa (virkjað)||39944||39944|52012| 008023|A10BA0201|Glucophage|töflur|1000|mg|30|stk|1|þpakki||A10BA02|01.01.2002||R|A|3|0|0|*|0|MCK|0|0|0|100|SEK|605|1705|lyfalmen|||00|30|0|15,0000|Icepharma hf|Merck Santé s.a.s.|Metformín||605||605|1705| 008028|J05AH0201|Tamiflu|mixtduft|12|mg/ml|1|stk|1|fl|750 mg í flösku|J05AH02|01.11.2002||R|A|2|0|0|0|0|RRL|0|0|0|100|DKK|3523|5697|lyfalmen|||00|1|0|5,0000|Icepharma hf|Roche Registration Limited|Oseltamivír||3523||3523|5697| 008058|B05BA1011|Oliclinomel N4 550E|irl|0| |1500|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|29248|38589|lyfsjukr|||00|6000|0|0,0000|Icepharma hf|Baxter Medical AB|Blöndur||29248||29248|38589| 008069|B05BA1011|Oliclinomel N4 550E|irl|0| |2000|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|36562|47768|lyfsjukr|||00|8000|0|0,0000|Icepharma hf|Baxter Medical AB|Blöndur||36562||36562|47768| 008097|N02CC0402|Maxalt Smelt|munnltfl|5|mg|6|stk|1|þpakki||N02CC04|01.03.2003||R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|5473|8364|lyfalmen|||00|6|0|3,0000|Icepharma hf|M.S.D.|Rizatriptan||5473||5473|8364| 008101|L03AB1001|PegIntron|sts|50|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.12.2002||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|91946|117275|lyfsjukr|||00|4|0|26,6700|Vistor hf|Schering-Plough|Peginterferón alfa 2b||91946||91946|117275| 008108|L03AB1001|PegIntron|sts|100|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.12.2002||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|184849|233868|lyfsjukr|||00|4|0|53,3300|Vistor hf|Schering-Plough|Peginterferón alfa 2b||184849||184849|233868| 008131|L03AB1001|PegIntron|sts|80|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.08.2003||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|134045|170109|lyfsjukr|||00|4|0|42,6700|Vistor hf|Schering-Plough|Peginterferón alfa 2b||134045||134045|170109| 008134|L03AB1001|PegIntron|sts|120|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.08.2003||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|152696|193516|lyfsjukr|||00|4|0|64,0000|Vistor hf|Schering-Plough|Peginterferón alfa 2b||152696||152696|193516| 008145|L03AB1001|PegIntron|sts|150|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.12.2002||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|230336|290954|lyfsjukr|||00|4|0|80,0000|Vistor hf|Schering-Plough|Peginterferón alfa 2b||230336||230336|290954| 008194|D07AA0208|Mildison Lipid|krem|10|mg/g|30|g|1|túpa|feitt|D07AA02|01.01.1990||L|A|3|0|0|0|0|ASP|0|0|1|100|IKR|||lyflausa|||20|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Hýdrókortisón|||||| 008196|D07AA0208|Mildison Lipid|krem|10|mg/g|100|g|1|túpa|feitt|D07AA02|01.01.1990||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|2022|3643|lyfalmen|||20|100|0|100,0000|Vistor hf|Astellas Pharma A/S|Hýdrókortisón||2022||2022|3643| 008219|D07AC0101|Betnovat|húðfl|1|mg/ml|20|ml|1|plglas||D07AC01|01.12.1980||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|281|1262|lyfalmen|||20|20|0|20,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||281||281|1262| 008223|B05BA1013|Oliclinomel N6 900E|irl|0| |1000|ml|6|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|38518|50223|lyfsjukr|||00|6000|0|0,0000|Icepharma hf|Baxter Medical AB|Blöndur||38518||38518|50223| 008234|B05BA1013|Oliclinomel N6 900E|irl|0| |1500|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|30076|39628|lyfsjukr|||00|6000|0|0,0000|Icepharma hf|Baxter Medical AB|Blöndur||30076||30076|39628| 008243|D07AC0101|Betnovat|húðlausn|1|mg/g|30|ml|1|plglas|í hársvörð|D07AC01|01.01.1985||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|462|1509|lyfalmen|||33|30|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||462||462|1509| 008245|B05BA1013|Oliclinomel N6 900E|irl|0| |2000|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|37692|49186|lyfsjukr|||00|8000|0|0,0000|Icepharma hf|Baxter Medical AB|Blöndur||37692||37692|49186| 008300|C09CA0601|Atacand|töflur|4|mg|98|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|8541|12561|lyfalmen|V2212|12561|00|98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||8541||8541|12561| 008301|N02AX0209|Tramol-L|forðatfl|100|mg|20|stk|1|þpakki||N02AX02|01.04.2002||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|1171|2479|lyfalmen|V0733|2479|00|20|0|6,6700|Actavis Group hf|Actavis hf|Tramadól||1171||1171|2479| 008318|C09CA0601|Atacand|töflur|8|mg|28|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|2976|4948|lyfalmen|V2213|4948|00|28|0|28,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||2976||2976|4948| 008326|D07AC0101|Betnovat|húðlausn|1|mg/g|100|ml|1|plglas|í hársvörð|D07AC01|01.07.1988||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|1216|2541|lyfalmen|||33|100|0|100,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||1216||1216|2541| 008334|C09CA0601|Atacand|töflur|8|mg|98|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|9472|13834|lyfalmen|V2214|13834|00|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||9472||9472|13834| 008338|N02AX0209|Tramol-L|forðatfl|100|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|3667|5894|lyfalmen|V0734|5894|00|100|0|33,3300|Actavis Group hf|Actavis hf|Tramadól||3667||3667|5894| 008360|N02AX0209|Tramol-L|forðatfl|150|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|5628|8549|lyfalmen|V0736|8542|00|100|0|50,0000|Actavis Group hf|Actavis hf|Tramadól||5608||5608|8549| 008368|N02AX0209|Tramol-L|forðatfl|200|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|8521|12534|lyfalmen|V0738|12534|00|100|0|66,6700|Actavis Group hf|Actavis hf|Tramadól||8521||8521|12534| 008370|V04CJ0101|Thyrogen|sts|0,9|mg/hgl|2|hgl|1|pakki|lausn|V04CJ01|01.01.2006||R|K|3|0|1|0|1|GEZ|0|0|0|100|XEU|205890|260274|lyfsjukr|||02|2|0|0,0000|Vistor hf|Genzyme BV|Thýrótrópín||205890||205890|260274| 008396|H03AA0104|Euthyrox|töflur|50|mcg|100|stk|1|þpakki||H03AA01|01.05.2002||R|A|3|0|0|B|0|MKA|0|0|0|100|SEK|820|1999|lyfalmen|V0431|1999|00|100|0|33,3300|Icepharma hf|Merck KgaA|Levótýroxínnatríum||820||820|1999| 008435|H03AA0104|Euthyrox|töflur|100|mcg|100|stk|1|þpakki||H03AA01|01.05.2002||R|A|3|0|0|B|0|MKA|0|0|0|100|SEK|713|1853|lyfalmen|V0430|1853|00|100|0|66,6700|Icepharma hf|Merck KgaA|Levótýroxínnatríum||713||713|1853| 008484|QP52AC1303|Zerofen, vet.|mixtúra|10|%|1000|ml|1|plbrús||QP52AC13|01.11.2001||R|A|3|0|0|0|0|CHP|0|0|0|100|USD|4837|8438|vetorma|||00|1000|0|0,0000|Icepharma hf|Chanelle Pharmaceuticals |||4837||4837|8438| 008497|QN05CM9203|Chanazine, vet.|stl|10|%|50|ml|1|hgl||QN05CM92|01.11.2001||R|A|5|0|0|0|0|CHP|1|0|0|100|XEU|10855|21016|vetalmen|||00|50|0|0,0000|Icepharma hf|Chanelle Pharmaceuticals |||10855||10855|21016| 008498|R06AX2201|Kestine|töflur|10|mg|10|stk|1|þpakki||R06AX22|01.04.1998||L|A|3|0|0|0|0|ALF|0|0|1|100|IKR|||lyflausa|||00|10|0|10,0000|Gróco ehf|Almirall-Prodesfarma S.A.|Ebastín|||||| 008523|R06AX2201|Kestine|töflur|10|mg|100|stk|1|þpakki||R06AX22|01.04.1998||R|A|3|0|0|E|0|ALF|0|0|1|100|DKK|4062|6434|lyfalmen|||00|100|0|100,0000|Gróco ehf|Almirall-Prodesfarma S.A.|Ebastín||4062||4062|6434| 008534|R06AX2201|Kestine|töflur|10|mg|30|stk|1|þpakki||R06AX22|01.04.1998||L|A|3|0|0|0|0|ALF|0|0|1|100|IKR|||lyflausa|||00|30|0|30,0000|Gróco ehf|Almirall-Prodesfarma S.A.|Ebastín|||||| 008545|G03FB0506|NovoFem|filmhtfl|0| |84|stk|1|skífup|1+1mg|G03FB05|01.06.2002||R|A|3|0|0|E|0|NON|0|0|0|100|DKK|2873|4807|lyfalmen|||23|84|0|84,0000|Vistor hf|Novo-Nordisk|Noretísterón og östrógen||2873||2873|4807| 008745|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2,5|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 008767|L03AB1101|Pegasys|stl|135|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|130653|165852|lyfsjukr|||00|2|0|0,0000|Icepharma hf|Roche Registration Limited|Peginterferón alfa 2a||130653||130653|165852| 008768|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 008782|L03AB1101|Pegasys|stl|180|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|122215|155262|lyfsjukr|||00|2|0|27,6900|Icepharma hf|Roche Registration Limited|Peginterferón alfa 2a||122215||122215|155262| 008831|D11AH0201|Elidel|krem|1|%|15|g|1|túpa||D11AH02|01.11.2002||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|3059|5062|lyfalmen|||00|15|0|15,0000|Vistor hf|Novartis Healthcare A/S-|Pímekrólímus||3059||3059|5062| 008888|C09DA0601|Atacand Plus|töflur|28,5|mg|28|stk|1|þpakki|16 + 12,5 mg|C09DA06|01.01.2001||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|3637|5852|lyfalmen|V2222|5852|00|28|0|56,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og þvagræsilyf||3637||3637|5852| 008904|D10AF0101|Dalacin|lausn|10|mg/ml|60|ml|1|glas|Áburður, lausn|D10AF01|01.01.1994||R|A|2,5|0|0|0|0|PER|0|0|0|100|DKK|2275|3989|lyfalmen|||20|60|0|60,0000|Icepharma hf|Pfizer ApS|Klindamýcín||2275||2275|3989| 008927|G04BE0801|Cialis|filmhtfl|20|mg|4|stk|1|þpakki||G04BE08|01.02.2003||R|A|2|0|0|0|0|LIL|0|0|0|100|XEU|6016|9107|lyfalmen|V1350|9107|00|4|0|8,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||6016|9107| 008950|G04BE0801|Cialis|filmhtfl|20|mg|8|stk|1|þpakki||G04BE08|01.02.2003||R|A|2|0|0|0|0|LIL|0|0|0|100|XEU|11852|17090|lyfalmen|V1351|16940|00|8|0|16,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||11852|17090| 009065|D11AH0201|Elidel|krem|1|%|30|g|1|túpa||D11AH02|01.11.2002||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|5162|7939|lyfalmen|||00|30|0|30,0000|Vistor hf|Novartis Healthcare A/S-|Pímekrólímus||5162||5162|7939| 009079|D11AH0201|Elidel|krem|1|%|100|g|1|túpa||D11AH02|01.11.2002||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|16022|22387|lyfalmen|||00|100|0|100,0000|Vistor hf|Novartis Healthcare A/S-|Pímekrólímus||16022||16022|22387| 009214|M01AH0401|Dynastat|sts|40|mg/hgl|10|hgl|1|pakki||M01AH04|01.06.2002||R|A|3|0|0|0|0|IPI|0|0|1|100|DKK|13864|19678|lyfalmen|||03|10|0|10,0000|Icepharma hf|Pfizer Limited|Parekoxíb||13864||13864|19678| 009278|J02AC0301|Vfend|töflur|50|mg|30|stk|1|þpakki||J02AC03|01.11.2002||R|A|2|0|0|0|1|PER|0|0|0|100|DKK|60580|77910|lyfsjukr|||00|30|0|0,0000|Icepharma hf|Pfizer ApS|Voricónazól||60580||60580|77910| 009282|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|20|lykjur|fyrir stl|V07AB|01.07.1995||L|A|3|0|0|0|0|FRP|0|0|0|100|DKK|||lyfalmen|||02|400|0|0,0000|Icepharma hf|Fresenius Kabi|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||1705| 009285|D11AH0101|Protopic|smyrsli|0,03|%|30|g|1|túpa||D11AH01|01.07.2003||R|A|3|0|0|E|0|ASP|0|0|1|100|XEU|5524|8434|lyfalmen|||00|30|0|0,0000|Vistor hf|Astellas Pharma A/S|Takrólímus||5524||5524|8434| 009340|V07AB13|Sterilt vatten/vann/vand Fresenius Kabi|leysir|0| |20|ml|20|plastl|fyrir stungulyf|V07AB|01.10.1994||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||00|400|0|0,0000|Icepharma hf|Fresenius Kabi|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||| 009409|G03CA0316|Vivelle Dot|forðapl|37,5|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1353|2728|lyfalmen|||23|8|0|21,0000|Vistor hf|Novartis Healthcare A/S-|Estradíól||1353||1353|2728| 009443|G03CA0316|Vivelle Dot|forðapl|50|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1455|2868|lyfalmen|||23|8|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Estradíól||1455||1455|2868| 009465|G03CA0316|Vivelle Dot|forðapl|75|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1714|3222|lyfalmen|||23|8|0|42,0000|Vistor hf|Novartis Healthcare A/S-|Estradíól||1714||1714|3222| 009489|G03CA0316|Vivelle Dot|forðapl|100|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1972|3575|lyfalmen|||23|8|0|56,0000|Vistor hf|Novartis Healthcare A/S-|Estradíól||1972||1972|3575| 009525|B05DB0005|Balance|kvið.sk|1,5|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|K||0|0|0|1|FMC|0|0|0|100|XEU|7476|10790|lyfsjukr|||00|8000|0|8,0000|Icepharma hf|Fresenius Medical Care Deutschland GmbH|||7476||7476|10790| 009560|B05DB0005|Balance|kvið.sk|4,25|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|K||0|0|0|1|FMC|0|0|0|100|XEU|7476|10790|lyfsjukr|||00|8000|0|8,0000|Icepharma hf|Fresenius Medical Care Deutschland GmbH|||7476||7476|10790| 009591|B05DB0005|Balance|kvið.sk|2,3|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|K||0|0|0|1|FMC|0|0|0|100|XEU|7476|10790|lyfsjukr|||00|8000|0|8,0000|Icepharma hf|Fresenius Medical Care Deutschland GmbH|||7476||7476|10790| 009609|J02AC0301|Vfend|töflur|200|mg|30|stk|1|þpakki||J02AC03|01.11.2002||R|A|2|0|0|0|1|PER|0|0|0|100|DKK|235279|297158|lyfsjukr|||00|30|0|15,0000|Icepharma hf|Pfizer ApS|Voricónazól||235279||235279|297158| 009649|D11AH0101|Protopic|smyrsli|0,1|%|30|g|1|túpa||D11AH01|01.07.2003||R|A|3|0|0|E|0|ASP|0|0|1|100|XEU|5665|8627|lyfalmen|||00|30|0|0,0000|Vistor hf|Astellas Pharma A/S|Takrólímus||5665||5665|8627| 009679|J05AF0701|Viread|filmhtfl|245|mg|30|stk|1|glas||J05AF07|01.04.2003||R|A|3|0|1|0|1|GIS|0|0|0|100|DKK|63280|81299|lyfsjukr|||00|30|0|30,0000|Gilead Sience Sweden AB|Gilead Science International ltd.|Tenófóvír dísóproxíl||63280||63280|81299| 009688|C09DA0601|Atacand Plus|töflur|28,5|mg|98|stk|1|þpakki|16 + 12,5 mg|C09DA06|01.01.2001|31.01.2011|R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|10741|15570|lyfalmen|||00|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og þvagræsilyf||10741||10741|15570| 009900|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk|sjálfs|N01BB03|01.03.1984||R|A|3|0|0|0|0|DPL|0|0|1|100|XEU|6544|9829|lyfalmen|||02|180|0|0,0000|Vistor hf|Dentsply Limited|Mepívakaín||6544||6544|9829| 009905|N01BB5402|Citanest Dental Octapressin|stl|||1,8|ml|100|rörlyk||N01BB54|01.12.1983||R|A|3|0|0|0|0|DPL|0|0|1|100|XEU|7451|11070|lyfalmen|||00|180|0|0,0000|Vistor hf|Dentsply Limited|Prílókaín í blöndum||7451||7451|11070| 009911|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml|N01BB52|01.12.1983||R|S|2|0|0|0|0|DPL|0|0|1|100|XEU|7493|11127|lyfalmen|||17|180|0|0,0000|Vistor hf|Dentsply Limited|||7493||7493|11127| 009913|N06AX1102|Remeron Smelt|munndr.t|15|mg|6|stk|1|þpakki||N06AX11|01.05.2003|31.01.2011|R|A|3|0|0|0|0|ORG|0|1|0|100|DKK|526|1597|lyfalmen|||00|6|0|3,0000|Vistor hf|N.V. Organon|Mirtazapín||526||526|1597| 009942|N01BB5402|Citanest Dental Octapressin|stl|||1,8|ml|100|rörlyk|sjálfsog|N01BB54|01.12.1983||R|A|3|0|0|0|0|DPL|0|0|1|100|XEU|8482|12480|lyfalmen|||00|180|0|0,0000|Vistor hf|Dentsply Limited|Prílókaín í blöndum||8482||8482|12480| 009945|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml-sjálfsog|N01BB52|01.12.1983||R|S|2|0|0|0|0|DPL|0|0|1|100|XEU|7642|11331|lyfalmen|||17|180|0|0,0000|Vistor hf|Dentsply Limited|||7642||7642|11331| 009947|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk||N01BB03|01.12.1983||R|A|3|0|0|0|0|DPL|0|0|1|100|XEU|5879|8919|lyfalmen|||02|180|0|0,0000|Vistor hf|Dentsply Limited|Mepívakaín||5879||5879|8919| 010002|N06AX1102|Remeron Smelt|munndr.t|15|mg|30|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|0|0|ORG|0|1|0|100|DKK|2317|4047|lyfalmen|V1151|2385|00|30|0|15,0000|Vistor hf|N.V. Organon|Mirtazapín||2317||2317|4047| 010035|N06AX1102|Remeron Smelt|munndr.t|30|mg|30|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|0|0|ORG|0|1|0|100|DKK|4112|6502|lyfalmen|V1152|4188|00|30|0|30,0000|Vistor hf|N.V. Organon|Mirtazapín||4112||4112|6502| 010057|N06AX1102|Remeron Smelt|munndr.t|45|mg|30|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|0|0|ORG|0|1|0|100|DKK|8781|12889|lyfalmen|||00|30|0|45,0000|Vistor hf|N.V. Organon|Mirtazapín||8781||8781|12889| 010070|L03AA1301|Neulasta|stl|6|mg/spr|0,6|ml|1|spr|áfyllt sprauta, lausn|L03AA13|01.12.2003||R|K|2,5|0|1|0|1|AEU|0|0|0|100|DKK|163046|206505|lyfsjukr|||00|1|0|20,0000|Vistor hf|Amgen Europe B.V.|Pegfilgrastím||163046||163046|206505| 010182|J05AB1401|Valcyte|filmhtfl|450|mg|60|stk|1|plglas||J05AB14|01.11.2002||R|A|3|0|0|0|1|RRL|0|0|0|100|DKK|225182|284486|lyfsjukr|||00|60|0|30,0000|Icepharma hf|Roche Registration Limited|Valgancíklóvír||225182||225182|284486| 010187|H01AX0101|Somavert|sts|10|mg|30|hgl|1|pakki|+ leysir|H01AX01|01.02.2004||R|A|2|0|1|0|1|PER|0|0|0|100|DKK|417085|525324|lyfsjukr|||00|30|0|30,0000|Icepharma hf|Pfizer ApS|Pegvisómant||417085||417085|525324| 010203|B03XA0201|Aranesp|stl|500|mcg/spr|1|ml|1|spr|áfyllt sprauta|B03XA02|01.04.2005||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|149098|189000|lyfsjukr|||00|1|0|111,1100|Vistor hf|Amgen|Darbepóetín alfa||149098||149098|189000| 010234|J01DH0301|Invanz|irs|1|g/hgl|1|hgl|1|pakki||J01DH03|01.08.2002||R|A|2|0|1|0|1|MSD|0|0|0|100|XEU|7219|10419|lyfsjukr|||00|1|0|1,0000|Icepharma hf|M.S.D.|Ertapenem||7219||7219|10419| 010240|N06AX1102|Remeron Smelt|munndr.t|30|mg|96|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|0|0|ORG|0|1|0|100|DKK|12763|18297|lyfalmen|V1153|6598|00|96|0|96,0000|Vistor hf|N.V. Organon|Mirtazapín||12763||12763|18297| 010254|N06AX1102|Remeron Smelt|munndr.t|45|mg|96|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|0|0|ORG|0|1|0|100|DKK|17995|24863|lyfalmen|||00|96|0|144,0000|Vistor hf|N.V. Organon|Mirtazapín||17995||17995|24863| 010290|N06DX0101|Ebixa|dropar|10|mg/g|50|g|1|fl||N06DX01|01.08.2010||R|A||0|0|E|0|LBK|0|0|0|100|DKK|14225|20131|lyfalmen|||00|50|0|25,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||||14225|20131| 010334|N06DX0101|Ebixa|töflur|10|mg|100|stk|1|þpakki||N06DX01|01.10.2002||R|A|4|0|0|E|0|LBK|0|0|0|100|DKK|23059|31218|lyfalmen|||00|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||23059||23059|31218| 010339|C09DA0701|MicardisPlus|töflur|92,5|mg|28|stk|1|þpakki|80 + 12,5 mg|C09DA07|01.02.2008||R|A|3|0|0|0|0|BII|0|0|0|100|DKK|3862|6160|lyfalmen|||00|28|0|56,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan og þvagræsilyf||3862||3862|6160| 010348|J07BB0203|Vaxigrip|bóluefni|0| |0,5|ml|10|spr|einnotaspr|J07BB02|01.10.1995||R|K|1|0|0|0|0|SPM|0|0|0|100|XEU|8897|13048|lyfalmen|||51|5|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Inflúensa, hreinsaðir mótefnavakar||8897||8897|13048| 010361|C09DA0701|MicardisPlus|töflur|92,5|mg|98|stk|1|þpakki|80 + 12,5 mg|C09DA07|01.02.2008||R|A|3|0|0|0|0|BII|0|0|0|100|DKK|12475|17935|lyfalmen|||00|98|0|196,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan og þvagræsilyf||12475||12475|17935| 010437|QI09AB1301|Stellamune One|stl|||100|ml|10|glös|Fleyti|QI09AB13|01.09.2008||R|K|3|0|0|0|0|PZR|0|0|0|100|DKK|73614|128416|vetorma|||00|1000|0|0,0000|Icepharma hf|Pfizer A/S (Í)|Óvirkar bakteríur í bóluefnum||73614||73614|128416| 010446|A07EC0204|Asacol|sh-tfl|800|mg|60|stk|1|þpakki||A07EC02|01.01.2003||R|A|2|0|0|B|0|TIL|0|0|0|100|SEK|7630|11315|lyfalmen|||00|60|0|32,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||7630||7630|11315| 010464|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|50|ml|50|pokar|lausn|B05BB01|01.11.2002||R|A|1,5|0|0|0|1|BAM|0|0|0|100|SEK|14689|20317|lyfsjukr|||00|2500|0|0,0000|Icepharma hf|Baxter Medical AB|Elektrólýtar||14689||14689|20317| 010534|B05BA0108|Vaminolac|irl|0| |100|ml|10|fl||B05BA01|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|8308|11991|lyfsjukr|||00|1000|0|1,0000|Icepharma hf|Fresenius Kabi|Amínósýrur||8308||8308|11991| 010573|S01AX1901|Oftaquix|augndr|5|mg/ml|5|ml|1|glas||S01AX19|01.08.2002||R|A|3|0|0|0|0|SAO|0|0|1|100|XEU|1183|2496|lyfalmen|||00|5|0|0,0000|Icepharma hf|Santen Oy|Levófloxacín||1183||1183|2496| 010591|M05BA0702|Optinate Septimum|filmhtfl|35|mg|4|stk|1|þpakki||M05BA07|01.12.2002||R|A|3|0|0|0|0|SNO|0|0|0|100|NOK|5418|8289|lyfalmen|||00|4|0|28,0000|Vistor hf|Sanofi-aventis Norge AS|Rísedrónsýru||5418||5418|8289| 010669|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|250|ml|30|pokar|lausn|B05BA03|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|7782|11231|lyfsjukr|||00|7500|0|7,5000|Icepharma hf|Baxter Medical AB|Kolvetni||7782||7782|11231| 010672|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|100|ml|50|pokar|lausn|B05BA03|01.11.2002||R|A|2,5|0|0|0|1|BAM|0|0|0|100|SEK|14271|19793|lyfsjukr|||00|5000|0|5,0000|Icepharma hf|Baxter Medical AB|Kolvetni||14271||14271|19793| 010683|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|500|ml|20|pokar|lausn|B05BA03|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|5431|7838|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter Medical AB|Kolvetni||5431||5431|7838| 010691|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|1000|ml|10|pokar|lausn|B05BA03|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|3112|4491|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter Medical AB|Kolvetni||3112||3112|4491| 010706|S01EE0301|Lumigan|augndr|0,3|mg/ml|3|ml|3|glös||S01EE03|01.04.2005||R|A|2|0|0|*|0|ALL|0|0|0|100|SEK|8875|13018|lyfalmen|||00|9|0|90,0000|Vistor hf|Allergan|Bimatóprost||8875||8875|13018| 010707|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|100|ml|50|pokar|lausn|B05BB01|01.11.2002||R|A|2,5|0|0|0|1|BAM|0|0|0|100|SEK|14271|19793|lyfsjukr|||00|5000|0|5,0000|Icepharma hf|Baxter Medical AB|Elektrólýtar||14271||14271|19793| 010729|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|250|ml|30|pokar|lausn|B05BB01|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|7834|11306|lyfsjukr|||00|7500|0|7,5000|Icepharma hf|Baxter Medical AB|Elektrólýtar||7834||7834|11306| 010740|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|500|ml|20|pokar|lausn|B05BB01|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|5222|7537|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter Medical AB|Elektrólýtar||5222||5222|7537| 010746|M05BA0702|Optinate Septimum|filmhtfl|35|mg|12|stk|1|þpakki||M05BA07|01.12.2002||R|A|3|0|0|0|0|SNO|0|0|0|100|NOK|14049|5595|lyfalmen|V0719|4311|00|12|0|84,0000|Vistor hf|Sanofi-aventis Norge AS|Rísedrónsýru||3449||3449|5595| 010760|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|1000|ml|10|pokar|lausn|B05BB01|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|2899|4184|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter Medical AB|Elektrólýtar||2899||2899|4184| 010804|C02KX0101|Tracleer|filmhtfl|62,5|mg|56|stk|1|þpakki||C02KX01|01.11.2003||R|A|4|0|1|0|1|ACR|0|0|0|100|DKK|415756|523656|lyfsjukr|||00|56|0|14,0000|Swedish Orphan International AB|Actelion Registration Ltd. (S)|Bósentan||415756||415756|523656| 010826|C02KX0101|Tracleer|filmhtfl|125|mg|56|stk|1|þpakki||C02KX01|01.11.2003||R|A|4|0|1|0|1|ACR|0|0|0|100|DKK|389239|490377|lyfsjukr|||00|56|0|28,0000|Swedish Orphan International AB|Actelion Registration Ltd. (S)|Bósentan||389239||389239|490377| 010837|H01AX0101|Somavert|sts|15|mg|30|hgl|1|pakki|+ leysir|H01AX01|01.02.2004||R|A|2|0|1|0|1|PER|0|0|0|100|DKK|623355|784193|lyfsjukr|||00|30|0|45,0000|Icepharma hf|Pfizer ApS|Pegvisómant||623355||623355|784193| 010848|H01AX0101|Somavert|sts|20|mg|30|hgl|1|pakki|+ leysir|H01AX01|01.02.2004||R|A|2|0|1|0|1|PER|0|0|0|100|DKK|829619|1043054|lyfsjukr|||00|30|0|60,0000|Icepharma hf|Pfizer ApS|Pegvisómant||829619||829619|1043054| 010890|A02BC0107|Lomex-T|sh-tfl|20|mg|28|stk|1|glas||A02BC01|01.06.2002||R|A|2|0|0|0|0|ACA|0|0|0|100|IKR|1358|2710|lyfalmen|||10|28|0|28,0000|Actavis Group hf|Actavis hf|Ómeprazól||1340||1340|2710| 010900|A01AB0301|Corsodyl|munnh.l|2|mg/ml|300|ml|1|fl||A01AB03|01.07.1986||L|A|3|0|0|0|0|SKI|0|0|1|100|IKR|||lyflausa|||00|300|0|20,0000|Icepharma hf|SmithKline Beecham Ltd (I)|Klórhexidín|||||| 010912|A02BC0107|Lomex-T|sh-tfl|20|mg|100|stk|1|glas||A02BC01|01.06.2002||R|A|2|0|0|E|0|ACA|0|0|0|100|IKR|4936|7200|lyfalmen|V2171|7200|10|100|0|100,0000|Actavis Group hf|Actavis hf|Ómeprazól||4622||4622|7200| 010923|A02BC0107|Lomex-T|sh-tfl|20|mg|56|stk|1|glas||A02BC01|01.06.2002||R|A|2|0|0|E|0|ACA|0|0|0|100|IKR|3182|4323|lyfalmen|V2170|4323|10|56|0|56,0000|Actavis Group hf|Actavis hf|Ómeprazól||2519||2519|4323| 010924|L01DC0103|Bleomycin Baxter|sts|15000|ae|10|hgl|1|pakki||L01DC01|01.04.1998||R|K|3,5|0|1|0|1|BAM|0|0|0|100|SEK|69478|89077|lyfsjukr|||03|10|0|0,0000|Icepharma hf|Baxter Medical AB|Bleómýcín||69478||69478|89077| 010935|J01CF0201|Ekvacillin|sts/irs|1|g|10|hgl|1|pakki||J01CF02|01.10.2003||R|A|3|0|0|0|1|REP|0|0|0|100|SEK|3258|4702|lyfsjukr|||03|10|0|5,0000|Vistor hf|Recip AB|Kloxacillín||3258||3258|4702| 010938|A02BC0304|Lanzo Melt|munndr.t|15|mg|28|stk|1|þpakki||A02BC03|01.01.2004||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|2953|4917|lyfalmen|||00|28|0|14,0000|Icepharma hf|Pfizer ApS|Lansóprazól||2953||2953|4917| 010951|N05AX1201|Abilify|töflur|10|mg|28|stk|1|þpakki||N05AX12|01.01.2005||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|20136|27550|lyfalmen|||00|28|0|18,6670|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||20136||20136|27550| 010953|N05AX1201|Abilify|töflur|15|mg|28|stk|1|þpakki||N05AX12|01.01.2005||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|19902|27256|lyfalmen|V1703|27256|00|28|0|28,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||19902||19902|27256| 010959|A01AB0301|Corsodyl|munnh.hl|10|mg/g|50|g|1|túpa||A01AB03|01.09.1982||L|A|3|0|0|0|0|SKI|0|0|1|100|IKR|||lyflausa|||00|50|0|16,6667|Icepharma hf|SmithKline Beecham Ltd (I)|Klórhexidín|||||| 011008|N05AX1201|Abilify|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.01.2005||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|34285|45307|lyfalmen|V1702|45306|00|56|0|37,3330|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||34285||34285|45307| 011019|N05AX1201|Abilify|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.01.2005||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|34052|45014|lyfalmen|||00|56|0|56,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||34052||34052|45014| 011163|A07EA0601|Entocort|forðahlk|3|mg|100|stk|1|glas||A07EA06|01.10.1996||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|20868|28468|lyfalmen|||00|100|0|33,3300|Vistor hf|AstraZeneca A/S DK|Búdesóníð||20868||20868|28468| 011207|M01AH0501|Arcoxia|filmhtfl|60|mg|28|stk|1|þpakki||M01AH05|01.10.2002||R|A|3|0|0|E|0|MSD|0|0|1|100|XEU|4496|7028|lyfalmen|||00|28|0|28,0000|Icepharma hf|M.S.D.|Etoríkoxíb||4496||4496|7028| 011271|M01AH0501|Arcoxia|filmhtfl|90|mg|28|stk|1|þpakki||M01AH05|01.10.2002||R|A|3|0|0|E|0|MSD|0|0|1|100|XEU|4672|7268|lyfalmen|||00|28|0|42,0000|Icepharma hf|M.S.D.|Etoríkoxíb||4672||4672|7268| 011314|N06AB1001|Cipralex|töflur|20|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|A|3|0|0|0|0|LBK|0|1|0|100|DKK|20235|26108|lyfalmen|V2172|7345|00|100|0|200,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||18987||18987|26108| 011326|M01AH0501|Arcoxia|filmhtfl|120|mg|7|stk|1|þpakki||M01AH05|01.01.2010||R|A||0|0|E|0|MSD|0|0|1|100|XEU|1192|2508|lyfalmen|||00|7|0|14,0000|Icepharma hf|M.S.D.|Etoríkoxíb||1192||1192|2508| 011335|C09CA0102|Lopress|töflur|12,5|mg|28|stk|1|glas||C09CA01|01.11.2002||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|992|2234|lyfalmen|V0195|2234|00|28|0|7,0000|Actavis Group hf|Actavis hf|Lósartan||992||992|2234| 011353|N05AF0502|Cisordinol Depot|stl|500|mg/ml|1|ml|5|lykjur||N05AF05|01.10.1988||R|A|4|0|0|*|0|LBK|0|1|0|100|DKK|12256|17660|lyfalmen|||02|5|0|166,6667|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||12256||12256|17660| 011369|C09CA0102|Lopress|töflur|50|mg|28|stk|1|glas||C09CA01|01.11.2002||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|1427|2829|lyfalmen|||00|28|0|28,0000|Actavis Group hf|Actavis hf|Lósartan||1427||1427|2829| 011380|C09CA0102|Lopress|töflur|50|mg|98|stk|1|glas||C09CA01|01.11.2002||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|4069|3872|lyfalmen|V0197|3872|00|98|0|98,0000|Actavis Group hf|Actavis hf|Lósartan||2189||2189|3872| 011409|R03AK0703|Symbicort forte Turbuhaler|innönddu|329|mcg/sk|60|sk|1|pakki|320+9 mcg/sk|R03AK07|01.05.2003||R|A|2|0|0|0|0|AZD|0|0|0|100|SEK|9361|13683|lyfalmen|||00|60|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||9361||9361|13683| 011489|N06BA0402|Concerta|forðatfl|18|mg|30|stk|1|glas||N06BA04|01.01.2003||R|A|3|1|0|0|0|JAS|0|0|0|100|SEK|7738|11462|lyfalmen|||00|30|0|18,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||7738||7738|11462| 011532|B05BC0101|Mannitol Baxter Viaflo|irl|150|mg/ml|500|ml|20|plpok|lausn|B05BC01|01.11.2007||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|9090|13119|lyfsjukr|||02|10000|0|0,0000|Icepharma hf|Baxter Medical AB|Mannitól||9090||9090|13119| 011540|N01AX1401|S-Ketamin "Pfizer"|stl|5|mg/ml|5|ml|10|lykjur|lausn|N01AX14|01.08.2005||R|A|3|1|0|0|1|PER|0|0|0|100|DKK|2406|3472|lyfsjukr|||00|50|0|0,0000|Icepharma hf|Pfizer ApS|Esketamín||2406||2406|3472| 011555|N06BA0402|Concerta|forðatfl|36|mg|30|stk|1|glas||N06BA04|01.01.2003||R|A|3|1|0|0|0|JAS|0|0|0|100|SEK|10109|14706|lyfalmen|||00|30|0|36,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||10109||10109|14706| 011561|QN05CM9203|Chanazine, vet.|stl|2|%|25|ml|1|hgl||QN05CM92|01.09.2002||R|A|5|0|0|0|0|CHP|1|0|0|100|USD|1559|3101|vetalmen|||00|25|0|0,0000|Icepharma hf|Chanelle Pharmaceuticals |||1559||1559|3101| 011609|N01AX1401|S-Ketamin "Pfizer"|stl|25|mg/ml|2|ml|10|lykjur|lausn|N01AX14|01.08.2005||R|A|3|1|0|0|1|PER|0|0|0|100|DKK|4812|6945|lyfsjukr|||00|20|0|0,0000|Icepharma hf|Pfizer ApS|Esketamín||4812||4812|6945| 011620|G03CA0311|Estrogel|hlaup|0,6|mg/g|64|sk|1|fl|með skammtadælu|G03CA03|01.03.2000||R|A|2|0|0|E|0|OLF|0|0|0|100|SEK|1599|3065|lyfalmen|||00|64|0|28,8000|Gróco ehf|Oy Leiras Finland Ab|Estradíól||1599||1599|3065| 011690|J05AB0402|Copegus|töflur|200|mg|168|stk|1|plglas||J05AB04|01.03.2003||R|A|3|0|1|0|1|RRL|0|0|0|100|DKK|97883|124726|lyfsjukr|||00|168|0|33,6000|Icepharma hf|Roche Registration Limited|Ribavirin||97883||97883|124726| 011810|D11AH0201|Elidel|krem|1|%|60|g|1|túpa||D11AH02|01.11.2002||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|10269|14925|lyfalmen|||00|60|0|60,0000|Vistor hf|Novartis Healthcare A/S-|Pímekrólímus||10269||10269|14925| 011863|N06AB0602|Sertral|töflur|100|mg|28|stk|1|glas||N06AB06|01.10.2005||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|1773|1947|lyfalmen|V0935|1947|00|28|0|56,0000|Actavis Group hf|Actavis hf|Sertralín||782||782|1947| 011880|N06AB0602|Sertral|töflur|100|mg|98|stk|1|glas||N06AB06|01.10.2005||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|5098|6575|lyfalmen|V0937|6575|00|98|0|196,0000|Actavis Group hf|Actavis hf|Sertralín||4165||4165|6575| 011953|N01BB0103|Marcain spinal|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|4777|6894|lyfsjukr|||02|20|0|0,0000|Vistor hf|AstraZeneca A/S DK|Búpívakaín||4777||4777|6894| 011969|N01BB0105|Marcain spinal tung|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|4339|6262|lyfsjukr|||02|20|0|0,0000|Vistor hf|AstraZeneca A/S DK|Búpívakaín||4339||4339|6262| 011985|N06DX0101|Ebixa|filmhtfl|10|mg|28|stk|1|þpakki||N06DX01|01.06.2009||R|A|4|0|0|E|0|LBK|0|0|0|100|DKK|7966|11774|lyfalmen|||00|28|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||||7966|11774| 012030|J05AG0301|Stocrin|töflur|600|mg|30|stk|1|glas||J05AG03|01.01.2003||R|A|2|0|1|0|1|MSD|0|0|0|100|XEU|40545|52766|lyfsjukr|||00|30|0|30,0000|Icepharma hf|M.S.D.|Efavirenz||40545||40545|52766| 012209|G04CB0201|Avodart|hylki|0,5|mg|90|stk|1|pakki|mjúk hylki|G04CB02|01.05.2003||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|11234|16245|lyfalmen|||00|90|0|90,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Dútasteríð||11234||11234|16245| 012260|R01AC0301|Lastin|nefúði|1|mg/ml|20|ml|1|glas||R01AC03|01.06.1998||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|1511|2944|lyfalmen|||00|20|0|35,7143|Vistor hf|Meda AB|Azelastínum||1511||1511|2944| 012273|G04BE0801|Cialis|filmhtfl|10|mg|4|stk|1|þpakki||G04BE08|01.02.2003||R|A|2|0|0|0|0|LIL|0|0|0|100|XEU|5996|9079|lyfalmen|||00|4|0|4,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||5996||5996|9079| 012278|N07BA0106|Nicotinell|forðapl|7|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|7|0|3,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 012309|QP52AA5104|Zantel|töflur|550|mg|20|stk|1|þpakki|50+500 mg|QP52AA51|01.12.2003||R|A|3|0|0|0|0|ICE|0|0|0|100|USD|5473|9547|vetorma|||00|20|0|0,0000|Icepharma hf|Icepharma hf|||5473||5473|9547| 012310|A10BB1201|Amaryl|töflur|1|mg|30|stk|1|þpakki||A10BB12|01.09.1997||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|903|2113|lyfalmen|||00|30|0|15,0000|Vistor hf|Aventis Pharma |Glímepíríð||903||903|2113| 012326|N06BA0402|Concerta|forðatfl|54|mg|30|stk|1|glas||N06BA04|01.08.2005||R|A|3|1|0|0|0|JAS|0|0|0|100|SEK|11980|17265|lyfalmen|||00|30|0|54,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||11980||11980|17265| 012461|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 012504|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 012508|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 012577|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 012640|QP52AA5104|Zantel|töflur|550|mg|100|stk|1|þpakki|50+500 mg|QP52AA51|01.12.2003||R|A|3|0|0|0|0|ICE|0|0|0|100|USD|25720|44867|vetorma|||00|100|0|0,0000|Icepharma hf|Icepharma hf|||25720||25720|44867| 012716|N07BA0106|Nicotinell|forðapl|14|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|7|0|7,0000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 012738|M05BC0101|InductOs|ígr.sett|12|mg|1|stk|1|pakki||M05BC01|01.09.2003||R|A|3|0|1|0|1|WTE|0|0|0|100|DKK|445905|561493|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Wyeth Europe|Díbótermín alfa||445905||445905|561493| 012799|N07BA0106|Nicotinell|forðapl|21|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|7|0|10,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 012880|J01CR0202|Augmentin|mixtduft|62,5|mg/ml|80|ml|1|glas|50+12.5 mg|J01CR02|01.10.1989||R|A|2|0|0|0|0|GSK|0|0|1|100|IKR|718|1859|lyfalmen|||08|80|0|4,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||718||718|1859| 012921|G03AA1301|Evra|forðapl|0| |9|stk|1|pakki|6 mg+600 mcg|G03AA13|01.11.2003||R|A|2|0|0|0|0|JCI|0|0|0|100|SEK|4796|7438|lyfalmen|||00|9|0|0,0000|Vistor hf|Janssen-Cilag International N.V.|Norelgestromín og östrógen||4796||4796|7438| 012953|G03BA0306|Testogel|hlaup|50|mg|30|sk-pokar|1|pakki||G03BA03|01.12.2003||R|A|3|0|0|E|0|LBI|0|0|0|100|SEK|7415|11021|lyfalmen|||00|30|0|30,0000|Icepharma hf|Laboratoires Besins International|Testósterón||7415||7415|11021| 013068|N06BA0403|Ritalin Uno|hylki|20|mg|30|stk|1|glas||N06BA04|01.02.2004||R|A|3|1|0|0|0|NOH|0|0|0|100|DKK|6151|9292|lyfalmen|||00|30|0|20,0000|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||6151||6151|9292| 013070|QM01AE9101|Rimadyl vet.|tuggutfl|50|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|6745|13124|vetalmen|||00|100|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||6745||6745|13124| 013079|N06BA0403|Ritalin Uno|hylki|40|mg|30|stk|1|glas||N06BA04|01.02.2004||R|A|3|1|0|0|0|NOH|0|0|0|100|DKK|9287|13581|lyfalmen|||00|30|0|40,0000|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||9287||9287|13581| 013082|QM01AE9101|Rimadyl vet.|tuggutfl|50|mg|20|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|1749|3479|vetalmen|||00|20|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||1749||1749|3479| 013097|A02BC0301|Lanzo|munndr.t|15|mg|14|stk|1|þpakki||A02BC03|01.02.2007||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|1128|2420|lyfalmen|||00|14|0|7,0000|Icepharma hf|Pfizer ApS|Lansóprazól||1128||1128|2420| 013100|R07AX0101|INOmax|innö.gas|400|ppm|2|l|1|gashyl||R07AX01|01.01.2004||R|A|2|0|1|0|1|AGA|0|0|0|100|XEU|22141|29669|lyfsjukr|||00|2|0|0,0000|Ísaga ehf|AGA AB|Nituroxíð||22141||22141|29669| 013172|J06BB0101|Rhophylac|stl|1500|ae|2|ml|1|spr||J06BB01|01.02.2004||R|K|3|0|0|0|1|ZLB|0|0|0|100|SEK|10623|15214|lyfsjukr|||17|2|0|0,0000|Icepharma hf|ZLB GmbH|And-D(rh) immúnóglóbúlín||10623||10623|15214| 013259|B02BD0901|BeneFIX|sts|||250|ae|1|hgl|+leysir|B02BD09|01.02.2004||R|K|3|0|0|0|1|WTE|0|0|0|100|DKK|29477|38876|lyfsjukr|||00|250|0|0,5600|Icepharma hf|Wyeth Europe|Storkuþáttur IX||29477||29477|38876| 013270|B02BD0901|BeneFIX|sts|||500|ae|1|hgl|+leysir|B02BD09|01.02.2004||R|K|3|0|0|0|1|WTE|0|0|0|100|DKK|58957|75874|lyfsjukr|||00|500|0|1,1100|Icepharma hf|Wyeth Europe|Storkuþáttur IX||58957||58957|75874| 013302|C02CA0405|Cardosin Retard|forðatfl|4|mg|100|stk|1|þpakki||C02CA04|01.09.2009||R|A||0|0|E|0|ANO|0|0|0|100|XEU|3365|4586|lyfalmen|V2120|4586|00|100|0|100,0000|Actavis Group PTC hf|Actavis Nordic A/S|Doxazósín||2711||2711|4586| 013308|QM01AE9101|Rimadyl vet.|tuggutfl|20|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|4430|8679|vetalmen|||00|100|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||4430||4430|8679| 013317|QM01AE9101|Rimadyl vet.|tuggutfl|100|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|10648|20618|vetalmen|||00|100|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||10648||10648|20618| 013328|QM01AE9101|Rimadyl vet.|tuggutfl|20|mg|20|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|1117|2222|vetalmen|||00|20|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||1117||1117|2222| 013341|B02BD0206|Advate|sts|1500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|K|2|0|0|0|1|BAL|0|0|0|100|SEK|217918|275370|lyfsjukr|||00|1|0|3,0000|Lyfjaver ehf|Baxter Medical AB (L)|Storkuþáttur VIII||217918||217918|275370| 013347|L01XE0201|Iressa|töflur|250|mg|30|stk|1|þpakki||L01XE02|01.03.2010||R|A||0|1|0|1|AZD|0|0|0|100|SEK|482686|607653|lyfsjukr|||00|30|0||Vistor hf|AstraZeneca A/S DK|||482686||482686|607653| 013362|B02BD0206|Advate|sts|250|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|K|2|0|0|0|1|BER|0|0|0|100|SEK|36319|47463|lyfsjukr|||00|1|0|0,5000|Lyfjaver ehf|Baxter AG (L)|Storkuþáttur VIII||36319||36319|47463| 013365|B02BD0206|Advate|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|K|2|0|0|0|1|BER|0|0|0|100|SEK|125945|159943|lyfsjukr|||00|1|0|2,0000|Lyfjaver ehf|Baxter AG (L)|Storkuþáttur VIII||125945||125945|159943| 013373|B02BD0206|Advate|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|K|2|0|0|0|1|BER|0|0|0|100|SEK|62974|80915|lyfsjukr|||00|1|0|2,0000|Lyfjaver ehf|Baxter AG (L)|Storkuþáttur VIII||62974||62974|80915| 013386|C10AX0901|Ezetrol|töflur|10|mg|28|stk|1|þpakki||C10AX09|01.01.2010||R|A||0|0|0|0|MSD|0|0|0|100|XEU|5405|8271|lyfalmen|||00|28|0||Icepharma hf|M.S.D.|Ezetimíb||5405||5405|8271| 013485|C10AX0901|Ezetrol|töflur|10|mg|98|stk|1|þpakki||C10AX09|01.05.2003||R|A|2|0|0|0|0|MSD|0|0|0|100|XEU|18766|25830|lyfalmen|||00|98|0|98,0000|Icepharma hf|M.S.D.|Ezetimíb||18766||18766|25830| 013544|L04AB0401|Humira|stl|40|mg/spr|0,8|ml|2|spr||L04AB04|01.12.2003||R|K|1,5|0|1|0|1|ABB|0|0|0|100|DKK|169109|209072|lyfsjukr|||00|2|0|27,5900|Vistor hf|Abbott|Adalimumab||165091||165091|209072| 013551|N02AA0503|Oxynorm|stl|10|mg/ml|1|ml|5|lykjur||N02AA05|01.08.2009||R|A||1|0|0|0|NOP|0|0|0|100|DKK|1215|2539|lyfalmen|||00|5|0|1,6700|Icepharma hf|Norpharma|Oxýcódon||||1215|2539| 013593|A01AA3001|Xerodent|munnstfl|||90|stk|1|plglas|28,6 mg /0,25 mg|A01AA30|01.01.2008||L|A|2|0|0|0|0|AGT|0|0|1|100|IKR|||lyfalmen|||00|90|0|0,0000|Actavis Group hf|Actavis Group hf|Blöndur|||||1408| 013628|N02AA0503|Oxynorm|stl|10|mg/ml|2|ml|5|lykjur||N02AA05|01.08.2009||R|A||1|0|0|0|NOP|0|0|0|100|DKK|2335|4071|lyfalmen|||00|5|0|3,3300|Icepharma hf|Norpharma|Oxýcódon||||2335|4071| 013672|N03AG0101|Depakine|mixtúra|200|mg/ml|40|ml|1|glas||N03AG01|01.12.1978||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|1393|2783|lyfalmen|||00|40|0|5,3333|Vistor hf|Sanofi-aventis Norge AS|Valpróínsýra||1393||1393|2783| 013707|N01BB0203|Xylocain|hlaup|20|mg/ml|30|g|1|túpa||N01BB02|01.10.2003||R|A|2|0|0|0|0|AZD|0|0|1|100|SEK|408|1435|lyfalmen|||00|30|0|0,0000|Vistor hf|AstraZeneca A/S DK|Lídókaín||408||408|1435| 013718|M05BA0801|Zometa|irþ|4|mg/hgl|5|ml|1|hgl|lausn|M05BA08|01.05.2004||R|A|3|0|1|0|1|NOE|0|0|0|100|DKK|39013|50844|lyfsjukr|||00|5|0|1,0000|Vistor hf|Novartis Europharm Ltd|Zoledronsýra||39013||39013|50844| 013756|C09DA0307|Diovan Comp 160/25 mg|filmhtfl|185|mg|28|stk|1|þpakki||C09DA03|01.04.2005||R|A|2|0|0|0|0|NOH|0|0|0|100|DKK|4683|7283|lyfalmen|||00|28|0|56,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og þvagræsilyf||4683||4683|7283| 013767|C09DA0307|Diovan Comp 160/25 mg|filmhtfl|185|mg|98|stk|1|þpakki||C09DA03|01.04.2005||R|A|2|0|0|0|0|NOH|0|0|0|100|DKK|14146|20032|lyfalmen|||00|98|0|196,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og þvagræsilyf||14146||14146|20032| 013802|H02AB0103|Diprospan|stl|7|mg/ml|1|ml|1|lykja||H02AB01|01.08.2009||R|A||0|0|B|0|SPL|0|0|1|100|DKK|963|2195|lyfalmen|||00|1|0|4,6700|Vistor hf|Schering-Plough Europe|Betametasón||||963|2195| 013861|J01CR0202|Augmentin|töflur|625|mg|20|stk|1|þpakki|500+125 mg|J01CR02|01.01.2003||R|A|3|0|0|0|0|GSK|0|0|1|100|IKR|1215|2539|lyfalmen|V0465|2539|00|20|0|10,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||1215||1215|2539| 013901|A10AC0108|Insulatard InnoLet|stl|100|ae/ml|3|ml|5|spr|áfylltar spr.|A10AC01|01.02.2002||R|K|2,5|0|0|*|0|NON|0|0|0|100|DKK|6935|10364|lyfalmen|||00|15|0|37,5000|Vistor hf|Novo-Nordisk|Insúlín (manna)||6935||6935|10364| 013909|A10AB0107|Actrapid NovoLet|stl|100|ae/ml|3|ml|5|rörlyk|einnotapen|A10AB01|01.08.2003||R|K|2,5|0|0|*|0|NON|0|0|0|100|DKK|5387|8246|lyfalmen|||51|15|0|37,5000|Vistor hf|Novo-Nordisk|Insúlín (manna)||5387||5387|8246| 013950|A10AB0101|Actrapid|stl|100|ae/ml|10|ml|1|hgl||A10AB01|01.03.2004||R|K|2,5|0|0|*|0|NON|0|0|0|100|DKK|2639|4487|lyfalmen|||51|10|0|25,0000|Vistor hf|Novo-Nordisk|Insúlín (manna)||2639||2639|4487| 013957|A10AC0109|Insulatard FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AC01|01.02.2004||R|K|2,5|0|0|*|0|NON|0|0|0|100|DKK|4622|7200|lyfalmen|||00|15|0|37,5000|Vistor hf|Novo-Nordisk|Insúlín (manna)||4622||4622|7200| 013982|L01XE0101|Glivec|filmhtfl|400|mg|30|stk|1|þpakki||L01XE01|01.05.2004||R|A|2|0|1|0|1|NOE|0|0|0|100|DKK|359703|453310|lyfsjukr|||00|30|0|0,0000|Vistor hf|Novartis Europharm Ltd|Imatiníb||359703||359703|453310| 014010|A10AC0103|Insulatard|stl|100|ae/ml|10|ml|1|hgl||A10AC01|01.04.1986||R|K|2,5|0|0|*|0|NON|0|0|0|100|DKK|2616|4456|lyfalmen|||71|10|0|25,0000|Vistor hf|Novo-Nordisk|Insúlín (manna)||2616||2616|4456| 014031|A02BC0501|Nexium|sts|40|mg|5|ml|10|hgl|lausn|A02BC05|01.04.2004||R|A|2|0|0|0|1|AZD|0|0|0|100|SEK|15356|21154|lyfsjukr|||00|50|0|13,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||15356||15356|21154| 014081|N03AX1401|Keppra|mixtúra|100|mg/ml|300|ml|1|glas||N03AX14|01.12.2006||R|A|3|0|0|0|0|UCB|0|0|0|100|DKK|23392|31636|lyfalmen|||00|300|0|20,0000|Vistor hf|U.C.B|Levetíracetam||23392||23392|31636| 014094|H05AA0202|Forsteo|stl|250|mcg/ml|3|ml|1|penni|20 mcg/80 mcl|H05AA02|01.11.2003||R|K|2|0|0|0|0|ELD|0|0|0|100|XEU|57125|73971|lyfalmen|||AC|3|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Teriparatíð||57125||57125|73971| 014138|B05BA1020|StructoKabiven elektrolyfri|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|35844|46867|lyfsjukr|||00|5908|0|0,0000|Icepharma hf|Fresenius Kabi|Blöndur||35844||35844|46867| 014185|R03AK0703|Symbicort forte Turbuhaler|innönddu|329|mcg/sk|180|sk|1|pakki|320+9 mcg/sk|R03AK07|01.08.2009||R|A||0|0|0|0|AZD|0|0|0|100|SEK|28081|37521|lyfalmen|||00|180|0|90,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||||28081|37521| 014261|D10AX0302|Finacea|hlaup|15|%|30|g|1|túpa||D10AX03|01.04.2005||R|A|3|0|0|0|0|IGB|0|0|0|100|SEK|1533|2974|lyfalmen|||00|30|0|30,0000|Icepharma hf|Intendis GmbH Berlin|Azelainsýra||1533||1533|2974| 014290|S01GX0201|Livostin|augndr|0,5|mg/ml|4|ml|1|glas||S01GX02|01.10.1991||L|A|2|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||29|4|0|0,0000|Vistor hf|McNeil Sweden AB|Levókabastín|||||| 014352|B05BA1015|StructoKabiven|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|19731|26645|lyfsjukr|||00|3944|0|0,0000|Icepharma hf|Fresenius Kabi|Blöndur||19731||19731|26645| 014361|B05BA1015|StructoKabiven|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|25830|34299|lyfsjukr|||00|5908|0|0,0000|Icepharma hf|Fresenius Kabi|Blöndur||25830||25830|34299| 014415|P01AB0106|Flagyl|mixtúra|40|mg/ml|100|ml|1|flaska||P01AB01|01.08.2009||R|A||0|0|0|0|PCO|0|0|1|100|IKR|2314|4043|lyfalmen|||00|100|1||Distica|Distica - óskráð lyf|Metrónídazól||||2314|4043| 014435|QM01AE03|Dolovet vet.|duft|2,4|g|15|g|3|pokar||QM01AE03|01.06.2009||R|A|3|0|0|0|0|VET|0|0|0|100|XEU|2288|4551|vetalmen|||00|45|0|0,0000|Dýraheilsa ehf|Vetcare Ltd.|||||2288|4551| 014453|G02BA0302|Mirena|leginnle|20|mcg/sólh|1|stk|1|pakki||G02BA03|01.04.1994||R|A|3|0|0|0|0|SCH|0|0|0|100|SEK|18446|25429|lyfalmen|||23|1|0|1825,0000|Icepharma hf|Schering Oy|Plast lyfjalykkja (IUD) með prógestógen||18446||18446|25429| 014510|J05AF0801|Hepsera|töflur|10|mg|30|stk|1|glas||J05AF08|01.03.2009||R|A|2|0|1|0|1|GIS|0|0|0|100|DKK|82515|105439|lyfsjukr|||0|30|0|30,0000|Gilead Sience Sweden AB|Gilead Science International ltd.|Adefovír||||82515|105439| 014541|QA02BX1202|Orbesealer vet.|spenalyf|2,6|g/dælu|24|dælur|1|pakki||QA02BX12|01.04.2005||R|A|5|0|0|0|0|PAL|0|0|0|100|XEU|5687|11092|vetalmen|||16|24|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||5687||5687|11092| 014583|J05AX0701|Fuzeon|sts|90|mg/ml|60|hgl|1|pakki|+ leysir|J05AX07|01.12.2003||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|240444|303640|lyfsjukr|||00|60|0|0,0000|Icepharma hf|Roche Registration Limited|Enfúvirtíð||240444||240444|303640| 014679|N02AA0501|Oxycontin|forðatfl|5|mg|28|stk|1|þpakki||N02AA05|01.12.2005||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|2404|4166|lyfalmen|||10|28|0|1,8600|Icepharma hf|Norpharma |Oxýcódon||2404||2404|4166| 014696|C03EA0111|Miloride|töflur|55|mg|100|stk|1|glas|5+50 mg|C03EA01|01.02.2010||R|A||0|0|E|0|MYL|0|0|0|100|SEK|1369|2750|lyfalmen|||00|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Hýdróklórtíazíð og kalíumsparandi lyf||||1369|2750| 014702|C09CA0601|Atacand|töflur|32|mg|28|stk|1|þpakki||C09CA06|01.06.2005|31.01.2011|R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|4805|7450|lyfalmen|||00|28|0|112,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||4805||4805|7450| 014713|C09CA0601|Atacand|töflur|32|mg|98|stk|1|þpakki||C09CA06|01.06.2005|31.01.2011|R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|15091|21218|lyfalmen|||00|98|0|392,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||15091||15091|21218| 014728|L03AA0201|Neupogen|stl|0,6|mg/ml|0,5|ml|5|spr|áfyllt sprauta, lausn|L03AA02|01.12.2003||R|K|2,5|0|1|0|1|AEU|0|0|0|100|DKK|62845|80753|lyfsjukr|||00|2|0|4,2900|Vistor hf|Amgen Europe B.V.|Fílgrastím||62845||62845|80753| 014739|L03AA0201|Neupogen|stl|0,96|mg/ml|0,5|ml|5|spr|áfyllt sprauta, lausn|L03AA02|01.12.2003||R|K|2,5|0|1|0|1|AEU|0|0|0|100|DKK|100548|128070|lyfsjukr|||00|2|0|6,8600|Vistor hf|Amgen Europe B.V.|Fílgrastím||100548||100548|128070| 014795|C03EA0112|Miloride mite|töflur|27,5|mg|100|stk|1|glas|2,5+25 mg|C03EA01|01.11.2009||R|A||0|0|E|0|MYL|0|0|0|100|SEK|880|2081|lyfalmen|||00|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Hýdróklórtíazíð og kalíumsparandi lyf||||880|2081| 014847|L04AA1801|Certican|töflur|0,25|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|A|3|0|1|*|0|NOH|0|0|0|100|DKK|19256|26445|lyfalmen|||00|60|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Everolímus||19256||19256|26445| 014853|L04AA1801|Certican|töflur|0,75|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|A|3|0|1|*|0|NOH|0|0|0|100|DKK|58106|75202|lyfalmen|||00|60|0|30,0000|Vistor hf|Novartis Healthcare A/S-|Everolímus||58106||58106|75202| 014859|L04AA1801|Certican|töflur|0,5|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|A|3|0|1|*|0|NOH|0|0|0|100|DKK|38677|50819|lyfalmen|||00|60|0|20,0000|Vistor hf|Novartis Healthcare A/S-|Everolímus||38677||38677|50819| 015037|M01AX0502|Glucosamin Pharma Nord|hylki|400|mg|90|stk|1|glas||M01AX05|01.10.2006||L|A|2|0|0|0|0|PNA|0|0|1|100|IKR|||lyflausa|||00|90|0|24,0000|Icepharma hf|Pharma Nord ApS|Glúkósamín|||||| 015230|R01AC0301|Lastin|nefúði|1|mg/ml|10|ml|1|glas||R01AC03|01.06.1998||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|769|1929|lyfalmen|||00|10|0|17,8571|Vistor hf|Meda AB|Azelastínum||769||769|1929| 015301|M01AX0502|Glucosamin Pharma Nord|hylki|400|mg|270|stk|1|glas||M01AX05|01.10.2006||L|A|2|0|0|0|0|PNA|0|0|1|100|IKR|||lyflausa|||00|270|0|72,0000|Icepharma hf|Pharma Nord ApS|Glúkósamín|||||| 015316|N06AX1103|Miron|filmhtfl|30|mg|100|stk|1|plglas||N06AX11|01.07.2003||R|A|2|0|0|B|0|ACA|0|1|0|100|IKR|4886|7365|lyfalmen|||00|100|0|100,0000|Actavis Group hf|Actavis hf|Mirtazapín||4743||4743|7365| 015343|A10AE0501|Levemir FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AE05|01.12.2005||R|K|2,5|0|0|*|0|NON|0|0|0|100|DKK|8580|12614|lyfalmen|||00|15|0|37,5000|Vistor hf|Novo-Nordisk|Insúlín detemír||8580||8580|12614| 015344|N06AX1103|Miron|filmhtfl|30|mg|30|stk|1|plglas||N06AX11|01.07.2003||R|A|2|0|0|0|0|ACA|0|1|0|100|IKR|1920|3504|lyfalmen|||00|30|0|30,0000|Actavis Group hf|Actavis hf|Mirtazapín||1920||1920|3504| 015381|H02AB0104|Betapred|lausnart|0,5|mg|100|stk|1|glas||H02AB01|01.01.1998||R|A||0|0|E|0|LVE|0|0|1|100|IKR|2760|4653|lyfalmen|||00|100|1|33,3333|Lyfjaver ehf|Lyfjaver - óskráð lyf|Betametasón||2760||2760|4653| 015419|G03CA0316|Vivelle Dot|forðapl|25|mcg/sólh|8|stk|1|pakki||G03CA03|01.02.2006||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1087|2364|lyfalmen|||23|8|0|14,0000|Vistor hf|Novartis Healthcare A/S-|Estradíól||1087||1087|2364| 015442|N02CC0103|Imigran Radis|filmhtfl|100|mg|6|stk|1|þpakki||N02CC01|01.10.2005||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|2084|3500|lyfalmen|V0832|3500|00|6|0|12,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||1917||1917|3500| 015443|N02CC0103|Imigran Radis|filmhtfl|50|mg|12|stk|1|þpakki||N02CC01|01.10.2005||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|3042|4623|lyfalmen|V0831|4623|00|12|0|12,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||2738||2738|4623| 015448|A10AE0502|Levemir Penfill|stl|100|ae/ml|3|ml|5|rörlyk||A10AE05|01.03.2007||R|K|2,5|0|0|*|0|NON|0|0|0|100|DKK|10564|15328|lyfalmen|||00|15|0|37,5000|Vistor hf|Novo-Nordisk|Insúlín detemír||10564||10564|15328| 015532|L01CX0101|Yondelis|irþ|1|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|K|3|0|1|0|1|PAM|0|0|0|100|DKK|344811|434620|lyfsjukr|||00|1|0|0,0000|Lyfjaver ehf|Pharma Mar S.A.|Trabecetedín||344811||344811|434620| 015598|L01CX0101|Yondelis|irþ|0,25|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|K|3|0|1|0|1|PAM|0|0|0|100|DKK|91649|116902|lyfsjukr|||00|1|0|0,0000|Lyfjaver ehf|Pharma Mar S.A.|Trabecetedín||91649||91649|116902| 015605|N04BA0301|Stalevo|filmhtfl|262,5|mg|30|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|6115|9242|lyfalmen|||00|30|0|3,3300|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||6115||6115|9242| 015652|N04BA0301|Stalevo|filmhtfl|262,5|mg|100|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|13475|19190|lyfalmen|V1732|19189|00|100|0|11,1100|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||13475||13475|19190| 015655|N04BA0301|Stalevo|filmhtfl|387,5|mg|30|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|6115|9242|lyfalmen|||00|30|0|10,0000|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||6115||6115|9242| 015663|N04BA0301|Stalevo|filmhtfl|387,5|mg|100|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|14567|20561|lyfalmen|V1731|20559|00|100|0|33,3300|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||14567||14567|20561| 015679|J05AE0801|Reyataz|hylki|200|mg|60|stk|1|þpakki||J05AE08|01.04.2005||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|79768|101991|lyfsjukr|||43|60|0|40,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||79768||79768|101991| 015695|J05AE0801|Reyataz|hylki|150|mg|60|stk|1|þpakki||J05AE08|01.04.2005||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|79768|101991|lyfsjukr|||43|60|0|30,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||79768||79768|101991| 015699|J05AE0801|Reyataz|hylki|150|mg|60|stk|1|plglas||J05AE08|01.06.2008||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|64601|82957|lyfsjukr|||43|60|0|30,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||64601||64601|82957| 015707|N04BA0301|Stalevo|filmhtfl|325|mg|30|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|6115|9242|lyfalmen|||00|30|0|6,6700|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||6115||6115|9242| 015718|N04BA0301|Stalevo|filmhtfl|325|mg|100|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|13333|19012|lyfalmen|V1730|19011|00|100|0|22,2200|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||13333||13333|19012| 015723|J05AE0801|Reyataz|hylki|200|mg|60|stk|1|plglas||J05AE08|01.06.2008||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|79768|101991|lyfsjukr|||43|60|0|40,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||79768||79768|101991| 015733|L04AA0602|Myfortic|sh-tfl|180|mg|120|stk|1|þpakki||L04AA06|01.11.2004||R|A|2,5|0|1|*|0|NOH|0|0|0|100|DKK|22543|30571|lyfalmen|||00|120|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Mýcófenólsýra||22543||22543|30571| 015755|L04AA0602|Myfortic|sh-tfl|360|mg|120|stk|1|þpakki||L04AA06|01.11.2004||R|A|2,5|0|1|*|0|NOH|0|0|0|100|DKK|48172|62735|lyfalmen|||00|120|0|21,6000|Vistor hf|Novartis Healthcare A/S-|Mýcófenólsýra||48172||48172|62735| 015800|S01FA0401|Cyclogyl 1 %|augndr|10|mg/ml|15|ml|1|glas||S01FA04|01.01.1977||R|A|2|0|0|E|0|SAL|0|0|0|100|USD|936|2158|lyfalmen|||06|15|0|0,0000|Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Cýklópentólat||936||936|2158| 015823|QP54AB5205|Advocate stórir kettir|bl.lausn|110|mg|0,8|ml|3|túpa|100+10 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BAN|0|0|0|100|DKK|3180|5547|vetorma|||16|2|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||3180||3180|5547| 015855|QP54AB5206|Advocate yfirstærðar hundar|bl.lausn|125|mg|4|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BAN|0|0|0|100|DKK|4468|7794|vetorma|||16|12|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||4468||4468|7794| 015873|QP54AB5202|Advocate litlir kettir|bl.lausn|110|mg|0,4|ml|3|túpa|100+10 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BAN|0|0|0|100|DKK|2837|4949|vetorma|||16|1|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||2837||2837|4949| 015882|QP54AB5203|Advocate millistórir hundar|bl.lausn|125|mg|1|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BAN|0|0|0|100|DKK|3556|6203|vetorma|||16|3|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||3556||3556|6203| 015883|M01CC0101|Atamir|hylki|250|mg|50|stk|1|þpakki||M01CC01|01.05.1978||R|A|5|0|0|B|0|SGM|0|0|0|100|DKK|4532|7077|lyfalmen|||10|50|0|25,0000|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||4532||4532|7077| 015904|QP54AB5204|Advocate stórir hundar|bl.lausn|125|mg|2,5|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BAN|0|0|0|100|DKK|3985|6952|vetorma|||16|8|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||3985||3985|6952| 015912|D11AH0101|Protopic|smyrsli|0,03|%|10|g|1|túpa||D11AH01|01.03.2009||R|A|3|0|0|E|0|ASP|0|0|1|100|XEU|2005|3620|lyfalmen|||0|10|0|0,0000|Vistor hf|Astellas Pharma A/S|Takrólímus||||2005|3620| 015923|D11AH0101|Protopic|smyrsli|0,1|%|10|g|1|túpa||D11AH01|01.10.2007||R|A|3|0|0|E|0|ASP|0|0|1|100|XEU|2252|3958|lyfalmen|||00|10|0|0,0000|Vistor hf|Astellas Pharma A/S|Takrólímus||2252||2252|3958| 015929|N02AA0110|Morphine Sulphate BP|stl|10|mg/ml|1|ml|10|lykjur||N02AA01|01.07.2003||R|A|3|1|0|0|0|MAP|0|0|0|100|GBP|1532|2973|lyfalmen|||02|10|0|3,3300|Icepharma hf|Martindale Pharmaceuticals|Morfín||1532||1532|2973| 015944|QP54AB5201|Advocate litlir hundar|bl.lausn|125|mg|0,4|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BAN|0|0|0|100|DKK|3180|5547|vetorma|||16|1|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||3180||3180|5547| 015964|N06AB0501|Seroxat|töflur|10|mg|28|stk|1|þpakki||N06AB05|01.12.2006||R|A|3|0|0|0|0|GSK|0|1|0|100|GBP|1473|2892|lyfalmen|||00|28|0|14,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||1473||1473|2892| 016017|C10AA0701|Crestor|filmhtfl|10|mg|100|stk|1|þpakki||C10AA07|01.03.2004||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|14829|20889|lyfalmen|V2208|20889|00|100|0|100,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||14829||14829|20889| 016021|N02AB0203|Pethidine BP|stl|50|mg/ml|1|ml|10|lykjur||N02AB02|01.07.2003||R|A|3|1|0|0|0|MAP|0|0|0|100|GBP|1138|2434|lyfalmen|||02|10|0|1,2500|Icepharma hf|Martindale Pharmaceuticals|Petidín||1138||1138|2434| 016028|C10AA0701|Crestor|filmhtfl|20|mg|100|stk|1|þpakki||C10AA07|01.03.2004||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|22204|30145|lyfalmen|V0341|30144|00|100|0|200,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||22204||22204|30145| 016032|N02AB0203|Pethidine BP|stl|50|mg/ml|2|ml|10|lykjur||N02AB02|01.01.2004||R|A|3|1|0|0|0|MAP|0|0|0|100|GBP|1206|2527|lyfalmen|||02|20|0|2,5000|Icepharma hf|Martindale Pharmaceuticals|Petidín||1206||1206|2527| 016038|N02CC0501|Almogran|töflur|12,5|mg|3|stk|1|þpakki|filmuhúðaðar töflur|N02CC05|01.05.2001||R|A|5|0|0|E|0|ALM|0|0|0|100|SEK|3047|5045|lyfalmen|||00|3|0|3,0000|Vistor hf|Almirall S.A.|Almótriptan||3047||3047|5045| 016066|R02AA0303|Strepsils Sukkerfri med Citron og Örter|sogtfl|0| |24|stk|1|þpakki||R02AA03|01.10.2005||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0|0,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||| 016125|M02AA1001|Orudis|hlaup|25|mg/g|60|g|1|túpa||M02AA10|01.03.2000||L|A|2|0|0|0|0|SNO|0|0|1|100|IKR|||lyflausa|||00|60|0|0,0000|Vistor hf|Sanofi-aventis Norge AS|Ketóprófen|||||| 016209|N05AX0801|Risperdal|töflur|2|mg|28|stk|1|þpakki|frostþ. töflur|N05AX08|01.09.2004||R|A|2|0|0|*|0|JAS|0|1|0|100|SEK|8854|12989|lyfalmen|||00|28|0|11,2000|Vistor hf|Janssen-Cilag AB|Risperídón||8854||8854|12989| 016285|N03AX1601|Lyrica|hylki|150|mg|14|stk|1|þpakki||N03AX16|01.12.2004||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|3280|5364|lyfalmen|||00|14|0|7,0000|Icepharma hf|Pfizer ApS|Pregabalín||3280||3280|5364| 016294|N03AX1601|Lyrica|hylki|75|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|6677|10011|lyfalmen|||00|56|0|14,0000|Icepharma hf|Pfizer ApS|Pregabalín||6677||6677|10011| 016296|G03GA0801|Ovitrelle|stl|250|mcg/spr|0,5|ml|1|spr|lausn|G03GA08|01.03.2004||R|K|2|0|1|E|0|MSE|0|0|0|100|SEK|5506|8409|lyfalmen|||00|0|0|1,0000|Icepharma hf|Merck Serono Europe Ltd|Chóríógónadótrópín alfa||5506||5506|8409| 016315|N03AX1601|Lyrica|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|10126|14729|lyfalmen|||00|56|0|28,0000|Icepharma hf|Pfizer ApS|Pregabalín||10126||10126|14729| 016318|N03AX1601|Lyrica|hylki|75|mg|14|stk|1|þpakki||N03AX16|01.12.2004||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|2203|3891|lyfalmen|||00|14|0|3,5000|Icepharma hf|Pfizer ApS|Pregabalín||2203||2203|3891| 016323|N03AX1601|Lyrica|hylki|300|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|14711|20741|lyfalmen|||00|56|0|56,0000|Icepharma hf|Pfizer ApS|Pregabalín||14711||14711|20741| 016337|C08CA0302|Lomir Retard|forðahlk|5|mg|100|stk|1|þpakki||C08CA03|01.04.1992||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|11138|16113|lyfalmen|||10|100|0|100,0000|Vistor hf|Novartis Healthcare A/S-|Ísradipín||11138||11138|16113| 016353|N05AX0801|Risperdal|töflur|1|mg|28|stk|1|þpakki|frostþ. töflur|N05AX08|01.08.2004||R|A|2|0|0|*|0|JAS|0|1|0|100|SEK|4987|7699|lyfalmen|||00|28|0|5,6000|Vistor hf|Janssen-Cilag AB|Risperídón||4987||4987|7699| 016364|L01BA0108|Methotrexate Pfizer|stl/irl|25|mg/ml|2|ml|5|hgl||L01BA01|01.10.1995|31.01.2011|R|A|2|0|1|0|1|PER|0|0|0|100|DKK|5647|8150|lyfsjukr|||00|10|0|0,0000|Icepharma hf|Pfizer ApS|Metótrexat||5647||5647|8150| 016382|J02AC0301|Vfend|mixtúra|40|mg/ml|70|ml|1|fl||J02AC03|01.03.2005||R|A|1,5|0|0|0|1|PER|0|0|0|100|DKK|140281|177935|lyfsjukr|||00|70|0|7,0000|Icepharma hf|Pfizer ApS|Voricónazól||140281||140281|177935| 016385|L01BC0108|Cytarabine Pfizer|stl/irl|100|mg/ml|10|ml|1|hgl||L01BC01|01.10.1995||R|A|1,5|0|1|0|1|PER|0|0|0|100|DKK|8508|12279|lyfsjukr|||00|10|0|0,0000|Icepharma hf|Pfizer ApS|Cýtarabín||8508||8508|12279| 016395|N03AX1601|Lyrica|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.01.2007||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|2610|4448|lyfalmen|||00|56|0|4,6667|Icepharma hf|Pfizer ApS|Pregabalín||2610||2610|4448| 016396|L01BA0108|Methotrexate Pfizer|stl/irl|25|mg/ml|20|ml|1|hgl||L01BA01|01.10.1995|31.01.2011|R|A|2|0|1|0|1|PER|0|0|0|100|DKK|7583|10944|lyfsjukr|||00|20|0|0,0000|Icepharma hf|Pfizer ApS|Metótrexat||7583||7583|10944| 016474|L01XA0209|Carboplatin Pfizer|irþ|10|mg/ml|5|ml|5|hgl||L01XA02|01.08.1998||R|A|2|0|1|0|1|PER|0|0|0|100|DKK|26669|35352|lyfsjukr|||00|25|0|0,0000|Icepharma hf|Pfizer ApS|Karbóplatín||26669||26669|35352| 016502|N07BA0111|Nicorette Classic|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.03.2004||L|A|2,5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 016516|L01XA0209|Carboplatin Pfizer|irþ|10|mg/ml|45|ml|5|hgl||L01XA02|01.08.1998||R|A|2|0|1|0|1|PER|0|0|0|100|DKK|223959|282951|lyfsjukr|||00|225|0|0,0000|Icepharma hf|Pfizer ApS|Karbóplatín||223959||223959|282951| 016524|N07BA0111|Nicorette Classic|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.03.2004||L|A|2,5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 016528|N07BA0111|Nicorette Classic|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.03.2004||L|A|2,5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 016534|L01XA0209|Carboplatin Pfizer|irþ|10|mg/ml|15|ml|5|hgl||L01XA02|01.08.1998||R|A|2|0|1|0|1|PER|0|0|0|100|DKK|78545|100456|lyfsjukr|||00|75|0|0,0000|Icepharma hf|Pfizer ApS|Karbóplatín||78545||78545|100456| 016561|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|105|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|105|0|7,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 016572|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.09.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 016589|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 016590|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 016596|N05AX1201|Abilify|töflur|5|mg|28|stk|1|þpakki||N05AX12|01.02.2006||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|17551|24306|lyfalmen|||00|28|0|9,3330|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||17551||17551|24306| 016605|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|105|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 016611|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.09.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 016622|A06AG1101|Microlax|innhl|0| |5|ml|50|túpa||A06AG11|01.09.2005||L|A|5|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||56|250|0|50,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, þ.m.t. í blöndum|||||7043| 016635|N05AX1201|Abilify|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.02.2006||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|34285|45307|lyfalmen|V0106|45306|00|56|0|18,6670|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||34285||34285|45307| 016637|J01CR0201|Amoksiklav|töflur|1000|mg|12|stk|1|pakki|875+125 mg|J01CR02|01.08.2003||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|1026|2266|lyfalmen|V0466|2266|00|12|0|12,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||1015||1015|2266| 016640|B03XA0103|NeoRecormon|stl|30000|ae/spr|0,6|ml|4|spr||B03XA01|01.05.2007||R|K|2|0|1|0|1|ROC|0|0|0|100|DKK|239749|302767|lyfsjukr|||00|2|0|180,0000|Icepharma hf|Roche|Epóetín||239749||239749|302767| 016686|H01AC0110|NutropinAq|stl|5|mg/ml|2|ml|3|rörlyk||H01AC01|01.03.2005||R|A|1,5|0|1|0|1|IPL|0|0|0|100|DKK|209596|264925|lyfsjukr|||00|6|0|0,0000|Icepharma hf|Ipsen Ltd.|Sómatrópín||209596||209596|264925| 016727|N06BA0403|Ritalin Uno|hylki|30|mg|30|stk|1|glas||N06BA04|01.02.2004||R|A|3|1|0|0|0|NOH|0|0|0|100|DKK|7824|11580|lyfalmen|||00|30|0|30,0000|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||7824||7824|11580| 016728|H01AC0110|NutropinAq|stl|5|mg/ml|2|ml|1|rörlyk||H01AC01|01.03.2005||R|A|1,5|0|1|0|1|IPL|0|0|0|100|DKK|69866|89564|lyfsjukr|||00|2|0|0,0000|Icepharma hf|Ipsen Ltd.|Sómatrópín||69866||69866|89564| 016736|N03AF0107|Tegretol Retard (Lyfjaver)|forðatfl|200|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|3063|5067|lyfalmen|V0789|5067|10|200|0|40,0000|Lyfjaver ehf|Lyfjaver ehf|Karbamazepín||3063||3063|5067| 016772|N03AF0107|Tegretol Retard (Lyfjaver)|forðatfl|400|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|5654|8612|lyfalmen|V0713|8612|10|200|0|80,0000|Lyfjaver ehf|Lyfjaver ehf|Karbamazepín||5654||5654|8612| 016791|H05BX0101|Mimpara|filmhtfl|60|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|A|4|0|0|0|0|AEU|0|0|0|100|DKK|64386|83084|lyfalmen|||00|28|0|28,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||64386||64386|83084| 016802|H05BX0101|Mimpara|filmhtfl|90|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|A|4|0|0|0|0|AEU|0|0|0|100|DKK|95171|121719|lyfalmen|||00|28|0|42,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||95171||95171|121719| 016868|H05BX0101|Mimpara|filmhtfl|30|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|A|4|0|0|0|0|AEU|0|0|0|100|DKK|30971|41148|lyfalmen|||00|28|0|0,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||30971||30971|41148| 016892|G03GA0502|Gonal-f|stl|900|ae/penna|1,5|ml|1|penni|áfylltur penni (66 mcg) |G03GA05|01.07.2004||R|K|1|0|1|E|0|MSE|0|0|0|100|SEK|62896|81214|lyfalmen|||00|2|0|12,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||62896||62896|81214| 016927|G03GA0502|Gonal-f|stl|300|ae/penna|0,5|ml|1|penni|(22 mcg) áfylltur penni|G03GA05|01.07.2004||R|K|1|0|1|E|0|MSE|0|0|0|100|SEK|24058|32472|lyfalmen|||00|0|0|4,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||24058||24058|32472| 016938|G03GA0502|Gonal-f|stl|450|ae/penna|0,75|ml|1|penni|áfylltur penni (33 mcg) |G03GA05|01.07.2004||R|K|1|0|1|E|0|MSE|0|0|0|100|SEK|36084|47565|lyfalmen|||00|1|0|6,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||36084||36084|47565| 016943|A02BC0301|Lanzo|munndr.t|30|mg|14|stk|1|þpakki||A02BC03|01.02.2007||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|2091|3738|lyfalmen|||00|14|0|14,0000|Icepharma hf|Pfizer ApS|Lansóprazól||2091||2091|3738| 016946|A02BC0301|Lanzo|munndr.t|15|mg|56|stk|1|þpakki||A02BC03|01.11.2009||R|A||0|0|0|0|PER|0|0|0|100|DKK|3555|5740|lyfalmen|||00|56|0|28,0000|Icepharma hf|Pfizer ApS|Lansóprazól||||3555|5740| 016954|A02BC0301|Lanzo|munndr.t|30|mg|28|stk|1|þpakki||A02BC03|01.01.2004||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|4057|6427|lyfalmen|||00|28|0|28,0000|Icepharma hf|Pfizer ApS|Lansóprazól||4057||4057|6427| 016957|A02BC0301|Lanzo|munndr.t|15|mg|98|stk|1|þpakki||A02BC03|01.01.2004||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|7901|11685|lyfalmen|||00|98|0|49,0000|Icepharma hf|Pfizer ApS|Lansóprazól||7901||7901|11685| 016965|A02BC0301|Lanzo|munndr.t|30|mg|56|stk|1|þpakki||A02BC03|01.01.2004||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|6375|9598|lyfalmen|||00|56|0|56,0000|Icepharma hf|Pfizer ApS|Lansóprazól||6375||6375|9598| 016973|J05AF0901|Emtriva|hylki|200|mg|30|stk|1|glas||J05AF09|01.04.2004||R|A|3|0|1|0|1|GIS|0|0|0|100|XEU|40286|52441|lyfsjukr|||00|30|0|30,0000|Gilead Sience Sweden AB|Gilead Science International ltd.|Emtrícítabín||40286||40286|52441| 016976|A02BC0301|Lanzo|munndr.t|30|mg|98|stk|1|þpakki||A02BC03|01.02.2007||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|13946|19781|lyfalmen|||00|98|0|98,0000|Icepharma hf|Pfizer ApS|Lansóprazól||13946||13946|19781| 016979|N02AE0103|Norspan|forðapl|5|mg|4|stk|1|þpakki||N02AE01|01.01.2006||R|A|2|1|0|E|0|NOP|0|0|0|100|DKK|3457|5606|lyfalmen|||00|4|0|16,6700|Icepharma hf|Norpharma |Búprenorfín||3457||3457|5606| 016981|QA02BX1202|Orbesealer vet.|spenalyf|2,6|g/dælu|60|dælur|1|pakki||QA02BX12|01.12.2006||R|A|5|0|0|0|0|PAL|0|0|0|100|DKK|18810|36291|vetalmen|||16|60|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||18810||18810|36291| 017006|B05BA1019|StructoKabiven Perifer|irl|830|kcal|1206|ml|4|pokar|fleyti|B05BA10|01.06.2005||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|32545|42726|lyfsjukr|||00|4824|0|0,0000|Icepharma hf|Fresenius Kabi|Blöndur||32545||32545|42726| 017020|G03DA0201|Depo-Provera|stl|50|mg/ml|3|ml|1|hgl||G03DA02|01.12.1972||R|A|5|0|0|E|0|PER|0|0|0|100|DKK|1532|2973|lyfalmen|||03|3|0|21,4286|Icepharma hf|Pfizer ApS|Medroxýprógesterón||1532||1532|2973| 017111|A09AA0201|Combizym|töflur|||100|stk|1|þpakki||A09AA02|01.07.1988||R|A|2|0|0|E|0|DSG|0|0|0|100|XEU|1551|2999|lyfalmen|||10|100|0|25,0000|Icepharma hf|Daiichi Sankyo Europe GmbH|Hvatablöndur (lípasi, próteasi o.s.frv.)||1551||1551|2999| 017130|L01BC0109|DepoCyte|stl|50|mg/hgl|5|ml|1|hgl||L01BC01|01.07.2005||R|K|2|0|1|0|1|SKY|0|0|0|100|DKK|288284|363679|lyfsjukr|||00|5|0|0,0000|Icepharma hf|SkyPharma PLC|Cýtarabín||288284||288284|363679| 017145|C08DB0102|Cardizem Retard|forðatfl|180|mg|60|stk|1|glas||C08DB01|01.04.1990||R|A|2|0|0|B|0|FRO|0|0|0|100|DKK|7917|11707|lyfalmen|||10|60|0|45,0000|Vistor hf|Ferrosan A/S|Diltíazem||7917||7917|11707| 017195|L01XX3201|Velcade|sts|3,5|mg/hgl|1|hgl|1|pakki|lausn|L01XX32|01.09.2004||R|A|3|0|1|0|1|JCI|0|0|0|100|SEK|190434|240877|lyfsjukr|||00|1|0|0,0000|Vistor hf|Janssen-Cilag International N.V.|Bortezomíb||190434||190434|240877| 017203|M05BA0601|Bondronat|irþ|1|mg/ml|6|ml|1|hgl||M05BA06|01.09.2004||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|45450|58922|lyfsjukr|||00|6|0|1,0000|Icepharma hf|Roche|Íbandrónsýra||45450||45450|58922| 017210|C03DA0102|Spirix|töflur|25|mg|100|stk|1|glas||C03DA01|01.02.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|1366|2746|lyfalmen|V0221|2746|00|100|0|33,3333|Gróco ehf|Nycomed Danmark A/S|Spírónólaktón||1366||1366|2746| 017234|L03AB0701|Avonex|stl|30|mcg/spr|0,5|ml|4|spr|lausn, áfylltar sprautur|L03AB07|01.12.2003||R|K|2|0|1|0|1|BIN|0|0|0|100|XEU|129548|164465|lyfsjukr|||00|2|0|27,9100|Icepharma hf|Biogen Idec Ltd|Interferón beta-1a||129548||129548|164465| 017238|M05BA0601|Bondronat|filmhtfl|50|mg|28|stk|1|þpakki||M05BA06|01.08.2004||R|A|1|0|0|0|0|ROC|0|0|0|100|DKK|50722|65935|lyfalmen|||00|28|0|28,0000|Icepharma hf|Roche|Íbandrónsýra||50722||50722|65935| 017247|M05BA0601|Bondronat|filmhtfl|50|mg|84|stk|1|þpakki||M05BA06|01.08.2004||R|A|1|0|0|0|0|ROC|0|0|0|100|DKK|151396|192281|lyfalmen|||00|84|0|84,0000|Icepharma hf|Roche|Íbandrónsýra||151396||151396|192281| 017266|N02AE0103|Norspan|forðapl|10|mg|4|stk|1|þpakki||N02AE01|01.01.2006||R|A|2|1|0|E|0|NOP|0|0|0|100|DKK|5466|8354|lyfalmen|||00|4|0|33,3300|Icepharma hf|Norpharma |Búprenorfín||5466||5466|8354| 017326|N02AE0103|Norspan|forðapl|20|mg|4|stk|1|þpakki||N02AE01|01.01.2006||R|A|2|1|0|E|0|NOP|0|0|0|100|DKK|11430|16513|lyfalmen|||00|4|0|66,6600|Icepharma hf|Norpharma |Búprenorfín||11430||11430|16513| 017327|C03DA0102|Spirix|töflur|50|mg|100|stk|1|glas||C03DA01|01.02.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|2701|4572|lyfalmen|||00|100|0|66,6667|Gróco ehf|Nycomed Danmark A/S|Spírónólaktón||2701||2701|4572| 017331|A04AD1201|Emend|hylki|0| |3|stk|1|þpakki|samsett pakkning|A04AD12|01.04.2004||R|A|2,5|0|0|0|1|MSD|0|0|0|100|XEU|9041|13048|lyfsjukr|||00|3|0|0,0000|Icepharma hf|M.S.D.|Aprepitant||9041||9041|13048| 017365|J01CR0201|Amoksiklav|töflur|375|mg|20|stk|1|glas|250+125 mg|J01CR02|01.12.2003||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|911|2123|lyfalmen|||00|20|0|5,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||911||911|2123| 017384|H02AB0701|Deltison|töflur|50|mg|30|stk|1|glas||H02AB07|01.08.2005||R|A|2|0|0|E|0|REP|0|0|1|100|SEK|3429|5568|lyfalmen|||00|30|0|150,0000|Vistor hf|Recip AB|Prednisón||3429||3429|5568| 017541|N07CA0101|Betaserc|töflur|16|mg|100|stk|1|þpakki||N07CA01|01.06.1999||R|A|5|0|0|E|0|SOL|0|0|0|100|DKK|7244|10787|lyfalmen|||00|100|0|66,6667|Medico ehf|Solvay Duphar |Betahistín||7244||7244|10787| 017556|J01CR0201|Amoksiklav|töflur|625|mg|20|stk|1|glas|500+125 mg|J01CR02|01.12.2003||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|1459|2623|lyfalmen|V0465|2539|00|20|0|12,5000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||1276||1276|2623| 017564|QM01AC0601|Metacam|mixtúra|15|mg/ml|100|ml|1|fl||QM01AC06|01.09.2004||R|A|2|0|0|0|0|BOI|0|0|0|100|DKK|6713|13063|vetalmen|||00|100|0|0,0000|Vistor hf|Boehringer Ingelheim|||6713||6713|13063| 017763|N06DA0401|Reminyl|forðahlk|16|mg|84|stk|1|þpakki||N06DA04|01.08.2005||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|42165|55196|lyfalmen|||00|84|0|84,0000|Vistor hf|Janssen-Cilag AB|Galantamín||42165||42165|55196| 017773|N06DA0401|Reminyl|forðahlk|8|mg|28|stk|1|þpakki||N06DA04|01.08.2005||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|13195|18839|lyfalmen|V1370|18838|00|28|0|14,0000|Vistor hf|Janssen-Cilag AB|Galantamín||13195||13195|18839| 017792|C03DA0401|Inspra|filmhtfl|50|mg|30|stk|1|þpakki||C03DA04|01.08.2005||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|11234|16245|lyfalmen|||00|30|0|30,0000|Icepharma hf|Pfizer ApS|Eplerenón||11234||11234|16245| 017809|N06DA0401|Reminyl|forðahlk|24|mg|84|stk|1|þpakki||N06DA04|01.08.2005||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|46952|61204|lyfalmen|||00|84|0|126,0000|Vistor hf|Janssen-Cilag AB|Galantamín||46952||46952|61204| 017963|C03DA0401|Inspra|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.08.2005||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|9543|13932|lyfalmen|||00|30|0|15,0000|Icepharma hf|Pfizer ApS|Eplerenón||9543||9543|13932| 018268|G03FA1701|Angemin|töflur|0| |84|stk|1|þpakki|2+1 mg|G03FA17|01.06.2005||R|A|5|0|0|0|0|BAP|0|0|0|100|SEK|7164|10677|lyfalmen|||00|84|0|84,0000|Icepharma hf|Bayer Schering Pharma AG|Dróspírenón og östrogen||7164||7164|10677| 018311|C09CA0801|Olmetec|filmhtfl|10|mg|28|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|0|0|DSH|0|0|0|100|DKK|2708|4582|lyfalmen|||00|28|0|14,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||2708||2708|4582| 018446|C09CA0801|Olmetec|filmhtfl|40|mg|28|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|0|0|DSH|0|0|0|100|DKK|3999|6348|lyfalmen|||00|28|0|56,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||3999||3999|6348| 018453|L02BA0301|Faslodex|stl|250|mg/spr|5|ml|1|spr||L02BA03|01.06.2004||R|K|3|0|1|0|1|ASZ|0|0|0|100|SEK|68503|74960|lyfsjukr|||00|5|0|0,0000|Vistor hf|AstraZeneca UK Ltd|Fulvestrant||58229||58229|74960| 018502|C09CA0801|Olmetec|filmhtfl|40|mg|98|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|0|0|DSH|0|0|0|100|DKK|12525|17998|lyfalmen|||00|98|0|196,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||12525||12525|17998| 018512|C09CA0801|Olmetec|filmhtfl|10|mg|98|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|0|0|DSH|0|0|0|100|DKK|8797|12911|lyfalmen|||00|98|0|49,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||8797||8797|12911| 018514|J07BA0101|FSME-Immun Junior|stl|1,2|mcg/sk|0,25|ml|1|spr|bóluefni|J07BA01|01.06.2004||R|K|2,5|0|0|0|0|BAA|0|0|0|100|SEK|3875|6178|lyfalmen|||02|0|0|0,0000|Icepharma hf|Baxter AG|Heilabólguveira óvirk, borin með blóðmaur||3875||3875|6178| 018527|J07BA0102|FSME-Immun Vuxen|stl|2,4|mcg/sk|0,5|ml|1|spr|bóluefni|J07BA01|01.06.2004||R|K|2,5|0|0|0|0|BAA|0|0|0|100|SEK|4232|6666|lyfalmen|||02|0|0|0,0000|Icepharma hf|Baxter AG|Heilabólguveira óvirk, borin með blóðmaur||4232||4232|6666| 018534|C09CA0801|Olmetec|filmhtfl|20|mg|98|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|0|0|DSH|0|0|0|100|DKK|10332|15011|lyfalmen|||00|98|0|98,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||10332||10332|15011| 018535|N03AX0901|Lamictal|dreifit.|25|mg|42|stk|1|þpakki||N03AX09|01.11.2004||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|1499|2450|lyfalmen|V0704|2450|00|42|0|3,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||1150||1150|2450| 018586|C09CA0801|Olmetec|filmhtfl|20|mg|28|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|0|0|DSH|0|0|0|100|DKK|3363|5478|lyfalmen|||00|28|0|28,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||3363||3363|5478| 018594|G04BD0801|Vesicare|filmhtfl|10|mg|30|stk|1|þpakki||G04BD08|01.11.2004||R|A|2|0|0|E|0|ASP|0|0|0|100|XEU|8294|12223|lyfalmen|||00|30|0|60,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||8294||8294|12223| 018663|J01DD0401|Rocephalin|sts|1|g|1|stk|5|hgl|+ leysir, lausn|J01DD04|01.10.1985||R|A|3|0|0|0|1|ROC|0|0|0|100|DKK|13710|19089|lyfsjukr|||03|5|0|2,5000|Icepharma hf|Roche|Ceftríaxón||13710||13710|19089| 018670|C09CA0301|Diovan|filmhtfl|40|mg|14|stk|1|þpakki||C09CA03|01.07.2005||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|1463|2879|lyfalmen|||00|14|0|7,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||1463||1463|2879| 018677|G04BD0801|Vesicare|filmhtfl|10|mg|90|stk|1|þpakki||G04BD08|01.11.2004||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|20323|27784|lyfalmen|||00|90|0|180,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||20323||20323|27784| 018681|C09CA0301|Diovan|filmhtfl|40|mg|28|stk|1|þpakki||C09CA03|01.07.2005||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|2927|4881|lyfalmen|||00|28|0|14,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||2927||2927|4881| 018682|H02AB0604|Decortin H|töflur|5|mg|100|stk|1|þpakki||H02AB06|11.06.2004||R|A|3|0|0|B|0|MKA|0|0|1|100|SEK|970|2204|lyfalmen|V2400|1862|00|100|0|50,0000|Icepharma hf|Merck KgaA|Prednisólón||970||970|2204| 018685|G04BD0801|Vesicare|filmhtfl|5|mg|30|stk|1|þpakki||G04BD08|01.11.2004||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|6543|9828|lyfalmen|||00|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||6543||6543|9828| 018694|G04BD0801|Vesicare|filmhtfl|5|mg|90|stk|1|þpakki||G04BD08|01.11.2004||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|16547|23046|lyfalmen|||00|90|0|90,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||16547||16547|23046| 018714|C03DA0401|Inspra|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.08.2005||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|37453|49283|lyfalmen|||00|100|0|100,0000|Icepharma hf|Pfizer ApS|Eplerenón||37453||37453|49283| 018779|L03AX1301|Copaxone|stl|20|mg/spr|28|spr|1|pakki|+ leysir|L03AX13|01.08.2004||R|K|2|0|1|0|1|TEP|0|0|0|100|NOK|128196|162768|lyfsjukr|||00|28|0|28,0000|Vistor hf|Teva Pharmaceuticals Limited|Glatíramer acetat||128196||128196|162768| 018956|R06AX2201|Kestine|töflur|20|mg|30|stk|1|þpakki||R06AX22|01.10.2005||R|A|3|0|0|E|0|ALF|0|0|1|100|DKK|3120|5145|lyfalmen|||00|30|0|60,0000|Gróco ehf|Almirall-Prodesfarma S.A.|Ebastín||3120||3120|5145| 018967|R06AX2201|Kestine|töflur|20|mg|100|stk|1|þpakki||R06AX22|01.10.2005||R|A|3|0|0|E|0|ALF|0|0|1|100|DKK|9652|14081|lyfalmen|||00|100|0|200,0000|Gróco ehf|Almirall-Prodesfarma S.A.|Ebastín||9652||9652|14081| 018975|J05AE0701|Telzir|filmhtfl|700|mg|60|stk|1|glas||J05AE07|01.12.2004||R|A|3|0|1|0|1|VII|0|0|0|100|GBP|58644|75481|lyfsjukr|||43|60|0|30,0000|GlaxoSmithKline ehf|Viiv Healthcare UK Ltd|Fosamprenavír||58644||58644|75481| 018978|C03CA0101|Furix|töflur|20|mg|100|stk|1|glas||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|597|1694|lyfalmen|||00|100|0|50,0000|Gróco ehf|Nycomed Danmark A/S|Fúrósemíð||597||597|1694| 018980|QN01BB5202|Lidokel Adrenalin vet. Kela|stl|20|mg/ml|100|ml|1|hgl|20mg/ml+36mcg/ml|QN01BB52|01.02.2004||R|S|2|0|0|0|0|KEL|1|0|0|100|NOK|1270|2526|vetalmen|||27|100|0|0,0000|Icepharma hf|Kela Laboratoria NV|||1270||1270|2526| 018995|N02AB0301|Durogesic|forðapl|75|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|13191|18834|lyfalmen|V1052|13850|00|5|0|62,5000|Vistor hf|Janssen-Cilag AB|Fentanýl||13191||13191|18834| 019065|N06DA0302|Exelon (Lyfjaver)|hylki|6|mg|56|stk|1|þpakki||N06DA03|01.04.2004||R|A|5|0|0|E|0|LVR|0|0|0|100|DKK|14731|20766|lyfalmen|||00|56|0|37,3300|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||14731||14731|20766| 019079|N06DA0302|Exelon (Lyfjaver)|hylki|4,5|mg|56|stk|1|þpakki||N06DA03|01.04.2004||R|A|5|0|0|E|0|LVR|0|0|0|100|DKK|14731|20766|lyfalmen|||00|56|0|28,0000|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||14731||14731|20766| 019082|N06DA0302|Exelon (Lyfjaver)|hylki|3|mg|56|stk|1|þpakki||N06DA03|01.04.2004||R|A|5|0|0|E|0|LVR|0|0|0|100|DKK|13887|19707|lyfalmen|V1372|19707|00|56|0|18,6700|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||13887||13887|19707| 019094|N02AB0301|Durogesic|forðapl|50|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|9488|13856|lyfalmen|V1051|10146|00|5|0|41,6667|Vistor hf|Janssen-Cilag AB|Fentanýl||9488||9488|13856| 019099|V08AB0201|Omnipaque|stl|300|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|32073|42134|lyfsjukr|||02|500|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||32073||32073|42134| 019102|N06DA0302|Exelon (Lyfjaver)|hylki|1,5|mg|28|stk|1|þpakki||N06DA03|01.04.2004||R|A|5|0|0|E|0|LVR|0|0|0|100|DKK|7365|10952|lyfalmen|||00|28|0|4,6667|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||7365||7365|10952| 019108|N02AB0301|Durogesic|forðapl|25|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|5133|7899|lyfalmen|V1050|5691|00|5|0|20,8333|Vistor hf|Janssen-Cilag AB|Fentanýl||5133||5133|7899| 019112|V08AB0201|Omnipaque|stl|350|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|38187|49807|lyfsjukr|||02|500|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||38187||38187|49807| 019121|V08AB0901|Visipaque|stl|270|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|35234|46101|lyfsjukr|||02|500|0|0,0000|Icepharma hf|GE Healthcare AS|Jódixanól||35234||35234|46101| 019132|V08AB0901|Visipaque|stl|320|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|40575|52804|lyfsjukr|||02|500|0|0,0000|Icepharma hf|GE Healthcare AS|Jódixanól||40575||40575|52804| 019167|N02AB0301|Durogesic|forðapl|100|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|16256|22680|lyfalmen|V1053|16471|00|5|0|83,3333|Vistor hf|Janssen-Cilag AB|Fentanýl||16256||16256|22680| 019175|C09CA0601|Atacand|töflur|32|mg|98|stk|1|þpakki||C09CA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|16259|22684|lyfalmen|||00|98|0|392,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||||16259|22684| 019194|C09CA0601|Atacand|töflur|32|mg|28|stk|1|þpakki||C09CA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|5177|7959|lyfalmen|||00|28|0|112,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||||5177|7959| 019293|B02BC3001|TachoSil|svampur|5,5|mg|1|stk|1|pakki|+ 2,0 IU - 9,5x4,8 cm|B02BC30|01.05.2005||R|A|3|0|1|0|1|NYG|0|0|0|100|DKK|57026|73450|lyfsjukr|||00|1|0|0,0000|Gróco ehf|Nycomed Danmark A/S|Fíbrínógen og Mannatromnín manna||57026||57026|73450| 019295|B01AE0601|Angiox|sts/irs|250|mg|10|hgl|1|pakki|þykkni, lausn|B01AE06|01.05.2005||R|A|3|0|1|0|1|NYG|0|0|0|100|XEU|744365|936061|lyfsjukr|||00|10|0|0,0000|Gróco ehf|Nycomed Danmark A/S|Bívalirúdín||744365||744365|936061| 019339|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|A|2,5|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019403|QJ51CE0901|Carepen vet.|spenalyf|600|mg|10|g|100|stk|10 áf.spr|QJ51CE09|01.04.2010||R|A||0|0|0|0|VET|0|0|0|100|DKK|21172|40826|vetalmen|||00|1000|0||Dýraheilsa ehf|Vetcare Ltd.|Benzylpenicillínprokaín||||21172|40826| 019421|N06AX2102|Yentreve|hylki|20|mg|56|stk|1|þpakki|sýruþ.hylki, hörð|N06AX21|01.10.2004||R|A|2|0|0|0|0|ELD|0|0|0|100|XEU|6846|10242|lyfalmen|||00|56|0|0,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||6846||6846|10242| 019445|L01XC0701|Avastin|irþ|25|mg/ml|4|ml|1|hgl|lausn|L01XC07|01.05.2005||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|52419|67668|lyfsjukr|||AC|4|0|0,0000|Icepharma hf|Roche Registration Limited|Bevacizúmab||52419||52419|67668| 019469|N06AX2102|Yentreve|hylki|40|mg|56|stk|1|þpakki|sýruþ.hylki, hörð|N06AX21|01.10.2004||R|A|2|0|0|0|0|ELD|0|0|0|100|XEU|6846|10242|lyfalmen|||00|56|0|0,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||6846||6846|10242| 019491|N06AX2102|Yentreve|hylki|40|mg|140|stk|1|þpakki|sýruþ.hylki, hörð|N06AX21|01.10.2004||R|A|2|0|0|0|0|ELD|0|0|0|100|XEU|16847|23422|lyfalmen|||00|140|0|0,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||16847||16847|23422| 019513|C03CA0101|Furix|töflur|40|mg|100|stk|1|glas||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|600|1698|lyfalmen|||00|100|0|100,0000|Gróco ehf|Nycomed Danmark A/S|Fúrósemíð||600||600|1698| 019659|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|12,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019670|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|0,0000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019672|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|12,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019681|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019711|L01BC0501|Gemzar|irs|200|mg|1|hgl|1|pakki||L01BC05|01.03.1999||R|A|3|0|1|0|1|ELI|0|0|0|100|XEU|6062|8749|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Eli Lilly Danmark A/S|Gemcitabín||6062||6062|8749| 019713|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019724|N07BA0114|Nicotinell Classic|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019745|C03CA0101|Furix|töflur|40|mg|250|stk|1|glas|til vélskömmtunar|C03CA01|01.04.2005||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|627|1735|lyfalmen|||00|250|0|250,0000|Gróco ehf|Nycomed Danmark A/S|Fúrósemíð||627||627|1735| 019760|L01BC0501|Gemzar|irs|1|g|1|hgl|1|pakki||L01BC05|01.03.1999||R|A|3|0|1|0|1|ELI|0|0|0|100|XEU|23737|31672|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Eli Lilly Danmark A/S|Gemcitabín||23737||23737|31672| 019781|L01XC0701|Avastin|irþ|25|mg/ml|16|ml|1|hgl|lausn|L01XC07|01.05.2005||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|194631|246144|lyfsjukr|||AC|16|0|0,0000|Icepharma hf|Roche Registration Limited|Bevacizúmab||194631||194631|246144| 019782|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019786|J01CA0411|Amoxicillin Mylan|hylki|500|mg|20|stk|1|glas||J01CA04|01.04.1993||R|A|4|0|0|0|0|MYL|0|0|1|100|SEK|1116|2404|lyfalmen|||10|20|0|10,0000|Actavis Group PTC ehf|Mylan AB|Amoxicillín||1116||1116|2404| 019793|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|96|stk|1|pakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019797|L01BA0401|Alimta|irþ|500|mg/hgl|1|hgl|1|pakki||L01BA04|01.03.2005||R|A|2|0|1|0|1|ELD|0|0|0|100|XEU|198835|251420|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Eli Lilly Nederland B.V.|Pemetrexed||198835||198835|251420| 019811|N06BA0901|Strattera|hylki|10|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|XEU|12179|17564|lyfalmen|||00|28|0|3,5000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12179||12179|17564| 019833|N06BA0901|Strattera|hylki|18|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|XEU|12179|17564|lyfalmen|||00|28|0|6,3000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12179||12179|17564| 019837|G03GA0601|Puregon|stl|900|ae/rörly|1,08|ml|1|lykja||G03GA06|01.10.2005||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|55698|72180|lyfalmen|||00|1|0|12,0000|Vistor hf|N.V. Organon|Follitrópín beta||55698||55698|72180| 019857|N06BA0901|Strattera|hylki|25|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|XEU|12179|17564|lyfalmen|||00|28|0|8,7500|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12179||12179|17564| 019882|N06BA0901|Strattera|hylki|40|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|XEU|12179|17564|lyfalmen|||00|28|0|14,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12179||12179|17564| 019904|N06BA0901|Strattera|hylki|60|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|XEU|12179|17564|lyfalmen|||00|28|0|21,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12179||12179|17564| 019916|V03AF0801|Kepivance|sts|6,25|mg/hgl|6|hgl|1|pakki|lausn|V03AF08|01.07.2006||R|K|4|0|1|0|1|BIA|0|0|0|100|DKK|786253|988630|lyfsjukr|||02|6|0|8,9300|Vistor hf|Biovitrum AB (publ)|Palifermín||786253||786253|988630| 019931|N04BC0403|Adartrel|filmhtfl|0,25|mg|12|stk|1|þpakki||N04BC04|01.12.2006||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|387|1407|lyfalmen|||00|12|0|0,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||387||387|1407| 019938|J05AR0201|Kivexa|filmhtfl|900|mg|30|stk|1|þpakki|600+300 mg|J05AR02|01.05.2004||R|A|3|0|1|0|1|GGL|0|0|0|100|GBP|66454|85282|lyfsjukr|||00|30|0|0,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Lamívúdín og abacavír||66454||66454|85282| 019968|J01CA0411|Amoxicillin Mylan|hylki|500|mg|30|stk|1|glas||J01CA04|01.04.1995||R|A|4|0|0|0|0|MYL|0|0|1|100|SEK|1671|3163|lyfalmen|||10|30|0|15,0000|Actavis Group PTC ehf|Mylan AB|Amoxicillín||1671||1671|3163| 020016|B03AA0704|Duroferon|forðatfl|100|mg|100|stk|1|glas||B03AA07|01.03.1979||L|A|3|0|0|0|0|GCO|0|0|1|100|IKR|||lyflausa|||43|100|0|50,0000|Vistor hf|GlaxoSmithKline CH AB|Ferrósúlfat|||||| 020048|M02AA1502|Voltaren|hlaup|11,6|mg/g|100|g|1|túpa||M02AA15|01.03.2009||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|100|0|0,0000|Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||| 020193|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|96|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 020238|G04CA0203|Omnic Ocas|forðatfl|0,4|mg|30|stk|1|þpakki||G04CA02|01.04.2006||R|A|2|0|0|E|0|ASP|0|0|0|100|XEU|4464|6984|lyfalmen|||00|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||4464||4464|6984| 020244|J07CA0204|Boostrix Polio|stl|0| |0,5|ml|10|áf.spr|dreifa|J07CA02|01.09.2007||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|25911|34797|lyfalmen|||00|5|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|barnaveiki, kíghósti, mænusótt, stífkrampi||25911||25911|34797| 020276|A06AB0203|Dulcolax (Lyfjaver)|eþ-stíll|10|mg|50|stk|1|þpakki||A06AB02|01.07.2005||R|A|5|0|0|0|0|LVR|0|0|0|100|NOK|2701|4572|lyfalmen|||04|50|0|50,0000|Lyfjaver ehf|Lyfjaver ehf|Bisakódýl||2701||2701|4572| 020277|N06AX1602|Efexor Depot|forðahlk|37,5|mg|7|stk|1|þpakki||N06AX16|01.02.2007||R|A|3|0|0|0|0|PER|0|1|0|100|DKK|722|1865|lyfalmen|V0953|1560|00|7|0|2,6300|Icepharma hf|Pfizer ApS|Venlafaxín||722||722|1865| 020292|M02AA1502|Voltaren|hlaup|11,6|mg/g|50|g|1|túpa||M02AA15|01.06.2010||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|50|0||Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||| 020338|G04CA0203|Omnic Ocas|forðatfl|0,4|mg|90|stk|1|þpakki||G04CA02|01.04.2006||R|A|2|0|0|E|0|ASP|0|0|0|100|XEU|6816|10201|lyfalmen|||00|90|0|90,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||6816||6816|10201| 020355|L02AE0203|Eligard|sts|22,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|K|2|0|1|*|0|ASP|0|0|0|100|XEU|53200|69045|lyfalmen|||02|2|0|0,0000|Vistor hf|Astellas Pharma A/S|Leuprórelín||53200||53200|69045| 020364|N04BC0403|Adartrel|filmhtfl|0,5|mg|84|stk|1|þpakki||N04BC04|01.06.2006||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|4076|6453|lyfalmen|||00|84|0|7,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||4076||4076|6453| 020417|N04BC0403|Adartrel|filmhtfl|2|mg|84|stk|1|þpakki||N04BC04|01.12.2006||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|11784|16997|lyfalmen|||00|84|0|28,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||11784||11784|16997| 020427|L02AE0203|Eligard|sts|7,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|K|2|0|1|*|0|ASP|0|0|0|100|XEU|24667|33236|lyfalmen|||02|2|0|0,0000|Vistor hf|Astellas Pharma A/S|Leuprórelín||24667||24667|33236| 020444|D07AB0201|Locoid|krem|1|mg/g|30|g|1|túpa||D07AB02|01.07.1985||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|726|1870|lyfalmen|||20|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||726||726|1870| 020456|M05BX0301|Protelos|mixt.kyr|2|g|28|sk-pokar|1|pakki|dreifa|M05BX03|01.08.2005||R|A|3|0|0|0|0|SEV|0|0|0|100|DKK|6922|10346|lyfalmen|||00|28|0|28,0000|Icepharma hf|Servier|Strontíum ranelat||6922||6922|10346| 020457|D07AB0201|Locoid|krem|1|mg/g|100|g|1|túpa||D07AB02|01.03.1977||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|2118|3775|lyfalmen|||20|100|0|100,0000|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||2118||2118|3775| 020494|N03AX1102|Topimax (Lyfjaver)|töflur|25|mg|60|stk|1|plglas||N03AX11|01.08.2004|31.12.2010|R|A|3|0|0|E|0|LVR|0|0|0|100|SEK|4196|6617|lyfalmen|||00|60|0|5,0000|Lyfjaver ehf|Lyfjaver ehf|Tópíramat||4196||4196|6617| 020510|N03AX1102|Topimax (Lyfjaver)|töflur|50|mg|60|stk|1|plglas||N03AX11|01.07.2005|31.12.2010|R|A|3|0|0|E|0|LVR|0|0|0|100|SEK|6908|10327|lyfalmen|||00|60|0|10,0000|Lyfjaver ehf|Lyfjaver ehf|Tópíramat||6908||6908|10327| 020516|N03AX1102|Topimax (Lyfjaver)|töflur|100|mg|60|stk|1|plglas||N03AX11|01.09.2004|31.12.2010|R|A|3|0|0|E|0|LVR|0|0|0|100|SEK|12477|17938|lyfalmen|||00|60|0|20,0000|Lyfjaver ehf|Lyfjaver ehf|Tópíramat||12477||12477|17938| 020523|N06AB1002|Cipralex (D.A.C.)|töflur|10|mg|28|stk|1|þpakki||N06AB10|01.07.2004|31.12.2010|R|A||0|0|0|0|DAC|0|1|0|100|DKK|3051|5007|lyfalmen|||00|28|0|28,0000|D.A.C. ehf|D.A.C. ehf|Escítalópram||3019||3019|5007| 020533|M05BX0301|Protelos|mixt.kyr|2|g|84|sk-pokar|1|pakki|dreifa|M05BX03|01.08.2005||R|A|3|0|0|0|0|SEV|0|0|0|100|DKK|20308|27766|lyfalmen|||00|84|0|84,0000|Icepharma hf|Servier|Strontíum ranelat||20308||20308|27766| 020648|R06AX2201|Kestine|töflur|20|mg|10|stk|1|þpakki||R06AX22|01.10.2005||L|A|3|0|0|0|0|ALF|0|0|1|100|IKR|||lyflausa|||00|10|0|20,0000|Gróco ehf|Almirall-Prodesfarma S.A.|Ebastín|||||| 020711|G03AD0102|Postinor|töflur|1500|mcg|1|stk|1|þpakki||G03AD01|01.01.2007||L|A|4|0|0|0|0|MEI|0|0|0|100|IKR|||lyflausa|||23|1|0|0,0000|Icepharma hf|Medimpex UK Limited|Levonorgestrel|||||| 020770|QP54AA5101|Eqvalan Duo|pasta|0| |7,74|g|1|sk-dæl||QP54AA51|01.10.2006||R|A|3|0|0|0|0|MES|0|0|0|100|XEU|2225|3881|vetorma|||16|8|0|0,0000|Vistor hf|Merial SAS|||2225||2225|3881| 020774|L04AB0101|Enbrel|sts|50|mg|4|hgl|1|pakki|+ leysir|L04AB01|01.10.2005||R|K|3|0|1|0|1|WTE|0|0|0|100|DKK|181895|230161|lyfsjukr|||00|4|0|28,5700|Icepharma hf|Wyeth Europe|Etanercept||181895||181895|230161| 020924|J01FA1003|Zithromax (D.A.C.)|töflur|500|mg|3|stk|1|þpakki||J01FA10|01.09.2007||R|A|2|0|0|0|0|DAC|0|0|1|100|DKK|2520|4255|lyfalmen|V0429|4255|00|3|0|5,0000|D.A.C. ehf|D.A.C. ehf|Azitrómýcín||2469||2469|4255| 021048|R03DC0301|Singulair|filmhtfl|10|mg|28|stk|1|þpakki||R03DC03|01.09.1998||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|6040|9140|lyfalmen|||63|28|0|28,0000|Icepharma hf|M.S.D.|Montelúkast||6040||6040|9140| 021053|D10AD0301|Differin|hlaup|0,1|%|60|g|1|túpa||D10AD03|01.12.2007||R|A|3|0|0|0|0|GAN|0|0|0|100|SEK|2567|4389|lyfalmen|||00|60|0|60,0000|Icepharma hf|Galderma Nordic AB|Adapalen||2567||2567|4389| 021057|J01CR0203|Augmentine (D.A.C.)|töflur|625|mg|12|stk|1|þpakki|500+125 mg|J01CR02|01.05.2005||R|A|2|0|0|0|0|DAC|0|0|1|100|IKR|827|1854|lyfalmen|||00|12|0|7,5000|D.A.C. ehf|D.A.C. ehf|Amoxicillín og ensímblokkar||714||714|1854| 021091|S01ED5107|Xalacom (D.A.C.)|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml|S01ED51|01.04.2010||R|K||0|0|*|0|DAC|0|0|0|100|DKK|3210|5268|lyfalmen|V0988|5268|06|2|0|0,0000|D.A.C. ehf|D.A.C. ehf|Tímólól í blöndum||||3210|5268| 021149|J01CR0203|Augmentine (D.A.C.)|töflur|1000|mg|12|stk|1|þpakki|875+125 mg|J01CR02|01.05.2005||R|A|1,5|0|0|0|0|DAC|0|0|1|100|IKR|1093|2266|lyfalmen|V0466|2266|00|12|0|12,0000|D.A.C. ehf|D.A.C. ehf|Amoxicillín og ensímblokkar||1015||1015|2266| 021161|M01AB0513|Vostar-S|filmhtfl|50|mg|30|stk|1|þpakki||M01AB05|01.03.2005||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|453|1478|lyfalmen|V0609|1478|00|30|0|15,0000|Actavis Group hf|Actavis hf|Díklófenak||439||439|1478| 021169|S01XA1201|Corneregel|augnhl|50|mg/g|10|g|1|túpa||S01XA12|01.08.2005||R|A|2|0|0|E|0|GEM|0|0|0|100|XEU|1018|2270|lyfalmen|||00|10|0|0,0000|Actavis Group hf|Gerhard Mann|Dexpantenól||1018||1018|2270| 021227|M01AB0513|Vostar-S|filmhtfl|50|mg|100|stk|1|þpakki||M01AB05|01.03.2005||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|1187|2501|lyfalmen|V0610|2501|00|100|0|50,0000|Actavis Group hf|Actavis hf|Díklófenak||1187||1187|2501| 021257|G03BA0307|Nebido|stl|250|mg/ml|4|ml|1|lykja||G03BA03|01.07.2005||R|A|5|0|0|E|0|BAP|0|0|0|100|SEK|18475|25465|lyfalmen|||02|4|0|55,5600|Icepharma hf|Bayer Schering Pharma AG|Testósterón||18475||18475|25465| 021345|R03DC0301|Singulair|filmhtfl|10|mg|98|stk|1|þpakki||R03DC03|01.09.1998||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|17244|23920|lyfalmen|||63|98|0|98,0000|Icepharma hf|M.S.D.|Montelúkast||17244||17244|23920| 021375|M01AB0512|Voltaren Dolo|töflur|12,5|mg|20|stk|1|þpakki||M01AB05|01.10.2004||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|20|0|2,5000|Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||| 021417|R01AD0504|Rhinocort (D.A.C.)|nefúði|64|mcg/sk|120|sk|1|fl||R01AD05|01.11.2004||R|A||0|0|E|0|DAC|0|0|1|100|XEU|1730|3244|lyfalmen|V0965|3244|24|120|0|38,4000|D.A.C. ehf|D.A.C. ehf|Búdesóníð||1730||1730|3244| 021428|A06AB0201|Dulcolax|eþ-stíll|10|mg|6|stk|1|pakki||A06AB02|01.01.1995||L|A|5|0|0|0|0|BOI|0|0|0|100|IKR|||lyflausa|||04|6|0|6,0000|Vistor hf|Boehringer Ingelheim|Bisakódýl|||||| 021469|R03DC0301|Singulair|tuggutfl|5|mg|98|stk|1|þpakki||R03DC03|01.09.1998||R|A|2|0|0|B|0|MSD|0|0|0|100|XEU|22609|30653|lyfalmen|||63|98|0|49,0000|Icepharma hf|M.S.D.|Montelúkast||22609||22609|30653| 021494|N01AX1003|Propolipid|stl|10|mg/ml|20|ml|5|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|1580|2280|lyfsjukr|||02|100|0|0,0000|Icepharma hf|Fresenius Kabi|Própófól||1580||1580|2280| 021593|H01BA0201|Minirin|frþ.tfl|60|mcg|30|stk|1|þpakki||H01BA02|01.10.2005||R|A|2|0|0|E|0|FEL|0|0|0|100|DKK|4646|7233|lyfalmen|||00|30|0|4,5000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||4646||4646|7233| 021604|H01BA0201|Minirin|frþ.tfl|60|mcg|100|stk|1|þpakki||H01BA02|01.10.2005||R|A|2|0|0|E|0|FEL|0|0|0|100|DKK|14682|20705|lyfalmen|||00|100|0|15,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||14682||14682|20705| 021613|C10AA0701|Crestor|filmhtfl|5|mg|98|stk|1|þpakki||C10AA07|01.01.2006||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|14497|20473|lyfalmen|||00|98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||14497||14497|20473| 021614|H01BA0201|Minirin|frþ.tfl|120|mcg|30|stk|1|þpakki||H01BA02|01.10.2005||R|A|2|0|0|E|0|FAB|0|0|0|100|DKK|8319|12257|lyfalmen|||00|30|0|9,0000|Vistor hf|Ferring AB, Svíþjóð|Desmópressín||8319||8319|12257| 021636|N01AX1003|Propolipid|stl|10|mg/ml|100|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|15802|21714|lyfsjukr|||02|1000|0|0,0000|Icepharma hf|Fresenius Kabi|Própófól||15802||15802|21714| 021641|H01BA0201|Minirin|frþ.tfl|120|mcg|100|stk|1|þpakki||H01BA02|01.10.2005||R|A|2|0|0|E|0|FEL|0|0|0|100|DKK|22962|31096|lyfalmen|||00|100|0|30,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||22962||22962|31096| 021647|N01AX1003|Propolipid|stl|20|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|15802|21714|lyfsjukr|||02|500|0|0,0000|Icepharma hf|Fresenius Kabi|Própófól||15802||15802|21714| 021659|V01AA0304|Alutard SQ, derm. pter.|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|24324|32806|lyfalmen|||02|20|0|0,0000|Vistor hf|ALK-Abello A/S|rykmaurar||24324||24324|32806| 021674|C10AA0701|Crestor|filmhtfl|5|mg|28|stk|1|þpakki||C10AA07|01.01.2006||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|4557|7111|lyfalmen|||00|28|0|14,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||4557||4557|7111| 021676|N01AX1003|Propolipid|stl|10|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|17155|23412|lyfsjukr|||02|500|0|0,0000|Icepharma hf|Fresenius Kabi|Própófól||17155||17155|23412| 021677|B02AA0202|Tranexamsyre "Pfizer"|stl|100|mg/ml|5|ml|10|lykjur||B02AA02|01.11.2005||R|A|3|0|0|0|1|PER|0|0|0|100|DKK|4586|6619|lyfsjukr|||02|50|0|2,5000|Icepharma hf|Pfizer ApS|Tranexamsýra||4586||4586|6619| 021709|V01AA0304|Alutard SQ, derm. pter.|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|19473|26718|lyfalmen|||02|5|0|0,0000|Vistor hf|ALK-Abello A/S|rykmaurar||19473||19473|26718| 021721|N06AX2101|Cymbalta|sh-hylki|30|mg|28|stk|1|þpakki||N06AX21|01.04.2005||R|A|3|0|0|0|0|ELD|0|1|0|100|XEU|3834|6122|lyfalmen|||00|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||3834||3834|6122| 021862|A02BC0505|Nexium (D.A.C.)|sh-tfl|40|mg|28|stk|1|veski||A02BC05|01.01.2010||R|A||0|0|0|0|DAC|0|0|0|100|SEK|5967|8829|lyfalmen|V0085|8829|00|28|0|37,3300|D.A.C. ehf|D.A.C. ehf|Esómeprazól||5813||5813|8829| 021950|B05AA0705|HyperHAES|irl|0| |250|ml|10|pokar||B05AA07|01.07.2005||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|25560|33960|lyfsjukr|||00|2500|0|2,5000|Icepharma hf|Fresenius Kabi|Hýdróxyetýl sterkja||25560||25560|33960| 021967|N06AX2101|Cymbalta|sh-hylki|60|mg|28|stk|1|þpakki||N06AX21|01.04.2005||R|A|3|0|0|0|0|ELD|0|1|0|100|XEU|5298|8125|lyfalmen|||00|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||5298||5298|8125| 021975|N06AX2101|Cymbalta|sh-hylki|60|mg|98|stk|1|þpakki||N06AX21|01.04.2005||R|A|3|0|0|0|0|ELD|0|1|0|100|XEU|18258|25193|lyfalmen|||00|98|0|98,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||18258||18258|25193| 022020|V01AA0304|Alutard SQ, derm. pter.|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|19473|26718|lyfalmen|||02|5|0|0,0000|Vistor hf|ALK-Abello A/S|rykmaurar||19473||19473|26718| 022045|L01XE0301|Tarceva|filmhtfl|25|mg|30|stk|1|þpakki||L01XE03|01.01.2006||R|A|3|0|1|0|1|RRL|0|0|0|100|DKK|90756|115781|lyfsjukr|||00|30|0|0,0000|Icepharma hf|Roche Registration Limited|Erlótiníb||90756||90756|115781| 022087|QG03DA0201|Perlutex, vet.|töflur|5|mg|20|stk|1|þpakki||QG03DA02|01.10.1995|28.02.2011|R|A|5|0|0|0|0|LAH|0|0|0|100|DKK|690|1373|vetalmen|||16|20|0|0,0000|Vistor hf|LEO Animal Health A/S|||690||690|1373| 022112|B05AA0112|Flexbumin|irl|200|g/líter|100|ml|12|pokar|lausn|B05AA01|01.06.2010||R|A||0|0|0|1|BAM|0|0|0|100|SEK|123964|157457|lyfsjukr|||00|1200|0|1,2000|Icepharma hf|Baxter Medical AB|Albúmín||123964||123964|157457| 022128|A01AA0117|Fludent Banan|munnstfl|0,25|mg|200|stk|1|plglas||A01AA01|01.01.2008||L|A|5|0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||00|200|0|45,4500|Actavis Group hf|Actavis Group hf|Natríumflúoríð|||||| 022135|C10BA0201|Inegy|töflur|30|mg|28|stk|1|þpakki|10 mg + 20 mg|C10BA02|01.01.2010||R|A||0|0|0|0|MSD|0|0|0|100|XEU|7193|10717|lyfalmen|||00|28|0|28,0000|Icepharma hf|M.S.D.|Ezetimíb og simvastatín||7193||7193|10717| 022157|C10BA0201|Inegy|töflur|50|mg|28|stk|1|þpakki|10 mg + 40 mg|C10BA02|01.01.2010||R|A||0|0|0|0|MSD|0|0|0|100|XEU|8431|12410|lyfalmen|||00|28|0|28,0000|Icepharma hf|M.S.D.|Ezetimíb og simvastatín||8431||8431|12410| 022159|C10BA0201|Inegy|töflur|50|mg|98|stk|1|þpakki|10 mg + 40 mg|C10BA02|01.09.2005||R|A|1,5|0|0|0|0|MSD|0|0|0|100|XEU|27985|37400|lyfalmen|||00|98|0|98,0000|Icepharma hf|M.S.D.|Ezetimíb og simvastatín||27985||27985|37400| 022165|A10AB0606|Apidra [Clikstar]|stl|100|ein/ml|3|ml|5|lykjur|rörlykjur fyrir Clikstar penna|A10AB06|01.07.2010||R|K||0|0|*|0|SAA|0|0|0|100|NOK|5271|8088|lyfalmen|||02|15|0|37,5000|Vistor hf|Sanofi - Aventis|Insúlín glúlisín||5271||5271|8088| 022174|C10BA0201|Inegy|töflur|90|mg|28|stk|1|þpakki|10 mg + 80 mg|C10BA02|01.01.2010||R|A||0|0|0|0|MSD|0|0|0|100|XEU|8991|13176|lyfalmen|||00|28|0|28,0000|Icepharma hf|M.S.D.|Ezetimíb og simvastatín||8991||8991|13176| 022191|L01XE0301|Tarceva|filmhtfl|100|mg|30|stk|1|þpakki||L01XE03|01.01.2006||R|A|3|0|1|0|1|RRL|0|0|0|100|DKK|313909|395838|lyfsjukr|||00|30|0|0,0000|Icepharma hf|Roche Registration Limited|Erlótiníb||313909||313909|395838| 022205|L01XE0301|Tarceva|filmhtfl|150|mg|30|stk|1|þpakki||L01XE03|01.01.2006||R|A|3|0|1|0|1|RRL|0|0|0|100|DKK|323850|408314|lyfsjukr|||00|30|0|0,0000|Icepharma hf|Roche Registration Limited|Erlótiníb||323850||323850|408314| 022215|N06AB0504|Paxetin|töflur|20|mg|20|stk|1|glas||N06AB05|01.01.2005||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|584|1226|lyfalmen|V0917|1226|00|20|0|20,0000|Actavis Group hf|Actavis hf|Paroxetín||255||255|1226| 022218|QP52AA5102|Drontal Comp.vet.|töflur|0| |24|stk|1|þpakki||QP52AA51|01.01.2006||R|A|5|0|0|0|0|BAN|0|0|0|100|DKK|10261|17900|vetorma|||00|24|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||10261||10261|17900| 022250|M03AX0103|Vistabel|sts|50|ein/hgl|1|hgl|1|pakki|4 Allerg.ein/0,1ml|M03AX01|01.02.2008||R|K|2|0|1|0|0|ALL|0|0|0|100|SEK|28840|38473|lyfalmen|||02|1|0|0,0000|Vistor hf|Allergan|Clostridium botulinum toxín-A||28840||28840|38473| 022261|QP52AA5107|Profender fyrir kisur 5-8 kg|bl.lausn|1,12|ml/sk|1,12|ml|2|skammt||QP52AA51|01.09.2006||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|2269|3958|vetorma|||00|2|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||2269||2269|3958| 022269|C08CA0101|Norvasc|töflur|5|mg|30|stk|1|þpakki||C08CA01|01.01.1992||R|A|4|0|0|B|0|PER|0|0|0|100|DKK|2915|4865|lyfalmen|||00|30|0|30,0000|Icepharma hf|Pfizer ApS|Amlódipín||2915||2915|4865| 022281|QP52AA5102|Drontal Comp.vet.|töflur|0| |2|stk|1|þpakki||QP52AA51|01.10.1991||L|A|5|0|0|0|0|BAN|0|0|0|100|DKK|1381|2409|vetorma|||00|2|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||||1381|2409| 022293|C08CA0101|Norvasc|töflur|5|mg|100|stk|1|þpakki||C08CA01|01.01.1992||R|A|4|0|0|B|0|PER|0|0|0|100|DKK|3899|2610|lyfalmen|V0308|2502|00|100|0|100,0000|Icepharma hf|Pfizer ApS|Amlódipín||1267||1267|2610| 022368|C08CA0101|Norvasc|töflur|10|mg|100|stk|1|þpakki||C08CA01|01.01.1992||R|A|4|0|0|B|0|PER|0|0|0|100|DKK|6738|3628|lyfalmen|V0310|3450|00|100|0|200,0000|Icepharma hf|Pfizer ApS|Amlódipín||2011||2011|3628| 022407|QP52AA5106|Profender fyrir kisur 2,5-5 kg|bl.lausn|0,7|ml/sk|0,7|ml|2|skammt||QP52AA51|01.09.2006||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|2149|3749|vetorma|||00|1|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||2149||2149|3749| 022440|D07AB0203|Locoid Lipid|krem|1|mg/g|30|g|1|túpa|feitt|D07AB02|01.07.1986||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|744|1895|lyfalmen|||20|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||744||744|1895| 022451|D07AB0203|Locoid Lipid|krem|1|mg/g|100|g|1|túpa|feitt|D07AB02|01.04.1987||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|2162|3835|lyfalmen|||20|100|0|100,0000|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||2162||2162|3835| 022465|QP52AA5105|Profender fyrir kisur 0,5-2,5 kg|bl.lausn|0,35|ml/sk|0,35|ml|2|skammt||QP52AA51|01.09.2006||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|1391|2427|vetorma|||00|1|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||1391||1391|2427| 022532|C09DA0303|Diovan Comp 160/12,5 mg|filmhtfl|172,5|mg|28|stk|1|þpakki||C09DA03|01.11.2003||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|4682|7282|lyfalmen|||00|28|0|56,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og þvagræsilyf||4682||4682|7282| 022537|N06AB0504|Paxetin|töflur|20|mg|100|stk|1|glas||N06AB05|01.01.2005||R|A||0|0|B|0|ACA|0|1|0|100|IKR|2400|2754|lyfalmen|V0919|2754|00|100|0|100,0000|Actavis Group hf|Actavis hf|Paroxetín||1372||1372|2754| 022577|N06AB0504|Paxetin|töflur|20|mg|60|stk|1|glas||N06AB05|01.01.2005||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|1554|1944|lyfalmen|V0918|1944|00|60|0|60,0000|Actavis Group hf|Actavis hf|Paroxetín||780||780|1944| 022585|L04AX0304|Metotrexato Lederle (D.A.C.)|töflur|2,5|mg|50|stk|1|glas||L04AX03|01.08.2005||R|A|3|0|0|*|0|DAC|0|0|0|100|DKK|1233|2437|lyfalmen|||00|50|0|50,0000|D.A.C. ehf|D.A.C. ehf|Metótrexat||1140||1140|2437| 022708|C09DA0303|Diovan Comp 160/12,5 mg|filmhtfl|172,5|mg|98|stk|1|þpakki||C09DA03|01.11.2003||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|13578|19319|lyfalmen|||00|98|0|196,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og þvagræsilyf||13578||13578|19319| 022802|L01XC0401|MabCampath|irþ|30|mg/ml|1|ml|3|hgl||L01XC04|01.07.2007||R|K|2|0|1|0|1|GEU|0|0|0|100|SEK|227026|286800|lyfsjukr|||00|3|0|0,0000|Icepharma hf|Genzyme Europe B.V. (I)|Alemtuzumab||227026||227026|286800| 022845|S01XA2019|Oftagel|augnhl|2,5|mg/g|0,5|g|30|sk-hyl||S01XA20|01.05.2007||L|A|3|0|0|E|0|SAO|0|0|0|100|XEU|||lyfalmen|||00|15|0|0,0000|Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar sam­setningar|||||2776| 022904|D10BA0102|Decutan|hylki|10|mg|30|stk|1|þpakki||D10BA01|01.02.2006||R|A|3|0|1|C|0|ACA|0|0|0|30|IKR|1407|2725|lyfalmen|V0409|2725|67|30|0|10,0000|Actavis Group hf|Actavis hf|Ísótretínóín||1351||1351|2725| 022915|D10BA0102|Decutan|hylki|20|mg|30|stk|1|þpakki||D10BA01|01.02.2006||R|A|3|0|1|C|0|ACA|0|0|0|30|IKR|2450|4095|lyfalmen|V0410|4095|67|30|0|20,0000|Actavis Group hf|Actavis hf|Ísótretínóín||2352||2352|4095| 022962|V01AA1104|Alutard SQ, hrossaværur|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|24324|32806|lyfalmen|||02|20|0|0,0000|Vistor hf|ALK-Abello A/S|dýr||24324||24324|32806| 022970|V01AA1104|Alutard SQ, hrossaværur|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|19473|26718|lyfalmen|||02|5|0|0,0000|Vistor hf|ALK-Abello A/S|dýr||19473||19473|26718| 023047|G04BD1001|Emselex|forðatfl|7,5|mg|28|stk|1|þpakki||G04BD10|01.07.2005||R|A|3|0|0|E|0|NOE|0|0|0|100|DKK|5661|8621|lyfalmen|||00|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Darífenacín||5661||5661|8621| 023063|J05AR0301|Truvada|filmhtfl|445|mg|30|stk|1|glas|200+245 mg|J05AR03|01.03.2006||R|A|3|0|1|0|1|GIS|0|0|0|100|DKK|92409|117856|lyfsjukr|||00|30|0|0,0000|Gilead Sience Sweden AB|Gilead Science International ltd.|Tenófóvír dísóproxíl og emtrícítabín||92409||92409|117856| 023066|V03AE0301|Fosrenol|tuggutfl|500|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|A|2|0|1|0|0|SHI|0|0|0|100|DKK|25742|34585|lyfalmen|||00|90|0|20,0000|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Lanthanum karbónat||25742||25742|34585| 023080|V03AE0301|Fosrenol|tuggutfl|750|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|A|2|0|1|0|0|SHI|0|0|0|100|DKK|40191|52719|lyfalmen|||00|90|0|30,0000|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Lanthanum karbónat||40191||40191|52719| 023124|G04BD1001|Emselex|forðatfl|7,5|mg|98|stk|1|þpakki||G04BD10|01.07.2005||R|A|3|0|0|E|0|NOE|0|0|0|100|DKK|20353|27822|lyfalmen|||00|98|0|0,0000|Vistor hf|Novartis Europharm Ltd|Darífenacín||20353||20353|27822| 023146|G04BD1001|Emselex|forðatfl|15|mg|28|stk|1|þpakki||G04BD10|01.07.2005||R|A|3|0|0|E|0|NOE|0|0|0|100|DKK|5718|8699|lyfalmen|||00|28|0|56,0000|Vistor hf|Novartis Europharm Ltd|Darífenacín||5718||5718|8699| 023193|G04BD1001|Emselex|forðatfl|15|mg|98|stk|1|þpakki||G04BD10|01.07.2005||R|A|3|0|0|E|0|NOE|0|0|0|100|DKK|20559|28081|lyfalmen|||00|98|0|0,0000|Vistor hf|Novartis Europharm Ltd|Darífenacín||20559||20559|28081| 023325|V03AB2501|Lanexat|stl|0,1|mg/ml|5|ml|5|lykjur||V03AB25|01.07.1989||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|20869|28073|lyfsjukr|||02|25|0|0,0000|Icepharma hf|Roche|Flúmazeníl||20869||20869|28073| 023329|N03AX1206|Gabapentin Mylan|hylki|300|mg|100|stk|1|glas||N03AX12|01.01.2010||R|A||0|0|E|0|MYL|0|0|0|100|SEK|4939|7439|lyfalmen|V0714|7311|00|100|0|16,6667|Actavis Group PTC ehf|Mylan AB|Gabapentín||4797||4797|7439| 023376|N03AX1206|Gabapentin Mylan|hylki|400|mg|100|stk|1|glas||N03AX12|01.01.2010||R|A||0|0|E|0|MYL|0|0|0|100|SEK|5838|8863|lyfalmen|V0715|8528|00|100|0|22,2200|Actavis Group PTC ehf|Mylan AB|Gabapentín||5838||5838|8863| 023409|N01BB2004|Oraqix|thhlaup|5|%|1,7|g|20|rörlyk||N01BB20|01.09.2006||R|A|3|0|0|0|0|DED|0|0|1|100|XEU|17200|23865|lyfalmen|||00|34|0|0,0000|Vistor hf|Dentsply DeTrey GmbH|Blöndur||17200||17200|23865| 023414|B03XA0201|Aranesp|stl|20|mcg/pen|0,5|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|8601|12413|lyfsjukr|||00|0|0|4,4400|Vistor hf|Amgen|Darbepóetín alfa||8601||8601|12413| 023419|B03XA0201|Aranesp|stl|80|mcg/pen|0,4|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|33858|44374|lyfsjukr|||00|0|0|17,7800|Vistor hf|Amgen|Darbepóetín alfa||33858||33858|44374| 023425|B03XA0201|Aranesp|stl|60|mcg/pen|0,3|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|25626|34043|lyfsjukr|||00|0|0|13,3300|Vistor hf|Amgen|Darbepóetín alfa||25626||25626|34043| 023441|B03XA0201|Aranesp|stl|150|mcg/pen|0,3|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|61004|78443|lyfsjukr|||00|0|0|33,3300|Vistor hf|Amgen|Darbepóetín alfa||61004||61004|78443| 023447|B03XA0201|Aranesp|stl|100|mcg/pen|0,5|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|40728|52996|lyfsjukr|||00|0|0|22,2200|Vistor hf|Amgen|Darbepóetín alfa||40728||40728|52996| 023448|J06BA0207|Kiovig|irl|100|mg/ml|10|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|9964|14381|lyfsjukr|||00|10|0|0,0000|Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||9964||9964|14381| 023452|B03XA0201|Aranesp|stl|300|mcg/pen|0,6|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|121929|154903|lyfsjukr|||00|1|0|66,6700|Vistor hf|Amgen|Darbepóetín alfa||121929||121929|154903| 023459|J06BA0207|Kiovig|irl|100|mg/ml|25|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|24910|33145|lyfsjukr|||00|25|0|0,0000|Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||24910||24910|33145| 023463|B03XA0201|Aranesp|stl|40|mcg/pen|0,4|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|16749|22902|lyfsjukr|||00|0|0|8,8900|Vistor hf|Amgen|Darbepóetín alfa||16749||16749|22902| 023468|B01AX0501|Arixtra|stl|2,5|mg/spr|0,5|ml|20|spr|áfyllt sprauta|B01AX05|01.08.2006|28.02.2011|R|A|2|0|0|E|0|GGL|0|0|0|100|GBP|12416|17861|lyfalmen|||00|10|0|20,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||12416||12416|17861| 023470|J06BA0207|Kiovig|irl|100|mg/ml|50|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|49821|64408|lyfsjukr|||00|50|0|0,0000|Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||49821||49821|64408| 023476|J06BA0207|Kiovig|irl|100|mg/ml|100|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|99640|126931|lyfsjukr|||00|100|0|0,0000|Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||99640||99640|126931| 023479|B01AX0501|Arixtra|stl|5|mg/spr|0,4|ml|7|spr|áfyllt sprauta|B01AX05|01.08.2006||R|A|3|0|0|E|0|GGL|0|0|0|100|GBP|8923|13083|lyfalmen|||00|3|0|14,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||8923||8923|13083| 023480|B03XA0201|Aranesp|stl|500|mcg/pen|1|ml|1|penni|áfyllur penni|B03XA02|01.07.2007||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|195009|246619|lyfsjukr|||00|1|0|111,1100|Vistor hf|Amgen|Darbepóetín alfa||195009||195009|246619| 023487|J06BA0207|Kiovig|irl|100|mg/ml|200|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|183941|232728|lyfsjukr|||00|200|0|0,0000|Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||183941||183941|232728| 023491|B01AX0501|Arixtra|stl|10|mg/spr|0,8|ml|7|spr|áfyllt sprauta|B01AX05|01.08.2006||R|A|3|0|0|E|0|GGL|0|0|0|100|GBP|17844|24673|lyfalmen|||00|6|0|28,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||17844||17844|24673| 023501|B01AX0501|Arixtra|stl|7,5|mg/spr|0,6|ml|7|spr|áfyllt sprauta|B01AX05|01.08.2006||R|A|3|0|0|E|0|GGL|0|0|0|100|GBP|13384|19076|lyfalmen|||00|4|0|21,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||13384||13384|19076| 023506|J05AE0901|Aptivus|hylki|250|mg|120|stk|1|glas||J05AE09|01.03.2007||R|A|3|0|1|0|1|BII|0|0|0|100|DKK|139529|176991|lyfsjukr|||00|120|0|30,0000|Vistor hf|Boehringer Ingelheim International |Tipranavír||139529||139529|176991| 023509|B01AC0401|Plavix|töflur|75|mg|100|stk|1|þpakki||B01AC04|01.07.2007||R|A|3|0|0|E|0|SBM|0|0|0|100|NOK|26484|30018|lyfalmen|V0090|15182|00|100|0|100,0000|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Klópídógrel||22103||22103|30018| 023544|B01AX0501|Arixtra|stl|2,5|mg/spr|0,5|ml|7|spr|áfyllt sprauta|B01AX05|01.08.2006||R|A|2|0|0|E|0|GGL|0|0|0|100|GBP|4343|6818|lyfalmen|||00|4|0|7,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||4343||4343|6818| 023590|S01ED0106|Timosan Depot|augnhl|1|mg/g|0,4|g|30|sk-hyl||S01ED01|01.07.2007||R|A|2,5|0|0|*|0|SAO|0|0|0|100|XEU|3612|5818|lyfalmen|||00|12|0|60,0000|Icepharma hf|Santen Oy|Tímólól||3612||3612|5818| 023708|J05AE0101|Invirase|filmhtfl|500|mg|120|stk|1|glas||J05AE01|01.01.2006||R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|56705|73047|lyfsjukr|||00|120|0|100,0000|Icepharma hf|Roche|Saquínavír||56705||56705|73047| 023809|A10AE0404|Lantus [OptiClik]|stl|100|ein/ml|3|ml|5|rörlyk|fyrir OptiClik|A10AE04|01.04.2007|31.01.2011|R|K|2|0|0|*|0|SDE|0|0|0|100|NOK|10043|14616|lyfalmen|||00|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||10043||10043|14616| 023968|G04BE0302|Revatio|filmhtfl|20|mg|90|stk|1|þpakki||G04BE03|01.08.2006||R|A|5|0|1|0|1|IPI|0|0|0|100|DKK|80614|103053|lyfsjukr|||00|90|0|36,0000|Icepharma hf|Pfizer Limited|Síldenafíl||80614||80614|103053| 024018|N04BA0204|Sinemet 25/100|töflur|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.10.1985||R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|3037|5032|lyfalmen|||00|100|0|16,6667|Icepharma hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||3037||3037|5032| 024024|J01AA1201|Tygacil|irs|50|mg|10|hgl|1|pakki||J01AA12|01.02.2007||R|A|1,5|0|0|0|1|WTE|0|0|0|100|DKK|77533|99186|lyfsjukr|||00|10|0|5,0000|Icepharma hf|Wyeth Europe|Tigecýklín||77533||77533|99186| 024037|J01DB0401|Kefzol|sts|1|g|10|stk|1|hgl||J01DB04|01.09.2005||R|A|2|0|0|0|1|NOM|0|0|0|100|DKK|5856|8452|lyfsjukr|||03|10|0|3,3333|Icepharma hf|NordMedica ApS|Cefazólín||5856||5856|8452| 024056|N02AB0301|Durogesic|forðapl|12|mcg/klst|5|stk|1|þpakki||N02AB03|01.02.2006||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|3541|5721|lyfalmen|V0102|5625|00|5|0|9,9900|Vistor hf|Janssen-Cilag AB|Fentanýl||3541||3541|5721| 024090|N04BD0201|Azilect|töflur|1|mg|30|stk|1|glas||N04BD02|01.10.2005||R|A|3|0|0|E|0|TPG|0|0|0|100|DKK|19777|27099|lyfalmen|||00|30|0|30,0000|Lundbeck Export A/S|Teva Pharma GmbH|Rasagilín||19777||19777|27099| 024135|B05BB0119|Ringer-Acetat Baxter Viaflo|irl|0| |1000|ml|10|pokar|lausn|B05BB01|01.10.2005||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|2487|3589|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter Medical AB|Elektrólýtar||2487||2487|3589| 024151|B05BA1020|StructoKabiven elektrolyfri|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.03.2010||R|A||0|0|0|1|FRP|0|0|0|100|DKK|31630|41578|lyfsjukr|||00|3944|0|3,9400|Icepharma hf|Fresenius Kabi|Blöndur||31630||31630|41578| 024200|N04BD0201|Azilect|töflur|1|mg|100|stk|1|þpakki||N04BD02|01.10.2005||R|A|3|0|0|E|0|TPG|0|0|0|100|DKK|63975|82568|lyfalmen|||00|100|0|100,0000|Lundbeck Export A/S|Teva Pharma GmbH|Rasagilín||63975||63975|82568| 024307|V01AA1105|Alutard SQ, hundahar|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|24324|32806|lyfalmen|||02|20|0|0,0000|Vistor hf|ALK-Abello A/S|dýr||24324||24324|32806| 024478|V04CL0016|Soluprick SQ ALK553 - hundahár|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|7657|11352|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7657||7657|11352| 024481|R03CC0301|Bricanyl|mixtúra|0,3|mg/ml|100|ml|1|fl||R03CC03|01.03.2006||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|445|1486|lyfalmen|||00|100|0|2,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||445||445|1486| 024482|V04CL0017|Soluprick SQ ALK555 - kattahár|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|7657|11352|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7657||7657|11352| 024504|V04CL0003|Soluprick SQ ALK106 - Rauðölur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|12902|18471|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||12902||12902|18471| 024510|V04CL0004|Soluprick SQ ALK107 - Gráölur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|12902|18471|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||12902||12902|18471| 024526|V04CL0006|Soluprick SQ ALK113 - Hesliviður|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|12924|18499|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||12924||12924|18499| 024532|V04CL0007|Soluprick SQ ALK203 - Háliðagras|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|12902|18471|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||12902||12902|18471| 024559|V04CL0008|Soluprick SQ ALK214 -Axhnoðapunktur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|12902|18471|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||12902||12902|18471| 024565|V04CL0009|Soluprick SQ ALK218 - Hávingull|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|13056|18664|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||13056||13056|18664| 024576|V04CL0010|Soluprick SQ ALK223 - Vallarrýgresi|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|12902|18471|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||12902||12902|18471| 024583|V04CL0011|Soluprick SQ ALK225 - Vallarfoxgras|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|7657|11352|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7657||7657|11352| 024589|V04CL0012|Soluprick SQ ALK228 - Vallarsveifgras|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|12902|18471|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||12902||12902|18471| 024590|M05BA0802|Aclasta|irl|5|mg|100|ml|1|fl|lausn|M05BA08|01.07.2005||R|A|3|0|1|0|0|NOE|0|0|0|100|DKK|72885|93750|lyfalmen|||00|100|0|360,0000|Vistor hf|Novartis Europharm Ltd|Zoledronsýra||72885||72885|93750| 024600|V04CL0013|Soluprick SQ ALK231 - Rúgur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|13056|18664|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||13056||13056|18664| 024603|V04CL0001|Soluprick Negativ Kontrol|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|3|0|0|0|0|ALK|0|0|0|100|DKK|1572|3028|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||1572||1572|3028| 024622|V04CL0005|Soluprick SQ ALK108 - Birkifrjó|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|7657|11352|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7657||7657|11352| 024644|V04CL0015|Soluprick SQ ALK552 - Hrossaværur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|7657|11352|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7657||7657|11352| 024670|V04CL0014|Soluprick SQ ALK504 - Rykmaur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|7657|11352|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7657||7657|11352| 024681|V04CL0002|Soluprick Positiv Kontrol|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|3|0|0|0|0|ALK|0|0|0|100|DKK|1572|3028|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||1572||1572|3028| 025142|D07AB0202|Locoid Crelo|lausn|1|mg/g|30|g|1|glas|á húð|D07AB02|01.04.1994||R|A|2|0|0|B|0|ASP|0|0|1|100|XEU|919|2134|lyfalmen|||20|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||919||919|2134| 025155|V01AA1105|Alutard SQ, hundahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|19473|26718|lyfalmen|||02|5|0|0,0000|Vistor hf|ALK-Abello A/S|dýr||19473||19473|26718| 025174|D07AB0202|Locoid Crelo|lausn|1|mg/g|100|g|1|glas|á húð|D07AB02|01.04.1994||R|A|2|0|0|B|0|ASP|0|0|1|100|XEU|2630|4475|lyfalmen|||20|100|0|100,0000|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||2630||2630|4475| 025180|R03BA0201|Pulmicort|innúðal|100|mcg/sk|120|sk|1|stauk||R03BA02|01.01.2009||R|A|2|0|0|0|0|AZD|0|0|0|100|SEK|2180|3859|lyfalmen|||0|120|0|15,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||2180||2180|3859| 025191|R03BA0201|Pulmicort|innúðal|200|mcg/sk|120|sk|1|stauk||R03BA02|01.01.2009||R|A|2|0|0|0|0|AZD|0|0|0|100|SEK|4148|6552|lyfalmen|||0|120|0|30,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||4148||4148|6552| 025262|V01AA1105|Alutard SQ, hundahar|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|19473|26718|lyfalmen|||02|5|0|0,0000|Vistor hf|ALK-Abello A/S|dýr||19473||19473|26718| 025300|J01DB0101|Keflex|mixtúrud|50|mg/ml|100|ml|1|glas||J01DB01|01.03.1983||R|A|3|0|0|0|0|PAD|0|0|1|100|DKK|956|2185|lyfalmen|||08|100|0|2,5000|Icepharma hf|PharmaCoDane ApS|Cefalexín||956||956|2185| 025306|M05BB0301|Fosavance|töflur|0| |12|stk|1|þpakki|70mg+70mcg|M05BB03|01.10.2006||R|A|1,5|0|0|0|0|MSD|0|0|0|100|XEU|13822|19626|lyfalmen|||00|12|0|84,0000|Icepharma hf|M.S.D.|Alendrónsýra og kólekalsíferól||13822||13822|19626| 025311|J01DB0101|Keflex|töflur|500|mg|14|stk|1|þpakki||J01DB01|01.07.1988||R|A|3|0|0|0|0|PAD|0|0|1|100|IKR|794|1963|lyfalmen|||00|14|0|3,5000|Icepharma hf|PharmaCoDane ApS|Cefalexín||794||794|1963| 025317|J05AF1001|Baraclude|filmhtfl|1|mg|30|stk|1|þpakki||J05AF10|01.09.2007||R|A|2|0|1|0|1|BSP|0|0|0|100|DKK|100166|127591|lyfsjukr|||00|30|0|60,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||100166||100166|127591| 025323|J05AF1001|Baraclude|filmhtfl|0,5|mg|30|stk|1|þpakki||J05AF10|01.09.2007||R|A|2|0|1|0|1|BSP|0|0|0|100|DKK|99026|126160|lyfsjukr|||00|30|0|30,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||99026||99026|126160| 025388|QM01AC0601|Metacam|stl|5|mg/ml|20|ml|1|hgl||QM01AC06|01.10.2006||R|A|3|0|0|0|0|BOI|1|0|0|100|DKK|9649|18700|vetalmen|||00|20|0|0,0000|Vistor hf|Boehringer Ingelheim|||9649||9649|18700| 025425|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|30|stk|1|þpakki|frostþurrkaðar|V01AA02|01.02.2008||R|A|3|0|1|0|0|ALK|0|0|0|100|DKK|17875|24712|lyfalmen|||00|30|0|0,0000|Vistor hf|ALK-Abello A/S|grasfrjó||17875||17875|24712| 025444|C09CA0301|Diovan|filmhtfl|320|mg|98|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.04.2007||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|21741|29564|lyfalmen|||00|98|0|392,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||21741||21741|29564| 025455|C09CA0301|Diovan|töflur|320|mg|28|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.04.2007||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|6342|9553|lyfalmen|||00|28|0|112,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||6342||6342|9553| 025555|N05AX0803|Risperdal Consta|sts|50|mg|1|hgl|1|pakki||N05AX08|01.04.2003||R|K|3|0|0|*|0|JAS|0|1|0|100|SEK|34981|46180|lyfalmen|||00|1|0|18,5200|Vistor hf|Janssen-Cilag AB|Risperídón||34981||34981|46180| 025578|S01EC0302|Trusopt (D.A.C.)|augndr|20|mg/ml|5|ml|1|glas||S01EC03|01.04.2010||R|A||0|0|*|0|DAC|0|0|0|100|XEU|1924|3509|lyfalmen|V1090|3509|06|5|0|16,6667|D.A.C. ehf|D.A.C. ehf|Dorzólamíð||1924||1924|3509| 025588|M05BA0602|Bonviva|filmhtfl|150|mg|1|stk|1|þpakki||M05BA06|01.01.2006||R|A|2|0|0|0|0|RRL|0|0|0|100|DKK|5284|8105|lyfalmen|||00|1|0|30,0000|Icepharma hf|Roche Registration Limited|Íbandrónsýra||5284||5284|8105| 025599|M05BA0602|Bonviva|filmhtfl|150|mg|3|stk|1|þpakki||M05BA06|01.01.2006||R|A|2|0|0|0|0|RRL|0|0|0|100|DKK|13782|19575|lyfalmen|||00|3|0|90,0000|Icepharma hf|Roche Registration Limited|Íbandrónsýra||13782||13782|19575| 025676|L01CB0201|Vumon|stl|10|mg/ml|5|ml|10|lykjur||L01CB02|01.05.1998||R|A||0|1|0|1|PCO|0|0|0|100|IKR|34429|45091|lyfsjukr|||00|50|1|0,0000|Distica|Distica - óskráð lyf|||34429||34429|45091| 025698|N05AX0803|Risperdal Consta|sts|25|mg|1|hgl|1|pakki||N05AX08|01.04.2003||R|K|3|0|0|*|0|JAS|0|1|0|100|SEK|18675|25716|lyfalmen|||00|1|0|9,2600|Vistor hf|Janssen-Cilag AB|Risperídón||18675||18675|25716| 025709|N05AX0803|Risperdal Consta|sts|37,5|mg|1|hgl|1|pakki||N05AX08|01.04.2003||R|K|3|0|0|*|0|JAS|0|1|0|100|SEK|27011|36178|lyfalmen|||00|1|0|13,8900|Vistor hf|Janssen-Cilag AB|Risperídón||27011||27011|36178| 025736|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|100|stk|1|þpakki|frostþurrkaðar|V01AA02|01.02.2008||R|A|3|0|1|0|0|ALK|0|0|0|100|DKK|55808|72318|lyfalmen|||00|100|0|0,0000|Vistor hf|ALK-Abello A/S|grasfrjó||55808||55808|72318| 025747|C01BB0101|Xylocard 100 mg/ 5 ml|stl|20|mg/ml|5|ml|5|gl-lyk||C01BB01|01.12.2006||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|7435|10731|lyfsjukr|||02|25|0|0,1667|Vistor hf|AstraZeneca A/S DK|Lídókaín||7435||7435|10731| 025841|V01AA1106|Alutard SQ, kattahar|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|24324|32806|lyfalmen|||02|20|0|0,0000|Vistor hf|ALK-Abello A/S|dýr||24324||24324|32806| 025958|M01AE0218|Naproxen Mylan|töflur|250|mg|100|stk|1|glas||M01AE02|01.01.1991||R|A|4|0|0|E|0|MYL|0|0|1|100|SEK|1013|2263|lyfalmen|||00|100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||1013||1013|2263| 025965|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|1|l|1|fl||QP54AA01|01.04.1992||R|A|3|0|0|0|0|MEF|0|0|0|100|XEU|4743|8274|vetorma|||16|1|0|0,0000|Vistor hf|Merial (MSD)|||4743||4743|8274| 025976|M01AE0218|Naproxen Mylan|töflur|500|mg|25|stk|1|glas||M01AE02|01.12.2009||R|A||0|0|E|0|MYL|0|0|1|100|SEK|553|1634|lyfalmen|||00|25|0|25,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||553||553|1634| 025994|M01AE0218|Naproxen Mylan|töflur|500|mg|100|stk|1|glas||M01AE02|01.01.1991||R|A|4|0|0|E|0|MYL|0|0|1|100|SEK|1862|3424|lyfalmen|||00|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||1862||1862|3424| 026021|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|2,5|l|1|fl||QP54AA01|01.04.1992||R|A|3|0|0|0|0|MEF|0|0|0|100|XEU|9344|16300|vetorma|||16|2|0|0,0000|Vistor hf|Merial (MSD)|||9344||9344|16300| 026096|V01AA1106|Alutard SQ, kattahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|19473|26718|lyfalmen|||02|5|0|0,0000|Vistor hf|ALK-Abello A/S|dýr||19473||19473|26718| 026101|L01CA0501|Javlor|irþ|25|mg/ml|2|ml|1|hgl|lausn|L01CA05|01.12.2010||R|K||0|1|0|1|PFM|0|0|0|100|DKK|43118|55996|lyfsjukr|||00|2|0||Vistor hf|Pierre Fabre Médicament|Vínflúnín||43118||43118|55996| 026114|L01CA0501|Javlor|irþ|25|mg/ml|10|ml|1|hgl|lausn|L01CA05|01.12.2010||R|K||0|1|0|1|PFM|0|0|0|100|DKK|215593|272452|lyfsjukr|||00|10|0||Vistor hf|Pierre Fabre Médicament|Vínflúnín||215593||215593|272452| 026569|R02AA0305|Strepsils Cool|sogtfl|||24|stk|1|þpakki||R02AA03|01.09.2010||L|A||0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0||Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||| 026571|N03AX1801|Vimpat|filmhtfl|50|mg|14|stk|1|þpakki||N03AX18|01.12.2009||R|A||0|0|E|0|UCB|0|0|0|100|DKK|1830|3381|lyfalmen|||00|14|0|2,3300|Vistor hf|U.C.B|Lacosamíð||||1830|3381| 026582|N03AX1801|Vimpat|filmhtfl|50|mg|56|stk|1|þpakki||N03AX18|01.12.2009||R|A||0|0|E|0|UCB|0|0|0|100|DKK|6934|10363|lyfalmen|||00|56|0|9,3300|Vistor hf|U.C.B|Lacosamíð||||6934|10363| 026593|N03AX1801|Vimpat|filmhtfl|100|mg|14|stk|1|þpakki||N03AX18|01.12.2009||R|A||0|0|E|0|UCB|0|0|0|100|DKK|3615|5822|lyfalmen|||00|14|0|4,6700|Vistor hf|U.C.B|Lacosamíð||||3615|5822| 026605|N03AX1801|Vimpat|filmhtfl|100|mg|56|stk|1|þpakki||N03AX18|01.12.2009||R|A||0|0|E|0|UCB|0|0|0|100|DKK|14318|20248|lyfalmen|||00|56|0|18,6700|Vistor hf|U.C.B|Lacosamíð||||14318|20248| 026627|N03AX1801|Vimpat|filmhtfl|150|mg|56|stk|1|þpakki||N03AX18|01.12.2009||R|A||0|0|E|0|UCB|0|0|0|100|DKK|21456|29206|lyfalmen|||00|56|0|28,0000|Vistor hf|U.C.B|Lacosamíð||||21456|29206| 026638|N03AX1801|Vimpat|filmhtfl|200|mg|56|stk|1|þpakki||N03AX18|01.12.2009||R|A||0|0|E|0|UCB|0|0|0|100|DKK|28595|38166|lyfalmen|||00|56|0|37,3300|Vistor hf|U.C.B|Lacosamíð||||28595|38166| 026682|J01XE0101|Furadantin|töflur|50|mg|100|stk|1|glas||J01XE01|01.03.2004||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|2090|3736|lyfalmen|||00|100|0|25,0000|Vistor hf|Recip AB|Nítrófúrantóín||2090||2090|3736| 026946|J01CA0412|Amoxicillin Mylan (D.A.C.)|hylki|500|mg|30|stk|1|glas||J01CA04|01.03.2011||R|A||0|0|0|0|DAC|0|0|1|100|NOK|||lyfalmen|||10|30|0|15,0000|D.A.C. ehf|D.A.C. ehf|Amoxicillín||1600||||28.02.2011 027094|J01XE0101|Furadantin|töflur|5|mg|50|stk|1|glas||J01XE01|01.03.2004||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|435|1472|lyfalmen|||00|50|0|1,2500|Vistor hf|Recip AB|Nítrófúrantóín||435||435|1472| 027144|M01CC0101|Atamir|hylki|150|mg|50|stk|1|þpakki||M01CC01|01.06.1982||R|A|5|0|0|B|0|SGM|0|0|0|100|DKK|2719|4597|lyfalmen|||10|50|0|15,0000|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||2719||2719|4597| 027202|S01ED5111|Azarga|augndr|15|mg/ml|5|ml|1|glas|10+5 mg/ml|S01ED51|01.10.2009||R|A||0|0|*|0|ALA|0|0|0|100|USD|2357|4102|lyfalmen|||00|5|0|0,0000|Vistor hf|Alcon Laboratories Ltd.|Tímólól í blöndum||2357||2357|4102| 027235|G03HA0104|Cyproteron Mylan|töflur|50|mg|50|stk|1|glas||G03HA01|01.04.1997||R|A|5|0|0|*|0|MYL|0|0|0|100|SEK|8360|12313|lyfalmen|||00|50|0|25,0000|Actavis Group PTC ehf|Mylan AB|Cýpróterón||8360||8360|12313| 027281|N06DA0204|Donepezil Actavis|filmhtfl|5|mg|100|stk|1|þpakki||N06DA02|01.05.2009||R|A|3|0|0|E|0|ACA|0|0|0|100|XEU|29785|38165|lyfalmen|V0375|38165|00|100|0|66,6600|Actavis Group hf|Actavis hf|Dónepezíl||28594||28594|38165| 027294|M03AC0902|Esmeron (Lyfjaver)|stl|10|mg/ml|5|ml|10|hgl||M03AC09|01.10.2009|31.12.2010|R|K||0|0|0|1|LVR|0|0|0|100|NOK|10527|15094|lyfsjukr|||00|50|0|0,0000|Lyfjaver ehf|Lyfjaver ehf|Rókúrón, brómíð||10527||10527|15094| 027305|N06DA0204|Donepezil Actavis|filmhtfl|10|mg|100|stk|1|þpakki||N06DA02|01.05.2009||R|A|3|0|0|E|0|ACA|0|0|0|100|XEU|33426|42508|lyfalmen|V0376|42508|00|100|0|133,3300|Actavis Group hf|Actavis hf|Dónepezíl||32055||32055|42508| 027306|N03AX1205|Neurontin (Lyfjaver)|hylki|300|mg|100|stk|1|þpakki||N03AX12|01.10.2009||R|A||0|0|E|0|LVR|0|0|0|100|DKK|4502|7036|lyfalmen|||00|100|0|16,6667|Lyfjaver ehf|Lyfjaver ehf|Gabapentín||4502||4502|7036|31.01.2011 027317|N03AX1205|Neurontin (Lyfjaver)|hylki|400|mg|100|stk|1|þpakki||N03AX12|01.10.2009||R|A||0|0|E|0|LVR|0|0|0|100|DKK|6224|8315|lyfalmen|||00|100|0|22,2222|Lyfjaver ehf|Lyfjaver ehf|Gabapentín||5437||5437|8315|31.12.2010 027328|N03AX1205|Neurontin (Lyfjaver)|filmhtfl|600|mg|100|stk|1|þpakki||N03AX12|01.10.2009||R|A||0|0|E|0|LVR|0|0|0|100|DKK|17210|12958|lyfalmen|V2160|12806|00|100|0|33,3300|Lyfjaver ehf|Lyfjaver ehf|Gabapentín||8831||8831|12958| 027339|L01XE0502|Nexavar (Lyfjaver)|filmhtfl|200|mg|112|stk|1|þpakki||L01XE05|01.10.2009|31.12.2010|R|A||0|1|0|1|LVR|0|0|0|100|SEK|622620|760115|lyfsjukr|||00|112|0|0,0000|Lyfjaver ehf|Lyfjaver ehf|Sorafeníb||604169||604169|760115| 027362|L01AX0302 |Temodal (Lyfjaver)|hylki|20|mg|20|stk|1|glas||L01AX03|01.05.2009|31.12.2010|R|A|3|0|1|0|1|LVR|0|0|0|100|NOK|71766|91949|lyfsjukr|||00|20|0|0,0000|Lyfjaver ehf|Lyfjaver ehf|Temozolomid||||71766|91949| 027373|L01AX0302 |Temodal (Lyfjaver)|hylki|100|mg|5|stk|1|glas||L01AX03|01.05.2009|31.12.2010|R|A|3|0|1|0|1|LVR|0|0|0|100|NOK|71930|92155|lyfsjukr|||00|5|0|0,0000|Lyfjaver ehf|Lyfjaver ehf|Temozolomid||71930||71930|92155| 027385|L01AX0302 |Temodal (Lyfjaver)|hylki|250|mg|5|stk|1|glas||L01AX03|01.05.2009|31.12.2010|R|A|3|0|1|0|1|LVR|0|0|0|100|NOK|178603|226029|lyfsjukr|||00|5|0|0,0000|Lyfjaver ehf|Lyfjaver ehf|Temozolomid||178603||178603|226029| 027397|G02CX0102|Tractocile (Lyfjaver)|stl|7,5|mg/ml|0,9|ml|1|hgl|lausn|G02CX01|01.05.2009|31.12.2010|R|K|2|0|1|0|1|LVR|0|0|0|100|NOK|5743|8289|lyfsjukr|||00|1|0|0,0400|Lyfjaver ehf|Lyfjaver ehf|Atosíban||||5743|8289| 027408|G02CX0102|Tractocile (Lyfjaver)|irþ|7,5|mg/ml|5|ml|1|hgl|lausn|G02CX01|01.05.2009|31.12.2010|R|K|2|0|1|0|1|LVR|0|0|0|100|NOK|17106|23351|lyfsjukr|||00|5|0|0,2300|Lyfjaver ehf|Lyfjaver ehf|Atosíban||||17106|23351| 027559|N03AX1501|Zonegran|hylki|25|mg|14|stk|1|þpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|2124|3783|lyfalmen|||00|14|0|1,7500|Vistor hf|Eisai Ltd|Zonisamíð||2124||2124|3783| 027586|N03AX1501|Zonegran|hylki|25|mg|56|stk|1|þpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|8499|12503|lyfalmen|||00|56|0|7,0000|Vistor hf|Eisai Ltd|Zonisamíð||8499||8499|12503| 027595|N03AX1501|Zonegran|hylki|50|mg|56|stk|1|þpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|11221|16227|lyfalmen|||00|56|0|14,0000|Vistor hf|Eisai Ltd|Zonisamíð||11221||11221|16227| 027604|N03AX1501|Zonegran|hylki|100|mg|56|stk|1|þpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|15027|21138|lyfalmen|||00|56|0|28,0000|Vistor hf|Eisai Ltd|Zonisamíð||15027||15027|21138| 027649|H03AA0105|Levaxin|töflur|0,05|mg|100|stk|1|glas||H03AA01|01.04.2004||R|A|2|0|0|B|0|NYG|0|0|0|100|DKK|846|2035|lyfalmen|V0431|1999|00|100|0|33,3300|Gróco ehf|Nycomed Danmark A/S|Levótýroxínnatríum||846||846|2035| 027656|H03AA0105|Levaxin|töflur|0,1|mg|100|stk|1|glas||H03AA01|01.03.2003||R|A|2|0|0|B|0|NYG|0|0|0|100|DKK|846|2035|lyfalmen|V0430|1853|00|100|0|66,6667|Gróco ehf|Nycomed Danmark A/S|Levótýroxínnatríum||846||846|2035| 027795|J02AC0401|Noxafil|mixtúra|40|mg/ml|105|ml|1|fl||J02AC04|01.08.2006||R|A|2|0|1|0|1|SPE|0|0|0|100|DKK|101208|128899|lyfsjukr|||00|105|0|0,7500|Vistor hf|SP Europe|Posacónazól||101208||101208|128899| 027968|N05AX1201|Abilify|munndr.t|10|mg|28|stk|1|þpakki||N05AX12|01.01.2007||R|A|1,5|0|0|*|0|OTS|0|1|0|100|DKK|23867|32232|lyfalmen|||00|28|0|18,6670|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||23867||23867|32232| 027976|N05AH0307|Zypadhera|sts|210|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|A||0|0|*|0|ELD|0|1|0|100|XEU|32191|42679|lyfalmen|||00|1|0|21,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||||32191|42679| 027977|N05AX1201|Abilify|munndr.t|15|mg|28|stk|1|þpakki||N05AX12|01.01.2007||R|A|1,5|0|0|*|0|OTS|0|1|0|100|DKK|23867|32232|lyfalmen|||00|28|0|28,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||23867||23867|32232| 027988|N05AH0307|Zypadhera|sts|300|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|A||0|0|*|0|ELD|0|1|0|100|XEU|46255|60329|lyfalmen|||00|1|0|30,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||||46255|60329| 027999|N05AH0307|Zypadhera|sts|405|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|A||0|0|*|0|ELD|0|1|0|100|XEU|59753|77269|lyfalmen|||00|1|0|40,5000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||||59753|77269| 028045|G03AB0001|Qlaira|töflur|||84|stk|1|þpakki|3x28 stk|G03AB|01.11.2009||R|A||0|0|0|0|BAP|0|0|0|100|SEK|5227|8028|lyfalmen|||00|84|0||Icepharma hf|Bayer Schering Pharma AG|Kaflaskipt lyf, prógestógen og östrógen||||5227|8028| 028112|R06AX2602|Nefoxef|filmhtfl|120|mg|30|stk|1|þpakki||R06AX26|01.07.2008||L|A|2|0|0|0|0|MYL|0|0|1|100|IKR|||lyflausa|||00|30|0|30,0000|Actavis Group PTC ehf|Mylan AB|Fexófenadín|||||| 028121|A10BD0701|Janumet|filmhtfl|1050|mg|196|stk|1|þpakki|50/1000mg|A10BD07|01.01.2010||R|A||0|0|*|0|MSD|0|0|0|100|XEU|24434|32944|lyfalmen|||00|196|0|98,0000|Icepharma hf|M.S.D.|Metforminum og sitagliptinum||24434||24434|32944| 028124|R06AX2602|Nefoxef|filmhtfl|120|mg|100|stk|1|þpakki||R06AX26|01.07.2008||R|A|2|0|0|E|0|MYL|0|0|1|100|SEK|3643|5374|lyfalmen|V1911|5374|00|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Fexófenadín||3287||3287|5374| 028168|C09XA5201|Rasilez HCT|filmhtfl|162,5|mg|28|stk|1|þpakki|150/12,5 mg|C09XA52|01.06.2009||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|3959|6293|lyfalmen|||00|28|0|0,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren og þvagræsilyf||||3959|6293| 028177|C10AD5201|Tredaptive|töflur|1020|mg|98|stk|2|þpakki|1000+20 mg|C10AD52|01.12.2009||R|A||0|0|0|0|MSD|0|0|0|100|XEU|18905|26005|lyfalmen|||00|196|0||Icepharma hf|M.S.D.|Nikótínsýra og afleiður-Nikótínsýra í blöndum||||18905|26005| 028179|C09XA5201|Rasilez HCT|filmhtfl|162,5|mg|98|stk|1|þpakki|150/12,5 mg|C09XA52|01.06.2009||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|13764|19553|lyfalmen|||00|98|0|0,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren og þvagræsilyf||||13764|19553| 028190|C09XA5201|Rasilez HCT|filmhtfl|175|mg|28|stk|1|þpakki|150/25 mg|C09XA52|01.06.2009||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|3959|6293|lyfalmen|||00|28|0|0,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren og þvagræsilyf||||3959|6293| 028201|C09XA5201|Rasilez HCT|filmhtfl|175|mg|98|stk|1|þpakki|150/25 mg|C09XA52|01.06.2009||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|13764|19553|lyfalmen|||00|98|0|0,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren og þvagræsilyf||||13764|19553| 028212|C09XA5201|Rasilez HCT|filmhtfl|312,5|mg|28|stk|1|þpakki|300/12,5 mg|C09XA52|01.06.2009||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|4564|7121|lyfalmen|||00|28|0|0,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren og þvagræsilyf||||4564|7121| 028224|C09XA5201|Rasilez HCT|filmhtfl|312,5|mg|98|stk|1|þpakki|300/12,5 mg|C09XA52|01.06.2009||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|15875|22202|lyfalmen|||00|98|0|0,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren og þvagræsilyf||||15875|22202| 028235|C09XA5201|Rasilez HCT|filmhtfl|325|mg|28|stk|1|þpakki|300/25 mg|C09XA52|01.06.2009||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|4564|7121|lyfalmen|||00|28|0|0,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren og þvagræsilyf||||4564|7121| 028246|C09XA5201|Rasilez HCT|filmhtfl|325|mg|98|stk|1|þpakki|300/25 mg|C09XA52|01.06.2009||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|15875|22202|lyfalmen|||00|98|0|0,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren og þvagræsilyf||||15875|22202| 028314|J07AP0301|Typhim Vi|stl|25|mcg/spr|0,5|ml|1|áf.spr|m/ aðsk. nál|J07AP03|01.05.2008||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|2549|4364|lyfalmen|||02|0|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Taugaveiki, hreinsaðir mótefnavakar||2549||2549|4364| 028351|J07BL0101|Stamaril|sts|0| |0,5|ml|10|hgl|+ 10 áf.spr. með leysi|J07BL01|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|21396|29131|lyfalmen|||02|5|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Gulusótt, veikluð veira||21396||21396|29131| 028360|J07BG0101|Rabies - Imovax|bóluefni|0| |1|ml|1|hgl||J07BG01|01.01.1996||R|K|3|0|0|0|0|MEX|0|0|0|100|XEU|8187|12077|lyfalmen|||02|1|0|0,0000|Icepharma hf|Aventis Pasteur MSD A/S|Hundaæði, dauð veira||8187||8187|12077| 028387|M03BX0105|Baklofen Mylan|töflur|25|mg|50|stk|1|glas|0|M03BX01|01.10.2008||R|A|3|0|0|E|0|MYL|0|0|1|100|SEK|1906|3485|lyfalmen|V0712|3485|00|50|0|25,0000|Actavis Group PTC ehf|Mylan AB|Baklófen||1906||1906|3485| 028405|M01AE0217|Naproxen-E Mylan|sh-tfl|500|mg|50|stk|1|plglas||M01AE02|01.07.1993||R|A|5|0|0|E|0|MYL|0|0|1|100|SEK|2137|3801|lyfalmen|||10|50|0|50,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||2137||2137|3801| 028498|C08DB0102|Cardizem Retard|forðatfl|120|mg|60|stk|1|glas||C08DB01|01.04.1987||R|A|3|0|0|B|0|FRO|0|0|0|100|DKK|5382|8240|lyfalmen|||10|60|0|30,0000|Vistor hf|Ferrosan A/S|Diltíazem||5382||5382|8240| 028575|N03AX0901|Lamictal|dreifit.|5|mg|56|stk|1|þpakki||N03AX09|01.05.2009||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|1278|2625|lyfalmen|||00|56|0|0,9334|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||||1278|2625| 028586|N03AX0901|Lamictal|dreifit.|100|mg|98|stk|1|þpakki||N03AX09|01.05.2009||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|5812|8127|lyfalmen|V0705|8127|00|98|0|32,6667|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||5300||5300|8127| 028598|N03AX0901|Lamictal|dreifit.|200|mg|98|stk|1|þpakki||N03AX09|01.05.2009||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|10358|15046|lyfalmen|||00|98|0|65,3333|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||||10358|15046| 028599|N04BC0503|Pramipexole Portfarma|töflur|0,088|mg|30|stk|1|þpakki||N04BC05|01.02.2010||R|A||0|0|E|0|POF|0|0|0|100|XEU|1417|1595|lyfalmen|V2010|1595|00|30|0|1,0600|Portfarma ehf|Portfarma|Pramipexól||525||525|1595| 028606|QN05CM1801|Dexdomitor|stl|0,5|mg/ml|10|ml|1|hgl||QN05CM18|01.11.2007||R|A|3|0|0|0|0|OCO|1|0|0|100|DKK|8008|15549|vetalmen|||27|10|0|0,0000|Icepharma hf|Orion Corporation (I)|||8008||8008|15549| 028610|N04BC0503|Pramipexole Portfarma|töflur|0,18|mg|100|stk|1|þpakki||N04BC05|01.02.2010||R|A||0|0|E|0|POF|0|0|0|100|XEU|8006|5601|lyfalmen|V2020|5601|00|100|0|7,2000|Portfarma ehf|Portfarma|Pramipexól||3453||3453|5601| 028622|N04BC0503|Pramipexole Portfarma|töflur|0,7|mg|100|stk|1|þpakki||N04BC05|01.02.2010||R|A||0|0|E|0|POF|0|0|0|100|XEU|29859|19135|lyfalmen|V2030|19135|00|100|0|28,0000|Portfarma ehf|Portfarma|Pramipexól||13431||13431|19135| 028761|A03FA0101|Primperan|stl|5|mg/ml|2|ml|12|lykjur||A03FA01|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|1006|2253|lyfalmen|||02|24|0|4,0000|Vistor hf|Sanofi-aventis Norge AS|Metóklópramíð||1006||1006|2253| 028907|J02AC0103|Fluconazole Portfarma|hylki|50|mg|7|stk|1|þpakki||J02AC01|01.05.2010||R|A||0|0|0|0|POF|0|0|1|100|IKR|1740|3257|lyfalmen|V0551|3257|10|7|0|1,7500|Portfarma ehf|Portfarma|Flúkónazól||1740||1740|3257| 028918|J02AC0103|Fluconazole Portfarma|hylki|50|mg|30|stk|1|þpakki||J02AC01|01.05.2010||R|A||0|0|0|0|POF|0|0|1|100|IKR|7143|8858|lyfalmen|V0552|8858|10|30|0|7,5000|Portfarma ehf|Portfarma|Flúkónazól||5834||5834|8858| 028929|J02AC0103|Fluconazole Portfarma|hylki|150|mg|1|stk|1|þpakki||J02AC01|01.05.2010||R|A||0|0|0|0|POF|0|0|1|100|IKR|754|1909|lyfalmen|V0554|1909|10|1|0|0,7500|Portfarma ehf|Portfarma|Flúkónazól||754||754|1909| 028940|J02AC0103|Fluconazole Portfarma|hylki|150|mg|2|stk|1|þpakki||J02AC01|01.05.2010||R|A||0|0|0|0|POF|0|0|1|100|IKR|1441|2848|lyfalmen|V0555|2848|10|2|0|1,5000|Portfarma ehf|Portfarma|Flúkónazól||1441||1441|2848| 028953|J02AC0103|Fluconazole Portfarma|hylki|150|mg|4|stk|1|þpakki||J02AC01|01.05.2010||R|A||0|0|0|0|POF|0|0|1|100|IKR|2500|4297|lyfalmen|V0556|4297|10|4|0|3,0000|Portfarma ehf|Portfarma|Flúkónazól||2500||2500|4297| 029066|R01AD0801|Flixonase|nefúði|50|mcg/sk|16|ml|1|stauk|120 sk|R01AD08|01.04.1992||R|A|2|0|0|E|0|GSK|0|0|1|100|GBP|1079|2353|lyfalmen|||24|16|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||||1079|2353| 029078|N06AX2201|Valdoxan|filmhtfl|25|mg|28|stk|1|þpakki||N06AX22|01.01.2010||R|A||0|0|0|0|SEV|0|1|0|100|DKK|7320|10891|lyfalmen|||00|28|0|28,0000|Icepharma hf|Servier|Agómelatín||7320||7320|10891| 029100|N06AX2201|Valdoxan|filmhtfl|25|mg|84|stk|1|þpakki||N06AX22|01.01.2010||R|A||0|0|0|0|SEV|0|1|0|100|DKK|21960|29839|lyfalmen|||00|84|0|84,0000|Icepharma hf|Servier|Agómelatín||21960||21960|29839| 029116|A03FA0101|Primperan|töflur|10|mg|40|stk|1|þpakki||A03FA01|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|1|100|NOK|596|1693|lyfalmen|||00|40|0|13,3333|Vistor hf|Sanofi-aventis Norge AS|Metóklópramíð||596||596|1693| 029287|C03DB0105|Amiloride|töflur|5|mg|28|stk|1|þpakki||C03DB01|01.04.2009||R|A|3|0|0|E|0|AUK|0|0|0|100|GBP|252|1222|lyfalmen|||00|28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Amiloridhýdróklóríð||||252|1222| 029307|A07EA0603|Entocort enema (D.A.C.)|endaþ.dr|0,02|mg/ml|7|stk|1|þpakki|samsett pk|A07EA06|01.01.2007||R|A||0|0|B|0|DAC|0|0|0|100|XEU|8333|12276|lyfalmen|V0291|12276|56|7|0|7,0000|D.A.C. ehf|D.A.C. ehf|Búdesóníð||8333||8333|12276| 029361|C10AA0103|Zocor (Lyfjaver)|töflur|20|mg|98|stk|1|þpakki||C10AA01|01.09.2005||R|A|3|0|0|0|0|LVR|0|0|0|100|XEU|7630|9216|lyfalmen|V0362|2199|00|98|0|65,3400|Lyfjaver ehf|Lyfjaver ehf|Simvastatín||6096||6096|9216| 029517|L01BB0503|Fludarabin Actavis|sts/irs|25|mg/ml|50|mg|1|hgl||L01BB05|01.04.2009||R|A|2|0|1|0|1|AGP|0|0|0|100|XEU|31621|41567|lyfsjukr|||00|50|0|0,0000|Actavis Group hf|Actavis Group PTC ehf|Flúdarabín||||31621|41567| 029528|L01CA0402 |Vinorelbin Actavis|irþ|10|mg/ml|5|ml|1|hgl||L01CA04|01.04.2009||R|K|3|0|1|0|1|AGP|0|0|0|100|XEU|5878|8483|lyfsjukr|||00|5|0|0,0000|Actavis Group hf|Actavis Group PTC ehf|Vínorelbín||5878||5878|8483| 029574|L01XX1904|Irinotecan Actavis|irþ|20|mg/ml|5|ml|1|hgl|lausn|L01XX19|01.04.2009||R|A|3|0|1|0|1|AGT|0|0|0|100|XEU|4898|7069|lyfsjukr|||00|5|0|0,0000|Actavis Group hf|Actavis Group hf|Írinótekan||4898||4898|7069| 029695|C09DA0601|Atacand Plus|töflur|44,5|mg|28|stk|1|þpakki|32+12,5 mg|C09DA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|5177|7959|lyfalmen|||00|28|0|112,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og þvagræsilyf||||5177|7959| 029706|C09DA0601|Atacand Plus|töflur|44,5|mg|98|stk|1|þpakki|32+12,5 mg|C09DA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|16259|22684|lyfalmen|||00|98|0|392,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og þvagræsilyf||||16259|22684| 029717|C09DA0601|Atacand Plus|töflur|57|mg|28|stk|1|þpakki|32+25 mg|C09DA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|5177|7959|lyfalmen|||00|28|0|112,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og þvagræsilyf||||5177|7959| 029729|C09DA0601|Atacand Plus|töflur|57|mg|98|stk|1|þpakki|32+25 mg|C09DA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|16259|22684|lyfalmen|||00|98|0|392,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og þvagræsilyf||||16259|22684| 029811|B02BX0401|Nplate|sts|250|mcg|1|hgl|1|pakki||B02BX04|01.04.2010||R|A||0|1|0|1|AEU|0|0|0|100|DKK|106770|135879|lyfsjukr|||00|1|0|8,3300|Vistor hf|Amgen Europe B.V.|Romiplóstím||||106770|135879| 029822|B02BX0401|Nplate|sts|500|mcg|1|hgl|1|pakki||B02BX04|01.04.2010||R|A||0|1|0|1|AEU|0|0|0|100|DKK|213540|269875|lyfsjukr|||00|1|0|16,6600|Vistor hf|Amgen Europe B.V.|||||213540|269875| 029860|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 029869|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|105|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|105|0|7,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 029878|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 029887|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 029896|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|105|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 029905|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 030054|J05AE0302|Norvir (D.A.C.)|hylki|100|mg|84|stk|1|glas|mjúk hylki|J05AE03|01.12.2008|31.01.2011|R|K|2|0|1|0|1|DAC|0|0|0|100|DKK|18225|24755|lyfsjukr|||00|84|0|7,0000|D.A.C. ehf|D.A.C. ehf|Ritonavír||18225||18225|24755| 030315|N03AX1501|Zonegran|hylki|100|mg|98|stk|1|þpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|26284|35266|lyfalmen|||00|98|0|49,0000|Vistor hf|Eisai Ltd|Zonisamíð||26284||26284|35266| 030588|M01AX0501|Glucomed|töflur|625|mg|60|stk|1|þpakki||M01AX05|01.07.2006||L|A|3|0|0|0|0|LEX|0|0|1|100|IKR|||lyflausa|||00|60|0|25,0000|Icepharma hf|Laboratories Expansvience|Glúkósamín|||||| 030627|N05AH0201|Leponex|töflur|100|mg|100|stk|1|glas||N05AH02|01.04.1993||R|A|5|0|0|*|0|NOH|0|1|0|100|DKK|9307|13609|lyfalmen|V1400|13607|00|100|0|33,3333|Vistor hf|Novartis Healthcare A/S-|Klózapín||9307||9307|13609| 030635|N05AH0201|Leponex|töflur|25|mg|100|stk|1|glas||N05AH02|01.04.1993||R|A|5|0|0|*|0|NOH|0|1|0|100|DKK|2969|4939|lyfalmen|V1401|4937|00|100|0|8,3333|Vistor hf|Novartis Healthcare A/S-|Klózapín||2969||2969|4939| 030754|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|770|l|1|hylki|kælt|V03AN01|01.03.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|770|0|0,0000|Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 030765|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|11000|l|1|hylki|kælt|V03AN01|01.03.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|11000|0|0,0000|Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 030822|QI02AB0001|Startvac|stl|||2|ml|20|glös|fleyti|QI02AB|01.05.2010||R|K||0|0|0|0|LHS|0|0|0|100|XEU|16272|28386|vetorma|||00|40|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Óvirkar bakteríur í bóluefnum||||16272|28386| 030940|C07AB0210|Metoprolol Mylan|töflur|50|mg|100|stk|1|glas||C07AB02|01.10.1995||R|A|3|0|0|B|0|MYL|0|0|0|100|SEK|1001|2247|lyfalmen|V2005|2247|00|100|0|33,3333|Actavis Group PTC ehf|Mylan AB|Metóprólól||1001||1001|2247| 031039|C07AB0210|Metoprolol Mylan|töflur|100|mg|100|stk|1|glas||C07AB02|01.10.1995||R|A|3|0|0|B|0|MYL|0|0|0|100|SEK|1460|2874|lyfalmen|||00|100|0|66,6667|Actavis Group PTC ehf|Mylan AB|Metóprólól||1460||1460|2874| 031070|A04AD0101|Scopoderm|forðapl|1|mg/72kls|2|stk|1|pakki||A04AD01|01.07.1985||R|A|2|0|0|0|0|NHE|0|0|1|100|DKK|840|2026|lyfalmen|||23|2|0|2,0000|Artasan ehf|Novartis Healthcare A/S-A|Skópólamín||840||840|2026| 031088|A10AB0401|Humalog|stl|100|ae/ml|10|ml|1|hgl||A10AB04|01.01.1997||R|K|2|0|0|*|0|ELD|0|0|0|100|XEU|3182|5230|lyfalmen|||17|10|0|25,0000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||3182||3182|5230| 031314|L01AX0301|Temodal|hylki|20|mg|20|skpokar|1|pakki||L01AX03|01.01.2010||R|A||0|1|0|1|SCP|0|0|0|100|DKK|60518|77833|lyfsjukr|||00|20|0||Vistor hf|Schering-Plough|Temozolomid||60518||60518|77833| 031325|L01AX0301|Temodal|hylki|100|mg|5|skpokar|1|pakki||L01AX03|01.01.2010||R|A||0|1|0|1|SCP|0|0|0|100|DKK|73434|94042|lyfsjukr|||00|5|0||Vistor hf|Schering-Plough|Temozolomid||73434||73434|94042| 031348|L01AX0301|Temodal|hylki|140|mg|5|skpokar|1|pakki||L01AX03|01.01.2010||R|A||0|1|0|1|SCP|0|0|0|100|DKK|102822|130924|lyfsjukr|||00|5|0||Vistor hf|Schering-Plough|Temozolomid||102822||102822|130924| 031371|L01AX0301|Temodal|hylki|180|mg|5|skpokar|1|pakki||L01AX03|01.01.2010||R|A||0|1|0|1|SCP|0|0|0|100|DKK|131489|166901|lyfsjukr|||00|5|0||Vistor hf|Schering-Plough|Temozolomid||131489||131489|166901| 031394|L01AX0301|Temodal|hylki|250|mg|5|skpokar|1|pakki||L01AX03|01.01.2010||R|A||0|1|0|1|SCP|0|0|0|100|DKK|182289|230655|lyfsjukr|||00|5|0||Vistor hf|Schering-Plough|Temozolomid||182289||182289|230655| 031773|C01DA0801|Sorbangil|töflur|20|mg|100|stk|1|glas||C01DA08|01.01.1985||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|2343|4082|lyfalmen|||00|100|0|33,3333|Vistor hf|Recip AB|Ísósorbíð dínítrat||2343||2343|4082| 031849|A10AB0503|NovoRapid Penfill|stl|100|ein/ml|3|ml|5|rörlyk||A10AB05|01.07.2002||R|K|2,5|0|0|*|0|NON|0|0|0|100|DKK|6328|9534|lyfalmen|||02|15|0|37,5000|Vistor hf|Novo-Nordisk|Insúlín aspart||6328||6328|9534| 031942|H01BA0401|Glypressin|sts|1|mg/hgl|1|mg|5|hgl|og leysir|H01BA04|01.01.1998||R|A|3|0|0|0|1|FEL|0|0|0|100|DKK|37262|48646|lyfsjukr|||00|5|0|0,4200|Vistor hf|Ferring Lægemidler A/S|Terlípressín||37262||37262|48646| 031971|C07AA0705|Sotalol Mylan|töflur|160|mg|100|stk|1|plglas||C07AA07|01.01.1994||R|A|4|0|0|B|0|MYL|0|0|0|100|SEK|2045|3675|lyfalmen|||00|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Sótalól||2045||2045|3675| 032122|N01AX1302|Lyfjatviköfnunarefnisoxid Strandmöllen|lyfjagas|100|%|4|l|1|hylki||N01AX13|01.02.2009||R|A|3|0|0|0|1|STM|0|0|0|100|DKK|9716|14023|lyfsjukr|||0|4|0|0,0000|Strandmöllen A/S|Strandmöllen A/S|di-Nitrogen oxíð||||9716|14023| 032145|N01AX1302|Lyfjatviköfnunarefnisoxid Strandmöllen|lyfjagas|100|%|10|l|1|hylki||N01AX13|01.02.2009||R|A|3|0|0|0|1|STM|0|0|0|100|DKK|14201|19705|lyfsjukr|||0|10|0|0,0000|Strandmöllen A/S|Strandmöllen A/S|di-Nitrogen oxíð||||14201|19705| 032179|N01AX1302|Lyfjatviköfnunarefnisoxid Strandmöllen|lyfjagas|100|%|50|l|1|hylki||N01AX13|01.02.2009||R|A|3|0|0|0|1|STM|0|0|0|100|DKK|49137|63549|lyfsjukr|||0|50|0|0,0000|Strandmöllen A/S|Strandmöllen A/S|di-Nitrogen oxíð||||49137|63549| 032190|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|1|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|1|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|1|0|0,0000|Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 032202|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|2|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|2|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|2|0|0,0000|Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 032236|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|4|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|4|0|0,0000|Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 032247|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|5|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|5|0|0,0000|Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 032258|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|10|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|10|0|0,0000|Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 032270|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|20|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|20|0|0,0000|Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 032281|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|50|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|50|0|0,0000|Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 032304|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|50|l|12|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|600|0|0,0000|Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 032523|N05AX1201|Abilify|mixtúra|1|mg/ml|150|ml|1|fl||N05AX12|01.02.2007||R|K|2|0|0|*|0|OTS|0|1|0|100|DKK|24784|33383|lyfalmen|||00|150|0|10,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||24784||24784|33383| 032649|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|50|ml|1|hgl|plast|QP54AA01|01.01.1985||R|A|5|0|0|0|0|MEF|1|0|0|100|XEU|3838|6695|vetorma|||27|50|0|0,0000|Vistor hf|Merial (MSD)|||3838||3838|6695| 032664|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|200|ml|1|fl||QP54AA01|01.01.1985||R|A|5|0|0|0|0|MEF|1|0|0|100|XEU|14977|26127|vetorma|||27|200|0|0,0000|Vistor hf|Merial (MSD)|||14977||14977|26127| 032723|N06AX1609|Venlafaxin Ranbaxy|forðahlk|75|mg|100|stk|1|þpakki||N06AX16|01.12.2009||R|A||0|0|B|0|RAN|0|1|0|100|XEU|9257|6073|lyfalmen|V0955|6073|00|100|0|75,0000|Gróco ehf|Ranbaxy (UK) Ltd|Venlafaxín||3798||3798|6073| 032756|N06AX1609|Venlafaxin Ranbaxy|forðahlk|150|mg|100|stk|1|þpakki||N06AX16|01.01.2010||R|A||0|0|B|0|RAN|0|1|0|100|XEU|16948|6073|lyfalmen|V0956|6073|00|100|0|150,0000|Gróco ehf|Ranbaxy (UK) Ltd|Venlafaxín||3798||3798|6073| 033124|L02BX0201|Firmagon|sts|80|mg|1|hgl|1|pakki|leysir|L02BX02|01.11.2010||R|A||0|1|0|1|FER|0|0|0|100|DKK|21581|28967|lyfsjukr|||00|1|0|29,6300|Vistor hf|Ferring|Degarelix||||21581|28967| 033135|L02BX0201|Firmagon|sts|120|mg|1|hgl|1|pakki|leysir|L02BX02|01.11.2010||R|A||0|1|0|1|FER|0|0|0|100|DKK|43042|55900|lyfsjukr|||00|1|0|44,4400|Vistor hf|Ferring|Degarelix||||43042|55900| 033201|QJ01DD9001|Eficur vet.|stl|50|mg/ml|100|ml|1|hgl||QJ01DD90|01.02.2010||R|A||0|0|0|0|LHS|0|0|0|100|XEU|9261|17955|vetalmen|||27|100|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Ceftiofurhydróklóríð||||9261|17955| 033251|S01CA0102|Tobradex|augndr|0| |5|ml|1|glas|3+1 mg/ml|S01CA01|01.06.2007||R|A|3|0|0|E|0|ALC|0|0|1|100|USD|1212|2535|lyfalmen|||00|5|0|0,0000|K.Pétursson hf|Alcon|Dexametasón||1212||1212|2535| 033884|J05AE1001|Prezista|filmhtfl|400|mg|60|stk|1|plglas||J05AE10|01.11.2009||R|A||0|1|0|1|JCI|0|0|0|100|SEK|96364|122819|lyfsjukr|||43|60|0||Vistor hf|Janssen-Cilag International N.V.|Darunavír||96364||96364|122819| 033895|J05AE1001|Prezista|filmhtfl|600|mg|60|stk|1|plglas||J05AE10|01.11.2009||R|A||0|1|0|1|JCI|0|0|0|100|SEK|142294|180461|lyfsjukr|||43|60|0||Vistor hf|Janssen-Cilag International N.V.|Darunavír||142294||142294|180461| 033918|L04AC0501|Stelara|stl|45|mg/hgl|0,5|ml|1|hgl||L04AC05|01.06.2009||R|K|1|0|1|0|1|JCI|0|0|0|100|SEK|622568|783205|lyfsjukr|||AC|0|0|83,3300|Vistor hf|Janssen-Cilag International N.V.|||||622568|783205| 034033|QJ01M0001|Baytril vet.|töflur|50|mg|10|stk|1|þpakki||QJ01MA90|01.03.2009||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|2504|4981|vetalmen|||0|10|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||||2504|4981| 034105|A07AA0905|Vancomycin Axellia|hylki|125|mg|28|stk|1|þpakki|hart hylki|A07AA09|01.04.1996|31.12.2010|R|A||0|0|E|0|AXE|0|0|1|100|DKK|11813|17037|lyfalmen|||0|28|0|1,7500|Actavis Group hf|Axellia Pharmaceuticals ApS|Vankómýcín||||11813|17037| 034117|A07AA0905|Vancomycin Axellia|hylki|250|mg|28|stk|1|þpakki|hart hylki|A07AA09|01.12.2010|31.12.2010|R|A|2|0|0|E|0|AXE|0|0|1|100|DKK|23658|31970|lyfalmen|||00|28|0|3,5000|Actavis Group hf|Axellia Pharmaceuticals ApS|Vankómýcín||||23658|31970| 034157|J07AM5104|Diftavax|bóluefni|0| |0,5|ml|1|spr|einnota sprauta|J07AM51|01.01.2000||R|K|3|0|0|0|0|SPM|0|0|1|100|XEU|755|1910|lyfalmen|||AC|0|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Stífkrampatoxóíð í blöndum með barnaveikistoxóíðum||755||755|1910| 034401|J06BA0208|Privigen|irl|100|mg/ml|25|ml|1|hgl||J06BA02|01.10.2009||R|A||0|0|0|1|CSB|0|0|0|100|SEK|24775|32975|lyfsjukr|||00|25|0|0,0000|Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||24775||24775|32975| 034468|B01AC2201|Efient|filmhtfl|5|mg|28|stk|1|þpakki||B01AC22|01.12.2009||R|A||0|0|E|0|ELD|0|0|0|100|XEU|8219|12120|lyfalmen|||0|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Prasugrel||||8219|12120| 034479|B01AC2201|Efient|filmhtfl|10|mg|28|stk|1|þpakki||B01AC22|01.12.2009||R|A||0|0|E|0|ELD|0|0|0|100|XEU|8219|12120|lyfalmen|||0|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Prasugrel||||8219|12120| 034616|N05CM0201|Heminevrin|mixtúra|50|mg/ml|300|ml|1|glas||N05CM02|01.07.2006||R|K|2|0|0|0|0|ARA|0|0|1|100|SEK|2391|4148|lyfalmen|||00|300|0|10,0000|Vistor hf|Astra|Clómetíazól||2391||2391|4148| 034934|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|20|sk-hyl||S01BC03|01.04.1996||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|1850|3408|lyfalmen|||00|6|0|0,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||1850||1850|3408| 034983|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|40|sk-hyl||S01BC03|01.04.1996||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|3173|5218|lyfalmen|||00|12|0|0,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||3173||3173|5218| 034988|L03AB0702|Rebif|stl|44|mcg/lykj|0,5|ml|4|rörlyk||L03AB07|01.03.2010||R|K||0|1|0|1|MSE|0|0|0|100|SEK|206778|261389|lyfsjukr|||00|2|0|40,9300|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||||206778|261389| 035024|V03AB1402|Protaminsulfat Leo Pharma|stl|10|mg/ml|5|ml|5|hgl||V03AB14|01.06.2007||R|A|3|0|0|0|1|LEP|0|0|0|100|DKK|7539|10881|lyfsjukr|||02|25|0|0,0000|Vistor hf|LEO Pharma A/S|Prótamín||7539||7539|10881| 035099|C02CA0404|Carduran CR (D.A.C.)|forðatfl|4|mg|100|stk|1|þpakki||C02CA04|01.05.2009||R|A|2|0|0|E|0|DAC|0|0|0|100|DKK|2635|4437|lyfalmen|||00|100|0|100,0000|D.A.C. ehf|D.A.C. ehf|Doxazósín||2602||2602|4437|31.01.2011 035113|B05XA0501|Addex-Magnesium|irþ|1|mmol/ml|10|ml|10|plhgl||B05XA05|01.03.2010||R|A||0|0|0|1|FRP|0|0|0|100|DKK|2301|3321|lyfsjukr|||00|100|0|0,1000|Icepharma hf|Fresenius Kabi|||2301||2301|3321| 035177|N03AX1203|Neurontin (D.A.C.)|hylki|300|mg|100|stk|1|þpakki||N03AX12|01.05.2009||R|A|3|0|0|E|0|DAC|0|0|0|100|DKK|6044|7311|lyfalmen|V0714|7311|10|100|0|16,6800|D.A.C. ehf|D.A.C. ehf|Gabapentín||4703||4703|7311| 035212|A07EC0202|Pentasa|forðatfl|500|mg|300|stk|1|þpakki||A07EC02|01.04.1992||R|A|3|0|0|B|0|FER|0|0|0|100|DKK|16157|22556|lyfalmen|||10|300|0|100,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||16157||16157|22556| 035222|N06DA0403|Reminyl (D.A.C.)|forðahlk|8|mg|28|stk|1|þpakki||N06DA04|01.05.2009||R|A|2|0|0|E|0|DAC|0|0|0|100|SEK|13194|18838|lyfalmen|V1370|18838|00|28|0|14,0000|D.A.C. ehf|D.A.C. ehf|Galantamín||13194||13194|18838| 035234|M01AB5502|Arthrotec (D.A.C.)|töflur|50,2|mg|100|stk|1|þpakki|0,2+50 mg|M01AB55|01.05.2009||R|A|3|0|0|E|0|DAC|0|0|1|100|DKK|4884|7558|lyfalmen|V2130|7558|0|100|0|50,0000|D.A.C. ehf|D.A.C. ehf|Díklófenaknatríum í blöndum||4884||4884|7558| 035444|C09CA0601|Atacand|töflur|16|mg|28|stk|1|þpakki||C09CA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|3637|5852|lyfalmen|V2215|5852|00|28|0|56,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||||3637|5852| 035506|N03AX0903|Lamotrin|dreifit.|25|mg|56|stk|1|þpakki||N03AX09|01.11.2005||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|1435|2840|lyfalmen|||00|56|0|4,6700|Actavis Group hf|Actavis hf|Lamótrigín||1435||1435|2840| 035515|N03AX0903|Lamotrin|dreifit.|50|mg|56|stk|1|þpakki||N03AX09|01.11.2005||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|1844|3223|lyfalmen|V0703|3223|00|56|0|9,3300|Actavis Group hf|Actavis hf|Lamótrigín||1715||1715|3223| 035524|N03AX0903|Lamotrin|dreifit.|100|mg|56|stk|1|þpakki||N03AX09|01.11.2005||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|3321|4805|lyfalmen|||00|56|0|18,6700|Actavis Group hf|Actavis hf|Lamótrigín||2871||2871|4805| 035533|N03AX0903|Lamotrin|dreifit.|200|mg|56|stk|1|þpakki||N03AX09|01.11.2005|31.01.2011|R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|5919|7691|lyfalmen|||00|56|0|37,3400|Actavis Group hf|Actavis hf|Lamótrigín||4981||4981|7691| 035542|S01LA0301|Macugen|stl|0,3|mg/spr|1|spr|1|pakki|lausn|S01LA03|01.06.2006||R|A|1,5|0|1|0|1|PER|0|0|0|100|DKK|121586|154473|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Pfizer ApS|Pegaptaníb||121586||121586|154473| 035568|C09CA0601|Atacand|töflur|16|mg|98|stk|1|þpakki||C09CA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|11574|16710|lyfalmen|||00|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||||11574|16710| 036062|V03AE0202|Renvela|filmhtfl|800|mg|180|stk|1|pakki||V03AE02|01.04.2010||R|A||0|0|0|0|GZE|0|0|0|100|XEU|30914|37341|lyfalmen|||00|180|0||Vistor hf|Genzyme Europe B.V.|Sevelamer||27938||27938|37341| 036108|L03AB0702|Rebif|stl|22|mcg/lykj|0,5|ml|4|rörlyk||L03AB07|01.03.2010||R|K||0|1|0|1|MSE|0|0|0|100|SEK|158938|201350|lyfsjukr|||00|2|0|20,4700|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||||158938|201350| 036145|M01AC0202|Tilcotil|töflur|20|mg|60|stk|1|glas||M01AC02|01.04.1988||R|A|3|0|0|E|0|MAS|0|0|1|100|SEK|6448|9698|lyfalmen|||00|60|0|60,0000|Vistor hf|Meda AS|Tenoxíkam||6448||6448|9698| 036152|C09CA0601|Atacand|töflur|8|mg|28|stk|1|þpakki||C09CA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|2976|4948|lyfalmen|V2213|4948|00|28|0|28,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||||2976|4948| 036228|C09CA0601|Atacand|töflur|8|mg|98|stk|1|þpakki||C09CA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|9472|13834|lyfalmen|V2214|13834|00|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||||9472|13834| 036290|J05AE0301|Norvir|filmhtfl|100|mg|30|stk|1|glas||J05AE03|01.10.2010||R|A||0|1|0|1|ABL|0|0|0|100|DKK|6205|8955|lyfsjukr|||00|30|0|2,5000|Vistor hf|Abbott Laboratories A/S|Ritonavír||6205||6205|8955| 036332|L01XE0401|Sutent|hylki|12,5|mg|30|stk|1|glas||L01XE04|01.10.2006||R|A|2|0|1|0|1|IPI|0|0|0|100|DKK|198992|251617|lyfsjukr|||00|30|0|0,0000|Icepharma hf|Pfizer Limited|Sunitíníb||198992||198992|251617| 036341|L01XE0401|Sutent|hylki|25|mg|30|stk|1|glas||L01XE04|01.10.2006||R|A|2|0|1|0|1|IPI|0|0|0|100|DKK|396907|500001|lyfsjukr|||00|30|0|0,0000|Icepharma hf|Pfizer Limited|Sunitíníb||396907||396907|500001| 036351|L01XE0401|Sutent|hylki|50|mg|30|stk|1|glas||L01XE04|01.10.2006||R|A|2|0|1|0|1|IPI|0|0|0|100|DKK|792145|996024|lyfsjukr|||00|30|0|0,0000|Icepharma hf|Pfizer Limited|Sunitíníb||792145||792145|996024| 036442|J01CE0204|Kaavepenin|töflur|800|mg|20|stk|1|þpakki||J01CE02|01.01.1988||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|863|2058|lyfalmen|||00|20|0|8,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||863||863|2058| 036517|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|60|ml|1|glas||J01CE02|01.07.1992||R|A|2|0|0|0|0|REP|0|0|1|100|SEK|1459|2873|lyfalmen|||08|60|0|3,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||1459||1459|2873| 036541|A03AX1301|Minifom|dropar|0| |30|ml|1|glas|+drteljari|A03AX13|01.12.1975||L|S|3|0|0|0|0|GCO|0|0|0|100|IKR|||lyflausa|||00|30|0|6,0000|Vistor hf|GlaxoSmithKline CH AB|Silíkonsambönd|||||| 036616|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|125|ml|1|glas||J01CE02|01.07.1992||R|A|2|0|0|0|0|REP|0|0|1|100|SEK|2879|4816|lyfalmen|||08|125|0|6,2500|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||2879||2879|4816| 036665|J01CE0204|Kaavepenin|töflur|800|mg|30|stk|1|þpakki||J01CE02|01.01.1988||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|873|2071|lyfalmen|||00|30|0|12,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||873||873|2071| 037278|N04BC0404|Requip Depot|forðatfl|2|mg|42|stk|1|plglas||N04BC04|01.09.2008|31.01.2011|R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|6561|9852|lyfalmen|||00|42|0|14,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||6561||6561|9852| 037287|N04BC0404|Requip Depot|forðatfl|2|mg|84|stk|1|plglas||N04BC04|01.09.2008||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|13280|18945|lyfalmen|||00|84|0|28,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||13280||13280|18945| 037305|N04BC0404|Requip Depot|forðatfl|4|mg|84|stk|1|plglas||N04BC04|01.09.2008||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|25401|34157|lyfalmen|||00|84|0|56,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||25401||25401|34157| 037323|N04BC0404|Requip Depot|forðatfl|8|mg|84|stk|1|plglas||N04BC04|01.09.2008||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|48677|63369|lyfalmen|||00|84|0|112,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||48677||48677|63369| 037358|N04BA0201|Madopar|töflur|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.07.1990||R|A|4|0|0|E|0|ROC|0|0|0|100|DKK|2541|4353|lyfalmen|||00|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2541||2541|4353| 037531|D07AC1301|Elocon|húðlausn|0,1|%|30|ml|1|glas||D07AC13|01.01.2009||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|1129|2422|lyfalmen|||0|30|0|30,0000|Vistor hf|Schering-Plough|Mómetasón||1129||1129|2422| 037846|A12BA0101|Kaleorid|forðatfl|750|mg|100|stk|1|glas||A12BA01|01.12.1972||L|A|5|0|0|E|0|LEP|0|0|0|100|DKK|||lyfalmen|||10|100|0|25,0000|Vistor hf|LEO Pharma A/S|Kalíumklóríð|||||2164| 037853|A12BA0101|Kaleorid|forðatfl|750|mg|250|stk|1|glas||A12BA01|01.12.1972||L|A|5|0|0|E|0|LEP|0|0|0|100|DKK|||lyfalmen|||10|250|0|62,5000|Vistor hf|LEO Pharma A/S|Kalíumklóríð|||||3576| 037895|C09CA0601|Atacand|töflur|4|mg|98|stk|1|þpakki||C09CA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|8541|12561|lyfalmen|V2212|12561|00|98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||||8541|12561| 038174|N06AB0501|Seroxat|töflur|20|mg|20|stk|1|þpakki||N06AB05|01.04.1993||R|A|3|0|0|B|0|GSK|0|1|0|100|IKR|664|1397|lyfalmen|V0917|1226|00|20|0|20,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||380||380|1397| 038257|N06AB0501|Seroxat|töflur|20|mg|60|stk|1|þpakki||N06AB05|01.04.1993||R|A|3|0|0|B|0|GSK|0|1|0|100|IKR|1766|2273|lyfalmen|V0918|1944|00|60|0|60,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||1020||1020|2273| 038448|N06AB0501|Seroxat|töflur|20|mg|100|stk|1|þpakki||N06AB05|01.04.1993||R|A|3|0|0|B|0|GSK|0|1|0|100|IKR|2667|3054|lyfalmen|V0919|2754|00|100|0|100,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||1591||1591|3054| 038513|D06BA0101|Flamazine|krem|10|mg/g|50|g|1|túpa||D06BA01|01.10.1988||R|A|3|0|0|0|0|SON|0|0|1|100|DKK|1052|2316|lyfalmen|||00|50|0|50,0000|Icepharma hf|Smith & Nephew|Silfursúlfadíazín||1052||1052|2316| 038554|C09CA0601|Atacand|töflur|4|mg|28|stk|1|þpakki||C09CA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|2771|4668|lyfalmen|V2211|4668|00|28|0|14,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||||2771|4668| 038607|L03AA1301|Neulasta|stl|6|mg/penna|0,6|ml|1|penni|áfylltur penni, lausn|L03AA13|01.07.2006||R|K|2,5|0|1|0|1|AEU|0|0|0|100|DKK|215334|272127|lyfsjukr|||00|1|0|0,0000|Vistor hf|Amgen Europe B.V.|Pegfilgrastím||215334||215334|272127| 038689|L04AB0101|Enbrel|sts|25|mg|4|hgl|1|pakki|+ leysir|L04AB01|01.04.2010||R|K||0|1|0|1|WTE|0|0|0|100|DKK|86984|111047|lyfsjukr|||00|4|0|14,2900|Icepharma hf|Wyeth Europe|Etanercept||||86984|111047| 038877|N07CA0101|Betaserc|töflur|8|mg|100|stk|1|þpakki||N07CA01|01.12.1982||R|A|5|0|0|E|0|SOL|0|0|0|100|DKK|4430|6937|lyfalmen|||00|100|0|33,3333|Medico ehf|Solvay Duphar |Betahistín||4430||4430|6937| 039005|L01XA0301|Eloxatin|irþ|5|mg/ml|10|ml|1|hgl||L01XA03|01.03.2007||R|A|3|0|1|0|1|SNO|0|0|0|100|NOK|42271|54933|lyfsjukr|||00|10|0|0,0000|Vistor hf|Sanofi-aventis Norge AS|Oxalíplatín||42271||42271|54933| 039014|L01XA0301|Eloxatin|irþ|5|mg/ml|20|ml|1|hgl||L01XA03|01.03.2007||R|A|3|0|1|0|1|SNO|0|0|0|100|NOK|67391|86458|lyfsjukr|||00|20|0|0,0000|Vistor hf|Sanofi-aventis Norge AS|Oxalíplatín||67391||67391|86458| 039575|D01AE1503|Lamisil (D.A.C.)|krem|10|mg/g|15|g|1|túpa||D01AE15|01.05.2009||L|A|5|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|15|0|15,0000|D.A.C. ehf|D.A.C. ehf|Terbínafín|||||| 039631|C01BD0701|Multaq|filmhtfl|400|mg|20|stk|1|þpakki||C01BD07|01.08.2010||R|A||0|0|0|0|SAA|0|0|0|100|NOK|4485|7013|lyfalmen|||00|20|0|10,0000|Vistor hf|Sanofi - Aventis|Dronedarón||||4485|7013| 039643|C01BD0701|Multaq|filmhtfl|400|mg|100|stk|1|þpakki||C01BD07|01.08.2010||R|A||0|0|0|0|SAA|0|0|0|100|NOK|21973|29855|lyfalmen|||00|100|0|50,0000|Vistor hf|Sanofi - Aventis|Dronedarón||||21973|29855| 039676|N06AX0307|Mianserin Mylan|filmhtfl|30|mg|100|stk|1|glas||N06AX03|01.06.2010||R|A|5|0|0|B|0|MYL|0|1|0|100|SEK|3368|5485|lyfalmen|||00|100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Míanserín||3368||3368|5485| 039698|C07AB0311|Atenolol Mylan|töflur|25|mg|98|stk|1|þpakki||C07AB03|01.04.1992||R|A|4|0|0|B|0|MYL|0|0|0|100|SEK|663|1784|lyfalmen|V0290|1631|00|98|0|32,6667|Actavis Group PTC ehf|Mylan AB|Atenólól||663||663|1784| 039709|C07AB0311|Atenolol Mylan|töflur|50|mg|98|stk|1|þpakki||C07AB03|01.01.1991||R|A|4|0|0|B|0|MYL|0|0|0|100|SEK|655|1773|lyfalmen|||00|98|0|65,3333|Actavis Group PTC ehf|Mylan AB|Atenólól||655||655|1773| 039776|J01FA1001|Zitromax|mixtúrud|40|mg/ml|15|ml|1|glas||J01FA10|01.07.1994||R|A|3|0|0|0|0|PER|0|0|1|100|DKK|1411|2807|lyfalmen|||00|15|0|2,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||1411||1411|2807| 039784|J01FA1001|Zitromax|mixtúrud|40|mg/ml|22,5|ml|1|glas||J01FA10|01.01.1995||R|A|3|0|0|0|0|PER|0|0|1|100|DKK|2277|3992|lyfalmen|||00|22|0|3,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||2277||2277|3992| 039909|L01AA0101|Sendoxan|sts|200|mg|1|stk|1|hgl||L01AA01|01.07.1992||R|A|3|0|1|0|1|BAM|0|0|0|100|SEK|527|761|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Baxter Medical AB|Cýklófosfamíð||527||527|761| 039935|C10AA0105|Simvastatin Actavis|filmhtfl|40|mg|98|stk|1|þpakki||C10AA01|01.06.2009||R|A|3|0|0|E|0|AGP|0|0|0|100|IKR|1630|2947|lyfalmen|V0367|2929|00|98|0|130,6700|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||1513||1513|2947| 039957|J05AB1104|Valaciclovir Actavis|filmhtfl|500|mg|42|stk|1|þpakki||J05AB11|01.01.2010||R|A||0|0|E|0|AGP|0|0|1|100|GBP|8398|9988|lyfalmen|V0508|9988|00|42|0|7,0000|Actavis Group hf|Actavis Group PTC ehf|Valacíklóvír||6660||6660|9988| 039958|L01AA0101|Sendoxan|sts|500|mg|1|stk|1|hgl||L01AA01|01.01.1988||R|A|3|0|1|0|1|BAM|0|0|0|100|SEK|1138|1642|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Baxter Medical AB|Cýklófosfamíð||1138||1138|1642| 039968|J05AB1104|Valaciclovir Actavis|filmhtfl|500|mg|10|stk|1|þpakki||J05AB11|01.01.2010||R|A||0|0|E|0|AGP|0|0|1|100|GBP|1819|2535|lyfalmen|V0507|2535|00|10|0|1,6667|Actavis Group hf|Actavis Group PTC ehf|Valacíklóvír||1212||1212|2535| 040089|L01AA0101|Sendoxan|sts|1|g|1|stk|1|hgl||L01AA01|01.07.1994||R|A|3|0|1|0|1|BAM|0|0|0|100|SEK|1951|2816|lyfsjukr|||02|1|0|0,0000|Icepharma hf|Baxter Medical AB|Cýklófosfamíð||1951||1951|2816| 040543|S01XA2012|Dacriosol|augndr|3|mg/ml|15|ml|1|glas||S01XA20|01.03.2000||L|A|4|0|0|E|0|SAL|0|0|0|100|IKR|||lyfalmen|||06|15|0|0,0000|Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Gervitár og aðrar óvirkar samsetningar|||||1621| 041423|G03AA1203|Yasminelle|töflur|0||63|stk|1|þpakki|3+0,02 mg|G03AA12|01.12.2006||R|A|5|0|0|0|0|BAP|0|0|0|100|SEK|3368|5485|lyfalmen|||00|63|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Dróspírenón og östrógen||3368||3368|5485| 041488|N06AB1002|Cipralex (D.A.C.)|filmhtfl|20|mg|98|stk|1|þpakki||N06AB10|01.05.2009|31.12.2010|R|A|3|0|0|0|0|DAC|0|1|0|100|DKK|19711|26523|lyfalmen|||00|98|0|196,0000|D.A.C. ehf|D.A.C. ehf|Escítalópram||19318||19318|26523| 041704|QI09AX0001|Improvac|stl|300|mcg|20|ml|12|fl||QI09AX00|01.08.2010||R|K||0|0|0|0|IPF|1|0|0|100|DKK|28246|49274|vetorma|||00|240|0||Icepharma hf|Pfizer Limited|GnRF hliðstæða samtengd próteini||||28246|49274| 041749|QI04AB0101|Lambivac, vet.|stl|126|Lf/ml|100|ml|1|fl|dreifa|QI04AB01|01.04.2007||R|K|3|0|0|0|0|INI|0|0|0|100|DKK|4424|7717|vetorma|||AA|100|0|0,0000|Icepharma hf|Intervet International B.V.|||4424||4424|7717| 041795|M02AA1503|Voltaren Emulgel (D.A.C.)|hlaup|11,6|mg/g|100|g|1|túpa||M02AA15|01.05.2009||L|A|3|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||0|100|0|0,0000|D.A.C. ehf|D.A.C. ehf|Díklófenak|||||| 041815|V08CA1101|Vasovist|stl|0,25|mmol/ml|10|ml|10|hgl|lausn|V08CA11|01.12.2006||R|A|3|0|0|0|0|TMC|0|0|0|100|SEK|206796|261808|lyfalmen|||02|100|0|0,0000|TMC Pharma Services Ltd|TMC Pharma Services Ltd|Gadófosveset||206796||206796|261808| 041898|N06AX0307|Mianserin Mylan|filmhtfl|10|mg|90|stk|1|þpakki||N06AX03|01.06.2008||R|A||0|0|B|0|MYL|0|1|0|100|SEK|1205|2526|lyfalmen|||00|90|0|15,0000|Actavis Group PTC ehf|Mylan AB|Míanserín||||1205|2526| 041996|A06AG1101|Microlax|innhl|0| |5|ml|4|túpa||A06AG11|01.12.1972||L|A|5|0|0|0|0|MCN|0|0|0|100|IKR|||lyflausa|||56|20|0|4,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, þ.m.t. í blöndum|||||| 042036|C07AB0205|Seloken|stl|1|mg/ml|5|ml|5|lykjur||C07AB02|01.01.1985||R|A|5|0|0|B|0|AZD|0|0|0|100|SEK|1549|2996|lyfalmen|||02|25|0|0,1667|Vistor hf|AstraZeneca A/S DK|Metóprólól||1549||1549|2996| 042101|N01BB0902|Naropin|irl|2|mg/ml|100|ml|5|plpok||N01BB09|01.05.1998||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|13035|18241|lyfsjukr|||00|500|0|0,0000|Vistor hf|AstraZeneca A/S DK|Rópívakaín||13035||13035|18241| 042305|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|3667|5292|lyfsjukr|||00|10000|0|0,0000|Icepharma hf|Fresenius Kabi|Kolvetni||3667||3667|5292| 042309|N01BB0902|Naropin|stl/irl|2|mg/ml|200|ml|5|plpok||N01BB09|01.07.2009|28.02.2011|R|A||0|0|0|1|AZD|0|0|0|100|SEK|22343|29923|lyfsjukr|||00|1000|0|0,0000|Vistor hf|AstraZeneca A/S DK|Rópívakaín||||22343|29923| 042314|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|4625|6675|lyfsjukr|||00|7500|0|0,0000|Icepharma hf|Fresenius Kabi|Kolvetni||4625||4625|6675| 042323|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|4371|6308|lyfsjukr|||00|10000|0|0,0000|Icepharma hf|Fresenius Kabi|Kolvetni||4371||4371|6308| 042332|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|6627|9564|lyfsjukr|||00|7500|0|0,0000|Icepharma hf|Fresenius Kabi|Kolvetni||6627||6627|9564| 042346|N07BA0137|Nicorette (D.A.C.)|innsogsl|10|mg|42|rör|1|pakki|þp+munnstk|N07BA01|01.05.2009|31.12.2010|L|A|3|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|42|0|7,0000|D.A.C. ehf|D.A.C. ehf|Nikótín|||||| 042357|N07BA0141|Nicotinell Fruktsmak (D.A.C.)|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.05.2009||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|204|0|13,6000|D.A.C. ehf|D.A.C. ehf|Nikótín|||||| 042360|B05BA0311|Glucos Fresenius Kabi|irl|500|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|7607|10979|lyfsjukr|||00|7500|0|0,0000|Icepharma hf|Fresenius Kabi|Kolvetni||7607||7607|10979| 042368|A06AB0602|Senokot|töflur|7,5|mg|500|stk|1|glas||A06AB06|01.04.2009||R|A|3|0|0|0|0|REB|0|0|0|100|GBP|2250|3955|lyfalmen|||00|500|0|0,0000|Icepharma hf|Reckitt Benckiser Healthcare Ltd.|Senna||||2250|3955| 042369|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|100|ml|40|plpok|Excel umbúðir|B05BA03|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|8320|12008|lyfsjukr|||00|4000|0|4,0000|Icepharma hf|Fresenius Kabi|Kolvetni||8320||8320|12008| 042378|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|250|ml|20|plpok|Freeflex umbúðir|B05BA03|01.03.2010||R|A||0|0|0|1|FRP|0|0|0|100|DKK|4223|6095|lyfsjukr|||00|5000|0|5,0000|Icepharma hf|Fresenius Kabi|Kolvetni||4223||4223|6095| 042387|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|4418|6376|lyfsjukr|||00|7500|0|0,0000|Icepharma hf|Fresenius Kabi|Kolvetni||4418||4418|6376| 042396|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|3242|4679|lyfsjukr|||00|10000|0|0,0000|Icepharma hf|Fresenius Kabi|Kolvetni||3242||3242|4679| 042405|B05BB0213|Kalium-Natrium-Glucose "Fresenius Kabi"|irl|0| |1000|ml|10|plpok|Freeflex umbúðir|B05BB02|01.05.2007||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2795|4034|lyfsjukr|||02|10000|0|0,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með kol­vetnum||2795||2795|4034| 042442|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|50|ml|40|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|9766|14095|lyfsjukr|||00|2000|0|0,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar||9766||9766|14095| 042451|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|20|plpok|Freeflex umbúðir|B05BB01|01.03.2010||R|A||0|0|0|1|FRP|0|0|0|100|DKK|3910|5643|lyfsjukr|||00|5000|0|5,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar||3910||3910|5643| 042460|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|2505|3615|lyfsjukr|||00|7500|0|0,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar||2505||2505|3615| 042469|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|1804|2604|lyfsjukr|||00|10000|0|0,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar||1804||1804|2604| 042478|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|40|plpok|Excel umbúðir|B05BB01|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|6124|8838|lyfsjukr|||00|4000|0|4,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar||6124||6124|8838| 042524|B05BB0115|Ringer-acetat Fresenius Kabi|irl|0| |1000|ml|10|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2044|2950|lyfsjukr|||00|10000|0|0,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar||2044||2044|2950| 042549|J07BF0301|Imovax Polio|bóluefni|0| |0,5|ml|1|dæla|einnota|J07BF03|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|779|1943|lyfalmen|||02|0|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Mænusótt, dauð veira||779||779|1943| 042551|B05BB0209|Glucos 100 mg/ml med Na40 + K20 Fres|irl|||1000|ml|10|plpok||B05BB02|01.04.2009||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|3166|4569|lyfsjukr|||00|10000|0|0,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með kol­vetnum||||3166|4569| 042556|J07BF0301|Imovax Polio|bóluefni|0| |0,5|ml|20|dælur|einnota|J07BF03|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|14884|20959|lyfalmen|||02|10|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Mænusótt, dauð veira||14884||14884|20959| 042561|QM01AH9201|Trocoxil|tuggutfl|6|mg|2|stk|1|þpakki||QM01AH92|01.12.2010||R|A||0|0|0|0|IPF|0|0|0|100|DKK|1350|2685|vetalmen|||00|2|0||Icepharma hf|Pfizer Limited|Mavakoxíb||1350||1350|2685| 042573|QM01AH9201|Trocoxil|tuggutfl|20|mg|2|stk|1|þpakki||QM01AH92|01.12.2010||R|A||0|0|0|0|IPF|0|0|0|100|DKK|2012|4002|vetalmen|||00|2|0||Icepharma hf|Pfizer Limited|Mavakoxíb||2012||2012|4002| 042584|QM01AH9201|Trocoxil|tuggutfl|30|mg|2|stk|1|þpakki||QM01AH92|01.12.2010||R|A||0|0|0|0|IPF|0|0|0|100|DKK|2698|5353|vetalmen|||00|2|0||Icepharma hf|Pfizer Limited|Mavakoxíb||2698||2698|5353| 042595|QM01AH9201|Trocoxil|tuggutfl|75|mg|2|stk|1|þpakki||QM01AH92|01.12.2010||R|A||0|0|0|0|IPF|0|0|0|100|DKK|5397|10536|vetalmen|||00|2|0||Icepharma hf|Pfizer Limited|Mavakoxíb||5397||5397|10536| 042607|QM01AH9201|Trocoxil|tuggutfl|95|mg|2|stk|1|þpakki||QM01AH92|01.12.2010||R|A||0|0|0|0|IPF|0|0|0|100|DKK|6206|12089|vetalmen|||00|2|0||Icepharma hf|Pfizer Limited|Mavakoxíb||6206||6206|12089| 042615|B05BB0210|Rehydrex m. gl. 25 mg/ml Fresenius Kabi|irl|0| |1000|ml|10|plpok|Freeflex umbúðir|B05BB02|01.05.2007||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|3435|4958|lyfsjukr|||00|10000|0|0,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með kol­vetnum||3435||3435|4958| 042669|V07AB13|Sterilt vatten/vann/vand Fresenius Kabi|leysir|0| |100|ml|40|plastl|fyrir stungulyf|V07AB|01.04.2008||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||00|4000|0|0,0000|Icepharma hf|Fresenius Kabi|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||| 043232|N05CD0306|Flunitrazepam Mylan|töflur|1|mg|30|stk|1|þpakki||N05CD03|01.10.1992||R|A|5|1|0|0|0|MYL|0|0|0|100|SEK|383|1401|lyfalmen|||00|30|0|30,0000|Actavis Group PTC ehf|Mylan AB|Flúnítrazepam||383||383|1401| 043257|N01BB0902|Naropin|stl/irl|2|mg/ml|20|ml|5|plastl||N01BB09|01.05.1998||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|3626|5233|lyfsjukr|||00|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|Rópívakaín||3626||3626|5233| 043379|R03AC1201|Serevent|innúðal|25|mcg/sk|120|sk|1|stauk|HFA 134a|R03AC12|01.04.2007||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|3763|5798|lyfalmen|||24|120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról||3597||3597|5798| 043547|N01BB0902|Naropin|stl|7,5|mg/ml|20|ml|5|plastl||N01BB09|01.05.1998||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|6665|9619|lyfsjukr|||00|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|Rópívakaín||6665||6665|9619| 043729|N05CD0503|Halcion|töflur|0,125|mg|30|stk|1|þpakki||N05CD05|01.12.1983||R|A|3|0|0|0|0|PER|0|0|1|100|DKK|567|1653|lyfalmen|||00|30|0|15,0000|Icepharma hf|Pfizer ApS|Tríazólam||567||567|1653| 043745|G03CA0401|Ovestin|töflur|2|mg|30|stk|1|þpakki||G03CA04|01.07.1989||R|A|5|0|0|E|0|ORG|0|0|0|100|DKK|1213|2537|lyfalmen|||10|30|0|30,0000|Vistor hf|N.V. Organon|Estríól||1213||1213|2537| 043919|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|10|ml|20|lykjur|fyrir stl|V07AB|01.07.1995||L|A|3|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||02|200|0|0,0000|Icepharma hf|Fresenius Kabi|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||| 043935|V07AB13|Sterilt vatten/vann/vand Fresenius Kabi|leysir|0| |10|ml|20|plastl|fyrir stungulyf|V07AB|01.10.1994||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||00|200|0|0,0000|Icepharma hf|Fresenius Kabi|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||| 043988|B03AA0705|Ferrous Sulphate|töflur|200|mg|100|stk|1|glas|sykurhúðaðar|B03AA07|01.09.2009||L|A||0|0|0|0|AUK|0|0|1|100|IKR|||lyflausa|||00|100|0|100,0000|Actavis Group hf|Actavis UK Ltd.|Ferrósúlfat|||||| 044360|B03AC0203|Venofer (Lyfjaver)|stl|20|mg/ml|5|ml|5|lykjur||B03AC02|01.05.2006||R|A|3|0|0|E|0|LVR|0|0|1|100|NOK|14135|19474|lyfalmen|V0011|19474|00|25|0|5,0000|Lyfjaver ehf|Lyfjaver ehf|Járnoxíð (sykurflétta)||13701||13701|19474| 044739|N04BC0502|Sifrol|forðatfl|0,52|mg|100|stk|1|pakki||N04BC05|01.02.2010||R|A||0|0|E|0|BII|0|0|0|100|DKK|25743|34587|lyfalmen|||00|100|0|100,0000|Vistor hf|Boehringer Ingelheim International|Pramipexól||||25743|34587| 044752|N04BC0502|Sifrol|forðatfl|2,1|mg|100|stk|1|pakki||N04BC05|01.02.2010||R|A||0|0|E|0|BII|0|0|0|100|DKK|96422|123289|lyfalmen|||00|100|0|100,0000|Vistor hf|Boehringer Ingelheim International|Pramipexól||||96422|123289| 044763|N04BC0502|Sifrol|forðatfl|0,52|mg|10|stk|1|pakki||N04BC05|01.02.2010||R|A||0|0|E|0|BII|0|0|0|100|DKK|3286|5372|lyfalmen|||00|10|0|10,0000|Vistor hf|Boehringer Ingelheim International|Pramipexól||||3286|5372| 045013|L01XX1902|Campto|irþ|20|mg/ml|5|ml|1|hgl||L01XX19|01.01.1999||R|A|3|0|1|0|1|PER|0|0|0|100|DKK|38110|49711|lyfsjukr|||00|5|0|0,0000|Icepharma hf|Pfizer ApS|Írinótekan||38110||38110|49711| 045385|J07BF0301|Imovax Polio|bóluefni|0| |0,5|ml|10|dælur|einnota|J07BF03|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|7441|11056|lyfalmen|||02|5|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Mænusótt, dauð veira||7441||7441|11056| 045510|C10AA0105|Simvastatin Actavis|filmhtfl|20|mg|98|stk|1|þpakki||C10AA01|01.06.2009||R|A|3|0|0|E|0|AGP|0|0|0|100|IKR|1050|2199|lyfalmen|V0362|2199|00|98|0|65,3400|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||966||966|2199| 045533|C10AA0105|Simvastatin Actavis|filmhtfl|10|mg|98|stk|1|þpakki||C10AA01|01.06.2009||R|A|3|0|0|E|0|AGP|0|0|0|100|IKR|868|1993|lyfalmen|V0361|1993|00|98|0|32,6700|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||816||816|1993| 045588|J01DC0204 |Cefuroxim Villerton|sts|750|mg/hgl|10|hgl|1|pakki||J01DC02|01.05.2009||R|A||0|0|0|1|VIL|0|0|0|100|NOK|4177|5246|lyfsjukr|||00|750|0|0,2500|Lyfjaver ehf|Villerton Invest AS|Cefúroxím||3635||3635|5246| 045599|J01DC0204 |Cefuroxim Villerton|sts|1500|mg/hgl|10|hgl|1|pakki||J01DC02|01.05.2009||R|A||0|0|0|1|VIL|0|0|0|100|NOK|7990|10628|lyfsjukr|||00|1500|0|0,5000|Lyfjaver ehf|Villerton Invest AS|Cefúroxím||7364||7364|10628| 045634|N02AA5907|Pinex Comp Forte|eþ-stíll|530|mg|10|stk|1|pakki|30+500 mg|N02AA59|01.01.2011||R|A||0|0|0|0|AGT|0|0|1|100|XEU|379|1396|lyfalmen|V0776|1396|04|10|0|3,3333|Actavis Group hf|Actavis Group hf|Kódein í blöndum nema með geðlyfjum||379||379|1396| 046077|QJ01DD9101|Convenia|sts|80|mg/ml|10|ml|1|hgl|+leysir, lausn|QJ01DD91|01.01.2008||R|K|2|0|0|0|0|PFV|0|0|0|100|DKK|21278|41030|vetalmen|||27|10|0|0,0000|Icepharma hf|Pfizer vet.|||21278||21278|41030| 046269|C09AA0502|Ramil|töflur|2,5|mg|100|stk|1|þpakki||C09AA05|01.03.2006||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|1943|3535|lyfalmen|||00|100|0|100,0000|Actavis Group hf|Actavis hf|Ramipríl||1943||1943|3535| 046396|A04AA0102|Ondansetron Vian|stl|2|mg/ml|2|ml|5|lykjur||A04AA01|01.02.2008||R|A|3|0|0|E|0|VIS|0|0|0|100|DKK|5256|8067|lyfalmen|V1088|8067|02|10|0|1,2500|Icepharma hf|Vian SA|Ondansetrón||5256||5256|8067| 046405|A10BB1202|Glimeryl|töflur|1|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|A|3|0|0|*|0|ACA|0|0|0|100|IKR|769|1929|lyfalmen|V0001|1929|00|90|0|45,0000|Actavis Group hf|Actavis hf|Glímepíríð||769||769|1929| 046414|A10BB1202|Glimeryl|töflur|2|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|A|3|0|0|*|0|ACA|0|0|0|100|IKR|1215|2539|lyfalmen|V0002|2539|00|90|0|90,0000|Actavis Group hf|Actavis hf|Glímepíríð||1215||1215|2539| 046423|A10BB1202|Glimeryl|töflur|3|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|A|3|0|0|*|0|ACA|0|0|0|100|IKR|1622|3096|lyfalmen|V0003|3096|00|90|0|135,0000|Actavis Group hf|Actavis hf|Glímepíríð||1622||1622|3096| 046687|A04AA0102|Ondansetron Vian|stl|2|mg/ml|4|ml|5|lykjur||A04AA01|01.02.2008||R|A|3|0|0|E|0|VIS|0|0|0|100|DKK|8429|12408|lyfalmen|V1089|12408|02|20|0|2,5000|Icepharma hf|Vian SA|Ondansetrón||8429||8429|12408| 047042|L04AB0101|Enbrel|stl|25|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.05.2008||R|K|2|0|1|0|1|WTE|0|0|0|100|DKK|73953|94694|lyfsjukr|||00|4|0|14,2900|Icepharma hf|Wyeth Europe|Etanercept||73953||73953|94694| 047159|C07AA0705|Sotalol Mylan|töflur|40|mg|100|stk|1|glas||C07AA07|01.01.1994||R|A|4|0|0|B|0|MYL|0|0|0|100|SEK|1033|2290|lyfalmen|||00|100|0|25,0000|Actavis Group PTC ehf|Mylan AB|Sótalól||1033||1033|2290| 047340|J01CA0406|Flemoxin Solutab|lausnart|500|mg|14|stk|1|þpakki||J01CA04|01.04.1992||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|960|2190|lyfalmen|||23|14|0|7,0000|Vistor hf|Astellas Pharma A/S|Amoxicillín||960||960|2190| 047442|N01AX1301|Niontix|lyfjagas|100|%|10|l|1|hylki||N01AX13|01.06.2008||R|A|5|0|0|0|1|AGA|0|0|0|100|IKR|13388|18684|lyfsjukr|||00|10|0|0,0000|Ísaga ehf|AGA AB|di-Nitrogen oxíð||13388||13388|18684| 047460|N01AX1301|Niontix|lyfjagas|100|%|50|l|1|hylki||N01AX13|01.06.2008||R|A|5|0|0|0|1|AGA|0|0|0|100|IKR|47555|61564|lyfsjukr|||00|50|0|0,0000|Ísaga ehf|AGA AB|di-Nitrogen oxíð||47555||47555|61564| 047560|L04AB0101|Enbrel|stl|50|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.05.2008||R|K|2|0|1|0|1|WTE|0|0|0|100|DKK|160057|202754|lyfsjukr|||00|4|0|28,5800|Icepharma hf|Wyeth Europe|Etanercept||160057||160057|202754| 047563|R03DC0101|Accolate|töflur|20|mg|98|stk|1|þpakki||R03DC01|01.04.1998|31.01.2011|R|A|3|0|0|B|0|AZA|0|0|0|100|SEK|9761|14230|lyfalmen|||00|98|0|49,0000|Vistor hf|AstraZeneca AB|Zafírlúkast||9761||9761|14230| 047986|L02BB0305|Bicalutamide Portfarma|filmhtfl|50|mg|30|stk|1|þpakki||L02BB03|01.02.2011||R|A||0|0|*|0|POF|0|0|0|100|XEU|12700|16041|lyfalmen|V0560|15435|00|30|0|30,0000|Portfarma ehf|Portfarma|Bíkalútamíð||11085||11085|16041| 047998|L02BB0305|Bicalutamide Portfarma|filmhtfl|150|mg|30|stk|1|þpakki||L02BB03|01.02.2011||R|A||0|0|*|0|POF|0|0|0|100|XEU|24050|32420|lyfalmen|V0562|31818|00|30|0|30,0000|Portfarma ehf|Portfarma|Bíkalútamíð||24017||24017|32420| 048015|B05AA0111|Albumin Baxter|irl|50|g/líter|250|ml|1|hgl||B05AA01|01.06.2007||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|5365|7743|lyfsjukr|||02|250|0|0,0000|Icepharma hf|Baxter Medical AB|Albúmín||5365||5365|7743| 048043|B05AA0111|Albumin Baxter|irl|200|g/líter|100|ml|1|hgl||B05AA01|01.06.2007||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|8469|12223|lyfsjukr|||02|100|0|0,0000|Icepharma hf|Baxter Medical AB|Albúmín||8469||8469|12223| 048100|N06AB1004|Esopram|töflur|5|mg|100|stk|1|þpakki||N06AB10|01.04.2010||R|A||0|0|B|0|APC|0|1|0|100|XEU|5797|6893|lyfalmen|V0940|6893|00|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||4398||4398|6893| 048111|N06AB1004|Esopram|töflur|10|mg|28|stk|1|þpakki||N06AB10|01.04.2010||R|A||0|0|0|0|APC|0|1|0|100|XEU|2527|3524|lyfalmen|V0939|3524|00|28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||1935||1935|3524| 048122|N06AB1004|Esopram|töflur|10|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|A||0|0|B|0|APC|0|1|0|100|XEU|9051|7345|lyfalmen|V0938|7345|00|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||4728||4728|7345| 048133|N06AB1004|Esopram|töflur|15|mg|28|stk|1|þpakki||N06AB10|01.04.2010||R|A||0|0|0|0|APC|0|1|0|100|XEU|4507|4024|lyfalmen|V0941|4024|00|28|0|42,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||2300||2300|4024| 048144|N06AB1004|Esopram|töflur|15|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|A||0|0|B|0|APC|0|1|0|100|XEU|17192|7345|lyfalmen|V0942|7345|00|100|0|150,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||4728||4728|7345| 048155|N06AB1004|Esopram|töflur|20|mg|28|stk|1|þpakki||N06AB10|01.04.2010||R|A||0|0|0|0|APC|0|1|0|100|XEU|5400|4392|lyfalmen|V0943|4392|00|28|0|56,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||2569||2569|4392| 048166|N06AB1004|Esopram|töflur|20|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|A||0|0|B|0|APC|0|1|0|100|XEU|18402|7345|lyfalmen|V2172|7345|00|100|0|200,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||4728||4728|7345| 048199|A03CA0201|Librax|töflur|||100|stk|1|glas||A03CA02|01.12.1972||R|A|5|0|0|E|0|MAB|0|0|0|100|DKK|1178|2489|lyfalmen|||00|100|0|0,0000|Vistor hf|Meda AB|Klídín og geðlyf||1178||1178|2489| 048297|C09DA0101|Cozaar Comp|filmhtfl|112,5|mg|98|stk|1|þpakki|100+12,5 mg|C09DA01|01.06.2007||R|A|3|0|0|0|0|MSD|0|0|0|100|XEU|13991|19838|lyfalmen|||00|98|0|196,0000|Icepharma hf|M.S.D.|Lósartan og þvagræsilyf||13991||13991|19838| 048355|C01DA0801|Sorbangil|töflur|40|mg|100|stk|1|glas||C01DA08|01.10.1988||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|4770|7402|lyfalmen|||00|100|0|66,6667|Vistor hf|Recip AB|Ísósorbíð dínítrat||4770||4770|7402| 048447|G03AA0901|Marvelon|töflur|||63|stk|1|þpakki||G03AA09|01.07.1986||R|A|3|0|0|0|0|ORG|0|0|0|100|DKK|1806|3348|lyfalmen|||23|63|0|84,0000|Vistor hf|N.V. Organon|Desógestrel og östrógen||1806||1806|3348| 048488|L04AA0601|Cellcept|töflur|500|mg|150|stk|1|þpakki||L04AA06|01.03.1999||R|A|3|0|1|*|0|ROC|0|0|0|100|DKK|65330|76757|lyfalmen|V2230|74828|00|150|0|37,5000|Icepharma hf|Roche|Mýcófenólsýra||59345||59345|76757| 048505|L03AX1601|Mozobil|stl|20|mg/ml|1,2|ml|1|hgl|lausn|L03AX16|01.07.2010||R|A||0|1|0|1|GZE|0|0|0|100|XEU|1126714|1415909|lyfsjukr|||00|1|0|1,4300|Vistor hf|Genzyme Europe B.V.|Plerixaforum||1126714||1126714|1415909| 048744|N02BE0101|Panodil|töflur|500|mg|100|stk|1|glas||N02BE01|01.03.1984||R|A|4|0|0|0|0|GCH|0|0|1|100|DKK|485|1541|lyfalmen|V0772|1464|00|100|0|16,6667|Icepharma hf|GlaxoSmithKline CH A/S|Paracetamól||485||485|1541| 049015|A02BA0201|Asyran|töflur|300|mg|100|stk|1|þpakki||A02BA02|01.10.1987||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|3269|5349|lyfalmen|||00|100|0|100,0000|Actavis Group hf|Actavis hf|Ranitidín||3269||3269|5349| 049169|M05BA0602|Bonviva|stl|1|mg/ml|3|ml|1|spr||M05BA06|01.10.2006||R|A|2|0|0|0|0|RRL|0|0|0|100|DKK|17046|23672|lyfalmen|||00|3|0|90,0000|Icepharma hf|Roche Registration Limited|Íbandrónsýra||17046||17046|23672| 049395|B01AC0701|Persantin|töflur|100|mg|100|stk|1|glas||B01AC07|01.10.1985||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|2621|4463|lyfalmen|||00|100|0|25,0000|Vistor hf|Boehringer Ingelheim|Dípýrídamól||2621||2621|4463| 049502|D01AC0801|Fungoral|sápa|20|mg/ml|60|ml|1|glas||D01AC08|01.07.1993||L|A|3|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||23|60|0|60,0000|Vistor hf|McNeil Sweden AB|Ketókónazól|||||| 049524|S01ED5110|Duotrav|augndr|0| |2,5|ml|1|glas|40 mcg/ml+5 mg/ml|S01ED51|01.06.2007||R|A|3|0|0|*|0|ALC|0|0|0|100|USD|3415|5549|lyfalmen|||00|2|0|0,0000|K.Pétursson hf|Alcon|Tímólól í blöndum||3415||3415|5549| 049533|S01ED5110|Duotrav|augndr|0| |2,5|ml|3|glas|40 mcg/ml+5 mg/ml|S01ED51|01.06.2007||R|A|3|0|0|*|0|ALC|0|0|0|100|USD|10052|14628|lyfalmen|||00|8|0|0,0000|K.Pétursson hf|Alcon|Tímólól í blöndum||10052||10052|14628| 049551|D01AE1601|Loceryl|lakk|50|mg/ml|5|ml|1|glas||D01AE16|01.10.1992||R|A|3|0|0|0|0|GAN|0|0|1|100|CHF|9237|13513|lyfalmen|||23|5|0|5,0000|Icepharma hf|Galderma Nordic AB|Amorolfín||9237||9237|13513| 049561|C10AA0104|Simvastatin (Portfarma)|filmhtfl|10|mg|98|stk|1|þpakki||C10AA01|01.07.2006||R|A|2|0|0|E|0|POF|0|0|0|100|IKR|1059|1993|lyfalmen|V0361|1993|00|98|0|32,6667|Portfarma ehf|Portfarma|Simvastatín||816||816|1993| 049579|C10AA0104|Simvastatin (Portfarma)|filmhtfl|20|mg|98|stk|1|þpakki||C10AA01|01.07.2006||R|A|2|0|0|E|0|POF|0|0|0|100|IKR|1154|2199|lyfalmen|V0362|2199|00|98|0|65,3400|Portfarma ehf|Portfarma|Simvastatín||966||966|2199| 049597|C10AA0104|Simvastatin (Portfarma)|filmhtfl|40|mg|100|stk|1|þpakki||C10AA01|01.07.2006||R|A|2|0|0|E|0|POF|0|0|0|100|IKR|1827|2989|lyfalmen|V0367|2989|00|100|0|133,3333|Portfarma ehf|Portfarma|Simvastatín||1544||1544|2989| 049650|D01BA0201|Lamisil|töflur|250|mg|28|stk|1|þpakki||D01BA02|01.04.1993||R|A|5|0|0|0|0|NOH|0|0|0|100|IKR|8006|4898|lyfalmen|V0343|4500|00|28|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Terbínafín||2939||2939|4898| 049678|C09AA0502|Ramil|töflur|5|mg|100|stk|1|þpakki||C09AA05|01.04.2006||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|1681|3177|lyfalmen|||00|100|0|200,0000|Actavis Group hf|Actavis hf|Ramipríl||1681||1681|3177| 049684|D01AE1501|Lamisil|krem|10|mg/g|30|g|1|túpa||D01AE15|01.04.1993||R|A|5|0|0|0|0|NHE|0|0|1|100|DKK|2034|3660|lyfalmen|||00|30|0|30,0000|Artasan ehf|Novartis Healthcare A/S-A|Terbínafín||2034||2034|3660| 049687|C09AA0502|Ramil|töflur|10|mg|100|stk|1|þpakki||C09AA05|01.08.2005||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|4132|3951|lyfalmen|||00|100|0|400,0000|Actavis Group hf|Actavis hf|Ramipríl||2247||2247|3951| 049750|L04AD0103|Sandimmun Neoral (D.A.C.)|hylki|25|mg|30|stk|1|þpakki||L04AD01|01.04.2006|31.01.2011|R|A|3|0|0|*|0|DAC|0|0|0|100|DKK|4868|7159|lyfalmen|||10|30|0|3,0000|D.A.C. ehf|D.A.C. ehf|Ciklospórín||4592||4592|7159| 049760|L04AD0103|Sandimmun Neoral (D.A.C.)|hylki|100|mg|30|stk|1|þpakki||L04AD01|01.04.2006|31.01.2011|R|A|3|0|0|*|0|DAC|0|0|0|100|DKK|17864|23684|lyfalmen|||10|30|0|12,0000|D.A.C. ehf|D.A.C. ehf|Ciklospórín||17056||17056|23684| 049908|L04AA0601|Cellcept|hylki|250|mg|300|stk|1|þpakki||L04AA06|01.03.1999||R|A|3|0|1|*|0|ROC|0|0|0|100|DKK|75129|96566|lyfalmen|||00|300|0|37,5000|Icepharma hf|Roche|Mýcófenólsýra||75129||75129|96566| 050179|N01AF0301|Pentothal Natrium|sts|2,5|g|1|stk|12|hgl||N01AF03|01.07.1990||R|A|4|0|0|0|1|HOS|0|0|0|100|DKK|8027|11585|lyfsjukr|||02|12|0|0,0000|Icepharma hf|Hospira Enterprises B.V. (I)|Tíópentalnatríum||8027||8027|11585| 050342|L01XE0501|Nexavar|filmhtfl|200|mg|112|stk|1|þpakki||L01XE05|01.12.2006||R|A|2,5|0|1|0|1|BAP|0|0|0|100|SEK|667956|815326|lyfsjukr|||00|112|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Sorafeníb||648162||648162|815326| 050510|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|28|stk|1|þpakki||A02BC01|01.05.2010||L|A|3|0|0|0|0|AGT|0|0|0|100|IKR|||lyflausa|||00|28|0|28,0000|Actavis Group hf|Actavis Group hf|Ómeprazól|||||| 050605|N03AX1601|Lyrica|hylki|225|mg|14|stk|1|þpakki||N03AX16|01.04.2007||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|3777|6044|lyfalmen|||00|14|0|10,5000|Icepharma hf|Pfizer ApS|Pregabalín||3777||3777|6044| 050614|N03AX1601|Lyrica|hylki|225|mg|56|stk|1|þpakki||N03AX16|01.04.2007||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|13469|19183|lyfalmen|||00|56|0|42,0000|Icepharma hf|Pfizer ApS|Pregabalín||13469||13469|19183| 050660|C02CA0402|Carduran Retard|forðatfl|4|mg|100|stk|1|þpakki||C02CA04|01.01.2007||R|A|2|0|0|E|0|PER|0|0|0|100|DKK|5542|5085|lyfalmen|V2120|4586|00|100|0|100,0000|Icepharma hf|Pfizer ApS|Doxazósín||3076||3076|5085| 050679|A02BC0108|Omeprazol Actavis|sh-hylki|10|mg|100|stk|1|glas||A02BC01|01.09.2010||R|A|3|0|0|E|0|AGT|0|0|0|100|IKR|5092|7599|lyfalmen|V2206|7599|00|100|0|50,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||4914||4914|7599| 050691|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|100|stk|1|glas||A02BC01|01.09.2010||R|A||0|0|E|0|AGT|0|0|0|100|IKR|4744|7200|lyfalmen|V2171|7200|00|100|0|100,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||4622||4622|7200| 050702|A02BC0108|Omeprazol Actavis|sh-hylki|40|mg|100|stk|1|plglas||A02BC01|01.08.2010||R|A||0|0|0|0|AGT|0|0|0|100|IKR|11336|13668|lyfalmen|||00|100|0|200,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||9350||9350|13668| 051011|D06BB0303|Zovir|krem|50|mg/g|2|g|1|túpa|+sk.dæla|D06BB03|01.07.1994||L|A|2|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||00|2|0|2,0000|Icepharma hf|GlaxoSmithKline CH A/S|Acíklóvír|||||| 051029|N03AG0102|Orfiril|sh-tfl|150|mg|100|stk|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|1716|3225|lyfalmen|||10|100|0|10,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||1716||1716|3225| 051058|M02AA1002|Orudis (D.A.C.)|hlaup|25|mg/g|60|g|1|túpa||M02AA10|01.01.2007||L|A|3|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|60|0|0,0000|D.A.C. ehf|D.A.C. ehf|Ketóprófen|||||| 051083|B01AB0401|Fragmin|stl|12500|ae/ml|0,2|ml|10|áf.spr|2500 a.e. anti-Xa/ml/sprautu|B01AB04|01.06.2010||R|A||0|0|0|0|PER|0|0|1|100|DKK|5208|8002|lyfalmen|||02|2|0|10,0000|Icepharma hf|Pfizer ApS|Dalteparín||5208||5208|8002| 051107|B01AB0401|Fragmin|stl|25000|ae/ml|0,2|ml|10|áf.spr|5000 a.e. anti-Xa/ml/sprautu|B01AB04|01.06.2010||R|A||0|0|0|0|PER|0|0|1|100|DKK|10412|15120|lyfalmen|||02|2|0|20,0000|Icepharma hf|Pfizer ApS|Dalteparín||10412||10412|15120| 051110|N03AG0102|Orfiril|sh-tfl|300|mg|100|stk|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|2064|3701|lyfalmen|||10|100|0|20,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||2064||2064|3701| 051349|R06AX2602|Nefoxef|filmhtfl|180|mg|30|stk|1|þpakki||R06AX26|01.07.2008||R|A||0|0|E|0|MYL|0|0|1|100|SEK|1861|2980|lyfalmen|V1912|2980|00|30|0|45,0000|Actavis Group PTC ehf|Mylan AB|Fexófenadín||1537||1537|2980| 051358|R06AX2602|Nefoxef|töflur|180|mg|100|stk|1|þpakki||R06AX26|01.07.2008||R|A|2|0|0|E|0|MYL|0|0|1|100|SEK|5383|7341|lyfalmen|V1913|7341|00|100|0|150,0000|Actavis Group PTC ehf|Mylan AB|Fexófenadín||4725||4725|7341| 051550|N03AX1401|Keppra|irþ|100|mg/ml|5|ml|10|hgl||N03AX14|01.02.2007||R|A|2|0|0|0|1|UCB|0|0|0|100|DKK|35251|46123|lyfsjukr|||00|50|0|3,3300|Vistor hf|U.C.B|Levetíracetam||35251||35251|46123| 051732|C08CA0104|Amlódipín Portfarma|töflur|5|mg|100|stk|1|þpakki||C08CA01|01.12.2006||R|A|3|0|0|B|0|POF|0|0|0|100|IKR|1909|2502|lyfalmen|V0308|2502|00|100|0|100,0000|Portfarma ehf|Portfarma|Amlódipín||1188||1188|2502| 051750|C08CA0104|Amlódipín Portfarma|töflur|10|mg|100|stk|1|þpakki||C08CA01|01.12.2006||R|A|3|0|0|B|0|POF|0|0|0|100|IKR|3111|3450|lyfalmen|V0310|3450|00|100|0|200,0000|Portfarma ehf|Portfarma|Amlódipín||1881||1881|3450| 052286|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|20|stk|1|þpakki||N05BA12|01.10.2009||R|A||0|0|0|0|MYL|0|0|0|100|SEK|217|1174|lyfalmen|V0858|1174|00|20|0|5,0000|Actavis Group PTC ehf|Mylan AB|Alprazólam||217||217|1174| 052297|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|50|stk|1|þpakki||N05BA12|01.10.2009||R|A||0|0|0|0|MYL|0|0|0|100|SEK|580|1671|lyfalmen|V0859|1671|00|50|0|12,5000|Actavis Group PTC ehf|Mylan AB|Alprazólam||580||580|1671| 052305|L01XE0601|Sprycel|filmhtfl|20|mg|60|stk|1|glas||L01XE06|01.09.2007||R|A|3|0|1|0|1|BSP|0|0|0|100|DKK|388194|489066|lyfsjukr|||00|60|0|0,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||388194||388194|489066| 052309|N05BA1205|Alprazolam Mylan|töflur|0,5|mg|20|stk|1|þpakki||N05BA12|01.07.2009||R|A||0|0|0|0|MYL|0|0|1|100|SEK|362|1372|lyfalmen|V0856|1372|00|20|0|10,0000|Actavis Group PTC ehf|Mylan AB|Alprazólam||||362|1372| 052320|N05BA1205|Alprazolam Mylan|töflur|0,5|mg|50|stk|1|þpakki||N05BA12|01.10.2009||R|A||0|0|0|0|MYL|0|0|0|100|SEK|1161|2465|lyfalmen|||00|50|0|25,0000|Actavis Group PTC ehf|Mylan AB|Alprazólam||1161||1161|2465| 052331|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|100|stk|1|glas||N05BA12|01.08.2009||R|A||0|0|0|0|MYL|0|0|0|100|SEK|897|2104|lyfalmen|V0855|2104|00|100|0|25,0000|Actavis Group PTC ehf|Mylan AB|Alprazólam||||897|2104| 052333|L01XE0601|Sprycel|filmhtfl|50|mg|60|stk|1|glas||L01XE06|01.09.2007||R|A|3|0|1|0|1|BSP|0|0|0|100|DKK|782148|983478|lyfsjukr|||00|60|0|0,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||782148||782148|983478| 052360|L01XE0601|Sprycel|filmhtfl|70|mg|60|stk|1|glas||L01XE06|01.09.2007||R|A|3|0|1|0|1|BSP|0|0|0|100|DKK|791094|994705|lyfsjukr|||00|60|0|0,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||791094||791094|994705| 052405|S01ED5112|Ganfort|augndr|5,3|mg/ml|3|ml|1|glas||S01ED51|01.01.2010||R|A||0|0|*|0|ALL|0|0|0|100|SEK|4318|6784|lyfalmen|||00|3|0||Vistor hf|Allergan|Tímólól í blöndum||4318||4318|6784| 052414|S01ED5112|Ganfort|augndr|5,3|mg/ml|3|ml|3|glös||S01ED51|01.01.2010||R|A||0|0|*|0|ALL|0|0|0|100|SEK|12479|17940|lyfalmen|||00|9|0||Vistor hf|Allergan|Tímólól í blöndum||12479||12479|17940| 052478|D06BB0305|Zovirax (D.A.C.)|krem|50|mg/g|2|g|1|túpa|+sk.dæla|D06BB03|01.03.2007||L|A|3|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|2|0|2,0000|D.A.C. ehf|D.A.C. ehf|Acíklóvír|||||| 052498|V03AF0302|Rescuvolin|sts|15|mg|1|stk|25|hgl||V03AF03|01.01.1995|31.01.2011|R|A|3|0|0|0|1|PHC|0|0|0|100|XEU|32190|42281|lyfsjukr|||63|25|0|6,2500|Actavis Group hf|Pharmachemie|Kalsíumfólínat||32190||32190|42281| 052505|B05BA1014|Kabiven|irl|1900|kcal|2053|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|41144|53518|lyfsjukr|||00|8212|0|8,2000|Icepharma hf|Fresenius Kabi|Blöndur||41144||41144|53518| 052515|B05BA1014|Kabiven|irl|2300|kcal|2566|ml|3|pokar||B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|33056|43368|lyfsjukr|||00|7698|0|7,7100|Icepharma hf|Fresenius Kabi|Blöndur||33056||33056|43368| 052522|V03AF0302|Rescuvolin|sts|50|mg|1|stk|10|hgl||V03AF03|01.01.1995||R|A|3|0|0|0|1|PHC|0|0|0|100|XEU|44591|57844|lyfsjukr|||63|10|0|8,3333|Actavis Group hf|Pharmachemie|Kalsíumfólínat||44591||44591|57844| 052524|B05BA1010|Kabiven Peripheral|irl|1400|kcal|1920|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|38250|49886|lyfsjukr|||00|7680|0|7,6800|Icepharma hf|Fresenius Kabi|Blöndur||38250||38250|49886| 052533|B05BA1010|Kabiven Peripheral|irl|1700|kcal|2400|ml|3|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|26843|35570|lyfsjukr|||00|7200|0|7,2000|Icepharma hf|Fresenius Kabi|Blöndur||26843||26843|35570| 052542|B05BA1015|StructoKabiven|irl|2100|kcal|1970|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|43082|55950|lyfsjukr|||00|7880|0|7,9000|Icepharma hf|Fresenius Kabi|Blöndur||43082||43082|55950| 052560|B05BA1019|StructoKabiven Perifer|irl|1300|kcal|1904|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|40082|52185|lyfsjukr|||00|7616|0|7,6000|Icepharma hf|Fresenius Kabi|Blöndur||40082||40082|52185| 053006|N05CF0204|Zolpidem Mylan|filmhtfl|10|mg|100|stk|1|þpakki||N05CF02|01.11.2006||R|A|2|0|0|0|0|MYL|0|0|0|100|SEK|3019|5007|lyfalmen|V0903|5007|00|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Zolpidem||3019||3019|5007| 053025|G03HB0102|Diane mite|töflur|||63|stk|1|þpakki||G03HB01|01.07.1989||R|A|5|0|0|0|0|BAP|0|0|0|100|SEK|2489|4282|lyfalmen|||23|63|0|63,0000|Icepharma hf|Bayer Schering Pharma AG|Cýpróterón og östrógen||2489||2489|4282| 053043|J05AE0601|Kaletra|filmhtfl|250|mg|120|stk|1|glös|200+50 mg|J05AE06|01.11.2006||R|A|2|0|1|0|1|ABT|0|0|0|100|DKK|66486|85322|lyfsjukr|||00|120|0|30,0000|Vistor hf|Abbott Laboratories Ltd|Lopinavír||66486||66486|85322| 053055|C01BA0302|Durbis Retard|forðatfl|250|mg|100|stk|1|þpakki||C01BA03|01.05.1983||R|A|1|0|0|B|0|SNO|0|0|0|100|NOK|5423|8296|lyfalmen|||10|100|0|62,5000|Vistor hf|Sanofi-aventis Norge AS|Dísópýramíð||5423||5423|8296| 053231|J07BB0201|Fluarix|bóluefni|0| |0,5|ml|10|spr|einnotaspr|J07BB02|01.10.1994||R|K|1|0|0|0|0|GSK|0|0|0|100|GBP|6063|9171|lyfalmen|||02|5|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Inflúensa, hreinsaðir mótefnavakar||6063||6063|9171| 053371|L04AA1301|Arava|töflur|10|mg|100|stk|1|glas||L04AA13|01.11.2000||R|A|3|0|1|*|0|SDE|0|0|0|100|NOK|38265|50302|lyfalmen|||00|100|0|50,0000|Vistor hf|Sanofi - aventis Deutschland GmbH|LeflúnómíðFvöðva||38265||38265|50302| 053413|L04AA1301|Arava|töflur|20|mg|100|stk|1|glas||L04AA13|01.11.2000||R|A|3|0|1|*|0|SDE|0|0|0|100|NOK|36607|48221|lyfalmen|||00|100|0|100,0000|Vistor hf|Sanofi - aventis Deutschland GmbH|LeflúnómíðFvöðva||36607||36607|48221| 053689|N05CF0204|Zolpidem Mylan|filmhtfl|10|mg|20|stk|1|þpakki||N05CF02|01.11.2006||R|A|2|0|0|0|0|MYL|0|0|1|100|SEK|643|1757|lyfalmen|V0902|1757|00|20|0|20,0000|Actavis Group PTC ehf|Mylan AB|Zolpidem||643||643|1757| 053905|N02AA0305|Hydromorphone Hydrochloride Inj. USP|stl|20|mg/ml|1|ml|10|lykjur||N02AA03|01.05.2006||R|A|2|1|0|0|0|MAP|0|0|0|100|GBP|15492|21722|lyfalmen|||00|10|0|50,0000|Icepharma hf|Martindale Pharmaceuticals|Hýdrómorphón||15492||15492|21722| 053932|N05AX1201|Abilify|stl|7,5|mg/ml|1,33|ml|1|hgl||N05AX12|01.01.2010||R|A||0|0|0|0|OTS|0|1|0|100|DKK|1564|3017|lyfalmen|||00|1|0|0,6650|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||1564||1564|3017| 053991|D10AF0101|Dalacin|lausn|10|mg/ml|30|ml|1|glas|Áburður, lausn|D10AF01|01.07.1985||R|A|2,5|0|0|0|0|PER|0|0|0|100|DKK|1166|2472|lyfalmen|||20|30|0|30,0000|Icepharma hf|Pfizer ApS|Klindamýcín||1166||1166|2472| 054213|J07AG0101|Act-Hib|bóluefni|34|mcg/hgl|0,5|ml|1|hgl|+ leysir (10+24 mcg)|J07AG01|01.07.1994||R|K|3|0|0|0|0|MEX|0|0|0|100|XEU|2638|4486|lyfalmen|||02|0|0|0,0000|Icepharma hf|Aventis Pasteur MSD A/S|Haemophilus influenzae B||2638||2638|4486| 054247|R01AA0503|Nezeril|nefdr|0,25|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|A|3|0|0|0|0|GCO|0|0|1|100|IKR|||lyflausa|||23|2|0|1,2500|Vistor hf|GlaxoSmithKline CH AB|Oxýmetazólín|||||| 054278|D01AE1502|Lamisil Once|húðlausn|1|%|4|g|1|túpa||D01AE15|01.12.2006||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|4|0|0,0000|Artasan ehf|Novartis Healthcare A/S-A|Terbínafín|||||| 054369|J05AB0402|Copegus|filmhtfl|400|mg|56|stk|1|plglas||J05AB04|01.05.2007||R|A|3|0|1|0|1|RRL|0|0|0|100|DKK|65256|83779|lyfsjukr|||00|56|0|22,4000|Icepharma hf|Roche Registration Limited|Ribavirin||65256||65256|83779| 054403|R01AA0503|Nezeril|nefdr|0,5|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|A|3|0|0|0|0|GCO|0|0|1|100|IKR|||lyflausa|||23|2|0|2,5000|Vistor hf|GlaxoSmithKline CH AB|Oxýmetazólín|||||| 054533|N05BB0101|Atarax|mixtúra|2|mg/ml|200|ml|1|glas||N05BB01|01.10.1994||R|A|3|0|0|0|0|UCN|0|0|1|100|SEK|1497|2925|lyfalmen|||00|200|0|5,3333|Vistor hf|UCB Nordic A/S|Hýdroxýzín||1497||1497|2925| 054552|N06AB0308|Fluoxetin Actavis|lausnart|20|mg|30|stk|1|þpakki||N06AB03|01.10.2006||R|A|3|0|0|0|0|ACA|0|1|0|100|XEU|1772|2839|lyfalmen|V0914|2839|10|30|0|30,0000|Actavis Group hf|Actavis hf|Flúoxetín||1434||1434|2839| 054594|QN02AE0101|Vetergesic vet.|stl|300|mcg/ml|10|ml|1|hgl|lausn|QN02AE01|01.10.2010||R|A||1|0|0|0|REB|0|0|0|100|DKK|4849|9483|vetalmen|||27|10|0||Icepharma hf|Reckitt Benckiser Healthcare Ltd.|Buprenorphinhýdróklóríð||||4849|9483| 054650|QG03DA0202|Veramix, vet.|sk-svamp|60|mg|1|stk|20|stk||QG03DA02|01.12.1978||R|A|5|0|0|0|0|PAL|1|0|0|100|DKK|7852|13697|vetorma|||16|20|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||7852||7852|13697| 054936|N06AB1003|Cipralex (Lyfjaver)|filmhtfl|10|mg|98|stk|1|þpakki||N06AB10|01.10.2009|31.12.2010|R|A||0|0|0|0|LVR|0|1|0|100|DKK|10025|14591|lyfalmen|||00|98|0|98,0000|Lyfjaver ehf|Lyfjaver ehf|Escítalópram||10025||10025|14591| 055164|S01AX2201|Vigamox|augndr|5|mg/ml|5|ml|1|glas|án rotvarnar|S01AX22|01.08.2010||R|A||0|0|0|0|ADA|0|0|1|100|USD|1677|3171|lyfalmen|||00|5|0||Vistor hf|Alcon Denmark A/S|Moxífloxasín hýdróklóríð||||1677|3171| 055186|J01FA0103|Ery-Max|sh-hylki|250|mg|20|stk|1|glas||J01FA01|01.01.1986||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|842|2029|lyfalmen|||10|20|0|5,0000|Vistor hf|Recip AB|Erýtrómýcín||842||842|2029| 055277|N02AA0101|Contalgin|forðatfl|60|mg|100|stk|1|þpakki||N02AA01|01.10.1995||R|A|3|1|0|E|0|PER|0|0|0|100|DKK|9406|13744|lyfalmen|||10|100|0|60,0000|Icepharma hf|Pfizer ApS|Morfín||9406||9406|13744| 055392|J04AK0102|Pyrazinamid|töflur|500|mg|100|stk|1|glas||J04AK01|01.04.2005||R|A||0|0|E|0|LDR|0|0|0|100|IKR|4350|6828|lyfalmen|||00|100|1|33,3333|Parlogis hf|Parlogis - óskráð lyf|Pýrazínamíð||4350||4350|6828| 055749|N07BA0107|Nicotinell Mint|munnstfl|1|mg|36|stk|1|pakki||N07BA01|01.06.2000||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|36|0|1,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 055939|N07BA0107|Nicotinell Mint|munnstfl|1|mg|96|stk|1|pakki||N07BA01|01.06.2000||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|96|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 056015|C10AA0503|Atacor|filmhtfl|10|mg|100|stk|1|glas||C10AA05|01.06.2006||R|A|2|0|0|E|0|ACA|0|0|0|100|IKR|4539|2426|lyfalmen|V2205|2426|00|100|0|50,0000|Actavis Group hf|Actavis hf|Atorvastatín||1132||1132|2426| 056024|C10AA0503|Atacor|filmhtfl|20|mg|100|stk|1|glas||C10AA05|01.06.2006||R|A|2|0|0|E|0|ACA|0|0|0|100|IKR|6185|3144|lyfalmen|V2207|3144|00|100|0|100,0000|Actavis Group hf|Actavis hf|Atorvastatín||1657||1657|3144| 056033|C10AA0503|Atacor|filmhtfl|40|mg|100|stk|1|glas||C10AA05|01.06.2006||R|A|2|0|0|0|0|ACA|0|0|0|100|IKR|7867|5945|lyfalmen|V0339|5945|00|100|0|200,0000|Actavis Group hf|Actavis hf|Atorvastatín||3705||3705|5945| 056514|L03AB0103|Multiferon|stl|3|millj ae|0,5|ml|6|áf.spr|lausn|L03AB01|01.11.2009||R|K||0|1|0|1|SOI|0|0|0|100|SEK|99415|126648|lyfsjukr|||00|3|0||Swedish Orphan International AB|Swedish Orphan International AB|||||99415|126648| 056523|J01FA0103|Ery-Max|sh-hylki|250|mg|40|stk|1|glas||J01FA01|01.01.1986||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|1359|2736|lyfalmen|||10|40|0|10,0000|Vistor hf|Recip AB|Erýtrómýcín||1359||1359|2736| 056879|V07AY02|Palacos cum Gentamicin (Paranova)|sement|500|mg|40,5|g|2|pakkar|+ leysir|V07AY|01.06.1997|28.02.2011|R|A|4|0|0|0|1|PAN|0|0|0|100|DKK|25868|34347|lyfsjukr|||00|81|0|0,0000|xxxxx|Paranova A/S|Ýmis tæknileg hjálparefni||25868||25868|34347| 056915|L04AA2301|Tysabri|irþ|300|mg/hgl|15|ml|1|hgl|lausn|L04AA23|01.09.2007||R|K|4|0|1|0|1|EPI|0|0|0|100|XEU|246405|311121|lyfsjukr|||00|15|0|30,0000|Icepharma hf|Elan Pharma International|Natalizumab||246405||246405|311121| 056961|J05AF0702|Viread (Paranova)|filmhtfl|245|mg|30|stk|1|plglas||J05AF07|01.05.2008||R|A|3|0|1|0|1|POF|0|0|0|100|DKK|63280|81299|lyfsjukr|||00|30|0|30,0000|Portfarma ehf|Portfarma|Tenófóvír dísóproxíl||63280||63280|81299| 057026|C09DA0601|Atacand Plus|töflur|28,5|mg|28|stk|1|þpakki|16 + 12,5 mg|C09DA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|3637|5852|lyfalmen|V2222|5852|00|28|0|56,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og þvagræsilyf||||3637|5852| 057042|C09DA0601|Atacand Plus|töflur|28,5|mg|98|stk|1|þpakki|16 + 12,5 mg|C09DA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|11571|16706|lyfalmen|||00|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og þvagræsilyf||||11571|16706| 057307|H01CB0201|Sandostatin|stl|200|mcg/ml|5|ml|1|hgl||H01CB02|01.01.1991||R|K|4|0|1|0|1|NOH|0|0|0|100|DKK|18978|25700|lyfsjukr|||02|5|0|1,4300|Vistor hf|Novartis Healthcare A/S-|Oktreótíð||18978||18978|25700| 057349|H01CB0201|Sandostatin|stl|100|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|K|3|0|1|0|1|NOH|0|0|0|100|DKK|10084|14538|lyfsjukr|||02|5|0|0,7100|Vistor hf|Novartis Healthcare A/S-|Oktreótíð||10084||10084|14538| 057422|B05XA3102|Tracel|irþ|0| |10|ml|20|plastl||B05XA31|01.01.1987||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|6566|9476|lyfsjukr|||00|200|0|0,2000|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með öðrum efnum||6566||6566|9476| 057455|H01CB0201|Sandostatin|stl|50|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|K|3|0|1|0|1|NOH|0|0|0|100|DKK|5429|7835|lyfsjukr|||02|5|0|0,3600|Vistor hf|Novartis Healthcare A/S-|Oktreótíð||5429||5429|7835| 057703|J01DD0401|Rocephalin|irþ|2|g|5|hgl|1|pakki|lausn|J01DD04|01.10.1985||R|A|3|0|0|0|1|ROC|0|0|0|100|DKK|25277|33605|lyfsjukr|||00|5|0|5,0000|Icepharma hf|Roche|Ceftríaxón||25277||25277|33605| 058014|N07BA0301|Champix|filmhtfl|1|mg|112|stk|1|þpakki||N07BA03|01.03.2009||R|A|2|0|0|0|0|IPI|0|0|1|100|DKK|20576|28102|lyfalmen|||0|112|0|56,0000|Icepharma hf|Pfizer Limited|Vareniclin||||20576|28102| 058164|A03BB0101|Buscopan|stl|20|mg/ml|1|ml|5|lykjur||A03BB01|01.10.1995||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|435|1472|lyfalmen|||02|5|0|1,6667|Vistor hf|Boehringer Ingelheim|Bútýlskópólamín||435||435|1472| 058272|L01XE1101|Votrient|filmhtfl|200|mg|30|stk|1|glas||L01XE11|01.02.2011||R|A||0|1|0|1|GGL|0|0|0|100|GBP|127817|162293|lyfsjukr|||00|30|0||GlaxoSmithKline ehf|Glaxo Group Limited|Pazópaníb||127817||127817|162293| 058283|QI01AD040|Avipro Thymovac|frþlyf|||500|sk|10|pakkar||QI01AD04|01.07.2009||R|A||0|0|0|0|LOH|0|0|0|100|XEU|165533|288764|vetorma|||00|5000|0|0,0000|Icepharma hf|Lohmann Animal Health|||||165533|288764| 058294|QI01AD040|Avipro Thymovac|frþlyf|||1000|sk|10|pakkar||QI01AD04|01.07.2009||R|A||0|0|0|0|LOH|0|0|0|100|XEU|251461|438661|vetorma|||00|10000|0|0,0000|Icepharma hf|Lohmann Animal Health|||||251461|438661| 058397|J07BM0101|Gardasil|stl|0| |0,5|ml|1|áf.spr|dreifa|J07BM01|01.01.2007||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|20539|28056|lyfalmen|||02|0|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Papillomavírus (manna gerð 6, 11, 16, 18)||20539||20539|28056| 058503|J01EA0107|Trimetoprim Meda|mixtúra|10|mg/ml|100|ml|1|fl|dreifa|J01EA01|01.01.2004||R|A|2|0|0|0|0|REP|0|0|1|100|SEK|1043|2304|lyfalmen|||00|100|0|2,5000|Vistor hf|Recip AB|Trímetóprím||1043||1043|2304| 058506|J05AF1001|Baraclude|mixtúra|0,05|mg/ml|210|ml|1|fl||J05AF10|01.09.2007||R|A|2|0|1|0|1|BSP|0|0|0|100|DKK|115529|146871|lyfsjukr|||00|210|0|21,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||115529||115529|146871| 058735|C03CA0105|Lasix Retard|forðahlk|30|mg|100|stk|1|þpakki||C03CA01|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|0|100|NOK|1615|3086|lyfalmen|||43|100|0|75,0000|Vistor hf|Sanofi-aventis Norge AS|Fúrósemíð||1615||1615|3086| 058768|C03CA0105|Lasix Retard|forðahlk|60|mg|100|stk|1|þpakki||C03CA01|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|0|100|NOK|2545|4359|lyfalmen|||43|100|0|150,0000|Vistor hf|Sanofi-aventis Norge AS|Fúrósemíð||2545||2545|4359| 058958|J07CA0601|Infanrix-Polio + Hib|bóluefni|0| |0,5|ml|1|dæla|einnota dæla|J07CA06|01.03.1999||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|4289|6744|lyfalmen|||51|0|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|barnaveiki, haemophilus influenza B, kíghósti, mænusótt, stí||4289||4289|6744| 059204|C01DA0801|Sorbangil|töflur|5|mg|250|stk|1|plglas||C01DA08|01.04.2004||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|1740|3257|lyfalmen|||00|250|0|20,8300|Vistor hf|Recip AB|Ísósorbíð dínítrat||1740||1740|3257| 059353|L04AB0601|Simponi|stl|50|mg|1|áf-penni|1|penni|áfylltur penni|L04AB06|01.02.2010||R|K||0|1|0|1|CEO|0|0|0|100|DKK|237117|299464|lyfsjukr|||00|1|0|30,1200|Vistor hf|Centocor B.V.|Golimumab||||237117|299464| 059364|L04AB0601|Simponi|stl|50|mg|1|spr|1|spr|áfyllt sprauta|L04AB06|01.02.2010||R|K||0|1|0|1|CEO|0|0|0|100|DKK|237117|299464|lyfsjukr|||00|1|0|30,1200|Vistor hf|Centocor B.V.|Golimumab||||237117|299464| 059569|L02AE0203|Eligard|sts|45|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.05.2008||R|K|2|0|1|*|0|ASP|0|0|0|100|XEU|105867|135142|lyfalmen|||02|2|0|0,0000|Vistor hf|Astellas Pharma A/S|Leuprórelín||105867||105867|135142| 059659|J07CA0601|Infanrix-Polio + Hib|bóluefni|0| |0,5|ml|10|spr||J07CA06|01.01.2007||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|32747|43377|lyfalmen|||51|5|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|barnaveiki, haemophilus influenza B, kíghósti, mænusótt, stí||32747||32747|43377| 059687|J05AR0302|Truvada (Paranova)|filmhtfl|445|mg|30|stk|1|plglas|200+245 mg|J05AR03|01.05.2008||R|A|3|0|1|0|1|POF|0|0|0|100|DKK|92409|117856|lyfsjukr|||00|30|0|0,0000|Portfarma ehf|Portfarma|Tenófóvír dísóproxíl og emtrícítabín||92409||92409|117856| 059767|N03AF0401|Zebinix|töflur|800|mg|30|stk|1|þpakki||N03AF04|01.03.2010||R|A||0|0|E|0|BPC|0|0|0|100|SEK|35939|47383|lyfalmen|||00|30|0|30,0000|Vistor hf|Bial-Portela & C.S.A.|Eslícarbazepín||35939||35939|47383| 059823|N07BC5101|Suboxone|tungur.t|2,5|mg|28|stk|1|þpakki|2+0,5 mg|N07BC51|01.05.2007||R|A|3|1|1|0|1|RBP|0|0|0|100|DKK|7376|10645|lyfsjukr|||00|28|0|7,0000|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín í blöndum||7376||7376|10645| 059842|N07BC5101|Suboxone|tungur.t|10|mg|28|stk|1|þpakki|8+2 mg|N07BC51|01.07.2007||R|A|3|1|1|0|1|RBP|0|0|0|100|DKK|14243|19757|lyfsjukr|||00|28|0|28,0000|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín í blöndum||14243||14243|19757| 059870|L04AD0201|Advagraf|forðahlk|3|mg|50|stk|1|þpakki||L04AD02|01.11.2010||R|A|3|0|1|*|0|APE|0|0|0|100|XEU|56182|72787|lyfalmen|||00|50|0|30,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||56182||56182|72787| 060560|V03AC0301|Exjade|dreifit.|500|mg|84|stk|1|þpakki||V03AC03|01.03.2007||R|A|3|0|1|0|0|NOE|0|0|0|100|DKK|398920|502924|lyfalmen|||00|84|0|0,0000|Vistor hf|Novartis Europharm Ltd|Deferasírox||398920||398920|502924| 060569|V03AC0301|Exjade|dreifit.|250|mg|84|stk|1|þpakki||V03AC03|01.03.2007||R|A|3|0|1|0|0|NOE|0|0|0|100|DKK|202025|255820|lyfalmen|||00|84|0|0,0000|Vistor hf|Novartis Europharm Ltd|Deferasírox||202025||202025|255820| 060578|V03AC0301|Exjade|dreifit.|125|mg|84|stk|1|þpakki||V03AC03|01.03.2007||R|A|3|0|1|0|0|NOE|0|0|0|100|DKK|101013|129050|lyfalmen|||00|84|0|0,0000|Vistor hf|Novartis Europharm Ltd|Deferasírox||101013||101013|129050| 060848|N06AA0402|Anafranil Retard|forðatfl|75|mg|100|stk|1|þpakki||N06AA04|01.10.1989||R|A|5|0|0|B|0|NOH|0|1|0|100|DKK|7765|11499|lyfalmen|||10|100|0|75,0000|Vistor hf|Novartis Healthcare A/S-|Klómípramín||7765||7765|11499| 060905|C01DA0204|Nitromex|tungur.t|0,5|mg|120|stk|1|glas||C01DA02|01.01.1993||L|A|2|0|0|B|0|AGT|0|0|0|100|DKK|||lyfalmen|||22|120|0|24,0000|Actavis Group hf|Actavis Group hf|Glýcerýltrínítrat|||||1937| 060913|C01DA0204|Nitromex|tungur.t|0,25|mg|120|stk|1|glas||C01DA02|01.01.1993||L|A|2|0|0|B|0|AGT|0|0|0|100|DKK|||lyfalmen|||22|120|0|12,0000|Actavis Group hf|Actavis Group hf|Glýcerýltrínítrat|||||1937| 061414|QA04AD901|Cerenia|töflur|60|mg|4|stk|1|þpakki||QA04AD90|01.02.2009||R|A|2|0|0|0|0|PFA|0|0|0|100|DKK|2802|5553|vetalmen|||0|4|0|0,0000|Icepharma hf|Pfizer Animal Health|||||2802|5553| 061442|QA04AD901|Cerenia|töflur|24|mg|4|stk|1|þpakki||QA04AD90|01.02.2009||R|A|2|0|0|0|0|PFA|0|0|0|100|DKK|1468|2920|vetalmen|||0|4|0|0,0000|Icepharma hf|Pfizer Animal Health|||||1468|2920| 061451|QA04AD901|Cerenia|stl|10|mg/ml|20|ml|1|hgl|lausn|QA04AD90|01.02.2009||R|A|2|0|0|0|0|PFA|1|0|0|100|DKK|8673|16826|vetalmen|||00|20|0|0,0000|Icepharma hf|Pfizer Animal Health|||||8673|16826| 061465|M02AA0701|Felden gel|hlaup|5|mg/g|50|g|1|glas||M02AA07|01.04.1996||L|A|3|0|0|0|0|PER|0|0|1|100|IKR|||lyflausa|||23|50|0|0,0000|Icepharma hf|Pfizer ApS|Píroxíkam|||||| 061481|G03CX0101|Livial|töflur|2,5|mg|84|stk|1|þpakki||G03CX01|01.07.1998||R|A|2|0|0|E|0|ORG|0|0|0|100|DKK|7187|10709|lyfalmen|||00|84|0|84,0000|Vistor hf|N.V. Organon|Tíbólón||7187||7187|10709| 061580|QP52AF0201|Banminth, vet.|pasta|11,4|g/skdæla|26|g|1|spr||QP52AF02|01.04.1992||L|A|1|0|0|0|0|PAL|0|0|0|100|DKK|1423|2482|vetorma|||16|26|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||||1423|2482| 061715|L01XE0901|Torisel|irþ|25|mg/ml|1|hgl|1|pakki||L01XE09|01.05.2008||R|A|2|0|1|0|1|WTE|0|0|0|100|DKK|159122|201581|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Wyeth Europe|Temsirolímus||159122||159122|201581| 061937|L04AD0101|Sandimmun|irþ|50|mg/ml|1|ml|10|lykjur||L04AD01|01.10.1985||R|A|4|0|0|0|1|NOH|0|0|0|100|DKK|6723|9703|lyfsjukr|||00|10|0|2,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||6723||6723|9703| 061961|J01XX0901|Cubicin|sts/irs|350|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|K|3|0|1|0|1|NOE|0|0|0|100|DKK|17662|24048|lyfsjukr|||00|1|0|1,2500|Vistor hf|Novartis Europharm Ltd|Daptomýcín||17662||17662|24048| 061970|J01XX0901|Cubicin|sts/irs|500|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|K|3|0|1|0|1|NOE|0|0|0|100|DKK|24999|33256|lyfsjukr|||00|1|0|1,7900|Vistor hf|Novartis Europharm Ltd|Daptomýcín||24999||24999|33256| 062117|N05BA1204|Tafil Retard|forðatfl|0,5|mg|30|stk|1|þpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PER|0|0|1|100|DKK|516|1583|lyfalmen|||10|30|0|15,0000|Icepharma hf|Pfizer ApS|Alprazólam||516||516|1583| 062265|M01AB0505|Voltaren|eþ-stíll|50|mg|10|stk|1|pakki||M01AB05|01.11.2010||R|A||0|0|E|0|NOH|0|0|1|100|DKK|422|1455|lyfalmen|||04|10|0|5,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||422||422|1455| 062341|L04AA0604|Mykofenolatmofetil Actavis|filmhtfl|500|mg|150|stk|1|þpakki||L04AA06|01.08.2010||R|A||0|1|*|0|AGP|0|0|0|100|XEU|60851|74828|lyfalmen|V2230|74828|00|150|0|37,5000|Actavis Group hf|Actavis Group PTC ehf|Mýcófenólsýra||57808||57808|74828| 062376|C05AA0103|Proctosedyl (D.A.C.)|eþ-smyr|||30|g|1|túpa||C05AA01|01.10.2009|31.12.2010|L|A||0|0|0|0|DAC|0|0|0|100|IKR|||lyflausa|||00|30|0|0,0000|D.A.C. ehf|D.A.C. ehf|Hýdrókortisón|||||| 062387|N04BC0502|Sifrol|forðatfl|0,26|mg|10|stk|1|pakki||N04BC05|01.02.2010||R|A||0|0|E|0|BII|0|0|0|100|DKK|1700|3203|lyfalmen|||00|10|0|10,0000|Vistor hf|Boehringer Ingelheim International|Pramipexól||||1700|3203| 062638|L01BA0105|Methotrexate Wyeth Lederle|stl/irl|25|mg/ml|20|ml|1|hgl||L01BA01|01.10.1985||R|A|3|0|1|0|1|PER|0|0|0|100|DKK|6785|9792|lyfsjukr|||02|20|0|0,0000|Icepharma hf|Pfizer ApS|Metótrexat||6785||6785|9792| 062661|L01BA0105|Methotrexate Wyeth Lederle|stl/irl|25|mg/ml|1|ml|1|hgl||L01BA01|01.10.1985||R|A|3|0|1|0|1|PER|0|0|0|100|DKK|477|688|lyfsjukr|||02|1|0|0,0000|Icepharma hf|Pfizer ApS|Metótrexat||477||477|688| 062704|R02AA0305|Strepsils Cool|sogtfl|||36|stk|1|þpakki||R02AA03|01.09.2010||L|A||0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|36|0||Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||| 062729|N05BA1204|Tafil Retard|forðatfl|0,5|mg|60|stk|1|þpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PER|0|0|0|100|DKK|944|2169|lyfalmen|||10|60|0|30,0000|Icepharma hf|Pfizer ApS|Alprazólam||944||944|2169| 062737|B03BA0102|Betolvex|töflur|1|mg|100|stk|1|glas||B03BA01|01.03.2008||R|A|5|0|0|E|0|AGT|0|0|1|100|XEU|2086|3731|lyfalmen|||00|100|0|100,0000|Actavis Group hf|Actavis Group hf|Cyanocobalamin||2086||2086|3731| 062745|QP53AF0102|Sebacil vet.|húðlausn|500|mg/ml|1000|ml|1|fl||QP53AF01|01.05.2005||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|18358|32025|vetorma|||16|1000|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||18358||18358|32025| 062935|G03AA1005|Harmonet|töflur|||63|stk|1|þpakki|20+75 mcg|G03AA10|01.11.1998||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|1765|3292|lyfalmen|||23|63|0|63,0000|Icepharma hf|Pfizer ApS|Gestóden og östrógen||1765||1765|3292| 062987|J07BM0201|Cervarix|stl|0| |0,5|ml|1|áf.spr|dreifa|J07BM02|01.11.2007||R|K|3|0|0|0|0|GLB|0|0|0|100|GBP|16478|22959|lyfalmen|||02|0|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Papillomavírus (manna gerð 16, 18)||16478||16478|22959| 063057|J05AB0901|Famvir|töflur|125|mg|10|stk|1|þpakki||J05AB09|01.10.1995||R|A|3|0|0|E|0|NOH|0|0|1|100|DKK|5235|8038|lyfalmen|||00|10|0|1,6667|Vistor hf|Novartis Healthcare A/S-|Famcíclóvír||5235||5235|8038| 063340|D05AX0202|Daivonex (D.A.C.)|krem|50|mcg/g|120|g|1|túpa||D05AX02|01.12.2009||R|A||0|0|B|0|DAC|0|0|0|100|DKK|6853|10252|lyfalmen|V0092|10252|00|120|0|120,0000|D.A.C. ehf|D.A.C. ehf|Kalcípótríól||6853||6853|10252| 063453|J01CA0406|Flemoxin Solutab|lausnart|750|mg|14|stk|1|þpakki||J01CA04|01.04.1992||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|2114|3769|lyfalmen|||23|14|0|10,5000|Vistor hf|Astellas Pharma A/S|Amoxicillín||2114||2114|3769| 063661|A06AD1107|Medilax|mixtúra|667|mg/ml|500|ml|1|plastf||A06AD11|01.06.2007||L|A|2|0|0|0|0|MET|0|0|0|100|DKK|||lyfalmen|||00|500|0|49,7761|Vistor hf|Medic Team|Laktúlósa|||||2884| 063697|D01BA0203|Terbinafin Actavis|töflur|250|mg|28|stk|1|glas||D01BA02|01.11.2006||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|2649|4501|lyfalmen|V0343|4500|00|28|0|28,0000|Actavis Group hf|Actavis hf|Terbínafín||2649||2649|4501| 063706|R06AX2702|Aerius (D.A.C.)|töflur|5|mg|30|stk|1|þpakki||R06AX27|01.11.2006||R|A|2|0|0|E|0|DAC|0|0|1|100|DKK|1646|3129|lyfalmen|V1901|3129|00|30|0|30,0000|D.A.C. ehf|D.A.C. ehf|Deslóratadín||1646||1646|3129| 063715|R06AX2702|Aerius (D.A.C.)|töflur|5|mg|100|stk|1|þpakki||R06AX27|01.05.2009||R|A|2|0|0|E|0|DAC|0|0|1|100|DKK|4440|6951|lyfalmen|||00|100|0|100,0000|D.A.C. ehf|D.A.C. ehf|Deslóratadín||4440||4440|6951|31.01.2011 063818|J06BB0102|Rhesonativ|stl|625|ae/ml|2|ml|1|lykja||J06BB01|01.05.2008||R|K|2,5|0|0|0|1|OCT|0|0|0|100|DKK|7933|11449|lyfsjukr|||17|2|0|0,0000|Vistor hf|Octapharma AB|And-D(rh) immúnóglóbúlín||7933||7933|11449| 063923|QP54AB5207|Equest Pramox vet|hlaup|0| |11,8|g|1|sk-dæl|19,5mg/g+121,7mg/g|QP54AB52|01.12.2006||R|A|2|0|0|0|0|FDV|0|0|0|100|XEU|2586|4511|vetorma|||16|12|0|0,0000|Vistor hf|Fort Dodge Veterinär GmbH|||2586||2586|4511| 063941|N05BA1204|Tafil Retard|forðatfl|1|mg|30|stk|1|þpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PER|0|0|1|100|DKK|1086|2363|lyfalmen|||10|30|0|30,0000|Icepharma hf|Pfizer ApS|Alprazólam||1086||1086|2363| 063958|N05BA1204|Tafil Retard|forðatfl|1|mg|60|stk|1|þpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PER|0|0|0|100|DKK|2078|3720|lyfalmen|||10|60|0|60,0000|Icepharma hf|Pfizer ApS|Alprazólam||2078||2078|3720| 064069|B01AC2101|Remodulin|irl|2,5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|A|2,5|0|1|0|1|UTE|0|0|0|100|XEU|1106914|1391060|lyfsjukr|||00|1|0|11,6300|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||1106914|1391060| 064106|B01AC2101|Remodulin|irl|1|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|A|2,5|0|1|0|1|UTE|0|0|0|100|XEU|442765|557553|lyfsjukr|||00|1|0|4,6500|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||442765|557553| 064170|N05BA1204|Tafil Retard|forðatfl|2|mg|30|stk|1|þpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PER|0|0|1|100|DKK|2389|4145|lyfalmen|||10|30|0|60,0000|Icepharma hf|Pfizer ApS|Alprazólam||2389||2389|4145| 064224|B01AC2101|Remodulin|irl|10|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|A|2,5|0|1|0|1|UTE|0|0|0|100|XEU|4427659|5558595|lyfsjukr|||00|1|0|46,5100|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||4427659|5558595| 064233|B01AC2101|Remodulin|irl|5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|A|2,5|0|1|0|1|UTE|0|0|0|100|XEU|2213830|2780239|lyfsjukr|||00|1|0|23,2600|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||2213830|2780239| 064733|J07BB0203|Vaxigrip|bóluefni|0| |0,5|ml|1|spr|einnotaspr|J07BB02|01.10.1985||R|K|1|0|0|0|0|SPM|0|0|0|100|XEU|891|2096|lyfalmen|||51|0|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Inflúensa, hreinsaðir mótefnavakar||891||891|2096| 065032|D10AF5101|Duac|hlaup|0| |25|g|1|túpa|50 mg/g + 10 mg/g|D10AF51|01.01.2007||R|A|1,5|0|0|0|0|SLL|0|0|0|100|DKK|1990|3599|lyfalmen|||38|25|0|0,0000|Vistor hf|Stiefel Laboratories (UK) Ltd.|Klindamýcín í blöndum||1990||1990|3599| 065314|G01AF0201|Canesten|sk-stíll|100|mg|6|stk|1|pakki|+stjaka|G01AF02|01.12.1982||L|A|4|0|0|0|0|BAI|0|0|0|100|IKR|||lyflausa|||25|6|0|6,0000|Icepharma hf|Bayer A/S|Klótrímazól|||||| 065332|G01AF0201|Canesten|sk-stíll|500|mg|1|stk|1|pakki|+stjaka|G01AF02|01.04.1985||L|A|5|0|0|0|0|BAI|0|0|0|100|IKR|||lyflausa|||25|1|0|5,0000|Icepharma hf|Bayer A/S|Klótrímazól|||||| 065441|V08AB0901|Visipaque|stl|320|mg J/ml|20|ml|10|glhgl||V08AB09|01.12.2009||R|A||0|0|0|1|GEH|0|0|0|100|NOK|19657|26552|lyfsjukr|||02|200|0||Icepharma hf|GE Healthcare AS|Jódixanól||||19657|26552| 065706|S01EE0101|Xalatan|augndr|50|mcg/sk|2,5|ml|1|glas||S01EE01|01.10.1999||R|K|3|0|0|*|0|PER|0|0|0|100|DKK|2552|3676|lyfalmen|V1989|2565|06|2|0|25,0000|Icepharma hf|Pfizer ApS|Latanóprost||2046||2046|3676| 065722|S01EE0101|Xalatan|augndr|50|mcg/ml|7,5|ml|1|pakki|3 glös í pakka|S01EE01|01.05.2009||R|K|3|0|0|*|0|PER|0|0|0|100|DKK|7649|10882|lyfalmen|V1989|7694|06|8|0|75,0000|Icepharma hf|Pfizer ApS|Latanóprost||7314||7314|10882| 065729|N07BA0142|Nicorette Invisi|forðapl|15|mg/16kls|14|stk|1|þpakki||N07BA01|01.03.2010||L|A||0|0|0|0|MCN|0|0|1|101|IKR|||lyflausa|||23|14|0|17,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 065740|N07BA0142|Nicorette Invisi|forðapl|15|mg/16kls|7|stk|1|þpakki||N07BA01|01.03.2010||L|A||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|7|0|8,5000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 065752|N07BA0142|Nicorette Invisi|forðapl|10|mg/16kls|14|stk|1|þpakki||N07BA01|01.03.2010||L|A||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|14|0|10,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 065775|N07BA0142|Nicorette Invisi|forðapl|25|mg/16kls|14|stk|1|þpakki||N07BA01|01.03.2010||L|A||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|14|0|25,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 065778|L04AB0101|Enbrel|stl|50|mg|4|pennar|1|pakki|lausn|L04AB01|01.12.2009||R|K||0|1|0|1|WTE|0|0|0|100|DKK|162109|205329|lyfsjukr|||00|4|0|28,5800|Icepharma hf|Wyeth Europe|Etanercept||||162109|205329| 065786|N07BA0142|Nicorette Invisi|forðapl|25|mg/16kls|7|stk|1|þpakki||N07BA01|01.03.2010||L|A||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|7|0|12,5000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 065870|V08AB0201|Omnipaque|stl|180|mg J/ml|10|ml|10|glhgl||V08AB02|01.12.2009||R|A||0|0|0|1|GEH|0|0|0|100|NOK|6414|9257|lyfsjukr|||02|100|0||Icepharma hf|GE Healthcare AS|Jóhexól||||6414|9257| 065979|C09CA0101|Cozaar|töflur|12,5|mg|28|stk|1|þpakki||C09CA01|01.03.1999||R|A|3|0|0|0|0|MSD|0|0|0|100|XEU|2176|3854|lyfalmen|V0195|2234|00|28|0|7,0000|Icepharma hf|M.S.D.|Lósartan||2176||2176|3854| 066278|R03BB0403|Spiriva Respimat|innöndl|2,5|mcg/sk|60|skammtar|1|pakki|lausn|R03BB04|01.04.2008||R|A|2|0|0|0|0|BII|0|0|0|100|DKK|7344|10923|lyfalmen|||00|60|0|30,0000|Vistor hf|Boehringer Ingelheim International |Tíótrópíumbrómíð||7344||7344|10923| 066287|B05AA0704|Voluven|irl|60|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05AA07|01.05.2008||R|A|5|0|0|0|1|FRP|0|0|0|100|DKK|29000|38278|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Fresenius Kabi|Hýdróxyetýl sterkja||29000||29000|38278| 066399|N07BA0106|Nicotinell|forðapl|7|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|21|0|10,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 066407|N07BA0106|Nicotinell|forðapl|14|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|21|0|21,0000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 066423|N07BA0106|Nicotinell|forðapl|21|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|21|0|31,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 066688|V08AB0201|Omnipaque|stl|240|mg J/ml|20|ml|6|glerfl||V08AB02|01.12.1983||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|4575|6603|lyfsjukr|||02|120|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||4575||4575|6603| 066751|C01BD0103|Cordarone (D.A.C.)|töflur|100|mg|30|stk|1|þpakki||C01BD01|01.11.2006||R|K|5|0|0|B|0|DAC|0|0|0|100|NOK|1754|3277|lyfalmen|||70|30|0|15,0000|D.A.C. ehf|D.A.C. ehf|Amíódarón||1754||1754|3277|31.01.2011 066862|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|14|stk|1|þpakki||A02BC01|01.05.2010||L|A||0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||00|14|0|14,0000|Actavis Group hf|Actavis Group hf|Ómeprazól|||||| 066897|L01CD0104|Paclitaxel Actavis|irþ|6|mg/ml|50|ml|1|hgl|lausn|L01CD01|01.06.2010||R|A||0|1|0|1|AGP|0|0|0|100|XEU|78196|22603|lyfsjukr|||00|50|0||Actavis Group hf|Actavis Group PTC ehf|Paklítaxel||16510||16510|22603| 067025|J01CA0406|Flemoxin Solutab|lausnart|125|mg|20|stk|1|þpakki||J01CA04|01.01.1992||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|656|1775|lyfalmen|||23|20|0|2,5000|Vistor hf|Astellas Pharma A/S|Amoxicillín||656||656|1775| 067124|N07CA0101|Betaserc|töflur|16|mg|84|stk|1|þpakki||N07CA01|01.04.1993||R|A|5|0|0|E|0|SOL|0|0|0|100|DKK|7244|10787|lyfalmen|||00|84|0|56,0000|Medico ehf|Solvay Duphar |Betahistín||7244||7244|10787| 067587|N05BB0101|Atarax|töflur|25|mg|100|stk|1|þpakki||N05BB01|01.07.1994||R|A|5|0|0|0|0|UCN|0|0|0|100|SEK|1497|2925|lyfalmen|||00|100|0|33,3333|Vistor hf|UCB Nordic A/S|Hýdroxýzín||1497||1497|2925| 067641|N05CD0204|Mogadon (D.A.C.)|töflur|5|mg|50|stk|1|þpakki||N05CD02|01.11.2006||R|A||0|0|0|0|DAC|0|0|1|100|DKK|771|1932|lyfalmen|V0901|1932|00|50|0|50,0000|D.A.C. ehf|D.A.C. ehf|Nítrazepam||771||771|1932| 067748|S01EE0104|Latanoprost Actavis|augndr|50|mcg/ml|2,5|ml|1|glas||S01EE01|01.09.2010||R|K||0|0|*|0|APC|0|0|0|100|DKK|1890|2812|lyfalmen|V1989|2565|06|2|0|25,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Latanóprost||1414||1414|2812| 067751|J02AC0102|Candizol|hylki|50|mg|7|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|1740|3257|lyfalmen|V0551|3257|10|7|0|1,7500|Actavis Group hf|Actavis hf|Flúkónazól||1740||1740|3257| 067769|J02AC0102|Candizol|hylki|50|mg|30|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|5834|8858|lyfalmen|V0552|8858|10|30|0|7,5000|Actavis Group hf|Actavis hf|Flúkónazól||5834||5834|8858| 067785|J02AC0102|Candizol|hylki|150|mg|1|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|754|1909|lyfalmen|V0554|1909|10|1|0|0,7500|Actavis Group hf|Actavis hf|Flúkónazól||754||754|1909| 067793|J02AC0102|Candizol|hylki|150|mg|2|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|1441|2848|lyfalmen|V0555|2848|10|2|0|1,5000|Actavis Group hf|Actavis hf|Flúkónazól||1441||1441|2848| 067801|J02AC0102|Candizol|hylki|150|mg|4|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|2500|4297|lyfalmen|V0556|4297|10|4|0|3,0000|Actavis Group hf|Actavis hf|Flúkónazól||2500||2500|4297| 067827|J02AC0102|Candizol|hylki|200|mg|30|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|22063|29968|lyfalmen|V0558|29335|10|30|0|30,0000|Actavis Group hf|Actavis hf|Flúkónazól||22063||22063|29968| 068043|R01AA0704|Otrivin ukonserveret|nefúði|1|mg/ml|10|ml|2|glas|sk-úðari|R01AA07|01.02.2010||L|A||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||06|10|0|25,0000|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||| 068312|QN01AX0302|Narketan, vet.|stl|100|mg/ml|50|ml|1|hgl||QN01AX03|01.01.1991||R|A|2,5|1|0|0|0|VEQ|1|0|0|100|XEU|6224|12124|vetalmen|||27|50|0|0,0000|Icepharma hf|Vétoquinol AG|||6224||6224|12124| 068437|C01BC0401|Tambocor|töflur|100|mg|20|stk|1|þpakki||C01BC04|01.04.1987||R|A|5|0|1|B|0|MEB|0|0|0|100|SEK|2518|4322|lyfalmen|||00|20|0|10,0000|Vistor hf|Meda AB (V)|Flekaíníð||2518||2518|4322| 068445|C01BC0401|Tambocor|töflur|100|mg|100|stk|1|þpakki||C01BC04|01.04.1987||R|A|5|0|1|B|0|MEB|0|0|0|100|SEK|7107|10599|lyfalmen|||00|100|0|50,0000|Vistor hf|Meda AB (V)|Flekaíníð||7107||7107|10599| 068896|B05XA0303|Natriumklorid B.Braun|irþ|1|mmol/ml|20|ml|20|plastl||B05XA03|01.09.2010||R|A||0|0|0|1|BRA|0|0|0|100|XEU|2564|3700|lyfsjukr|||00|400|0|0,4000|Actavis Group hf|Braun|Natríumklóríð||2564||2564|3700| 068905|B05XA0103|Kaliumklorid B.Braun|irþ|1|mmol/ml|20|ml|20|plastl||B05XA01|01.09.2010||R|A||0|0|0|1|BRA|0|0|0|100|XEU|3191|4605|lyfsjukr|||00|400|0|0,4000|Actavis Group hf|Braun|Kalíumklóríð||3191||3191|4605| 068923|V07AB1001|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|10|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||00|200|0|0,0000|Actavis Group hf|Braun|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||| 068933|V07AB1001|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|20|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||00|400|0|0,0000|Actavis Group hf|Braun|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||| 068951|V07AB09|Sterilt Vann B. Braun|leysir|0||10|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|200|0|0,0000|Actavis Group hf|Braun|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||| 068960|V07AB09|Sterilt Vann B. Braun|leysir|0||20|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|400|0|0,0000|Actavis Group hf|Braun|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||| 069799|D01AE1501|Lamisil|krem|10|mg/g|15|g|1|túpa||D01AE15|01.04.1993||L|A|5|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|15|0|15,0000|Artasan ehf|Novartis Healthcare A/S-A|Terbínafín|||||| 069807|D01BA0201|Lamisil|töflur|250|mg|14|stk|1|þpakki||D01BA02|01.04.1993||R|A|5|0|0|0|0|NOH|0|0|0|100|IKR|4952|3267|lyfalmen|||00|14|0|14,0000|Vistor hf|Novartis Healthcare A/S-|Terbínafín||1747||1747|3267| 069815|D01BA0201|Lamisil|töflur|250|mg|98|stk|1|þpakki||D01BA02|01.04.1993||R|A|5|0|0|0|0|NOH|0|0|0|100|IKR|31896|17160|lyfalmen|||00|98|0|98,0000|Vistor hf|Novartis Healthcare A/S-|Terbínafín||11903||11903|17160| 069833|J01DB0101|Keflex|töflur|500|mg|40|stk|1|þpakki||J01DB01|01.07.2007||R|A|3|0|0|0|0|PAD|0|0|1|100|DKK|3182|5230|lyfalmen|||00|40|0|10,0000|Icepharma hf|PharmaCoDane ApS|Cefalexín||3182||3182|5230| 069842|J01DB0101|Keflex|töflur|500|mg|20|stk|1|þpakki||J01DB01|01.07.2007||R|A|3|0|0|0|0|PAD|0|0|1|100|DKK|1602|3069|lyfalmen|||00|20|0|5,0000|Icepharma hf|PharmaCoDane ApS|Cefalexín||1602||1602|3069| 070020|N05AX0803|Risperdal Consta|sts|25|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.04.2010||R|K||0|0|*|0|JAS|0|1|0|100|SEK|18675|25716|lyfalmen|||00|1|0|9,2600|Vistor hf|Janssen-Cilag AB|Risperídón||||18675|25716| 070031|N05AX0803|Risperdal Consta|sts|37,5|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.04.2010||R|K||0|0|*|0|JAS|0|1|0|100|SEK|27011|36178|lyfalmen|||00|1|0|13,8900|Vistor hf|Janssen-Cilag AB|Risperídón||||27011|36178| 070042|N05AX0803|Risperdal Consta|sts|50|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.04.2010||R|K||0|0|*|0|JAS|0|1|0|100|SEK|34981|46180|lyfalmen|||00|1|0|18,5200|Vistor hf|Janssen-Cilag AB|Risperídón||||34981|46180| 070342|V08AB0201|Omnipaque|stl|350|mg J/ml|100|ml|10|glerfl||V08AB02|01.12.1983||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|70999|90986|lyfsjukr|||02|1000|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||70999||70999|90986| 070359|L01DB0701|Novantrone|irþ|2|mg/ml|10|ml|1|hgl||L01DB07|01.07.1987||R|A|3|0|1|0|1|MEB|0|0|0|100|USD|30869|40623|lyfsjukr|||00|10|0|0,0000|Vistor hf|Meda AB (V)|Mítoxantrón||30869||30869|40623| 070514|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|30|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|5500|7938|lyfsjukr|||00|7500|0|0,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar||5500||5500|7938| 070523|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|20|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|5131|7405|lyfsjukr|||00|10000|0|0,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar||5131||5131|7405| 070533|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|250|ml|30|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|9012|13007|lyfsjukr|||00|7500|0|0,0000|Icepharma hf|Fresenius Kabi|Kolvetni||9012||9012|13007| 070542|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|20|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|5735|8277|lyfsjukr|||00|10000|0|0,0000|Icepharma hf|Fresenius Kabi|Kolvetni||5735||5735|8277| 070557|QH01BB0203|Partoxin vet.|stl|17|mcg|10|ml|10|hgl||QH01BB02|01.12.2006||R|A|2|0|0|0|0|PSW|1|0|0|100|DKK|8444|16386|vetalmen|||27|100|0|0,0000|Vistor hf|Pharmaxim Sweden AB|||8444||8444|16386| 070797|N05AX0801|Risperdal|mixtúra|1|mg/ml|100|ml|1|fl|með skammtasprautu|N05AX08|01.01.1997||R|A|2|0|0|*|0|JAS|0|1|0|100|SEK|18986|26107|lyfalmen|||00|100|0|20,0000|Vistor hf|Janssen-Cilag AB|Risperídón||18986||18986|26107| 071076|QA12CE9902|Selevitan, vet.|kyrni|0| |1250|g|1|plbrús||QA12CE99|01.12.2006||R|A|3|0|0|0|0|PSW|0|0|0|100|SEK|6378|12419|vetalmen|||16|1250|0|0,0000|Vistor hf|Pharmaxim Sweden AB|||6378||6378|12419| 071134|N05AN0104|Litiumsitrat Actavis|töflur|500|mg|100|stk|1|glas||N05AN01|01.10.1995||R|A|5|0|0|*|0|ACA|0|1|0|100|IKR|728|1873|lyfalmen|||00|100|0|22,1631|Actavis Group hf|Actavis hf|Litíum||728||728|1873| 071223|N02BG0801|Prialt|irl|100|mcg/ml|1|ml|1|hgl||N02BG08|01.06.2007||R|K|3|0|1|0|1|EIS|0|0|0|100|SEK|67349|86405|lyfsjukr|||00|1|0|8,3300|Vistor hf|Eisai Ltd|Ziconotíð||67349||67349|86405| 071232|N02BG0801|Prialt|irl|100|mcg/ml|5|ml|1|hgl||N02BG08|01.06.2007||R|K|3|0|1|0|1|EIS|0|0|0|100|SEK|336746|424499|lyfsjukr|||00|5|0|41,6500|Vistor hf|Eisai Ltd|Ziconotíð||336746||336746|424499| 071611|G04BE0305|Vizarsin (Lyfis)|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|A||0|0|0|0|LYF|0|0|0|100|XEU|14968|13635|lyfalmen|V0100|13635|00|12|0|24,0000|Lyfís ehf|Lyfis ehf|Síldenafíl||9326||9326|13635| 072044|B01AC0402|Grepid|töflur|75|mg|30|stk|1|þpakki||B01AC04|01.01.2010||R|A||0|0|E|0|PSA|0|0|0|100|XEU|6962|5654|lyfalmen|V1091|5654|00|30|0|30,0000|Portfarma ehf|Pharmathen S.A.|Klópídógrel||3492||3492|5654| 072132|QN05CM9001|Domosedan, vet.|stl|10|mg/ml|5|ml|1|hgl||QN05CM90|01.01.1991||R|A|3|0|0|0|0|ORF|1|0|0|100|DKK|6333|12333|vetalmen|||27|5|0|0,0000|Vistor hf|Orion-Farmos|||6333||6333|12333| 072233|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|300|stk|1|þpakki||N07BA01|01.02.2010||L|A||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 072380|B01AC0402|Grepid|töflur|75|mg|100|stk|1|þpakki||B01AC04|01.12.2009||R|A||0|0|E|0|PSA|0|0|0|100|XEU|23085|15182|lyfalmen|V0090|15182|00|100|0|100,0000|Portfarma ehf|Pharmathen S.A.|Klópídógrel||10457||10457|15182| 072520|V01AA1104|Alutard SQ, hrossaværur|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|19473|26718|lyfalmen|||02|5|0|0,0000|Vistor hf|ALK-Abello A/S|dýr||19473||19473|26718| 072751|N01AH0301|Sufenta|stl|5|mcg/ml|2|ml|5|lykjur||N01AH03|01.06.2000||R|A|3|1|0|0|1|JAS|0|0|0|100|SEK|677|977|lyfsjukr|||02|10|0|0,0000|Vistor hf|Janssen-Cilag AB|Súfentaníl||677||677|977| 072770|L04AB0401|Humira|stl|40|mg/penna|0,8|ml|2|pennar||L04AB04|01.06.2007||R|K|1,5|0|1|0|1|ABB|0|0|0|100|DKK|165091|209072|lyfsjukr|||00|2|0|27,5900|Vistor hf|Abbott|Adalimumab||165091||165091|209072| 072978|A10BX0401|Byetta|stl|5|mcg/sk|1,2|ml|1|penni|lausn|A10BX04|01.05.2007||R|K|2|0|0|*|0|ELD|0|0|0|100|XEU|15181|21331|lyfalmen|||00|1|0|20,0000|Icepharma hf|Eli Lilly Nederland B.V.|Exenatíð||15181||15181|21331| 072996|A10BX0401|Byetta|stl|10|mcg/sk|2,4|ml|1|penni|lausn|A10BX04|01.05.2007||R|K|2|0|0|*|0|ELD|0|0|0|100|XEU|15181|21331|lyfalmen|||00|2|0|40,0000|Icepharma hf|Eli Lilly Nederland B.V.|Exenatíð||15181||15181|21331| 073205|N05AF0103|Fluanxol Mite|filmhtfl|0,5|mg|100|stk|1|glas||N05AF01|01.12.1972||R|A|2|0|0|*|0|LBK|0|1|0|100|DKK|1330|2697|lyfalmen|||00|100|0|8,3333|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||1330||1330|2697| 073224|A09AA0205|Creon|sh-hylki|150|mg|100|stk|1|plglas||A09AA02|01.01.2008||R|A|2|0|0|E|0|SOY|0|0|0|100|XEU|3925|5374|lyfalmen|V0295|5374|10|100|0|100,0000|Medico ehf|Solvay Pharmaceuticals GmbH|Hvatablöndur (lípasi, próteasi o.s.frv.)||3287||3287|5374| 073559|G04CA5201|Duodart|hylki|0,9|mg|30|stk|1|glas|0,5 mg + 0,4 mg|G04CA52|01.12.2010||R|A||0|0|E|0|GSK|0|0|0|100|GBP|3744|5999|lyfalmen|||00|30|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Dútasteríð og tamsúlósínhýdroklóríð||3744||3744|5999| 073684|N05AF0103|Fluanxol Mite|filmhtfl|1|mg|100|stk|1|glas||N05AF01|01.12.1972||R|A|2|0|0|*|0|LBK|0|1|0|100|DKK|1667|3158|lyfalmen|||00|100|0|16,6667|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||1667||1667|3158| 073825|N05BA1203|Tafil|töflur|0,25|mg|20|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PER|0|0|1|100|DKK|311|1303|lyfalmen|V0858|1174|00|20|0|5,0000|Icepharma hf|Pfizer ApS|Alprazólam||311||311|1303| 073833|N05BA1203|Tafil|töflur|0,25|mg|50|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|837|2022|lyfalmen|V0859|1671|00|50|0|12,5000|Icepharma hf|Pfizer ApS|Alprazólam||837||837|2022| 073841|N05BA1203|Tafil|töflur|0,25|mg|100|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|1213|2537|lyfalmen|V0855|2104|00|100|0|25,0000|Icepharma hf|Pfizer ApS|Alprazólam||1213||1213|2537| 073858|N05BA1203|Tafil|töflur|0,5|mg|20|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PER|0|0|1|100|DKK|525|1595|lyfalmen|V0856|1372|00|20|0|10,0000|Icepharma hf|Pfizer ApS|Alprazólam||525||525|1595| 073874|N05BA1203|Tafil|töflur|0,5|mg|100|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|1810|3353|lyfalmen|||00|100|0|50,0000|Icepharma hf|Pfizer ApS|Alprazólam||1810||1810|3353| 073947|L04AX0102|Imurel|töflur|25|mg|50|stk|1|þpakki||L04AX01|01.12.2010||R|A|5|0|0|*|0|AEG|0|0|0|100|GBP|1331|2698|lyfalmen|||10|50|0|8,3333|GlaxoSmithKline ehf|Aspen Europe GmbH|Azatíóprín||1331||1331|2698| 074016|G04BE0303|Viagra (D.A.C.)|filmhtfl|25|mg|4|stk|1|þpakki||G04BE03|01.12.2009||R|A||0|0|0|0|DAC|0|0|0|100|DKK|4729|7346|lyfalmen|V0096|7346|00|4|0|2,0000|D.A.C. ehf|D.A.C. ehf|Síldenafíl||4729||4729|7346| 074027|G04BE0303|Viagra (D.A.C.)|filmhtfl|50|mg|4|stk|1|þpakki||G04BE03|01.12.2009|31.12.2010|R|A||0|0|0|0|DAC|0|0|0|100|DKK|5202|7993|lyfalmen|||00|4|0|4,0000|D.A.C. ehf|D.A.C. ehf|Síldenafíl||2997||5202|7993| 074038|N02AB0304|Durogesic (D.A.C.)|forðapl|12|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2009||R|A||1|0|E|0|DAC|0|0|0|100|SEK|3471|5625|lyfalmen|V0102|5625|00|5|0|9,9900|D.A.C. ehf|D.A.C. ehf|Fentanýl||3471||3471|5625| 074042|C09DB0101|Exforge|filmhtfl|85|mg|28|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|0|0|NOE|0|0|0|100|DKK|3656|5878|lyfalmen|||00|28|0|0,0000|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||3656||3656|5878| 074051|C09DB0101|Exforge|filmhtfl|85|mg|98|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|0|0|NOE|0|0|0|100|DKK|10648|15443|lyfalmen|||00|98|0|0,0000|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||10648||10648|15443| 074060|C09DB0101|Exforge|filmhtfl|165|mg|28|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|0|0|NOE|0|0|0|100|DKK|4665|7259|lyfalmen|||00|28|0|0,0000|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||4665||4665|7259| 074069|C09DB0101|Exforge|filmhtfl|165|mg|98|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|0|0|NOE|0|0|0|100|DKK|13732|19513|lyfalmen|||00|98|0|0,0000|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||13732||13732|19513| 074078|C09DB0101|Exforge|filmhtfl|170|mg|28|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|0|0|NOE|0|0|0|100|DKK|4665|7259|lyfalmen|||00|28|0|0,0000|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||4665||4665|7259| 074083|B03BB0106|Folic Acid (D.A.C.)|töflur|5|mg|28|stk|1|þpakki||B03BB01|01.03.2011||R|A||0|0|E|0|DAC|0|0|1|100|GBP|400|1424|lyfalmen|V0012|1424|00|28|0|28,0000|D.A.C. ehf|D.A.C. ehf|Fólínsýra||400||400|1424| 074087|C09DB0101|Exforge|filmhtfl|170|mg|98|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|0|0|NOE|0|0|0|100|DKK|15413|21622|lyfalmen|||00|98|0|0,0000|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||15413||15413|21622| 074443|V08CA0301|Omniscan|stl|0,5|mmol/ml|5|ml|10|hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|38393|50066|lyfsjukr|||00|50|0|0,0000|Icepharma hf|GE Healthcare AS|Gadódíamíð||38393||38393|50066| 074468|N05BA0105|Stesolid|töflur|5|mg|25|stk|1|glas||N05BA01|01.12.1972||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|234|1197|lyfalmen|||00|25|0|12,5000|Actavis Group hf|Actavis Group hf|Díazepam||234||234|1197| 074484|N05BA0105|Stesolid|töflur|5|mg|50|stk|1|glas||N05BA01|01.12.1980||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|474|1526|lyfalmen|||00|50|0|25,0000|Actavis Group hf|Actavis Group hf|Díazepam||474||474|1526| 074617|QI06AA0402|Fel-O-Vax PCT vet.|bóluefni|||1|ml|25|spr|áfyllt sprauta|QI06AA04|01.06.2000||R|K|2|0|0|0|0|SCA|1|0|0|100|DKK|21085|36782|vetorma|||58|25|0|0,0000|Vistor hf|Scan Vet Animal Health AS|||21085||21085|36782| 074667|N06AA0905|Amitriptyline|filmhtfl|10|mg|98|stk|1|þpakki||N06AA09|01.03.2011||R|A||0|0|B|0|AUK|0|1|0|100|GBP|410|1438|lyfalmen|||00|98|0|13,0700|Actavis Group hf|Actavis UK Ltd.|Amitriptýlín||410||410|1438| 074679|N06AA0905|Amitriptyline|filmhtfl|25|mg|98|stk|1|þpakki||N06AA09|01.02.2011||R|A||0|0|B|0|AUK|0|1|0|100|GBP|749|1902|lyfalmen|||00|98|0|32,6600|Actavis Group hf|Actavis UK Ltd.|Amitriptýlín||749||749|1902| 074736|C01AA0504|Lanoxin mite|töflur|62,5|mcg|100|stk|1|glas||C01AA05|01.05.2010|31.01.2011|R|A|5|0|0|B|0|AEG|0|0|0|100|XEU|385|1404|lyfalmen|||00|100|0|25,0000|GlaxoSmithKline ehf|Aspen Europe GmbH|Digoxín||385||385|1404| 074758|C01AA0503|Lanoxin|mixtúra|50|mcg/ml|60|ml|1|glas||C01AA05|01.12.2010||R|A|3|0|0|B|0|AEG|0|0|0|100|GBP|949|2175|lyfalmen|||00|60|0|12,0000|GlaxoSmithKline ehf|Aspen Europe GmbH|Digoxín||949||949|2175| 074782|C01AA0503|Lanoxin|töflur|0,25|mg|100|stk|1|glas||C01AA05|01.09.2010||R|A|5|0|0|B|0|AEG|0|0|0|100|GBP|506|1569|lyfalmen|||00|100|0|100,0000|GlaxoSmithKline ehf|Aspen Europe GmbH|Digoxín||506||506|1569| 074922|R06AX2601|Telfast|töflur|120|mg|30|stk|1|þpakki||R06AX26|01.11.1999||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|1533|2342|lyfalmen|||00|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||1071||1071|2342| 075031|R03AC1801|Onbrez Breezhaler|innönddu|150|mcg|30|hylki|1|pakki||R03AC18|01.03.2010||R|A||0|0|0|0|NOE|0|0|1|100|DKK|4979|7688|lyfalmen|||00|30|0||Vistor hf|Novartis Europharm Ltd|Indacaterol||4979||4979|7688| 075042|R03AC1801|Onbrez Breezhaler|innönddu|150|mcg|90|hylki|1|pakki||R03AC18|01.03.2010||R|A||0|0|0|0|NOE|0|0|1|100|DKK|14935|21023|lyfalmen|||00|90|0||Vistor hf|Novartis Europharm Ltd|Indacaterol||14935||14935|21023| 075044|J02AB0201|Fungoral|töflur|200|mg|10|stk|1|þpakki||J02AB02|01.01.1985||R|A|5|0|0|0|0|JAS|0|0|1|100|SEK|1841|3396|lyfalmen|||69|10|0|10,0000|Vistor hf|Janssen-Cilag AB|Ketókónazól||1841||1841|3396| 075064|R03AC1801|Onbrez Breezhaler|innönddu|300|mcg|30|hylki|1|pakki||R03AC18|01.03.2010||R|A||0|0|0|0|NOE|0|0|1|100|DKK|4979|7688|lyfalmen|||00|30|0||Vistor hf|Novartis Europharm Ltd|Indacaterol||4979||4979|7688| 075068|N07BA0131|Nicorette Microtab Classic|tungur.t|2|mg|20|stk|1|þpakki||N07BA01|01.10.2008||L|A|2,5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|20|0|1,3300|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 075069|R06AX2601|Telfast|töflur|180|mg|30|stk|1|þpakki||R06AX26|01.11.1999||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|2168|3221|lyfalmen|V1912|2980|00|30|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||1713||1713|3221| 075075|R03AC1801|Onbrez Breezhaler|innönddu|300|mcg|90|hylki|1|pakki||R03AC18|01.03.2010||R|A||0|0|0|0|NOE|0|0|1|100|DKK|14935|21023|lyfalmen|||00|90|0||Vistor hf|Novartis Europharm Ltd|Indacaterol||14935||14935|21023| 075078|N07BA0131|Nicorette Microtab Classic|tungur.t|2|mg|90|stk|1|þpakki||N07BA01|01.10.2008||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|90|0|6,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 075087|N02BE5102|Parkodin|töflur|510|mg|300|stk|1|plglas|10+500 mg|N02BE51|01.07.2007||R|A|5|1|0|0|0|ACA|0|0|1|100|IKR|1950|3545|lyfalmen|||00|300|0|50,0000|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema með geðlyfjum (psycholeptica)||1950||1950|3545| 075096|N02AA5902|Parkodin forte|töflur|530|mg|300|stk|1|plglas|30+500 mg|N02AA59|01.07.2007||R|A|5|1|0|0|0|ACA|0|0|1|100|NOK|3018|5006|lyfalmen|||00|300|0|300,0000|Actavis Group hf|Actavis hf|Kódein í blöndum nema með geðlyfjum||3018||3018|5006| 075288|N05AX1203|Abilify (Lyfjaver)|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.12.2009||R|A||0|0|*|0|LVR|0|1|0|100|DKK|34284|45306|lyfalmen|V0106|45306|00|56|0|18,6670|Lyfjaver ehf|Lyfjaver ehf|Aripiprazól||34284||34284|45306| 075299|M01AH0103|Celebra (Lyfjaver)|hylki|100|mg|100|stk|1|þpakki||M01AH01|01.12.2009||R|A|3|0|0|E|0|LVR|0|0|1|100|DKK|7017|10476|lyfalmen|V2142|10476|00|100|0|50,0000|Lyfjaver ehf|Lyfjaver ehf|Celekoxíb||7017||7017|10476| 075305|N02BE0108|Paratabs Retard|forðatfl|500|mg|300|stk|1|plglas||N02BE01|01.10.2007||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|1536|2978|lyfalmen|||10|300|0|50,0000|Actavis Group hf|Actavis hf|Paracetamól||1536||1536|2978| 075310|M01AH0103|Celebra (Lyfjaver)|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.12.2009||R|A|3|0|0|E|0|LVR|0|0|1|100|DKK|13523|19250|lyfalmen|V2140|19250|00|100|0|100,0000|Lyfjaver ehf|Lyfjaver ehf|Celekoxíb||13523||13523|19250| 075382|V04CL0030|Soluprick SQ, rauðölur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7560|11219|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7560||7560|11219| 075391|N05AL0502|Solian (Lyfjaver)|töflur|200|mg|90|stk|1|þpakki||N05AL05|01.12.2009||R|A||0|0|*|0|LVR|0|1|0|100|NOK|20302|27758|lyfalmen|V0105|27758|00|90|0|45,0000|Lyfjaver ehf|Lyfjaver ehf|Amísúlpríð||||20302|27758| 075402|N05AL0502|Solian (Lyfjaver)|töflur|50|mg|90|stk|1|þpakki||N05AL05|01.12.2009||R|A||0|0|*|0|LVR|0|1|0|100|NOK|7319|10889|lyfalmen|V0104|10889|00|90|0|11,2500|Lyfjaver ehf|Lyfjaver ehf|Amísúlpríð||||7319|10889| 075408|V04CL0022|Soluprick SQ, graölur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7560|11219|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7560||7560|11219| 075424|V04CL0019|Soluprick SQ, birkifrjo|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7560|11219|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7560||7560|11219| 075440|V04CL0026|Soluprick SQ, hesliviður|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7560|11219|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7560||7560|11219| 075458|N03AX1602|Lyrica (Lyfjaver)|hylki|300|mg|56|stk|1|þpakki||N03AX16|01.12.2009|31.12.2010|R|A||0|0|0|0|LVR|0|0|0|100|DKK|14460|20426|lyfalmen|||00|56|0|56,0000|Lyfjaver ehf|Lyfjaver ehf|Pregabalín||||14460|20426| 075465|V04CL0024|Soluprick SQ, haliðagras|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7560|11219|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7560||7560|11219| 075470|L01CD0201|Taxotere|irþ|20|mg|1|ml|1|hgl|lausn|L01CD02|01.06.2010||R|A||0|1|0|1|AVS|0|0|0|100|NOK|30474|40127|lyfsjukr|||00|1|0||Vistor hf|Aventis Pharma SA|Docetaxel||30474||30474|40127| 075481|V04CL0023|Soluprick SQ, hafrar|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7560|11219|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7560||7560|11219| 075482|L01CD0201|Taxotere|irþ|80|mg|4|ml|1|hgl|lausn|L01CD02|01.06.2010||R|A||0|1|0|1|AVS|0|0|0|100|NOK|114381|145431|lyfsjukr|||00|4|0||Vistor hf|Aventis Pharma SA|Docetaxel||114381||114381|145431| 075507|V04CL0018|Soluprick SQ, axhnoðapunktur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7560|11219|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7560||7560|11219| 075523|V04CL0025|Soluprick SQ, havingull|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7560|11219|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7560||7560|11219| 075549|V04CL0033|Soluprick SQ, vallarrygresi|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7560|11219|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7560||7560|11219| 075564|V04CL0032|Soluprick SQ, vallarfoxgras|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7560|11219|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7560||7560|11219| 075580|V04CL0034|Soluprick SQ, vallarsveifgras|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7560|11219|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7560||7560|11219| 075606|V04CL0031|Soluprick SQ, rugur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7560|11219|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7560||7560|11219| 075663|V04CL0021|Soluprick SQ, derm.pter.|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7560|11219|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7560||7560|11219| 075689|V04CL0027|Soluprick SQ, hrossaværur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7560|11219|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7560||7560|11219| 075705|V04CL0028|Soluprick SQ, hundahar|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7560|11219|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7560||7560|11219| 075721|V04CL0029|Soluprick SQ, kattahar|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7560|11219|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7560||7560|11219| 075724|B02BD0901|BeneFIX|sts|||1000|ae|1|hgl|+leysir|B02BD09|01.02.2004||R|K|3|0|0|0|1|WTE|0|0|0|100|DKK|99640|126931|lyfsjukr|||00|1000|0|2,2200|Icepharma hf|Wyeth Europe|Storkuþáttur IX||99640||99640|126931| 075777|QG03DA0201|Perlutex, vet.|töflur|5|mg|20|stk|1|þpakki||QG03DA02|01.03.2011||R|A|5|0|0|0|0|LAH|0|0|0|100|DKK|711|1414|vetalmen|||16|20|0||Vistor hf|LEO Animal Health A/S|||711||711|1414| 075787|QS02CA0102|Canaural|eyrnadr|||25|ml|1|glas||QS02CA01|01.12.1982||R|A|3|0|0|0|0|DEC|0|0|0|100|DKK|2119|4215|vetalmen|||13|25|0|0,0000|Vistor hf|Dechra Veterinary Products A/S|||2119||2119|4215| 075869|B05DB0005|Balance|kvið.sk|1,5|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|K||0|0|0|1|FMC|0|0|0|100|XEU|6081|8776|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Fresenius Medical Care Deutschland GmbH|||6081||6081|8776| 075888|B05DB0005|Balance|kvið.sk|2,3|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|K||0|0|0|1|FMC|0|0|0|100|XEU|6081|8776|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Fresenius Medical Care Deutschland GmbH|||6081||6081|8776| 075906|B05DB0005|Balance|kvið.sk|4,25|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|K||0|0|0|1|FMC|0|0|0|100|XEU|5971|8618|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Fresenius Medical Care Deutschland GmbH|||5971||5971|8618| 075936|P01BC0104|Quinine Sulphate Actavis|filmhtfl|200|mg|28|stk|1|þpakki||P01BC01|01.07.2010||R|A||0|0|0|0|AUK|0|0|0|100|GBP|439|1478|lyfalmen|||00|28|0|3,7300|Actavis Group hf|Actavis UK Ltd.|Kínín||439||439|1478| 075947|J01EE0107|Trimezol|töflur|480|mg|20|stk|1|þpakki|80+400 mg|J01EE01|01.12.2009||R|A||0|0|0|0|AEA|0|0|1|100|XEU|458|1504|lyfalmen|||00|20|0|5,0000|Actavis hf|Actavis EAD|Súlfametoxazól og trímetóprím||458||458|1504| 076024|A10BH0101|Januvia|filmhtfl|100|mg|28|stk|1|þpakki||A10BH01|01.01.2010||R|A||0|0|*|0|MSD|0|0|0|100|XEU|6670|10001|lyfalmen|||00|28|0|28,0000|Icepharma hf|M.S.D.|Sítagliptín||6670||6670|10001| 076033|A10BH0101|Januvia|filmhtfl|100|mg|98|stk|1|þpakki||A10BH01|01.11.2007||R|A|3|0|0|*|0|MSD|0|0|0|100|XEU|23074|31237|lyfalmen|||00|98|0|98,0000|Icepharma hf|M.S.D.|Sítagliptín||23074||23074|31237| 076181|L04AA0603|Cellcept (D.A.C.)|töflur|500|mg|50|stk|1|þpakki||L04AA06|01.12.2009||R|A||0|1|*|0|DAC|0|0|0|100|DKK|21342|27291|lyfalmen|||00|50|0|12,5000|D.A.C. ehf|D.A.C. ehf|Mýcófenólsýra||19930||19930|27291| 076361|V03AN0101|Conoxia|innö.gas|100|%|2|l|1|hylki|MO2LIV|V03AN01|01.12.2009||L|A||0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|2|0|0,0000|Ísaga ehf|AGA AB|Súrefni|||||| 076369|N05AX0805|Risperidon Portfarma|filmhtfl|0,5|mg|20|stk|1|þpakki||N05AX08|01.07.2007||R|A|3|0|0|*|0|POF|0|1|0|100|IKR|738|1887|lyfalmen|V1070|1887|00|20|0|2,0000|Portfarma ehf|Portfarma|Risperídón||738||738|1887| 076378|N05AX0805|Risperidon Portfarma|filmhtfl|0,5|mg|60|stk|1|þpakki||N05AX08|01.07.2007||R|A|3|0|0|*|0|POF|0|1|0|100|IKR|2033|3241|lyfalmen|V1075|3241|00|60|0|6,0000|Portfarma ehf|Portfarma|Risperídón||1728||1728|3241| 076387|N05AX0805|Risperidon Portfarma|filmhtfl|1|mg|60|stk|1|þpakki||N05AX08|01.07.2007||R|A|3|0|0|*|0|POF|0|1|0|100|IKR|2876|4103|lyfalmen|V0791|4103|00|60|0|12,0000|Portfarma ehf|Portfarma|Risperídón||2358||2358|4103| 076533|N05AB0301|Trilafon|filmhtfl|2|mg|100|stk|1|þpakki||N05AB03|01.04.2009||R|A|2|0|0|*|0|SCP|0|1|0|100|DKK|905|2115|lyfalmen|||00|100|0|6,6667|Vistor hf|Schering-Plough|Perfenazín||||905|2115| 076542|N05AB0301|Trilafon|filmhtfl|4|mg|100|stk|1|þpakki||N05AB03|01.04.2009||R|A|2|0|0|*|0|SCP|0|1|0|100|DKK|1256|2595|lyfalmen|||00|100|0|13,3333|Vistor hf|Schering-Plough|Perfenazín||||1256|2595| 076551|N05AB0301|Trilafon|filmhtfl|8|mg|100|stk|1|þpakki||N05AB03|01.04.2009||R|A|2|0|0|*|0|SCP|0|1|0|100|DKK|1789|3325|lyfalmen|||00|100|0|26,6667|Vistor hf|Schering-Plough|Perfenazín||||1789|3325| 076752|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|100|ml|1|hgl|plast|QP54AA01|01.01.1985||R|A|5|0|0|0|0|MEF|1|0|0|100|XEU|7265|12673|vetorma|||27|100|0|0,0000|Vistor hf|Merial (MSD)|||7265||7265|12673| 076814|J07AL5201|Synflorix|stl|||0,5|ml|1|áf.spr|dreifa|J07AL52|01.12.2009||R|K||0|0|0|0|GLB|0|0|0|100|GBP|7690|11397|lyfalmen|||00|0|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Lungnabólga a.v. pneumok.-Hreins pneumok polysakk móte.v Hae||7690||7690|11397| 076859|M01AH0104|Celebrex (D.A.C.)|hylki|200|mg|20|stk|1|þpakki||M01AH01|01.04.2010||R|A||0|0|E|0|DAC|0|0|1|100|DKK|2649|4501|lyfalmen|||00|20|0|20,0000|D.A.C. ehf|D.A.C. ehf|Celekoxíb||2649||2649|4501|28.02.2011 076871|G01AF0202|Canesten (D.A.C.)|sk-stíll|500|mg|1|stk|1|pakki|+stjaka|G01AF02|01.12.2009||L|A||0|0|0|0|DAC|0|0|0|100|IKR|||lyflausa|||25|1|0|5,0000|D.A.C. ehf|D.A.C. ehf|Klótrímazól|||||| 077215|A06AH0101|Relistor|stl|20|mg/ml|0,6|ml|1|hgl|lausn|A06AH01|01.01.2009||R|A|2|0|0|0|0|WTE|0|0|0|100|DKK|5713|8692|lyfalmen|||0|1|0|2,0000|Icepharma hf|Wyeth Europe|Metýlnaltrexónbrómíð||5713||5713|8692| 077420|N02BE5102|Parkodin|töflur|510|mg|30|stk|1|pakki|þp 10+500 mg|N02BE51|01.01.1985||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|240|1206|lyfalmen|||00|30|0|5,0000|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema með geðlyfjum (psycholeptica)||240||240|1206| 077446|N02BE5102|Parkodin|töflur|510|mg|100|stk|1|pakki|þp 10+500 mg|N02BE51|01.01.1985||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|707|1844|lyfalmen|||00|100|0|16,6667|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema með geðlyfjum (psycholeptica)||707||707|1844| 077821|B01AC0403|Clopidogrel Actavis|filmhtfl|75|mg|100|stk|1|glas||B01AC04|01.07.2010||R|A||0|0|E|0|APC|0|0|0|100|XEU|15338|15182|lyfalmen|V0090|15182|00|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Klópídógrel||10457||10457|15182| 077875|A02BA0205|Zantac|stl|25|mg/ml|2|ml|5|lykjur||A02BA02|01.10.1987||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|705|1842|lyfalmen|||02|10|0|0,8333|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ranitidín||705||705|1842| 077951|M01AB0514|Voltfast (D.A.C.)|filmhtfl|50|mg|30|stk|1|þpakki||M01AB05|01.04.2007|31.01.2011|R|A|5|0|0|0|0|DAC|0|0|1|100|IKR|881|1465|lyfalmen|||10|30|0|15,0000|D.A.C. ehf|D.A.C. ehf|Díklófenak||430||430|1465| 078182|D01AC0302|Pevaryl (D.A.C.)|krem|10|mg/g|30|g|1|túpa||D01AC03|01.12.2009||L|A||0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|30|0|30,0000|D.A.C. ehf|D.A.C. ehf|Ekónazól|||||| 078193|D01AC0102|Canesten (D.A.C.)|krem|1|%|20|g|1|túpa||D01AC01|01.12.2009||L|A||0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|20|0|20,0000|D.A.C. ehf|D.A.C. ehf|Klótrímazól|||||| 078239|S01GX0202|Livostin (D.A.C.)|augndr|0,5|mg/ml|4|ml|1|glas||S01GX02|01.12.2009||L|A||0|0|0|0|DAC|0|0|0|100|IKR|||lyflausa|||29|4|0||D.A.C. ehf|D.A.C. ehf|Levókabastín|||||| 078250|D01AC0803|Fungoral (D.A.C.)|sápa|20|mg/ml|120|ml|1|plastf||D01AC08|01.12.2009||L|A||0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||23|120|0|120,0000|D.A.C. ehf|D.A.C. ehf|Ketókónazól|||||| 078307|J02AC0103|Fluconazole Portfarma|hylki|200|mg|28|stk|1|þpakki||J02AC01|01.12.2010||R|A||0|0|0|0|POF|0|0|1|100|IKR|22063|27379|lyfalmen|V0558|27379|10|28|0|28,0000|Portfarma ehf|Portfarma|Flúkónazól||20000||20000|27379| 078318|L03AB0504|IntronA (D.A.C.)|stl|18|millj ae|1,2|ml|1|penni|fjölskammtapenni|L03AB05|01.12.2009|31.12.2010|R|K||0|1|0|1|DAC|0|0|0|100|DKK|25779|34235|lyfsjukr|||00|1|0|9,0000|D.A.C. ehf|D.A.C. ehf|Interferón alfa-2b||25779||25779|34235| 078330|L03AB0504|IntronA (D.A.C.)|stl|30|millj ae|1,2|ml|1|penni|fjölskammtapenni|L03AB05|01.12.2009|31.12.2010|R|K||0|1|0|1|DAC|0|0|0|100|DKK|41990|54580|lyfsjukr|||00|1|0|15,0000|D.A.C. ehf|D.A.C. ehf|Interferón alfa-2b||41990||41990|54580| 078341|L03AB0504|IntronA (D.A.C.)|stl|60|millj ae|1,2|ml|1|penni|fjölskammtapenni|L03AB05|01.12.2009|31.12.2010|R|K||0|1|0|1|DAC|0|0|0|100|DKK|85955|109756|lyfsjukr|||00|1|0|30,0000|D.A.C. ehf|D.A.C. ehf|Interferón alfa-2b||85955||85955|109756| 078568|J01CE0204|Kaavepenin|töflur|250|mg|20|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|538|1613|lyfalmen|||00|20|0|2,5000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||538||538|1613| 078576|J01CE0204|Kaavepenin|töflur|250|mg|40|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|819|1998|lyfalmen|||00|40|0|5,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||819||819|1998| 078709|N06AB0303|Serol|töflur|10|mg|30|stk|1|glas||N06AB03|01.04.1994|31.01.2011|R|A|5|0|0|B|0|ACA|0|1|0|100|IKR|998|2201|lyfalmen|||00|30|0|15,0000|Actavis Group hf|Actavis hf|Flúoxetín||968||968|2201| 078933|L03AB0801|Betaferon|sts|8|mi.ae/ml|15|spr|1|pakki|+leysir|L03AB08|01.01.2002||R|A|2|0|1|0|1|SAG|0|0|0|100|SEK|151729|192302|lyfsjukr|||00|15|0|30,0000|Icepharma hf|Schering AG|Interferón beta-1b||151729||151729|192302| 079061|C09CA0101|Cozaar|töflur|50|mg|98|stk|1|þpakki||C09CA01|01.01.1995||R|A|3|0|0|0|0|MSD|0|0|0|100|XEU|9044|6065|lyfalmen|V0197|3872|00|98|0|98,0000|Icepharma hf|M.S.D.|Lósartan||3792||3792|6065| 079103|L01AA0601|Holoxan|sts/irs|500|mg|1|stk|1|hgl||L01AA06|01.07.1998||R|A|5|0|1|0|1|BAM|0|0|0|100|SEK|2677|3864|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Baxter Medical AB|Ífosfamíð||2677||2677|3864| 079111|L01AA0601|Holoxan|sts/irs|1|g|1|stk|1|hgl||L01AA06|01.07.1998||R|A|5|0|1|0|1|BAM|0|0|0|100|SEK|4755|6863|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Baxter Medical AB|Ífosfamíð||4755||4755|6863| 079129|L01AA0601|Holoxan|sts/irs|2|g|1|stk|1|hgl||L01AA06|01.07.1998||R|A|5|0|1|0|1|BAM|0|0|0|100|SEK|8002|11549|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Baxter Medical AB|Ífosfamíð||8002||8002|11549| 079202|J05AH0201|Tamiflu|hylki|75|mg|10|stk|1|þpakki||J05AH02|01.11.2002||R|A|5|0|0|0|0|RRL|0|0|0|100|DKK|3402|5531|lyfalmen|||00|10|0|4,6700|Icepharma hf|Roche Registration Limited|Oseltamivír||3402||3402|5531| 079269|N05AB0302|Trilafon decanoat|stl|108,2|mg/ml|1|ml|10|lykjur||N05AB03|01.01.1988||R|A|3|0|0|*|0|SCP|0|1|0|100|DKK|18731|25786|lyfalmen|||02|10|0|154,5714|Vistor hf|Schering-Plough|Perfenazín||18731||18731|25786| 079358|N07BA0143|Nicotinell IceMint|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.05.2010||L|A||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 079370|N07BA0143|Nicotinell IceMint|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.05.2010||L|A||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|12,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 079381|N07BA0143|Nicotinell IceMint|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.05.2010||L|A||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 079495|N06AB0308|Fluoxetin Actavis|lausnart|20|mg|100|stk|1|þpakki||N06AB03|01.05.2010||R|A||0|0|B|0|ACA|0|1|0|100|XEU|5428|6870|lyfalmen|V0915|6870|00|100|0|100,0000|Actavis Group hf|Actavis hf|Flúoxetín||4381||4381|6870| 079749|J01CF0101|Diclocil|sts/irs|1|g|1|stk|5|hgl||J01CF01|01.04.1987||R|A|3|0|0|0|1|BRS|0|0|0|100|DKK|2103|3035|lyfsjukr|||03|5|0|2,5000|Vistor hf|Bristol-Myers Squibb|Díkloxacillín||2103||2103|3035| 080106|J01MA0203|Siprox|töflur|250|mg|10|stk|1|þpakki||J01MA02|01.10.1992||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|393|1415|lyfalmen|V0514|1415|00|10|0|2,5000|Actavis Group hf|Actavis hf|Cíprófloxacín||393||393|1415| 080115|J01MA0203|Siprox|töflur|250|mg|20|stk|1|þpakki||J01MA02|01.10.1992||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|638|1750|lyfalmen|V0518|1750|00|20|0|5,0000|Actavis Group hf|Actavis hf|Cíprófloxacín||638||638|1750| 080124|J01MA0203|Siprox|töflur|500|mg|10|stk|1|þpakki||J01MA02|01.05.2008||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|647|1762|lyfalmen|V0522|1762|00|10|0|5,0000|Actavis Group hf|Actavis hf|Cíprófloxacín||647||647|1762| 080133|J01MA0203|Siprox|töflur|500|mg|20|stk|1|þpakki||J01MA02|01.01.1994||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|1168|2475|lyfalmen|V0526|2475|00|20|0|10,0000|Actavis Group hf|Actavis hf|Cíprófloxacín||1168||1168|2475| 080156|QN02AF0101|Morphasol handa hundum og köttum|stl|4|mg/ml|10|ml|1|hgl||QN02AF01|01.06.2010||R|A||0|0|0|0|ANI|1|0|0|100|XEU|4075|7997|vetalmen|||27|10|0||Dýraheilsa ehf|aniMedica GmbH|Bútorfanóltartrat||||4075|7997| 080424|G01AF0502|Pevaryl Depot|sk-stíll|150|mg|1|stk|1|still||G01AF05|01.04.1989||L|A|3|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||05|1|0|1,5000|Vistor hf|McNeil Sweden AB|Ekónazól|||||| 080507|N06AA1001|Noritren|töflur|50|mg|100|stk|1|glas||N06AA10|01.04.1986||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|2281|3998|lyfalmen|||00|100|0|66,6667|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||2281||2281|3998| 080524|N06AX1202|Wellbutrin Retard|töflur|300|mg|30|stk|1|þpakki|m/br. losunarhraða|N06AX12|01.07.2007||R|A|1,5|0|0|0|0|GSK|0|1|1|100|GBP|6151|9292|lyfalmen|||00|30|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Buprofienum||6151||6151|9292| 080538|G04BE0306|Sildenafil Actavis|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|A||0|0|0|0|AGP|0|0|0|100|XEU|4367|4951|lyfalmen|V0097|4813|00|4|0|4,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||2978||2978|4951| 080542|N06AX1202|Wellbutrin Retard|töflur|150|mg|30|stk|1|þpakki|m/br. losunarhraða|N06AX12|01.07.2007||R|A|1,5|0|0|0|0|GSK|0|1|1|100|GBP|3056|5058|lyfalmen|||00|30|0|15,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Buprofienum||3056||3056|5058| 080549|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|500|ml|1|fl||QP54AA01|01.01.1985||R|A|5|0|0|0|0|MEF|1|0|0|100|XEU|34674|60487|vetorma|||27|500|0|0,0000|Vistor hf|Merial (MSD)|||34674||34674|60487| 080550|G04BE0306|Sildenafil Actavis|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|A||0|0|0|0|AGP|0|0|0|100|XEU|13074|12852|lyfalmen|V0098|12688|00|12|0|12,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||8754||8754|12852| 080561|G04BE0306|Sildenafil Actavis|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|A||0|0|0|0|AGP|0|0|0|100|XEU|4683|5081|lyfalmen|V0099|4944|00|4|0|8,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||3073||3073|5081| 080564|L01DB0601|Zavedos|sts|5|mg|1|stk|1|hgl||L01DB06|01.01.1992||R|A|3|0|1|0|1|PER|0|0|0|100|DKK|24398|32502|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Pfizer ApS|Ídarúbicín||24398||24398|32502| 080573|G04BE0306|Sildenafil Actavis|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|A||0|0|0|0|AGP|0|0|0|100|XEU|13768|13803|lyfalmen|V0100|13635|00|12|0|24,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||9449||9449|13803| 080820|L01DB0601|Zavedos|sts|10|mg|1|stk|1|hgl||L01DB06|01.01.1992||R|A|3|0|1|0|1|PER|0|0|0|100|DKK|40536|52755|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Pfizer ApS|Ídarúbicín||40536||40536|52755| 081315|M09AX0101|Artzal|stl|10|mg/ml|2,5|ml|5|dælur|einnota dælur plast|M09AX01|01.11.1998||R|A|3,5|0|0|E|0|NDR|0|0|0|100|SEK|43428|56781|lyfalmen|||02|12|0|34,7222|Vistor hf|Nordic Drugs AB|Natríumhýalúrónat||43428||43428|56781| 081507|G04BE0802|Cialis (D.A.C.)|filmhtfl|20|mg|4|stk|1|þpakki||G04BE08|01.05.2007||R|A|3|0|0|0|0|DAC|0|0|0|100|NOK|6131|9264|lyfalmen|V1350|9107|00|4|0|8,0000|D.A.C. ehf|D.A.C. ehf|Tadalafíl||6131||6131|9264| 081525|V03AN0101|Conoxia|innö.gas|100|%|10|l|1|hylki|MO10|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|10|0|0,0000|Ísaga ehf|AGA AB|Súrefni|||||| 081534|V03AN0101|Conoxia|innö.gas|100|%|20|l|1|hylki|MO20|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|20|0|0,0000|Ísaga ehf|AGA AB|Súrefni|||||| 081543|V03AN0101|Conoxia|innö.gas|100|%|50|l|1|hylki|Mo50|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|50|0|0,0000|Ísaga ehf|AGA AB|Súrefni|||||| 081552|V03AN0101|Conoxia|innö.gas|100|%|5|l|1|hylki|MO5|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|5|0|0,0000|Ísaga ehf|AGA AB|Súrefni|||||| 081561|V03AN0101|Conoxia|innö.gas|100|%|50|l|12|hylki|MS5I|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|600|0|0,0000|Ísaga ehf|AGA AB|Súrefni|||||| 081571|V03AN0101|Conoxia|innö.gas|100|%|2|l|1|hylki|MO2c|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|2|0|0,0000|Ísaga ehf|AGA AB|Súrefni||||||28.02.2011 081589|V03AN0101|Conoxia|innö.gas|100|%|1|l|1|hylki|MO1|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|1|0|0,0000|Ísaga ehf|AGA AB|Súrefni|||||| 081598|V03AN0101|Conoxia|innö.gas|100|%|2,5|l|1|hylki|MO2,5c|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|2|0|0,0000|Ísaga ehf|AGA AB|Súrefni||||||28.02.2011 081613|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.05.2010||L|A||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 081624|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|96|stk|1|þpakki||N07BA01|01.05.2010||L|A||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 081625|V03AN0101|Conoxia|innö.gas|100|%|2|l|1|hylki|MO2|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|2|0|0,0000|Ísaga ehf|AGA AB|Súrefni|||||| 081634|V03AN0101|Conoxia|innö.gas|100|%|4|l|1|hylki|MO4b|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|4|0|0,0000|Ísaga ehf|AGA AB|Súrefni|||||| 081635|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.05.2010||L|A||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 081671|V03AN0101|Conoxia|innö.gas|100|%|4|l|1|hylki|MO4|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|4|0|0,0000|Ísaga ehf|AGA AB|Súrefni|||||| 081680|V03AN0101|Conoxia|innö.gas|100|%|4|l|1|hylki|MO4c|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|4|0|0,0000|Ísaga ehf|AGA AB|Súrefni||||||28.02.2011 081689|V03AN0101|Conoxia|innö.gas|100|%|1|l|1|hylki|MO1c|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|1|0|0,0000|Ísaga ehf|AGA AB|Súrefni||||||28.02.2011 081745|N05CD0801|Dormicum|stl|5|mg/ml|1|ml|10|lykjur||N05CD08|01.07.1985||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|2098|3028|lyfsjukr|||02|10|0|3,3333|Icepharma hf|Roche|Mídazólam||2098||2098|3028| 081897|N05AH0305|Zyprexa Velotab (D.A.C.)|munndr.t|10|mg|28|stk|1|þpakki||N05AH03|01.04.2010||R|A|3|0|0|*|0|DAC|0|1|0|100|XEU|19876|27223|lyfalmen|V0813|27223|00|28|0|28,0000|D.A.C. ehf|D.A.C. ehf|Olanzapín||||19876|27223| 081987|A10AB0602|Apidra [Solostar]|stl|100|ein/ml|3|ml|5|lyfjap|áfylltir lyfjapennar|A10AB06|01.01.2008||R|K|2|0|0|*|0|SAA|0|0|0|100|NOK|5730|8716|lyfalmen|||02|15|0|37,5000|Vistor hf|Sanofi - Aventis|Insúlín glúlisín||5730||5730|8716| 081996|A10AE0403|Lantus [SoloStar]|stl|100|ein/ml|3|ml|5|lyfjap|áfylltir lyfjapennar|A10AE04|01.01.2008||R|K|2|0|0|*|0|SDE|0|0|0|100|NOK|9697|14142|lyfalmen|||00|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||9697||9697|14142| 082021|L02BG0302|Anastrozol Actavis|filmhtfl|1|mg|98|stk|1|þpakki||L02BG03|01.03.2011||R|A||0|0|*|0|AGP|0|0|0|100|XEU|38539|50646|lyfalmen|||00|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Anastrózól||38539||38539|50646| 082040|D07XC0101|Diprosalic|áburður|0||100|ml|1|glas||D07XC01|01.01.1987||R|A|2|0|0|B|0|SCP|0|0|1|100|DKK|3371|5489|lyfalmen|||20|100|0|100,0000|Vistor hf|Schering-Plough|Betametasón||||3371|5489| 082233|V03AN0101|Conoxia|innö.gas|100|%|36|l|1|hylki|Hemlox|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|36|0|0,0000|Ísaga ehf|AGA AB|Súrefni|||||| 082685|R03BA0502|Flixotide Diskus|innúðadu|250|mcg/sk|60|sk|1|pakki|í diskus-t|R03BA05|01.07.1995||R|A|3|0|0|B|0|GSK|0|0|0|100|GBP|3154|4716|lyfalmen|||23|60|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2806||2806|4716| 082701|J01CA0411|Amoxicillin Mylan|mixt.kyr|50|mg/ml|60|ml|1|glas||J01CA04|01.07.1998||R|A|2|0|0|0|0|MYL|0|0|1|100|SEK|710|1848|lyfalmen|||00|60|0|3,0000|Actavis Group PTC ehf|Mylan AB|Amoxicillín||710||710|1848| 082719|R03BA0502|Flixotide Diskus|innúðadu|500|mcg/sk|60|sk|1|pakki|í diskus-t|R03BA05|01.07.1995||R|A|3|0|0|B|0|GSK|0|0|0|100|GBP|5152|7925|lyfalmen|||23|60|0|50,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||5152||5152|7925| 082792|J01CA0411|Amoxicillin Mylan|mixt.kyr|50|mg/ml|125|ml|1|glas||J01CA04|01.07.1998||R|A|2|0|0|0|0|MYL|0|0|1|100|SEK|1110|2396|lyfalmen|||00|125|0|6,2500|Actavis Group PTC ehf|Mylan AB|Amoxicillín||1110||1110|2396| 082842|J01CA0411|Amoxicillin Mylan|mixt.kyr|50|mg/ml|200|ml|1|glas||J01CA04|01.07.1998||R|A|2|0|0|0|0|MYL|0|0|1|100|SEK|1774|3304|lyfalmen|||00|200|0|10,0000|Actavis Group PTC ehf|Mylan AB|Amoxicillín||1774||1774|3304| 082883|R03BA0201|Pulmicort|innúðal|0,125|mg/ml|20|plhylk|1|pakki|í vél|R03BA02|01.01.1997||R|A|2|0|0|0|0|AZD|0|0|0|100|SEK|5576|8505|lyfalmen|||00|100|0|6,2500|Vistor hf|AstraZeneca A/S DK|Búdesóníð||5576||5576|8505| 082933|R03BA0201|Pulmicort|innúðal|0,25|mg/ml|20|plhylk|1|pakki|í vél|R03BA02|01.01.1997||R|A|2|0|0|0|0|AZD|0|0|0|100|SEK|6127|9259|lyfalmen|||00|40|0|12,5000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||6127||6127|9259| 082958|N06DA0301|Exelon|hylki|1,5|mg|56|stk|1|þpakki||N06DA03|01.10.2008||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|13297|18967|lyfalmen|||00|56|0|9,3350|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||13297||13297|18967| 083113|L02BG0301|Arimidex|töflur|1|mg|28|stk|1|þpakki||L02BG03|01.03.1998||R|A|5|0|0|*|0|AZA|0|0|0|100|SEK|19421|26652|lyfalmen|||00|28|0|28,0000|Vistor hf|AstraZeneca AB|Anastrózól||19421||19421|26652| 083121|N06DA0301|Exelon|hylki|3|mg|56|stk|1|þpakki||N06DA03|01.10.2008||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|13888|19709|lyfalmen|V1372|19707|00|56|0|18,6700|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||13888||13888|19709| 083154|R03BA0201|Pulmicort|innúðal|0,5|mg/ml|20|plhylk|1|pakki|í vél|R03BA02|01.01.1997||R|A|2|0|0|0|0|AZD|0|0|0|100|SEK|7791|11535|lyfalmen|||00|40|0|25,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||7791||7791|11535| 083592|J05AE0301|Norvir|mixtúra|80|mg/ml|90|ml|5|glös||J05AE03|01.08.2003||R|K|0,5|0|1|0|1|ABL|0|0|0|100|DKK|77608|99281|lyfsjukr|||00|450|0|30,0000|Vistor hf|Abbott Laboratories A/S|Ritonavír||77608||77608|99281| 083634|N06DA0301|Exelon|hylki|6|mg|112|stk|1|þpakki||N06DA03|01.01.1999||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|30136|40100|lyfalmen|||00|112|0|74,6667|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||30136||30136|40100| 083980|L02AE0101|Suprefact|stl|1|mg/ml|5,5|ml|2|hgl||L02AE01|01.10.1987||R|A|3|0|1|0|1|SNO|0|0|0|100|NOK|8201|11836|lyfsjukr|||02|11|0|7,3333|Vistor hf|Sanofi-aventis Norge AS|Búserelín||8201||8201|11836| 084160|C03CA0101|Furix|stl|10|mg/ml|2|ml|5|lykjur||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|271|1248|lyfalmen|||02|10|0|2,5000|Gróco ehf|Nycomed Danmark A/S|Fúrósemíð||271||271|1248| 084376|C03CA0101|Furix|stl|10|mg/ml|4|ml|5|lykjur||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|524|1594|lyfalmen|||02|20|0|5,0000|Gróco ehf|Nycomed Danmark A/S|Fúrósemíð||524||524|1594| 084669|B03XA0301|Mircera|stl|150|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|64175|82422|lyfsjukr|||00|0|0|37,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||64175||64175|82422| 084678|B03XA0301|Mircera|stl|200|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|83684|106906|lyfsjukr|||00|0|0|50,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||83684||83684|106906| 084687|B03XA0301|Mircera|stl|250|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|99773|127098|lyfsjukr|||00|0|0|62,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||99773||99773|127098| 084696|B03XA0301|Mircera|stl|50|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|21524|28895|lyfsjukr|||00|0|0|12,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||21524||21524|28895| 084705|B03XA0301|Mircera|stl|75|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|32208|42304|lyfsjukr|||00|0|0|18,7500|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||32208||32208|42304| 084714|B03XA0301|Mircera|stl|100|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|42843|55650|lyfsjukr|||00|0|0|25,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||42843||42843|55650| 084751|B03XA0301|Mircera|stl|30|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.05.2009||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|12772|17911|lyfsjukr|||00|0|0|7,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||||12772|17911| 084778|B03XA0301|Mircera|stl|120|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.05.2009||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|48688|62986|lyfsjukr|||00|0|0|30,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||||48688|62986| 084787|B03XA0301|Mircera|stl|360|mcg/spr|0,6|ml|1|áf.spr||B03XA03|01.05.2009||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|149955|190076|lyfsjukr|||00|1|0|90,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||||149955|190076| 084878|N03AF0301|Inovelon|filmhtfl|100|mg|10|stk|1|þpakki||N03AF03|01.09.2007||R|A|3|0|1|E|0|EIS|0|0|0|100|SEK|1142|2439|lyfalmen|||00|10|0|0,7100|Vistor hf|Eisai Ltd|Rúfínamíð||1142||1142|2439| 084887|N03AF0301|Inovelon|filmhtfl|200|mg|60|stk|1|þpakki||N03AF03|01.09.2007||R|A|3|0|1|E|0|EIS|0|0|0|100|SEK|13198|18843|lyfalmen|||00|60|0|8,5700|Vistor hf|Eisai Ltd|Rúfínamíð||13198||13198|18843| 084896|N03AF0301|Inovelon|filmhtfl|400|mg|100|stk|1|þpakki||N03AF03|01.09.2007||R|A|3|0|1|E|0|EIS|0|0|0|100|SEK|44000|57499|lyfalmen|||00|100|0|28,5700|Vistor hf|Eisai Ltd|Rúfínamíð||44000||44000|57499| 085068|N02AA0101|Contalgin|forðatfl|100|mg|100|stk|1|þpakki||N02AA01|01.10.1985||R|A|3|1|0|E|0|PER|0|0|0|100|DKK|15634|21900|lyfalmen|||10|100|0|100,0000|Icepharma hf|Pfizer ApS|Morfín||15634||15634|21900| 085132|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|56|stk|1|þpakki||A02BC01|01.02.2009||R|A|3|0|0|E|0|AGT|0|0|0|100|IKR|2540|4352|lyfalmen|V2170|4323|0|56|0|56,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||||2540|4352| 085160|A02BC0108|Omeprazol Actavis|sh-hylki|40|mg|28|stk|1|þpakki||A02BC01|01.02.2009||R|A|3|0|0|0|0|AGT|0|0|0|100|IKR|3291|5379|lyfalmen|||0|28|0|56,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||||3291|5379| 085184|L01XD0301|Metvix|krem|160|mg/g|2|g|1|túpa||L01XD03|01.09.2010||R|K|1|0|1|*|0|GAN|0|0|0|100|NOK|42536|55662|lyfalmen|||00|2|0||Icepharma hf|Galderma Nordic AB|Metýlamínólevúlínat||42536||42536|55662| 085205|S01AX1901|Oftaquix|augndr|5|mg/ml|0,5|ml|30|sk-hyl||S01AX19|01.03.2008||R|A|2|0|0|0|0|SAO|0|0|1|100|XEU|3072|5080|lyfalmen|||00|15|0|0,0000|Icepharma hf|Santen Oy|Levófloxacín||3072||3072|5080| 085316|N06DA0301|Exelon|hylki|4,5|mg|112|stk|1|þpakki||N06DA03|01.01.1999||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|30136|40100|lyfalmen|||00|112|0|56,0000|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||30136||30136|40100| 085407|R03AC0206|Ventoline|lausn|1|mg/ml|20|lykjur|1|pakki|f. vél|R03AC02|01.04.1992||R|A|3|0|0|0|0|GSK|0|0|1|100|GBP|776|1939|lyfalmen|||00|50|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||776||776|1939| 085423|B01AB0401|Fragmin|stl|25000|ae/ml|4|ml|1|hgl|með rotvörn|B01AB04|01.04.1993||R|A|2|0|0|0|1|PER|0|0|0|100|DKK|13228|18484|lyfsjukr|||00|4|0|40,0000|Icepharma hf|Pfizer ApS|Dalteparín||13228||13228|18484| 085542|G03GA0202|Menopur|sts|0| |75|ae|5|hgl|+ leysir|G03GA02|01.03.2001||R|A|2|0|1|E|0|FEL|0|0|0|100|DKK|20508|28017|lyfalmen|||00|375|0|12,5000|Vistor hf|Ferring Lægemidler A/S|Menótrópín||20508||20508|28017| 085551|G03GA0202|Menopur|sts|0| |75|ae|10|hgl|+ leysir|G03GA02|01.03.2001||R|A|2|0|1|E|0|FEL|0|0|0|100|DKK|36486|48069|lyfalmen|||00|750|0|25,0000|Vistor hf|Ferring Lægemidler A/S|Menótrópín||36486||36486|48069| 085770|G04BE0804|Adcirca|filmhtfl|20|mg|56|stk|1|þpakki||G04BE08|01.12.2010||R|A||0|1|0|1|ELD|0|0|0|100|XEU|92210|117606|lyfsjukr|||00|56|0|112,0000|Icepharma hf|Eli Lilly Nederland B.V.|Tadalafíl||92210||92210|117606| 085804|M05BX0401|Prolia|stl|60|mg/ml|1|ml|1|áf.spr|lausn|M05BX04|01.10.2010||R|K|3|0|0|0|0|AEU|0|0|0|100|DKK|40844|53538|lyfalmen|||00|1|0|181,8100|Vistor hf|Amgen Europe B.V.|Denosúmab||40844||40844|53538| 085829|S01EB0104|Pilokarpin|augndr|2|%|0,5|ml|20|skammt|án rotvarnar|S01EB01|01.01.1998||R|A||0|1|E|0|LDR|0|0|0|100|IKR|2270|3982|lyfalmen|||00|10|1|7,5000|Parlogis hf|Parlogis - óskráð lyf|Pílókarpín||2270||2270|3982| 085969|R06AX2601|Telfast|töflur|120|mg|100|stk|1|þpakki||R06AX26|01.11.1999||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|5324|5467|lyfalmen|V1911|5374|00|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||3355||3355|5467| 086108|R06AX2601|Telfast|töflur|180|mg|100|stk|1|þpakki||R06AX26|01.11.1999||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|6402|7619|lyfalmen|V1913|7341|00|100|0|150,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||4928||4928|7619| 086207|J01DD0202|Fortum|sts|1|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|A|3|0|0|0|1|GSK|0|0|0|100|GBP|8163|11781|lyfsjukr|||03|5|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ceftazidím||8163||8163|11781| 086231|J01DD0202|Fortum|sts|2|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|A|3|0|0|0|1|GSK|0|0|0|100|GBP|14190|19691|lyfsjukr|||03|5|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ceftazidím||14190||14190|19691| 086434|L04AA2401|Orencia|stl/irþ|250|mg/hgl|1|hgl|1|hgl|+ sprauta|L04AA24|01.02.2008||R|K|2|0|1|0|1|BSP|0|0|0|100|DKK|59116|76073|lyfsjukr|||00|1|0|9,2600|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |||59116||59116|76073| 086969|J05AB1401|Valcyte|mixtúrud|50|mg/ml|100|ml|1|glerfl|lausn|J05AB14|01.09.2009||R|A||0|0|0|1|ROA|0|0|0|100|DKK|48534|62793|lyfsjukr|||00|100|0|5,5000|Icepharma hf|Roche A.S.|Valgancíklóvír||||48534|62793| 087114|G03CX0101|Livial|töflur|2,5|mg|28|stk|1|þpakki||G03CX01|01.07.1998||R|A|2|0|0|E|0|ORG|0|0|0|100|DKK|3266|5345|lyfalmen|||00|28|0|28,0000|Vistor hf|N.V. Organon|Tíbólón||3266||3266|5345| 087215|A03AX1335|Imogaze|hylki|240|mg|30|stk|1|þpakki|mjúk hylki|A03AX13|01.12.2008||L|A|3|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||00|30|0|14,4000|Vistor hf|McNeil Sweden AB|Silíkonsambönd|||||| 087260|J05AX0901|Celsentri|filmhtfl|150|mg|60|stk|1|þpakki||J05AX09|01.04.2008||R|A|3|0|1|0|1|VII|0|0|0|100|DKK|162369|205656|lyfsjukr|||00|60|0|15,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Maravíroc||162369||162369|205656| 087304|N05CF0101|Imovane|töflur|7,5|mg|10|stk|1|þpakki||N05CF01|01.10.1995||R|A|3|0|0|0|0|SNO|0|0|1|100|NOK|286|1268|lyfalmen|||00|10|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||286||286|1268| 087312|N05CF0101|Imovane|töflur|7,5|mg|30|stk|1|þpakki||N05CF01|01.10.1995||R|A|3|0|0|0|0|SNO|0|0|0|100|NOK|251|1221|lyfalmen|V0886|1221|00|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||251||251|1221| 087320|N05CF0101|Imovane|töflur|7,5|mg|100|stk|1|þpakki||N05CF01|01.10.1995||R|A|3|0|0|0|0|SNO|0|0|0|100|NOK|2977|4950|lyfalmen|||00|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||2977||2977|4950| 087445|A02BX1301|Gaviscon|mixtúra|||500|ml|1|glas||A02BX13|01.08.1984||L|A|2|0|0|0|0|NDR|0|0|0|100|IKR|||lyfalmen|||01|500|0|0,0000|Vistor hf|Nordic Drugs AB|Algínsýra|||||3485| 087759|G03GB0202|Pergotime|töflur|50|mg|5|stk|1|þpakki||G03GB02|01.07.1986||R|A|5|0|0|E|0|MEC|0|0|0|100|SEK|888|2092|lyfalmen|||00|5|0|27,7778|Icepharma hf|Merck AB|Klómífen||888||888|2092| 087788|B01AC0403|Clopidogrel Actavis|filmhtfl|75|mg|28|stk|1|þpakki||B01AC04|01.11.2010||R|A||0|0|E|0|APC|0|0|0|100|XEU|5541|5335|lyfalmen|V1091|5277|00|28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Klópídógrel||3259||3259|5335| 087832|L02BB0304|Bicalutamid Actavis|filmhtfl|50|mg|30|stk|1|þpakki||L02BB03|01.09.2007||R|A|3|0|0|*|0|AGP|0|0|0|100|XEU|12699|15435|lyfalmen|V0560|15435|00|30|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Bíkalútamíð||10642||10642|15435| 087867|QP52AA5108|Prazitel Plus|töflur|||104|stk|1|þpakki|50/144/150|QP52AA51|01.07.2010||R|A||0|0|0|0|CHP|0|0|0|100|XEU|31762|55407|vetorma|||00|104|0||Icepharma hf|Chanelle Pharmaceuticals|||31762||31762|55407| 087932|A02BX1301|Gaviscon|tuggutfl|||20|stk|1|þpakki||A02BX13|01.10.1993||L|A|1,5|0|0|0|0|NDR|0|0|0|100|IKR|||lyflausa|||00|20|0|0,0000|Vistor hf|Nordic Drugs AB|Algínsýra|||||| 088051|L03AB0503|IntronA (Lyfjaver)|stl|18|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.06.2007|31.12.2010|R|K|1,25|0|1|0|1|LVR|0|0|0|100|NOK|26274|34856|lyfsjukr|||00|1|0|9,0000|Lyfjaver ehf|Lyfjaver ehf|Interferón alfa-2b||26274||26274|34856| 088224|L03AB0503|IntronA (Lyfjaver)|stl|30|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.06.2007|31.12.2010|R|K|1,25|0|1|0|1|LVR|0|0|0|100|NOK|43220|56124|lyfsjukr|||00|1|0|15,0000|Lyfjaver ehf|Lyfjaver ehf|Interferón alfa-2b||43220||43220|56124| 088233|L03AB0503|IntronA (Lyfjaver)|stl|60|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.06.2007|31.12.2010|R|K|1,25|0|1|0|1|LVR|0|0|0|100|NOK|88466|112907|lyfsjukr|||00|1|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Interferón alfa-2b||88466||88466|112907| 088261|R01AD1201|Avamys|nefúði|27,5|mcg/sk|120|sk|1|glas||R01AD12|01.04.2008||R|A|3|0|0|E|0|GGL|0|0|1|100|GBP|1351|2725|lyfalmen|||00|120|0|30,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Flútíkasón fúróat||1351||1351|2725| 088310|M01AX0101|Relifex|lausnart|1|g|20|stk|1|þpakki||M01AX01|01.04.1995||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|1866|3430|lyfalmen|||14|20|0|20,0000|Vistor hf|Meda AB|Nabúmeton||1866||1866|3430| 088328|M01AX0101|Relifex|lausnart|1|g|100|stk|1|þpakki||M01AX01|01.04.1995||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|9249|13529|lyfalmen|||14|100|0|100,0000|Vistor hf|Meda AB|Nabúmeton||9249||9249|13529| 088393|A03FA0101|Primperan|eþ-stíll|20|mg|6|stk|1|pakki||A03FA01|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|1|100|NOK|523|1593|lyfalmen|||04|6|0|4,0000|Vistor hf|Sanofi-aventis Norge AS|Metóklópramíð||523||523|1593| 088705|D05AX5201|Daivobet|hlaup|||60|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.02.2011||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|9873|14383|lyfalmen|||00|60|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||9873||9873|14383| 088723|L01XE0701|Tyverb|filmhtfl|250|mg|70|stk|1|þpakki||L01XE07|01.11.2008||R|A|2|0|1|0|1|GGL|0|0|0|100|GBP|166858|211289|lyfsjukr|||00|70|0|0,0000|GlaxoSmithKline ehf|Glaxo Group Limited|||||166858|211289| 088814|L02BB0304|Bicalutamid Actavis|filmhtfl|150|mg|30|stk|1|þpakki||L02BB03|01.12.2008||R|A|3|0|0|*|0|AGP|0|0|0|100|XEU|24050|31818|lyfalmen|V0562|31818|00|30|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Bíkalútamíð||23537||23537|31818| 088964|S01EE0103|Latanoprost Portfarma|augndr|50|mcg/ml|7,5|ml|1|pakki|3 glös í pakka|S01EE01|01.08.2010||R|K||0|0|*|0|POF|0|0|0|100|DKK|7461|7758|lyfalmen|V1989|7694|06|8|0|75,0000|Portfarma ehf|Portfarma|Latanóprost||5030||5030|7758| 089094|A02BX1301|Gaviscon|tuggutfl|||120|stk|1|þpakki||A02BX13|01.01.1989||L|A|1,5|0|0|0|0|NDR|0|0|0|100|IKR|||lyfalmen|||00|120|0|0,0000|Vistor hf|Nordic Drugs AB|Algínsýra|||||5572| 089114|J05AX0901|Celsentri|filmhtfl|300|mg|60|stk|1|þpakki||J05AX09|01.04.2008||R|A|3|0|1|0|1|VII|0|0|0|100|DKK|162369|205656|lyfsjukr|||00|60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Maravíroc||162369||162369|205656| 089156|A03AA0406|Mebeverin Dura|filmhtfl|135|mg|100|stk|1|þpakki||A03AA04|01.07.2010||R|A||0|0|E|0|MYD|0|0|0|100|SEK|4056|6426|lyfalmen|||00|100|0|45,0000|Actavis Group PTC ehf|Mylan dura GmbH|Mebeverín||4056||4056|6426| 090159|C08DB0101|Cardizem|töflur|60|mg|100|stk|1|glas||C08DB01|01.10.1995||R|A|3|0|0|B|0|FRO|0|0|0|100|DKK|2550|4366|lyfalmen|||00|100|0|25,0000|Vistor hf|Ferrosan A/S|Diltíazem||2550||2550|4366| 090232|L01XC0601|Erbitux|irl|5|mg/ml|20|ml|1|hgl|lausn|L01XC06|01.04.2007||R|K|3|0|1|0|1|MKA|0|0|0|100|SEK|44754|58049|lyfsjukr|||00|20|0|0,0000|Icepharma hf|Merck KgaA|Cetúxímab||44754||44754|58049| 090242|L01XC0601|Erbitux|irl|5|mg/ml|100|ml|1|hgl|lausn|L01XC06|01.04.2007||R|K|3|0|1|0|1|MKA|0|0|0|100|SEK|223769|282713|lyfsjukr|||00|100|0|0,0000|Icepharma hf|Merck KgaA|Cetúxímab||223769||223769|282713| 090662|R01AD1101|Nasacort|nefúði|55|mcg/sk|16,5|ml|1|stauk|120 sk|R01AD11|01.11.1998||R|A|2|0|0|E|0|SNO|0|0|1|100|NOK|1743|3262|lyfalmen|||24|16|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Tríamcínólón||1743||1743|3262| 090688|A06AB0602|Senokot|töflur|7,5|mg|60|stk|1|þpakki||A06AB06|01.10.1990||R|A|3|0|0|0|0|REB|0|0|0|100|GBP|863|2058|lyfalmen|||00|60|0|0,0000|Icepharma hf|Reckitt Benckiser Healthcare Ltd.|Senna||863||863|2058| 091345|N06BA0403|Ritalin Uno|hylki|10|mg|30|stk|1|glas||N06BA04|01.03.2011||R|A||1|0|0|0|NOH|0|0|0|100|DKK|3384|5506|lyfalmen|||00|30|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||3384||3384|5506| 091751|A10BB1201|Amaryl|töflur|1|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|1938|2446|lyfalmen|V0001|1929|00|90|0|45,0000|Vistor hf|Aventis Pharma |Glímepíríð||1147||1147|2446| 091769|A10BB1201|Amaryl|töflur|2|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|3488|3366|lyfalmen|V0002|2539|00|90|0|90,0000|Vistor hf|Aventis Pharma |Glímepíríð||1819||1819|3366| 092005|N06AB1001|Cipralex|dropar|20|mg/ml|15|ml|1|glerfl||N06AB10|01.04.2009||R|A|2|0|0|0|0|LBK|0|0|0|100|DKK|3889|6197|lyfalmen|||00|15|0|30,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||||3889|6197| 092130|QJ01CA0401|Clamoxyl, vet.|töflur|200|mg|100|stk|1|þpakki||QJ01CA04|01.10.1987||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|7345|14276|vetalmen|||16|100|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||7345||7345|14276| 092361|B01AC0401|Plavix|töflur|75|mg|28|stk|1|þpakki||B01AC04|01.12.1999||R|A|3|0|0|E|0|SBM|0|0|0|100|NOK|7761|10476|lyfalmen|V1091|5277|00|28|0|28,0000|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Klópídógrel||7017||7017|10476| 092553|N07BA0144|Nicorette Whitemint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.08.2010||L|A||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 092575|N07BA0144|Nicorette Whitemint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.08.2010||L|A||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 092586|N07BA0144|Nicorette Whitemint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.08.2010||L|A||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 092609|N07BA0144|Nicorette Whitemint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.08.2010||L|A||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 092655|G03CA0310|Vagifem|sk-tfl|10|mcg|18|stk|1|pakki||G03CA03|01.03.2011||R|A||0|0|E|0|NON|0|0|0|100|DKK|2284|4002|lyfalmen|||05|18|0|7,2000|Vistor hf|Novo-Nordisk|Estradíól||2284||2284|4002| 092750|N05AH0203|Leponex (D.A.C.)|töflur|100|mg|100|stk|1|glas||N05AH02|01.05.2007||R|A||0|0|*|0|DAC|0|1|0|100|DKK|9306|13607|lyfalmen|V1400|13607|00|100|0|33,3333|D.A.C. ehf|D.A.C. ehf|Klózapín||9306||9306|13607| 092787|C09DA0306|Diovan Comp 320/25 mg|filmhtfl|345|mg|98|stk|1|þpakki|320/25 mg|C09DA03|01.11.2008||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|26605|35668|lyfalmen|||00|98|0|392,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og þvagræsilyf||||26605|35668| 092879|M01AB0103|Indometacin Actavis|hylki|25|mg|28|stk|1|þpakki||M01AB01|01.03.2010||R|A||0|0|E|0|AUK|0|0|1|100|GBP|427|1461|lyfalmen|||10|28|0|7,0000|Actavis Group hf|Actavis UK Ltd.|Indómetacín||427||427|1461| 092891|M01AB0103|Indometacin Actavis|hylki|50|mg|28|stk|1|þpakki||M01AB01|01.03.2010||R|A||0|0|E|0|AUK|0|0|1|100|GBP|556|1638|lyfalmen|||10|28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Indómetacín||556||556|1638| 092958|M05BA0408|Ostacid|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.05.2010||R|A||0|0|E|0|POF|0|0|0|100|XEU|3889|4780|lyfalmen|V0718|4780|00|12|0|84,0000|Portfarma ehf|Portfarma|Alendrónsýra||2853||2853|4780| 093260|N02CC0101|Imigran|stl|12|mg/ml|0,5|ml|2|spr|+ penni|N02CC01|01.10.1992||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|5353|8200|lyfalmen|||00|1|0|2,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||5353||5353|8200| 093617|QG03DA0202|Veramix, vet.|sk-svamp|60|mg|1|stk|100|stk||QG03DA02|01.10.1991||R|A|5|0|0|0|0|PAL|1|0|0|100|DKK|26566|46343|vetorma|||00|100|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||26566||26566|46343| 093708|L01DB0701|Novantrone|irþ|2|mg/ml|5|ml|1|hgl||L01DB07|01.07.1987||R|A|3|0|1|0|1|MEB|0|0|0|100|USD|15564|21415|lyfsjukr|||00|5|0|0,0000|Vistor hf|Meda AB (V)|Mítoxantrón||15564||15564|21415| 093736|L02AE0305|Zoladex LA (D.A.C.)|vefjalyf|10,8|mg|1|stk|1|áf.spr||L02AE03|01.06.2010||R|A||0|1|*|0|DAC|0|0|0|100|SEK|70329|90542|lyfalmen|V0565|90542|00|1|0|83,7209|D.A.C. ehf|D.A.C. ehf|Góserelín||70329||70329|90542| 093757|N02AA0501|Oxycontin|forðatfl|80|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|17794|24611|lyfalmen|||10|28|0|29,8700|Icepharma hf|Norpharma |Oxýcódon||17794||17794|24611| 093770|L02AE0304|Zoladex (D.A.C.)|vefjalyf|3,6|mg|1|stk|1|áf.spr||L02AE03|01.06.2010||R|A||0|1|*|0|DAC|0|0|0|100|SEK|26264|35240|lyfalmen|V0564|35240|00|1|0|27,9070|D.A.C. ehf|D.A.C. ehf|Góserelín||26264||26264|35240| 093799|N02AA0501|Oxycontin|forðatfl|80|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|45720|59658|lyfalmen|||10|98|0|261,3300|Icepharma hf|Norpharma |Oxýcódon||45720||45720|59658| 093969|G03FB0507|Trisekvens (D.A.C.)|töflur|||84|stk|1|skífup||G03FB05|01.05.2007||R|A|4|0|0|E|0|DAC|0|0|0|100|DKK|2555|4372|lyfalmen|||23|84|0|84,0000|D.A.C. ehf|D.A.C. ehf|Noretísterón og östrógen||2555||2555|4372|28.02.2011 094111|N02CC0501|Almogran|töflur|12,5|mg|6|stk|1|þpakki|filmuhúðaðar töflur|N02CC05|01.07.2010||R|A|5|0|0|E|0|ALM|0|0|0|100|SEK|5902|8951|lyfalmen|||00|6|0|6,0000|Vistor hf|Almirall S.A.|Almótriptan||5902||5902|8951| 094122|N02CC0501|Almogran|töflur|12,5|mg|9|stk|1|þpakki|filmuhúðaðar töflur|N02CC05|01.07.2010||R|A|5|0|0|E|0|ALM|0|0|0|100|SEK|8357|12309|lyfalmen|||00|9|0|9,0000|Vistor hf|Almirall S.A.|Almótriptan||8357||8357|12309| 094132|QM01A0001|Metacam fyrir ketti|mixtúra|0,5|mg/ml|15|ml|1|fl||QM01AC06|01.01.2009||R|A|3|0|0|0|0|BOI|0|0|0|100|DKK|1790|3561|vetalmen|||00|8|0|0,0000|Vistor hf|Boehringer Ingelheim|||1790||1790|3561| 094287|L04AD0201|Advagraf|forðahlk|0,5|mg|50|stk|1|þpakki||L04AD02|01.10.2007||R|A|3|0|1|*|0|APE|0|0|0|100|XEU|13074|18687|lyfalmen|||00|50|0|5,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||13074||13074|18687| 094296|L04AD0201|Advagraf|forðahlk|1|mg|50|stk|1|þpakki||L04AD02|01.10.2007||R|A|3|0|1|*|0|APE|0|0|0|100|XEU|18727|25781|lyfalmen|||00|50|0|10,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||18727||18727|25781| 094305|L04AD0201|Advagraf|forðahlk|5|mg|50|stk|1|þpakki||L04AD02|01.10.2007||R|A|3|0|1|*|0|APE|0|0|0|100|XEU|84266|108033|lyfalmen|||00|50|0|50,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||84266||84266|108033| 094801|J05AR0401|Trizivir|filmhtfl|750|mg|60|stk|1|þpakki|300+150+300 mg|J05AR04|01.08.2003||R|A|2|0|1|0|1|VII|0|0|0|100|GBP|79574|101748|lyfsjukr|||00|60|0||GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Zídóvúdín, lamívúdín og abacavír||79574||79574|101748| 094812|N01BX0403|Qutenza|plástur|179|mg|1|plástur|1|pakki||N01BX04|01.01.2011||R|A||0|0|0|0|APE|0|0|0|100|XEU|47617|62038|lyfalmen|||00|1|0||Vistor hf|Astellas Phama Europe B.V.|Capsaicin||||47617|62038| 094834|QI09AB0801|Suiseng Vet|stl|||50|ml|1|hgl|dreifa|QI09AB08|01.05.2010||R|K||0|0|0|0|LHS|0|0|0|100|XEU|6497|11334|vetorma|||00|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Bakteríubólefni gegn Escherichia coli + Clostridium||6497||6497|11334| 094933|A06AH0101|Relistor|stl|20|mg/ml|0,6|ml|7|hgl|lausn|A06AH01|01.01.2009||R|A|2|0|0|0|0|WTE|0|0|0|100|DKK|39950|52416|lyfalmen|||0|4|0|14,0000|Icepharma hf|Wyeth Europe|Metýlnaltrexónbrómíð||39950||39950|52416| 095208|G04BX0101|Emgesan|töflur|250|mg|100|stk|1|glas||G04BX01|01.03.2001||R|A||0|0|0|0|PCO|0|0|0|100|IKR|1577|3035|lyfalmen|||00|100|1|50,0000|Distica|Distica - óskráð lyf|||1577||1577|3035| 095418|G04BE0305|Vizarsin (Lyfis)|filmhtfl|50|mg|8|stk|1|pakki||G04BE03|01.02.2011||R|A||0|0|0|0|LYF|0|0|0|100|XEU|6056|8178|lyfalmen|||00|8|0|8,0000|Lyfis ehf|Lyfis ehf|Síldenafíl||5337||5337|8178| 095588|N07BB0101|Antabus|freyðit|400|mg|50|stk|1|glas||N07BB01|01.12.1972||R|A|5|0|0|E|0|AGT|0|0|0|100|DKK|3321|5420|lyfalmen|||00|50|0|100,0000|Actavis Group hf|Actavis Group hf|Dísúlfíram||3321||3321|5420| 095652|N05AX1301|Invega|forðatfl|3|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|18044|24924|lyfalmen|||00|28|0|14,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||18044||18044|24924| 095680|N05AX1301|Invega|forðatfl|6|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|18044|24924|lyfalmen|||00|28|0|28,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||18044||18044|24924| 095692|J01MA0204|Ciprofloxacin Portfarma|irl|2|mg/ml|100|ml|1|hgl||J01MA02|01.12.2010||R|A||0|0|0|0|POF|0|0|0|100|XEU|1927|3513|lyfalmen|||00|100|0|0,4000|Portfarma ehf|Portfarma|Cíprófloxacín||1927||1927|3513| 095704|J01MA0204|Ciprofloxacin Portfarma|irl|2|mg/ml|200|ml|1|hgl||J01MA02|01.12.2010||R|A||0|0|0|0|POF|0|0|0|100|XEU|3019|5007|lyfalmen|||00|200|0|0,8000|Portfarma ehf|Portfarma|Cíprófloxacín||3019||3019|5007| 095707|N05AX1301|Invega|forðatfl|9|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|18044|24924|lyfalmen|||00|28|0|42,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||18044||18044|24924| 095924|QM01AE9102|Canidryl|töflur|20|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|A|3|0|0|0|0|CHD|0|0|0|100|XEU|3658|7196|vetalmen|||00|100|0|0,0000|Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||3658||3658|7196| 095933|QM01AE9102|Canidryl|töflur|50|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|A|3|0|0|0|0|CHD|0|0|0|100|XEU|4827|9441|vetalmen|||00|100|0|0,0000|Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||4827||4827|9441| 095942|QM01AE9102|Canidryl|töflur|100|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|A|3|0|0|0|0|CHD|0|0|0|100|XEU|8791|17053|vetalmen|||00|100|0|0,0000|Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||8791||8791|17053| 096115|V03AF0101|Uromitexan|stl|100|mg/ml|4|ml|15|lykjur||V03AF01|01.10.1990||R|A|5|0|0|0|1|BAM|0|0|0|100|SEK|2903|4190|lyfsjukr|||02|60|0|0,0000|Icepharma hf|Baxter Medical AB|Mesna||2903||2903|4190| 096169|J06BA0103|Gammanorm|stl|165|mg/ml|10|ml|1|hgl|0|J06BA01|01.10.2008||R|K|3|0|0|0|1|OCT|0|0|0|100|DKK|13728|19111|lyfsjukr|||17|10|0|0,0000|Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, sem ekki eru gefin í æð||13728||13728|19111| 096178|J06BA0103|Gammanorm|stl|165|mg/ml|10|ml|10|hgl|0|J06BA01|01.10.2008||R|K|3|0|0|0|1|OCT|0|0|0|100|DKK|100372|127849|lyfsjukr|||17|100|0|0,0000|Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, sem ekki eru gefin í æð||100372||100372|127849| 096251|D06AX1301|Altargo|smyrsli|1|%|5|g|1|túpa||D06AX13|01.11.2007||R|A|2|0|0|0|0|GGL|0|0|1|100|GBP|1433|2838|lyfalmen|||00|5|0|0,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Retapamúlín||1433||1433|2838| 096260|N06DA0301|Exelon|forðapl|4,6|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|A|2|0|0|E|0|NOE|0|0|0|100|DKK|16144|22540|lyfalmen|||00|30|0|14,5300|Vistor hf|Novartis Europharm Ltd|Rívastigmín||16144||16144|22540| 096488|L04AX0401|Revlimid|hylki|5|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|A|3|0|1|0|1|CEE|0|0|0|100|XEU|974268|1224589|lyfsjukr|||0|21|0|0,0000|Celgene Europe ltd|Celgene Europe ltd|||||974268|1224589| 096497|L04AX0401|Revlimid|hylki|10|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|A|3|0|1|0|1|CEE|0|0|0|100|XEU|894534|1124523|lyfsjukr|||0|21|0|0,0000|Celgene Europe ltd|Celgene Europe ltd|||||894534|1124523| 096506|L04AX0401|Revlimid|hylki|15|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|A|3|0|1|0|1|CEE|0|0|0|100|XEU|941324|1183244|lyfsjukr|||0|21|0|0,0000|Celgene Europe ltd|Celgene Europe ltd|||||941324|1183244| 096515|L04AX0401|Revlimid|hylki|25|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|A|3|0|1|0|1|CEE|0|0|0|100|XEU|849028|1067413|lyfsjukr|||0|21|0|0,0000|Celgene Europe ltd|Celgene Europe ltd|||849028||849028|1067413| 096679|N06DA0301|Exelon|forðapl|9,5|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|A|2|0|0|E|0|NOE|0|0|0|100|DKK|16144|22540|lyfalmen|||00|30|0|30,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||16144||16144|22540| 096685|C03BA1102|Natrilix Retard|forðatfl|1,5|mg|30|stk|1|þpakki||C03BA11|01.03.1999||R|A|2|0|0|E|0|SEV|0|0|0|100|DKK|1544|2989|lyfalmen|||00|30|0|18,0000|Icepharma hf|Servier|Indapamíð||1544||1544|2989| 096688|N06DA0301|Exelon|forðapl|9,5|mg/sólh|60|pokar|1|pakki||N06DA03|01.01.2008||R|A|2|0|0|E|0|NOE|0|0|0|100|DKK|32289|42802|lyfalmen|||00|60|0|60,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||32289||32289|42802| 096896|J02AX0601|Ecalta|irs|100|mg/hgl|1|hgl|1|pakki|+ leysir, lausn|J02AX06|01.03.2008||R|A|3|0|1|0|1|IPI|0|0|0|100|DKK|89032|113618|lyfsjukr|||00|1|0|1,0000|Icepharma hf|Pfizer Limited|Anidulafungin||89032||89032|113618| 097033|B05AA0706|Tetraspan|irl|60|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05AA07|01.04.2010||R|A||0|0|0|1|BRA|0|0|0|100|XEU|34365|36677|lyfsjukr|||00|10000|0|10,0000|Actavis Group hf|Braun|Hýdróxyetýl sterkja||27725||27725|36677| 097092|QN02AF0102|Alvegesic vet.|stl|10|mg/ml|10|ml|1|hgl||QN02AF01|01.08.2010||R|A||0|0|0|0|AUW|1|0|0|100|XEU|8117|15758|vetalmen|||27|10|0||Icepharma hf|ALVETRA u. WERFFTt GmbH|Bútorfanóltartrat||||8117|15758| 097269|J01FF0103|Dalacin (D.A.C.)|hylki|300|mg|20|stk|1|þpakki||J01FF01|01.06.2007||R|A|5|0|0|0|0|DAC|0|0|1|100|DKK|2190|3813|lyfalmen|V0426|3813|00|20|0|5,0000|D.A.C. ehf|D.A.C. ehf|Klindamýcín||2146||2146|3813| 097288|R06AX2701|Aerius|mixtúra|0,5|mg/ml|120|ml|1|fl||R06AX27|01.10.2008||R|A|2|0|0|E|0|SCP|0|0|1|100|DKK|1115|2403|lyfalmen|||00|120|0|12,0000|Vistor hf|Schering-Plough|Deslóratadín||1115||1115|2403| 097442|L01CB0101|Vepesid|hylki|50|mg|20|stk|1|glas||L01CB01|01.01.1998||R|A||0|1|0|1|PCO|0|0|0|100|IKR|23026|30780|lyfsjukr|||00|20|1|0,0000|Distica|Distica - óskráð lyf|||23026||23026|30780| 097881|A10BB1201|Amaryl|töflur|3|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|4528|4170|lyfalmen|V0003|3096|00|90|0|135,0000|Vistor hf|Aventis Pharma |Glímepíríð||2407||2407|4170| 097887|N02CC0104|Sumacta|húðuðtfl|50|mg|12|stk|1|þpakki||N02CC01|01.11.2007||R|A|3|0|0|E|0|AGP|0|0|0|100|IKR|2738|4623|lyfalmen|V0831|4623|00|12|0|12,0000|Actavis Group hf|Actavis Group PTC ehf|Súmatriptan||2738||2738|4623| 097896|N02CC0104|Sumacta|húðuðtfl|100|mg|6|stk|1|þpakki||N02CC01|01.11.2007||R|A|3|0|0|E|0|AGP|0|0|0|100|IKR|1917|3500|lyfalmen|V0832|3500|00|6|0|12,0000|Actavis Group hf|Actavis Group PTC ehf|Súmatriptan||1917||1917|3500| 097905|N06AX1104|Miron Smelt|munndr.t|15|mg|30|stk|1|þpakki||N06AX11|01.11.2007||R|A|2|0|0|0|0|AGP|0|1|0|100|XEU|1102|2385|lyfalmen|V1151|2385|00|30|0|15,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||1102||1102|2385| 098059|C09CA0303|Valpress|filmhtfl|80|mg|98|stk|1|þpakki||C09CA03|01.12.2007||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|7494|3872|lyfalmen|V2209|3872|00|98|0|98,0000|Actavis Group hf|Actavis hf|Valsartan||2189||2189|3872| 098068|C09CA0303|Valpress|filmhtfl|160|mg|98|stk|1|þpakki||C09CA03|01.12.2007||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|11051|3915|lyfalmen|V2210|3915|00|98|0|196,0000|Actavis Group hf|Actavis hf|Valsartan||2221||2221|3915| 098459|N06AB0309 |Fontex (D.A.C.)|dreifit.|20|mg|30|stk|1|þpakki||N06AB03|01.05.2009||R|A|2|0|0|0|0|DAC|0|1|0|100|XEU|3185|5171|lyfalmen|V0914|2839|00|30|0|30,0000|D.A.C. ehf|D.A.C. ehf|Flúoxetín||3139||3139|5171| 098468|N06AB0309 |Fontex (D.A.C.)|dreifit.|20|mg|100|stk|1|þpakki||N06AB03|01.05.2009||R|A|2|0|0|0|0|DAC|0|1|0|100|XEU|10598|12152|lyfalmen|V0915|6870|00|100|0|100,0000|D.A.C. ehf|D.A.C. ehf|Flúoxetín||8242||8242|12152| 098582|S01ED0201|Betoptic|augndr|5|mg/ml|5|ml|1|glas||S01ED02|01.04.2006||R|A|3|0|0|*|0|PCO|0|0|0|100|IKR|1186|2500|lyfalmen|||06|5|1|25,0000|Distica|Distica - óskráð lyf|||1186||1186|2500| 098722|J07BM0101|Gardasil|stl|0| |0,5|ml|1|áf.spr|dreifa|J07BM01|01.08.2008||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|20324|27786|lyfalmen|||02|0|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Papillomavírus (manna gerð 6, 11, 16, 18)||20324||20324|27786| 099204|L02BA0301|Faslodex|stl|250|mg/spr|5|ml|2|spr||L02BA03|01.12.2010||R|K|3|0|1|0|1|ASZ|0|0|0|100|SEK|100901|128513|lyfsjukr|||00|10|0||Vistor hf|AstraZeneca UK Ltd|Fulvestrant||100901||100901|128513| 099242|S01AA1301|Fucithalmic|augndr|10|mg/g|5|g|1|túpa||S01AA13|01.04.1988|31.01.2011|R|A|3|0|0|E|0|LEP|0|0|1|100|DKK|692|1824|lyfalmen|||07|5|0|0,0000|Vistor hf|LEO Pharma A/S|Fúsidínsýra||692||692|1824| 099476|N05AH0406|Quetiapin Mylan|filmhtfl|25|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|A|2|0|0|*|0|MYL|0|1|0|100|SEK|6236|9408|lyfalmen|V0725|9408|00|100|0|6,2500|Actavis Group PTC ehf|Mylan AB|Quetíapín||6236||6236|9408| 099485|N05AH0406|Quetiapin Mylan|filmhtfl|100|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|A|2|0|0|*|0|MYL|0|1|0|100|SEK|14240|20150|lyfalmen|V0726|20150|00|100|0|25,0000|Actavis Group PTC ehf|Mylan AB|Quetíapín||14240||14240|20150| 099494|N05AH0406|Quetiapin Mylan|filmhtfl|200|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|A|2|0|0|*|0|MYL|0|1|0|100|SEK|23044|31199|lyfalmen|V0727|31199|00|100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Quetíapín||23044||23044|31199| 099620|N02AX0210|Nobligan (D.A.C.)|hylki|50|mg|20|stk|1|pakki||N02AX02|01.09.2007||R|A|5|0|0|E|0|DAC|0|0|1|100|DKK|577|1439|lyfalmen|V0730|1278|10|20|0|3,3333|D.A.C. ehf|D.A.C. ehf|Tramadól||411||411|1439| 099705|D08AG0201|Betadine|áburður|100|mg/ml|500|ml|1|brusar|vatnsl|D08AG02|01.04.1985||L|A|3|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||00|500|0|500,0000|Icepharma hf|Norpharma a/s|Joð/pólývídón|||||| 099721|D08AG0201|Betadine|lyf.sápa|75|mg/ml|500|ml|1|brusar||D08AG02|01.04.1985||L|A|3|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||00|500|0|500,0000|Icepharma hf|Norpharma a/s|Joð/pólývídón|||||| 099835|N03AX1107|Topiramat Actavis|filmhtfl|25|mg|60|stk|1|plglas||N03AX11|01.08.2010||R|A||0|0|E|0|AGP|0|0|0|100|XEU|3121|4294|lyfalmen|V0709|4294|00|60|0|5,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||2498||2498|4294| 099847|N03AX1107|Topiramat Actavis|filmhtfl|50|mg|60|stk|1|plglas||N03AX11|01.09.2010||R|A||0|0|E|0|AGP|0|0|0|100|XEU|4072|6167|lyfalmen|V0710|6167|00|60|0|10,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||3867||3867|6167| 099858|N03AX1107|Topiramat Actavis|filmhtfl|100|mg|60|stk|1|plglas||N03AX11|01.08.2010||R|A||0|0|E|0|AGP|0|0|0|100|XEU|9139|12129|lyfalmen|V0711|12129|00|60|0|20,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||8225||8225|12129| 099902|H02AB0605|Prednisolone Actavis|töflur|5|mg|98|stk|1|þpakki||H02AB06|01.01.2011||R|A||0|0|B|0|AUK|0|0|1|100|GBP|693|1825|lyfalmen|V2400|1825|00|98|0|49,0000|Actavis Group hf|Actavis UK Ltd.|Prednisólón||693||693|1825| 100008|V08AB0501|Ultravist|stl/irl|300|mg J/ml|50|ml|10|hgl||V08AB05|01.04.1987||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|52232|67434|lyfsjukr|||02|500|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Jóprómíð||52232||52232|67434| 100016|V08AB0501|Ultravist|stl/irl|300|mg J/ml|100|ml|10|hgl||V08AB05|01.04.1987||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|77318|98917|lyfsjukr|||02|1000|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Jóprómíð||77318||77318|98917| 100024|V08AB0501|Ultravist|stl/irl|370|mg J/ml|50|ml|10|hgl||V08AB05|01.04.1987||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|56556|72860|lyfsjukr|||02|500|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Jóprómíð||56556||56556|72860| 100032|V08AB0501|Ultravist|stl/irl|370|mg J/ml|100|ml|10|hgl||V08AB05|01.04.1987||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|125575|159479|lyfsjukr|||02|1000|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Jóprómíð||125575||125575|159479| 100291|G04BE0801|Cialis|filmhtfl|2,5|mg|28|stk|1|þpakki||G04BE08|01.11.2008||R|A|2|0|0|0|0|LIL|0|0|0|100|XEU|13181|18821|lyfalmen|||00|28|0|7,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||13181|18821| 100300|G04BE0801|Cialis|filmhtfl|5|mg|28|stk|1|þpakki||G04BE08|01.11.2008||R|A|2|0|0|0|0|LIL|0|0|0|100|XEU|13181|18821|lyfalmen|||00|28|0|14,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||13181|18821| 101106|N03AX1201|Neurontin|filmhtfl|600|mg|100|stk|1|þpakki||N03AX12|01.03.2009||R|A|2|0|0|E|0|PER|0|0|0|100|DKK|17211|13219|lyfalmen|V2160|12806|0|100|0|33,3300|Icepharma hf|Pfizer ApS|Gabapentín||9022||9022|13219| 101115|N03AX1201|Neurontin|filmhtfl|800|mg|100|stk|1|þpakki||N03AX12|01.03.2009||R|A|2|0|0|E|0|PER|0|0|0|100|DKK|29012|38689|lyfalmen|||0|100|0|44,4400|Icepharma hf|Pfizer ApS|Gabapentín||29012||29012|38689| 101691|C08CA0502|Adalat Oros|forðatfl|20|mg|28|stk|1|þpakki||C08CA05|01.10.1999||R|A|4|0|0|B|0|BAP|0|0|0|100|SEK|2255|3962|lyfalmen|||00|28|0|18,6667|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||2255||2255|3962| 101709|C08CA0502|Adalat Oros|forðatfl|20|mg|98|stk|1|þpakki||C08CA05|01.10.1999||R|A|4|0|0|B|0|BAP|0|0|0|100|SEK|7074|10554|lyfalmen|||00|98|0|65,3333|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||7074||7074|10554| 101742|N06AX1104|Miron Smelt|munndr.t|30|mg|30|stk|1|þpakki||N06AX11|01.11.2007||R|A|2|0|0|0|0|AGP|0|1|0|100|XEU|2420|4188|lyfalmen|V1152|4188|00|30|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||2420||2420|4188| 101751|N06AX1104|Miron Smelt|munndr.t|30|mg|96|stk|1|þpakki||N06AX11|01.11.2007||R|A|2|0|0|B|0|AGP|0|1|0|100|XEU|4241|6598|lyfalmen|V1153|6598|00|96|0|96,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||4182||4182|6598| 101756|C09DA0106|Lopress Comp|filmhtfl|62,5|mg|100|stk|1|glas|50+12,5 mg|C09DA01|01.11.2010||R|A||0|0|B|0|APC|0|0|0|100|XEU|3877|4821|lyfalmen|V2219|4810|00|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Lósartan og þvagræsilyf||2883||2883|4821| 101767|C09DA0106|Lopress Comp|filmhtfl|125|mg|100|stk|1|glas|100+25 mg|C09DA01|01.11.2010||R|A||0|0|B|0|APC|0|0|0|100|XEU|6524|4911|lyfalmen|V2220|4900|00|100|0|200,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Lósartan og þvagræsilyf||2949||2949|4911| 101769|N02AX0211|Nobligan Retard (D.A.C.)|forðatfl|150|mg|100|stk|1|þpakki||N02AX02|01.09.2007||R|A|5|0|0|E|0|DAC|0|0|1|100|DKK|8829|8542|lyfalmen|V0736|8542|00|100|0|50,0000|D.A.C. ehf|D.A.C. ehf|Tramadól||5603||5603|8542| 101823|QM01AC0602|Metacam fyrir hesta|mixtúra|15|mg/ml|250|ml|1|fl||QM01AC06|01.02.2009||R|A|2|0|0|0|0|BOI|0|0|0|100|SEK|17425|33631|vetalmen|||0|250|0|0,0000|Vistor hf|Boehringer Ingelheim|||||17425|33631| 102871|C01DA1401|Imdur|forðatfl|60|mg|98|stk|1|þpakki||C01DA14|01.07.1989||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|3760|6021|lyfalmen|V0139|3654|43|98|0|147,0000|Vistor hf|AstraZeneca A/S DK|Ísósorbíð mónónítrat||3760||3760|6021| 102905|N01AX1001|Diprivan|stl|10|mg/ml|50|ml|1|dæla|einnota dæla|N01AX10|01.01.1994||R|A|2|0|0|0|1|AZA|0|0|0|100|SEK|2623|3786|lyfsjukr|||02|50|0|0,0000|Vistor hf|AstraZeneca AB|Própófól||2623||2623|3786| 102939|N01AX1001|Diprivan|stl|20|mg/ml|50|ml|1|dæla|einnota dæla|N01AX10|01.01.1988||R|A|2|0|0|0|1|AZA|0|0|0|100|SEK|5443|7856|lyfsjukr|||00|50|0|0,0000|Vistor hf|AstraZeneca AB|Própófól||5443||5443|7856| 103033|N03AX1207|Gabapentin Ranbaxy|filmhtfl|600|mg|100|stk|1|þpakki||N03AX12|01.08.2010||R|A||0|0|E|0|RAN|0|0|0|100|XEU|11932|12806|lyfalmen|V2160|12806|00|100|0|33,3300|Gróco ehf.|Ranbaxy (UK) Ltd|Gabapentín||8720||8720|12806| 103633|C09DA0105|Presmin Combo|filmhtfl|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.02.2008||R|A|2,25|0|0|B|0|POF|0|0|0|100|XEU|8350|4714|lyfalmen|V2219|4714|00|98|0|98,0000|Portfarma ehf|Portfarma|Lósartan og þvagræsilyf||2805||2805|4714| 103642|C09DA0105|Presmin Combo|filmhtfl|125|mg|98|stk|1|þpakki|100+25 mg|C09DA01|01.02.2008||R|A|2,25|0|0|B|0|POF|0|0|0|100|XEU|13824|4802|lyfalmen|V2220|4802|00|98|0|196,0000|Portfarma ehf|Portfarma|Lósartan og þvagræsilyf||2869||2869|4802| 103651|C09CA0104|Presmin|filmhtfl|50|mg|98|stk|1|þpakki||C09CA01|01.02.2008||R|A|3|0|0|B|0|POF|0|0|0|100|IKR|4295|3872|lyfalmen|V0197|3872|00|98|0|98,0000|Portfarma ehf|Portfarma|Lósartan||2189||2189|3872| 103660|J05AB1103|Valaciklovir Portfarma|töflur|500|mg|10|stk|1|þpakki||J05AB11|01.02.2008||R|A|3|0|0|E|0|POF|0|0|1|100|GBP|2502|2557|lyfalmen|V0507|2535|00|10|0|1,6667|Portfarma ehf|Portfarma|Valacíklóvír||1228||1228|2557| 103669|J05AB1103|Valaciklovir Portfarma|töflur|500|mg|40|stk|1|þpakki||J05AB11|01.02.2008||R|A|3|0|0|E|0|POF|0|0|1|100|GBP|10402|10053|lyfalmen|V0508|9512|00|40|0|6,6700|Portfarma ehf|Portfarma|Valacíklóvír||6708||6708|10053| 103678|N06AX1604|Venlafaxin Portfarma|forðahlk|75|mg|100|stk|1|þpakki||N06AX16|01.12.2007||R|A|3|0|0|B|0|POF|0|1|0|100|XEU|14798|6073|lyfalmen|V0955|6073|00|100|0|75,0000|Portfarma ehf|Portfarma|Venlafaxín||3798||3798|6073| 103687|N06AX1604|Venlafaxin Portfarma|forðahlk|150|mg|100|stk|1|þpakki||N06AX16|01.12.2007||R|A|3|0|0|B|0|POF|0|1|0|100|XEU|28163|6073|lyfalmen|V0956|6073|00|100|0|150,0000|Portfarma ehf|Portfarma|Venlafaxín||3798||3798|6073| 103937|A06AG0201|Toilax|innhl|2|mg/ml|5|ml|5|túpa||A06AG02|01.12.1975||L|A|2|0|0|0|0|ERC|0|0|0|100|DKK|||lyfalmen|||56|25|0|5,0000|Vistor hf|Orion Pharma|Bisakódýl|||||1809| 103952|A06AG0201|Toilax|innhl/tf|0| |1|stk|1|pakki|túpa+4 tfl|A06AG02|01.12.1972||L|A|2|0|0|0|0|ERC|0|0|0|100|IKR|||lyflausa|||00|1|0|1,0000|Vistor hf|Orion Pharma|Bisakódýl|||||| 104026|V08AB0901|Visipaque|stl|270|mg J/ml|20|ml|10|glhgl||V08AB09|01.12.2009||R|A||0|0|0|1|GEH|0|0|0|100|NOK|20227|27267|lyfsjukr|||02|200|0||Icepharma hf|GE Healthcare AS|Jódixanól||||20227|27267| 104471|H01BA0201|Minirin|nefdr|0,1|mg/ml|2,5|ml|1|glas|+2 slöngur|H01BA02|01.01.1988||R|K|3|0|0|E|0|FEL|0|0|0|100|DKK|3724|5971|lyfalmen|||23|2|0|10,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||3724||3724|5971| 104498|N05CH0101|Circadin|forðatfl|2|mg|21|stk|1|þpakki||N05CH01|01.11.2007||R|A|5|0|0|0|0|NEU|0|0|1|100|DKK|2166|3840|lyfalmen|||00|21|0|21,0000|Gróco ehf|Neurim Pharmaceuticals EEC Ltd|Melatonin||2166||2166|3840| 104760|A07EC0202|Pentasa|eþ-stíll|1|g|28|stk|1|pakki||A07EC02|01.07.1991||R|A|3|0|0|B|0|FER|0|0|0|100|DKK|8302|12234|lyfalmen|||04|28|0|18,6667|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||8302||8302|12234| 104836|A07EC0202|Pentasa|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.01.1990||R|A|2|0|0|B|0|FER|0|0|0|100|DKK|5452|8335|lyfalmen|V0300|7876|56|700|0|4,6667|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||5452||5452|8335| 104851|A07EC0202|Pentasa|forðatfl|500|mg|100|stk|1|þpakki||A07EC02|01.04.1992||R|A|3|0|0|B|0|FER|0|0|0|100|DKK|5276|8095|lyfalmen|||10|100|0|33,3333|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||5276||5276|8095| 104959|B03XA0201|Aranesp|stl|100|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|128930|163690|lyfsjukr|||00|2|0|88,8900|Vistor hf|Amgen|Darbepóetín alfa||||128930|163690| 105278|A02BC0505|Nexium (D.A.C.)|sh-tfl|20|mg|28|stk|1|veski||A02BC05|01.09.2007||R|A|3|0|0|0|0|DAC|0|0|0|100|SEK|4431|6939|lyfalmen|V0084|6939|00|28|0|18,6700|D.A.C. ehf|D.A.C. ehf|Esómeprazól||4431||4431|6939| 105297|A02BC0505|Nexium (D.A.C.)|sh-tfl|20|mg|100|stk|1|glas||A02BC05|01.09.2007||R|A|3|0|0|0|0|DAC|0|0|0|100|SEK|15247|21414|lyfalmen|V0087|21414|00|100|0|66,6700|D.A.C. ehf|D.A.C. ehf|Esómeprazól||15247||15247|21414| 105306|A02BC0505|Nexium (D.A.C.)|sh-tfl|40|mg|100|stk|1|glas||A02BC05|01.09.2007||R|A||0|0|0|0|DAC|0|0|0|100|SEK|20385|27862|lyfalmen|||00|100|0|133,3300|D.A.C. ehf|D.A.C. ehf|Esómeprazól||20385||20385|27862|28.02.2011 105315|G03AA0705|Microgynon (D.A.C.)|töflur|||63|stk|1|þpakki||G03AA07|01.05.2009||R|A|5|0|0|0|0|DAC|0|0|0|100|SEK|1210|2532|lyfalmen|V2200|2532|23|63|0|84,0000|D.A.C. ehf|D.A.C. ehf|Levónorgestrel og östrógen||1210||1210|2532| 105586|C09XA0201|Rasilez|filmhtfl|150|mg|28|stk|1|þpakki||C09XA02|01.01.2008||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|3959|6293|lyfalmen|||00|28|0|0,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||3959||3959|6293| 105597|C09XA0201|Rasilez|filmhtfl|150|mg|98|stk|1|þpakki|2 x 49 töflur|C09XA02|01.01.2008||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|13764|19553|lyfalmen|||00|98|0|98,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||13764||13764|19553| 105608|C09XA0201|Rasilez|filmhtfl|300|mg|28|stk|1|þpakki||C09XA02|01.01.2008||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|4564|7121|lyfalmen|||00|28|0|56,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||4564||4564|7121| 105620|C09XA0201|Rasilez|filmhtfl|300|mg|98|stk|1|þpakki|2 x 49 töflur|C09XA02|01.01.2008||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|15875|22202|lyfalmen|||00|98|0|196,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||15875||15875|22202| 105785|N01BB0301|Carbocain|stl|10|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|2653|4506|lyfalmen|||02|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|Mepívakaín||2653||2653|4506| 105796|N01BB0301|Carbocain|stl|20|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|2890|4831|lyfalmen|||02|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|Mepívakaín||2890||2890|4831| 106021|J01FA0901|Klacid|töflur|250|mg|14|stk|1|þpakki||J01FA09|01.04.1992||R|A|5|0|0|0|0|ABS|0|0|1|100|DKK|3344|5452|lyfalmen|||63|14|0|7,0000|Vistor hf|Abbott Scandinavia AB|Klaritrómýcín||3344||3344|5452| 106486|C09AA0207|Enalapril Portfarma|töflur|5|mg|100|stk|1|þpakki||C09AA02|01.01.2009||R|A|2|0|0|B|0|POF|0|0|0|100|IKR|802|1598|lyfalmen|||0|100|0|50,0000|Portfarma ehf|Portfarma|Enalapríl||527||527|1598|31.12.2010 106497|C09AA0207|Enalapril Portfarma|töflur|10|mg|100|stk|1|þpakki||C09AA02|01.01.2009||R|A|2|0|0|B|0|POF|0|0|0|100|IKR|1153|2078|lyfalmen|V0168|2078|0|100|0|100,0000|Portfarma ehf|Portfarma|Enalapríl||878||878|2078| 106508|C09AA0207|Enalapril Portfarma|töflur|20|mg|100|stk|1|þpakki||C09AA02|01.01.2009||R|A|2|0|0|B|0|POF|0|0|0|100|IKR|2725|2374|lyfalmen|||0|100|0|200,0000|Portfarma ehf|Portfarma|Enalapríl||1094||1094|2374|31.12.2010 106567|J05AB0102|Zovir|irs|500|mg/hgl|5|hgl|1|pakki||J05AB01|01.01.1995||R|A|5|0|0|0|1|GSK|0|0|0|100|GBP|18391|24963|lyfsjukr|||00|5|0|0,6250|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||18391||18391|24963| 106898|J05AB0102|Zovir|irs|250|mg/hgl|5|hgl|1|pakki||J05AB01|01.07.1989||R|A|5|0|0|0|1|GSK|0|0|0|100|GBP|10170|14646|lyfsjukr|||00|5|0|0,3125|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||10170||10170|14646| 107219|A07EC0102|Salazopyrin EN|sh-tfl|500|mg|100|stk|1|glas||A07EC01|01.04.1987||R|A|5|0|0|B|0|PER|0|0|0|100|DKK|1794|3331|lyfalmen|||10|100|0|25,0000|Icepharma hf|Pfizer ApS|Súlfasalazín||1794||1794|3331| 107532|N02BE0106|Parasupp|eþ-stíll|60|mg|10|stk|1|pakki||N02BE01|01.06.1984||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||04|10|0|0,2000|Actavis Group hf|Actavis hf|Paracetamól|||||| 107583|N03AF0202|Trileptal (D.A.C.)|filmhtfl|300|mg|100|stk|1|þpakki||N03AF02|01.05.2009||R|A|3|0|0|E|0|DAC|0|0|0|100|DKK|4708|7318|lyfalmen|||00|100|0|30,0000|D.A.C. ehf|D.A.C. ehf|Oxkarbazepín||4708||4708|7318|31.01.2011 107594|QP54AA0104|Bimectin Horse Oral Paste|pasta|18,7|mg/g|6,42|g|1|áf.spr||QP54AA01|01.04.2008||L|A|2|0|0|0|0|ICV|0|0|0|100|XEU|1547|2699|vetorma|||16|6|0|0,0000|Dýraheilsa/Icevet ehf|Icevet ehf|||||1547|2699| 107607|A02BA0201|Asyran|töflur|150|mg|60|stk|1|þpakki||A02BA02|01.07.1986||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|982|2221|lyfalmen|||00|60|0|30,0000|Actavis Group hf|Actavis hf|Ranitidín||982||982|2221| 108308|C08CA0501|Adalat|töflur|10|mg|100|stk|1|þpakki||C08CA05|01.01.1991||R|A|4|0|0|B|0|BAP|0|0|0|100|SEK|3462|5613|lyfalmen|||63|100|0|33,3333|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||3462||3462|5613| 108540|A10BH0201|Galvus|töflur|50|mg|30|stk|1|þpakki||A10BH02|01.09.2008||R|A|2|0|0|*|0|NOE|0|0|0|100|DKK|3306|5400|lyfalmen|||00|30|0|15,0000|Vistor hf|Novartis Europharm Ltd|Vildagliptín||3306||3306|5400| 108562|A10BH0201|Galvus|töflur|50|mg|90|stk|1|þpakki||A10BH02|01.09.2008||R|A|2|0|0|*|0|NOE|0|0|0|100|DKK|9812|14300|lyfalmen|||00|90|0|45,0000|Vistor hf|Novartis Europharm Ltd|Vildagliptín||9812||9812|14300| 108845|R01AD0501|Rhinocort Aqua|nefúði|32|mcg/sk|120|sk|1|fl||R01AD05|01.10.1988||R|A|2|0|0|E|0|AZD|0|0|1|100|SEK|1182|2494|lyfalmen|||24|120|0|19,2000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||1182||1182|2494| 108852|R01AD0501|Rhinocort Aqua|nefúði|64|mcg/sk|120|sk|1|fl||R01AD05|01.10.1988||R|A|2|0|0|E|0|AZD|0|0|1|100|SEK|1797|3335|lyfalmen|V0965|3244|24|120|0|38,4000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||1797||1797|3335| 108860|N02AX0203|Tramol|hylki|50|mg|20|stk|1|glas||N02AX02|01.03.1998||R|A|5|0|0|E|0|ACA|0|0|1|100|IKR|293|1278|lyfalmen|V0730|1278|00|20|0|3,3333|Actavis Group hf|Actavis hf|Tramadól||293||293|1278| 108878|N02AX0203|Tramol|hylki|50|mg|100|stk|1|glas||N02AX02|01.03.1998||R|A||0|0|E|0|ACA|0|0|1|100|IKR|1087|1877|lyfalmen|V0731|1877|00|100|0|16,6667|Actavis Group hf|Actavis hf|Tramadól||731||731|1877| 109207|N02AA5901|Panocod|töflur|530|mg|20|stk|1|pakki|þp 30+500 mg|N02AA59|01.01.1992||R|A|5|0|0|0|0|SNO|0|0|1|100|NOK|241|1207|lyfalmen|V0775|1207|00|20|0|6,6667|Vistor hf|Sanofi-aventis Norge AS|Kódein í blöndum nema með geðlyfjum||241||241|1207| 109223|N02AA5901|Panocod|töflur|530|mg|100|stk|1|pakki|þp 30+500 mg|N02AA59|01.01.1992||R|A|5|1|0|0|0|SNO|0|0|1|100|NOK|921|2137|lyfalmen|V0780|2137|00|100|0|33,3333|Vistor hf|Sanofi-aventis Norge AS|Kódein í blöndum nema með geðlyfjum||921||921|2137| 109421|V01AA0303|Alutard SQ, derm.farinae|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|24324|32806|lyfalmen|||02|20|0|0,0000|Vistor hf|ALK-Abello A/S|rykmaurar||24324||24324|32806| 109439|V01AA0303|Alutard SQ, derm.farinae|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|19473|26718|lyfalmen|||02|5|0|0,0000|Vistor hf|ALK-Abello A/S|rykmaurar||19473||19473|26718| 109462|V04CL0020|Soluprick SQ, derm.farinae|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7560|11219|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7560||7560|11219| 109678|N02BE0107|Paratabs|töflur|500|mg|20|stk|1|þpakki||N02BE01|01.12.1983||L|A|5|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|20|0|3,3333|Actavis Group hf|Actavis hf|Paracetamól|||||| 109728|N02BE0107|Paratabs|töflur|500|mg|30|stk|1|þpakki||N02BE01|01.07.1992||L|A|5|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|30|0|5,0000|Actavis Group hf|Actavis hf|Paracetamól|||||| 109751|N02BE0107|Paratabs|töflur|500|mg|100|stk|1|þpakki||N02BE01|01.11.1981||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|429|1464|lyfalmen|V0772|1464|00|100|0|16,6667|Actavis Group hf|Actavis hf|Paracetamól||429||429|1464| 110072|S01ED0105|Optimol|augndr|2,5|mg/ml|5|ml|1|glas||S01ED01|01.01.1987||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|641|1754|lyfalmen|||06|5|0|25,0000|Icepharma hf|Santen Oy|Tímólól||641||641|1754| 110080|S01ED0105|Optimol|augndr|5|mg/ml|5|ml|1|glas||S01ED01|01.01.1987||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|715|1855|lyfalmen|||06|5|0|25,0000|Icepharma hf|Santen Oy|Tímólól||715||715|1855| 110242|V03AN0101|Conoxia|innö.gas|100|%|3|l|1|hylki|MO3LIV|V03AN01|01.04.2008||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|3|0|0,0000|Ísaga ehf|AGA AB|Súrefni|||||| 110395|G03AA0902|Mercilon|töflur|||63|stk|1|þpakki||G03AA09|01.07.1990||R|A|3|0|0|0|0|ORG|0|0|0|100|DKK|1543|2988|lyfalmen|||23|63|0|84,0000|Vistor hf|N.V. Organon|Desógestrel og östrógen||1543||1543|2988| 110635|C08DA0104|Veraloc Retard|forðatfl|200|mg|100|stk|1|glas||C08DA01|01.10.1988||R|A|4|0|0|B|0|ORC|0|0|0|100|DKK|4519|7059|lyfalmen|||10|100|0|83,3333|Vistor hf|Orion Corporation|Verapamíl||4519||4519|7059| 111505|G04BE0802|Cialis (D.A.C.)|filmhtfl|20|mg|8|stk|1|þpakki||G04BE08|01.10.2007||R|A|3|0|0|0|0|DAC|0|0|0|100|NOK|12079|16940|lyfalmen|V1351|16940|00|8|0|16,0000|D.A.C. ehf|D.A.C. ehf|Tadalafíl||11742||11742|16940| 111955|N02BE0101|Panodil|töflur|1|g|100|stk|1|glas||N02BE01|01.05.2003||R|A|5|0|0|0|0|GCH|0|0|1|100|DKK|751|1905|lyfalmen|||00|100|0|33,3300|Icepharma hf|GlaxoSmithKline CH A/S|Paracetamól||751||751|1905| 112022|G03AC0802|Implanon NXT|vefjalyf|68|mg|1|stk|1|pakki||G03AC08|01.02.2011||R|A|5|0|0|0|0|ORG|0|0|0|100|DKK|21794|29631|lyfalmen|||00|1|0|1014,9254|Vistor hf|N.V. Organon|Etónógestrel||21794||21794|29631| 112359|S01AA1101|Garamycin|augndr|3|mg/ml|5|ml|1|glas||S01AA11|01.03.1977|28.02.2011|R|A|4|0|0|E|0|SCP|0|0|1|100|DKK|784|1950|lyfalmen|||06|5|0|0,0000|Vistor hf|Schering-Plough|Gentamícín||784||784|1950| 112615|C01DA0201|Discotrine|forðapl|15|mg/sólh|30|stk|1|þpakki||C01DA02|01.01.1994||R|A|3|0|0|B|0|MEB|0|0|0|100|SEK|4312|6776|lyfalmen|||23|30|0|90,0000|Vistor hf|Meda AB (V)|Glýcerýltrínítrat||4312||4312|6776| 112641|M05BA0407|Alendronat Ranbaxy|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.04.2009||R|A|2|0|0|E|0|RAN|0|0|0|100|XEU|8240|4780|lyfalmen|V0718|4780|00|12|0|84,0000|Gróco ehf|Ranbaxy (UK) Ltd|Alendrónsýra||2853||2853|4780| 113394|A10BD0801|Eucreas|filmhtfl|900|mg|60|stk|1|þpakki|50mg/850mg|A10BD08|01.11.2008||R|A|1,5|0|0|*|0|NOE|0|0|0|100|DKK|9665|14098|lyfalmen|||00|60|0|30,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||||9665|14098| 113403|A10BD0801|Eucreas|filmhtfl|900|mg|180|stk|1|þpakki|50mg/850mg|A10BD08|01.11.2008||R|A|1,5|0|0|*|0|NOE|0|0|0|100|DKK|26605|35668|lyfalmen|||00|180|0|90,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||||26605|35668| 113412|A10BD0801|Eucreas|filmhtfl|1050|mg|60|stk|1|þpakki|50mg/1000mg|A10BD08|01.11.2008||R|A|1,5|0|0|*|0|NOE|0|0|0|100|DKK|9665|14098|lyfalmen|||00|60|0|30,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||||9665|14098| 113415|B01AB0501|Klexane|stl|100|mg/ml|0,2|ml|10|stk|einnota dæla|B01AB05|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|3809|6088|lyfalmen|||00|2|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||3809||3809|6088| 113421|A10BD0801|Eucreas|filmhtfl|1050|mg|180|stk|1|þpakki|50mg/1000mg|A10BD08|01.11.2008||R|A|1,5|0|0|*|0|NOE|0|0|0|100|DKK|26605|35668|lyfalmen|||00|180|0|90,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||||26605|35668| 113704|B01AB0501|Klexane|stl|100|mg/ml|0,4|ml|10|stk|einnota dæla|B01AB05|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|6590|9892|lyfalmen|||00|4|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||6590||6590|9892| 113796|L01XC0602|Erbitux (Lyfjaver)|irl|5|mg/ml|20|ml|1|hgl|lausn|L01XC06|01.04.2008|31.12.2010|R|K|2|0|1|0|1|LVR|0|0|0|100|NOK|37771|49285|lyfsjukr|||00|20|0|0,0000|Lyfjaver ehf|Lyfjaver ehf|Cetúxímab||37771||37771|49285| 113818|L01XE0801|Tasigna|hylki|200|mg|112|stk|1|þpakki||L01XE08|01.06.2008||R|A|3|0|1|0|1|NOE|0|0|0|100|DKK|737779|927795|lyfsjukr|||00|112|0|0,0000|Vistor hf|Novartis Europharm Ltd|Nilotiníb||737779||737779|927795| 113894|J01CE0204|Kaavepenin|töflur|1|g|20|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|723|1866|lyfalmen|||00|20|0|10,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||723||723|1866| 113902|J01CE0204|Kaavepenin|töflur|1|g|30|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|918|2133|lyfalmen|||00|30|0|15,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||918||918|2133| 113910|J01CE0204|Kaavepenin|töflur|1|g|40|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|1401|2794|lyfalmen|||00|40|0|20,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||1401||1401|2794| 114033|R03AC0210|Ventolin Diskus|innúðadu|200|mcg/sk|60|skammtar|1|stk|Diskus tæki|R03AC02|01.03.1999||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|780|1944|lyfalmen|||23|60|0|15,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||780||780|1944| 114440|M01AH0501|Arcoxia|filmhtfl|30|mg|28|stk|1|þpakki||M01AH05|01.01.2010||R|A||0|0|E|0|MSD|0|0|1|100|XEU|4138|6538|lyfalmen|||00|28|0|14,0000|Icepharma hf|M.S.D.|Etoríkoxíb||4138||4138|6538| 114447|S01ED5101|Cosopt|augndr|5|mg/ml|5|ml|1|glas|+ dorzólamíð 20 mg|S01ED51|01.03.1999||R|A|2|0|0|*|0|MSD|0|0|0|100|XEU|2361|4107|lyfalmen|||06|5|0|0,0000|Icepharma hf|M.S.D.|Tímólól í blöndum||2361||2361|4107| 114512|D06BB0401|Condyline|áburður|5|mg/ml|3,5|ml|1|glas|til penslu|D06BB04|01.11.2010||R|A|2|0|0|0|0|GAN|0|0|1|100|XEU|2220|3914|lyfalmen|||23|4|0|3,5000|Icepharma hf|Galderma Nordic AB|Pódófýllótoxín||2220||2220|3914| 115163|B01AE0701|Pradaxa|hylki|75|mg|10|stk|1|þpakki|hart|B01AE07|01.01.2009||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|3535|5713|lyfalmen|||0|750|0|3,4100|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||3535||3535|5713| 115241|V03AB1504|Naloxon B. Braun|stl|0,4|mg/ml|1|ml|10|lykjur||V03AB15|01.09.2010||R|A||0|0|0|1|BRA|0|0|0|100|IKR|11868|16777|lyfsjukr|||00|10|0||Actavis Group hf|Braun|Naloxón||11868||11868|16777| 115285|J01CA0411|Amoxicillin Mylan|töflur|750|mg|20|stk|1|þpakki||J01CA04|01.10.1998||R|A|4|0|0|0|0|MYL|0|0|1|100|SEK|2039|3666|lyfalmen|||00|20|0|15,0000|Actavis Group PTC ehf|Mylan AB|Amoxicillín||2039||2039|3666| 115318|B01AE0701|Pradaxa|hylki|75|mg|30|stk|1|þpakki|hart|B01AE07|01.01.2009||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|10594|15369|lyfalmen|||0|2250|0|10,2300|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||10594||10594|15369| 115330|B01AE0701|Pradaxa|hylki|75|mg|60|stk|1|þpakki|hart|B01AE07|01.01.2009||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|21189|28871|lyfalmen|||0|4500|0|20,4600|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||21189||21189|28871| 115341|B01AE0701|Pradaxa|hylki|110|mg|10|stk|1|þpakki|hart|B01AE07|01.01.2009||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|3535|5713|lyfalmen|||0|1100|0|5,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||3535||3535|5713| 115353|B01AE0701|Pradaxa|hylki|110|mg|30|stk|1|þpakki|hart|B01AE07|01.01.2009||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|10594|15369|lyfalmen|||0|3300|0|15,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||10594||10594|15369| 115364|B01AE0701|Pradaxa|hylki|110|mg|60|stk|1|þpakki|hart|B01AE07|01.01.2009||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|21189|28871|lyfalmen|||0|6600|0|30,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||21189||21189|28871| 115642|S01EC0301|Trusopt|augndr|20|mg/ml|5|ml|1|glas||S01EC03|01.04.1996||R|A|2|0|0|*|0|MSD|0|0|0|100|XEU|1925|3511|lyfalmen|V1090|3509|06|5|0|16,6667|Icepharma hf|M.S.D.|Dorzólamíð||1925||1925|3511| 115931|R03AC1202|Serevent Diskus|innúðadu|50|mcg/sk|60|sk|1|pakki||R03AC12|01.01.1995||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|3599|5800|lyfalmen|||23|60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról||3599||3599|5800| 115980|P03AX0301|Prioderm|húðlausn|5|mg/ml|55|ml|1|glas||P03AX03|01.12.1983||L|A|2|0|0|0|0|NOP|0|0|0|100|IKR|||lyflausa|||23|55|0|0,0000|Icepharma hf|Norpharma |Malatíón|||||| 116004|J01DC0202|Zinacef|sts|1,5|g|5|hgl|1|pakki||J01DC02|01.06.2005||R|A|2|0|0|0|1|GSK|0|0|0|100|GBP|3669|5295|lyfsjukr|||03|5|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||3669||3669|5295| 116046|J01DC0202|Zinacef|sts|750|mg|1|stk|5|hgl||J01DC02|01.09.1983||R|A|2|0|0|0|1|GSK|0|0|0|100|GBP|1918|2768|lyfsjukr|||03|5|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||1918||1918|2768| 116244|D11AF01|Verucid|áburður|||10|ml|1|glas||D11AF|01.11.1981||L|K|2|0|0|0|0|GAN|0|0|0|100|IKR|||lyflausa|||23|10|0|10,0000|Icepharma hf|Galderma Nordic AB|Lyf við vörtum og líkþornum|||||| 116327|D07AC1301|Elocon|krem|0,1|%|100|g|1|túpa||D07AC13|01.04.2009||R|A|2|0|0|B|0|SCP|0|0|1|100|DKK|3001|4982|lyfalmen|||0|100|0|100,0000|Vistor hf|Schering-Plough|Mómetasón||||3001|4982| 116418|D07AC1301|Elocon|smyrsli|0,1|%|100|g|1|túpa||D07AC13|01.04.2009||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|3001|4982|lyfalmen|||0|100|0|100,0000|Vistor hf|Schering-Plough|Mómetasón||||3001|4982| 116551|M01AE0102|Ibufen|töflur|200|mg|20|stk|1|þpakki||M01AE01|01.12.2008||L|A|5|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|20|0|3,3333|Actavis Group hf|Actavis hf|Íbúprófen|||||| 116573|M01AE0102|Ibufen|töflur|400|mg|30|stk|1|þpakki||M01AE01|01.05.2008||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|30|0|10,0000|Actavis Group hf|Actavis hf|Íbúprófen|||||| 116584|M01AE0102|Ibufen|töflur|400|mg|100|stk|1|þpakki||M01AE01|01.08.2008||R|A|5|0|0|E|0|ACA|0|0|1|100|XEU|793|1962|lyfalmen|||00|100|0|33,3333|Actavis Group hf|Actavis hf|Íbúprófen||793||793|1962| 116595|M01AE0102|Ibufen|töflur|600|mg|30|stk|1|þpakki||M01AE01|01.07.2008||R|A|2|0|0|E|0|ACA|0|0|1|100|XEU|444|1485|lyfalmen|||00|30|0|15,0000|Actavis Group hf|Actavis hf|Íbúprófen||444||444|1485| 116606|M01AE0102|Ibufen|töflur|600|mg|100|stk|1|þpakki||M01AE01|01.05.2008||R|A|2|0|0|E|0|ACA|0|0|1|100|XEU|1028|2283|lyfalmen|||00|100|0|50,0000|Actavis Group hf|Actavis hf|Íbúprófen||1028||1028|2283| 116694|G04BD1101|Toviaz|forðatfl|4|mg|84|stk|1|þpakki||G04BD11|01.11.2008||R|A|2|0|0|E|0|IPI|0|0|0|100|DKK|18253|25187|lyfalmen|||00|84|0|84,0000|Icepharma hf|Pfizer Limited|Fesóteródín||||18253|25187| 116705|G04BD1101|Toviaz|forðatfl|4|mg|28|stk|1|þpakki||G04BD11|01.11.2008||R|A|2|0|0|E|0|IPI|0|0|0|100|DKK|6459|9713|lyfalmen|||00|28|0|28,0000|Icepharma hf|Pfizer Limited|Fesóteródín||||6459|9713| 116716|G04BD1101|Toviaz|forðatfl|8|mg|28|stk|1|þpakki||G04BD11|01.11.2008||R|A|2|0|0|E|0|IPI|0|0|0|100|DKK|6861|10263|lyfalmen|||00|28|0|56,0000|Icepharma hf|Pfizer Limited|Fesóteródín||||6861|10263| 116727|G04BD1101|Toviaz|forðatfl|8|mg|84|stk|1|þpakki||G04BD11|01.11.2008||R|A|2|0|0|E|0|IPI|0|0|0|100|DKK|20674|28225|lyfalmen|||00|84|0|168,0000|Icepharma hf|Pfizer Limited|Fesóteródín||||20674|28225| 116928|J07AL0202|Prevenar 13|stl|2,2|mcg|0,5|ml|1|áf.spr||J07AL02|01.04.2010||R|K||0|0|0|0|WLV|0|0|0|100|DKK|8270|12190|lyfalmen|||00|0|0||Icepharma hf|Wyeth Lederle Vaccines SA|Hreinsuð pneumococca poly­sakkaríð mótefnavakar (cojugated)||8270||8270|12190| 116985|N06AX1607|Efexor Depot (D.A.C.)|forðahlk|75|mg|98|stk|1|þpakki||N06AX16|01.05.2009|31.12.2010|R|A|3|0|0|0|0|DAC|0|1|0|100|USD|11550|16677|lyfalmen|||00|98|0|73,5000|D.A.C. ehf|D.A.C. ehf|Venlafaxín||11550||11550|16677| 116997|N05AX1203|Abilify (Lyfjaver)|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.05.2008||R|A||0|0|*|0|LVR|0|1|0|100|DKK|34284|45306|lyfalmen|V1702|45306|00|56|0|37,3330|Lyfjaver ehf|Lyfjaver ehf|Aripiprazól||34284||34284|45306| 117408|QA12AX0001|Calcimag vet. Kela|irl|0| |500|ml|12|plastf||QA12AX00|01.04.2004||R|A|2|0|0|0|0|KEL|1|0|0|100|NOK|10284|19919|vetalmen|||00|6000|0|0,0000|Icepharma hf|Kela Laboratoria NV|||10284||10284|19919| 117515|M01AE0303|Orudis|forðahlk|200|mg|100|stk|1|hylki||M01AE03|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|1|100|NOK|8781|12889|lyfalmen|||10|100|0|133,3333|Vistor hf|Sanofi-aventis Norge AS|Ketóprófen||8781||8781|12889| 117531|N04BA0201|Madopar|hylki|250|mg|100|stk|1|glas|200+50 mg|N04BA02|01.07.1974||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|5848|8877|lyfalmen|||00|100|0|33,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||5848||5848|8877| 117550|N05AH0405|Seroquel Prolong|forðatfl|50|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|14896|20974|lyfalmen|||00|100|0|12,5000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||14896|20974| 117561|N05AH0405|Seroquel Prolong|forðatfl|200|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|26327|35319|lyfalmen|||00|100|0|50,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||26327|35319| 117564|N04BA0201|Madopar|hylki|62,5|mg|100|stk|1|glas|50+12.5 mg|N04BA02|01.06.1981||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|2411|4175|lyfalmen|||10|100|0|8,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2411||2411|4175| 117573|N05AH0405|Seroquel Prolong|forðatfl|300|mg|10|stk|1|þpakki||N05AH04|01.12.2008||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|4552|7104|lyfalmen|||00|10|0|7,5000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||4552|7104| 117584|N05AH0405|Seroquel Prolong|forðatfl|300|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|45523|59410|lyfalmen|||00|100|0|75,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||45523|59410| 117595|N05AH0405|Seroquel Prolong|forðatfl|400|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|52654|68360|lyfalmen|||00|100|0|100,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||52654|68360| 117676|L01DB0103|Caelyx|irþ|2|mg/ml|10|ml|1|hgl||L01DB01|01.01.2011||R|K|1,6|0|1|0|1|JCI|0|0|0|100|SEK|64123|82357|lyfsjukr|||00|10|0||Vistor hf|Janssen-Cilag International N.V.|Doxórúbicín||64123||64123|82357| 117721|D11AF01|Verucid|hlaup|||5|g|1|túpa||D11AF|01.08.1984|31.01.2011|L|K|3|0|0|0|0|GAN|0|0|0|100|IKR|||lyflausa|||23|5|0|5,0000|Icepharma hf|Galderma Nordic AB|Lyf við vörtum og líkþornum|||||| 117770|QP51AJ0101|Baycox Vet.|mixtúra|50|mg/ml|250|ml|1|fl||QP51AJ01|01.12.2005||R|A|5|0|0|0|0|BAN|0|0|0|100|DKK|9740|16991|vetorma|||00|250|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||9740||9740|16991| 117788|C08CA0502|Adalat Oros|forðatfl|30|mg|28|stk|1|þpakki||C08CA05|01.07.1994||R|A|4|0|0|B|0|BAP|0|0|0|100|SEK|3173|5218|lyfalmen|||61|28|0|28,0000|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||3173||3173|5218| 117796|C08CA0502|Adalat Oros|forðatfl|30|mg|98|stk|1|þpakki||C08CA05|01.07.1994||R|A|4|0|0|B|0|BAP|0|0|0|100|SEK|5581|8512|lyfalmen|||61|98|0|98,0000|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||5581||5581|8512| 117820|C08CA0502|Adalat Oros|forðatfl|60|mg|98|stk|1|þpakki||C08CA05|01.07.1994||R|A|4|0|0|B|0|BAP|0|0|0|100|SEK|9073|13289|lyfalmen|||61|98|0|196,0000|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||9073||9073|13289| 117929|QA12AA0001|Calci-kel vet. Kela|irl|20,8|mg/ml|100|ml|12|fl||QA12AA00|01.04.2004||R|A|2|0|0|0|0|KEL|0|0|0|100|NOK|7183|13965|vetalmen|||00|1200|0|0,0000|Icepharma hf|Kela Laboratoria NV|||7183||7183|13965| 117937|QA12AA0001|Calci-kel vet. Kela|irl|20,8|mg/ml|500|ml|12|plastf||QA12AA00|01.04.2004||R|A|2|0|0|0|0|KEL|0|0|0|100|NOK|12599|24365|vetalmen|||00|6000|0|0,0000|Icepharma hf|Kela Laboratoria NV|||12599||12599|24365| 118020|N05AH0306|Olanzapin Actavis|filmhtfl|2,5|mg|28|stk|1|þpakki||N05AH03|01.05.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|4008|4208|lyfalmen|V0809|4208|00|28|0|7,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||2435||2435|4208| 118043|N05AH0306|Olanzapin Actavis|filmhtfl|5|mg|28|stk|1|þpakki||N05AH03|01.04.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|5696|5244|lyfalmen|V0810|5244|00|28|0|14,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||3192||3192|5244| 118076|N05AH0306|Olanzapin Actavis|filmhtfl|10|mg|56|stk|1|þpakki||N05AH03|01.03.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|22091|19527|lyfalmen|V0812|19527|00|56|0|56,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||13743||13743|19527| 118087|N05AH0306|Olanzapin Actavis|filmhtfl|15|mg|28|stk|1|þpakki||N05AH03|01.04.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|16876|15238|lyfalmen|V0815|15238|00|28|0|42,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||10498||10498|15238| 118158|J01DC0203|Zinnat|mixt.kyr|25|mg/ml|100|ml|1|glas||J01DC02|01.10.1990||R|A|2|0|0|0|0|GSK|0|0|1|100|GBP|1738|3255|lyfalmen|||65|100|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||1738||1738|3255| 118231|N01AX1301|Niontix|lyfjagas|100|%|4|l|1|hylki||N01AX13|01.06.2008||R|A|3|0|0|0|1|AGA|0|0|0|100|IKR|9512|13728|lyfsjukr|||00|4|0|0,0000|Ísaga ehf|AGA AB|di-Nitrogen oxíð||9512||9512|13728| 118307|A02BA0201|Asyran|töflur|150|mg|30|stk|1|þpakki||A02BA02|01.04.1994||L|A|3|0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa|||00|30|0|15,0000|Actavis Group hf|Actavis hf|Ranitidín|||||| 118315|M01AB0505|Voltaren|eþ-stíll|100|mg|5|stk|1|pakki||M01AB05|01.01.1986||R|A|3|0|0|E|0|NOH|0|0|1|100|DKK|713|1853|lyfalmen|||04|5|0|5,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||713||713|1853| 118323|M01AB0505|Voltaren|eþ-stíll|100|mg|50|stk|1|pakki||M01AB05|01.01.1986||R|A|3|0|0|E|0|NOH|0|0|1|100|DKK|7145|10651|lyfalmen|||04|50|0|50,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||7145||7145|10651| 118406|A02BA0201|Asyran|töflur|300|mg|30|stk|1|þpakki||A02BA02|01.04.1994||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|1062|2330|lyfalmen|||00|30|0|30,0000|Actavis Group hf|Actavis hf|Ranitidín||1062||1062|2330| 118484|N05AH0306|Olanzapin Actavis|filmhtfl|7,5|mg|56|stk|1|þpakki||N05AH03|01.04.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|17367|15652|lyfalmen|V0811|15652|00|56|0|42,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||10801||10801|15652| 118570|A07EC0203|Pentasa Sachets|forðakyr|1|g|50|stk|1|pakki||A07EC02|01.04.1998||R|A|2|0|0|B|0|FER|0|0|0|100|DKK|9211|13477|lyfalmen|||00|50|0|33,3333|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||9211||9211|13477| 118612|A07EC0203|Pentasa Sachets|forðakyr|1|g|150|stk|1|pakki|3 x 50 stk|A07EC02|01.04.1998||R|A|2|0|0|B|0|FER|0|0|0|100|DKK|27093|36281|lyfalmen|||00|150|0|100,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||27093||27093|36281| 118674|N05AH0204|Leponex (Lyfjaver)|töflur|25|mg|100|stk|1|glas||N05AH02|01.05.2008||R|A|5|0|0|*|0|LVR|0|1|0|100|DKK|2968|4937|lyfalmen|V1401|4937|00|100|0|8,3333|Lyfjaver ehf|Lyfjaver ehf|Klózapín||2968||2968|4937| 118685|N05AH0204|Leponex (Lyfjaver)|töflur|100|mg|100|stk|1|glas||N05AH02|01.05.2008||R|A|5|0|0|*|0|LVR|0|1|0|100|DKK|9306|13607|lyfalmen|V1400|13607|00|100|0|33,3333|Lyfjaver ehf|Lyfjaver ehf|Klózapín||9306||9306|13607| 118793|C01AA0504|Lanoxin mite|töflur|62,5|mcg|120|stk|1|þpakki||C01AA05|01.12.2010||R|A||0|0|B|0|AEG|0|0|0|100|XEU|490|1548|lyfalmen|||00|120|0|30,0000|GlaxoSmithKline ehf|Aspen Europe GmbH|Digoxín||490||490|1548| 119031|L01XC0801|Vectibix|irþ|20|mg/ml|5|ml|1|hgl|lausn|L01XC08|01.06.2008||R|K|3|0|1|0|1|AEU|0|0|0|100|DKK|84209|107565|lyfsjukr|||00|5|0|0,0000|Vistor hf|Amgen Europe B.V.|Panitúmúmab||84209||84209|107565| 119962|M01AE0109|Ibuprofen Portfarma|filmhtfl|400|mg|30|stk|1|þpakki||M01AE01|01.03.2008||L|A|3|0|0|0|0|POF|0|0|1|100|IKR|||lyflausa|||00|30|0|10,0000|Portfarma ehf|Portfarma|Íbúprófen|||||| 119984|C02KX0201|Volibris|filmhtfl|5|mg|30|stk|1|þpakki||C02KX02|01.12.2008||R|A|2|0|1|0|0|GGL|0|0|0|100|GBP|478358|602618|lyfalmen|||00|30|0|20,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Ambrisentanum||||478358|602618| 120007|C02KX0201|Volibris|filmhtfl|10|mg|30|stk|1|þpakki||C02KX02|01.12.2008||R|A|2|0|1|0|0|GGL|0|0|0|100|GBP|478358|602618|lyfalmen|||00|30|0|40,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Ambrisentanum||||478358|602618| 120022|S01FA0401|Cyclogyl 1 %|augndr|10|mg/ml|10|ml|1|glas||S01FA04|01.10.2003||R|A|2|0|0|E|0|SAL|0|0|0|100|USD|937|2159|lyfalmen|||06|10|0|0,0000|Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Cýklópentólat||937||937|2159| 120062|L01BA0401|Alimta|irþ|100|mg/hgl|1|hgl|1|pakki||L01BA04|01.11.2008||R|A|2|0|1|0|1|LIL|0|0|0|100|XEU|47180|61093|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Lilly ICOS Limited|Pemetrexed||||47180|61093| 120341|N06DA0402|Reminyl (Lyfjaver)|forðahlk|8|mg|28|stk|1|þpakki||N06DA04|01.05.2008||R|A|2|0|0|E|0|LVR|0|0|0|100|SEK|13194|18838|lyfalmen|V1370|18838|00|28|0|14,0000|Lyfjaver ehf|Lyfjaver ehf|Galantamín||13194||13194|18838| 120950|N06AB1003|Cipralex (Lyfjaver)|filmhtfl|10|mg|28|stk|1|þpakki||N06AB10|01.05.2008|31.12.2010|R|A|3|0|0|0|0|LVR|0|1|0|100|DKK|3050|5049|lyfalmen|||00|28|0|28,0000|Lyfjaver ehf|Lyfjaver ehf|Escítalópram||3050||3050|5049| 120961|N06AB1003|Cipralex (Lyfjaver)|filmhtfl|10|mg|200|stk|1|plglas||N06AB10|01.05.2008|31.12.2010|R|A|3|0|0|0|0|LVR|0|1|0|100|NOK|22014|29907|lyfalmen|||00|200|0|200,0000|Lyfjaver ehf|Lyfjaver ehf|Escítalópram||22014||22014|29907| 121164|A02BC0501|Nexium|mixt.kyr|10|mg|28|sk-pokar|1|pakki|dreifa|A02BC05|01.04.2009||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|6091|9209|lyfalmen|||00|28|0|9,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||||6091|9209| 121286|M03AC0901|Esmeron|stl|10|mg/ml|5|ml|10|hgl||M03AC09|01.04.2009||R|K|3|0|0|0|1|ORG|0|0|0|100|DKK|8113|11709|lyfsjukr|||00|50|0|0,0000|Vistor hf|N.V. Organon|Rókúrón, brómíð||8113||8113|11709| 121327|R03AC0204|Ventolin|innúðal|0,1|mg/sk|200|sk|1|stauk||R03AC02|01.12.1972||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|354|1361|lyfalmen|||24|200|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||354||354|1361| 121562|B03BB0104|Folic Acid|töflur|5|mg|28|stk|1|þpakki||B03BB01|01.01.2008||R|A|2|0|0|E|0|AUK|0|0|1|100|GBP|401|1426|lyfalmen|V0012|1424|00|28|0|28,0000|Actavis Group hf|Actavis UK Ltd.|Fólínsýra||401||401|1426| 121582|N06AA0401|Anafranil|töflur|25|mg|100|stk|1|þpakki||N06AA04|01.03.1977||R|A|5|0|0|B|0|NOH|0|1|0|100|DKK|2007|3623|lyfalmen|V0908|2192|00|100|0|25,0000|Vistor hf|Novartis Healthcare A/S-|Klómípramín||2007||2007|3623| 121691|H02AB0605|Prednisolone Actavis|töflur|1|mg|28|stk|1|þpakki||H02AB06|01.01.2011||R|A||0|0|B|0|AUK|0|0|1|100|GBP|268|1244|lyfalmen|||00|28|0|2,8000|Actavis Group hf|Actavis UK Ltd.|Prednisólón||268||268|1244| 121863|A07EC0204|Asacol|eþ-stíll|500|mg|30|stk|1|pakki||A07EC02|01.01.2000||R|A|3|0|0|B|0|TIL|0|0|0|100|SEK|3765|6028|lyfalmen|||98|30|0|10,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||3765||3765|6028| 122411|QI09AA0701|Ingelvac CircoFLEX|stl|||50|ml|1|hgl|dreifa|QI09AA07|01.12.2010||R|K||0|0|0|0|BIV|0|0|0|100|DKK|10842|18913|vetorma|||00|50|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Porcine circovirus Type ORF-2 protein||10842||10842|18913| 123216|N05BA0105|Stesolid|eþ-stíll|5|mg|10|stk|1|pakki||N05BA01|01.07.2005||R|A|3|0|0|0|0|AGT|0|0|1|100|DKK|552|1632|lyfalmen|||04|10|0|5,0000|Actavis Group hf|Actavis Group hf|Díazepam||552||552|1632| 123224|N05BA0105|Stesolid|eþ-stíll|10|mg|10|stk|1|pakki||N05BA01|01.07.2005||R|A|3|0|0|0|0|AGT|0|0|1|100|DKK|862|2056|lyfalmen|||04|10|0|10,0000|Actavis Group hf|Actavis Group hf|Díazepam||862||862|2056| 123273|N05BA0603|Temesta|töflur|1|mg|100|stk|1|þpakki||N05BA06|01.11.2005||R|A|3|0|0|0|0|PCO|0|0|1|100|DKK|2132|3794|lyfalmen|||00|100|1|40,0000|Distica|Distica - óskráð lyf|Lórazepam||2132||2132|3794| 123992|N07XX0201|Rilutek|töflur|50|mg|56|stk|1|þpakki||N07XX02|01.05.1998||R|A|3|0|0|E|0|AVS|0|0|0|100|NOK|44591|58241|lyfalmen|||00|56|0|28,0000|Vistor hf|Aventis Pharma SA|Rílúzól||44591||44591|58241| 124020|QM01AC0603|Rheumocam|mixtúra|1,5|mg/ml|42|ml|1|plastf||QM01AC06|01.08.2009||R|A||0|0|0|0|CHP|0|0|0|100|XEU|1827|3634|vetalmen|||00|42|0|0,0000|Icepharma hf|Chanelle Pharmaceuticals|||||1827|3634| 124119|B01AC0401|Plavix|töflur|300|mg|30|stk|1|þpakki||B01AC04|01.09.2009||R|A||0|0|0|0|SBM|0|0|0|100|NOK|37218|48988|lyfalmen|||00|30|0|120,0000|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Klópídógrel||||37218|48988| 124354|G02AB0101|Methergin|töflur|0,125|mg|30|stk|1|þpakki||G02AB01|01.03.1980||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|1002|2248|lyfalmen|||00|30|0|18,7500|Vistor hf|Novartis Healthcare A/S-|Metýlergómetrín||1002||1002|2248| 124727|C09AA0201|Daren|töflur|10|mg|30|stk|1|glas||C09AA02|01.01.1994||R|A|2|0|0|0|0|ACA|0|0|0|100|IKR|612|1714|lyfalmen|||00|30|0|30,0000|Actavis Group hf|Actavis hf|Enalapríl||612||612|1714| 125054|C09AA0201|Daren|töflur|10|mg|100|stk|1|glas||C09AA02|01.01.1994||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|878|2078|lyfalmen|V0168|2078|00|100|0|100,0000|Actavis Group hf|Actavis hf|Enalapríl||878||878|2078| 125163|C01BD0104|Cordarone (Lyfjaver)|töflur|100|mg|30|stk|1|þpakki||C01BD01|01.01.2009||R|A|5|0|0|B|0|LVR|0|0|0|100|NOK|1853|3412|lyfalmen|V0144|3412|0|30|0|15,0000|Lyfjaver ehf|Lyfjaver ehf|Amíódarón||1853||1853|3412| 126163|N05AX1202|Abilify (D.A.C)|töflur|5|mg|28|stk|1|þpakki||N05AX12|01.05.2008||R|A||0|0|*|0|DAC|0|1|0|100|DKK|16845|23420|lyfalmen|||00|28|0|9,3330|D.A.C. ehf|D.A.C. ehf|Aripiprazól||16845||16845|23420|31.01.2011 126231|N04BA0302|Stalevo (Lyfjaver)|filmhtfl|262,5|mg|100|stk|1|glas|50+12,5+200mg|N04BA03|01.05.2008||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|13474|19189|lyfalmen|V1732|19189|00|100|0|11,1100|Lyfjaver ehf|Lyfjaver ehf|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||13474||13474|19189| 126242|N04BA0302|Stalevo (Lyfjaver)|filmhtfl|325|mg|100|stk|1|glas|100+25+200mg|N04BA03|01.05.2008||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|13332|19011|lyfalmen|V1730|19011|00|100|0|22,2200|Lyfjaver ehf|Lyfjaver ehf|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||13332||13332|19011| 126253|N04BA0302|Stalevo (Lyfjaver)|filmhtfl|387,5|mg|100|stk|1|glas|150+37,5+200mg|N04BA03|01.05.2008||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|14566|20559|lyfalmen|V1731|20559|00|100|0|33,3300|Lyfjaver ehf|Lyfjaver ehf|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||14566||14566|20559| 126326|A07DA0301|Imodium|töflur|2|mg|16|stk|1|þpakki||A07DA03|01.10.1991||L|A|5|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||10|16|0|3,2000|Vistor hf|McNeil Sweden AB|Lóperamíð|||||| 126374|L01XX1702|Hycamtin|hylki|1|mg|10|stk|1|þpakki|hart|L01XX17|01.11.2008||R|K|3|0|1|0|1|SKB|0|0|0|100|GBP|111554|141883|lyfsjukr|||00|10|0|0,0000|GlaxoSmithKline ehf|SmithKline Beecham Ltd|Tópótecan||||111554|141883| 126385|L01XX1702|Hycamtin|hylki|0,25|mg|10|stk|1|þpakki|hart|L01XX17|01.11.2008||R|K|3|0|1|0|1|SKB|0|0|0|100|GBP|28629|37812|lyfsjukr|||00|10|0|0,0000|GlaxoSmithKline ehf|SmithKline Beecham Ltd|Tópótecan||||28629|37812| 126540|J01GB0303|Gentacoll|vefjasv|1,3|mg/fercm|1|stk|1|pakki|10X10 cm|J01GB03|01.10.1995||R|A|3|0|0|0|1|INN|0|0|0|100|XEU|25433|33801|lyfsjukr|||00|1|0|0,5417|Innocoll Pharmaceuticals Ltd.|Innocoll Pharmaceuticals Ltd.|Gentamícín||25433||25433|33801| 126649|J01GB0303|Gentacoll|vefjasv|1,3|mg/fercm|1|stk|1|pakki|5X5 cm|J01GB03|01.10.1995||R|A|3|0|0|0|1|INN|0|0|0|100|XEU|8477|12234|lyfsjukr|||00|1|0|0,1354|Innocoll Pharmaceuticals Ltd.|Innocoll Pharmaceuticals Ltd.|Gentamícín||8477||8477|12234| 126684|J06BA0208|Privigen|irl|100|mg/ml|50|ml|1|hgl||J06BA02|01.10.2009||R|A||0|0|0|1|CSB|0|0|0|100|SEK|49549|64066|lyfsjukr|||00|50|0|0,0000|Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||49549||49549|64066| 126695|J06BA0208|Privigen|irl|100|mg/ml|100|ml|1|hgl||J06BA02|01.10.2009||R|A||0|0|0|1|CSB|0|0|0|100|SEK|99098|126250|lyfsjukr|||00|100|0|0,0000|Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||99098||99098|126250| 126707|J06BA0208|Privigen|irl|100|mg/ml|200|ml|1|hgl||J06BA02|01.10.2009||R|A||0|0|0|1|CSB|0|0|0|100|SEK|198197|250620|lyfsjukr|||00|200|0|0,0000|Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||198197||198197|250620| 126953|A07DA0301|Imodium|töflur|2|mg|100|stk|1|þpakki||A07DA03|01.10.1991||R|A|5|0|0|E|0|MCS|0|0|0|100|SEK|1221|2548|lyfalmen|||10|100|0|20,0000|Vistor hf|McNeil Sweden AB|Lóperamíð||1221||1221|2548| 126974|N06AX2104|Cymbalta (D.A.C.)|sh-hylki|30|mg|28|stk|1|þpakki||N06AX21|01.07.2008||R|A||0|0|0|0|DAC|0|1|0|100|XEU|3718|5963|lyfalmen|||00|28|0|14,0000|D.A.C. ehf|D.A.C. ehf|Duloxetín||3718||3718|5963|28.02.2011 127383|R02AA0302|Strepsils med honning og citron|sogtfl|0||36|stk|1|þpakki||R02AA03|01.01.2009||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|36|0|0,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||| 128058|N05AH0301|Zyprexa|húðuðtfl|5|mg|28|stk|1|þpakki||N05AH03|01.03.1998||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|8742|6115|lyfalmen|V0810|5244|00|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||3829||3829|6115| 128131|QG51BE0002|Sulfa-Streptocillin vet.|legstíl|||30|stk|1|þpakki||QG51BE00|01.03.2009||R|A|2|0|0|0|0|BID|1|0|0|100|DKK|6076|11839|vetalmen|||0|30|0|0,0000|Vistor hf|Boehringer Ingelheim Danmark|||||6076|11839| 128173|C08DA0108|Verapamil Mylan|töflur|40|mg|100|stk|1|glas||C08DA01|01.01.1990||R|A|5|0|0|B|0|MYL|0|0|0|100|SEK|885|2088|lyfalmen|||00|100|0|16,6667|Actavis Group PTC ehf|Mylan AB|Verapamíl||885||885|2088| 128348|C03AB0102|Centyl mite med kaliumklorid|töflur|0| |100|stk|1|glas||C03AB01|01.05.1999||R|A|3|0|0|E|0|LEP|0|0|0|100|DKK|1235|2567|lyfalmen|||10|100|0|50,0000|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíð og kalíum||1235||1235|2567| 128777|N02BA5102|Treo|freyðit|0| |60|stk|1|glas||N02BA51|01.07.1988||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||14|60|0|10,0000|Vistor hf|McNeil Denmark ApS|Acetýlsalicýlsýra í blöndum, þó ekki með geðlyfjum (psychole|||||| 128864|N07BA0136|Nicorette Spicemint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.12.2008|31.12.2010|L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 128875|N07BA0136|Nicorette Spicemint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.12.2008|31.12.2010|L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 128886|N07BA0136|Nicorette Spicemint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.12.2008|31.12.2010|L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 128897|N07BA0136|Nicorette Spicemint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.12.2008|31.12.2010|L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 128934|V03AF0101|Uromitexan|stl|100|mg/ml|10|ml|10|lykjur||V03AF01|01.10.1990||R|A|5|0|0|0|1|BAM|0|0|0|100|SEK|4823|6961|lyfsjukr|||02|100|0|0,0000|Icepharma hf|Baxter Medical AB|Mesna||4823||4823|6961| 129098|N05AH0301|Zyprexa|húðuðtfl|7,5|mg|56|stk|1|þpakki||N05AH03|01.03.1998||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|29526|18548|lyfalmen|V0811|15652|00|56|0|42,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||12963||12963|18548| 129106|N05AH0301|Zyprexa|húðuðtfl|10|mg|56|stk|1|þpakki||N05AH03|01.03.1998||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|34256|22974|lyfalmen|V0812|19527|00|56|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||16490||16490|22974| 129158|H02AB0605|Prednisolone Actavis|töflur|5|mg|28|stk|1|þpakki||H02AB06|01.02.2011||R|A||0|0|B|0|AUK|0|0|1|100|GBP|225|1185|lyfalmen|||00|28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Prednisólón||225||225|1185| 129668|A02AH0002|Natriumbikarbonat|töflur|1|g|100|stk|1|glas||A02AH00|01.08.2005||L|A|5|0|0|0|0|REP|0|0|0|100|SEK|||lyfalmen|||00|100|0|0,0000|Vistor hf|Recip AB|Natríumhýdrógenkarbonat|||||3122| 129817|R03BB0101|Atrovent|innúðal|0,25|mg/ml|60|plastl|1|pakki|í vél|R03BB01|01.04.1989||R|A|2|0|0|B|0|BOI|0|0|0|100|DKK|4677|7275|lyfalmen|||00|120|0|100,0000|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíð||4677||4677|7275| 130013|N05AH0401|Seroquel|töflur|100|mg|100|stk|1|þpakki||N05AH04|01.09.1998||R|A|3|0|0|*|0|AZA|0|1|0|100|SEK|18635|22687|lyfalmen|V0726|20150|00|100|0|25,0000|Vistor hf|AstraZeneca AB|Quetíapín||16261||16261|22687| 130021|N05AH0401|Seroquel|töflur|200|mg|100|stk|1|þpakki||N05AH04|01.09.1998||R|A|3|0|0|*|0|AZA|0|1|0|100|SEK|29498|34587|lyfalmen|V0727|31199|00|100|0|50,0000|Vistor hf|AstraZeneca AB|Quetíapín||25743||25743|34587| 130286|C01CA2406|Adrenalin Mylan|stl|1|mg/ml|1|ml|10|gl-lyk||C01CA24|01.06.2009||R|K|3|0|0|0|0|MYL|0|0|1|100|SEK|2346|4086|lyfalmen|||63|10|0|20,0000|Actavis Group PTC ehf|Mylan AB|Adrenalín tartrat||||2346|4086| 130575|C03CA0101|Furix|stl|10|mg/ml|25|ml|5|lykjur||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|4005|6356|lyfalmen|||02|125|0|31,2500|Gróco ehf|Nycomed Danmark A/S|Fúrósemíð||4005||4005|6356| 130591|A03BA0103|Atropin Mylan|stl|0,5|mg/ml|1|ml|10|gl-lyk||A03BA01|01.06.2009||R|A|5|0|0|0|0|MYL|0|0|1|100|SEK|2443|4219|lyfalmen|||63|10|0|3,3400|Actavis Group PTC ehf|Mylan AB|Atrópínsúlfat||||2443|4219| 130596|N07BA0301|Champix|filmhtfl|||53|stk|1|þpakki|0,5 mg og 1 mg|N07BA03|01.02.2009||R|A|2|0|0|0|0|IPI|0|0|1|100|DKK|11396|16466|lyfalmen|||0|53|0|20,6700|Icepharma hf|Pfizer Limited|Vareniclin||||11396|16466| 130772|QI10A0001|Alpha Ject 3000|stl|||500|ml|1|plpoki||QI10A|01.05.2009||R|K|1,25|0|0|0|0|PHA|0|0|0|100|NOK|62954|109820|vetorma|||0|500|0|0,0000|Vistor hf|PHARMAQ AS|||||62954|109820| 131136|C01CA2601|Efedrin Mylan|stl|50|mg/ml|1|ml|10|gl-lyk||C01CA26|01.06.2009||R|A|5|0|0|0|0|MYL|0|0|0|100|SEK|3357|5469|lyfalmen|||00|10|0|10,0000|Actavis Group PTC ehf|Mylan AB|Efedrínhýdróklóríð||||3357|5469| 131334|N03AB0205|Fenantoin Recip|töflur|100|mg|100|stk|1|glas||N03AB02|01.06.2004||R|A|3|0|0|E|0|REP|0|0|0|100|SEK|473|1524|lyfalmen|||00|100|0|33,3333|Vistor hf|Recip AB|Fenýtóín||473||473|1524| 131383|N03AA0204|Fenemal Recip|töflur|15|mg|100|stk|1|glas||N03AA02|01.06.2004||R|A|5|0|0|E|0|REP|0|0|0|100|SEK|908|2119|lyfalmen|||00|100|0|15,0000|Vistor hf|Recip AB|||908||908|2119| 131417|N03AA0204|Fenemal Recip|töflur|50|mg|100|stk|1|glas||N03AA02|01.06.2004||R|A|5|0|0|E|0|REP|0|0|0|100|SEK|994|2237|lyfalmen|||00|100|0|50,0000|Vistor hf|Recip AB|||994||994|2237| 131441|N03AA0204|Fenemal Recip|töflur|100|mg|100|stk|1|glas||N03AA02|01.06.2004||R|A|5|0|0|E|0|REP|0|0|0|100|SEK|1100|2382|lyfalmen|||00|100|0|100,0000|Vistor hf|Recip AB|||1100||1100|2382| 131565|G03CA0306|Evorel|forðapl|100|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|6633|9951|lyfalmen|||23|26|0|182,0000|Vistor hf|Janssen-Cilag AB|Estradíól||6633||6633|9951| 131729|N07BA0132|Nicorette Microtab Lemon|tungur.t|2|mg|20|stk|1|þpakki||N07BA01|01.10.2008||L|A|2,5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|20|0|1,3300|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 131740|N07BA0132|Nicorette Microtab Lemon|tungur.t|2|mg|90|stk|1|þpakki||N07BA01|01.10.2008||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|90|0|6,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 131817|B01AX0601 |Xarelto|filmhtfl|10|mg|10|stk|1|þpakki||B01AX06|01.05.2009||R|A|3|0|0|E|0|BAP|0|0|0|100|SEK|9029|13228|lyfalmen|||0|10|0|10,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||||9029|13228| 131828|B01AX0601 |Xarelto|filmhtfl|10|mg|30|stk|1|þpakki||B01AX06|01.05.2009||R|A|3|0|0|E|0|BAP|0|0|0|100|SEK|27086|36272|lyfalmen|||0|30|0|30,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||||27086|36272| 131840|B01AX0601 |Xarelto|filmhtfl|10|mg|100|stk|1|þpakki||B01AX06|01.05.2009||R|A|3|0|0|E|0|BAP|0|0|0|100|SEK|90285|115587|lyfalmen|||0|100|0|100,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||||90285|115587| 132229|N06AA0905|Amitriptyline|töflur|10|mg|28|stk|1|þpakki||N06AA09|01.04.2008||R|A|3|0|0|B|0|AUK|0|1|0|100|GBP|250|1143|lyfalmen|||00|28|0|3,7300|Actavis Group hf|Actavis UK Ltd.|Amitriptýlín||194||194|1143| 132240|N06AA0905|Amitriptyline|töflur|25|mg|28|stk|1|þpakki||N06AA09|01.04.2008||R|A|3|0|0|B|0|AUK|0|1|0|100|GBP|261|1234|lyfalmen|||00|28|0|9,3300|Actavis Group hf|Actavis UK Ltd.|Amitriptýlín||261||261|1234| 132361|C09DA0309|Valpress Comp|filmhtfl|172,5|mg|98|stk|1|þpakki||C09DA03|01.10.2008||R|A|2,5|0|0|B|0|AGP|0|0|0|100|XEU|14517|5203|lyfalmen|||00|98|0|196,0000|Actavis Group hf|Actavis Group PTC ehf|Valsartan og þvagræsilyf||3162||3162|5203| 132372|C09DA0309|Valpress Comp|filmhtfl|92,5|mg|98|stk|1|þpakki||C09DA03|01.10.2008||R|A|2,5|0|0|B|0|AGP|0|0|0|100|XEU|10047|5162|lyfalmen|V2221|5162|00|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Valsartan og þvagræsilyf||3132||3132|5162| 132662|R05DA0403|Kodein Recip|töflur|25|mg|100|stk|1|glas||R05DA04|01.08.2005||R|A|5|1|0|E|0|REP|0|0|1|100|SEK|1747|3267|lyfalmen|||00|100|0|25,0000|Vistor hf|Recip AB|Kódein||1747||1747|3267| 132663|N06BA0402|Concerta|forðatfl|27|mg|30|stk|1|glas||N06BA04|01.02.2009||R|A|3|1|0|0|0|JAS|0|0|0|100|SEK|8960|13134|lyfalmen|||0|30|0|27,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||||8960|13134| 132761|D08AG0201|Betadine|áburður|100|mg/ml|8|ml|1|glas||D08AG02|01.01.1986||L|A|3|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||23|8|0|8,0000|Icepharma hf|Norpharma a/s|Joð/pólývídón|||||| 132845|S01HA0401|Alcaine|augndr|5|mg/ml|15|ml|1|glas||S01HA04|01.09.2003||R|K|2|0|0|0|0|SAL|0|0|0|100|USD|1069|2340|lyfalmen|||06|15|0|0,0000|Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Proxýmetakaín||1069||1069|2340| 132852|A07BA0104|Kolsuspension|mixtúra|150|mg/ml|100|ml|1|fl|dreifa|A07BA01|01.08.2005||L|A|3|0|0|0|0|ABI|0|0|0|100|IKR|||lyflausa|||00|100|0|3,0000|Vistor hf|Abigo Medical AB|Lyfjakol|||||| 132902|G03AB0402|Trinovum 28|töflur|0| |84|stk|1|þpakki||G03AB04|01.01.1993||R|A|2,5|0|0|0|0|JAS|0|0|0|100|SEK|1386|2773|lyfalmen|||23|84|0|84,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||1386||1386|2773| 133097|M03AX0104|NeuroBloc|stl|5000|ein/ml|0,5|ml|1|hgl||M03AX01|01.02.2009||R|K|0|0|1|0|1|EIS|0|0|0|100|SEK|39658|51653|lyfsjukr|||0|1|0|0,0000|Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||||39658|51653| 133109|M03AX0104|NeuroBloc|stl|5000|ein/ml|1|ml|1|hgl||M03AX01|01.02.2009||R|K|0|0|1|0|1|EIS|0|0|0|100|SEK|44307|57488|lyfsjukr|||0|1|0|0,0000|Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||||44307|57488| 133120|M03AX0104|NeuroBloc|stl|5000|ein/ml|2|ml|1|hgl||M03AX01|01.02.2009||R|K|0|0|1|0|1|EIS|0|0|0|100|SEK|49230|63666|lyfsjukr|||0|1|0|0,0000|Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||||49230|63666| 133736|J04AB0201|Rimactan|hylki|150|mg|100|stk|1|glas||J04AB02|01.04.1993||R|A|4|0|0|E|0|SAD|0|0|0|100|DKK|8985|13168|lyfalmen|||10|100|0|25,0000|Icepharma hf|Sandoz GmbH|Rífampicín||8985||8985|13168| 134274|J02AC0302|Vfend (D.A.C.)|filmhtfl|200|mg|14|stk|1|þpakki||J02AC03|01.05.2008||R|A|3|0|0|0|1|DAC|0|0|0|100|DKK|109795|139653|lyfsjukr|||00|14|0|7,0000|D.A.C. ehf|D.A.C. ehf|Voricónazól||109777||109777|139653| 134338|J01FA0901|Klacid|mixt.kyr|50|mg/ml|50|ml|1|glas|pl.fl. m/sk.sprautu|J01FA09|01.07.1998||R|A|2|0|0|0|0|ABS|0|0|1|100|DKK|2375|4126|lyfalmen|||00|50|0|5,0000|Vistor hf|Abbott Scandinavia AB|Klaritrómýcín||2375||2375|4126| 134352|S01EE0501|Taflotan|augndr|15|mcg/ml|0,3|ml|30|sk-hyl||S01EE05|01.03.2010||R|K||0|0|*|0|SAO|0|0|0|100|XEU|4006|6357|lyfalmen|||00|9|0||Icepharma hf|Santen Oy|Taflúprost||4006||4006|6357| 134374|S01EE0501|Taflotan|augndr|15|mcg/ml|0,3|ml|90|sk-hyl||S01EE05|01.06.2010||R|K||0|0|*|0|SAO|0|0|0|100|XEU|12009|17350|lyfalmen|||00|27|0||Icepharma hf|Santen Oy|Taflúprost||12009||12009|17350| 134498|L01DB0302 |Epirubicin Actavis|stl|2|mg/ml|5|ml|1|hgl||L01DB03|01.04.2009||R|K|3|0|1|0|1|AGT|0|0|0|100|XEU|2553|3685|lyfsjukr|||0|5|0|0,0000|Actavis Group hf|Actavis Group hf|Epírúbicín||||2553|3685| 134509|L01DB0302 |Epirubicin Actavis|stl|2|mg/ml|10|ml|1|hgl||L01DB03|01.04.2009||R|K|3|0|1|0|1|AGT|0|0|0|100|XEU|3815|5506|lyfsjukr|||0|10|0|0,0000|Actavis Group hf|Actavis Group hf|Epírúbicín||||3815|5506| 134520|L01DB0302 |Epirubicin Actavis|stl|2|mg/ml|25|ml|1|hgl||L01DB03|01.04.2009||R|K|3|0|1|0|1|AGT|0|0|0|100|XEU|4732|6829|lyfsjukr|||0|25|0|0,0000|Actavis Group hf|Actavis Group hf|Epírúbicín||4732||4732|6829| 134642|J05AE0801|Reyataz|hylki|300|mg|30|stk|1|plglas||J05AE08|01.01.2010||R|A||0|1|0|1|BRS|0|0|0|100|DKK|87584|111800|lyfsjukr|||43|30|0|30,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||87584||87584|111800| 134862|J05AR0601|Atripla|filmhtfl|0| |30|stk|1|glas|600+200+245 mg|J05AR06|01.07.2008||R|A|2|0|1|0|1|GSI|0|0|0|100|DKK|137583|174549|lyfsjukr|||00|30|0|0,0000|Lyfjaver ehf|Gilead Science International (L)|Emtrícítabín, tenófóvír dísóproxíl og efavírenz||137583||137583|174549| 135111|H01AC0101|Genotropin|sts|12|mg|1|rörlyk|1|pakki|tvíhólfa|H01AC01|01.04.1992||R|K|3|0|1|0|1|PER|0|0|0|100|DKK|52951|68336|lyfsjukr|||00|12|0|17,9910|Icepharma hf|Pfizer ApS|Sómatrópín||52951||52951|68336| 135319|C08DA0108|Verapamil Mylan|töflur|80|mg|100|stk|1|glas||C08DA01|01.01.1990||R|A|5|0|0|B|0|MYL|0|0|0|100|SEK|1104|2387|lyfalmen|||00|100|0|33,3333|Actavis Group PTC ehf|Mylan AB|Verapamíl||1104||1104|2387| 135434|R03BA0502|Flixotide Diskus|innúðadu|100|mcg/sk|60|sk|1|pakki|í diskus-t|R03BA05|01.07.1995||R|A|2|0|0|0|0|GSK|0|0|0|100|GBP|2208|3898|lyfalmen|||23|60|0|10,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2208||2208|3898| 136168|G03AB0401|Trinovum|töflur|0| |63|stk|1|þpakki||G03AB04|01.10.1988||R|A|2,5|0|0|0|0|JAS|0|0|0|100|SEK|1831|3382|lyfalmen|||23|63|0|84,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||1831||1831|3382| 136200|J04AC0102|Tibinide|töflur|300|mg|100|stk|1|glas||J04AC01|01.07.2005||R|A|5|0|0|0|0|REP|0|0|0|100|SEK|7379|10971|lyfalmen|||00|100|0|100,0000|Vistor hf|Recip AB|Ísóníazíð||7379||7379|10971| 136564|V08CA0101|Magnevist|stl|469|mg/ml|15|ml|10|hgl|röntgenskuggaefni|V08CA01|01.01.1993||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|121190|153976|lyfsjukr|||02|150|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||121190||121190|153976| 136572|V08CA0101|Magnevist|stl|469|mg/ml|10|ml|10|hgl|röntgenskuggaefni|V08CA01|01.06.1997||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|89740|114506|lyfsjukr|||02|100|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||89740||89740|114506| 136964|L01CD0103|Paclitaxel Hospira|irþ|6|mg/ml|5|ml|1|hgl||L01CD01|01.10.2005||R|A|2|0|1|0|1|HUK|0|0|0|100|SEK|19484|26335|lyfsjukr|||00|5|0|0,0000|Icepharma hf|Hospira UK Ltd|Paklítaxel||||19484|26335| 136975|L01CD0103|Paclitaxel Hospira|irþ|6|mg/ml|16,7|ml|1|hgl|lausn|L01CD01|01.10.2005||R|A|2|0|1|0|1|HUK|0|0|0|100|SEK|39244|51134|lyfsjukr|||00|17|0|0,0000|Icepharma hf|Hospira UK Ltd|Paklítaxel||||39244|51134| 136987|L01CD0103|Paclitaxel Hospira|irþ|6|mg/ml|25|ml|1|hgl|lausn|L01CD01|01.10.2005||R|A|2|0|1|0|1|HUK|0|0|0|100|SEK|96343|122793|lyfsjukr|||00|25|0|0,0000|Icepharma hf|Hospira UK Ltd|Paklítaxel||||96343|122793| 136998|L01CD0103|Paclitaxel Hospira|irþ|6|mg/ml|50|ml|1|hgl|lausn|L01CD01|01.10.2005||R|A|2|0|1|0|1|HUK|0|0|0|100|SEK|18195|24717|lyfsjukr|||00|50|0|0,0000|Icepharma hf|Hospira UK Ltd|Paklítaxel||18195||18195|24717| 137513|S01XA2011|Oculac|augndr|0| |10|ml|1|glas|með rotvörn|S01XA20|01.10.1999||L|A|2|0|0|E|0|NOH|0|0|0|100|DKK|||lyfalmen|||00|10|0|0,0000|Vistor hf|Novartis Healthcare A/S-|Gervitár og aðrar óvirkar sam­setningar|||||1574| 137521|S01XA2011|Oculac|augndr|0| |0,4|ml|20|sk-hyl|án rotvarnar|S01XA20|01.10.1999||L|A|2|0|0|E|0|NOH|0|0|0|100|DKK|||lyfalmen|||00|8|0|0,0000|Vistor hf|Novartis Healthcare A/S-|Gervitár og aðrar óvirkar sam­setningar|||||1952| 137679|A09AA0205|Creon|sh-hylki|150|mg|100|stk|1|plglas|plastglas|A09AA02|01.04.1990||R|A|2|0|0|E|0|KAC|0|0|0|100|XEU|4364|6847|lyfalmen|V0295|5374|10|100|0|100,0000|Medico ehf|Kali-Chemie|Hvatablöndur (lípasi, próteasi o.s.frv.)||4364||4364|6847| 137809|M05BA0302|Pamidronatdinatrium Hospira|irþ|3|mg/ml|5|ml|5|hgl|lausn|M05BA03|01.05.2005||R|A|3|0|0|0|1|MAY|0|0|0|100|SEK|34128|44713|lyfsjukr|||00|25|0|1,2500|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||34128||34128|44713| 137820|M05BA0302|Pamidronatdinatrium Hospira|irþ|3|mg/ml|10|ml|1|hgl|lausn |M05BA03|01.05.2005||R|A|3|0|0|0|1|MAY|0|0|0|100|SEK|14074|19545|lyfsjukr|||00|10|0|0,5000|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||14074||14074|19545| 137831|M05BA0302|Pamidronatdinatrium Hospira|irþ|6|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.05.2005||R|A|3|0|0|0|1|MAY|0|0|0|100|SEK|18450|25037|lyfsjukr|||00|10|0|1,0000|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||18450||18450|25037| 137842|M05BA0302|Pamidronatdinatrium Hospira|irþ|9|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.05.2005||R|A|3|0|0|0|1|MAY|0|0|0|100|SEK|6303|9097|lyfsjukr|||00|10|0|1,5000|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||6303||6303|9097| 137992|J01XA0106|Vancomycin Hospira|irs|500|mg/hgl|500|mg|1|hgl||J01XA01|01.04.1997||R|A|2|0|0|0|1|HOS|0|0|0|100|DKK|528|762|lyfsjukr|||00|500|0|0,2500|Icepharma hf|Hospira Enterprises B.V. (I)|Vankómýcín||528||528|762| 138073|J01XA0106|Vancomycin Hospira|irs|1|g/hgl|1|g|1|hgl||J01XA01|01.04.1997||R|A|2|0|0|0|1|HOS|0|0|0|100|DKK|1510|2179|lyfsjukr|||00|1|0|0,5000|Icepharma hf|Hospira Enterprises B.V. (I)|Vankómýcín||1510||1510|2179| 138594|S01ED0105|Optimol|augndr|5|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED01|01.01.1995||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|2137|3801|lyfalmen|||00|15|0|60,0000|Icepharma hf|Santen Oy|Tímólól||2137||2137|3801| 139840|R06AA0401|Tavegyl|töflur|1|mg|100|stk|1|þpakki||R06AA04|01.08.1981||R|A|5|0|0|E|0|NHE|0|0|1|100|DKK|2986|4962|lyfalmen|||00|100|0|50,0000|Artasan ehf|Novartis Healthcare A/S-A|Klemastín||2986||2986|4962| 140130|V03AB3501|Bridion|stl|100|mg/ml|2|ml|10|hgl||V03AB35|01.04.2009||R|A|3|0|1|0|1|ORG|0|0|0|100|DKK|170399|179120|lyfsjukr|||00|20|0|0,0000|Vistor hf|N.V. Organon|Sugammadex||141225||141225|179120| 140141|V03AB3501|Bridion|stl|100|mg/ml|5|ml|10|hgl||V03AB35|01.04.2009||R|A|3|0|1|0|1|ORG|0|0|0|100|DKK|425999|444948|lyfsjukr|||00|50|0|0,0000|Vistor hf|N.V. Organon|Sugammadex||353040||353040|444948| 140327|N04BC0502|Sifrol|töflur|0,088|mg|30|stk|1|þpakki||N04BC05|01.05.2005||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|1699|3201|lyfalmen|V2010|1595|00|30|0|1,0600|Vistor hf|Boehringer Ingelheim International |Pramipexól||1699||1699|3201| 140442|N05AF0503|Cisordinol-Acutard|stl|50|mg/ml|1|ml|10|lykjur||N05AF05|01.01.1991||R|A|2|0|0|0|1|LBK|0|1|0|100|DKK|14085|19559|lyfsjukr|||02|10|0|33,3333|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||14085||14085|19559| 140566|H01BB0201|Syntocinon|stl|10|ae/ml|1|ml|5|lykjur||H01BB02|01.12.1972||R|K|5|0|0|0|1|DES|0|0|0|100|DKK|635|916|lyfsjukr|||02|5|0|3,3333|Swedish Orphan A/S|Defiante Farmaceutica S.A.|Oxýtócín||635||635|916| 140954|N07BA0103|Nicorette|nefúði|10|mg/ml|10|ml|1|glas||N07BA01|01.04.1994||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|10|0|3,3300|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 141044|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|spr|einnotaspr|H02AB04|01.04.1994||R|A|5|0|0|B|0|PER|0|0|1|100|DKK|1344|2716|lyfalmen|||03|2|0|4,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||1344||1344|2716| 141164|N01BB2005|Emla (D.A.C.)|krem|5|%|5|g|5|túpa||N01BB20|01.11.2008||R|A||0|0|0|0|DAC|0|0|1|100|SEK|3660|5884|lyfalmen|V2002|5884|00|25|0|5,0000|D.A.C. ehf|D.A.C. ehf|Blöndur||3660||3660|5884| 141175|J01CA0409|Flemoxin (D.A.C.)|mixtúrud|50|mg/ml|100|ml|1|glas||J01CA04|01.10.2008|31.12.2010|R|A|4|0|0|0|0|DAC|0|0|1|100|XEU|1321|2684|lyfalmen|||08|100|0|0,0000|D.A.C. ehf|D.A.C. ehf|Amoxicillín||1321||1321|2684| 141197|N02BE0112|Perfalgan (D.A.C.)|irl|10|mg/ml|100|ml|12|hgl||N02BE01|01.05.2008||R|A|2|0|0|0|1|DAC|0|0|0|100|DKK|8865|12794|lyfsjukr|||00|1200|0|4,0000|D.A.C. ehf|D.A.C. ehf|Paracetamól||8865||8865|12794| 141208|B03AC0204|Venofer (D.A.C.)|stl|20|mg/ml|5|ml|5|lykjur||B03AC02|01.10.2008|28.02.2011|R|A|3|0|0|E|0|DAC|0|0|1|100|CHF|15040|19739|lyfalmen|||00|25|0|5,0000|D.A.C. ehf|D.A.C. ehf|Járnoxíð (sykurflétta)||13912||13912|19739| 141219|J02AC0302|Vfend (D.A.C.)|irs|200|mg|1|hgl|1|pakki||J02AC03|01.05.2008||R|A|3|0|0|0|1|DAC|0|0|0|100|DKK|22126|29651|lyfsjukr|||00|1|0|0,5000|D.A.C. ehf|D.A.C. ehf|Voricónazól||22126||22126|29651| 141432|N04BC0502|Sifrol|töflur|0,18|mg|30|stk|1|þpakki||N04BC05|01.05.2005||R|A||0|0|E|0|BII|0|0|0|100|DKK|3285|5371|lyfalmen|||00|30|0|2,1600|Vistor hf|Boehringer Ingelheim International |Pramipexól||3285||3285|5371| 141684|G03AA1205|Yaz|filmhtfl|0||84|stk|1|þpakki|0,02mg/3mg|G03AA12|01.02.2009||R|A|5|0|0|0|0|BAB|0|0|0|100|SEK|4884|6049|lyfalmen|||0|84|0|0,0000|Icepharma hf|Bayer AB|Dróspírenón og östrógen||3781||3781|6049| 141945|N04BC0502|Sifrol|töflur|0,18|mg|100|stk|1|þpakki||N04BC05|01.05.2005||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|8581|12616|lyfalmen|V2020|5601|00|100|0|7,2000|Vistor hf|Boehringer Ingelheim International|Pramipexól||8581||8581|12616| 142059|C07AA0511|Propranolol Mylan|töflur|10|mg|100|stk|1|glas||C07AA05|01.10.1992||R|A|4|0|0|B|0|MYL|0|0|0|100|SEK|621|1727|lyfalmen|||00|100|0|6,2500|Actavis Group PTC ehf|Mylan AB|Própranólól||621||621|1727| 142190|C07AA0511|Propranolol Mylan|töflur|40|mg|100|stk|1|glas||C07AA05|01.10.1992||R|A|5|0|0|B|0|MYL|0|0|0|100|SEK|715|1855|lyfalmen|||00|100|0|25,0000|Actavis Group PTC ehf|Mylan AB|Própranólól||715||715|1855| 142299|C01BD0101|Cordarone|stl|50|mg/ml|3|ml|10|lykjur||C01BD01|01.04.1987||R|A|2|0|0|0|1|SNO|0|0|0|100|NOK|3195|4611|lyfsjukr|||02|30|0|7,5000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||3195||3195|4611| 142307|C01BD0101|Cordarone|töflur|200|mg|30|stk|1|þpakki||C01BD01|01.04.1987||R|A|5|0|0|B|0|SNO|0|0|0|100|NOK|1090|2368|lyfalmen|||70|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||1090||1090|2368| 142323|J01XX0501|Haiprex|töflur|1|g|100|stk|1|glas||J01XX05|01.10.1995||R|A|5|0|0|0|0|MEB|0|0|1|100|SEK|2885|4824|lyfalmen|||00|100|0|50,0000|Vistor hf|Meda AB (V)|Metenamín||2885||2885|4824| 142596|C07AA0511|Propranolol Mylan|töflur|80|mg|100|stk|1|glas||C07AA05|01.10.1992||R|A|4|0|0|B|0|MYL|0|0|0|100|SEK|1540|2984|lyfalmen|||00|100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Própranólól||1540||1540|2984| 142928|S01EE0102|Xalatan (D.A.C.)|augndr|50|mcg/ml|7,5|ml|1|pakki|3 glös í pakka|S01EE01|01.09.2010||R|K||0|0|*|0|DAC|0|0|0|100|NOK|7192|7694|lyfalmen|V1989|7694|06|8|0|75,0000|D.A.C. ehf|D.A.C. ehf|Latanóprost||4983||4983|7694| 143339|H02AB0403|Solu-Medrol|sts|125|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.07.1974||R|A|5|0|0|B|0|PER|0|0|1|100|DKK|2048|3679|lyfalmen|||03|1|0|6,2500|Icepharma hf|Pfizer ApS|Metýlprednisólón||2048||2048|3679| 143347|H02AB0403|Solu-Medrol|sts|500|mg|1|stk|1|hgl|+ leysir|H02AB04|01.07.1974||R|A|5|0|0|0|1|PER|0|0|0|100|DKK|2261|3263|lyfsjukr|||03|1|0|25,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||2261||2261|3263| 143412|S01BA0401|Ultracortenol|augnsm|5|mg/g|5|g|1|túpa||S01BA04|01.12.1972||R|A|2|0|0|E|0|ANS|0|0|1|100|DKK|728|1873|lyfalmen|||07|5|0|0,0000|Vistor hf|Anstalt zur gewerblichen Produktion|Prednisólón||728||728|1873| 143511|J07BC2002|Twinrix Paediatric|bóluefni|||0,5|ml|1|dæla|einnota dæla|J07BC20|01.01.1999||R|K|3|0|0|0|0|GLB|0|0|0|100|GBP|3409|5541|lyfalmen|||00|0|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Lifrarbólgubóluefni (hepatitis)-Blöndur||3409||3409|5541| 143586|S01FA0601|Mydriacyl 1 %|augndr|10|mg/ml|15|ml|1|glas||S01FA06|01.09.2003||R|A|3|0|0|0|0|SAL|0|0|0|100|USD|883|2085|lyfalmen|||06|15|0|0,0000|Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Trópíkamíð||883||883|2085| 143602|J01FA1001|Zitromax|töflur|500|mg|2|stk|1|þpakki||J01FA10|01.11.1998||R|A|3|0|0|0|0|PER|0|0|1|100|DKK|1737|3253|lyfalmen|||00|2|0|3,3333|Icepharma hf|Pfizer ApS|Azitrómýcín||1737||1737|3253| 143610|N02CX0201|Catapresan|töflur|25|mcg|100|stk|1|þpakki||N02CX02|01.04.1974||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|2223|3918|lyfalmen|||00|100|0|25,0000|Vistor hf|Boehringer Ingelheim|Klónidín||2223||2223|3918| 143631|A10BD0701|Janumet|filmhtfl|1050|mg|56|stk|1|þpakki|50/1000mg|A10BD07|01.03.2009||R|A|2|0|0|*|0|MSD|0|0|0|100|XEU|8660|12724|lyfalmen|||0|56|0|28,0000|Icepharma hf|M.S.D.|Metforminum og sitagliptinum||||8660|12724| 143727|D07AB0201|Locoid|smyrsli|1|mg/g|30|g|1|túpa||D07AB02|01.07.1985||R|A|5|0|0|B|0|ASP|0|0|1|100|XEU|919|2134|lyfalmen|||20|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||919||919|2134| 143800|N05AN0101|Litarex|forðatfl|564|mg|100|stk|1|glas||N05AN01|01.04.1974||R|A|5|0|0|*|0|AGT|0|1|0|100|DKK|1199|2517|lyfalmen|||10|100|0|25,0000|Actavis Group hf|Actavis Group hf|Litíum||1199||1199|2517| 143891|J01FA1001|Zitromax|töflur|500|mg|3|stk|1|þpakki||J01FA10|01.11.1998||R|A|3|0|0|0|0|PER|0|0|1|100|DKK|2521|4326|lyfalmen|V0429|4255|00|3|0|5,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||2521||2521|4326| 143917|L01DB0301|Farmorubicin|stl|2|mg/ml|5|ml|1|hgl|plasthgl|L01DB03|01.09.1998||R|K|3|0|1|0|1|PER|0|0|0|100|DKK|4209|6075|lyfsjukr|||02|5|0|0,0000|Icepharma hf|Pfizer ApS|Epírúbicín||4209||4209|6075| 143933|L01DB0301|Farmorubicin|stl|2|mg/ml|10|ml|1|hgl|plasthgl|L01DB03|01.09.1998||R|K|3|0|1|0|1|PER|0|0|0|100|DKK|8089|11674|lyfsjukr|||02|10|0|0,0000|Icepharma hf|Pfizer ApS|Epírúbicín||8089||8089|11674| 144030|N04BA0207|Sinemet depot mite|forðatfl|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.04.1992||R|A|2|0|0|E|0|MSD|0|0|0|100|XEU|2568|4390|lyfalmen|||10|100|0|16,6667|Icepharma hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||2568||2568|4390| 144089|J07BC0203|Vaqta|bóluefni|50|ein|1|ml|1|spr|áfyllt spr. með nál|J07BC02|01.03.2001||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|4745|7368|lyfalmen|||51|1|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||4745||4745|7368| 144105|L01DB0301|Farmorubicin|stl|2|mg/ml|25|ml|1|hgl|plasthgl|L01DB03|01.09.1998||R|K|3|0|1|0|1|PER|0|0|0|100|DKK|14230|19741|lyfsjukr|||02|25|0|0,0000|Icepharma hf|Pfizer ApS|Epírúbicín||14230||14230|19741| 144139|H01AC0106|Norditropin Simplexx|stl|10|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|K|2|0|1|0|1|NON|0|0|0|100|DKK|80394|102777|lyfsjukr|||AC|2|0|22,4888|Vistor hf|Novo-Nordisk|Sómatrópín||80394||80394|102777| 144436|H01AC0106|Norditropin Simplexx|stl|6,7|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|K|2|0|1|0|1|NON|0|0|0|100|DKK|60087|77292|lyfsjukr|||AC|2|0|15,0675|Vistor hf|Novo-Nordisk|Sómatrópín||60087||60087|77292| 144725|H01AC0106|Norditropin Simplexx|stl|3,3|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|K|2|0|1|0|1|NON|0|0|0|100|DKK|39068|50913|lyfsjukr|||AC|2|0|7,4213|Vistor hf|Novo-Nordisk|Sómatrópín||39068||39068|50913| 144808|D07AB0201|Locoid|lausn|1|mg/ml|30|ml|1|glas||D07AB02|01.10.1986||R|A|2|0|0|B|0|ASP|0|0|1|100|XEU|898|2106|lyfalmen|||20|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||898||898|2106| 144964|N05BA0205|Risolid|filmhtfl|10|mg|24|stk|1|plglas||N05BA02|01.04.2008||R|A|5|0|0|0|0|AGT|0|0|1|100|XEU|417|1448|lyfalmen|||00|24|0|8,0000|Actavis Group hf|Actavis Group hf|Klórdíazepoxíð||417||417|1448| 144980|N05BA0205|Risolid|filmhtfl|25|mg|24|stk|1|plglas||N05BA02|01.04.2008||R|A|5|0|0|0|0|AGT|0|0|1|100|XEU|721|1864|lyfalmen|||00|24|0|20,0000|Actavis Group hf|Actavis Group hf|Klórdíazepoxíð||721||721|1864| 145292|J07BC0203|Vaqta|bóluefni|25|ein|0,5|ml|1|spr|áfyllt spr. með nál|J07BC02|01.03.2001||R|K|2|0|0|0|0|SPM|0|0|0|100|XEU|3176|5222|lyfalmen|||51|0|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||3176||3176|5222| 145508|D07AC0104|Diproderm|krem|0,5|mg/g|100|g|1|túpa||D07AC01|01.03.1977||R|A|5|0|0|B|0|SCP|0|0|1|100|DKK|4922|7610|lyfalmen|||20|100|0|100,0000|Vistor hf|Schering-Plough|Betametasón||4922||4922|7610| 145540|P02CX0101|Vanquin|mixtúra|10|mg/ml|30|ml|1|glas||P02CX01|01.12.1972||L|A|3|0|0|0|0|REP|0|0|0|100|IKR|||lyflausa|||24|30|0|0,0000|Vistor hf|Recip AB|Pýrvín|||||| 145607|P02CX0101|Vanquin|töflur|50|mg|8|stk|1|þpakki||P02CX01|01.12.1972||L|A|3|0|0|0|0|REP|0|0|0|100|IKR|||lyflausa|||23|8|0|0,0000|Vistor hf|Recip AB|Pýrvín|||||| 145631|P02CX0101|Vanquin|töflur|50|mg|32|stk|1|þpakki||P02CX01|01.01.1995||L|A|3|0|0|0|0|REP|0|0|0|100|IKR|||lyflausa|||23|32|0|0,0000|Vistor hf|Recip AB|Pýrvín|||||| 145698|N05AH0301|Zyprexa|húðuðtfl|10|mg|28|stk|1|þpakki||N05AH03|01.03.1998||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|17841|12155|lyfalmen|||00|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||8244||8244|12155| 146207|L01XX1903|Irinotecan Hospira|irþ|20|mg/ml|2|ml|1|hgl|lausn|L01XX19|01.03.2009||R|A|3|0|1|0|1|HUK|0|0|0|100|XEU|10377|14906|lyfsjukr|||0|2|0|0,0000|Icepharma hf|Hospira UK Ltd|Írinótekan||||10377|14906| 146218|L01XX1903|Irinotecan Hospira|irþ|20|mg/ml|5|ml|1|hgl|lausn|L01XX19|01.03.2009||R|A|3|0|1|0|1|HUK|0|0|0|100|XEU|6159|8889|lyfsjukr|||0|5|0|0,0000|Icepharma hf|Hospira UK Ltd|Írinótekan||6159||6159|8889| 146473|N06BA0901|Strattera|hylki|80|mg|28|stk|1|glas|hart|N06BA09|01.01.2010||R|A||0|1|0|0|ELI|0|0|0|100|XEU|18053|24936|lyfalmen|||00|28|0|28,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||18053||18053|24936| 146530|P01AB0102|Flagyl|töflur|400|mg|10|stk|1|þpakki||P01AB01|01.10.1995||R|A|4|0|0|0|0|SNO|0|0|1|100|NOK|852|2043|lyfalmen|||41|10|0|2,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||852||852|2043| 147241|L01BC0102|Arabine|stl/irl|100|mg/ml|1|ml|5|hgl||L01BC01|01.03.2009||R|A|3|0|1|0|1|HOP|0|0|0|100|XEU|4819|6955|lyfsjukr|||0|5|0|0,0000|Icepharma hf|Hospira Nordic AB|Cýtarabín||||4819|6955| 147252|L01BC0102|Arabine|stl/irl|100|mg/ml|10|ml|1|hgl||L01BC01|01.03.2009||R|A|3|0|1|0|1|HOP|0|0|0|100|XEU|4065|5867|lyfsjukr|||0|10|0|0,0000|Icepharma hf|Hospira Nordic AB|Cýtarabín||||4065|5867| 147702|B05AA0501|Macrodex 60 mg/ml med glukos|irl|||500|ml|12|pokar||B05AA05|01.07.1991|28.02.2011|R|A|2|0|0|0|1|MAB|0|0|0|100|SEK|14086|19560|lyfsjukr|||00|6000|0|6,0000|Vistor hf|Meda AB|Dextran||14086||14086|19560| 147728|B05AA0508|Rheomacrodex med glukos|irl|100|mg/ml|500|ml|12|pokar||B05AA05|01.07.1991|28.02.2011|R|A|2|0|0|0|1|MAB|0|0|0|100|SEK|22517|30141|lyfsjukr|||00|6000|0|6,0000|Vistor hf|Meda AB|Dextran||22517||22517|30141| 148213|R05CB1301|Pulmozyme|innúðal|1|mg/ml|2,5|ml|30|lykjur||R05CB13|01.01.1997||R|K|2|0|0|0|0|ROA|0|0|1|100|DKK|112696|143713|lyfalmen|||00|750|0|30,0000|Icepharma hf|Roche A.S.|Dornase alfa||112696||112696|143713| 148452|N04AA0201|Akineton|töflur|2|mg|100|stk|1|þpakki||N04AA02|01.11.2005||R|A|5|0|0|*|0|LFS|0|1|0|100|DKK|1058|2325|lyfalmen|||00|100|0|20,0000|Vistor hf|Laboratorio Farmaceutico (S.I.T.)|Bíperíden||1058||1058|2325| 148741|L01CA0207|Vincristine Hospira|stl|1|mg/ml|1|ml|5|hgl||L01CA02|01.01.1991||R|K|2|0|1|0|1|HOP|0|0|0|100|SEK|8489|12252|lyfsjukr|||02|5|0|0,0000|Icepharma hf|Hospira Nordic AB|Vínkristín||8489||8489|12252| 148752|L01CA0207|Vincristine Hospira|stl|1|mg/ml|2|ml|5|hgl||L01CA02|01.07.2004||R|K|2|0|1|0|1|HOP|0|0|0|100|SEK|13287|18558|lyfsjukr|||02|10|0|0,0000|Icepharma hf|Hospira Nordic AB|Vínkristín||13287||13287|18558| 148917|L01BA0301|Tomudex|irs|2|mg/hgl|1|hgl|1|pakki||L01BA03|01.03.1998||R|A|3|0|1|0|1|HOS|0|0|0|100|SEK|25621|34037|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Hospira Enterprises B.V. (I)|Raltítrexed||25621||25621|34037| 148939|D05AX5202|Daivobet (D.A.C.)|smyrsli|||120|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.11.2008||R|A||0|0|B|0|DAC|0|0|0|100|NOK|12530|17575|lyfalmen|V2001|17575|00|120|0|120,0000|D.A.C. ehf|D.A.C. ehf|Kalcípótríól í blöndum||12188||12188|17575| 148961|N06DA0203|Aricept (D.A.C.)|töflur|10|mg|98|stk|1|þpakki||N06DA02|01.05.2009|31.12.2010|R|A|3|0|0|E|0|DAC|0|0|0|100|DKK|46832|61053|lyfalmen|||00|98|0|130,6700|D.A.C. ehf|D.A.C. ehf|Dónepezíl||46832||46832|61053| 148999|QN05CM9201|Rompun, vet.|stl|20|mg/ml|25|ml|1|hgl||QN05CM92|01.12.1972||R|A|3,25|0|0|0|0|BAN|1|0|0|100|DKK|3629|7141|vetalmen|||27|25|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||3629||3629|7141| 149146|N05AG0201|Orap|töflur|1|mg|75|stk|1|þpakki||N05AG02|01.03.2004||R|A|5|0|0|0|0|PCO|0|1|0|100|SEK|2115|3770|lyfalmen|||00|75|1|18,7500|Distica|Distica - óskráð lyf|Pímózíð||2115||2115|3770| 149375|S01EE0103|Latanoprost Portfarma|augndr|50|mcg/ml|2,5|ml|1|glas||S01EE01|01.03.2010||R|K||0|0|*|0|POF|0|0|0|100|DKK|2043|2812|lyfalmen|V1989|2565|06|2|0|25,0000|Portfarma ehf|Portfarma|Latanóprost||1414||1414|2812| 150243|J04AB0201|Rimactan|hylki|300|mg|100|stk|1|glas||J04AB02|01.04.1993||R|A|4|0|0|E|0|SAD|0|0|0|100|DKK|15751|22047|lyfalmen|||10|100|0|50,0000|Icepharma hf|Sandoz GmbH|Rífampicín||15751||15751|22047| 150521|B03XA0201|Aranesp|stl|40|mcg/spr|0,4|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|52384|67624|lyfsjukr|||00|2|0|35,5600|Vistor hf|Amgen|Darbepóetín alfa||||52384|67624| 150539|C10AD5201|Tredaptive|töflur|1020|mg|28|stk|1|þpakki|1000+20 mg|C10AD52|01.12.2009||R|A||0|0|0|0|MSD|0|0|0|100|XEU|3783|6052|lyfalmen|||00|28|0||Icepharma hf|M.S.D.|Nikótínsýra og afleiður-Nikótínsýra í blöndum||||3783|6052| 150550|C10AD5201|Tredaptive|töflur|1020|mg|56|stk|1|þpakki|1000+20 mg|C10AD52|01.12.2009||R|A||0|0|0|0|MSD|0|0|0|100|XEU|6275|9461|lyfalmen|||00|56|0||Icepharma hf|M.S.D.|Nikótínsýra og afleiður-Nikótínsýra í blöndum||||6275|9461| 150996|J07AH0401|Mencevax ACWY|stl|50|mcg|0,5|ml|1|hgl||J07AH04|01.11.2008||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|3580|5775|lyfalmen|||00|0|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Meningókokka polysakkaríð mótefnavakar||||3580|5775| 151191|N05AF0102|Fluanxol Depot|stl|20|mg/ml|1|ml|10|lykjur||N05AF01|01.03.1977||R|A|4|0|0|*|0|LBK|0|1|0|100|DKK|7164|10677|lyfalmen|||02|10|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||7164||7164|10677| 151217|G01AF0102|Flagyl|sk-stíll|500|mg|10|stk|1|pakki|+ hanskar|G01AF01|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|1149|2449|lyfalmen|||05|10|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||1149||1149|2449| 151518|N06DX0101|Ebixa|filmhtfl|20|mg|28|stk|1|þpakki||N06DX01|01.11.2008||R|A|4|0|0|E|0|LBK|0|0|0|100|DKK|15933|22275|lyfalmen|||00|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||||15933|22275| 151529|N06DX0101|Ebixa|filmhtfl|20|mg|98|stk|1|þpakki||N06DX01|01.11.2008||R|A|4|0|0|E|0|LBK|0|0|0|100|DKK|49195|61075|lyfalmen|||00|28|0|98,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||46849||46849|61075| 151640|G04CA0204|Tamsulogen|hylki|0,4|mg|90|stk|1|þpakki|með br. losunarhraða|G04CA02|01.05.2006||R|A|3|0|0|E|0|MYL|0|0|0|100|SEK|7310|5122|lyfalmen|V0437|4760|00|90|0|90,0000|Actavis Group PTC ehf|Mylan AB|Tamsúlósín||3103||3103|5122| 151928|N06AA1201|Sinquan|hylki|25|mg|100|stk|1|þpakki||N06AA12|01.12.1972||R|A|5|0|0|B|0|PER|0|1|0|100|DKK|1606|3074|lyfalmen|||10|100|0|25,0000|Icepharma hf|Pfizer ApS|Doxepín||1606||1606|3074| 152223|M03BX0103|Lioresal|stl|50|mcg/ml|1|ml|5|lykjur|stl.intrathecal.|M03BX01|01.10.1995||R|A|3|0|0|0|1|NOH|0|0|0|100|DKK|698|1007|lyfsjukr|||02|5|0|0,4500|Vistor hf|Novartis Healthcare A/S-|Baklófen||698||698|1007| 152318|D01BA0204|Terbinafine (D.A.C.)|töflur|250|mg|28|stk|1|þpakki||D01BA02|01.12.2010||R|A||0|0|0|0|DAC|0|0|0|100|IKR|2938|4500|lyfalmen|V0343|4500|00|28|0|28,0000|D.A.C. ehf|D.A.C. ehf|Terbínafín||2648||2648|4500| 152348|M02AA0701|Felden gel|hlaup|5|mg/g|25|g|1|glas||M02AA07|01.04.1996||L|A|3|0|0|0|0|PER|0|0|1|100|IKR|||lyflausa|||23|25|0|0,0000|Icepharma hf|Pfizer ApS|Píroxíkam|||||| 152397|R03BA0202|Pulmicort Turbuhaler|innúðadu|100|mcg/sk|200|sk|1|stauk||R03BA02|01.04.1991||R|A|2|0|0|0|0|AZD|0|0|0|100|SEK|4561|7116|lyfalmen|||23|200|0|25,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||4561||4561|7116| 152413|R03BA0202|Pulmicort Turbuhaler|innúðadu|200|mcg/sk|200|sk|1|stauk||R03BA02|01.10.1989||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|6825|10214|lyfalmen|||23|200|0|50,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||6825||6825|10214| 152421|R03BA0202|Pulmicort Turbuhaler|innúðadu|400|mcg/sk|200|sk|1|stauk||R03BA02|01.10.1989||R|A|2|0|0|B|0|ASZ|0|0|0|100|SEK|11818|17044|lyfalmen|||23|200|0|100,0000|Vistor hf|AstraZeneca UK Ltd|Búdesóníð||11818||11818|17044| 152663|N04BC0504|Oprymea (Lyfis)|töflur|0,7|mg|100|stk|1|þpakki||N04BC05|01.07.2010||R|A||0|0|E|0|LYF|0|0|0|100|XEU|26865|19135|lyfalmen|V2030|19135|00|100|0|28,0000|Lyfis ehf|Lyfis ehf|Pramipexól||13431||13431|19135| 152991|J02AC0201|Sporanox|hylki|100|mg|4|stk|1|þpakki|hart|J02AC02|01.01.1995||R|A|3|0|0|0|0|JAS|0|0|1|100|SEK|1919|3502|lyfalmen|||10|4|0|2,0000|Vistor hf|Janssen-Cilag AB|Ítracónazól||1919||1919|3502| 153080|R06AE0704|Histasin|töflur|10|mg|10|stk|1|þpakki||R06AE07|01.01.1998||L|A|3|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|10|0|10,0000|Actavis Group hf|Actavis hf|Cetirizín|||||| 153122|N01BB5203|Xylocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|(10mg+5míkróg)/ml|N01BB52|01.10.1995||R|S|2|0|0|0|0|AZD|0|0|1|100|SEK|1797|3335|lyfalmen|||17|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|||1797||1797|3335| 153197|R06AE0704|Histasin|töflur|10|mg|30|stk|1|þpakki||R06AE07|01.01.1998||L|A|3|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|30|0|30,0000|Actavis Group hf|Actavis hf|Cetirizín|||||| 153222|B03XA0201|Aranesp|stl|30|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|39784|51811|lyfsjukr|||00|1|0|26,6700|Vistor hf|Amgen|Darbepóetín alfa||||39784|51811| 153254|N01BB0203|Xylocain|stl|20|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.03.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|2325|4058|lyfalmen|||02|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|Lídókaín||2325||2325|4058| 153270|N01BB0203|Xylocain|stl|10|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.03.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|1604|3071|lyfalmen|||02|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|Lídókaín||1604||1604|3071| 153288|R06AE0704|Histasin|töflur|10|mg|100|stk|1|þpakki||R06AE07|01.01.1998||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|2465|4249|lyfalmen|||00|100|0|100,0000|Actavis Group hf|Actavis hf|Cetirizín||2465||2465|4249| 153379|J02AA0104|AmBisome|irs|50|mg/hgl|10|hgl|1|pakki||J02AA01|01.07.2001||R|A|3|0|0|0|1|GIS|0|0|0|100|DKK|228960|289227|lyfsjukr|||00|10|0|14,2857|Gilead Sience Sweden AB|Gilead Science International ltd.|Amfóterícín||228960||228960|289227| 153536|J02AC0201|Sporanox|hylki|100|mg|15|stk|1|þpakki|hart|J02AC02|01.04.1995||R|A|3|0|0|0|0|JAS|0|0|1|100|SEK|6430|9673|lyfalmen|||10|15|0|7,5000|Vistor hf|Janssen-Cilag AB|Ítracónazól||6430||6430|9673| 153575|M01AH0104|Celebrex (D.A.C.)|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.05.2009||R|A||0|0|E|0|DAC|0|0|1|100|DKK|13523|19250|lyfalmen|V2140|19250|00|100|0|100,0000|D.A.C. ehf|D.A.C. ehf|Celekoxíb||13523||13523|19250| 153601|B03BA0302|Vibeden|stl|1|mg/ml|1|ml|1|lykja||B03BA03|01.06.2010||R|K|2|0|0|E|0|HEX|0|0|1|100|DKK|1624|3099|lyfalmen|||02|1|0|50,0000|Vistor hf|Hexal A/S|Hýdroxókóbalamín||1624||1624|3099| 154464|D05AX5203|Xamiol|hlaup|||30|g|1|plastf|50 mcg/g+0,5 mg/g|D05AX52|01.05.2009||R|A||0|0|B|0|LEP|0|0|0|100|DKK|4705|7313|lyfalmen|||00|30|0|0,0000|Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||||4705|7313| 154475|D05AX5203|Xamiol|hlaup|||60|g|1|plastf|50 mcg/g+0,5 mg/g|D05AX52|01.05.2009||R|A||0|0|B|0|LEP|0|0|0|100|DKK|9009|13201|lyfalmen|||00|60|0|0,0000|Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||||9009|13201| 154484|G04CA0102|Xatral Uno|forðatfl|10|mg|30|stk|1|þpakki||G04CA01|01.01.2003||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|6238|9411|lyfalmen|||00|30|0|40,0000|Vistor hf|Sanofi-aventis Norge AS|Alfúzósín||6238||6238|9411| 154591|M01AB5501|Arthrotec|töflur|50,2|mg|20|stk|1|pakki|þp (0,2+50 mg)|M01AB55|01.04.1993||R|A|3|0|0|E|0|PER|0|0|1|100|DKK|1348|2721|lyfalmen|||10|20|0|10,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||1348||1348|2721| 154708|M01AB5501|Arthrotec|töflur|50,2|mg|100|stk|1|pakki|þp (0,2+50 mg)|M01AB55|01.04.1993||R|A|3|0|0|E|0|PER|0|0|1|100|DKK|4885|7560|lyfalmen|V2130|7558|10|100|0|50,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||4885||4885|7560| 154728|N06AX1608|Venlafaxin Actavis|forðahlk|75|mg|28|stk|1|þpakki|hart|N06AX16|01.08.2009||R|A||0|0|0|0|AGP|0|0|0|100|XEU|1991|3463|lyfalmen|V0954|3463|00|28|0|21,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||1890||1890|3463| 154732|G04CA0102|Xatral Uno|forðatfl|10|mg|90|stk|1|þpakki||G04CA01|01.01.2003||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|7192|10716|lyfalmen|V0438|8591|00|90|0|120,0000|Vistor hf|Sanofi-aventis Norge AS|Alfúzósín||7192||7192|10716| 154739|N06AX1608|Venlafaxin Actavis|forðahlk|75|mg|98|stk|1|þpakki|hart|N06AX16|01.08.2009||R|A||0|0|B|0|AGP|0|0|0|100|XEU|8077|6073|lyfalmen|V0955|5952|00|98|0|73,5000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||3798||3798|6073| 154750|N06AX1608|Venlafaxin Actavis|forðahlk|150|mg|28|stk|1|þpakki|hart|N06AX16|01.08.2009||R|A||0|0|0|0|AGP|0|0|0|100|XEU|3445|4383|lyfalmen|V0957|4383|00|28|0|42,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||2563||2563|4383| 154761|N06AX1608|Venlafaxin Actavis|forðahlk|150|mg|98|stk|1|þpakki|hart|N06AX16|01.08.2009||R|A||0|0|B|0|AGP|0|0|0|100|XEU|13364|6073|lyfalmen|V0956|5952|00|98|0|147,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||3798||3798|6073| 155085|L01AA0201|Leukeran|töflur|2|mg|25|stk|1|glas||L01AA02|01.06.2001||R|K|3|0|0|*|0|GSK|0|0|0|100|XEU|1576|3033|lyfalmen|||00|25|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Chlorambucíl||1576||1576|3033| 155219|N03AX1106|Topiramate Portfarma|filmhtfl|25|mg|60|stk|1|þpakki||N03AX11|01.04.2010||R|A||0|0|E|0|POF|0|0|0|100|XEU|3028|4294|lyfalmen|V0709|4294|00|60|0|5,0000|Portfarma ehf|Portfarma|Tópíramat||2498||2498|4294| 155230|N03AX1106|Topiramate Portfarma|filmhtfl|50|mg|60|stk|1|þpakki||N03AX11|01.04.2010||R|A||0|0|E|0|POF|0|0|0|100|XEU|4072|6167|lyfalmen|V0710|6167|00|60|0|10,0000|Portfarma ehf|Portfarma|Tópíramat||3867||3867|6167| 155241|N03AX1106|Topiramate Portfarma|filmhtfl|100|mg|60|stk|1|þpakki||N03AX11|01.04.2010||R|A||0|0|E|0|POF|0|0|0|100|XEU|8894|12129|lyfalmen|V0711|12129|00|60|0|20,0000|Portfarma ehf|Portfarma|Tópíramat||8225||8225|12129| 155390|N05AF0301|Truxal|töflur|50|mg|100|stk|1|glas||N05AF03|01.12.1972||R|A|5|0|0|*|0|LBK|0|1|0|100|DKK|1683|3180|lyfalmen|||00|100|0|16,6667|Lundbeck Export A/S|H. Lundbeck A/S|Klórprótixen||1683||1683|3180| 155432|N05AF0301|Truxal|töflur|15|mg|100|stk|1|glas||N05AF03|01.12.1972||R|A|5|0|0|*|0|LBK|0|1|0|100|DKK|521|1590|lyfalmen|||00|100|0|5,0000|Lundbeck Export A/S|H. Lundbeck A/S|Klórprótixen||521||521|1590| 155648|J02AC0201|Sporanox|hylki|100|mg|28|stk|1|þpakki|hart|J02AC02|01.04.1995||R|A|3|0|0|0|0|JAS|0|0|1|100|SEK|12165|17546|lyfalmen|||00|28|0|14,0000|Vistor hf|Janssen-Cilag AB|Ítracónazól||12165||12165|17546| 156505|A08AB0101|Xenical|hylki|120|mg|42|stk|1|þpakki||A08AB01|01.07.1999||R|A|3|0|0|0|0|ROC|0|0|0|100|DKK|6329|9535|lyfalmen|||00|42|0|14,0000|Icepharma hf|Roche|Orlístat||6329||6329|9535| 156528|J01XE0101|Furadantin|töflur|50|mg|15|stk|1|þpakki||J01XE01|01.08.2010||R|A||0|0|0|0|REP|0|0|1|100|SEK|436|1474|lyfalmen|||00|15|0|3,7500|Vistor hf|Recip AB|Nítrófúrantóín||||436|1474| 156563|L01XA0210|Carboplatin Hospira|irþ|10|mg/ml|15|ml|1|hgl||L01XA02|01.04.1992||R|A|2|0|1|0|1|HOP|0|0|0|100|SEK|18713|25367|lyfsjukr|||00|15|0|0,0000|Icepharma hf|Hospira Nordic AB|Karbóplatín||18713||18713|25367| 156574|L01XA0210|Carboplatin Hospira|irþ|10|mg/ml|5|ml|1|hgl||L01XA02|01.04.1992||R|A|2|0|1|0|1|HOP|0|0|0|100|SEK|6352|9168|lyfsjukr|||00|5|0|0,0000|Icepharma hf|Hospira Nordic AB|Karbóplatín||6352||6352|9168| 156585|L01XA0210|Carboplatin Hospira|irþ|10|mg/ml|45|ml|1|hgl||L01XA02|01.04.1992||R|A|2|0|1|0|1|HOP|0|0|0|100|SEK|20780|27961|lyfsjukr|||00|45|0|0,0000|Icepharma hf|Hospira Nordic AB|Karbóplatín||20780||20780|27961| 156596|A08AB0101|Xenical|hylki|120|mg|84|stk|1|þpakki||A08AB01|01.07.1999||R|A|3|0|0|0|0|ROC|0|0|0|100|DKK|8432|12412|lyfalmen|||00|84|0|28,0000|Icepharma hf|Roche|Orlístat||8432||8432|12412| 156597|L01XA0210|Carboplatin Hospira|irþ|10|mg/ml|60|ml|1|hgl||L01XA02|01.04.2007||R|A|2|0|1|0|1|HOP|0|0|0|100|SEK|38630|50363|lyfsjukr|||00|60|0|0,0000|Icepharma hf|Hospira Nordic AB|Karbóplatín||38630||38630|50363| 156661|P02CA0101|Vermox|töflur|100|mg|6|stk|1|þpakki||P02CA01|01.12.1982||R|A|3|0|0|0|0|JAS|0|0|0|100|SEK|952|2180|lyfalmen|||00|6|0|3,0000|Vistor hf|Janssen-Cilag AB|Mebendazól||952||952|2180| 156964|N07BA0137|Nicorette (D.A.C.)|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.05.2009|31.12.2010|L|A|2,5|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||23|210|0|14,0000|D.A.C. ehf|D.A.C. ehf|Nikótín|||||| 156986|N07BA0138|Nicorette Freshmint (D.A.C.)|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.05.2009|31.12.2010|L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||23|105|0|14,0000|D.A.C. ehf|D.A.C. ehf|Nikótín|||||| 156997|N07BA0138|Nicorette Freshmint (D.A.C.)|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.05.2009|31.12.2010|L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|210|0|28,0000|D.A.C. ehf|D.A.C. ehf|Nikótín|||||| 157020|N07BA0138|Nicorette Freshmint (D.A.C.)|tyggigúm|2|mg|105|stk|1|þpakki||N07BA01|01.05.2009|31.12.2010|L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||23|105|0|7,0000|D.A.C. ehf|D.A.C. ehf|Nikótín|||||| 157031|N07BA0138|Nicorette Freshmint (D.A.C.)|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.05.2009|31.12.2010|L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|210|0|14,0000|D.A.C. ehf|D.A.C. ehf|Nikótín|||||| 157053|N07BA0139 |Nicorette Fruitmint (D.A.C.)|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.05.2009||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||23|105|0|14,0000|D.A.C. ehf|D.A.C. ehf|Nikótín|||||| 157064|N07BA0139 |Nicorette Fruitmint (D.A.C.)|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.05.2009||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|210|0|28,0000|D.A.C. ehf|D.A.C. ehf|Nikótín|||||| 157086|N07BA0139 |Nicorette Fruitmint (D.A.C.)|tyggigúm|2|mg|105|stk|1|þpakki||N07BA01|01.05.2009||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||23|105|0|7,0000|D.A.C. ehf|D.A.C. ehf|Nikótín|||||| 157097|N07BA0139 |Nicorette Fruitmint (D.A.C.)|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.05.2009||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|210|0|14,0000|D.A.C. ehf|D.A.C. ehf|Nikótín|||||| 157206|QP52AF0201|Banminth, vet.|pasta|11,4|g/skdæla|26|g|10|spr||QP52AF02|01.04.1992||R|A|1|0|0|0|0|PAL|0|0|0|100|DKK|7298|12731|vetorma|||16|260|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||7298||7298|12731| 157419|N07BA0134|Nicotinell Mint (D.A.C.)|munnstfl|1|mg|204|stk|1|pakki||N07BA01|01.05.2009|31.12.2010|L|A|3|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||23|204|0|6,8000|D.A.C. ehf|D.A.C. ehf|Nikótín|||||| 157430|N07BA0140|Nicorette Peppermynte (D.A.C.)|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.05.2009|31.12.2010|L|A|2,5|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||23|210|0|14,0000|D.A.C. ehf|D.A.C. ehf|Nikótín|||||| 157463|N07BA0134|Nicotinell Mint (D.A.C.)|munnstfl|2|mg|96|stk|1|pakki||N07BA01|01.05.2009|31.12.2010|L|A|3|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||23|96|0|6,4000|D.A.C. ehf|D.A.C. ehf|Nikótín|||||| 157598|N07BA0134|Nicotinell Mint (D.A.C.)|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.12.2008|31.12.2010|L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|96|0|12,8000|D.A.C. ehf|D.A.C. ehf|Nikótín|||||| 157609|N07BA0134|Nicotinell Mint (D.A.C.)|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.12.2008|31.12.2010|L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|204|0|27,2000|D.A.C. ehf|D.A.C. ehf|Nikótín|||||| 157642|N07BA0134|Nicotinell Mint (D.A.C.)|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.12.2008|31.12.2010|L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|204|0|13,6000|D.A.C. ehf|D.A.C. ehf|Nikótín|||||| 157768|S01AA3001|Terramycin Polymyxin B|augnsm|0| |3,5|g|1|túpa||S01AA30|01.01.2000||R|S|5|0|0|E|0|PCO|0|0|1|100|DKK|497|1557|lyfalmen|||07|4|1|0,0000|Distica|Distica - óskráð lyf|||497||497|1557| 157863|N03AF0104|Tegretol|töflur|200|mg|100|stk|1|þpakki||N03AF01|01.01.2010||R|A||0|0|E|0|NOH|0|0|0|100|DKK|1526|2965|lyfalmen|||00|100|0|20,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||1526||1526|2965| 158287|N03AF0104|Tegretol|töflur|200|mg|50|stk|1|þpakki||N03AF01|01.12.1972||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|1008|2256|lyfalmen|||00|50|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||1008||1008|2256| 158431|B02BD0801|NovoSeven|sts|1|mg|1|hgl|1|pakki|+leysir, lausn|B02BD08|01.04.2009||R|A|2|0|1|0|1|NON|0|0|0|100|DKK|103536|131820|lyfsjukr|||00|1|0|0,0000|Vistor hf|Novo-Nordisk|Eptacog alfa (virkjað)||||103536|131820| 158442|B02BD0801|NovoSeven|sts|2|mg|1|hgl|1|pakki|+leysir, lausn|B02BD08|01.04.2009||R|A|2|0|1|0|1|NON|0|0|0|100|DKK|207072|261758|lyfsjukr|||00|1|0|0,0000|Vistor hf|Novo-Nordisk|Eptacog alfa (virkjað)||||207072|261758| 158453|B02BD0801|NovoSeven|sts|5|mg|1|hgl|1|pakki|+leysir, lausn|B02BD08|01.04.2009||R|A|2|0|1|0|1|NON|0|0|0|100|DKK|587148|738753|lyfsjukr|||00|1|0|0,0000|Vistor hf|Novo-Nordisk|Eptacog alfa (virkjað)||||587148|738753| 158608|J02AX0501|Mycamine|irs|50|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|A|3|0|1|0|1|APG|0|0|0|100|XEU|52971|68361|lyfsjukr|||0|1|0|0,5000|Vistor hf|Astellas Pharma GmbH|Micafungin||||52971|68361| 158619|J02AX0501|Mycamine|irs|100|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|A|3|0|1|0|1|APG|0|0|0|100|XEU|75565|96717|lyfsjukr|||0|1|0|1,0000|Vistor hf|Astellas Pharma GmbH|Micafungin||75565||75565|96717| 158683|H01BB0201|Syntocinon|nefúði|6,7|mcg/sk|5|ml|1|stauk||H01BB02|01.07.1988||R|K|4|0|0|E|0|DES|0|0|0|100|DKK|1121|2411|lyfalmen|||23|5|0|13,3333|Swedish Orphan A/S|Defiante Farmaceutica S.A.|Oxýtócín||1121||1121|2411| 158725|M01AB0515|Diklofenak Merck NM|sþ-tfl|50|mg|100|stk|1|þpakki||M01AB05|01.12.2008||R|A|5|0|0|E|0|MYL|0|0|1|100|SEK|1035|2293|lyfalmen|V0608|2293|10|100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Díklófenak||||1035|2293| 158729|C07AB0208|Selo-ZOC (D.A.C.)|forðatfl|47,5|mg|98|stk|1|þpakki||C07AB02|01.11.2008||R|A|3|0|0|B|0|DAC|0|0|0|100|SEK|2441|2902|lyfalmen|V2003|2816|00|98|0|31,0300|D.A.C. ehf|D.A.C. ehf|Metóprólól||1480||1480|2902| 159107|N02AB0303|Fentanyl Actavis|forðapl|25|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|A|2|1|0|E|0|AGP|0|0|0|100|XEU|3519|5691|lyfalmen|V1050|5691|00|5|0|20,8333|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||||3519|5691| 159118|N02AB0303|Fentanyl Actavis|forðapl|50|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|A|2|1|0|E|0|AGP|0|0|0|100|XEU|6776|10146|lyfalmen|V1051|10146|00|5|0|41,6667|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||||6776|10146| 159130|N02AB0303|Fentanyl Actavis|forðapl|75|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|A|2|1|0|E|0|AGP|0|0|0|100|XEU|9483|13850|lyfalmen|V1052|13850|00|5|0|62,5000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||||9483|13850| 159141|N02AB0303|Fentanyl Actavis|forðapl|100|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|A|2|1|0|E|0|AGP|0|0|0|100|XEU|11399|16471|lyfalmen|V1053|16471|00|5|0|83,3333|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||||11399|16471| 159517|N06AB0401|Cipramil|töflur|20|mg|56|stk|1|þpakki||N06AB04|01.04.1993||R|A|5|0|0|0|0|LBK|0|1|0|100|DKK|6503|4569|lyfalmen|V0925|3309|00|56|0|56,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||2699||2699|4569| 159533|L02BG0601|Aromasin|töflur|25|mg|30|stk|1|þpakki||L02BG06|01.06.2001||R|A|3|0|0|*|0|PER|0|0|0|100|DKK|25749|34594|lyfalmen|||00|30|0|30,0000|Icepharma hf|Pfizer ApS|Exemestan||25749||25749|34594| 159541|N06AB0401|Cipramil|töflur|40|mg|56|stk|1|þpakki||N06AB04|01.04.1993||R|A|5|0|0|0|0|LBK|0|1|0|100|DKK|13312|12265|lyfalmen|||00|56|0|112,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||8325||8325|12265| 159558|N06AB0401|Cipramil|töflur|10|mg|28|stk|1|þpakki||N06AB04|01.04.1993||R|A|5|0|0|0|0|LBK|0|1|0|100|DKK|1882|2543|lyfalmen|V0921|1939|00|28|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||1218||1218|2543| 159632|N06AB0401|Cipramil|töflur|20|mg|28|stk|1|þpakki||N06AB04|01.04.1993||R|A|5|0|0|0|0|LBK|0|1|0|100|DKK|3259|3602|lyfalmen|V0923|1820|00|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||1992||1992|3602| 159640|N06AB0401|Cipramil|töflur|40|mg|28|stk|1|þpakki||N06AB04|01.04.1993||R|A|5|0|0|0|0|LBK|0|1|0|100|DKK|6715|4814|lyfalmen|V0927|2062|00|28|0|56,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||2878||2878|4814| 159672|R05CB0105|Acetylcystein Mylan|freyðit|200|mg|25|stk|1|pakki||R05CB01|01.03.2010||R|A||0|0|E|0|MYL|0|0|1|100|SEK|499|1560|lyfalmen|||72|25|0|10,0000|Actavis Group PTC ehf|Mylan AB|Acetýlcýstein||499||499|1560| 159683|R05CB0105|Acetylcystein Mylan|freyðit|200|mg|100|stk|1|pakki||R05CB01|01.03.2010||R|A||0|0|E|0|MYL|0|0|1|100|SEK|1608|3077|lyfalmen|||72|100|0|40,0000|Actavis Group PTC ehf|Mylan AB|Acetýlcýstein||1608||1608|3077| 159772|B01AD0701|Rapilysin|sts|10|ae/hgl|2|hgl|1|pakki|+ leysir|B01AD07|01.02.2002||R|A|3|0|0|0|1|APC|0|0|0|100|DKK|170109|215369|lyfsjukr|||00|2|0|1,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Reteplasi||170109||170109|215369| 160325|N05BA0105|Stesolid|stl|5|mg/ml|2|ml|25|lykjur||N05BA01|01.04.1974||R|A|3|0|0|0|1|AGT|0|0|0|100|DKK|2276|3285|lyfsjukr|||02|50|0|25,0000|Actavis Group hf|Actavis Group hf|Díazepam||2276||2276|3285| 160408|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|81248|103849|lyfsjukr|||00|100|0|0,0000|Icepharma hf|GE Healthcare AS|Gadódíamíð||81248||81248|103849| 160457|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|102665|130727|lyfsjukr|||00|150|0|0,0000|Icepharma hf|GE Healthcare AS|Gadódíamíð||102665||102665|130727| 160523|N05AB0401|Stemetil|töflur|5|mg|100|stk|1|þpakki||N05AB04|01.06.1981||R|A|5|0|0|*|0|SNO|0|1|0|100|NOK|973|2208|lyfalmen|||00|100|0|5,0000|Vistor hf|Sanofi-aventis Norge AS|Próklórperazín||973||973|2208| 160531|C10AC0101|Questran|skammtar|4|g|50|skammtar|1|pakki||C10AC01|01.04.1988||R|A|5|0|0|0|0|BRS|0|0|0|100|DKK|2371|4121|lyfalmen|||42|50|0|14,2857|Vistor hf|Bristol-Myers Squibb|Kólestýramín||2371||2371|4121| 160622|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|162494|205812|lyfsjukr|||00|200|0|0,0000|Icepharma hf|GE Healthcare AS|Gadódíamíð||162494||162494|205812| 160739|M01AB0516|Diklofenak Mylan|sþ-tfl|50|mg|30|stk|1|þpakki||M01AB05|01.12.2008||R|A|5|0|0|E|0|MYL|0|0|1|100|SEK|391|1412|lyfalmen|||10|30|0|15,0000|Actavis Group PTC ehf|Mylan AB|Díklófenak||||391|1412| 160852|R01AX0301|Atrovent|nefúði|21|mcg/sk|15|ml|1|glas|180 sk, lausn|R01AX03|01.09.2009||R|A||0|0|E|0|BOI|0|0|1|100|DKK|1415|2813|lyfalmen|||24|15|0|15,7500|Vistor hf|Boehringer Ingelheim|Ípratrópínbrómíð||1415||1415|2813| 160945|N02AA5901|Panocod|freyðit|530|mg|20|stk|1|pakki|þp 30+500 mg|N02AA59|01.01.1992||R|A|4|0|0|0|0|SNO|0|0|1|100|NOK|379|1396|lyfalmen|||14|20|0|6,6667|Vistor hf|Sanofi-aventis Norge AS|Kódein í blöndum nema með geðlyfjum||379||379|1396| 161065|J05AG0401|Intelence|töflur|100|mg|120|stk|1|glas||J05AG04|01.02.2009||R|A|2|0|1|0|1|JCI|0|0|0|100|SEK|91331|116503|lyfsjukr|||0|120|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Etravírín||||91331|116503| 161075|H02AB0403|Solu-Medrol|sts|40|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.08.1980||R|A|2|0|0|B|0|PER|0|0|1|100|DKK|767|1926|lyfalmen|||03|1|0|2,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||767||767|1926| 161091|H02AB0901|Solu-Cortef|sts|250|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|A|5|0|0|0|1|PER|0|0|0|100|DKK|1795|2591|lyfsjukr|||03|1|0|8,3333|Icepharma hf|Pfizer ApS|Hýdrókortisón||1795||1795|2591| 161117|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|5|hgl|Act-O-Vial |H02AB09|01.08.1998||R|A|5|0|0|0|1|PER|0|0|0|100|DKK|1137|1641|lyfsjukr|||03|5|0|16,6667|Icepharma hf|Pfizer ApS|Hýdrókortisón||1137||1137|1641| 161125|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|A|5|0|0|B|0|PER|0|0|1|100|DKK|704|1840|lyfalmen|||03|1|0|3,3333|Icepharma hf|Pfizer ApS|Hýdrókortisón||704||704|1840| 161133|G03CA0306|Evorel|forðapl|75|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|5904|8954|lyfalmen|||23|26|0|136,5000|Vistor hf|Janssen-Cilag AB|Estradíól||5904||5904|8954| 161547|L02BG0601|Aromasin|töflur|25|mg|100|stk|1|þpakki||L02BG06|01.06.2001||R|A|3|0|0|*|0|PER|0|0|0|100|DKK|60440|78131|lyfalmen|||00|100|0|100,0000|Icepharma hf|Pfizer ApS|Exemestan||60440||60440|78131| 161802|V03AF0401|Isovorin|stl|10|mg/ml|2,5|ml|1|hgl||V03AF04|01.02.1998||R|K|2|0|0|0|1|PER|0|0|0|100|DKK|3071|4432|lyfsjukr|||00|2|0|0,8333|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||3071||3071|4432| 161901|D11AC0301|Selsun|hársápa|25|mg/ml|120|ml|1|glas||D11AC03|01.12.1972||L|A|3|0|0|0|0|CHT|0|0|0|100|IKR|||lyflausa|||01|120|0|120,0000|Vitaflo Scandinavia AB|Chattem Clobal Consumer Products|Selensambönd|||||| 162016|V03AF0401|Isovorin|stl|10|mg/ml|5|ml|1|hgl||V03AF04|01.02.1998||R|K|2|0|0|0|1|PER|0|0|0|100|DKK|6031|8704|lyfsjukr|||00|5|0|1,6667|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||6031||6031|8704| 162305|V03AF0401|Isovorin|stl|10|mg/ml|17,5|ml|1|hgl||V03AF04|01.02.1998||R|K|2|0|0|0|1|PER|0|0|0|100|DKK|19047|25786|lyfsjukr|||00|18|0|5,8333|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||19047||19047|25786| 162354|A07EC0101|Salazopyrin|töflur|500|mg|100|stk|1|glas||A07EC01|01.12.1972||R|A|5|0|0|B|0|PER|0|0|0|100|DKK|2372|4122|lyfalmen|||00|100|0|25,0000|Icepharma hf|Pfizer ApS|Súlfasalazín||2372||2372|4122| 162929|G04CA0205|Ranomax|forðahlk|0,4|mg|100|stk|1|þpakki||G04CA02|01.04.2009||R|A|4|0|0|E|0|RAN|0|0|0|100|XEU|4769|5289|lyfalmen|V0437|5289|00|100|0|100,0000|Gróco ehf|Ranbaxy (UK) Ltd|Tamsúlósín||3225||3225|5289| 162933|R03BA0501|Flixotide|innúðal|50|mcg/sk|120|sk|1|stauk||R03BA05|01.07.1994||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|2208|3898|lyfalmen|||24|120|0|20,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2208||2208|3898| 163089|N06BA0401|Ritalin|töflur|10|mg|30|stk|1|þpakki||N06BA04|01.12.1972||R|A|2|1|0|0|0|NOH|0|0|0|100|DKK|1148|2448|lyfalmen|||00|30|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||1148||1148|2448| 163246|P01AB0102|Flagyl|töflur|400|mg|30|stk|1|þpakki||P01AB01|01.10.1995||R|A|4|0|0|0|0|SNO|0|0|1|100|NOK|1876|3444|lyfalmen|||41|30|0|6,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||1876||1876|3444| 163274|C03AA0304|Dehydratin Neo|töflur|25|mg|20|stk|1|pakki||C03AA03|01.02.2009||R|A|3|0|0|E|0|AEA|0|0|0|100|XEU|203|1155|lyfalmen|||0|20|0|20,0000|Actavis hf|Actavis EAD|hýdróklórtíazíð||||203|1155| 163493|R03BA0501|Flixotide|innúðal|125|mcg/sk|120|sk|1|stauk||R03BA05|01.07.1994||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|2942|4716|lyfalmen|||24|120|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2806||2806|4716| 163709|V03AE0101|Resonium|duft|||454|g|1|stauk||V03AE01|01.01.2000||R|A||0|0|0|0|PCO|0|0|0|100|IKR|8140|12012|lyfalmen|||00|454|1|10,0800|Distica|Distica - óskráð lyf|Pólýstýren súlfónat||8140||8140|12012| 164251|L01BB0201|Puri-nethol|töflur|50|mg|25|stk|1|glas||L01BB02|01.06.2001||R|A|5|0|0|*|0|GSK|0|0|0|100|XEU|3471|5625|lyfalmen|||00|25|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Merkaptópúrín||3471||3471|5625| 164807|N04BD0105|Selegilin Mylan|töflur|5|mg|100|stk|1|glas||N04BD01|01.10.1995||R|A|1,5|0|0|E|0|MYL|0|0|0|100|SEK|3019|5007|lyfalmen|||00|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Selegilín||||3019|5007| 164818|N04BD0105|Selegilin Mylan|töflur|10|mg|100|stk|1|glas||N04BD01|01.05.2010||R|A||0|0|E|0|MYL|0|0|0|100|SEK|9954|14494|lyfalmen|||00|100|0|200,0000|Actavis Group PTC ehf|Mylan AB|Selegilín||9954||9954|14494| 164829|N06AA0406|Klomipramin Mylan|töflur|10|mg|100|stk|1|glas||N06AA04|01.10.2010||R|A|5|0|0|B|0|MYL|0|1|0|100|SEK|1041|2301|lyfalmen|||00|100|0|10,0000|Actavis Group PTC ehf|Mylan AB|Klómípramín||1041||1041|2301| 164840|N06AA0406|Klomipramin Mylan|töflur|25|mg|100|stk|1|glas||N06AA04|01.10.1992||R|A|5|0|0|B|0|MYL|0|1|0|100|SEK|961|2192|lyfalmen|V0908|2192|00|100|0|25,0000|Actavis Group PTC ehf|Mylan AB|Klómípramín||||961|2192| 164871|A07EC0204|Asacol|eþ-stíll|500|mg|60|stk|1|pakki||A07EC02|01.01.2000||R|A|3|0|0|B|0|TIL|0|0|0|100|SEK|7375|10966|lyfalmen|V0299|10966|98|60|0|20,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||7375||7375|10966| 165001|C05AA0102|Proctosedyl|eþ-stíll|||12|stk|1|pakki||C05AA01|01.12.1972||L|K|1,5|0|0|0|0|SNO|0|0|0|100|IKR|||lyflausa|||04|12|0|0,0000|Vistor hf|Sanofi-aventis Norge AS|Hýdrókortisón|||||| 165019|C05AA0102|Proctosedyl|eþ-smyr|0| |30|g|1|túpa||C05AA01|01.03.1981||L|A|3|0|0|0|0|SNO|0|0|0|100|IKR|||lyflausa|||00|30|0|0,0000|Vistor hf|Sanofi-aventis Norge AS|Hýdrókortisón|||||| 165306|QN05CM9501|Dorbene vet.|stl|1|mg/ml|10|mg|1|hgl||QN05CM95|01.05.2009||R|A|3|0|0|0|0|LAS|1|0|0|100|XEU|6944|13506|vetalmen|||0|10|0||Dýraheilsa ehf|Laboratorios SYVA S.A.|||6944||6944|13506| 165431|C08CA0202|Plendil|forðatfl|2,5|mg|98|stk|1|þpakki||C08CA02|01.01.1992||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|5852|8882|lyfalmen|||43|98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Felódipín||5852||5852|8882| 165449|C08CA0202|Plendil|forðatfl|10|mg|98|stk|1|þpakki||C08CA02|01.10.1995||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|5109|7866|lyfalmen|V0324|3967|43|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Felódipín||5109||5109|7866| 165548|C08CA0202|Plendil|forðatfl|5|mg|98|stk|1|þpakki||C08CA02|01.10.1995||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|3297|5387|lyfalmen|V0316|2821|43|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Felódipín||3297||3297|5387| 165639|H01CA0201|Synarela|nefúði|200|mcg/sk|4|ml|1|stauk|30 sk|H01CA02|01.04.1992||R|A|2|0|1|E|0|PER|0|0|0|100|DKK|14469|20438|lyfalmen|||23|4|0|15,0000|Icepharma hf|Pfizer ApS|Nafarelín||14469||14469|20438| 165662|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|gl-hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|A||0|0|0|1|GEH|0|0|0|100|NOK|53693|69267|lyfsjukr|||00|100|0||Icepharma hf|GE Healthcare AS|Gadódíamíð||53693||53693|69267| 165670|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|gl-hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|A||0|0|0|1|GEH|0|0|0|100|NOK|60335|77603|lyfsjukr|||00|150|0||Icepharma hf|GE Healthcare AS|Gadódíamíð||60335||60335|77603| 165761|R06AE0501|Postafen|töflur|25|mg|100|stk|1|þpakki||R06AE05|01.12.1972||R|A|5|0|0|E|0|UCN|0|0|1|100|SEK|1040|2300|lyfalmen|||00|100|0|50,0000|Vistor hf|UCB Nordic A/S|Meklózín||1040||1040|2300| 165779|R06AE0501|Postafen|töflur|25|mg|25|stk|1|þpakki||R06AE05|01.12.1972||R|A|5|0|0|E|0|UCN|0|0|1|100|SEK|369|1382|lyfalmen|||00|25|0|12,5000|Vistor hf|UCB Nordic A/S|Meklózín||369||369|1382| 165787|R06AE0501|Postafen|töflur|25|mg|10|stk|1|þpakki||R06AE05|01.12.1972||L|A|5|0|0|0|0|UCN|0|0|1|100|IKR|||lyflausa|||00|10|0|5,0000|Vistor hf|UCB Nordic A/S|Meklózín|||||| 165878|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|gl-hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|A||0|0|0|1|GEH|0|0|0|100|NOK|107386|136652|lyfsjukr|||00|200|0||Icepharma hf|GE Healthcare AS|Gadódíamíð||107386||107386|136652| 165894|V08CA0301|Omniscan|stl|0,5|mmol/ml|50|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|351836|443437|lyfsjukr|||00|500|0|0,0000|Icepharma hf|GE Healthcare AS|Gadódíamíð||351836||351836|443437| 166008|QJ51RC2202|Nafpenzal vet.|spenalyf|0||3|g|20|spr||QJ51RC22|01.02.2010||R|A||0|0|0|0|INI|0|0|0|100|DKK|4697|9192|vetalmen|||16|60|0||Icepharma hf|Intervet International B.V.|||||4697|9192| 166033|R06AB0201|Polaramin|forðatfl|6|mg|100|stk|1|þpakki||R06AB02|01.06.1980|31.01.2011|R|A|3|0|0|E|0|SCP|0|0|1|100|DKK|2394|4152|lyfalmen|||10|100|0|100,0000|Vistor hf|Schering-Plough|Dexklórfeníramín||2394||2394|4152| 166090|N05AA0401|Plegicil|töflur|10|mg|10|stk|1|glas||N05AA04|01.03.2007||R|A|5|0|0|0|0|PSW|0|0|0|100|SEK|1079|2353|lyfalmen|||00|10|0|1,0000|Vistor hf|Pharmaxim Sweden AB|Aceprómazín||1079||1079|2353| 166157|P01BA0201|Plaquenil|töflur|200|mg|100|stk|1|þpakki||P01BA02|01.12.1972||R|A|3|0|0|B|0|SNO|0|0|0|100|NOK|2580|4407|lyfalmen|||00|100|0|38,7597|Vistor hf|Sanofi-aventis Norge AS|Hydroxýklórókín||2580||2580|4407| 166165|H01CA0201|Synarela|nefúði|200|mcg/sk|8|ml|1|stauk|60 sk|H01CA02|01.04.1992||R|A|2|0|1|E|0|PER|0|0|0|100|DKK|15253|21422|lyfalmen|||23|8|0|30,0000|Icepharma hf|Pfizer ApS|Nafarelín||15253||15253|21422| 166351|M01AE0217|Naproxen-E Mylan|sh-tfl|250|mg|100|stk|1|glas||M01AE02|01.07.1993||R|A|5|0|0|E|0|MYL|0|0|1|100|SEK|2237|3937|lyfalmen|||10|100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||2237||2237|3937| 166362|M01AE0217|Naproxen-E Mylan|sh-tfl|500|mg|100|stk|1|glas||M01AE02|01.07.1993||R|A|5|0|0|E|0|MYL|0|0|1|100|SEK|4235|6671|lyfalmen|||10|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||4235||4235|6671| 166709|G04CA0103|Alfuzosin Ranbaxy|forðatfl|10|mg|90|stk|1|þpakki||G04CA01|01.07.2009||R|A||0|0|E|0|RAN|0|0|0|100|XEU|9926|8591|lyfalmen|V0438|8591|00|90|0|120,0000|Gróco ehf|Ranbaxy (UK) Ltd|Alfúzósín||5639||5639|8591| 166869|N02BA0110|Aspirin Actavis|töflur|300|mg|100|stk|1|glas||N02BA01|01.11.2010||L|A||0|0|0|0|AUK|0|0|1|100|IKR|||lyflausa|||00|100|0|10,0000|Actavis Group hf|Actavis UK Ltd.|Acetýlsalicýlsýra|||||| 167319|N06AX1608|Venlafaxin Actavis|forðahlk|37,5|mg|7|stk|1|þpakki|hart|N06AX16|01.08.2009||R|A||0|0|0|0|AGP|0|0|0|100|XEU|499|1560|lyfalmen|V0953|1560|00|7|0|2,6300|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||||499|1560| 168275|M04AA0104|Allopurinol|töflur|100|mg|100|stk|1|þpakki||M04AA01|01.06.2009||R|A|3|0|0|E|0|AUK|0|0|0|100|GBP|614|1717|lyfalmen|||00|100|0|25,0000|Actavis Group hf|Actavis UK Ltd.|Allópúrinol||||614|1717| 168309|A02BC0306|Lanser|sþ-hylki|30|mg|98|stk|1|þpakki||A02BC03|01.08.2009||R|A||0|0|E|0|AGP|0|0|0|100|IKR|4762|6621|lyfalmen|||00|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Lansóprazól||4199||4199|6621| 168739|C07AB0209|Metoprolol Actavis|forðatfl|23,75|mg|100|stk|1|þpakki||C07AB02|01.12.2009||R|A||0|0|B|0|AGP|0|0|0|100|XEU|2077|3694|lyfalmen|V0091|3694|00|100|0|15,8300|Actavis Group hf|Actavis Group PTC ehf|Metóprólól||2059||2059|3694| 168740|N03AF0105|Tegretol Retard|forðatfl|200|mg|200|stk|1|þpakki||N03AF01|01.07.1988||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|3064|5069|lyfalmen|V0789|5067|10|200|0|40,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||3064||3064|5069| 168750|C07AB0209|Metoprolol Actavis|forðatfl|47,5|mg|98|stk|1|þpakki||C07AB02|01.09.2009||R|A||0|0|B|0|AGP|0|0|0|100|XEU|1714|2816|lyfalmen|V2003|2816|00|98|0|31,0300|Actavis Group hf|Actavis Group PTC ehf|Metóprólól||1417||1417|2816| 168761|C07AB0209|Metoprolol Actavis|forðatfl|95|mg|98|stk|1|þpakki||C07AB02|01.09.2009||R|A||0|0|B|0|AGP|0|0|0|100|XEU|2690|4223|lyfalmen|V2004|4223|00|98|0|62,0700|Actavis Group hf|Actavis Group PTC ehf|Metóprólól||2446||2446|4223| 168815|N03AF0105|Tegretol Retard|forðatfl|400|mg|30|stk|1|þpakki||N03AF01|01.07.1988||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|1203|2523|lyfalmen|||10|30|0|12,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||1203||1203|2523| 168971|N03AF0105|Tegretol Retard|forðatfl|400|mg|200|stk|1|þpakki||N03AF01|01.07.1988||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|5655|8613|lyfalmen|V0713|8612|10|200|0|80,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||5655||5655|8613| 168997|L01CA0401|Navelbine|irþ|10|mg/ml|1|ml|10|hgl||L01CA04|01.03.1998||R|K|3|0|1|0|1|PFP|0|0|0|100|SEK|54888|70767|lyfsjukr|||00|10|0|0,0000|Vistor hf|Pierre Fabre Pharma|Vínorelbín||54888||54888|70767| 169433|L01CA0401|Navelbine|irþ|10|mg/ml|5|ml|10|hgl||L01CA04|01.03.1998||R|K|3|0|1|0|1|PFP|0|0|0|100|SEK|236485|298671|lyfsjukr|||00|50|0|0,0000|Vistor hf|Pierre Fabre Pharma|Vínorelbín||236485||236485|298671| 169557|J05AB0601|Cymevene|irs|500|mg|5|hgl|1|pakki|+innr.sía|J05AB06|01.10.1995||R|A|3|0|0|0|1|ROA|0|0|0|100|DKK|24352|32444|lyfsjukr|||00|5|0|5,0000|Icepharma hf|Roche A.S.|Gancíklóvír||24352||24352|32444| 169664|J07BK0101|Varilrix|bóluefni|0| |0,5|ml|1|hgl|þurrefni + 0.5 ml leysir|J07BK01|01.10.1995||R|K|2|0|0|0|0|GSK|0|0|0|100|GBP|5498|8398|lyfalmen|||02|0|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Hlaupabóla, veikluð veira||5498||5498|8398| 169729|D10BA0105|Isotretinoin Portfarma|hylki|10|mg|30|stk|1|þpakki||D10BA01|01.10.2009||R|A||0|1|C|0|POF|0|0|0|30|IKR|1407|2725|lyfalmen|V0409|2725|67|30|0|10,0000|Portfarma ehf|Portfarma|Ísótretínóín||1351||1351|2725| 169740|D10BA0105|Isotretinoin Portfarma|hylki|20|mg|30|stk|1|þpakki||D10BA01|01.10.2009||R|A||0|1|C|0|POF|0|0|0|30|IKR|2450|4095|lyfalmen|V0410|4095|67|30|0|20,0000|Portfarma ehf|Portfarma|Ísótretínóín||2352||2352|4095| 169751|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|500|mg|20|stk|1|þpakki||J01MA02|01.06.2009||R|A|3|0|0|0|0|POF|0|0|1|100|IKR|1168|2475|lyfalmen|V0526|2475|00|20|0|10,0000|Portfarma ehf|Portfarma|Cíprófloxacín||1168||1168|2475| 169762|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|500|mg|10|stk|1|þpakki||J01MA02|01.06.2009||R|A|3|0|0|0|0|POF|0|0|1|100|IKR|647|1762|lyfalmen|V0522|1762|00|10|0|5,0000|Portfarma ehf|Portfarma|Cíprófloxacín||647||647|1762| 169773|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|250|mg|20|stk|1|þpakki||J01MA02|01.06.2009||R|A|3|0|0|0|0|POF|0|0|1|100|IKR|638|1750|lyfalmen|V0518|1750|00|20|0|5,0000|Portfarma ehf|Portfarma|Cíprófloxacín||638||638|1750| 169784|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|250|mg|10|stk|1|þpakki||J01MA02|01.06.2009||R|A|3|0|0|0|0|POF|0|0|1|100|IKR|393|1415|lyfalmen|V0514|1415|00|10|0|2,5000|Portfarma ehf|Portfarma|Cíprófloxacín||393||393|1415| 169912|N01BB0102|Marcain|stl|2,5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|3496|5660|lyfalmen|||02|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|Búpívakaín||3496||3496|5660| 169920|N01BB0102|Marcain|stl|5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|3757|6017|lyfalmen|||02|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|Búpívakaín||3757||3757|6017| 170062|L04AC0701|RoActemra|irþ|20|mg/ml|4|ml|1|hgl||L04AC07|01.07.2009||R|A||0|1|0|1|RRL|0|0|0|100|DKK|24385|32486|lyfsjukr|||00|4|0|4,0000|Icepharma hf|Roche Registration Limited|Tocilizúmabi||||24385|32486| 170085|L04AC0701|RoActemra|irþ|20|mg/ml|10|ml|1|hgl||L04AC07|01.07.2009||R|A||0|1|0|1|RRL|0|0|0|100|DKK|60521|77836|lyfsjukr|||00|10|0|10,0000|Icepharma hf|Roche Registration Limited|Tocilizúmabi||||60521|77836| 170092|J07BC2001|Twinrix Adult|bóluefni|||1|ml|1|dæla|einnota dæla|J07BC20|01.01.1999||R|K|3|0|0|0|0|GLB|0|0|0|100|GBP|5035|7765|lyfalmen|||00|1|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Lifrarbólgubóluefni (hepatitis)-Blöndur||5035||5035|7765| 170107|L04AC0701|RoActemra|irþ|20|mg/ml|20|ml|1|hgl||L04AC07|01.07.2009||R|A||0|1|0|1|RRL|0|0|0|100|DKK|120418|153007|lyfsjukr|||00|20|0|20,0000|Icepharma hf|Roche Registration Limited|Tocilizúmabi||||120418|153007| 170225|R01AA0702|Otrivin|nefdr|1|mg/ml|10|ml|1|glas||R01AA07|01.12.1972|31.01.2011|L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||06|10|0|12,5000|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||| 170233|R01AA0702|Otrivin|nefdr|0,5|mg/ml|10|ml|1|glas||R01AA07|01.12.1972|31.01.2011|L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||06|10|0|6,2500|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||| 170514|C01BC0301|Rytmonorm|töflur|150|mg|100|stk|1|þpakki||C01BC03|01.04.1996||R|A|5|0|1|B|0|ABS|0|0|0|100|XEU|4908|7591|lyfalmen|||59|100|0|50,0000|Vistor hf|Abbott Scandinavia AB|Própafenón||4908||4908|7591| 170548|C01BC0301|Rytmonorm|töflur|300|mg|100|stk|1|þpakki||C01BC03|01.04.1996||R|A|5|0|1|B|0|ABS|0|0|0|100|XEU|9015|13209|lyfalmen|||59|100|0|100,0000|Vistor hf|Abbott Scandinavia AB|Própafenón||9015||9015|13209| 170555|N01BB5301|Carbocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|10 mg+5 míkróg/ml|N01BB53|01.12.1982||R|S|2|0|0|0|0|AZD|0|0|1|100|SEK|2519|4323|lyfalmen|||17|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|||2519||2519|4323| 170697|M05BA0406|Alendronat Actavis|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.06.2009||R|A|2|0|0|E|0|AGP|0|0|0|100|XEU|3984|4780|lyfalmen|V0718|4780|00|12|0|84,0000|Actavis Group hf|Actavis Group PTC ehf|Alendrónsýra||2853||2853|4780| 170763|M05BA0706|Risedronate sodium Portfarma|filmhtfl|35|mg|12|stk|1|þpakki||M05BA07|01.03.2011||R|A||0|0|E|0|POF|0|0|0|100|XEU|12363|4965|lyfalmen|V0719|4311|00|12|0|84,0000|Portfarma ehf|Portfarma|Rísedrónsýru||2988||2988|4965| 170997|L01BC0701|Vidaza|irþ|25|mg/ml|4|ml|1|hgl||L01BC07|01.09.2009||R|A||0|1|0|1|CEE|0|0|0|100|XEU|66047|84771|lyfsjukr|||00|4|0|0,0000|Celgene Europe ltd|Celgene Europe ltd|Azasitidín||||66047|84771| 171603|N01BB5101|Marcain adrenalin|stl|2,5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|S|2|0|0|0|0|AZD|0|0|1|100|SEK|3689|5924|lyfalmen|||17|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|||3689||3689|5924| 171611|N01BB5101|Marcain adrenalin|stl|5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|S|2|0|0|0|0|AZD|0|0|1|100|SEK|3974|6313|lyfalmen|||17|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|||3974||3974|6313| 171777|H03BB0101|Neo-Mercazole|töflur|5|mg|100|stk|1|glas||H03BB01|01.08.2005||R|A||0|0|B|0|LDR|0|0|0|100|NOK|1521|2958|lyfalmen|||00|100|1|33,3333|Parlogis hf|Parlogis - óskráð lyf|||1521||1521|2958| 171793|N03AX1101|Topimax|töflur|25|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|4503|7037|lyfalmen|V0709|4294|00|60|0|5,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||4503||4503|7037| 171876|N03AX1101|Topimax|töflur|50|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|7413|11018|lyfalmen|V0710|6167|00|60|0|10,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||7413||7413|11018| 171991|V08CA0101|Magnevist|stl|469|mg/ml|15|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|45450|58922|lyfsjukr|||02|75|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||45450||45450|58922| 172049|V08CA0101|Magnevist|stl|469|mg/ml|10|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|30300|39909|lyfsjukr|||02|50|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||30300||30300|39909| 172353|N03AX1101|Topimax|töflur|100|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|13386|19079|lyfalmen|V0711|12129|00|60|0|20,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||13386||13386|19079| 172395|N03AX1101|Topimax|töflur|200|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|27454|36734|lyfalmen|||00|60|0|40,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||27454||27454|36734| 172411|V08CA0101|Magnevist|stl|469|mg/ml|20|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|82242|105096|lyfsjukr|||02|100|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||82242||82242|105096| 172619|L01AB0101|Myleran|filmhtfl|2|mg|100|stk|1|glas||L01AB01|01.06.2001||R|A|3|0|1|*|0|GSK|0|0|0|100|XEU|3506|5673|lyfalmen|||00|100|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Búsúlfan||3506||3506|5673| 172627|C07FB0202|Logimax forte|forðatfl|105|mg|98|stk|1|pakki|þp 10 + 95 mg|C07FB02|01.07.1999||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|14991|21093|lyfalmen|||00|98|0|0,0000|Vistor hf|AstraZeneca A/S DK|Metóprólól og önnur blóðþrýstingslækkandi lyf||14991||14991|21093| 172684|N02AA0303|Palladon|forðahlk|4|mg|56|stk|1|þpakki||N02AA03|01.09.2000||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|6670|10001|lyfalmen|||10|56|0|11,2000|Icepharma hf|Norpharma |Hýdrómorphón||6670||6670|10001| 172692|N02AA0303|Palladon|forðahlk|8|mg|56|stk|1|þpakki||N02AA03|01.09.2000||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|12729|18254|lyfalmen|||10|56|0|22,4000|Icepharma hf|Norpharma |Hýdrómorphón||12729||12729|18254| 172759|N02AA0303|Palladon|forðahlk|16|mg|56|stk|1|þpakki||N02AA03|01.09.2000||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|21171|28849|lyfalmen|||10|56|0|44,8000|Icepharma hf|Norpharma |Hýdrómorphón||21171||21171|28849| 172767|J07AJ5204|DiTeKik|bóluefni|0| |0,5|ml|1|hgl||J07AJ52|01.11.1998||R|K|2|0|0|0|0|SSI|0|0|0|100|DKK|2302|4026|lyfalmen|||51|0|0|0,0000|Icepharma hf|Statens Serum Institut|Kíghósti, í blöndum með öðrum toxóíðum||2302||2302|4026| 172775|J07AJ5204|DiTeKik|bóluefni|0| |0,5|ml|1|spr|einnota sprauta|J07AJ52|01.11.1998||R|K|2|0|0|0|0|SSI|0|0|0|100|DKK|2302|4026|lyfalmen|||51|0|0|0,0000|Icepharma hf|Statens Serum Institut|Kíghósti, í blöndum með öðrum toxóíðum||2302||2302|4026| 172916|N02AA0303|Palladon|forðahlk|24|mg|56|stk|1|þpakki||N02AA03|01.09.2000||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|24305|32782|lyfalmen|||10|56|0|67,2000|Icepharma hf|Norpharma |Hýdrómorphón||24305||24305|32782| 173088|N05CD0202|Mogadon|töflur|5|mg|50|stk|1|þpakki||N05CD02|01.12.1972||R|A|5|0|0|0|0|MAB|0|0|1|100|DKK|786|1952|lyfalmen|V0901|1932|00|50|0|50,0000|Vistor hf|Meda AB|Nítrazepam||786||786|1952| 173310|N05BE0108|Buspiron Mylan|töflur|5|mg|100|stk|1|þpakki||N05BE01|01.04.1995||R|A|5|0|0|E|0|MYL|0|0|1|100|SEK|2904|4850|lyfalmen|||00|100|0|16,6667|Actavis Group PTC ehf|Mylan AB|Búspírón hýdróklóríð||2904||2904|4850| 173344|A06AG1101|Microlax|innhl|0| |5|ml|12|túpa||A06AG11|01.12.1972||L|A|5|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||56|60|0|12,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, þ.m.t. í blöndum|||||3483| 173518|N05BE0108|Buspiron Mylan|töflur|10|mg|100|stk|1|þpakki||N05BE01|01.04.1995||R|A|5|0|0|E|0|MYL|0|0|1|100|SEK|6200|9359|lyfalmen|||00|100|0|33,3333|Actavis Group PTC ehf|Mylan AB|Búspírón hýdróklóríð||6200||6200|9359| 173641|M01AC0202|Tilcotil|töflur|20|mg|10|stk|1|þpakki||M01AC02|01.04.1988||R|A|5|0|0|E|0|MAS|0|0|1|100|SEK|1114|2401|lyfalmen|||00|10|0|10,0000|Vistor hf|Meda AS|Tenoxíkam||1114||1114|2401| 173856|N05CF0105|Zopiklon Mylan|töflur|5|mg|30|stk|1|þpakki||N05CF01|01.10.2001||R|A|2|0|0|0|0|MYL|0|0|1|100|SEK|356|1364|lyfalmen|||00|30|0|20,0000|Actavis Group PTC ehf|Mylan AB|Zópíklón||356||356|1364| 173898|N07AA0201|Mestinon|töflur|10|mg|250|stk|1|glas||N07AA02|01.05.1998||R|A||0|0|0|0|PCO|0|0|0|100|SEK|2962|4929|lyfalmen|||00|250|1|13,8889|Distica|Distica - óskráð lyf|Pyridostigmin||2962||2962|4929| 173948|N07AA0201|Mestinon|töflur|60|mg|150|stk|1|glas||N07AA02|01.05.1998||R|A||0|0|0|0|PCO|0|0|0|100|SEK|12971|18558|lyfalmen|||00|150|1|50,0000|Distica|Distica - óskráð lyf|Pyridostigmin||12971||12971|18558| 173955|N05BA0106|Stesolid Novum|stl|5|mg/ml|2|ml|10|lykjur||N05BA01|01.07.1985||R|A|2|0|0|0|1|AGT|0|0|0|100|DKK|1382|1995|lyfsjukr|||02|20|0|10,0000|Actavis Group hf|Actavis Group hf|Díazepam||1382||1382|1995| 174300|J01CE0204|Kaavepenin|töflur|800|mg|14|stk|1|þpakki||J01CE02|01.01.1989||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|680|1807|lyfalmen|||00|14|0|5,6000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||680||680|1807| 174359|J01CE0204|Kaavepenin|töflur|1|g|14|stk|1|þpakki||J01CE02|01.01.1989||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|695|1828|lyfalmen|||00|14|0|7,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||695||695|1828| 174433|S01EA0501|Alphagan|augndr|2|mg/ml|5|ml|1|glas||S01EA05|01.04.2009||R|A|4|0|0|*|0|ALL|0|0|0|100|SEK|2078|3720|lyfalmen|||00|5|0|25,0000|Vistor hf|Allergan|Brímónidín||||2078|3720| 174615|N05CF0105|Zopiklon Mylan|töflur|7,5|mg|30|stk|1|þpakki||N05CF01|01.09.1999||R|A|2|0|0|0|0|MYL|0|0|0|100|SEK|263|1237|lyfalmen|V0886|1221|00|30|0|30,0000|Actavis Group PTC ehf|Mylan AB|Zópíklón||||263|1237| 174664|S01EA0501|Alphagan|augndr|2|mg/ml|5|ml|3|glös||S01EA05|01.04.2009||R|A|4|0|0|*|0|ALL|0|0|0|100|SEK|6096|9216|lyfalmen|||00|15|0|150,0000|Vistor hf|Allergan|Brímónidín||||6096|9216| 175612|J05AB1101|Valtrex|töflur|500|mg|10|stk|1|þpakki||J05AB11|01.10.1996||R|A|3|0|0|E|0|GSK|0|0|1|100|GBP|2502|2680|lyfalmen|V0507|2535|00|10|0|1,6667|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Valacíklóvír||1318||1318|2680| 176214|N05AH0301|Zyprexa|húðuðtfl|2,5|mg|28|stk|1|þpakki||N05AH03|01.01.1999||R|A|2|0|0|*|0|ELD|0|1|0|100|XEU|6660|4877|lyfalmen|V0809|4208|00|28|0|7,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||2924||2924|4877| 177022|J01MA0101|Tarivid|töflur|200|mg|20|stk|1|þpakki||J01MA01|01.10.1988||R|A|3|0|0|0|0|SNO|0|0|1|100|NOK|4574|7134|lyfalmen|||00|20|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Ófloxacín||4574||4574|7134| 177253|N03AG0101|Depakine|sh-tfl|200|mg|40|stk|1|glas||N03AG01|01.04.1986||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|799|1970|lyfalmen|||43|40|0|5,3333|Vistor hf|Sanofi-aventis Norge AS|Valpróínsýra||799||799|1970| 177311|QJ51RC2202|Nafpenzal vet.|spenalyf|0| |3|g|4|spr||QJ51RC22|01.04.1985||R|A|2|0|0|0|0|INI|0|0|0|100|XEU|636|1265|vetalmen|||16|12|0|0,0000|Icepharma hf|Intervet International B.V.|||636||636|1265| 178004|H02AB0801|Kenalog|stl|40|mg/ml|1|ml|1|hgl||H02AB08|01.02.2002||R|A|3|0|0|E|0|PCO|0|0|1|100|IKR|610|1712|lyfalmen|||03|1|1|5,3330|Distica|Distica - óskráð lyf|Tríamcínólón||610||610|1712| 179267|M03AC0901|Esmeron|stl|10|mg/ml|5|ml|12|hgl||M03AC09|01.01.1997||R|K|3|0|0|0|1|ORG|0|0|0|100|DKK|10129|14594|lyfsjukr|||00|60|0|0,0000|Vistor hf|N.V. Organon|Rókúrón, brómíð||10129||10129|14594| 179333|R02AA0304|Strepsils Menthol|sogtfl|0| |24|stk|1|þpakki||R02AA03|01.12.2005||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0|0,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||| 180166|A07EC0301|Dipentum|hylki|250|mg|100|stk|1|glas||A07EC03|01.01.1990||R|A|5|0|0|B|0|UCB|0|0|0|100|DKK|5778|8781|lyfalmen|||10|100|0|25,0000|Vistor hf|U.C.B|Olsalazín||5778||5778|8781| 180539|R01AA0705|Otrivin Menthol ukonserveret|nefúði|1|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.05.2001||L|A|2,5|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||06|10|0|12,5000|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||| 180729|S03CA0401|Hydrocortison m.Terram.|aug.eydr|0| |5|ml|1|túpa|+ Polymyxin B|S03CA04|01.11.1981||R|A|3|0|0|E|0|PER|0|0|1|100|DKK|801|1973|lyfalmen|||30|5|0|0,0000|Icepharma hf|Pfizer ApS|Hýdrókortisón og sýkingalyf||801||801|1973| 181131|J01EE0103|Primazol|mixtúra|48|mg/ml|100|ml|1|glas|8+40 mg/ml|J01EE01|01.04.1989||R|A|2|0|0|0|0|ACA|0|0|1|100|XEU|741|1891|lyfalmen|||01|100|0|2,5000|Actavis Group hf|Actavis hf|Súlfametoxazól og trímetóprím||741||741|1891| 181255|G01AF0201|Canesten|sk-krem|10|mg/g|50|g|1|sett|+stjaka|G01AF02|01.12.1982||L|A|3|0|0|0|0|BAI|0|0|0|100|IKR|||lyflausa|||23|50|0|5,0000|Icepharma hf|Bayer A/S|Klótrímazól|||||| 181552|QJ51DA3201|Pathozone, vet.|spenalyf|250|mg/dælu|10|ml|10|dælur|dæla + rýja|QJ51DA32|01.10.1995||R|A|1,5|0|0|0|0|PFV|0|0|0|100|DKK|7482|14539|vetalmen|||16|100|0|0,0000|Icepharma hf|Pfizer vet.|||7482||7482|14539| 181750|L01BA0105|Methotrexate Wyeth Lederle|irþ|100|mg/ml|10|ml|1|hgl||L01BA01|01.04.1991||R|A|3|0|1|0|1|PER|0|0|0|100|DKK|9822|14176|lyfsjukr|||00|10|0|0,0000|Icepharma hf|Pfizer ApS|Metótrexat||9822||9822|14176| 181990|L01BA0105|Methotrexate Wyeth Lederle|irþ|100|mg/ml|50|ml|1|hgl||L01BA01|01.04.1991||R|A|3|0|1|0|1|PER|0|0|0|100|DKK|37077|48414|lyfsjukr|||00|50|0|0,0000|Icepharma hf|Pfizer ApS|Metótrexat||37077||37077|48414| 182170|QM01AG9001|Finadyne, vet.|kyrni|25|mg/g|10|g|10|skammt||QM01AG90|01.01.1991||R|A|2|0|0|0|0|IBV|0|0|0|100|DKK|4900|9581|vetalmen|||16|100|0|0,0000|Vistor hf|Intervet International BV|||4900||4900|9581| 183327|QM01AG9001|Finadyne, vet.|stl|50|mg/ml|50|ml|1|hgl||QM01AG90|01.07.1992||R|A|2|0|0|0|0|IBV|1|0|0|100|DKK|5416|10572|vetalmen|||27|50|0|0,0000|Vistor hf|Intervet International BV|||5416||5416|10572| 183871|H02AA0201|Florinef|töflur|0,1|mg|100|stk|1|glas||H02AA02|01.12.1972||R|K|2|0|0|B|0|BRS|0|0|0|100|DKK|1194|2511|lyfalmen|||00|100|0|100,0000|Vistor hf|Bristol-Myers Squibb|Flúdrókortisón||1194||1194|2511| 183947|P01AB0102|Flagyl|töflur|200|mg|21|stk|1|þpakki||P01AB01|01.10.1995||R|A|5|0|0|0|0|SNO|0|0|1|100|NOK|936|2158|lyfalmen|||41|21|0|2,1000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||936||936|2158| 184176|J01CR0201|Amoksiklav|mixtúrud|31,25|mg/ml|100|ml|1|glas|25+6.25 mg/ml|J01CR02|01.01.1996||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|503|1565|lyfalmen|||08|100|0|2,5000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||503||503|1565| 184192|J01CR0201|Amoksiklav|mixtúrud|62,5|mg/ml|100|ml|1|glas|50+12.5 mg/ml|J01CR02|01.01.1996||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|1643|2019|lyfalmen|||08|100|0|5,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||835||835|2019| 184200|J01CR0201|Amoksiklav|töflur|375|mg|15|stk|1|glas|250+125 mg|J01CR02|01.01.1996||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|638|1750|lyfalmen|||00|15|0|3,7500|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||638||638|1750| 184234|A07EC0204|Asacol|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.02.2000||R|A|3|0|0|B|0|TIL|0|0|0|100|SEK|5116|7876|lyfalmen|V0300|7876|98|700|0|4,6667|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||5116||5116|7876| 184259|L02BG0401|Femar|töflur|2,5|mg|30|stk|1|þpakki||L02BG04|01.03.1998||R|A|5|0|0|*|0|NOH|0|0|0|100|DKK|23420|31671|lyfalmen|||00|30|0|30,0000|Vistor hf|Novartis Healthcare A/S-|Letrózól||23420||23420|31671| 184275|L02BG0401|Femar|töflur|2,5|mg|100|stk|1|þpakki||L02BG04|01.03.1998||R|A|5|0|0|*|0|NOH|0|0|0|100|DKK|55478|71904|lyfalmen|||00|100|0|100,0000|Vistor hf|Novartis Healthcare A/S-|Letrózól||55478||55478|71904| 184341|J01CR0201|Amoksiklav|töflur|625|mg|16|stk|1|glas|500+125 mg|J01CR02|01.01.1996||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|1214|2538|lyfalmen|||00|16|0|8,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||1214||1214|2538| 184432|N02CC0302|Zomig Rapimelt|munnltfl|2,5|mg|6|stk|1|þpakki||N02CC03|01.05.2001||R|A|3|0|0|E|0|AZA|0|0|0|100|SEK|5611|8553|lyfalmen|||00|6|0|6,0000|Vistor hf|AstraZeneca AB|Zolmítriptan||5611||5611|8553| 187203|B01AA0101|Dicumarol|töflur|20|mg|100|stk|1|glas||B01AA01|01.01.1998||R|A||0|0|E|0|PCO|0|0|0|100|DKK|5308|8138|lyfalmen|||00|100|1|20,0000|Distica|Distica - óskráð lyf|||5308||5308|8138| 188631|N03AG0102|Orfiril|mixtúra|60|mg/ml|250|ml|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|2945|4906|lyfalmen|||00|250|0|10,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||2945||2945|4906| 188987|S01EC0101|Diamox|töflur|250|mg|100|stk|1|glas||S01EC01|01.12.1972||R|A|4|0|0|*|0|GPL|0|0|0|100|USD|1920|3504|lyfalmen|||00|100|0|33,3333|Icepharma hf|Goldshield Pharmaceuticals Ltd|Acetazólamíð||1920||1920|3504| 189175|V03AC0101|Desferal|irs|500|mg|10|hgl|1|pakki|lausn|V03AC01|01.04.2007||R|A|4|0|0|0|1|NOH|0|0|0|100|DKK|10457|15006|lyfsjukr|||00|10|0|0,0000|Vistor hf|Novartis Healthcare A/S-|Deferoxamín||10457||10457|15006| 189506|H02AB0401|Depo-Medrol|stl|40|mg/ml|5|ml|1|hgl||H02AB04|01.12.1972||R|A|5|0|0|B|0|PER|0|0|1|100|DKK|3051|5051|lyfalmen|||03|5|0|10,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||3051||3051|5051| 189514|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|hgl||H02AB04|01.12.1972||R|A|5|0|0|B|0|PER|0|0|1|100|DKK|1032|2289|lyfalmen|||03|2|0|4,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||1032||1032|2289| 189522|H02AB0401|Depo-Medrol|stl|40|mg/ml|1|ml|1|hgl||H02AB04|01.12.1972||R|A|5|0|0|B|0|PER|0|0|1|100|DKK|499|1560|lyfalmen|||03|1|0|2,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||499||499|1560| 190702|M01AB0101|Confortid|eþ-stíll|100|mg|10|stk|1|pakki||M01AB01|01.12.1972||R|A|3|0|0|E|0|AGT|0|0|1|100|DKK|810|1985|lyfalmen|||04|10|0|10,0000|Actavis Group hf|Actavis Group hf|Indómetacín||810||810|1985| 190728|M01AB0101|Confortid|eþ-stíll|50|mg|10|stk|1|pakki||M01AB01|01.12.1972||R|A|3|0|0|E|0|AGT|0|0|1|100|DKK|439|1478|lyfalmen|||04|10|0|5,0000|Actavis Group hf|Actavis Group hf|Indómetacín||439||439|1478| 191064|B05XC03|Vitalipid Infant|irþ|0| |10|ml|10|lykjur||B05XC|01.10.1985||R|K|2|0|0|0|1|FRP|0|0|0|100|DKK|4491|6482|lyfsjukr|||00|100|0|0,1000|Icepharma hf|Fresenius Kabi|||4491||4491|6482| 191247|B05XC02|Vitalipid Adult|irþ|0| |10|ml|10|lykjur||B05XC|01.10.1985||R|K|2|0|0|0|1|FRP|0|0|0|100|DKK|4580|6610|lyfsjukr|||00|100|0|0,1000|Icepharma hf|Fresenius Kabi|||4580||4580|6610| 191254|B05XC01|Soluvit|irs|0| |10|ml|10|hgl||B05XC|01.10.1985||R|K||0|0|0|1|FRP|0|0|0|100|DKK|3814|5505|lyfsjukr|||00|100|0|0,1000|Icepharma hf|Fresenius Kabi|||3814||3814|5505| 191403|R01AA0503|Nezeril|nefúði|0,25|mg/ml|7,5|ml|1|glas|sk-úðari|R01AA05|01.10.1994||L|A|3|0|0|0|0|GCO|0|0|1|100|IKR|||lyflausa|||23|8|0|4,6875|Vistor hf|GlaxoSmithKline CH AB|Oxýmetazólín|||||| 191916|S01AA0101|Chloromycetin|augnsm|10|mg/g|4|g|1|túpa||S01AA01|01.12.1972||R|A||0|0|E|0|PER|0|0|1|100|DKK|524|1594|lyfalmen|||07|4|0||Icepharma hf|Pfizer ApS|Klóramfeníkól||524||524|1594| 192617|C03AB0101|Centyl med kaliumklorid|sh-tfl|0| |100|stk|1|glas||C03AB01|01.12.1972||R|A|3|0|0|E|0|LEP|0|0|0|100|DKK|1614|3085|lyfalmen|||10|100|0|100,0000|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíð og kalíum||1614||1614|3085| 192625|C03AB0101|Centyl med kaliumklorid|sh-tfl|0| |25|stk|1|glas||C03AB01|01.12.1972||R|A|3|0|0|E|0|LEP|0|0|0|100|DKK|450|1493|lyfalmen|||10|25|0|25,0000|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíð og kalíum||450||450|1493| 193821|A12AA0601|Calcium-Sandoz|freyðit|500|mg|20|stk|1|glas||A12AA06|01.12.1972||L|A|3|0|0|0|0|SAN|0|0|0|100|IKR|||lyfalmen|||14|20|0|21,6000|Vistor hf|Sandoz A/S|Kalsíumlaktóglúkónat|||||2132| 193862|A12AA0201|Calcium Sandoz|stl|100|mg/ml|10|ml|5|lykjur||A12AA02|01.12.1972||R|A|5|0|0|0|0|SAN|0|0|0|100|DKK|1131|2424|lyfalmen|||02|50|0|2,5091|Vistor hf|Sandoz A/S|Kalsíumglúbíónat||1131||1131|2424| 194209|L01BA0105|Methotrexate Wyeth Lederle|stl/irl|25|mg/ml|2|ml|1|hgl||L01BA01|01.10.1985||R|A|3|0|1|0|1|PER|0|0|0|100|DKK|1069|1543|lyfsjukr|||02|2|0|0,0000|Icepharma hf|Pfizer ApS|Metótrexat||1069||1069|1543| 194258|A03BB0101|Buscopan|töflur|10|mg|100|stk|1|glas||A03BB01|01.12.1972||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|2065|3702|lyfalmen|||00|100|0|16,6667|Vistor hf|Boehringer Ingelheim|Bútýlskópólamín||2065||2065|3702| 195040|C07AB0311|Atenolol Mylan|töflur|25|mg|250|stk|1|glas||C07AB03|01.07.2009||R|A||0|0|B|0|MYL|0|0|0|100|SEK|1849|3407|lyfalmen|||00|250|0|83,3300|Actavis Group PTC ehf|Mylan AB|Atenólól||1849||1849|3407| 195149|B03BA0201|Betolvex|stl|1|mg/ml|1|ml|5|lykjur||B03BA02|01.11.1981||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|1934|3523|lyfalmen|||03|5|0|250,0000|Actavis Group hf|Actavis Group hf|Cýanókóbalamíntannín-komplex||1934||1934|3523| 195156|B03BA0201|Betolvex|stl|1|mg/ml|1|ml|1|lykja||B03BA02|01.12.1972||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|790|1958|lyfalmen|||03|1|0|50,0000|Actavis Group hf|Actavis Group hf|Cýanókóbalamíntannín-komplex||790||790|1958| 195610|G03AC0801|Implanon|vefjalyf|68|mg|1|stk|1|pakki||G03AC08|01.02.2001|31.01.2011|R|A|5|0|0|0|0|ORG|0|0|0|100|DKK|21008|28644|lyfalmen|||00|1|0|1014,9254|Vistor hf|N.V. Organon|Etónógestrel||21008||21008|28644| 195669|D01AC2002|Pevisone|krem|0| |15|g|1|túpa||D01AC20|01.10.1988||R|A|4|0|0|0|0|JAS|0|0|1|100|SEK|810|1985|lyfalmen|||20|15|0|15,0000|Vistor hf|Janssen-Cilag AB|Blöndur||810||810|1985| 195768|R01BA0101|Rinexin|forðatfl|50|mg|30|stk|1|þpakki||R01BA01|01.03.1981||R|A|5|0|0|E|0|REP|0|0|1|100|SEK|390|1411|lyfalmen|||10|30|0|15,0000|Vistor hf|Recip AB|Fenýlprópanólamín||390||390|1411| 195776|R01BA0101|Rinexin|forðatfl|50|mg|100|stk|1|glas||R01BA01|01.03.1981||R|A|5|0|0|E|0|REP|0|0|1|100|SEK|924|2141|lyfalmen|||10|100|0|50,0000|Vistor hf|Recip AB|Fenýlprópanólamín||924||924|2141| 196022|C07AB0311|Atenolol Mylan|töflur|50|mg|250|stk|1|glas||C07AB03|01.07.2009||R|A||0|0|B|0|MYL|0|0|0|100|SEK|2362|4108|lyfalmen|||00|250|0|166,6700|Actavis Group PTC ehf|Mylan AB|Atenólól||2362||2362|4108| 196121|G03AB0302|Triquilar|töflur|80|mcg|63|stk|1|pakki|þp, 50+30 míkróg etc.|G03AB03|01.01.1985||R|A|5|0|0|0|0|BAP|0|0|0|100|SEK|1472|2891|lyfalmen|||23|63|0|84,0000|Icepharma hf|Bayer Schering Pharma AG|Levónorgestrel og östrógen||1472||1472|2891| 196327|N07BA0145|Nicorette Freshdrops|munnstfl|2|mg|24|stk|1|þpakki||N07BA01|01.12.2010||L|A||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|24|0|1,6000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 196913|B03XA0201|Aranesp|stl|20|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|26691|35380|lyfsjukr|||00|2|0|17,7800|Vistor hf|Amgen|Darbepóetín alfa||||26691|35380| 197103|QH01CA9001|Receptal, vet.|stl|4|mcg/ml|10|ml|1|hgl||QH01CA90|01.07.1998||R|A|5|0|0|0|0|INI|1|0|0|100|DKK|2568|5104|vetalmen|||27|10|0|0,0000|Icepharma hf|Intervet International B.V.|||2568||2568|5104| 197111|QH01CA9001|Receptal, vet.|stl|4|mcg/ml|10|ml|5|hgl||QH01CA90|01.07.1986||R|A|5|0|0|0|0|INI|1|0|0|100|DKK|12227|23650|vetalmen|||27|50|0|0,0000|Icepharma hf|Intervet International B.V.|||12227||12227|23650| 197343|D11AX0101|Regaine|húðlausn|20|mg/ml|60|ml|1|glas||D11AX01|01.10.1988||L|A|4|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||00|60|0|60,0000|Vistor hf|McNeil Denmark ApS|Mínoxidíl|||||5992| 197400|S01GA5101|Antistina-Privin|augndr|5,25|mg/ml|10|ml|1|glas|5+0,25 mg|S01GA51|01.03.1981||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|765|1924|lyfalmen|||06|10|0|0,0000|Vistor hf|Novartis Healthcare A/S-|Nafazólín í blöndum með öðrum efnum||765||765|1924| 197657|N05BA1203|Tafil|töflur|1|mg|20|stk|1|þpakki||N05BA12|01.10.1990||R|A|3|0|0|0|0|PER|0|0|1|100|DKK|855|2047|lyfalmen|||00|20|0|20,0000|Icepharma hf|Pfizer ApS|Alprazólam||855||855|2047| 197673|N05BA1203|Tafil|töflur|1|mg|100|stk|1|þpakki||N05BA12|01.10.1990||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|4051|6419|lyfalmen|||00|100|0|100,0000|Icepharma hf|Pfizer ApS|Alprazólam||4051||4051|6419| 197848|N01BB0203|Xylocain|hlaup|20|mg/ml|10|g|10|plspr||N01BB02|01.10.2003||R|A|2|0|0|0|0|AZD|0|0|1|100|SEK|2342|4081|lyfalmen|||00|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|Lídókaín||2342||2342|4081| 198580|L01AA0301|Alkeran|töflur|2|mg|25|stk|1|glas||L01AA03|01.06.2001||R|K|2|0|1|*|0|GSK|0|0|0|100|XEU|2119|3776|lyfalmen|||00|25|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Melphalan||2119||2119|3776| 198648|L01BC0203|Flurablastin|stl|50|mg/ml|20|ml|10|hgl||L01BC02|01.04.1991||R|A|2|0|1|0|1|PER|0|0|0|100|DKK|10198|14681|lyfsjukr|||02|200|0|0,0000|Icepharma hf|Pfizer ApS|Flúóróúracíl||10198||10198|14681| 198861|N04AA0201|Akineton|stl|5|mg/ml|1|ml|5|lykjur||N04AA02|01.12.1975||R|A|5|0|0|0|1|LFS|0|1|0|100|DKK|417|602|lyfsjukr|||02|5|0|2,5000|Vistor hf|Laboratorio Farmaceutico (S.I.T.)|Bíperíden||417||417|602| 199091|L01XX1101|Estracyt|hylki|140|mg|100|stk|1|glas||L01XX11|01.12.1978||R|A|5|0|0|*|0|PER|0|0|0|100|DKK|37223|48994|lyfalmen|||00|100|0|0,0000|Icepharma hf|Pfizer ApS|Estramústín||37223||37223|48994| 199539|N05CD0503|Halcion|töflur|0,25|mg|30|stk|1|þpakki||N05CD05|01.11.1981||R|A|4|0|0|0|0|PER|0|0|1|100|DKK|631|1740|lyfalmen|||00|30|0|30,0000|Icepharma hf|Pfizer ApS|Tríazólam||631||631|1740| 199692|B03XA0201|Aranesp|stl|300|mcg/spr|0,6|ml|1|áf.spr|nálavörn|B03XA02|01.11.2010||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|94012|119868|lyfsjukr|||00|1|0|66,6700|Vistor hf|Amgen|Darbepóetín alfa||||94012|119868| 199737|G02CB0301|Dostinex|töflur|0,5|mg|8|stk|1|glas||G02CB03|01.07.1993||R|A|2|0|0|E|0|PER|0|0|0|100|DKK|6286|9476|lyfalmen|||44|8|0|4,0000|Icepharma hf|Pfizer ApS|Kabególín||6286||6286|9476| 199836|B01AC1301|ReoPro|stl|2|mg/ml|5|ml|1|hgl||B01AC13|01.09.1997||R|K|3|0|0|0|1|CET|0|0|0|100|XEU|56594|72908|lyfsjukr|||00|5|0|0,4000|Icepharma hf|Centocor -|Abciximab||56594||56594|72908| 300373|A05AA0201|Destolit|töflur|150|mg|60|stk|1|glas||A05AA02|01.01.1998||R|A||0|0|E|0|PCO|0|0|0|100|GBP|5279|7929|lyfalmen|||00|60|1|12,0000|Distica|Distica - óskráð lyf|||5155||5155|7929| 370007|B02BA0102|Konakion Novum|stl|10|mg/ml|0,2|ml|5|lykjur||B02BA01|01.10.1995||R|A|3|0|0|0|1|ROC|0|0|0|100|DKK|573|827|lyfsjukr|||02|1|0|0,5000|Icepharma hf|Roche|Fýtómenadíón||573||573|827| 370353|V08AB0501|Ultravist|stl/irl|300|mg J/ml|20|ml|10|hgl||V08AB05|01.04.1989||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|21286|28596|lyfsjukr|||02|200|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Jóprómíð||21286||21286|28596| 370940|J01DB0401|Kefzol|sts|1|g|1|stk|1|hgl||J01DB04|01.07.1995||R|A|2|0|0|0|1|NOM|0|0|0|100|DKK|586|846|lyfsjukr|||03|1|0|0,3333|Icepharma hf|NordMedica ApS|Cefazólín||586||586|846| 371583|A06AG1001|Klyx|innhl|0| |240|ml|1|fl||A06AG10|01.12.1978||L|A|1,5|0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa|||23|240|0|1,0000|Vistor hf|Ferring Lægemidler A/S|Dókúsatnatríum, þ.m.t. í blöndum|||||| 371609|A06AG1001|Klyx|innhl|0| |120|ml|1|fl||A06AG10|01.12.1978||L|A|1,5|0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa|||23|120|0|1,0000|Vistor hf|Ferring Lægemidler A/S|Dókúsatnatríum, þ.m.t. í blöndum|||||| 371617|A06AG1001|Klyx|innhl|0| |120|ml|10|fl||A06AG10|01.12.1978||L|A|1,5|0|0|0|0|FEL|0|0|0|100|SEK|||lyfalmen|||23|1200|0|10,0000|Vistor hf|Ferring Lægemidler A/S|Dókúsatnatríum, þ.m.t. í blöndum|||||9903| 371658|A02BA0201|Asyran|töflur|150|mg|10|stk|1|þpakki||A02BA02|01.10.1995||L|A|3|0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa|||00|10|0|5,0000|Actavis Group hf|Actavis hf|Ranitidín|||||| 372037|N05AL0501|Solian|töflur|50|mg|30|stk|1|þpakki||N05AL05|01.01.2005||R|A|3|0|0|*|0|SNO|0|1|0|100|NOK|3133|5163|lyfalmen|||00|30|0|3,7500|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríð||3133||3133|5163| 372045|N05AL0501|Solian|töflur|50|mg|90|stk|1|þpakki||N05AL05|01.01.2005||R|A|3|0|0|*|0|SNO|0|1|0|100|NOK|7320|10891|lyfalmen|V0104|10889|00|90|0|11,2500|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríð||7320||7320|10891| 372151|N04BA0209|Madopar Quick "125"|lausnart|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.11.2000||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|4130|6527|lyfalmen|||00|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||4130||4130|6527| 372177|N07BA0103|Nicorette|innsogsl|10|mg|42|rör|1|pakki|þp+munnstk|N07BA01|01.09.1977||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|42|0|7,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 372185|N07BA0103|Nicorette|innsogsl|10|mg|18|rör|1|pakki|þp+munnstk|N07BA01|01.09.1977||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|18|0|3,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 372722|B02BD0801|NovoSeven|sts|1,2|mg|1|hgl|1|pakki|+leysir|B02BD08|01.10.2006||R|K|2|0|0|0|1|NON|0|0|0|100|DKK|104563|133109|lyfsjukr|||00|1|0|0,0000|Vistor hf|Novo-Nordisk|Eptacog alfa (virkjað)||104563||104563|133109| 372730|B02BD0801|NovoSeven|sts|2,4|mg|1|hgl|1|pakki|+leysir|B02BD08|01.10.2006||R|K|2|0|0|0|1|NON|0|0|0|100|DKK|208549|263611|lyfsjukr|||00|1|0|0,0000|Vistor hf|Novo-Nordisk|Eptacog alfa (virkjað)||208549||208549|263611| 372748|B02BD0801|NovoSeven|sts|4,8|mg|1|hgl|1|pakki|+leysir|B02BD08|01.10.2006||R|K|2|0|0|0|1|NON|0|0|0|100|DKK|551713|694282|lyfsjukr|||00|1|0|0,0000|Vistor hf|Novo-Nordisk|Eptacog alfa (virkjað)||551713||551713|694282| 373001|G03AB0501|Gracial|töflur|||66|stk|1|pakki|þp 3 x (15+7 stk)|G03AB05|01.07.1998||R|A|3|0|0|0|0|ORG|0|0|0|100|DKK|2504|4303|lyfalmen|||23|66|0|88,0000|Vistor hf|N.V. Organon|Desógestrel og östrógen||2504||2504|4303| 373241|N05AL0501|Solian|töflur|200|mg|90|stk|1|þpakki||N05AL05|01.01.2005||R|A|3|0|0|*|0|SNO|0|1|0|100|NOK|20302|27758|lyfalmen|V0105|27758|00|90|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríð||20302||20302|27758| 373324|R03AK0602|Seretide Diskus|innúðadu|150|mcg/sk|60|sk|1|pakki|50+100 mcg, discus|R03AK06|01.05.2000||R|A|1,5|0|0|B|0|GSK|0|0|0|100|GBP|4043|6408|lyfalmen|||23|60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||4043||4043|6408| 373340|R03AK0602|Seretide Diskus|innúðadu|300|mcg/sk|60|sk|1|pakki|50+250 mcg, discus|R03AK06|01.05.2000||R|A|1,5|0|0|0|0|GSK|0|0|0|100|GBP|7361|10947|lyfalmen|||23|60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||7361||7361|10947| 373365|R03AK0602|Seretide Diskus|innúðadu|550|mcg/sk|60|sk|1|pakki|50+500 mcg, discus|R03AK06|01.05.2000||R|A|1,5|0|0|0|0|GSK|0|0|0|100|GBP|9836|14332|lyfalmen|||23|60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||9836||9836|14332| 373951|G02CB0301|Dostinex|töflur|0,5|mg|2|stk|1|glas||G02CB03|01.04.1998||R|A|2|0|0|E|0|PER|0|0|0|100|DKK|2922|4874|lyfalmen|||44|2|0|1,0000|Icepharma hf|Pfizer ApS|Kabególín||2922||2922|4874| 374231|A10BA0201|Glucophage|töflur|500|mg|100|stk|1|þpakki||A10BA02|01.01.1987||R|A|5|0|0|*|0|MCK|0|0|0|100|SEK|688|1818|lyfalmen|||00|100|0|25,0000|Icepharma hf|Merck Santé s.a.s.|Metformín||688||688|1818| 374348|G04CA0201|Omnic|forðahlk|0,4|mg|30|stk|1|þpakki||G04CA02|01.08.1998||R|A|4|0|0|E|0|YAM|0|0|0|100|XEU|4597|7166|lyfalmen|||00|30|0|30,0000|Vistor hf|Yamanouchi Europe|Tamsúlósín||4597||4597|7166| 374397|J05AB1101|Valtrex|töflur|250|mg|60|stk|1|þpakki||J05AB11|01.01.2003||R|A|2|0|0|E|0|GSK|0|0|1|100|GBP|11278|16305|lyfalmen|||00|60|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Valacíklóvír||11278||11278|16305| 374504|G01AF0502|Pevaryl Depot|krem/sti|||15|g|1|sett|kr.+1sk-stíll m.forðaverkun|G01AF05|01.01.1997||L|A|3|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||00|15|0|1,5000|Vistor hf|McNeil Sweden AB|Ekónazól|||||| 374579|R01AC0101|Lomudal Nasal|nefúði|5,2|mg/sk|15|ml|1|glas||R01AC01|01.10.1992||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|2827|4744|lyfalmen|||23|15|0|15,0000|Vistor hf|Sanofi-aventis Norge AS|Krómóglíkatsýra||2827||2827|4744| 374587|B01AB0501|Klexane|stl|100|mg/ml|0,6|ml|10|lykjur|einnota dæla|B01AB05|01.01.1993||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|9099|13324|lyfalmen|||00|6|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||9099||9099|13324| 374595|B01AB0501|Klexane|stl|100|mg/ml|0,8|ml|10|lykjur|einnota dæla|B01AB05|01.01.1993||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|10954|15862|lyfalmen|||00|8|0|40,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||10954||10954|15862| 374603|B01AB0501|Klexane|stl|100|mg/ml|1|ml|10|lykjur|einnota dæla|B01AB05|01.01.1993||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|12670|18180|lyfalmen|||00|10|0|50,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||12670||12670|18180| 376509|L04AD0202|Prograf|hylki|1|mg|50|stk|1|þpakki||L04AD02|01.06.2010||R|A||0|1|*|0|ASP|0|0|0|100|XEU|20317|27777|lyfalmen|||00|50|0|10,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||20317||20317|27777| 376533|L04AD0202|Prograf|hylki|5|mg|50|stk|1|þpakki||L04AD02|01.06.2010||R|A||0|1|*|0|ASP|0|0|0|100|XEU|93097|119116|lyfalmen|||00|50|0|50,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||93097||93097|119116| 377242|J01FA0901|Klacid|töflur|500|mg|14|stk|1|þpakki||J01FA09|01.04.1992||R|A|5|0|0|0|0|ABS|0|0|1|100|DKK|4486|7014|lyfalmen|||63|14|0|14,0000|Vistor hf|Abbott Scandinavia AB|Klaritrómýcín||4486||4486|7014| 377333|J05AB1101|Valtrex|töflur|500|mg|42|stk|1|þpakki||J05AB11|01.10.1996||R|A|3|0|0|E|0|GSK|0|0|1|100|GBP|10923|10673|lyfalmen|V0508|9988|00|42|0|7,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Valacíklóvír||7161||7161|10673| 379669|H01CB0202|Sandostatin Lar|sts|10|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|K|3|0|1|0|1|NOH|0|0|0|100|DKK|121571|154454|lyfsjukr|||00|2|0|14,2900|Vistor hf|Novartis Healthcare A/S-|Oktreótíð||121571||121571|154454| 379677|H01CB0202|Sandostatin Lar|sts|20|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|K|3|0|1|0|1|NOH|0|0|0|100|DKK|164060|207778|lyfsjukr|||00|2|0|28,5700|Vistor hf|Novartis Healthcare A/S-|Oktreótíð||164060||164060|207778| 379685|H01CB0202|Sandostatin Lar|sts|30|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|K|3|0|1|0|1|NOH|0|0|0|100|DKK|205701|260037|lyfsjukr|||00|2|0|42,8600|Vistor hf|Novartis Healthcare A/S-|Oktreótíð||205701||205701|260037| 379875|N05BA0105|Stesolid|innhl|5|mg/2.5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|A|3|0|0|0|0|AGT|0|0|1|100|DKK|1507|2939|lyfalmen|||00|12|0|2,5000|Actavis Group hf|Actavis Group hf|Díazepam||1507||1507|2939| 379883|N05BA0105|Stesolid|innhl|10|mg/2.5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|A|3|0|0|0|0|AGT|0|0|1|100|DKK|1863|3426|lyfalmen|||00|12|0|5,0000|Actavis Group hf|Actavis Group hf|Díazepam||1863||1863|3426| 379925|L01CD0201|Taxotere|irs|40|mg/ml|0,5|ml|1|hgl|+ leysir|L01CD02|01.10.1996||R|K|1,5|0|1|0|1|AVS|0|0|0|100|NOK|29586|39013|lyfsjukr|||00|0|0|0,0000|Vistor hf|Aventis Pharma SA|Docetaxel||29586||29586|39013| 379933|L01CD0201|Taxotere|irs|40|mg/ml|2|ml|1|hgl|+ leysir|L01CD02|01.10.1996||R|K|2|0|1|0|1|AVS|0|0|0|100|NOK|114381|145431|lyfsjukr|||00|2|0|0,0000|Vistor hf|Aventis Pharma SA|Docetaxel||114381||114381|145431| 380642|A10AD0402|Humalog Mix50 100 E/ml Pen|stl|100|ae/ml|3|ml|5|pennar||A10AD04|01.12.2001||R|K|2|0|0|*|0|ELD|0|0|0|100|XEU|5999|9084|lyfalmen|||17|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insulín lispro||5999||5999|9084| 381194|A10AD0401|Humalog Mix25 100 E/ml Pen|stl|100|ae/ml|3|ml|5|pennar||A10AD04|01.09.1999||R|K|2|0|0|*|0|ELD|0|0|0|100|XEU|5596|8532|lyfalmen|||00|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insulín lispro||5596||5596|8532| 381505|G04BE0305|Vizarsin (Lyfis)|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|A||0|0|0|0|LYF|0|0|0|100|XEU|14212|12688|lyfalmen|V0098|12688|00|12|0|12,0000|Lyfís ehf|Lyfis ehf|Síldenafíl||8634||8634|12688| 383000|R03CC1201|Bambec|töflur|10|mg|100|stk|1|glas||R03CC12|01.10.1991||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|7046|10516|lyfalmen|||00|100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Bambúteról||7046||7046|10516| 383117|QP52AA5103|Drontal Vet.|töflur|250|mg|2|stk|1|pakki|230+20 mg|QP52AA51|01.06.2000||L|A|5|0|0|0|0|BAN|0|0|0|100|DKK|1285|2242|vetorma|||00|2|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||||1285|2242| 383133|QP52AA5103|Drontal Vet.|töflur|250|mg|20|stk|1|pakki|230+20 mg|QP52AA51|01.06.2000||R|A|5|0|0|0|0|BAN|0|0|0|100|DKK|7738|13499|vetorma|||00|20|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||7738||7738|13499| 383257|D01AC0802|Dermatin|sápa|20|mg/ml|60|ml|1|glas||D01AC08|01.07.1998||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||23|60|0|60,0000|Actavis Group hf|Actavis hf|Ketókónazól|||||| 383265|D01AC0802|Dermatin|sápa|20|mg/ml|120|ml|1|glas||D01AC08|01.07.1998||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||23|120|0|120,0000|Actavis Group hf|Actavis hf|Ketókónazól|||||| 386278|G04BE0305|Vizarsin (Lyfis)|filmhtfl|100|mg|8|stk|1|pakki||G04BE03|01.02.2011||R|A||0|0|0|0|LYF|0|0|0|100|XEU|6158|8319|lyfalmen|||00|8|0|16,0000|Lyfis ehf|Lyfis ehf|Síldenafíl||5440||5440|8319| 386953|L02BG0301|Arimidex|töflur|1|mg|98|stk|1|þpakki||L02BG03|01.03.1998||R|A|5|0|0|*|0|AZA|0|0|0|100|SEK|63501|81973|lyfalmen|||00|98|0|98,0000|Vistor hf|AstraZeneca AB|Anastrózól||63501||63501|81973| 387662|QA12CC0202|Magnesiumsulfat Icepharma vet.|stl|200|mg/ml|100|ml|1|plhgl||QA12CC02|01.07.1996||R|A|3|0|0|0|0|ICE|0|0|0|100|XEU|732|1456|vetalmen|||00|100|0|0,0000|Icepharma hf|Icepharma hf|||732||732|1456| 387746|J02AA0101|Abelcet|irþ|5|mg/ml|20|ml|10|hgl|+ síunálar|J02AA01|01.04.1996||R|K|2|0|0|0|1|ZPL|0|0|0|100|DKK|177797|225018|lyfsjukr|||00|200|0|28,5714|Zeneus Pharma Limited|Zeneus Pharma Limited|Amfóterícín||177797||177797|225018| 388256|N01BB2001|Emla|krem|0| |5|g|5|túpa|+12 umbúð.|N01BB20|01.01.1987||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|3735|5987|lyfalmen|V2002|5884|00|25|0|5,0000|Vistor hf|AstraZeneca A/S DK|Blöndur||3735||3735|5987| 388264|N01BB2001|Emla|krem|0| |30|g|1|túpa||N01BB20|01.01.1987||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|4212|6639|lyfalmen|||00|30|0|30,0000|Vistor hf|AstraZeneca A/S DK|Blöndur||4212||4212|6639| 388272|N01BB2001|Emla|plástur|0| |2|stk|1|pakki||N01BB20|01.04.1994||L|A|2|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||23|2|0|0,0000|Vistor hf|AstraZeneca A/S DK|Blöndur|||||| 388280|N01BB2001|Emla|plástur|0| |20|stk|1|pakki||N01BB20|01.04.1994||R|A|2|0|0|0|0|AZD|0|0|1|100|SEK|8193|12085|lyfalmen|||23|20|0|0,0000|Vistor hf|AstraZeneca A/S DK|Blöndur||8193||8193|12085| 388660|C09BA0201|Darazið|töflur|22,5|mg|100|stk|1|glas|10+12.5 mg|C09BA02|01.04.1998||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|2966|4935|lyfalmen|||00|100|0|100,0000|Actavis Group hf|Actavis hf|Enalapríl og þvagræsilyf||2966||2966|4935| 389106|G03FA0103|Femanor|töflur|0| |84|stk|1|pakki|þp 2+1 mg |G03FA01|01.08.1998||R|A|3|0|0|E|0|BIP|0|0|0|100|DKK|2377|4129|lyfalmen|V0388|4129|23|84|0|84,0000|Vistor hf|BioPhausia AB|Noretísterón og östrógen||2377||2377|4129| 389122|G03FB0503|Femasekvens|töflur|0| |84|stk|1|pakki|þp samsett pk. |G03FB05|01.08.1998||R|A|3|0|0|E|0|BIP|0|0|0|100|DKK|2172|3848|lyfalmen|||23|84|0|84,0000|Vistor hf|BioPhausia AB|Noretísterón og östrógen||2172||2172|3848| 389155|G03CA0312|Femanest|töflur|2|mg|84|stk|1|þpakki||G03CA03|01.05.1997||R|A|3|0|0|E|0|BIP|0|0|0|100|DKK|689|1820|lyfalmen|V0408|1820|00|84|0|84,0000|Vistor hf|BioPhausia AB|Estradíól||689||689|1820| 389171|G03CA0312|Femanest|töflur|1|mg|84|stk|1|þpakki||G03CA03|01.05.1997||R|A|3|0|0|E|0|BIP|0|0|0|100|DKK|638|1750|lyfalmen|||00|84|0|42,0000|Vistor hf|BioPhausia AB|Estradíól||638||638|1750| 389361|V08AB0501|Ultravist|stl/irl|300|mg J/ml|500|ml|8|fl||V08AB05|01.04.1989||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|372889|469858|lyfsjukr|||02|4000|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Jóprómíð||372889||372889|469858| 389395|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|10|sk-hyl|einnota hylki|S01BC03|01.04.1996||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|971|2206|lyfalmen|||00|3|0|0,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||971||971|2206| 389414|G04BE0305|Vizarsin (Lyfis)|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|A||0|0|0|0|LYF|0|0|0|100|XEU|5044|4813|lyfalmen|V0097|4813|00|4|0|4,0000|Lyfis ehf|Lyfis ehf|Síldenafíl||2877||2877|4813| 389443|N04BC0504|Oprymea (Lyfis)|töflur|0,18|mg|100|stk|1|þpakki||N04BC05|01.07.2010||R|A||0|0|E|0|LYF|0|0|0|100|XEU|7203|5601|lyfalmen|V2020|5601|00|100|0|7,2000|Lyfis ehf|Lyfis ehf|Pramipexól||3453||3453|5601| 390757|A07AA0201|Mycostatin|mixtúra|100000|ae/ml|100|ml|1|glas||A07AA02|01.04.1974||R|K|1|0|0|E|0|BRS|0|0|1|100|DKK|2929|4884|lyfalmen|||01|100|0|6,6667|Vistor hf|Bristol-Myers Squibb|Nýstatín||2929||2929|4884| 390971|M01AH0101|Celebra|hylki|100|mg|100|stk|1|þpakki||M01AH01|01.07.2002||R|A|3|0|0|E|0|PER|0|0|1|100|DKK|7018|10478|lyfalmen|V2142|10476|00|100|0|50,0000|Icepharma hf|Pfizer ApS|Celekoxíb||7018||7018|10478| 390997|M01AH0101|Celebra|hylki|200|mg|20|stk|1|þpakki||M01AH01|01.07.2002||R|A|3|0|0|E|0|PER|0|0|1|100|DKK|2772|4669|lyfalmen|||00|20|0|20,0000|Icepharma hf|Pfizer ApS|Celekoxíb||2772||2772|4669| 391268|M01AH0101|Celebra|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.07.2002||R|A|3|0|0|E|0|PER|0|0|1|100|DKK|13524|19252|lyfalmen|V2140|19250|00|100|0|100,0000|Icepharma hf|Pfizer ApS|Celekoxíb||13524||13524|19252| 391730|N01BB0203|Xylocain|úðalyf|100|mg/ml|50|ml|1|glas|+ sk-úðari|N01BB02|01.10.1990||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|3402|5531|lyfalmen|||00|50|0|0,0000|Vistor hf|AstraZeneca A/S DK|Lídókaín||3402||3402|5531| 392225|V08CA0301|Omniscan|stl|0,5|mmol/ml|50|ml|10|plastf|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|A||0|0|0|1|GEH|0|0|0|100|NOK|268465|338806|lyfsjukr|||00|500|0||Icepharma hf|GE Healthcare AS|Gadódíamíð||268465||268465|338806| 392563|A04AA0103|Zofran|mixtúra|0,8|mg/ml|50|ml|1|flaska||A04AA01|01.08.2009||R|A||0|0|E|0|PCO|0|0|0|100|IKR|12000|17339|lyfalmen|||00|50|1||Distica|Distica - óskráð lyf|Ondansetrón||||12000|17339| 393918|QJ51CF0204|Orbenin vet.|spenalyf|500|mg/dælu|1|stk|24|spr||QJ51CF02|01.09.1983||R|S|4|0|0|0|0|PAL|0|0|0|100|XEU|5031|9833|vetalmen|||16|24|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||5031||5031|9833| 393934|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 393942|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 393959|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 394262|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 395954|V08CA0101|Magnevist|stl|469|mg/ml|30|ml|10|hgl|röntgenskuggaefni|V08CA01|01.04.2007||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|181800|230042|lyfsjukr|||02|300|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||181800||181800|230042| 397745|L01BC0601|Xeloda|töflur|150|mg|60|stk|1|þpakki||L01BC06|01.01.2002||R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|10765|15393|lyfsjukr|||00|60|0|0,0000|Icepharma hf|Roche|Capecitabín||10765||10765|15393| 397752|L01BC0601|Xeloda|töflur|500|mg|120|stk|1|þpakki||L01BC06|01.01.2002||R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|56917|73313|lyfsjukr|||00|120|0|0,0000|Icepharma hf|Roche|Capecitabín||56917||56917|73313| 399241|B01AC0404|Clopidogrel Krka (Lyfis)|filmhtfl|75|mg|28|stk|1|þpakki||B01AC04|01.07.2010||R|A||0|0|E|0|LYF|0|0|0|100|XEU|6345|5335|lyfalmen|V1091|5277|00|28|0|28,0000|Lyfis ehf|Lyfis ehf|Klópídógrel||3259||3259|5335| 399519|N03AX0901|Lamictal|dreifit.|50|mg|56|stk|1|þpakki||N03AX09|01.03.1999||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|2049|3223|lyfalmen|V0703|3223|00|56|0|9,3333|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||1715||1715|3223| 399733|B01AB0401|Fragmin|stl|25000|ae/ml|0,3|ml|10|áf.spr|7500 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.1993||R|A|3|0|0|E|0|PER|0|0|1|100|DKK|9048|13254|lyfalmen|||02|3|0|30,0000|Icepharma hf|Pfizer ApS|Dalteparín||9048||9048|13254| 399782|D06BB0601|Vectavir|krem|10|mg/g|2|g|1|túpa||D06BB06|01.04.1997||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|2|0|2,0000|Artasan ehf|Novartis Healthcare A/S-A|Pencíklóvír|||||| 400044|S03CA0102|Sofradex|aug.eydr|0| |8|ml|1|glas||S03CA01|01.03.1980||R|A|2|0|0|E|0|SNO|0|0|1|100|NOK|1743|3262|lyfalmen|||06|8|0|0,0000|Vistor hf|Sanofi-aventis Norge AS|Dexametasón og sýkingalyf||1743||1743|3262| 400101|R05DB2002|Pektolin|mixtúra|0| |150|ml|1|glas||R05DB20|01.06.1981||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|150|0|0,0000|Actavis Group hf|Actavis hf|Blöndur|||||| 400143|C10AB0401|Lopid|hylki|300|mg|100|stk|1|þpakki||C10AB04|01.04.1988||R|A|5|0|0|0|0|PER|0|0|0|100|DKK|5584|8516|lyfalmen|||10|100|0|25,0000|Icepharma hf|Pfizer ApS|Gemfíbrózíl||5584||5584|8516| 400267|N05BA0402|Sobril|töflur|25|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|A|3|0|0|0|0|PER|0|0|1|100|DKK|363|1374|lyfalmen|||00|25|0|12,5000|Icepharma hf|Pfizer ApS|Oxazepam||363||363|1374| 400424|N05BA0402|Sobril|töflur|15|mg|100|stk|1|þpakki||N05BA04|01.01.1985||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|433|1470|lyfalmen|||00|100|0|30,0000|Icepharma hf|Pfizer ApS|Oxazepam||433||433|1470| 400432|N05BA0402|Sobril|töflur|15|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|A|3|0|0|0|0|PER|0|0|1|100|DKK|258|1230|lyfalmen|||00|25|0|7,5000|Icepharma hf|Pfizer ApS|Oxazepam||258||258|1230| 400804|N07BA0103|Nicorette|forðapl|15|mg/16kls|7|stk|1|pakki||N07BA01|01.07.1992|31.01.2011|L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|7|0|7,5000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 401828|N06AA1001|Noritren|töflur|10|mg|100|stk|1|glas||N06AA10|01.01.1985||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|760|1917|lyfalmen|||00|100|0|13,3333|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||760||760|1917| 401851|N06AA1001|Noritren|töflur|25|mg|100|stk|1|glas||N06AA10|01.01.1985||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|1217|2542|lyfalmen|||00|100|0|33,3333|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||1217||1217|2542| 401877|C09AA0103|Katopril|töflur|25|mg|100|stk|1|pakki||C09AA01|01.10.1995||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|1246|2582|lyfalmen|||00|100|0|50,0000|Actavis Group hf|Actavis hf|Kaptópríl||1246||1246|2582| 401901|C09AA0103|Katopril|töflur|50|mg|100|stk|1|pakki||C09AA01|01.10.1995||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|2000|3613|lyfalmen|||00|100|0|100,0000|Actavis Group hf|Actavis hf|Kaptópríl||2000||2000|3613| 402651|J07BB0205|Influvac|bóluefni|0| |0,5|ml|1|spr|einnotaspr|J07BB02|01.12.1998||R|K|1|0|0|0|0|SOB|0|0|0|100|XEU|655|1773|lyfalmen|||51|0|0|0,0000|Icepharma hf|Solvay Biologicals B.V.|Inflúensa, hreinsaðir mótefnavakar||655||655|1773| 402743|QJ01RA0102|Streptocillin, vet.|stl|0| |100|ml|1|hgl||QJ01RA01|01.11.1979||R|K|2|0|0|0|0|BID|0|0|0|100|DKK|1595|3173|vetalmen|||58|100|0|0,0000|Vistor hf|Boehringer Ingelheim Danmark|||1595||1595|3173| 403226|L04AA0605|Myfenax (Lyfis)|hylki|250|mg|100|stk|1|þpakki||L04AA06|01.03.2011||R|A||0|1|*|0|LYF|0|0|0|100|XEU|25045|28998|lyfalmen|||00|100|0|12,5000|Lyfis ehf|Lyfis ehf|Mýcófenólsýra||21290||21290|28998| 403444|QG02AD9001|Estrumat, vet.|stl|0,25|mg/ml|20|ml|1|hgl||QG02AD90|01.01.1991||R|A|2|0|0|0|0|IBV|1|0|0|100|DKK|5153|10067|vetalmen|||27|20|0|0,0000|Vistor hf|Intervet International BV|||5153||5153|10067| 403550|C08CA0302|Lomir Retard|forðahlk|2,5|mg|100|stk|1|þpakki||C08CA03|01.10.1992||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|7020|10480|lyfalmen|||10|100|0|50,0000|Vistor hf|Novartis Healthcare A/S-|Ísradipín||7020||7020|10480| 403915|S01GX0101|Lomudal|augndr|20|mg/ml|13,5|ml|1|glas||S01GX01|01.07.1992||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|1393|2783|lyfalmen|||06|14|0|0,0000|Vistor hf|Sanofi-aventis Norge AS|Krómóglíkatsýra||1393||1393|2783| 404426|S01XA2019|Oftagel|augngel|2,5|mg/g|10|g|1|túpa||S01XA20|01.04.2004||L|A|2,5|0|0|E|0|SAO|0|0|0|100|XEU|||lyfalmen|||00|10|0|0,0000|Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar sam­setningar|||||1758| 404533|B01AD0201|Actilyse|sts/irs|50|mg|1|stk|1|hgl|+ leysir|B01AD02|01.07.1989||R|A|3|0|0|0|1|BOI|0|0|0|100|DKK|75564|96715|lyfsjukr|||02|1|0|0,5000|Vistor hf|Boehringer Ingelheim|Alteplasi||75564||75564|96715| 404939|B02BA0102|Konakion Novum|stl|10|mg/ml|1|ml|5|lykjur||B02BA01|01.04.1991||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|628|906|lyfsjukr|||02|5|0|2,5000|Icepharma hf|Roche|Fýtómenadíón||628||628|906| 405589|J07BD5203|Priorix|bóluefni|0| |0,5|ml|1|hgl|+ einnota dæla|J07BD52|01.03.1999||R|K|2|0|0|0|0|GSK|0|0|0|100|GBP|1756|3279|lyfalmen|||00|0|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|mislingar í blöndum með hettusótt og rauðum hundum (veiklaða||1756||1756|3279| 405597|J07BD5203|Priorix|bóluefni|0| |0,5|ml|10|hgl||J07BD52|01.11.2001||R|K|2|0|0|0|0|GSK|0|0|0|100|GBP|21666|29470|lyfalmen|||00|5|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|mislingar í blöndum með hettusótt og rauðum hundum (veiklaða||21666||21666|29470| 405985|N05AE0301|Serdolect|filmhtfl|12|mg|28|stk|1|þpakki||N05AE03|01.01.2006||R|A|5|0|0|*|0|LBK|0|1|0|100|DKK|20677|28229|lyfalmen|||00|28|0|21,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||20677||20677|28229| 406025|V08AB0201|Omnipaque|stl|300|mg J/ml|50|ml|10|plastf||V08AB02|01.12.1983||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|20662|27813|lyfsjukr|||02|500|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||20662||20662|27813| 406033|N05AE0301|Serdolect|filmhtfl|16|mg|28|stk|1|þpakki||N05AE03|01.01.2006||R|A|5|0|0|*|0|LBK|0|1|0|100|DKK|20677|28229|lyfalmen|||00|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||20677||20677|28229| 406165|N05AE0301|Serdolect|filmhtfl|20|mg|28|stk|1|þpakki||N05AE03|01.01.2006||R|A|5|0|0|*|0|LBK|0|1|0|100|DKK|20677|28229|lyfalmen|||00|28|0|35,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||20677||20677|28229| 406322|N05AE0301|Serdolect|filmhtfl|4|mg|100|stk|1|glas||N05AE03|01.10.2006||R|A|5|0|0|*|0|LBK|0|1|0|100|DKK|20883|28487|lyfalmen|||00|100|0|25,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||20883||20883|28487| 406355|V08AB0201|Omnipaque|stl|350|mg J/ml|50|ml|10|plastf||V08AB02|01.12.1983||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|23122|30901|lyfsjukr|||02|500|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||23122||23122|30901| 406371|N05AE0301|Serdolect|filmhtfl|12|mg|100|stk|1|glas||N05AE03|01.10.2006||R|A|5|0|0|*|0|LBK|0|1|0|100|DKK|62958|81291|lyfalmen|||00|100|0|75,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||62958||62958|81291| 406389|N05AE0301|Serdolect|filmhtfl|16|mg|100|stk|1|glas||N05AE03|01.10.2006||R|A|5|0|0|*|0|LBK|0|1|0|100|DKK|68285|87977|lyfalmen|||00|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||68285||68285|87977| 406397|N05AE0301|Serdolect|filmhtfl|20|mg|100|stk|1|glas||N05AE03|01.10.2006||R|A|5|0|0|*|0|LBK|0|1|0|100|DKK|73613|94663|lyfalmen|||00|100|0|125,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||73613||73613|94663| 406462|N05AE0301|Serdolect|filmhtfl|4|mg|30|stk|1|þpakki||N05AE03|01.01.2006||R|A|5|0|0|*|0|LBK|0|1|0|100|DKK|6978|10423|lyfalmen|||00|30|0|7,5000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||6978||6978|10423| 407395|N02CA7201|Anervan|töflur|160,5|mg|100|stk|1|pakki|þp (0,5+10+50+100 mg)|N02CA72|01.10.1995||R|A|3|0|0|E|0|REP|0|0|0|100|SEK|2298|4021|lyfalmen|||00|100|0|50,0000|Vistor hf|Recip AB|Ergotamínlyf í blöndum með geðlyfjum (psycoleptica)||2298||2298|4021| 407981|N05BA0402|Sobril|töflur|10|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|A|1,5|0|0|0|0|PER|0|0|1|100|DKK|244|1211|lyfalmen|||00|25|0|5,0000|Icepharma hf|Pfizer ApS|Oxazepam||244||244|1211| 407999|N05BA0402|Sobril|töflur|10|mg|100|stk|1|þpakki||N05BA04|01.01.1985||R|A|1,5|0|0|0|0|PER|0|0|0|100|DKK|379|1396|lyfalmen|||00|100|0|20,0000|Icepharma hf|Pfizer ApS|Oxazepam||379||379|1396| 408740|D07AC0104|Diproderm|smyrsli|0,5|mg/g|100|g|1|túpa||D07AC01|01.03.1977||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|4884|7558|lyfalmen|||20|100|0|100,0000|Vistor hf|Schering-Plough|Betametasón||4884||4884|7558| 408773|D07AC0104|Diproderm|áburður|0,5|mg/ml|100|ml|1|glas||D07AC01|01.03.1977||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|2908|4855|lyfalmen|||20|100|0|100,0000|Vistor hf|Schering-Plough|Betametasón||2908||2908|4855| 409078|J02AC0101|Diflucan|mixtúrud|10|mg/ml|35|ml|1|glas||J02AC01|01.07.1992||R|A|2|0|0|0|0|PER|0|0|1|100|DKK|5229|8030|lyfalmen|||08|35|0|1,7500|Icepharma hf|Pfizer ApS|Flúkónazól||5229||5229|8030| 409417|C09CA0701|Micardis|töflur|80|mg|28|stk|1|þpakki||C09CA07|01.02.2008||R|A|4|0|0|0|0|BII|0|0|0|100|DKK|3862|6160|lyfalmen|||00|28|0|56,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||3862||3862|6160| 409425|R01AD0502|Rhinocort Turbuhaler|nefúðad|100|mcg/sk|200|sk|1|stauk||R01AD05|01.01.1992||R|A|2|0|0|E|0|AZD|0|0|1|100|SEK|4475|6999|lyfalmen|||23|200|0|100,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||4475||4475|6999| 409474|C09CA0701|Micardis|töflur|80|mg|98|stk|1|þpakki||C09CA07|01.02.2008||R|A|4|0|0|0|0|BII|0|0|0|100|DKK|12475|17935|lyfalmen|||00|98|0|196,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||12475||12475|17935| 409516|C09CA0701|Micardis|töflur|40|mg|28|stk|1|þpakki||C09CA07|01.02.2008||R|A|4|0|0|0|0|BII|0|0|0|100|DKK|3043|5040|lyfalmen|||00|28|0|28,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||3043||3043|5040| 409532|QN05AA0402|Plegicil vet.|stl|10|mg/ml|20|ml|6|hgl||QN05AA04|01.11.2007||R|A|3|0|0|0|0|PSW|1|0|0|100|DKK|10617|20559|vetalmen|||27|120|0|0,0000|Vistor hf|Pharmaxim Sweden AB|||10617||10617|20559| 409631|C07AB0309|Atenolol Actavis|töflur|25|mg|100|stk|1|glas||C07AB03|01.04.1987||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|575|1664|lyfalmen|V0290|1664|00|100|0|33,3333|Actavis Group hf|Actavis hf|Atenólól||||575|1664| 409763|C09CA0701|Micardis|töflur|40|mg|98|stk|1|þpakki||C09CA07|01.02.2008||R|A|4|0|0|0|0|BII|0|0|0|100|DKK|10109|14706|lyfalmen|||00|98|0|98,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||10109||10109|14706| 410639|P01BA0102|Klorokinfosfat Recip|filmhtfl|250|mg|20|stk|1|þpakki||P01BA01|01.08.2005||R|A|5|0|0|0|0|REP|0|0|0|100|SEK|1335|2703|lyfalmen|||00|20|0|10,0000|Vistor hf|Recip AB|Klórókín||1335||1335|2703| 410712|D10AD0102|Aberela|krem|0,05|%|30|g|1|túpa||D10AD01|01.10.2007||R|A|2|0|0|0|0|JAS|0|0|0|100|SEK|782|1947|lyfalmen|||23|30|0|30,0000|Vistor hf|Janssen-Cilag AB|Tretínóín||782||782|1947| 411033|M03BX0105|Baklofen Mylan|töflur|10|mg|50|stk|1|þpakki||M03BX01|01.01.1990||R|A|3|0|0|E|0|MYL|0|0|1|100|SEK|684|1813|lyfalmen|||00|50|0|10,0000|Actavis Group PTC ehf|Mylan AB|Baklófen||684||684|1813| 411389|N05CD0801|Dormicum|stl|5|mg/ml|10|ml|5|lykjur||N05CD08|01.10.1990||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|4154|5995|lyfsjukr|||02|50|0|16,6667|Icepharma hf|Roche|Mídazólam||4154||4154|5995| 411827|J05AF0501|Epivir|töflur|150|mg|60|stk|1|glas||J05AF05|01.03.1999||R|A|2|0|1|0|1|VII|0|0|0|100|GBP|24878|33104|lyfsjukr|||00|60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Lamívúdín||24878||24878|33104| 411868|M01AB0505|Voltaren|sh-tfl|25|mg|100|stk|1|þpakki||M01AB05|01.11.1981||R|A|5|0|0|E|0|NOH|0|0|1|100|DKK|1866|3430|lyfalmen|||67|100|0|25,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||1866||1866|3430| 411918|N02CC0101|Imigran|nefúði|20|mg/sk|6|sk|1|pakki||N02CC01|01.07.2000||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|7573|11237|lyfalmen|||98|6|0|6,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||7573||7573|11237| 412049|L02AE0301|Zoladex|vefjalyf|3,6|mg|1|stk|1|áf.spr|+ dæla|L02AE03|01.01.1990||R|A|3|0|1|*|0|AZA|0|0|0|100|SEK|26264|35240|lyfalmen|V0564|35240|00|1|0|27,9070|Vistor hf|AstraZeneca AB|Góserelín||26264||26264|35240| 412361|B01AB0501|Klexane|stl|100|mg/ml|3|ml|1|hgl|með rotv.|B01AB05|01.02.1999||R|A|2|0|0|0|1|SNO|0|0|0|100|NOK|4143|5979|lyfsjukr|||00|3|0|15,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||4143||4143|5979| 412395|QM01AE0301|Romefen, vet.|stl|100|mg/ml|100|ml|1|hgl||QM01AE03|01.10.1995||R|A|3|0|0|0|0|MER|1|0|0|100|DKK|10037|19445|vetalmen|||02|100|0|0,0000|Vistor hf|Merial|||10037||10037|19445| 412825|L02BA0107|Tamoxifen Mylan|töflur|10|mg|100|stk|1|glas||L02BA01|01.01.1990||R|A|5|0|0|*|0|MYL|0|0|0|100|SEK|3437|5579|lyfalmen|||00|100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Tamoxífen||3437||3437|5579| 412924|L02BA0107|Tamoxifen Mylan|töflur|20|mg|100|stk|1|glas||L02BA01|01.01.2010||R|A||0|0|*|0|MYL|0|0|0|100|SEK|4778|7413|lyfalmen|||00|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Tamoxífen||4778||4778|7413| 414458|V04CF0102|Tuberkulin|stl|2|TU/0,1ml|1,5|ml|1|hgl||V04CF01|01.01.1998||R|K||0|0|0|0|LDR|0|0|0|100|DKK|2148|3816|lyfalmen|||00|2|1|0,0000|Parlogis hf|Parlogis - óskráð lyf|||2148||2148|3816| 414680|C03BA1102|Natrilix Retard|forðatfl|1,5|mg|90|stk|1|þpakki||C03BA11|01.03.1999||R|A|2|0|0|E|0|SEV|0|0|0|100|DKK|4553|7106|lyfalmen|||00|90|0|54,0000|Icepharma hf|Servier|Indapamíð||4553||4553|7106| 414789|N03AF0104|Tegretol|mixtúra|20|mg/ml|300|ml|1|glas||N03AF01|01.09.2007||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|1455|2868|lyfalmen|||00|300|0|6,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||1455||1455|2868| 415556|B03AC0204|Venofer (D.A.C.)|stl|20|mg/ml|5|ml|5|hgl||B03AC02|01.03.2011||R|A|3|0|0|E|0|DAC|0|0|1|100|CHF|15064|19766|lyfalmen|V0011|19474|00|25|0|5,0000|D.A.C. ehf|D.A.C. ehf|Járnoxíð (sykurflétta)||13934||13934|19766| 415679|G03CA0310|Vagifem|sk-tfl|25|mcg|15|stk|1|pakki||G03CA03|01.01.1995||R|A|3|0|0|E|0|NON|0|0|0|100|DKK|1903|3480|lyfalmen|||05|15|0|15,0000|Vistor hf|Novo-Nordisk|Estradíól||1903||1903|3480| 416222|C09DA0101|Cozaar Comp|filmhtfl|62,5|mg|28|stk|1|þpakki|50+12,5 mg|C09DA01|01.09.1997||R|A|3|0|0|0|0|MSD|0|0|0|100|XEU|3592|5791|lyfalmen|||00|28|0|28,0000|Icepharma hf|M.S.D.|Lósartan og þvagræsilyf||3592||3592|5791| 416446|C09DA0101|Cozaar Comp|filmhtfl|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.09.1997||R|A|3|0|0|0|0|MSD|0|0|0|100|XEU|9515|9461|lyfalmen|V2219|4714|00|98|0|98,0000|Icepharma hf|M.S.D.|Lósartan og þvagræsilyf||6275||6275|9461| 416818|A02BA0205|Zantac|mixtúra|15|mg/ml|300|ml|1|glas||A02BA02|01.07.2000||R|A||0|0|E|0|PCO|0|0|0|100|GBP|4985|7696|lyfalmen|||00|300|1|15,0000|Distica|Distica - óskráð lyf|Ranitidín||4985||4985|7696| 416829|N07BC0101|Subutex|tungur.t|8|mg|7|stk|1|þpakki||N07BC01|01.03.2011||R|A|1|1|0|0|1|RBP|0|0|0|100|DKK|4915|7094|lyfsjukr|||00|7|0|7,0000|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín||4915||4915|7094| 416859|A01AA0101|Duraphat|tannlakk|22,6|mg/ml|10|ml|1|túpa||A01AA01|01.10.1995||R|A|5|0|0|E|0|GOG|0|0|1|100|XEU|2901|4846|lyfalmen|||23|10|0|0,0000|Icepharma hf|Colgate Palmolive A/S|Natríumflúoríð||2901||2901|4846| 416867|A01AA0101|Duraphat|tannlakk|22,6|mg/ml|30|ml|5|túpa||A01AA01|01.10.1988||R|A|5|0|0|E|0|GOG|0|0|1|100|XEU|24394|32894|lyfalmen|||23|150|0|0,0000|Icepharma hf|Colgate Palmolive A/S|Natríumflúoríð||24394||24394|32894| 416883|D10AX0301|Skinoren|krem|200|mg/g|30|g|1|túpa||D10AX03|01.07.1991||R|A|5|0|0|0|0|IGB|0|0|0|100|SEK|1239|2572|lyfalmen|||00|30|0|30,0000|Icepharma hf|Intendis GmbH Berlin|Azelainsýra||1239||1239|2572| 417832|J05AF0601|Ziagen|filmhtfl|300|mg|60|stk|1|þpakki||J05AF06|01.07.2005||R|A|3|0|1|0|1|VII|0|0|0|100|GBP|40719|52985|lyfsjukr|||00|60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Abacavír||40719||40719|52985| 418483|A07EC0201|Mesasal|sh-tfl|250|mg|100|stk|1|þpakki||A07EC02|01.10.1991||R|A|3|0|0|B|0|SNO|0|0|0|100|NOK|4735|7354|lyfalmen|||10|100|0|16,6667|Vistor hf|Sanofi-aventis Norge AS|Mesalazín (5-amínósalicýlsýra)||4735||4735|7354| 418665|D07XC0101|Diprosalic|smyrsli|0| |50|g|1|túpa||D07XC01|01.11.1979||R|A|5|0|0|B|0|SCP|0|0|1|100|DKK|1745|3264|lyfalmen|||20|50|0|50,0000|Vistor hf|Schering-Plough|Betametasón||1745||1745|3264| 418731|A07EC0201|Mesasal|eþ-stíll|500|mg|60|stk|1|pakki||A07EC02|01.10.1991||R|A|4|0|0|B|0|SNO|0|0|0|100|NOK|9631|14052|lyfalmen|V0299|10966|00|60|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Mesalazín (5-amínósalicýlsýra)||9631||9631|14052| 418988|QA07AA0101|Colinovina, vet.|mixtúra|200|mg/ml|200|ml|1|glas||QA07AA01|01.03.1981||R|A|2|0|0|0|0|BID|0|0|0|100|DKK|1953|3885|vetalmen|||13|200|0|0,0000|Vistor hf|Boehringer Ingelheim Danmark|||1953||1953|3885| 418996|QA07AA0101|Colinovina, vet.|mixtúra|200|mg/ml|200|ml|1|sett|+ dæla|QA07AA01|01.03.1981||R|A|2|0|0|0|0|BID|0|0|0|100|DKK|2535|5040|vetalmen|||13|200|0|0,0000|Vistor hf|Boehringer Ingelheim Danmark|||2535||2535|5040| 419242|A11CC0301|Etalpha|hylki|0,25|mcg|100|stk|1|þpakki||A11CC03|01.11.1979||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|4094|6478|lyfalmen|||10|100|0|25,0000|Vistor hf|LEO Pharma A/S|Alfakalsídól||4094||4094|6478| 419309|A11CC0301|Etalpha|hylki|1|mcg|100|stk|1|þpakki||A11CC03|01.11.1979||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|7132|10633|lyfalmen|||10|100|0|100,0000|Vistor hf|LEO Pharma A/S|Alfakalsídól||7132||7132|10633| 419440|L01DB0103|Caelyx|irþ|2|mg/ml|10|ml|1|hgl||L01DB01|01.05.1999|31.12.2010|R|K|1,6|0|1|0|1|SCP|0|0|0|100|DKK|59270|76266|lyfsjukr|||00|10|0|0,0000|Vistor hf|Schering-Plough|Doxórúbicín||59270||59270|76266| 419820|J05AE0201|Crixivan|hylki|400|mg|180|stk|1|glas||J05AE02|01.04.1997||R|A|3|0|1|0|1|MSD|0|0|0|100|XEU|55597|71657|lyfsjukr|||00|180|0|30,0000|Icepharma hf|M.S.D.|Indínavír||55597||55597|71657| 419838|A16AA0401|Cystagon|hylki|150|mg|100|stk|1|glas||A16AA04|01.02.2008||R|A|2|0|1|0|1|ORP|0|0|0|100|DKK|46950|60805|lyfsjukr|||00|100|0|7,5000|Swedish Orphan International AB|Orphan Europe (S)|Mecaptamín||46950||46950|60805| 419945|D07AD0101|Dermovat|húðlausn|0,5|mg/ml|25|ml|1|glas|í hársvörð|D07AD01|01.09.1982||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|823|2003|lyfalmen|||20|25|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||823||823|2003| 420117|B01AB0401|Fragmin|stl|10000|ae/ml|1|ml|10|lykjur||B01AB04|01.04.1993||R|A|3|0|0|E|0|PER|0|0|1|100|DKK|12090|17452|lyfalmen|||02|10|0|40,0000|Icepharma hf|Pfizer ApS|Dalteparín||12090||12090|17452| 421180|C01BD0101|Cordarone|töflur|100|mg|30|stk|1|þpakki||C01BD01|01.07.1989||R|A|5|0|0|B|0|SNO|0|0|0|100|NOK|1854|3413|lyfalmen|V0144|3412|70|30|0|15,0000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||1854||1854|3413| 422121|C07AB0205|Seloken|töflur|50|mg|100|stk|1|þpakki||C07AB02|01.05.2009||R|A|5|0|0|B|0|AZD|0|0|0|100|SEK|1710|3216|lyfalmen|V2005|2247|00|100|0|33,3300|Vistor hf|AstraZeneca A/S DK|Metóprólól||||1710|3216| 422246|C07AB0206|Seloken ZOC|forðatfl|95|mg|98|stk|1|þpakki||C07AB02|01.07.1988||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|3756|5315|lyfalmen|V2004|4223|43|98|0|62,0700|Vistor hf|AstraZeneca A/S DK|Metóprólól||3244||3244|5315| 422337|C07AB0206|Seloken ZOC|forðatfl|190|mg|98|stk|1|þpakki||C07AB02|01.07.1988||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|7398|10997|lyfalmen|||43|98|0|124,1300|Vistor hf|AstraZeneca A/S DK|Metóprólól||7398||7398|10997| 422659|G02CB0102|Parlodel|töflur|2,5|mg|100|stk|1|glas||G02CB01|01.11.1979||R|A|3|0|0|E|0|MAS|0|0|0|100|SEK|9613|14027|lyfalmen|||49|100|0|50,0000|Vistor hf|Meda AS|Brómókriptín||9613||9613|14027| 424960|QP52AC1302|Panacur, vet.|pasta|187,5|mg/g|24|g|1|sk-dæl||QP52AC13|01.05.1999||L|A|3|0|0|0|0|INI|0|0|0|100|DKK|1626|2836|vetorma|||16|24|0|0,0000|Icepharma hf|Intervet International B.V.|||||1626|2836| 425181|N05CD0306|Flunitrazepam Mylan|töflur|1|mg|100|stk|1|glas||N05CD03|01.10.1992||R|A|5|1|0|0|0|MYL|0|0|0|100|SEK|1074|2346|lyfalmen|||00|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Flúnítrazepam||1074||1074|2346| 425538|N04BC0102|Parlodel|hylki|10|mg|100|stk|1|þpakki||N04BC01|01.11.1979||R|A|4|0|0|E|0|MAS|0|0|0|100|SEK|33360|44146|lyfalmen|||52|100|0|25,0000|Vistor hf|Meda AS|Brómókriptín||33360||33360|44146| 426122|R01AA0503|Nezeril|nefdr|0,1|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|A|2|0|0|0|0|GCO|0|0|1|100|IKR|||lyflausa|||23|2|0|0,5000|Vistor hf|GlaxoSmithKline CH AB|Oxýmetazólín|||||| 426312|J02AC0101|Diflucan|hylki|150|mg|2|stk|1|þpakki||J02AC01|01.04.1993||R|A|5|0|0|0|0|PER|0|0|1|100|DKK|3429|5568|lyfalmen|V0555|2848|10|2|0|1,5000|Icepharma hf|Pfizer ApS|Flúkónazól||3429||3429|5568| 426593|J01CE0204|Kaavepenin|töflur|500|mg|20|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|680|1807|lyfalmen|||00|20|0|5,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||680||680|1807| 426601|J01CE0204|Kaavepenin|töflur|500|mg|30|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|888|2092|lyfalmen|||00|30|0|7,5000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||888||888|2092| 427351|N07BA0103|Nicorette|forðapl|5|mg/16kls|14|stk|1|pakki||N07BA01|01.07.1992|31.01.2011|L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|14|0|5,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 427369|N07BA0103|Nicorette|forðapl|10|mg/16kls|14|stk|1|pakki||N07BA01|01.07.1992|31.01.2011|L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|14|0|10,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 427377|N07BA0103|Nicorette|forðapl|15|mg/16kls|14|stk|1|pakki||N07BA01|01.07.1992|31.01.2011|L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|14|0|15,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 427765|A06AB0801|Laxoberal|dropar|7,5|mg/ml|30|ml|1|plglas||A06AB08|01.09.2008||L|A|3|0|0|0|0|BII|0|0|0|100|IKR|||lyfalmen|||00|30|0|45,0000|Vistor hf|Boehringer Ingelheim International |Natríum pícós|||||2636| 428441|D07AC1301|Elocon|krem|0,1|%|30|g|1|túpa||D07AC13|01.08.2008||R|A|2|0|0|B|0|SCP|0|0|1|100|DKK|997|2241|lyfalmen|||20|30|0|30,0000|Vistor hf|Schering-Plough|Mómetasón||997||997|2241| 428524|D07AC1301|Elocon|smyrsli|0,1|%|30|g|1|túpa||D07AC13|01.08.2008||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|990|2232|lyfalmen|||20|30|0|30,0000|Vistor hf|Schering-Plough|Mómetasón||990||990|2232| 428672|J01CA0406|Flemoxin Solutab|lausnart|125|mg|14|stk|1|þpakki||J01CA04|01.04.1992||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|503|1565|lyfalmen|||23|14|0|1,7500|Vistor hf|Astellas Pharma A/S|Amoxicillín||503||503|1565| 428680|J01CA0406|Flemoxin Solutab|lausnart|250|mg|14|stk|1|þpakki||J01CA04|01.04.1992||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|830|2013|lyfalmen|||23|14|0|3,5000|Vistor hf|Astellas Pharma A/S|Amoxicillín||830||830|2013| 428813|C07AB0309|Atenolol Actavis|töflur|25|mg|30|stk|1|glas||C07AB03|01.01.1992||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|180|1123|lyfalmen|||00|30|0|10,0000|Actavis Group hf|Actavis hf|Atenólól||180||180|1123| 429167|J07CA0602|Pentavac|bóluefni|0| |0,5|ml|1|hgl|+ dreifa í dælu|J07CA06|01.10.1999||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|5575|8504|lyfalmen|||AC|0|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|barnaveiki, haemophilus influenza B, kíghósti, mænusótt, stí||5575||5575|8504| 429225|J07CA0602|Pentavac|bóluefni|0| |0,5|ml|10|hgl||J07CA06|01.12.1999||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|41701|54614|lyfalmen|||AC|5|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|barnaveiki, haemophilus influenza B, kíghósti, mænusótt, stí||41701||41701|54614| 429837|C03DA0101|Aldactone|töflur|100|mg|100|stk|1|þpakki||C03DA01|01.11.1981||R|A|5|0|0|E|0|PER|0|0|0|100|DKK|5749|8742|lyfalmen|||00|100|0|133,3333|Icepharma hf|Pfizer ApS|Spírónólaktón||5749||5749|8742| 430009|N01AH0102|Leptanal|stl|50|mcg/ml|10|ml|5|lykjur||N01AH01|01.10.1989||R|A|3|1|0|0|1|JAS|0|0|0|100|SEK|1714|2474|lyfsjukr|||02|50|0|0,0000|Vistor hf|Janssen-Cilag AB|Fentanýl||1714||1714|2474| 430074|N05CD0801|Dormicum|stl|1|mg/ml|5|ml|10|lykjur||N05CD08|01.07.1990||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|1955|2822|lyfsjukr|||02|50|0|3,3333|Icepharma hf|Roche|Mídazólam||1955||1955|2822| 430157|QJ01EW1001|Tribrissen, vet.|stl|480|mg/ml|100|ml|1|hgl|80+400 mg/ml|QJ01EW10|01.10.1990||R|A|3|0|0|0|0|IBV|0|0|0|100|DKK|3837|7540|vetalmen|||27|100|0|0,0000|Vistor hf|Intervet International BV|||3837||3837|7540| 430521|G04BE0305|Vizarsin (Lyfis)|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|A||0|0|0|0|LYF|0|0|0|100|XEU|5409|4944|lyfalmen|V0099|4944|00|4|0|8,0000|Lyfís ehf|Lyfis ehf|Síldenafíl||2973||2973|4944| 430710|J07AP0301|Typhim Vi|bóluefni|||0,5|ml|1|spr|einnotaspr|J07AP03|01.07.1994||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|2549|4364|lyfalmen|||02|0|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Taugaveiki, hreinsaðir mótefnavakar||2549||2549|4364| 431023|D06AX0101|Fucidin|smyrsli|20|mg/g|15|g|1|túpa||D06AX01|01.04.1989||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|763|1921|lyfalmen|||20|15|0|15,0000|Vistor hf|LEO Pharma A/S|Fúsidínsýra||763||763|1921| 431049|C01DA0801|Sorbangil|töflur|10|mg|100|stk|1|þpakki||C01DA08|01.07.1989||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|1375|2758|lyfalmen|||00|100|0|16,6667|Vistor hf|Recip AB|Ísósorbíð dínítrat||1375||1375|2758| 431759|M01AB5503|Arthrotec Forte|töflur|75,2|mg|20|stk|1|þpakki|75+0,2 mg|M01AB55|01.09.2009||R|A||0|0|E|0|PER|0|0|1|100|DKK|1417|2816|lyfalmen|||00|20|0|15,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||||1417|2816| 431783|M01AB5503|Arthrotec Forte|töflur|75,2|mg|100|stk|1|þpakki|75+0,2 mg|M01AB55|01.09.2009||R|A||0|0|E|0|PER|0|0|1|100|DKK|6434|9679|lyfalmen|||00|100|0|75,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||||6434|9679| 432880|N02BE0107|Paratabs|töflur|500|mg|300|stk|1|glas|öryggislok|N02BE01|01.11.1981||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|1180|2491|lyfalmen|||00|300|0|50,0000|Actavis Group hf|Actavis hf|Paracetamól||1180||1180|2491| 433250|N04BX0201|Comtess|töflur|200|mg|100|stk|1|glas||N04BX02|01.07.1999||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|11088|16045|lyfalmen|||0|100|0|20,0000|Vistor hf|Orion Corporation|Entakapón||11088||11088|16045| 433292|N02AA0106|Contalgin Uno|forðahlk|30|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|A|3|1|0|E|0|PER|0|0|0|100|DKK|2487|4279|lyfalmen|||00|28|0|8,4000|Icepharma hf|Pfizer ApS|Morfín||2487||2487|4279| 433318|N02AA0106|Contalgin Uno|forðahlk|90|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|A|3|1|0|E|0|PER|0|0|0|100|DKK|6100|9222|lyfalmen|||00|28|0|25,2000|Icepharma hf|Pfizer ApS|Morfín||6100||6100|9222| 433342|N02AA0106|Contalgin Uno|forðahlk|150|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|A|3|1|0|E|0|PER|0|0|0|100|DKK|8799|12914|lyfalmen|||00|28|0|42,0000|Icepharma hf|Pfizer ApS|Morfín||8799||8799|12914| 434639|QP52AC1302|Panacur, vet.|töflur|250|mg|10|stk|1|þpakki||QP52AC13|01.04.1992||L|A|5|0|0|0|0|INI|0|0|0|100|DKK|1139|1987|vetorma|||99|10|0|0,0000|Icepharma hf|Intervet International B.V.|||||1139|1987| 434670|D01AC2001|Daktacort|krem|||50|g|1|túpa||D01AC20|01.10.1988||R|K|3|0|0|0|0|MCS|0|0|1|100|SEK|1668|3159|lyfalmen|||20|50|0|50,0000|Vistor hf|McNeil Sweden AB|Blöndur||1668||1668|3159| 434829|C01CA2404|EpiPen|stl|0,3|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|A|1,7|0|0|B|0|ALK|0|0|1|100|DKK|5815|8832|lyfalmen|||00|1|0|0,6000|Vistor hf|ALK-Abello A/S|Adrenalín tartrat||5815||5815|8832| 434837|C01CA2405|EpiPen Junior|stl|0,15|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|A|1,75|0|0|B|0|ALK|0|0|1|100|DKK|5815|8832|lyfalmen|||00|1|0|0,3000|Vistor hf|ALK-Abello A/S|Adrenalín tartrat||5815||5815|8832| 434852|N06AB0302|Fontex|dreifit.|20|mg|100|stk|1|pakki|þp (10x10 stk)|N06AB03|01.06.1998||R|A|2|0|0|0|0|ELI|0|1|0|100|XEU|10311|14982|lyfalmen|V0915|6870|00|100|0|100,0000|Icepharma hf|Eli Lilly Danmark A/S|Flúoxetín||10311||10311|14982| 435537|N02CC0301|Zomig|töflur|5|mg|6|stk|1|þpakki||N02CC03|01.06.1999||R|A|3|0|0|E|0|ASZ|0|0|0|100|SEK|6763|10129|lyfalmen|||00|6|0|12,0000|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||6763||6763|10129| 435594|N02CC0301|Zomig|töflur|2,5|mg|6|stk|1|þpakki||N02CC03|01.11.1998||R|A|3|0|0|E|0|ASZ|0|0|0|100|SEK|5283|8104|lyfalmen|||00|6|0|6,0000|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||5283||5283|8104| 435651|N05AH0401|Seroquel|töflur|25|mg|100|stk|1|þpakki||N05AH04|01.09.1998||R|A|3|0|0|*|0|AZA|0|1|0|100|SEK|8346|10837|lyfalmen|V0725|9408|00|100|0|6,2500|Vistor hf|AstraZeneca AB|Quetíapín||7281||7281|10837| 435974|C01DA0801|Sorbangil|töflur|10|mg|250|stk|1|plglas||C01DA08|01.04.2004||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|3199|5253|lyfalmen|||00|250|0|41,6700|Vistor hf|Recip AB|Ísósorbíð dínítrat||3199||3199|5253| 436022|C09DA0308|Diovan Comp 80 mg/12,5 mg|töflur|92,5|mg|28|stk|1|pakki||C09DA03|01.10.1999||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|3732|5982|lyfalmen|||00|28|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og þvagræsilyf||3732||3732|5982| 436030|C09DA0308|Diovan Comp 80 mg/12,5 mg|töflur|92,5|mg|98|stk|1|pakki||C09DA03|01.10.1999||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|9840|14338|lyfalmen|V2221|5162|00|98|0|98,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og þvagræsilyf||9840||9840|14338| 436147|M01AE0217|Naproxen-E Mylan|sh-tfl|250|mg|20|stk|1|þpakki||M01AE02|01.07.1993||L|A|5|0|0|0|0|MYL|0|0|1|100|IKR|||lyflausa|||10|20|0|10,0000|Actavis Group PTC ehf|Mylan AB|Naproxen|||||| 436410|D06AX0101|Fucidin|krem|20|mg/g|15|g|1|túpa||D06AX01|01.01.1989||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|743|1894|lyfalmen|||20|15|0|15,0000|Vistor hf|LEO Pharma A/S|Fúsidínsýra||743||743|1894| 436915|N05AD0101|Haldol|töflur|1|mg|100|stk|1|þpakki||N05AD01|01.12.1972||R|A|5|0|0|*|0|JAS|0|1|0|100|SEK|1043|2304|lyfalmen|||00|100|0|12,5000|Vistor hf|Janssen-Cilag AB|Halóperídól||1043||1043|2304| 436931|N05AD0101|Haldol|töflur|4|mg|100|stk|1|þpakki||N05AD01|01.12.1972||R|A|5|0|0|*|0|JAS|0|1|0|100|SEK|3654|5876|lyfalmen|||00|100|0|50,0000|Vistor hf|Janssen-Cilag AB|Halóperídól||3654||3654|5876| 437013|B01AC0404|Clopidogrel Krka (Lyfis)|filmhtfl|75|mg|100|stk|1|þpakki||B01AC04|01.07.2010||R|A||0|0|E|0|LYF|0|0|0|100|XEU|21043|15182|lyfalmen|V0090|15182|00|100|0|100,0000|Lyfis ehf|Lyfis ehf|Klópídógrel||10457||10457|15182| 438218|N06AX1602|Efexor Depot|forðahlk|75|mg|100|stk|1|glas||N06AX16|01.10.1998||R|A|3|0|0|0|0|PER|0|1|0|100|DKK|11493|16599|lyfalmen|V0955|6073|00|100|0|75,0000|Icepharma hf|Pfizer ApS|Venlafaxín||11493||11493|16599| 438333|N06AX1602|Efexor Depot|forðahlk|150|mg|28|stk|1|þpakki||N06AX16|01.10.1998||R|A|3|0|0|0|0|PER|0|1|0|100|DKK|6180|9331|lyfalmen|V0957|4383|00|28|0|42,0000|Icepharma hf|Pfizer ApS|Venlafaxín||6180||6180|9331| 438374|N07BC0201|Metadon|töflur|5|mg|20|stk|1|glas||N07BC02|01.01.1998||R|A||1|0|0|0|LDR|0|0|0|100|IKR|742|1892|lyfalmen|||00|20|1|4,0000|Parlogis hf|Parlogis - óskráð lyf|||742||742|1892| 438416|S02CA0301|Ciproxin-Hydrocortison|eyrnadr|||10|ml|1|túpa|2 mg + 10 mg/ml|S02CA03|01.09.2002||R|A|2|0|0|E|0|SAL|0|0|1|100|USD|1181|2493|lyfalmen|||00|10|0|0,0000|Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Hýdrókortisón og sýkingalyf||1181||1181|2493| 438424|N06AX1602|Efexor Depot|forðahlk|75|mg|28|stk|1|þpakki||N06AX16|01.10.1998||R|A|3|0|0|0|0|PER|0|1|0|100|DKK|3238|5307|lyfalmen|V0954|3463|00|28|0|21,0000|Icepharma hf|Pfizer ApS|Venlafaxín||3238||3238|5307| 438432|N06AX1602|Efexor Depot|forðahlk|75|mg|98|stk|1|þpakki||N06AX16|01.10.1998||R|A|3|0|0|0|0|PER|0|1|0|100|DKK|11133|16107|lyfalmen|V0955|5952|00|98|0|73,5000|Icepharma hf|Pfizer ApS|Venlafaxín||11133||11133|16107| 438457|N06AX1602|Efexor Depot|forðahlk|150|mg|98|stk|1|þpakki||N06AX16|01.10.1998||R|A|3|0|0|0|0|PER|0|1|0|100|DKK|21137|28806|lyfalmen|V0956|5952|00|98|0|147,0000|Icepharma hf|Pfizer ApS|Venlafaxín||21137||21137|28806| 438465|N06AX1602|Efexor Depot|forðahlk|150|mg|100|stk|1|glas||N06AX16|01.10.1998||R|A|3|0|0|0|0|PER|0|1|0|100|DKK|19485|26733|lyfalmen|V0956|6073|00|100|0|150,0000|Icepharma hf|Pfizer ApS|Venlafaxín||19485||19485|26733| 438762|R06AX1301|Clarityn|töflur|10|mg|10|stk|1|þpakki||R06AX13|01.07.1989||L|A|4|0|0|0|0|SCP|0|0|1|100|IKR|||lyflausa|||00|10|0|10,0000|Vistor hf|Schering-Plough|Lóratadín|||||| 438770|R06AX1301|Clarityn|töflur|10|mg|30|stk|1|þpakki||R06AX13|01.07.1989||R|A|4|0|0|E|0|SCP|0|0|1|100|DKK|1967|3568|lyfalmen|||00|30|0|30,0000|Vistor hf|Schering-Plough|Lóratadín||1967||1967|3568| 438788|R06AX1301|Clarityn|töflur|10|mg|100|stk|1|þpakki||R06AX13|01.07.1989||R|A|4|0|0|E|0|SCP|0|0|1|100|DKK|5938|9000|lyfalmen|V0984|3174|00|100|0|100,0000|Vistor hf|Schering-Plough|Lóratadín||5938||5938|9000| 438806|B03XA0201|Aranesp|stl|130|mcg/spr|0,65|ml|4|áf.spr|nálavörn|B03XA02|01.12.2010||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|164985|208939|lyfsjukr|||00|3|0|115,5600|Vistor hf|Amgen|Darbepóetín alfa||164985||164985|208939| 439208|J01DC0203|Zinnat|töflur|250|mg|14|stk|1|þpakki||J01DC02|01.10.1990||R|A|3|0|0|0|0|GSK|0|0|1|100|GBP|2261|3970|lyfalmen|||66|14|0|7,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||2261||2261|3970| 439489|C07FB0201|Logimax|forðatfl|55|mg|98|stk|1|pakki|þp 5+50 mg|C07FB02|01.04.1997||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|9755|14222|lyfalmen|||00|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Metóprólól og önnur blóðþrýstingslækkandi lyf||9755||9755|14222| 439794|R01AA0704|Otrivin ukonserveret|nefúði|1|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.05.2001||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||06|10|0|12,5000|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||| 440099|J01CR0202|Augmentin|mixtduft|91,4|mg/ml|70|ml|1|glas|80+11,4 mg/ml|J01CR02|01.08.1998||R|A|2|0|0|0|0|GSK|0|0|1|100|IKR|1066|2335|lyfalmen|||00|70|0|5,6000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||1066||1066|2335| 440677|J01CE0106|Penicillin Actavis|sts|600|mg/hgl|10|hgl|1|pakki|1 millj.ae|J01CE01|01.07.2004||R|A|5|0|0|0|1|AGT|0|0|0|100|DKK|1484|2142|lyfsjukr|||00|10|0|1,6700|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||1484||1484|2142| 440693|J01CE0106|Penicillin Actavis|sts|1,2|g/hgl|10|hgl|1|pakki|2 millj.ae|J01CE01|01.07.2004||R|A|5|0|0|0|1|AGT|0|0|0|100|DKK|2343|3382|lyfsjukr|||00|10|0|3,3300|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||2343||2343|3382| 441006|C03DA0101|Aldactone|töflur|25|mg|100|stk|1|þpakki||C03DA01|01.12.1972||R|A|5|0|0|E|0|PER|0|0|0|100|DKK|1451|2862|lyfalmen|V0221|2746|00|100|0|33,3333|Icepharma hf|Pfizer ApS|Spírónólaktón||1451||1451|2862| 441279|D01AC2002|Pevisone|krem|0| |30|g|1|túpa||D01AC20|01.10.1988||R|A|4|0|0|0|0|JAS|0|0|1|100|SEK|1445|2854|lyfalmen|||20|30|0|30,0000|Vistor hf|Janssen-Cilag AB|Blöndur||1445||1445|2854| 441634|P03AC0401|Nix|hársápa|10|mg/ml|59|ml|1|pakki||P03AC04|01.01.1996||L|A|2|0|0|0|0|ACH|0|0|0|100|IKR|||lyflausa|||00|59|0|0,0000|Aco Hud Nordic AB|ACO Hud AB|Permetrín|||||| 441949|G03DC0202|Primolut N|töflur|5|mg|30|stk|1|glas||G03DC02|01.12.1972||R|A|5|0|0|E|0|BAP|0|0|0|100|SEK|1005|2252|lyfalmen|||00|30|0|30,0000|Icepharma hf|Bayer Schering Pharma AG|Noretísterón||1005||1005|2252| 442152|J05AF0101|Retrovir|hylki|250|mg|40|stk|1|þpakki||J05AF01|01.07.1995||R|A|5|0|1|0|1|VII|0|0|0|100|GBP|29935|39451|lyfsjukr|||61|40|0|16,6667|GlaxoSmithKline ehf|Viiv Healthcare UK Ltd|Zídóvúdín||29935||29935|39451| 443135|H04AA0102|GlucaGen Hypokit|sts|1|mg|1|stk|1|hgl|dæla|H04AA01|01.01.1989||R|K|3|0|0|*|0|NON|0|0|1|100|DKK|3675|5904|lyfalmen|||02|1|0|1,0000|Vistor hf|Novo-Nordisk|Glúkagon||3675||3675|5904| 443358|N02AA0101|Contalgin|forðatfl|200|mg|90|stk|1|þpakki||N02AA01|01.04.1993||R|A|3|1|0|E|0|PER|0|0|0|100|DKK|27061|36241|lyfalmen|||10|90|0|180,0000|Icepharma hf|Pfizer ApS|Morfín||27061||27061|36241| 444240|J05AF0401|Zerit|hylki|30|mg|56|stk|1|þpakki||J05AF04|01.11.1998||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|45244|58664|lyfsjukr|||00|56|0|21,0000|Vistor hf|Bristol-Myers Squibb|Stavúdín||45244||45244|58664| 444299|J05AF0401|Zerit|hylki|40|mg|56|stk|1|þpakki||J05AF04|01.11.1998||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|45891|59476|lyfsjukr|||00|56|0|28,0000|Vistor hf|Bristol-Myers Squibb|Stavúdín||45891||45891|59476| 444315|N06AB0302|Fontex|dreifit.|20|mg|30|stk|1|pakki|þp (2 x 15 stk)|N06AB03|01.06.1998||R|A|2|0|0|0|0|ELI|0|1|0|100|DKK|3133|5163|lyfalmen|V0914|2839|00|30|0|30,0000|Icepharma hf|Eli Lilly Danmark A/S|Flúoxetín||3133||3133|5163| 444430|N04BA0208|Madopar Quick "62,5"|lausnart|62,5|mg|100|stk|1|glas|50+12,5 mg|N04BA02|01.11.2000||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|2189|3872|lyfalmen|||00|100|0|8,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2189||2189|3872| 444927|M05BA0601|Bondronat|irþ|1|mg/ml|2|ml|1|hgl||M05BA06|01.04.2006||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|15088|20818|lyfsjukr|||00|2|0|0,3300|Icepharma hf|Roche|Íbandrónsýra||15088||15088|20818| 445155|D07CA0102|Fucidin-Hydrocortison|krem|30|mg/g|30|g|1|túpa|20 + 10 mg|D07CA01|01.02.1998||R|A|3|0|0|B|0|LEO|0|0|1|100|DKK|1688|3186|lyfalmen|||00|30|0|30,0000|Vistor hf|LEO A/S|Hýdrókortisón og sýklalyf||1688||1688|3186| 446187|QA12CX9001|Tonophosphan, vet.|stl|200|mg/ml|50|ml|1|hgl||QA12CX90|01.12.1972||R|A|5|0|0|0|0|INI|0|0|0|100|DKK|1449|2882|vetalmen|||27|50|0|0,0000|Icepharma hf|Intervet International B.V.|||1449||1449|2882| 446807|J02AC0101|Diflucan|hylki|50|mg|7|stk|1|þpakki||J02AC01|01.04.1990||R|A|5|0|0|0|0|PER|0|0|1|100|DKK|4052|6420|lyfalmen|V0551|3257|10|7|0|1,7500|Icepharma hf|Pfizer ApS|Flúkónazól||4052||4052|6420| 447052|B01AB0401|Fragmin|stl|25000|ae/ml|0,72|ml|5|áf.spr|18000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|A|3|0|0|E|0|PER|0|0|0|100|DKK|11295|16328|lyfalmen|||00|4|0|3,6000|Icepharma hf|Pfizer ApS|Dalteparín||11295||11295|16328| 447110|B01AB0401|Fragmin|stl|25000|ae/ml|0,4|ml|5|áf.spr|10000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|A|3|0|0|E|0|PER|0|0|0|100|DKK|6443|9691|lyfalmen|||00|2|0|2,0000|Icepharma hf|Pfizer ApS|Dalteparín||6443||6443|9691| 447136|B01AB0401|Fragmin|stl|25000|ae/ml|0,5|ml|5|áf.spr|12500 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|A|3|0|0|E|0|PER|0|0|0|100|DKK|7892|11673|lyfalmen|||00|2|0|2,5000|Icepharma hf|Pfizer ApS|Dalteparín||7892||7892|11673| 447151|B01AB0401|Fragmin|stl|25000|ae/ml|0,6|ml|5|áf.spr|15000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|A|3|0|0|E|0|PER|0|0|0|100|DKK|9477|13841|lyfalmen|||00|3|0|3,0000|Icepharma hf|Pfizer ApS|Dalteparín||9477||9477|13841| 448217|C05AA0801|Doloproct|eþ-stíll|||10|stk|1|pakki||C05AA08|01.01.1991||R|A|4|0|0|0|0|IGB|0|0|0|100|SEK|637|1749|lyfalmen|||04|10|0|0,0000|Icepharma hf|Intendis GmbH Berlin|Flúókortólón||637||637|1749| 448233|C05AA0801|Doloproct|eþ-krem|||30|g|1|túpa||C05AA08|01.01.1991||R|A|3|0|0|0|0|IGB|0|0|0|100|SEK|1243|2578|lyfalmen|||00|30|0|0,0000|Icepharma hf|Intendis GmbH Berlin|Flúókortólón||1243||1243|2578| 448688|M03BX0103|Lioresal|töflur|25|mg|50|stk|1|þpakki||M03BX01|01.12.1972||R|A|5|0|0|E|0|NOH|0|0|1|100|DKK|2363|4110|lyfalmen|V0712|3485|00|50|0|25,0000|Vistor hf|Novartis Healthcare A/S-|Baklófen||2363||2363|4110| 449611|C07AB0311|Atenolol Mylan|töflur|100|mg|98|stk|1|þpakki||C07AB03|01.01.1991||R|A|4|0|0|B|0|MYL|0|0|0|100|SEK|1406|2801|lyfalmen|||00|98|0|130,6667|Actavis Group PTC ehf|Mylan AB|Atenólól||1406||1406|2801| 449819|J01CE0106|Penicillin Actavis|sts|3|g/hgl|10|hgl|1|pakki|5 millj.ae|J01CE01|01.07.2004||R|A|5|0|0|0|1|AGT|0|0|0|100|DKK|5558|8022|lyfsjukr|||00|10|0|8,3300|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||5558||5558|8022| 450155|J01CR0202|Augmentin|töflur|1|g|12|stk|1|pakki|þp 875+125 mg|J01CR02|01.01.1997||R|A|2|0|0|0|0|GSK|0|0|1|100|IKR|1115|2281|lyfalmen|V0466|2266|00|12|0|10,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||1026||1026|2281| 450734|N05CF0201|Stilnoct|töflur|10|mg|20|stk|1|þpakki||N05CF02|01.10.1992||R|A|5|0|0|0|0|SNO|0|0|1|100|NOK|1089|1847|lyfalmen|V0902|1757|00|20|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||709||709|1847| 450775|N05CF0201|Stilnoct|töflur|10|mg|100|stk|1|þpakki||N05CF02|01.10.1992||R|A|5|0|0|0|0|SNO|0|0|0|100|NOK|3835|5346|lyfalmen|V0903|5007|00|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||3267||3267|5346| 451153|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|A|3|0|0|0|0|GEH|0|0|0|100|NOK|53693|69664|lyfalmen|||00|100|0|0,0000|Icepharma hf|GE Healthcare AS|Gadódíamíð||53693||53693|69664| 451419|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|A|3|0|0|0|0|GEH|0|0|0|100|NOK|80540|103357|lyfalmen|||00|150|0|0,0000|Icepharma hf|GE Healthcare AS|Gadódíamíð||80540||80540|103357| 451476|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|A|3|0|0|0|0|GEH|0|0|0|100|NOK|107386|137049|lyfalmen|||00|200|0|0,0000|Icepharma hf|GE Healthcare AS|Gadódíamíð||107386||107386|137049| 451989|N06AB0401|Cipramil|töflur|30|mg|28|stk|1|þpakki||N06AB04|01.11.1999||R|A|3|0|0|0|0|LBK|0|1|0|100|DKK|5738|7941|lyfalmen|||00|28|0|42,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||5164||5164|7941| 451997|N06AB0401|Cipramil|töflur|30|mg|100|stk|1|glas||N06AB04|01.11.1999||R|A|3|0|0|0|0|LBK|0|1|0|100|DKK|15154|21297|lyfalmen|||00|100|0|150,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||15154||15154|21297| 452284|M01AB1501|Toradol|stl|30|mg/ml|1|ml|5|lykjur||M01AB15|01.04.1992||R|A|3|0|0|E|0|ROA|0|0|1|100|DKK|1164|2470|lyfalmen|||00|5|0|5,0000|Icepharma hf|Roche A.S.|Ketórólak||1164||1164|2470| 452300|J02AC0101|Diflucan|hylki|50|mg|100|stk|1|þpakki||J02AC01|01.04.1990|31.01.2011|R|A|5|0|0|0|0|PER|0|0|1|100|DKK|53691|69661|lyfalmen|||10|100|0|25,0000|Icepharma hf|Pfizer ApS|Flúkónazól||53691||53691|69661| 452467|QI09AB0401|Rhiniseng|stl|||50|ml|1|hgl|dreifa|QI09AB04|01.03.2011||R|K||0|0|0|0|LHS|0|0|0|100|XEU|11199|19536|vetorma|||00|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Óvirkar bakteríur í bóluefnum||11199||11199|19536| 452482|V07AB09|Sterilt Vann B. Braun|leysir|0||100|ml|10|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|1000|0|0,0000|Actavis Group hf|Braun|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||| 452862|D06BB1001|Aldara|krem|50|mg/g|250|mg|12|stk|einnota pokar|D06BB10|01.03.2000||R|A|2|0|0|0|0|LAB|0|0|1|100|SEK|15574|21824|lyfalmen|||00|3000|0|3,0000|Vistor hf|Laboratories 3M Santé|Imikvímóð||15574||15574|21824| 452896|A06AD1701|Phosphoral|mixtúra|||45|ml|2|fl||A06AD17|01.03.1999||R|A|3|0|0|0|0|LCF|0|0|0|100|DKK|3030|5022|lyfalmen|||00|90|0|0,0000|Clean Chemical Sweden AB|Laboratorios Casen-Fleet S.L.U.|Natríumfosföt||3030||3030|5022| 452904|N02AA0501|Oxycontin|forðatfl|10|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|2562|4382|lyfalmen|||10|28|0|3,7300|Icepharma hf|Norpharma |Oxýcódon||2562||2562|4382| 452920|N02AA0501|Oxycontin|forðatfl|10|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|7454|11074|lyfalmen|||10|98|0|13,0700|Icepharma hf|Norpharma |Oxýcódon||7454||7454|11074| 452953|L04AX0102|Imurel|töflur|50|mg|100|stk|1|þpakki||L04AX01|01.10.1995||R|A|5|0|0|*|0|AEG|0|0|0|100|GBP|2534|4344|lyfalmen|||10|100|0|33,3333|GlaxoSmithKline ehf|Aspen Europe GmbH|Azatíóprín||2534||2534|4344| 452995|N02AA0501|Oxycontin|forðatfl|20|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|4840|7498|lyfalmen|||10|28|0|7,4700|Icepharma hf|Norpharma |Oxýcódon||4840||4840|7498| 453126|QP54AA0101|Eqvalan, vet.|pasta|18,7|mg/g|6,4|g|1|sk-dæl||QP54AA01|01.01.1991||L|A|3|0|0|0|0|MEF|0|0|0|100|XEU|1479|2580|vetorma|||16|6|0|0,0000|Vistor hf|Merial (MSD)|||||1479|2580| 453175|N02AA0501|Oxycontin|forðatfl|20|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|14458|20424|lyfalmen|||10|98|0|26,1300|Icepharma hf|Norpharma |Oxýcódon||14458||14458|20424| 453498|N02AA0501|Oxycontin|forðatfl|40|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|9748|14212|lyfalmen|||10|28|0|14,9300|Icepharma hf|Norpharma |Oxýcódon||9748||9748|14212| 453571|N02AA0501|Oxycontin|forðatfl|40|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|24715|33296|lyfalmen|||10|98|0|52,2700|Icepharma hf|Norpharma|Oxýcódon||24715||24715|33296| 453753|N05AE0401|Zeldox|sts|20|mg/hgl|1|hgl|1|pakki|+leysir|N05AE04|01.03.2002||R|A|3|0|0|0|1|PER|0|1|0|100|DKK|3620|5225|lyfsjukr|||02|1|0|0,5000|Icepharma hf|Pfizer ApS|Ziprasidon||3620||3620|5225| 453795|J07AL0102|Pneumo 23|bóluefni|0| |0,5|ml|1|dæla||J07AL01|01.09.2003||R|K|2|0|0|0|0|SPM|0|0|0|100|XEU|2307|4033|lyfalmen|||00|0|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Hreinsuð pneumococca poly­sakkaríð mótefnavakar||2307||2307|4033| 454439|N06DA0201|Aricept|töflur|5|mg|28|stk|1|þpakki||N06DA02|01.09.1998||R|A|3|0|0|E|0|PER|0|0|0|100|DKK|15412|21621|lyfalmen|||00|28|0|18,6667|Icepharma hf|Pfizer ApS|Dónepezíl||15412||15412|21621| 454454|N06DA0201|Aricept|töflur|5|mg|98|stk|1|þpakki||N06DA02|01.09.1998||R|A|3|0|0|E|0|PER|0|0|0|100|DKK|43636|38808|lyfalmen|V0375|37402|00|98|0|65,3333|Icepharma hf|Pfizer ApS|Dónepezíl||29107||29107|38808| 454678|N06DA0201|Aricept|töflur|10|mg|28|stk|1|þpakki||N06DA02|01.09.1998||R|A|3|0|0|E|0|PER|0|0|0|100|DKK|17388|24101|lyfalmen|||00|28|0|37,3333|Icepharma hf|Pfizer ApS|Dónepezíl||17388||17388|24101| 454686|N06DA0201|Aricept|töflur|10|mg|98|stk|1|þpakki||N06DA02|01.09.1998||R|A|3|0|0|E|0|PER|0|0|0|100|DKK|48076|43280|lyfalmen|V0376|41658|00|98|0|130,6667|Icepharma hf|Pfizer ApS|Dónepezíl||32670||32670|43280| 454850|L01XX1701|Hycamtin|irs|4|mg/hgl|1|hgl|1|pakki||L01XX17|01.02.1999||R|A|3|0|1|0|1|SKB|0|0|0|100|GBP|52466|67727|lyfsjukr|||00|1|0|0,0000|GlaxoSmithKline ehf|SmithKline Beecham Ltd|Tópótecan||52466||52466|67727| 454918|QJ01CE0902|Penovet, vet.|stl|300000|ae/ml|100|ml|1|hgl||QJ01CE09|01.10.1997||R|K|2|0|0|0|0|BID|0|0|0|100|DKK|1097|2182|vetalmen|||16|100|0|0,0000|Vistor hf|Boehringer Ingelheim Danmark|||1097||1097|2182| 455329|A10BF0101|Glucobay|töflur|50|mg|30|stk|1|þpakki||A10BF01|01.12.1997||R|A|3|0|0|*|0|BAP|0|0|0|100|SEK|1025|2279|lyfalmen|||00|30|0|5,0000|Icepharma hf|Bayer Schering Pharma AG|Acarbósa||1025||1025|2279| 455337|A10BF0101|Glucobay|töflur|50|mg|120|stk|1|þpakki||A10BF01|01.12.1997||R|A|3|0|0|*|0|BAP|0|0|0|100|SEK|3685|5918|lyfalmen|||00|120|0|20,0000|Icepharma hf|Bayer Schering Pharma AG|Acarbósa||3685||3685|5918| 455584|J05AB0901|Famvir|töflur|500|mg|21|stk|1|þpakki||J05AB09|01.10.1995||R|A|3|0|0|E|0|NOH|0|0|1|100|DKK|21990|29877|lyfalmen|||00|21|0|14,0000|Vistor hf|Novartis Healthcare A/S-|Famcíclóvír||21990||21990|29877| 455949|J01AA0207|Doxylin|töflur|100|mg|10|stk|1|þpakki|0|J01AA02|01.10.2008||R|A|4|0|0|0|0|AGT|0|0|1|100|XEU|1001|2247|lyfalmen|||00|10|0|10,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||1001||1001|2247| 455956|J01AA0207|Doxylin|töflur|100|mg|15|stk|1|þpakki||J01AA02|01.01.2009||R|A|4|0|0|0|0|AGT|0|0|1|100|XEU|1092|2371|lyfalmen|||0|15|0|15,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||1092||1092|2371| 455972|J01AA0207|Doxylin|töflur|100|mg|30|stk|1|þpakki|0|J01AA02|01.10.2008||R|A|4|0|0|0|0|AGT|0|0|1|100|XEU|2392|4149|lyfalmen|||00|30|0|30,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||2392||2392|4149| 456079|B05DA0001|Dianeal PD1 Glucose|kvið.sk|13,6|mg/ml|6000|ml|2|pokar||B05DA00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|4928|7112|lyfsjukr|||00|12000|0|12,0000|Icepharma hf|Baxter|||4928||4928|7112| 456202|B05DB0001|Dianeal PD1 Glucose|kvið.sk|22,7|mg/ml|6000|ml|2|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|4928|7112|lyfsjukr|||00|12000|0|12,0000|Icepharma hf|Baxter|||4928||4928|7112| 456277|B05DA0001|Dianeal PD1 Glucose|kvið.sk|13,6|mg/ml|5000|ml|2|pokar||B05DA00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|5380|7765|lyfsjukr|||00|10000|0|0,0000|Icepharma hf|Baxter|||5380||5380|7765| 456392|B05DB0001|Dianeal PD1 Glucose|kvið.sk|22,7|mg/ml|5000|ml|2|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|5380|7765|lyfsjukr|||00|10000|0|0,0000|Icepharma hf|Baxter|||5380||5380|7765| 457002|B05DA0001|Dianeal PD1 Glucose|kvið.sk|13,6|mg/ml|2000|ml|5|pokar||B05DA00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|8055|11625|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter|||8055||8055|11625| 457036|B05DB0001|Dianeal PD1 Glucose|kvið.sk|22,7|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|8055|11625|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter|||8055||8055|11625| 457069|B05DB0001|Dianeal PD1 Glucose|kvið.sk|38,6|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|8055|11625|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter|||8055||8055|11625| 457119|B05DA0002|Dianeal PD1 Glucose Duo|kvið.sk|13,6|mg/ml|2000|ml|5|pokar||B05DA00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|10083|14537|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter|||10083||10083|14537| 457242|B05DB0002|Dianeal PD1 Glucose Duo|kvið.sk|22,7|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|9829|14186|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter|||9829||9829|14186| 457291|B05DB0002|Dianeal PD1 Glucose Duo|kvið.sk|38,6|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|13067|18282|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter|||13067||13067|18282| 458067|N05CM0201|Heminevrin|hylki|300|mg|25|stk|1|glas||N05CM02|01.12.1998||R|A|2|0|0|0|0|ARA|0|0|1|100|SEK|1183|2496|lyfalmen|||00|25|0|5,0000|Vistor hf|Astra|Clómetíazól||1183||1183|2496| 458349|J01CA0801|Selexid|töflur|200|mg|20|stk|1|þpakki||J01CA08|01.12.1980||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|1446|2855|lyfalmen|||43|20|0|6,6667|Vistor hf|LEO Pharma A/S|Pívmecillínam||1446||1446|2855| 458356|J01CA0801|Selexid|töflur|200|mg|30|stk|1|þpakki||J01CA08|01.12.1980||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|2102|3753|lyfalmen|||43|30|0|10,0000|Vistor hf|LEO Pharma A/S|Pívmecillínam||2102||2102|3753| 458422|J01CA0801|Selexid|töflur|200|mg|100|stk|1|þpakki||J01CA08|01.12.2007||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|8761|12862|lyfalmen|V0456|12862|00|100|0|33,3333|Vistor hf|LEO Pharma A/S|Pívmecillínam||8761||8761|12862| 458737|B05DA0003|Dianeal PD4 Glucose Duo|kvið.sk|13,6|mg/ml|2000|ml|5|pokar||B05DA00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|13171|18412|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter|||13171||13171|18412| 458778|B05DB0003|Dianeal PD4 Glucose Duo|kvið.sk|22,7|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|13171|18412|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter|||13171||13171|18412| 458794|B05DB0003|Dianeal PD4 Glucose Duo|kvið.sk|38,6|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|13171|18412|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter|||13171||13171|18412| 458865|A07AA0906|Vancomycin Xellia|hylki|250|mg|28|stk|1|þpakki|hart hylki|A07AA09|01.01.2011||R|A||0|0|E|0|XEL|0|0|1|100|DKK|24286|32758|lyfalmen|||00|28|0|3,5000|Actavis Group hf|Xellia Pharmaceuticals ApS|Vankómýcín||24286||24286|32758| 459354|J01FF0101|Dalacin|stl|150|mg/ml|2|ml|1|lykja||J01FF01|01.11.1979||R|A|2|0|0|0|1|PER|0|0|0|100|DKK|1426|2058|lyfsjukr|||02|2|0|0,1667|Icepharma hf|Pfizer ApS|Klindamýcín||1426||1426|2058| 459412|M05BA0601|Bondronat|irþ|1|mg/ml|2|ml|5|lykjur||M05BA06|01.02.2002||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|85652|109376|lyfsjukr|||00|10|0|1,6700|Icepharma hf|Roche|Íbandrónsýra||85652||85652|109376| 459420|J01FF0101|Dalacin|stl|150|mg/ml|4|ml|1|lykja||J01FF01|01.11.1979||R|A|2|0|0|0|1|PER|0|0|0|100|DKK|1573|2270|lyfsjukr|||02|4|0|0,3333|Icepharma hf|Pfizer ApS|Klindamýcín||1573||1573|2270| 459727|S01ED0105|Optimol|augndr|2,5|mg/ml|5|ml|3|glös||S01ED01|01.01.1995||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|2028|3651|lyfalmen|||06|15|0|75,0000|Icepharma hf|Santen Oy|Tímólól||2028||2028|3651| 459743|S01ED0105|Optimol|augndr|5|mg/ml|5|ml|3|glös||S01ED01|01.01.1995||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|2223|3918|lyfalmen|||06|15|0|75,0000|Icepharma hf|Santen Oy|Tímólól||2223||2223|3918| 459828|N07BA0145|Nicorette Freshdrops|munnstfl|2|mg|96|stk|1|þpakki||N07BA01|01.12.2010||L|A||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|96|0|6,4000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 459859|B02AA0201|Cyklokapron|töflur|500|mg|30|stk|1|þpakki||B02AA02|01.04.1989||R|A|3|0|0|E|0|MAS|0|0|1|100|SEK|2688|4554|lyfalmen|||00|30|0|7,5000|Vistor hf|Meda AS|Tranexamsýra||2688||2688|4554| 459867|B02AA0201|Cyklokapron|töflur|500|mg|60|stk|1|þpakki||B02AA02|01.04.1989||R|A|3|0|0|E|0|MAS|0|0|1|100|SEK|4838|7495|lyfalmen|||00|60|0|15,0000|Vistor hf|Meda AS|Tranexamsýra||4838||4838|7495| 460071|J01CA0406|Flemoxin Solutab|lausnart|250|mg|20|stk|1|þpakki||J01CA04|01.07.1989||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|1010|2259|lyfalmen|||23|20|0|5,0000|Vistor hf|Astellas Pharma A/S|Amoxicillín||1010||1010|2259| 460170|J07BC0202|Avaxim|bóluefni|0| |0,5|ml|1|dæla|einnota dæla|J07BC02|01.04.1998||R|K|3|0|0|0|0|MEX|0|0|0|100|XEU|4260|6705|lyfalmen|||51|0|0|0,0000|Icepharma hf|Aventis Pasteur MSD A/S|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||4260||4260|6705| 460196|J01CA0406|Flemoxin Solutab|lausnart|500|mg|20|stk|1|þpakki||J01CA04|01.07.1989||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|1107|2392|lyfalmen|||23|20|0|10,0000|Vistor hf|Astellas Pharma A/S|Amoxicillín||1107||1107|2392| 460303|J01CA0406|Flemoxin Solutab|lausnart|750|mg|20|stk|1|þpakki||J01CA04|01.07.1989||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|2316|4045|lyfalmen|||23|20|0|15,0000|Vistor hf|Astellas Pharma A/S|Amoxicillín||2316||2316|4045| 460782|D01AC0801|Fungoral|sápa|20|mg/ml|120|ml|1|glas||D01AC08|01.10.1992||L|A|3|0|0|0|0|MCS|0|0|1|100|SEK|||lyflausa|||23|120|0|120,0000|Vistor hf|McNeil Sweden AB|Ketókónazól|||||| 460972|J07BB0205|Influvac|bóluefni|0| |0,5|ml|10|spr|einnotaspr|J07BB02|01.12.1998||R|K|1|0|0|0|0|SOB|0|0|0|100|XEU|6095|9215|lyfalmen|||51|5|0|0,0000|Icepharma hf|Solvay Biologicals B.V.|Inflúensa, hreinsaðir mótefnavakar||6095||6095|9215| 461731|N02BE5102|Parkodin|töflur|510|mg|10|stk|1|pakki|þp 10+500 mg|N02BE51|01.01.1989||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|193|1141|lyfalmen|||00|10|0|1,6667|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema með geðlyfjum (psycholeptica)||193||193|1141| 462028|D07AD0101|Dermovat|krem|0,5|mg/g|25|g|1|túpa||D07AD01|01.09.1982||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|657|1776|lyfalmen|||20|25|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||657||657|1776| 462044|D07AD0101|Dermovat|smyrsli|0,5|mg/g|25|g|1|túpa||D07AD01|01.09.1982||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|657|1776|lyfalmen|||20|25|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||657||657|1776| 462358|A07EA0601|Entocort|endaþ.dr|20|mcg/ml|7|stk|1|þpakki|samsett pk|A07EA06|01.04.1993||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|8653|12714|lyfalmen|V0291|12276|56|7|0|7,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||8653||8653|12714| 462813|A07AA0906|Vancomycin Xellia|hylki|125|mg|28|stk|1|þpakki|hart hylki|A07AA09|01.01.2011||R|A||0|0|E|0|XEL|0|0|1|100|DKK|12126|17497|lyfalmen|||0|28|0|1,7500|Actavis Group hf|Xellia Pharmaceuticals ApS|Vankómýcín||12126||12126|17497| 462986|QM01AE9101|Rimadyl vet.|stl|50|mg/ml|20|ml|1|hgl||QM01AE91|01.06.2000||R|K|3|0|0|0|0|PAL|1|0|0|100|DKK|6724|13084|vetalmen|||02|20|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||6724||6724|13084| 463612|QM01AE9101|Rimadyl vet.|töflur|50|mg|100|stk|1|pakki||QM01AE91|01.06.2000||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|5364|10472|vetalmen|||00|100|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||5364||5364|10472| 464164|N02BE0101|Panodil|töflur|500|mg|30|stk|1|þpakki||N02BE01|01.04.1992||L|A|5|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||00|30|0|5,0000|Icepharma hf|GlaxoSmithKline CH A/S|Paracetamól|||||| 464370|N05AD0301|Buronil|töflur|25|mg|100|stk|1|glas||N05AD03|01.12.1972||R|A|5|0|0|*|0|LPI|0|1|0|100|DKK|1775|3305|lyfalmen|||00|100|0|8,3333|Swedish Orphan International AB|Lundbeck Pharmaceuticals Ireland Ltd.|Melperón||1775||1775|3305| 465203|QJ01RA0103|Depomycine, vet.|stl|0| |100|ml|1|hgl||QJ01RA01|01.12.1982||R|K|2|0|0|0|0|INI|0|0|0|100|DKK|1191|2369|vetalmen|||58|100|0|0,0000|Icepharma hf|Intervet International B.V.|||1191||1191|2369| 465237|QJ01CR5001|Duplocillin L.A., vet.|stl|0| |100|ml|1|hgl||QJ01CR50|01.05.1983||R|S|3|0|0|0|0|INI|1|0|0|100|DKK|1125|2238|vetalmen|||58|100|0|0,0000|Icepharma hf|Intervet International B.V.|||1125||1125|2238| 465260|QJ01AA0603|Engemycin, vet.|stl|100|mg/ml|100|ml|1|hgl||QJ01AA06|01.12.1982||R|A|3|0|0|0|0|INI|0|0|0|100|DKK|1206|2399|vetalmen|||27|100|0|0,0000|Icepharma hf|Intervet International B.V.|||1206||1206|2399| 465278|QJ51RC2301|Nafpenzal DC, vet.|spenalyf|0| |3|g|4|spr||QJ51RC23|01.04.1985||R|A|3|0|0|0|0|INI|0|0|0|100|XEU|636|1265|vetalmen|||16|12|0|0,0000|Icepharma hf|Intervet International B.V.|||636||636|1265| 466086|N02AA0101|Contalgin|forðatfl|10|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|A|3|1|0|E|0|PER|0|0|0|100|DKK|752|1906|lyfalmen|||10|25|0|2,5000|Icepharma hf|Pfizer ApS|Morfín||752||752|1906| 466094|N02AA0101|Contalgin|forðatfl|10|mg|100|stk|1|þpakki||N02AA01|01.08.1984||R|A|3|1|0|E|0|PER|0|0|0|100|DKK|2071|3710|lyfalmen|||10|100|0|10,0000|Icepharma hf|Pfizer ApS|Morfín||2071||2071|3710| 466169|N02AA0101|Contalgin|forðatfl|30|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|A|3|1|0|E|0|PER|0|0|0|100|DKK|1601|3067|lyfalmen|||10|25|0|7,5000|Icepharma hf|Pfizer ApS|Morfín||1601||1601|3067| 466219|N02AA0101|Contalgin|forðatfl|30|mg|100|stk|1|þpakki||N02AA01|01.08.1984||R|A|3|1|0|E|0|PER|0|0|0|100|DKK|6127|9259|lyfalmen|||10|100|0|30,0000|Icepharma hf|Pfizer ApS|Morfín||6127||6127|9259| 466466|N02AA0101|Contalgin|forðatfl|60|mg|25|stk|1|þpakki||N02AA01|01.10.1995||R|A|3|1|0|E|0|PER|0|0|0|100|DKK|3078|5088|lyfalmen|||10|25|0|15,0000|Icepharma hf|Pfizer ApS|Morfín||3078||3078|5088| 466482|L04AD0102|Sandimmun Neoral|hylki|25|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|A|3|0|0|*|0|NOH|0|0|0|100|DKK|7939|11737|lyfalmen|||10|50|0|5,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||7939||7939|11737| 466680|N02AA0101|Contalgin|forðatfl|100|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|A|3|1|0|E|0|PER|0|0|0|100|DKK|4927|7617|lyfalmen|||10|25|0|25,0000|Icepharma hf|Pfizer ApS|Morfín||4927||4927|7617| 466813|N06AG0201|Aurorix|töflur|150|mg|100|stk|1|þpakki||N06AG02|01.10.1990||R|A|5|0|0|B|0|MAS|0|1|0|100|SEK|5815|8832|lyfalmen|||64|100|0|50,0000|Vistor hf|Meda AS|Móklóbemíð||5815||5815|8832| 467191|L03AA0201|Neupogen|stl|0,6|mg/ml|0,5|ml|1|spr|áfyllt sprauta, lausn|L03AA02|01.02.2004||R|K|2,5|0|1|0|1|AEU|0|0|0|100|DKK|15913|21853|lyfsjukr|||00|0|0|0,8600|Vistor hf|Amgen Europe B.V.|Fílgrastím||15913||15913|21853| 467258|L03AA0201|Neupogen|stl|0,96|mg/ml|0,5|ml|1|spr|áfyllt sprauta, lausn|L03AA02|01.02.2004||R|K|2,5|0|1|0|1|AEU|0|0|0|100|DKK|24940|33182|lyfsjukr|||00|0|0|1,3700|Vistor hf|Amgen Europe B.V.|Fílgrastím||24940||24940|33182| 467480|L03AB0502|IntronA|stl|18|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.02.2001||R|K|1,25|0|1|0|1|SCP|0|0|0|100|DKK|27003|35771|lyfsjukr|||00|1|0|9,0000|Vistor hf|Schering-Plough|Interferón alfa-2b||27003||27003|35771| 467498|L03AB0502|IntronA|stl|30|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.02.2001||R|K|1,25|0|1|0|1|SCP|0|0|0|100|DKK|43985|57084|lyfsjukr|||00|1|0|15,0000|Vistor hf|Schering-Plough|Interferón alfa-2b||43985||43985|57084| 467514|L04AA1001|Rapamune|mixtúra|1|mg/ml|60|ml|1|fl||L04AA10|01.04.2004||R|A|2|0|1|*|0|WTE|0|0|0|100|DKK|33973|44915|lyfalmen|||00|60|0|20,0000|Icepharma hf|Wyeth Europe|Sirolimus||33973||33973|44915| 467563|L04AD0102|Sandimmun Neoral|hylki|50|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|A|3|0|0|*|0|NOH|0|0|0|100|DKK|15489|21718|lyfalmen|||10|50|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||15489||15489|21718| 467621|L03AB0502|IntronA|stl|60|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.02.2001||R|K|1,25|0|1|0|1|SCP|0|0|0|100|DKK|90036|114878|lyfsjukr|||00|1|0|30,0000|Vistor hf|Schering-Plough|Interferón alfa-2b||90036||90036|114878| 467720|L04AD0102|Sandimmun Neoral|hylki|100|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|A|3|0|0|*|0|NOH|0|0|0|100|DKK|29491|39290|lyfalmen|||10|50|0|20,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||29491||29491|39290| 467993|N05AD0101|Haldol|stl|5|mg/ml|1|ml|5|lykjur||N05AD01|01.08.2000||R|A|5|0|0|0|1|JAS|0|1|0|100|SEK|842|1215|lyfsjukr|||00|5|0|3,1250|Vistor hf|Janssen-Cilag AB|Halóperídól||842||842|1215| 468082|N06AB0401|Cipramil|töflur|10|mg|100|stk|1|plglas||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|6427|6576|lyfalmen|V0922|4575|00|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||4166||4166|6576| 468116|N01AH0102|Leptanal|stl|50|mcg/ml|2|ml|5|lykjur||N01AH01|01.11.2001||R|A|3|1|0|0|1|JAS|0|0|0|100|SEK|387|559|lyfsjukr|||02|10|0|0,0000|Vistor hf|Janssen-Cilag AB|Fentanýl||387||387|559| 468124|N06AB0401|Cipramil|töflur|20|mg|100|stk|1|glas||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|9359|6260|lyfalmen|V0926|4374|00|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||3935||3935|6260| 468165|N06AB0401|Cipramil|töflur|40|mg|100|stk|1|glas||N06AB04|01.04.1993||R|A|5|0|0|0|0|LBK|0|1|0|100|DKK|23647|12711|lyfalmen|V0930|7316|00|100|0|200,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||8651||8651|12711| 468803|M05BA0705|Risedronat Actavis|filmhtfl|35|mg|12|stk|1|þpakki||M05BA07|01.03.2011||R|A||0|0|E|0|APC|0|0|0|100|IKR|4530|4311|lyfalmen|V0719|4311|00|12|0|84,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rísedrónsýru||2510||2510|4311| 469346|C10AB0401|Lopid|töflur|600|mg|98|stk|1|þpakki||C10AB04|01.07.1991||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|10194|14822|lyfalmen|||00|98|0|49,0000|Icepharma hf|Pfizer ApS|Gemfíbrózíl||10194||10194|14822| 469742|N02AX0206|Nobligan Retard|forðatfl|200|mg|20|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|2911|4859|lyfalmen|||00|20|0|13,3333|Icepharma hf|Grunenthal|Tramadól||2911||2911|4859| 469817|N02AX0206|Nobligan Retard|forðatfl|200|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|11865|17108|lyfalmen|V0738|12534|00|100|0|66,6667|Icepharma hf|Grunenthal|Tramadól||11865||11865|17108| 469866|N02AX0206|Nobligan Retard|forðatfl|150|mg|20|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|2276|3991|lyfalmen|||00|20|0|10,0000|Icepharma hf|Grunenthal|Tramadól||2276||2276|3991| 469874|N02AX0206|Nobligan Retard|forðatfl|150|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|9009|13201|lyfalmen|V0736|8542|00|100|0|50,0000|Icepharma hf|Grunenthal|Tramadól||9009||9009|13201| 469890|N02AX0206|Nobligan Retard|forðatfl|100|mg|20|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|1547|2993|lyfalmen|V0733|2479|00|20|0|6,6667|Icepharma hf|Grunenthal|Tramadól||1547||1547|2993| 469932|N02AX0206|Nobligan Retard|forðatfl|100|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|6154|9296|lyfalmen|V0734|5894|00|100|0|33,3333|Icepharma hf|Grunenthal|Tramadól||6154||6154|9296| 470385|R03BA0501|Flixotide|innúðal|250|mcg/sk|120|sk|1|stauk||R03BA05|01.04.1995||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|5307|8137|lyfalmen|||24|120|0|50,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||5307||5307|8137| 470989|V08AB0201|Omnipaque|stl|180|mg J/ml|15|ml|10|plastf||V08AB02|01.01.2005||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|11558|16388|lyfsjukr|||02|150|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||11558||11558|16388| 471144|V08AB0201|Omnipaque|stl|240|mg J/ml|20|ml|10|plastf||V08AB02|01.10.1998||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|9340|13480|lyfsjukr|||02|200|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||9340||9340|13480| 471151|V08AB0201|Omnipaque|stl|300|mg J/ml|10|ml|10|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|6396|9231|lyfsjukr|||02|100|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||6396||6396|9231| 471169|V08AB0201|Omnipaque|stl|300|mg J/ml|20|ml|10|plastf||V08AB02|01.10.1998||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|15593|21452|lyfsjukr|||02|200|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||15593||15593|21452| 471177|V08AB0201|Omnipaque|stl|350|mg J/ml|20|ml|10|plastf||V08AB02|01.10.1998||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|13401|18701|lyfsjukr|||02|200|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||13401||13401|18701| 471425|A10BB0701|Mindiab|töflur|5|mg|100|stk|1|þpakki||A10BB07|01.07.1990||R|A|5|0|0|*|0|PER|0|0|0|100|DKK|1996|3608|lyfalmen|||68|100|0|50,0000|Icepharma hf|Pfizer ApS|Glípízíð||1996||1996|3608| 471821|QP52AC1302|Panacur, vet.|töflur|250|mg|20|stk|1|þpakki||QP52AC13|01.04.1992||L|A|5|0|0|0|0|INI|0|0|0|100|DKK|2131|3717|vetorma|||99|20|0|0,0000|Icepharma hf|Intervet International B.V.|||||2131|3717| 471938|L01AA0101|Sendoxan|töflur|50|mg|100|stk|1|þpakki||L01AA01|01.01.1988||R|A|3|0|0|*|0|BAM|0|0|0|100|SEK|3356|5468|lyfalmen|||00|100|0|0,0000|Icepharma hf|Baxter Medical AB|Cýklófosfamíð||3356||3356|5468| 471953|QV03AB9001|Antisedan, vet.|stl|5|mg/ml|10|ml|1|hgl||QV03AB90|01.08.2006||R|A|3|0|0|0|0|ORC|1|0|0|100|DKK|4775|9341|vetalmen|||27|10|0|0,0000|Vistor hf|Orion Corporation|||4775||4775|9341| 472092|C07AB0206|Seloken ZOC|forðatfl|47,5|mg|98|stk|1|þpakki||C07AB02|01.07.1989||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2490|3702|lyfalmen|V2003|2816|43|98|0|31,0300|Vistor hf|AstraZeneca A/S DK|Metóprólól||2065||2065|3702| 472332|J07BC0201|Havrix|bóluefni|1440|ein/ml|0,5|ml|1|dæla|einnota dæla|J07BC02|01.10.1995||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|2457|4238|lyfalmen|||02|0|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||2457||2457|4238| 474007|B05AA0507|Promiten|stl|150|mg/ml|20|ml|20|lykjur|plastlykjur|B05AA05|01.03.1999||R|A|3|0|0|0|1|MAB|0|0|0|100|SEK|15619|21484|lyfsjukr|||00|400|0|0,4000|Vistor hf|Meda AB|Dextran||15619||15619|21484| 474106|M02AA1301|Deep Relief|hlaup|5|%|50|g|1|túpa||M02AA13|01.06.2000||L|A|3|0|0|0|0|MEN|0|0|1|100|IKR|||lyflausa|||00|50|0|0,0000|Icepharma hf|Mentholatum Company Ltd.|Íbúprófen|||||| 474114|N02CA7201|Anervan|töflur|160,5|mg|30|stk|1|pakki|þp (0,5+10+50+100 mg)|N02CA72|01.10.1995||R|A|3|0|0|E|0|REP|0|0|0|100|SEK|1120|2409|lyfalmen|||00|30|0|15,0000|Vistor hf|Recip AB|Ergotamínlyf í blöndum með geðlyfjum (psycoleptica)||1120||1120|2409| 474197|M02AA1301|Deep Relief|hlaup|5|%|15|g|1|túpa||M02AA13|01.06.2000||L|A|3|0|0|0|0|MEN|0|0|1|100|IKR|||lyflausa|||00|15|0|0,0000|Icepharma hf|Mentholatum Company Ltd.|Íbúprófen|||||| 474395|J05AG0101|Viramune|töflur|200|mg|60|stk|1|þpakki||J05AG01|01.03.2007||R|A|3|0|1|0|1|BII|0|0|0|100|DKK|41787|54325|lyfsjukr|||00|60|0|30,0000|Vistor hf|Boehringer Ingelheim International |Nevírapín||41787||41787|54325| 474551|R01AD0901|Nasonex|nefúði|50|mcg/sk|140|skammtar|1|úðagl|18 g í pakkn.|R01AD09|01.05.1998||R|A|3|0|0|E|0|SCP|0|0|1|100|DKK|1856|3416|lyfalmen|||00|140|0|35,0000|Vistor hf|Schering-Plough|Mómetasón||1856||1856|3416| 474657|N04BC0504|Oprymea (Lyfis)|töflur|0,088|mg|30|stk|1|þpakki||N04BC05|01.07.2010||R|A||0|0|E|0|LYF|0|0|0|100|XEU|1274|1595|lyfalmen|V2010|1595|00|30|0|1,0600|Lyfis ehf|Lyfis ehf|Pramipexól||525||525|1595| 475327|N02BE0113|Pinex Junior|eþ-stíll|250|mg|10|stk|1|pakki||N02BE01|01.07.2008||L|A|5|0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||04|10|0|0,8333|Actavis Group hf|Actavis Group hf|Paracetamól|||||| 475434|B01AA0301|Kovar|töflur|2|mg|100|stk|1|glas||B01AA03|01.10.1995||R|A|5|0|0|E|0|ACA|0|0|0|100|IKR|720|1862|lyfalmen|||00|100|0|26,6667|Actavis Group hf|Actavis hf|Warfarín||720||720|1862| 475467|G03CA0306|Evorel|forðapl|50|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|4558|7112|lyfalmen|||23|26|0|91,0000|Vistor hf|Janssen-Cilag AB|Estradíól||4558||4558|7112| 475491|N02AA5902|Parkodin forte|töflur|530|mg|20|stk|1|pakki|þp 30+500 mg|N02AA59|01.04.1992||R|A|2|0|0|0|0|ACA|0|0|1|100|NOK|280|1260|lyfalmen|V0775|1207|00|20|0|6,6667|Actavis Group hf|Actavis hf|Kódein í blöndum nema með geðlyfjum||280||280|1260| 475533|N02AA5902|Parkodin forte|töflur|530|mg|30|stk|1|pakki|þp 30+500 mg|N02AA59|01.04.1992||R|A|2|0|0|0|0|ACA|0|0|1|100|NOK|341|1344|lyfalmen|||00|30|0|10,0000|Actavis Group hf|Actavis hf|Kódein í blöndum nema með geðlyfjum||341||341|1344| 475715|N02AA5902|Parkodin forte|töflur|530|mg|100|stk|1|pakki|þp 30+500 mg|N02AA59|01.04.1992||R|A|2|1|0|0|0|ACA|0|0|1|100|NOK|954|2182|lyfalmen|V0780|2137|00|100|0|33,3333|Actavis Group hf|Actavis hf|Kódein í blöndum nema með geðlyfjum||954||954|2182| 475798|R03AC1302|Oxis Turbuhaler|innúðadu|4,5|mcg/sk|60|sk|1|stauk||R03AC13|01.10.1997||R|A|2|0|0|0|0|AZD|0|0|1|100|SEK|3726|5974|lyfalmen|||00|60|0|11,2500|Vistor hf|AstraZeneca A/S DK|Formóteról||3726||3726|5974| 475822|R03AC1302|Oxis Turbuhaler|innúðadu|9|mcg/sk|60|sk|1|stauk||R03AC13|01.10.1997||R|A|2|0|0|0|0|AZD|0|0|1|100|SEK|4985|7696|lyfalmen|||00|60|0|22,5000|Vistor hf|AstraZeneca A/S DK|Formóteról||4985||4985|7696| 475921|A10AB0404|Humalog Pen|stl|100|ae/ml|3|ml|5|pennar|einnota pennar|A10AB04|01.11.1999||R|K|2|0|0|*|0|ELD|0|0|0|100|XEU|5598|8535|lyfalmen|||00|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||5598||5598|8535| 476093|A10AC0106|Humulin NPH Pen|stl|100|ae/ml|3|ml|5|pennar|Einnota pennar|A10AC01|01.06.1999||R|K|2|0|0|*|0|ELI|0|0|0|100|XEU|4754|7380|lyfalmen|||51|15|0|37,5000|Icepharma hf|Eli Lilly Danmark A/S|Insúlín (manna)||4754||4754|7380| 476434|B03XA0201|Aranesp|stl|60|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|77696|99391|lyfsjukr|||00|1|0|53,3300|Vistor hf|Amgen|Darbepóetín alfa||||77696|99391| 476580|R03AC0206|Ventoline|lausn|2|mg/ml|20|lykjur|1|pakki|f. vél|R03AC02|01.04.1992||R|A|3|0|0|0|0|GSK|0|0|1|100|GBP|1134|2429|lyfalmen|||00|50|0|10,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||1134||1134|2429| 476648|N05AH0401|Seroquel|töflur|100|mg|30|stk|1|þpakki|stakskammtar|N05AH04|01.09.1998||R|A|3|0|0|*|0|AZA|0|1|0|100|SEK|7601|11275|lyfalmen|||00|30|0|7,5000|Vistor hf|AstraZeneca AB|Quetíapín||7601||7601|11275| 476655|N05AH0401|Seroquel|töflur|200|mg|30|stk|1|þpakki|stakskammtar|N05AH04|01.09.1998|31.01.2011|R|A|3|0|0|*|0|AZA|0|1|0|100|SEK|10722|15544|lyfalmen|||00|30|0|15,0000|Vistor hf|AstraZeneca AB|Quetíapín||10722||10722|15544| 477059|P01BB5101|Malarone|filmhtfl|350|mg|12|stk|1|glas|250 + 100 mg|P01BB51|01.02.2006||R|A|5|0|0|0|0|GSK|0|0|0|100|GBP|4452|6967|lyfalmen|||00|12|0|3,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Prógúaníl í blöndum||4452||4452|6967| 477547|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|0| |20|ml|10|hgl|fyrir stungulyf|V07AB00|01.02.2007||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||00|200|0|0,0000|Icepharma hf|Fresenius Kabi|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||| 477554|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|0| |50|ml|10|hgl|fyrir stungulyf|V07AB00|01.02.2007||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||00|500|0|0,0000|Icepharma hf|Fresenius Kabi|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||| 477752|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|A|3|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||02|200|0|0,0000|Icepharma hf|Fresenius Kabi|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||| 477760|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|50|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|A|3|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||02|500|0|0,0000|Icepharma hf|Fresenius Kabi|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||| 477786|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|100|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|A|3|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||02|1000|0|0,0000|Icepharma hf|Fresenius Kabi|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||| 479691|C09AA0701|Cibacen|töflur|10|mg|98|stk|1|þpakki||C09AA07|01.07.1991||R|A|3|0|0|0|0|MAS|0|0|0|100|SEK|11153|16134|lyfalmen|||00|98|0|130,6667|Vistor hf|Meda AS|Benazepríl||11153||11153|16134| 479717|C09AA0701|Cibacen|töflur|20|mg|98|stk|1|þpakki||C09AA07|01.07.1991||R|A|3|0|0|0|0|MAS|0|0|0|100|SEK|23928|32309|lyfalmen|||00|98|0|261,3333|Vistor hf|Meda AS|Benazepríl||23928||23928|32309| 480863|G03XC0101|Evista|töflur|60|mg|28|stk|1|þpakki||G03XC01|01.02.1999||R|A|3|0|0|E|0|DSG|0|0|0|100|SEK|5160|7936|lyfalmen|||00|28|0|28,0000|Icepharma hf|Daiichi Sankyo Europe GmbH|Raloxífen||5160||5160|7936| 480897|G03XC0101|Evista|töflur|60|mg|84|stk|1|þpakki||G03XC01|01.02.1999||R|A|3|0|0|E|0|DSG|0|0|0|100|SEK|13361|19047|lyfalmen|||00|84|0|84,0000|Icepharma hf|Daiichi Sankyo Europe GmbH|Raloxífen||13361||13361|19047| 481176|N06AX1201|Zyban|forðatfl|150|mg|100|stk|1|þpakki||N06AX12|01.09.2000||R|A|2|0|0|0|0|GSK|0|1|1|100|GBP|11506|16617|lyfalmen|||00|100|0|50,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Buprofienum||11506||11506|16617| 483602|J02AC0101|Diflucan|irl|2|mg/ml|50|ml|1|fl||J02AC01|01.04.1990||R|A|5|0|0|0|1|PER|0|0|0|100|DKK|3609|5209|lyfsjukr|||00|50|0|0,5000|Icepharma hf|Pfizer ApS|Flúkónazól||3609||3609|5209| 483685|J02AC0101|Diflucan|irl|2|mg/ml|100|ml|1|hgl||J02AC01|01.03.2001||R|A|5|0|0|0|1|PER|0|0|0|100|DKK|4799|6926|lyfsjukr|||00|100|0|1,0000|Icepharma hf|Pfizer ApS|Flúkónazól||4799||4799|6926| 484022|L02AE0401|Decapeptyl Depot|sts|3,75|mg|1|stk|3|spr|+ leysir|L02AE04|01.01.1995||R|K|3|0|1|0|1|FER|0|0|0|100|DKK|82534|105463|lyfsjukr|||00|3|0|83,9552|Vistor hf|Ferring|Triptórelín||82534||82534|105463| 484238|D11AX1001|Propecia|töflur|1|mg|28|stk|1|þpakki||D11AX10|01.08.1999||R|A|3|0|0|0|0|MSD|0|0|0|100|XEU|5957|9026|lyfalmen|||00|28|0|28,0000|Icepharma hf|M.S.D.|Fínasteríð||5957||5957|9026| 484327|L03AA1301|Neulasta|stl|6|mg/spr|0,6|ml|1|spr|nálavörn|L03AA13|01.11.2010||R|K||0|1|0|1|AEU|0|0|0|100|DKK|169211|214242|lyfsjukr|||00|1|0|20,0000|Vistor hf|Amgen Europe B.V.|Pegfilgrastím||||169211|214242| 484618|A01AD0201|Andolex|lausn|1,5|mg/ml|300|ml|1|glas|lausn til munnskolunar|A01AD02|01.01.1996||R|A|3|0|0|E|0|MEB|0|0|1|100|SEK|1471|2889|lyfalmen|||00|300|0|0,0000|Vistor hf|Meda AB (V)|Benzýdamín||1471||1471|2889| 486779|M01AE0218|Naproxen Mylan|töflur|250|mg|20|stk|1|þpakki||M01AE02|01.04.1995||L|A|4|0|0|0|0|MYL|0|0|1|100|IKR|||lyflausa|||00|20|0|10,0000|Actavis Group PTC ehf|Mylan AB|Naproxen|||||| 486860|S01BA0101|Maxidex|augndr|1|mg/ml|5|ml|1|glas||S01BA01|01.01.1977||R|A|3|0|0|E|0|SAL|0|0|1|100|USD|451|1494|lyfalmen|||29|5|0|0,0000|Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Dexametasón||451||451|1494| 486886|S01CA0101|Maxitrol|augndr|||5|ml|1|glas||S01CA01|01.07.1990||R|A|2|0|0|E|0|SAL|0|0|1|100|USD|644|1758|lyfalmen|||29|5|0|0,0000|Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Dexametasón||644||644|1758| 487280|C09AA0401|Coversyl|töflur|4|mg|30|stk|1|þpakki||C09AA04|01.01.1992||R|A|2|0|0|0|0|SEV|0|0|0|100|DKK|3643|5861|lyfalmen|||00|30|0|30,0000|Icepharma hf|Servier|Perindópríl||3643||3643|5861| 487900|J01XE0101|Furadantin|töflur|50|mg|25|stk|1|þpakki||J01XE01|01.03.2004||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|892|2097|lyfalmen|||00|25|0|6,2500|Vistor hf|Recip AB|Nítrófúrantóín||892||892|2097| 487959|N02BE0113|Pinex Junior|eþ-stíll|125|mg|10|stk|1|pakki||N02BE01|01.07.2008||L|A|5|0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||04|10|0|0,4167|Actavis Group hf|Actavis Group hf|Paracetamól|||||| 488049|M01AX0101|Relifex|töflur|500|mg|20|stk|1|þpakki||M01AX01|01.04.1995||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|960|2190|lyfalmen|||00|20|0|10,0000|Vistor hf|Meda AB|Nabúmeton||960||960|2190| 488056|M01AX0101|Relifex|töflur|500|mg|60|stk|1|plglas||M01AX01|01.07.1998||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|2857|4785|lyfalmen|||00|60|0|30,0000|Vistor hf|Meda AB|Nabúmeton||2857||2857|4785| 488114|N02BE0114|Pinex|eþ-stíll|500|mg|10|stk|1|pakki||N02BE01|01.07.2008||L|A|5|0|0|0|0|AGT|0|0|1|100|IKR|||lyfalmen|||04|10|0|1,6667|Actavis Group hf|Actavis Group hf|Paracetamól|||||1315| 488767|D05BB0201|Neotigason|hylki|10|mg|50|stk|1|þpakki||D05BB02|01.04.1992||R|A|3|0|1|B|0|APC|0|0|0|100|DKK|6300|9495|lyfalmen|||67|50|0|14,2857|Actavis Group PTC ehf|Actavis Group PTC ehf|Acitretín||6300||6300|9495| 488791|D05BB0201|Neotigason|hylki|25|mg|50|stk|1|þpakki||D05BB02|01.04.1992||R|A|3|0|1|B|0|APC|0|0|0|100|DKK|17625|24398|lyfalmen|||67|50|0|35,7143|Actavis Group PTC ehf|Actavis Group PTC ehf|Acitretín||17625||17625|24398| 489259|B03XA0201|Aranesp|stl|80|mcg/spr|0,4|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|103568|131860|lyfsjukr|||00|2|0|71,1100|Vistor hf|Amgen|Darbepóetín alfa||||103568|131860| 489591|M01AB0506|Voltaren Rapid|töflur|50|mg|10|stk|1|þpakki||M01AB05|01.01.1996||R|A|3|0|0|0|0|NOH|0|0|1|100|IKR|338|1140|lyfalmen|||67|10|0|5,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||192||192|1140| 489609|M01AB0506|Voltaren Rapid|töflur|50|mg|30|stk|1|þpakki||M01AB05|01.01.1996||R|A|3|0|0|0|0|NOH|0|0|1|100|IKR|882|1516|lyfalmen|V0609|1478|67|30|0|15,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||467||467|1516| 490417|G03FB0504|Evorel Sequi|forðapl|0| |8|stk|1|pakki||G03FB05|01.08.1999||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|2685|4550|lyfalmen|||23|8|0|28,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||2685||2685|4550| 490425|G03FA0104|Evorel Conti|forðapl|0| |8|stk|1|pakki||G03FA01|01.08.1999||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|2993|4972|lyfalmen|||23|8|0|28,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||2993||2993|4972| 490797|C10AA0501|Zarator|töflur|10|mg|30|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|4733|7352|lyfalmen|||00|30|0|15,0000|Icepharma hf|Pfizer ApS|Atorvastatín||4733||4733|7352| 490805|C10AA0501|Zarator|töflur|10|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|10857|10508|lyfalmen|V2205|2426|00|100|0|50,0000|Icepharma hf|Pfizer ApS|Atorvastatín||7040||7040|10508| 490813|C10AA0501|Zarator|töflur|20|mg|30|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|7345|10925|lyfalmen|||00|30|0|30,0000|Icepharma hf|Pfizer ApS|Atorvastatín||7345||7345|10925| 490821|C10AA0501|Zarator|töflur|20|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|15408|14282|lyfalmen|V2207|3144|00|100|0|100,0000|Icepharma hf|Pfizer ApS|Atorvastatín||9799||9799|14282| 490839|C10AA0501|Zarator|töflur|40|mg|30|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|11401|16473|lyfalmen|||00|30|0|60,0000|Icepharma hf|Pfizer ApS|Atorvastatín||11401||11401|16473| 490854|C10AA0501|Zarator|töflur|40|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|19596|17796|lyfalmen|V0339|5945|00|100|0|200,0000|Icepharma hf|Pfizer ApS|Atorvastatín||12364||12364|17796| 491860|L03AX0301|Oncotice|duft|500|millj ae|3|hgl|1|pakki|Fyrir ídreypivökva.|L03AX03|01.03.1999||R|K|1|0|1|0|1|ORG|0|0|0|100|DKK|45484|58965|lyfsjukr|||00|3|0|21,0084|Vistor hf|N.V. Organon|BCG bóluefni||45484||45484|58965| 492405|N04BA0202|Madopar Depot|forðahlk|125|mg|100|stk|1|hylki|100+25 mg|N04BA02|01.01.1991||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|3324|5424|lyfalmen|||10|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3324||3324|5424| 492512|A02BC0102|Losec|sh-tfl|10|mg|14|stk|1|þpakki||A02BC01|01.09.2009||L|A||0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||00|14|0|7,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól|||||| 492520|A02BC0102|Losec|sh-tfl|10|mg|100|stk|1|glas||A02BC01|01.01.1999||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|12684|18198|lyfalmen|V2206|7599|00|100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól||12684||12684|18198| 492546|A02BC0102|Losec|sh-tfl|20|mg|14|stk|1|þpakki||A02BC01|01.05.2009||L|A|3|0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa|||00|14|0|14,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól|||||| 493324|N05AX1202|Abilify (D.A.C)|töflur|15|mg|28|stk|1|þpakki||N05AX12|01.03.2011||R|A||0|0|*|0|DAC|0|1|0|100|XEU|19910|27266|lyfalmen|V1703|27256|00|28|0|28,0000|D.A.C. ehf|D.A.C. ehf|Aripiprazól||19910||19910|27266| 494013|N06AA0601|Surmontil|töflur|25|mg|100|stk|1|glas||N06AA06|01.10.1995||R|A|5|0|0|B|0|SNO|0|1|0|100|NOK|1657|3144|lyfalmen|||00|100|0|16,6667|Vistor hf|Sanofi-aventis Norge AS|Trímípramín||1657||1657|3144| 494138|N02CX0101|Sandomigrin|töflur|0,5|mg|100|stk|1|þpakki||N02CX01|01.04.1974||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|3939|6266|lyfalmen|||00|100|0|33,3333|Vistor hf|Novartis Healthcare A/S-|Pízótífen||3939||3939|6266| 494237|L01XC0201|MabThera|irþ|100|mg|10|ml|2|hgl|lausn|L01XC02|01.11.2003||R|A|2,5|0|1|0|1|RRL|0|0|0|100|DKK|81062|103615|lyfsjukr|||00|20|0|0,0000|Icepharma hf|Roche Registration Limited|Rítúxímab||81062||81062|103615| 494286|L01XC0201|MabThera|irþ|500|mg|50|ml|1|hgl|lausn|L01XC02|01.11.2003||R|A|2,5|0|1|0|1|RRL|0|0|0|100|DKK|202656|256216|lyfsjukr|||00|50|0|0,0000|Icepharma hf|Roche Registration Limited|Rítúxímab||202656||202656|256216| 494559|D10AF0101|Dalacin|fleyti|10|mg/ml|60|ml|1|glas|Áburður, fleyti|D10AF01|01.10.1995||R|A|2|0|0|0|0|PER|0|0|0|100|DKK|2275|3989|lyfalmen|||00|60|0|60,0000|Icepharma hf|Pfizer ApS|Klindamýcín||2275||2275|3989| 494682|G03CA0320|Estrofem 2 mg|töflur|2|mg|84|stk|1|skífup||G03CA03|01.12.1980||R|A|4|0|0|E|0|NON|0|0|0|100|DKK|2595|4427|lyfalmen|V0408|1820|23|84|0|84,0000|Vistor hf|Novo-Nordisk|Estradíól||2595||2595|4427| 494724|G03FA0102|Kliogest|töflur|0| |84|stk|1|skífup||G03FA01|01.10.1986||R|A|4|0|0|E|0|NON|0|0|0|100|DKK|3292|5381|lyfalmen|V0388|4129|23|84|0|84,0000|Vistor hf|Novo-Nordisk|Noretísterón og östrógen||3292||3292|5381| 494831|B01AC0702|Persantin retard|forðahlk|200|mg|60|stk|1|glas|hart hylki|B01AC07|01.04.2006||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|2203|3891|lyfalmen|||00|60|0|30,0000|Vistor hf|Boehringer Ingelheim International |Dípýrídamól||2203||2203|3891| 495283|A04AA0101|Zofran|töflur|8|mg|15|stk|1|þpakki||A04AA01|01.01.1991||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|18271|25209|lyfalmen|||00|15|0|7,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||18271||18271|25209| 495382|A04AA0101|Zofran|stl|2|mg/ml|2|ml|5|lykjur||A04AA01|01.01.1991||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|7106|8203|lyfalmen|V1088|8067|02|10|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||5355||5355|8203| 495390|A04AA0101|Zofran|stl|2|mg/ml|4|ml|5|lykjur||A04AA01|01.01.1991||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|10153|12610|lyfalmen|V1089|12408|02|20|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||8577||8577|12610| 495820|J05AH0101|Relenza|innúðadu|5|mg/úðask|20|sk|1|stauk|+diskhaler|J05AH01|01.02.2000||R|A|5|0|0|0|0|GSK|0|0|0|100|GBP|2788|4691|lyfalmen|||00|20|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Zanamivír||2788||2788|4691| 496174|QJ01M0001|Baytril vet.|töflur|150|mg|10|stk|1|þpakki||QJ01MA90|01.03.2009||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|4237|8308|vetalmen|||0|10|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||||4237|8308| 496547|C07AG0101|Trandate|stl|5|mg/ml|20|ml|5|lykjur||C07AG01|01.01.1985||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|4027|6386|lyfalmen|||02|100|0|0,8333|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Labetalól||4027||4027|6386| 496554|C07AG0101|Trandate|filmhtfl|100|mg|50|stk|1|glas||C07AG01|01.02.1982||R|A|5|0|0|B|0|GSK|0|0|0|100|GBP|1017|2268|lyfalmen|||00|50|0|8,3333|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Labetalól||1017||1017|2268| 496752|C07AG0101|Trandate|filmhtfl|200|mg|100|stk|1|glas||C07AG01|01.01.1986||R|A|5|0|0|B|0|GSK|0|0|0|100|GBP|3190|5241|lyfalmen|||00|100|0|33,3333|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Labetalól||3190||3190|5241| 496935|N02AG0201|Ketogan|eþ-stíll|||10|stk|1|pakki||N02AG02|01.07.1994||R|A|3|1|0|E|0|PER|0|0|0|100|DKK|559|1642|lyfalmen|||04|10|0|4,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||559||559|1642| 496950|N02AG0201|Ketogan|töflur|0| |20|stk|1|þpakki|5 + 25 mg|N02AG02|01.07.1994||R|A|5|1|0|E|0|PER|0|0|0|100|DKK|850|2040|lyfalmen|||00|20|0|2,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||850||850|2040| 497099|N02AG0201|Ketogan|töflur|0| |100|stk|1|þpakki|5 + 25 mg|N02AG02|01.07.1994||R|A|5|1|0|E|0|PER|0|0|0|100|DKK|3236|5304|lyfalmen|||00|100|0|10,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||3236||3236|5304| 497263|N06BA0103|Amfetamin Actavis|töflur|5|mg|30|stk|1|glas||N06BA01|01.07.1991||R|A|3|1|0|0|0|ACA|0|0|0|100|IKR|1036|2294|lyfalmen|||00|30|0|10,0000|Actavis Group hf|Actavis hf|Amfetamín||1036||1036|2294| 497289|C09AA0201|Daren|töflur|5|mg|30|stk|1|glas||C09AA02|01.07.1990||R|A|2|0|0|0|0|ACA|0|0|0|100|IKR|419|1450|lyfalmen|||00|30|0|15,0000|Actavis Group hf|Actavis hf|Enalapríl||419||419|1450| 497297|C09AA0201|Daren|töflur|5|mg|100|stk|1|glas||C09AA02|01.07.1990||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|527|1598|lyfalmen|||00|100|0|50,0000|Actavis Group hf|Actavis hf|Enalapríl||527||527|1598| 497313|C09AA0201|Daren|töflur|20|mg|100|stk|1|glas||C09AA02|01.07.1990||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|1094|2374|lyfalmen|||00|100|0|200,0000|Actavis Group hf|Actavis hf|Enalapríl||1094||1094|2374| 497511|D08AC0202|Hibitane|sk-krem|10|mg/ml|250|ml|1|glas||D08AC02|01.12.1983||L|A|3|0|0|0|0|BIG|0|0|0|100|IKR|||lyflausa|||00|250|0|250,0000|Icepharma hf|Bioglan AB|Klórhexidín|||||| 497818|D07AC0401|Synalar|smyrsli|0,25|mg/g|30|g|1|túpa||D07AC04|01.04.1998||R|A|3|0|0|B|0|BIG|0|0|1|100|SEK|888|2092|lyfalmen|||20|30|0|30,0000|Icepharma hf|Bioglan AB|Flúócínólón||888||888|2092| 498048|H02AB0103|Diprospan|stl|7|mg/ml|2|ml|1|hgl|5 + 2 mg/ml|H02AB01|01.09.2004||R|A|2|0|0|B|0|SCP|0|0|1|100|DKK|1364|2743|lyfalmen|||03|2|0|35,0000|Vistor hf|Schering-Plough|Betametasón||1364||1364|2743| 498964|N05AE0401|Zeldox|hylki|20|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|A|4|0|0|*|0|PER|0|1|0|100|DKK|17001|23615|lyfalmen|||00|56|0|14,0000|Icepharma hf|Pfizer ApS|Ziprasidon||17001||17001|23615| 498980|N05AE0401|Zeldox|hylki|40|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|A|4|0|0|*|0|PER|0|1|0|100|DKK|18135|25039|lyfalmen|||00|56|0|28,0000|Icepharma hf|Pfizer ApS|Ziprasidon||18135||18135|25039| 499004|N05AE0401|Zeldox|hylki|60|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|A|4|0|0|*|0|PER|0|1|0|100|DKK|26785|35894|lyfalmen|||00|56|0|42,0000|Icepharma hf|Pfizer ApS|Ziprasidon||26785||26785|35894| 499020|N05AE0401|Zeldox|hylki|80|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|A|4|0|0|*|0|PER|0|1|0|100|DKK|27292|36531|lyfalmen|||00|56|0|56,0000|Icepharma hf|Pfizer ApS|Ziprasidon||27292||27292|36531| 500314|D07AC0401|Synalar|krem|0,25|mg/g|30|g|1|túpa||D07AC04|01.04.1998||R|A|3,5|0|0|B|0|BIG|0|0|1|100|SEK|888|2092|lyfalmen|||20|30|0|30,0000|Icepharma hf|Bioglan AB|Flúócínólón||888||888|2092| 501734|M01AB0508|Vostar-R|forðatfl|75|mg|100|stk|1|glas||M01AB05|01.03.2000||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|3199|5253|lyfalmen|||67|100|0|75,0000|Actavis Group hf|Actavis hf|Díklófenak||3199||3199|5253| 502047|N04BA0201|Madopar|hylki|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.12.1983||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|2935|4892|lyfalmen|||10|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2935||2935|4892| 502633|N06AA2101|Ludiomil|töflur|25|mg|100|stk|1|þpakki||N06AA21|01.06.1977||R|A|5|0|0|B|0|AMD|0|1|0|100|DKK|2992|4970|lyfalmen|||00|100|0|25,0000|Vistor hf|Amdipharm Ltd|Maprótilín||2992||2992|4970| 503151|L02AE0401|Decapeptyl Depot|sts|3,75|mg|1|stk|1|spr|+ leysir|L02AE04|01.01.1995||R|K|3|0|1|0|1|FER|0|0|0|100|DKK|30965|40744|lyfsjukr|||00|1|0|27,9851|Vistor hf|Ferring|Triptórelín||30965||30965|40744| 504191|N02BA5102|Treo|freyðit|0| |20|stk|1|glas||N02BA51|01.07.1988||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||14|20|0|3,3333|Vistor hf|McNeil Denmark ApS|Acetýlsalicýlsýra í blöndum, þó ekki með geðlyfjum (psychole|||||| 504266|G03CA0401|Ovestin|töflur|1|mg|90|stk|1|þpakki||G03CA04|01.01.1988||R|A|5|0|0|E|0|ORG|0|0|0|100|DKK|2227|3924|lyfalmen|||00|90|0|45,0000|Vistor hf|N.V. Organon|Estríól||2227||2227|3924| 504878|N05BA0801|Lexotan|töflur|3|mg|100|stk|1|glas||N05BA08|01.01.1987||R|A|5|0|0|0|0|ROC|0|0|1|100|DKK|1164|2470|lyfalmen|||00|100|0|30,0000|Icepharma hf|Roche|Brómazepam||1164||1164|2470| 505743|N06AA2101|Ludiomil|töflur|75|mg|100|stk|1|þpakki||N06AA21|01.05.1978||R|A|5|0|0|B|0|AMD|0|1|0|100|DKK|8231|12137|lyfalmen|||00|100|0|75,0000|Vistor hf|Amdipharm Ltd|Maprótilín||8231||8231|12137| 505834|L01DB0101|Adriamycin|stl|2|mg/ml|5|ml|1|plhgl||L01DB01|01.05.2008||R|K|2|0|1|0|1|PER|0|0|0|100|DKK|3313|4781|lyfsjukr|||02|5|0|0,0000|Icepharma hf|Pfizer ApS|Doxórúbicín||3313||3313|4781| 505875|L01DB0101|Adriamycin|stl|2|mg/ml|10|ml|1|plhgl||L01DB01|01.05.2008||R|K|2|0|1|0|1|PER|0|0|0|100|DKK|6450|9309|lyfsjukr|||02|10|0|0,0000|Icepharma hf|Pfizer ApS|Doxórúbicín||6450||6450|9309| 505883|L01DB0101|Adriamycin|stl|2|mg/ml|25|ml|1|plhgl||L01DB01|01.05.2008||R|K|2|0|1|0|1|PER|0|0|0|100|DKK|8246|11901|lyfsjukr|||02|25|0|0,0000|Icepharma hf|Pfizer ApS|Doxórúbicín||8246||8246|11901| 506949|N01AB0601|Forene|innönd.l|0| |250|ml|1|stauk||N01AB06|01.10.1993||R|A|5|0|0|0|1|ABS|0|0|0|100|DKK|29042|38330|lyfsjukr|||00|250|0|0,0000|Vistor hf|Abbott Scandinavia AB|Ísóflúran||29042||29042|38330| 506972|N06AA1201|Sinquan|hylki|50|mg|100|stk|1|þpakki||N06AA12|01.12.1972||R|A|5|0|0|B|0|PER|0|1|0|100|DKK|2456|4237|lyfalmen|||10|100|0|50,0000|Icepharma hf|Pfizer ApS|Doxepín||2456||2456|4237| 506998|A06AB0202|Toilax|sh-tfl|5|mg|25|stk|1|þpakki||A06AB02|01.12.1975||L|A|3|0|0|0|0|ERC|0|0|0|100|IKR|||lyflausa|||10|25|0|12,5000|Vistor hf|Orion Pharma|Bisakódýl|||||| 507004|A06AB0202|Toilax|sh-tfl|5|mg|100|stk|1|þpakki||A06AB02|01.12.1975||R|A|3|0|0|0|0|ERC|0|0|0|100|DKK|401|1426|lyfalmen|||10|100|0|50,0000|Vistor hf|Orion Pharma|Bisakódýl||401||401|1426| 507103|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|24|g|1|spr||QP52AF02|01.07.1995||L|A|5|0|0|0|0|PAL|0|0|0|100|DKK|660|1151|vetorma|||16|24|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||||660|1151| 507111|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|24|g|5|spr||QP52AF02|01.07.1995||L|A|5|0|0|0|0|PAL|0|0|0|100|DKK|2808|4898|vetorma|||16|120|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||||2808|4898| 507343|QP52AC1302|Panacur, vet.|mixtúra|100|mg/ml|1000|ml|1|fl||QP52AC13|01.12.1978||R|A|5|0|0|0|0|INI|0|0|0|100|DKK|16122|28124|vetorma|||13|1000|0|0,0000|Icepharma hf|Intervet International B.V.|||16122||16122|28124| 507582|QJ01EW1001|Tribrissen, vet.|stl|480|mg/ml|50|ml|1|hgl|80+400 mg/ml|QJ01EW10|01.06.1999||R|A|3|0|0|0|0|IBV|0|0|0|100|DKK|2520|5011|vetalmen|||27|50|0|0,0000|Vistor hf|Intervet International BV|||2520||2520|5011| 508622|C08DA0103|Isoptin retard|forðatfl|240|mg|98|stk|1|þpakki||C08DA01|01.10.1993||R|A|3|0|0|B|0|ABS|0|0|0|100|DKK|2563|4383|lyfalmen|||10|98|0|98,0000|Vistor hf|Abbott Scandinavia AB|Verapamíl||2563||2563|4383| 508671|QJ01M0001|Baytril vet.|mixtúra|25|mg/ml|100|ml|1|plastf||QJ01MA90|01.03.2009||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|5123|10009|vetalmen|||0|100|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||||5123|10009| 508689|QJ01M0001|Baytril vet.|stl|50|mg/ml|50|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|4109|8062|vetalmen|||0|50|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||4109||4109|8062| 508705|QJ01M0001|Baytril vet.|stl|100|mg/ml|100|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|12711|24580|vetalmen|||0|100|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||12711||12711|24580| 509042|N05AF0502|Cisordinol Depot|stl|200|mg/ml|1|ml|10|lykjur||N05AF05|01.03.1984||R|A|3|0|0|*|0|LBK|0|1|0|100|DKK|10006|14565|lyfalmen|||02|10|0|133,3333|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||10006||10006|14565| 509273|G03CA0401|Ovestin|sk-krem|1|mg/g|15|g|1|túpa|+stjaka|G03CA04|01.01.1988||L|A|3|0|0|E|0|ORG|0|0|0|100|DKK|||lyfalmen|||00|15|0|75,0000|Vistor hf|N.V. Organon|Estríól|||||2723| 509653|J05AR0101|Combivir|filmhtfl|450|mg|60|stk|1|þpakki|150+300 mg|J05AR01|01.05.2004||R|A|2|0|1|0|1|VII|0|0|0|100|GBP|47256|61189|lyfsjukr|||00|60|0|0,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Zídóvúdín og lamívúdín||47256||47256|61189| 510255|B03XA0103|NeoRecormon|stl|2000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|23968|31962|lyfsjukr|||00|2|0|12,0000|Icepharma hf|Roche|Epóetín||23968||23968|31962| 510263|B03XA0103|NeoRecormon|stl|3000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|29369|38741|lyfsjukr|||00|2|0|18,0000|Icepharma hf|Roche|Epóetín||29369||29369|38741| 510271|B03XA0103|NeoRecormon|stl|5000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|47054|60935|lyfsjukr|||00|2|0|30,0000|Icepharma hf|Roche|Epóetín||47054||47054|60935| 510305|B03XA0103|NeoRecormon|stl|10000|ae/spr|0,6|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|91430|116627|lyfsjukr|||00|4|0|60,0000|Icepharma hf|Roche|Epóetín||91430||91430|116627| 510810|B03XA0201|Aranesp|stl|150|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|188072|237913|lyfsjukr|||00|1|0|133,3300|Vistor hf|Amgen|Darbepóetín alfa||||188072|237913| 510974|G04CB0102|Finol|töflur|5|mg|98|stk|1|glas||G04CB01|01.01.1998||R|A|3|0|0|E|0|ACA|0|0|0|100|XEU|4181|5439|lyfalmen|||00|98|0|98,0000|Actavis Group hf|Actavis hf|Fínasteríð||3335||3335|5439| 511071|C09CA0701|Micardis|töflur|20|mg|28|stk|1|þpakki||C09CA07|01.03.2008||R|A|3|0|0|0|0|BII|0|0|0|100|DKK|2858|4787|lyfalmen|||00|28|0|14,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||2858||2858|4787| 511303|G03FB0501|Trisekvens|töflur|||84|stk|1|skífup||G03FB05|01.12.1980||R|A|4|0|0|E|0|NON|0|0|0|100|DKK|2699|4569|lyfalmen|||23|84|0|84,0000|Vistor hf|Novo-Nordisk|Noretísterón og östrógen||2699||2699|4569| 511493|B05AA0509|Rheomacrodex med NaCl|irl|100|mg/ml|500|ml|12|pokar||B05AA05|01.07.1991||R|A|2|0|0|0|1|MAB|0|0|0|100|SEK|23496|31370|lyfsjukr|||00|6000|0|6,0000|Vistor hf|Meda AB|Dextran||23496||23496|31370| 511501|B05AA0502|Macrodex 60 mg/ml med NaCl|irl|0| |500|ml|12|pokar||B05AA05|01.07.1991||R|A|3|0|0|0|1|MAB|0|0|0|100|SEK|14698|20328|lyfsjukr|||00|6000|0|6,0000|Vistor hf|Meda AB|Dextran||14698||14698|20328| 512608|B05XA3101|Peditrace|irþ|0| |10|ml|10|hgl||B05XA31|01.07.1993||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|9533|13759|lyfsjukr|||00|100|0|0,1000|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með öðrum efnum||9533||9533|13759| 513309|D04AB0101|Xylocain|smyrsli|5|%|35|g|1|pakki||D04AB01|01.09.2003||L|A|5|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||00|35|0|0,0000|Vistor hf|AstraZeneca A/S DK|Lídókaín|||||| 514265|R03AC0302|Bricanyl Turbuhaler|innúðadu|0,25|mg/sk|200|sk|1|stauk||R03AC03|01.07.1993||R|A|2|0|0|B|0|AZD|0|0|1|100|SEK|2206|3895|lyfalmen|||23|200|0|25,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||2206||2206|3895| 515031|N06AX1801|Edronax|töflur|4|mg|20|stk|1|þpakki||N06AX18|01.06.2000||R|A|3|0|0|B|0|PER|0|1|0|100|DKK|2104|1452|lyfalmen|||00|20|0|10,0000|Icepharma hf|Pfizer ApS|Reboxetin||420||420|1452| 515049|N06AX1801|Edronax|töflur|4|mg|60|stk|1|þpakki||N06AX18|01.06.2000||R|A|3|0|0|B|0|PER|0|1|0|100|DKK|4429|4218|lyfalmen|||00|60|0|30,0000|Icepharma hf|Pfizer ApS|Reboxetin||2442||2442|4218| 516476|A02BC0105|Losec MUPS|sh-tfl|10|mg|14|stk|1|glas||A02BC01|01.01.1999||R|A|2|0|0|0|0|AZD|0|0|0|100|SEK|2029|3653|lyfalmen|||00|14|0|7,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól||2029||2029|3653| 517714|A10BX0201|Novonorm|töflur|0,5|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|A|5|0|0|*|0|NON|0|0|0|100|DKK|2961|4928|lyfalmen|||00|90|0|11,2500|Vistor hf|Novo-Nordisk|Repaglíníð||2961||2961|4928| 517755|A10BX0201|Novonorm|töflur|1|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|A|5|0|0|*|0|NON|0|0|0|100|DKK|3225|5289|lyfalmen|||00|90|0|22,5000|Vistor hf|Novo-Nordisk|Repaglíníð||3225||3225|5289| 517813|A10BX0201|Novonorm|töflur|2|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|A|5|0|0|*|0|NON|0|0|0|100|DKK|3467|5620|lyfalmen|||00|90|0|45,0000|Vistor hf|Novo-Nordisk|Repaglíníð||3467||3467|5620| 518241|M01AB0509|Modifenac|forðahlk|75|mg|20|stk|1|þpakki||M01AB05|01.11.2000||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|920|2136|lyfalmen|||00|20|0|15,0000|Actavis Group hf|Actavis Group hf|Díklófenak||920||920|2136| 518258|M01AB0509|Modifenac|forðahlk|75|mg|100|stk|1|þpakki||M01AB05|01.11.2000||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|3390|5515|lyfalmen|||00|100|0|75,0000|Actavis Group hf|Actavis Group hf|Díklófenak||3390||3390|5515| 518332|G03AC0901|Cerazette|töflur|75|mcg|84|stk|1|þpakki|3x28 stk|G03AC09|01.01.2001||R|A|3|0|0|0|0|ORG|0|0|0|100|DKK|2090|3736|lyfalmen|||23|84|0|84,0000|Vistor hf|N.V. Organon|Desógestrel||2090||2090|3736| 518944|J01CE0205|Kaavepenin Frukt|mixt.kyr|50|mg/ml|125|ml|1|glas||J01CE02|01.10.1985||R|A|2|0|0|0|0|REP|0|0|1|100|SEK|1113|2400|lyfalmen|||08|125|0|3,1250|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||1113||1113|2400| 519819|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|1|spr|einnota sprauta|M09AX01|01.01.2001||R|A|3|0|0|E|0|NYG|0|0|0|100|DKK|8295|12224|lyfalmen|||02|2|0|5,7222|Gróco ehf|Nycomed Danmark A/S|Natríumhýalúrónat||8295||8295|12224| 520239|G04BE0301|Viagra|filmhtfl|25|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PER|0|0|0|100|DKK|4825|7478|lyfalmen|V0096|7346|00|4|0|2,0000|Icepharma hf|Pfizer ApS|Síldenafíl||4825||4825|7478| 520288|G04BE0301|Viagra|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PER|0|0|0|100|DKK|5449|8331|lyfalmen|V0097|4813|00|4|0|4,0000|Icepharma hf|Pfizer ApS|Síldenafíl||5449||5449|8331| 520338|G04BE0301|Viagra|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PER|0|0|0|100|DKK|15354|21548|lyfalmen|V0098|12688|00|12|0|12,0000|Icepharma hf|Pfizer ApS|Síldenafíl||15354||15354|21548| 520346|G04BE0301|Viagra|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PER|0|0|0|100|DKK|5844|8872|lyfalmen|V0099|4944|00|4|0|8,0000|Icepharma hf|Pfizer ApS|Síldenafíl||5844||5844|8872| 520379|G04BE0301|Viagra|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PER|0|0|0|100|DKK|16170|22572|lyfalmen|V0100|13635|00|12|0|24,0000|Icepharma hf|Pfizer ApS|Síldenafíl||16170||16170|22572| 520502|C08CA0102|Amlo|töflur|5|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|1355|2502|lyfalmen|V0308|2502|00|100|0|100,0000|Actavis Group hf|Actavis hf|Amlódipín||1188||1188|2502| 520577|C08CA0102|Amlo|töflur|10|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|2163|3450|lyfalmen|V0310|3450|00|100|0|200,0000|Actavis Group hf|Actavis hf|Amlódipín||1881||1881|3450| 520759|M03BC5101|Norgesic|töflur|0| |30|stk|1|þpakki||M03BC51|01.03.1981||R|A|5|0|0|E|0|MEB|0|0|1|100|SEK|449|1491|lyfalmen|||00|30|0|8,7500|Vistor hf|Meda AB (V)|Orfenadrín í blöndum||449||449|1491| 521203|N04BC0502|Sifrol|töflur|0,7|mg|100|stk|1|þpakki||N04BC05|01.05.2005||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|32140|42615|lyfalmen|V2030|19135|00|100|0|28,0000|Vistor hf|Boehringer Ingelheim International|Pramipexól||32140||32140|42615| 521757|L01XX0501|Hydrea|hylki|500|mg|100|stk|1|glas||L01XX05|01.01.1998||R|A||0|1|0|1|PCO|0|0|0|100|IKR|11102|15816|lyfsjukr|||00|100|1|0,0000|Distica|Distica - óskráð lyf|Hýdroxýkarbamíð||11102||11102|15816| 522003|QJ01RA0102|Streptocillin, vet.|spenalyf|||8|g|40|spr||QJ01RA01|01.12.1982||R|A|3|0|0|0|0|BID|0|0|0|100|DKK|8008|15549|vetalmen|||16|320|0|0,0000|Vistor hf|Boehringer Ingelheim Danmark|||8008||8008|15549| 522599|J07CA0202|Tetravac|bóluefni|0| |0,5|ml|1|spr|einnota dæla|J07CA02|01.10.1999||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|3334|5438|lyfalmen|||AC|0|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|barnaveiki, kíghósti, mænusótt, stífkrampi||3334||3334|5438| 522706|L04AC0201|Simulect|sts|20|mg|1|hgl|1|pakki|+leysir|L04AC02|01.06.2004||R|K|1,5|0|1|0|1|NOE|0|0|0|100|DKK|207166|261876|lyfsjukr|||00|1|0|0,5000|Vistor hf|Novartis Europharm Ltd|Basiliximab||207166||207166|261876| 522730|N02AX0204|Tradolan|töflur|50|mg|20|stk|1|þpakki||N02AX02|01.08.1998||R|A|5|0|0|E|0|LAN|0|0|1|100|SEK|491|1549|lyfalmen|V0730|1278|00|20|0|3,3300|Vistor hf|Lannacher Heimittel Gmbh|Tramadól||491||491|1549| 522771|N02AX0204|Tradolan|töflur|50|mg|100|stk|1|þpakki||N02AX02|01.08.1998||R|A|5|0|0|E|0|LAN|0|0|1|100|SEK|853|2044|lyfalmen|V0731|1877|00|100|0|16,6700|Vistor hf|Lannacher Heimittel Gmbh|Tramadól||853||853|2044| 522797|N02AX0204|Tradolan|töflur|50|mg|250|stk|1|þpakki||N02AX02|01.08.1998||R|A|5|0|0|E|0|LAN|0|0|1|100|DKK|9760|14228|lyfalmen|||00|250|0|208,3333|Vistor hf|Lannacher Heimittel Gmbh|Tramadól||9760||9760|14228| 522813|N02AX0204|Tradolan|stl|50|mg/ml|2|ml|5|lykjur||N02AX02|01.08.1998||R|A|5|0|0|E|0|LAN|0|0|1|100|DKK|863|2058|lyfalmen|V0732|2058|02|10|0|1,6667|Vistor hf|Lannacher Heimittel Gmbh|Tramadól||863||863|2058| 522839|D05AX0201|Daivonex|lausn|50|mcg/ml|120|ml|1|glas|í hársvörð|D05AX02|01.12.2001||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|8909|13064|lyfalmen|||00|120|0|0,0000|Vistor hf|LEO Pharma A/S|Kalcípótríól||8909||8909|13064| 523043|N02AA5902|Parkodin forte|töflur|530|mg|40|stk|1|pakki|þp 30+500 mg|N02AA59|01.11.1998||R|A|2|0|0|0|0|ACA|0|0|1|100|NOK|436|1474|lyfalmen|||00|40|0|13,3333|Actavis Group hf|Actavis hf|Kódein í blöndum nema með geðlyfjum||436||436|1474| 523274|S01XA2008|Artelac|augndr|0| |10|ml|1|glas|plastglas|S01XA20|01.05.1998||L|A|3|0|0|E|0|GEM|0|0|0|100|IKR|||lyfalmen|||00|10|0|0,0000|Actavis Group hf|Gerhard Mann|Gervitár og aðrar óvirkar sam­setningar|||||1293| 523779|R06AD0201|Phenergan|töflur|25|mg|100|stk|1|þpakki||R06AD02|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|1|100|NOK|1233|2564|lyfalmen|||00|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Prómetazín||1233||1233|2564| 524215|C01DA1401|Imdur|forðatfl|30|mg|28|stk|1|þpakki||C01DA14|01.07.1993||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|1129|2422|lyfalmen|||43|28|0|21,0000|Vistor hf|AstraZeneca A/S DK|Ísósorbíð mónónítrat||1129||1129|2422| 524223|C01DA1401|Imdur|forðatfl|30|mg|98|stk|1|þpakki||C01DA14|01.07.1993||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2869|4802|lyfalmen|||43|98|0|73,5000|Vistor hf|AstraZeneca A/S DK|Ísósorbíð mónónítrat||2869||2869|4802| 524694|C01DA0204|Nitromex|tungur.t|0,25|mg|30|stk|1|glas||C01DA02|01.12.1983||L|A|2|0|0|B|0|AGT|0|0|0|100|DKK|||lyfalmen|||22|30|0|3,0000|Actavis Group hf|Actavis Group hf|Glýcerýltrínítrat|||||1166| 524710|C01DA0204|Nitromex|tungur.t|0,5|mg|30|stk|1|glas||C01DA02|01.11.1981||L|A|2|0|0|B|0|AGT|0|0|0|100|DKK|||lyfalmen|||22|30|0|6,0000|Actavis Group hf|Actavis Group hf|Glýcerýltrínítrat|||||1145| 524934|QM01AE9001|Quadrisol|hlaup|100|mg/ml|1|spr|1|pakki|f. hesta|QM01AE90|01.07.2010||R|A|3|0|0|0|0|INI|0|0|0|100|DKK|1904|3787|vetalmen|||00|1|0||Icepharma hf|Intervet International B.V.|Vedaprófen||1904||1904|3787| 525014|M03BC5101|Norgesic|töflur|0| |100|stk|1|þpakki||M03BC51|01.06.1981||R|A|5|0|0|E|0|MEB|0|0|1|100|SEK|1232|2563|lyfalmen|||00|100|0|29,2000|Vistor hf|Meda AB (V)|Orfenadrín í blöndum||1232||1232|2563| 525030|M01AB0505|Voltaren|stl|25|mg/ml|3|ml|5|lykjur|lausn|M01AB05|01.05.2007||R|A|2|0|0|0|0|NOH|0|0|0|100|DKK|1013|2263|lyfalmen|||00|15|0|0,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||1013||1013|2263| 525147|M01AB0504|Klofen-L|forðahlk|100|mg|30|stk|1|hylki||M01AB05|01.01.1993||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|1532|2973|lyfalmen|||10|30|0|30,0000|Actavis Group hf|Actavis hf|Díklófenak||1532||1532|2973| 525170|M01AB0504|Klofen-L|forðahlk|100|mg|100|stk|1|hylki||M01AB05|01.01.1993||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|5105|7861|lyfalmen|||10|100|0|100,0000|Actavis Group hf|Actavis hf|Díklófenak||5105||5105|7861| 525188|N06BA0701|Modiodal|töflur|100|mg|30|stk|1|þpakki||N06BA07|01.03.2002||R|A|5|0|0|0|0|CPA|0|0|0|100|DKK|10141|14750|lyfalmen|||00|30|0|10,0000|Vistor hf|Cephalon France (V)|Modafinil||10141||10141|14750| 525857|B05XA0103|Kaliumklorid B.Braun|irþ|1|mmol/ml|50|ml|20|hgl||B05XA01|01.09.2010||R|A||0|0|0|1|BRA|0|0|0|100|XEU|5439|7850|lyfsjukr|||00|1000|0|1,0000|Actavis Group hf|Braun|Kalíumklóríð||5439||5439|7850| 525865|B05XA0303|Natriumklorid B.Braun|irþ|1|mmol/ml|50|ml|20|hgl||B05XA03|01.09.2010||R|A||0|0|0|1|BRA|0|0|0|100|XEU|4952|7147|lyfsjukr|||00|1000|0|1,0000|Actavis Group hf|Braun|Natríumklóríð||4952||4952|7147| 525998|V07AB1001|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|50|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||00|1000|0|0,0000|Actavis Group hf|Braun|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||| 526004|V07AB09|Sterilt Vann B. Braun|leysir|0||50|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|1000|0|0,0000|Actavis Group hf|Braun|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||| 526368|N04BA0201|Madopar|töflur|250|mg|100|stk|1|glas|200+50 mg|N04BA02|01.11.1981||R|A|5|0|0|E|0|ROC|0|0|0|100|DKK|7310|10877|lyfalmen|||00|100|0|33,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||7310||7310|10877| 526376|N03AG0103|Orfiril Retard|forðatfl|300|mg|100|stk|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|4164|6573|lyfalmen|||10|100|0|20,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||4164||4164|6573| 526384|QJ01EW1001|Tribrissen, vet.|pasta|400|mg/g|37,5|g|5|spr|til inntöku|QJ01EW10|01.03.2007||R|A|5|0|0|0|0|IBV|0|0|0|100|DKK|6679|12997|vetalmen|||16|188|0|0,0000|Vistor hf|Intervet International BV|||6679||6679|12997| 526798|N03AG0102|Orfiril|sh-tfl|600|mg|100|stk|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|3562|5750|lyfalmen|||10|100|0|40,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||3562||3562|5750| 527143|J01XD0102|Flagyl|irl|5|g/1000ml|100|ml|20|pokar||J01XD01|01.12.1983||R|A|3|0|0|0|1|SNO|0|0|0|100|NOK|14904|20587|lyfsjukr|||00|2000|0|6,6667|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||14904||14904|20587| 527523|S01GX0601|Emadine|augndr|0,5|mg/ml|5|ml|1|glas||S01GX06|01.05.2003||R|A|2,5|0|0|E|0|ALC|0|0|0|100|USD|1192|2508|lyfalmen|||00|5|0|0,0000|K.Pétursson hf|Alcon|Emedastín||1192||1192|2508| 529263|N07BC0101|Subutex|tungur.t|2|mg|7|stk|1|þpakki||N07BC01|01.11.1999||R|A|1|1|0|0|1|RBP|0|0|0|100|DKK|1922|2774|lyfsjukr|||00|7|0|1,7500|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín||1922||1922|2774| 529289|R02AA0301|Strepsils|sogtfl|0| |24|stk|1|þpakki||R02AA03|01.09.1982||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0|0,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||| 529438|QJ51RC2002|Ampiclox vet.|spenalyf|0| |3|g|24|spr|spenadælur|QJ51RC20|01.06.1998||R|A|1,5|0|0|0|0|PAL|0|0|0|100|DKK|4286|8402|vetalmen|||16|72|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||4286||4286|8402| 529446|QJ01CA0401|Clamoxyl, vet.|töflur|40|mg|100|stk|1|þpakki||QJ01CA04|01.10.1987||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|3692|7262|vetalmen|||16|100|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||3692||3692|7262| 529586|N07BC0101|Subutex|tungur.t|8|mg|7|stk|1|þpakki||N07BC01|01.11.1999|28.02.2011|R|A|1|1|0|0|1|RBP|0|0|0|100|DKK|4771|6886|lyfsjukr|||00|7|0|7,0000|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín||4771||4771|6886| 529735|N03AB0501|Pro-Epanutin|irþ|50|mg/ml|10|ml|10|hgl||N03AB05|01.12.2001||R|K|2|0|0|0|1|PER|0|0|0|100|DKK|68706|88109|lyfsjukr|||00|100|0|11,1000|Icepharma hf|Pfizer ApS|Fosfenýtóín||68706||68706|88109| 530741|G03FA0105|Activelle|töflur|0| |84|stk|1|pakki|þp 1+0,5 mg|G03FA01|01.03.2000||R|A|3|0|0|E|0|NON|0|0|0|100|DKK|3107|5127|lyfalmen|||23|84|0|84,0000|Vistor hf|Novo-Nordisk|Noretísterón og östrógen||3107||3107|5127| 531459|R03CC0303|Bricanyl Retard|forðatfl|7,5|mg|100|stk|1|glas||R03CC03|01.01.1985||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|3003|4985|lyfalmen|||43|100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||3003||3003|4985| 531913|J05AG0101|Viramune|mixtúra|10|mg/ml|240|ml|1|fl||J05AG01|01.03.2007||R|A|0,5|0|1|0|1|BII|0|0|0|100|DKK|9080|13105|lyfsjukr|||00|240|0|6,0000|Vistor hf|Boehringer Ingelheim International |Nevírapín||9080||9080|13105| 532048|L04AA0605|Myfenax (Lyfis)|hylki|500|mg|50|stk|1|þpakki||L04AA06|01.03.2011||R|A||0|1|*|0|LYF|0|0|0|100|XEU|20282|22835|lyfalmen|||00|50|0|12,5000|Lyfis ehf|Lyfis ehf|Mýcófenólsýra||16379||16379|22835| 532374|P02CA0101|Vermox|mixtúra|20|mg/ml|30|ml|1|glas||P02CA01|01.12.1982||R|A|5|0|0|0|0|JAS|0|0|0|100|SEK|898|2106|lyfalmen|||01|30|0|3,0000|Vistor hf|Janssen-Cilag AB|Mebendazól||898||898|2106| 532671|J01EA0107|Trimetoprim Meda|töflur|100|mg|30|stk|1|glas||J01EA01|01.03.2010||R|A||0|0|0|0|MEB|0|0|1|100|SEK|350|1356|lyfalmen|||00|30|0|7,5000|Vistor hf|Meda AB (V)|Trímetóprím||350||350|1356| 532697|J01EA0107|Trimetoprim Meda|töflur|100|mg|100|stk|1|glas||J01EA01|01.03.2010||R|A||0|0|0|0|MEB|0|0|1|100|SEK|1015|2266|lyfalmen|||00|100|0|25,0000|Vistor hf|Meda AB (V)|Trímetóprím||1015||1015|2266| 532705|J01EA0107|Trimetoprim Meda|töflur|160|mg|14|stk|1|glas||J01EA01|01.03.2010||R|A||0|0|0|0|MEB|0|0|1|100|SEK|281|1262|lyfalmen|||00|14|0|5,6000|Vistor hf|Meda AB (V)|Trímetóprím||281||281|1262| 532721|J01EA0107|Trimetoprim Meda|töflur|160|mg|100|stk|1|glas||J01EA01|01.03.2010||R|A||0|0|0|0|MEB|0|0|1|100|SEK|1789|3325|lyfalmen|||00|100|0|40,0000|Vistor hf|Meda AB (V)|Trímetóprím||1789||1789|3325| 533737|R03CC0303|Bricanyl Retard|forðatfl|5|mg|100|stk|1|glas||R03CC03|01.04.1986||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2028|3651|lyfalmen|||43|100|0|33,3333|Vistor hf|AstraZeneca A/S DK|Terbútalín||2028||2028|3651| 535773|P03AA5401|Tenutex|áburður|245|mg/g|100|g|1|túpa|(20 mg + 225 mg)/g|P03AA54|01.12.1997||L|K|3|0|0|0|0|BIG|0|0|0|100|IKR|||lyflausa|||00|100|0|0,0000|Icepharma hf|Bioglan AB|Dísúlfíram í blöndum|||||| 535898|G04BD0401|Ditropan|töflur|5|mg|84|stk|1|þpakki||G04BD04|01.06.1998||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|6380|9605|lyfalmen|||00|84|0|28,0000|Vistor hf|Sanofi-aventis Norge AS|Oxýbútýnín||6380||6380|9605| 536037|S01EB0105|Isopto Carpine|augndr|20|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|A|4|0|0|*|0|SAL|0|0|0|100|USD|420|1452|lyfalmen|||06|10|0|25,0000|Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Pílókarpín||420||420|1452| 536052|S01EB0105|Isopto Carpine|augndr|40|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|A|4|0|0|*|0|SAL|0|0|0|100|USD|536|1610|lyfalmen|||06|10|0|25,0000|Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Pílókarpín||536||536|1610| 536938|N04BC0102|Parlodel|hylki|5|mg|100|stk|1|þpakki||N04BC01|01.05.1983||R|A|4|0|0|E|0|MAS|0|0|0|100|SEK|17300|23991|lyfalmen|||52|100|0|12,5000|Vistor hf|Meda AS|Brómókriptín||17300||17300|23991| 537373|QP52AF0201|Banminth, vet.|pasta|115,3|mg/g|2|g|1|spr||QP52AF02|01.07.1995||L|A|3|0|0|0|0|PAL|0|0|0|100|DKK|590|1029|vetorma|||16|2|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||||590|1029| 537811|G03CA0401|Ovestin|sk-stíll|0,5|mg|15|stk|1|pakki||G03CA04|01.01.1988||L|A|3|0|0|E|0|ORG|0|0|0|100|DKK|||lyfalmen|||05|15|0|37,5000|Vistor hf|N.V. Organon|Estríól|||||2311| 538181|A02AD0106|Rennie|sog/tugg|0| |24|stk|1|þpakki||A02AD01|01.10.1995||L|A|5|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||00|24|0|2,4000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||| 538199|A02AD0106|Rennie|sog/tugg|0| |48|stk|1|þpakki||A02AD01|01.10.1995||L|A|5|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||00|48|0|4,8000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||| 538207|A02AD0106|Rennie|sog/tugg|0| |96|stk|1|þpakki||A02AD01|01.10.1995||L|A|5|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||00|96|0|9,6000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||| 538496|L03AB0702|Rebif|stl|22|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.05.1999||R|K|2|0|1|0|1|MSE|0|0|0|100|SEK|142497|180716|lyfsjukr|||00|6|0|61,3953|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||142497||142497|180716| 539031|N03AG0401|Sabrilex|töflur|500|mg|100|stk|1|þpakki||N03AG04|01.10.1992||R|A|5|0|1|E|0|SNO|0|0|0|100|NOK|10567|15332|lyfalmen|||00|100|0|25,0000|Vistor hf|Sanofi-aventis Norge AS|Vígabatrín||10567||10567|15332| 539551|N05BA0105|Stesolid|töflur|2|mg|25|stk|1|glas||N05BA01|01.12.1972||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|176|1118|lyfalmen|||00|25|0|5,0000|Actavis Group hf|Actavis Group hf|Díazepam||176||176|1118| 539577|N05BA0105|Stesolid|töflur|2|mg|100|stk|1|glas||N05BA01|01.12.1972||R|A|5|0|0|0|0|AGT|0|0|0|100|DKK|382|1400|lyfalmen|||00|100|0|20,0000|Actavis Group hf|Actavis Group hf|Díazepam||382||382|1400| 539783|D01AC2001|Daktacort|krem|0| |15|g|1|túpa||D01AC20|01.04.1986||L|K|3|0|0|0|0|JAS|0|0|1|100|IKR|||lyflausa|||20|15|0|15,0000|Vistor hf|Janssen-Cilag AB|Blöndur|||||| 539973|G01AA1001|Dalacin|sk-krem|20|mg/g|40|g|1|sett|+7 stjökur|G01AA10|01.10.1994||R|A|2|0|0|E|0|PER|0|0|0|100|DKK|2549|4364|lyfalmen|||23|40|0|8,0000|Icepharma hf|Pfizer ApS|Klindamýcín||2549||2549|4364| 540070|D06BA0101|Flamazine|krem|10|mg/g|250|g|1|dos||D06BA01|01.10.1988||R|A|3|0|0|0|0|SON|0|0|1|100|DKK|2793|4698|lyfalmen|||00|250|0|250,0000|Icepharma hf|Smith & Nephew|Silfursúlfadíazín||2793||2793|4698| 540989|S01ED5101|Cosopt|augndr|5|mg/ml|5|ml|3|glös|+ dorzólamíð 20 mg|S01ED51|01.07.2000||R|A|2|0|0|*|0|MSD|0|0|0|100|XEU|5891|8936|lyfalmen|||06|15|0|0,0000|Icepharma hf|M.S.D.|Tímólól í blöndum||5891||5891|8936| 541060|R03AC0302|Bricanyl Turbuhaler|innúðadu|0,5|mg/sk|200|sk|1|stauk||R03AC03|01.01.1989||R|A|2|0|0|B|0|AZD|0|0|1|100|SEK|2147|3814|lyfalmen|||23|200|0|50,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||2147||2147|3814| 541128|M01CC0101|Atamir|hylki|150|mg|200|stk|1|glas||M01CC01|01.09.1983||R|A|5|0|0|B|0|SGM|0|0|0|100|DKK|9528|13911|lyfalmen|||10|200|0|60,0000|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||9528||9528|13911| 541136|M01CC0101|Atamir|hylki|250|mg|200|stk|1|plglas||M01CC01|12.10.2004||R|A|5|0|0|B|0|SGM|0|0|0|100|DKK|15433|21647|lyfalmen|||10|200|0|100,0000|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||15433||15433|21647| 541169|R02AA0302|Strepsils med honning og citron|sogtfl|0| |24|stk|1|þpakki||R02AA03|01.09.1982||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0|0,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||| 542803|C08DA0103|Isoptin retard|forðatfl|240|mg|28|stk|1|þpakki||C08DA01|01.10.1993||R|A|3|0|0|B|0|ABS|0|0|0|100|DKK|1499|2928|lyfalmen|||10|28|0|28,0000|Vistor hf|Abbott Scandinavia AB|Verapamíl||1499||1499|2928| 542977|J04BA0201|Dapson|töflur|50|mg|100|stk|1|glas||J04BA02|01.05.1998||R|A||0|1|E|0|LDR|0|0|0|100|IKR|4474|6997|lyfalmen|||00|100|1|100,0000|Parlogis hf|Parlogis - óskráð lyf|Dapsón||4474||4474|6997| 543330|C07AA0302|Visken|töflur|10|mg|98|stk|1|þpakki||C07AA03|01.12.1983||R|A|5|0|0|B|0|NOH|0|0|0|100|DKK|4410|6910|lyfalmen|||00|98|0|65,3333|Vistor hf|Novartis Healthcare A/S-|Pindólól||4410||4410|6910| 543710|A06AC0101|Vi-Siblin|kyrni|610|mg/g|250|g|1|stauk||A06AC01|01.06.1999||L|A|3|0|0|0|0|REP|0|0|0|100|IKR|||lyflausa|||42|250|0|21,7857|Vistor hf|Recip AB|Semen psyllii (ispaghula)|||||| 543744|R01AA0503|Nezeril|nefúði|0,5|mg/ml|7,5|ml|1|glas|sk-úðari|R01AA05|01.10.1994||L|A|3|0|0|0|0|GCO|0|0|1|100|IKR|||lyflausa|||23|8|0|9,3750|Vistor hf|GlaxoSmithKline CH AB|Oxýmetazólín|||||| 544429|L04AD0202|Prograf|hylki|0,5|mg|50|stk|1|þpakki||L04AD02|01.06.2010||R|A|3|0|1|*|0|ASP|0|0|0|100|XEU|13038|18642|lyfalmen|||00|50|0|5,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||13038||13038|18642| 545681|D06AX0901|Bactroban|smyrsli|20|mg/g|15|g|1|túpa||D06AX09|01.07.1994||R|A|2|0|0|0|0|GSK|0|0|1|100|GBP|723|1866|lyfalmen|||00|15|0|15,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Múpírócín||723||723|1866| 545814|N05AF0501|Cisordinol|töflur|2|mg|100|stk|1|glas||N05AF05|01.06.1984||R|A|2|0|0|*|0|LBK|0|1|0|100|DKK|1193|2509|lyfalmen|||00|100|0|6,6667|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||1193||1193|2509| 545848|N05AF0501|Cisordinol|töflur|10|mg|100|stk|1|glas||N05AF05|01.06.1984||R|A|2|0|0|*|0|LBK|0|1|0|100|DKK|3170|5214|lyfalmen|||00|100|0|33,3333|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||3170||3170|5214| 545996|V01AA0507|Alutard SQ, birkifrjo|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA05|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|30284|40286|lyfalmen|||02|20|0|0,0000|Vistor hf|ALK-Abello A/S|trjáfrjó||30284||30284|40286| 546002|V01AA0507|Alutard SQ, birkifrjo|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA05|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|24417|32922|lyfalmen|||02|5|0|0,0000|Vistor hf|ALK-Abello A/S|trjáfrjó||24417||24417|32922| 546044|V01AA0210|Alutard SQ, vallarfoxgras|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA02|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|30463|40510|lyfalmen|||02|20|0|0,0000|Vistor hf|ALK-Abello A/S|grasfrjó||30463||30463|40510| 546051|V01AA0210|Alutard SQ, vallarfoxgras|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA02|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|25880|34758|lyfalmen|||02|5|0|0,0000|Vistor hf|ALK-Abello A/S|grasfrjó||25880||25880|34758| 546143|N02BE0108|Paratabs Retard|forðatfl|500|mg|30|stk|1|þpakki||N02BE01|01.10.1993||L|A|5|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||10|30|0|5,0000|Actavis Group hf|Actavis hf|Paracetamól|||||| 546168|N02BE0108|Paratabs Retard|forðatfl|500|mg|100|stk|1|þpakki||N02BE01|01.10.1993||R|A|5|0|0|0|0|ACA|0|0|1|100|XEU|980|2018|lyfalmen|||10|100|0|16,6667|Actavis Group hf|Actavis hf|Paracetamól||834||834|2018| 546531|N06AF0101|Marplan|töflur|10|mg|56|stk|1|glas||N06AF01|01.10.2001||R|A||0|0|E|0|LDR|0|0|0|100|DKK|8276|12198|lyfalmen|||00|56|1|37,3333|Parlogis hf|Parlogis - óskráð lyf|||8276||8276|12198| 547612|A02BX0202|Antepsin|töflur|1|g|60|stk|1|þpakki||A02BX02|01.01.1986||L|A|5|0|0|0|0|ORC|0|0|0|100|IKR|||lyfalmen|||23|60|0|15,0000|Vistor hf|Orion Corporation|Súkralfat|||||4690| 547687|B01AC1601|Integrilin|irl|0,75|mg/ml|100|ml|1|fl||B01AC16|01.07.2000||R|K|3|0|1|0|1|GGL|0|0|0|100|GBP|10091|14547|lyfsjukr|||00|100|0|0,3800|GlaxoSmithKline ehf|Glaxo Group Limited|Eptifibatíð||10091||10091|14547| 547695|B01AC1601|Integrilin|stl|2|mg/ml|10|ml|1|hgl||B01AC16|01.07.2000||R|K|3|0|1|0|1|GGL|0|0|0|100|GBP|3325|4799|lyfsjukr|||00|10|0|0,1000|GlaxoSmithKline ehf|Glaxo Group Limited|Eptifibatíð||3325||3325|4799| 547729|G03GA0601|Puregon|stl|100|ae/hgl|0,5|ml|1|hgl||G03GA06|01.01.2000||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|8589|12627|lyfalmen|||63|0|0|1,3333|Vistor hf|N.V. Organon|Follitrópín beta||8589||8589|12627| 547893|G03GA0601|Puregon|stl|50|ae/hgl|0,5|ml|1|hgl||G03GA06|01.01.2000||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|4411|6911|lyfalmen|||63|0|0|0,6667|Vistor hf|N.V. Organon|Follitrópín beta||4411||4411|6911| 548776|M05BA0701|Optinate|filmhtfl|5|mg|28|stk|1|þpakki||M05BA07|01.03.2001||R|A|5|0|0|0|0|SNO|0|0|0|100|NOK|5970|9044|lyfalmen|||00|28|0|28,0000|Vistor hf|Sanofi-aventis Norge AS|Rísedrónsýru||5970||5970|9044| 548784|M05BA0701|Optinate|filmhtfl|5|mg|84|stk|1|þpakki||M05BA07|01.03.2001||R|A|5|0|0|0|0|SNO|0|0|0|100|NOK|16297|22732|lyfalmen|||00|84|0|84,0000|Vistor hf|Sanofi-aventis Norge AS|Rísedrónsýru||16297||16297|22732| 549113|J06BB1601|Synagis|sts|50|mg/hgl|1|hgl|1|pakki||J06BB16|01.01.2004||R|K|2|0|0|0|1|ABT|0|0|0|100|DKK|103944|132332|lyfsjukr|||17|1|0|0,0000|Vistor hf|Abbott Laboratories Ltd|Palivisumab||103944||103944|132332| 549139|N05AD0102|Haldol Depot|stl|100|mg/ml|1|ml|5|lykjur||N05AD01|01.01.1987||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|9556|13949|lyfalmen|||02|5|0|151,5152|Vistor hf|Janssen-Cilag AB|Halóperídól||9556||9556|13949| 549170|J06BB1601|Synagis|sts|100|mg/hgl|1|hgl|1|pakki||J06BB16|01.01.2004||R|K|2|0|0|0|1|ABT|0|0|0|100|DKK|148260|187949|lyfsjukr|||17|1|0|0,0000|Vistor hf|Abbott Laboratories Ltd|Palivisumab||148260||148260|187949| 550020|J07AP0302|Typherix|bóluefni|50|mcg/ml|0,5|ml|1|spr|einnota sprauta|J07AP03|01.10.2001||R|K|2|0|0|0|0|GSK|0|0|0|100|GBP|2107|3760|lyfalmen|||00|0|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Taugaveiki, hreinsaðir mótefnavakar||2107||2107|3760| 550061|N02BE0102|Panodil Brus|freyðit|500|mg|24|stk|1|þpakki||N02BE01|01.04.1992||L|A|4|0|0|0|0|GCH|0|0|1|100|IKR|||lyfalmen|||00|24|0|4,0000|Icepharma hf|GlaxoSmithKline CH A/S|Paracetamól|||||1490| 550624|N02BE0103|Panodil Junior|mixtúra|24|mg/ml|60|ml|1|glas||N02BE01|01.11.1981||L|A|3|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||00|60|0|0,4800|Icepharma hf|GlaxoSmithKline CH A/S|Paracetamól|||||| 550731|N02BE0103|Panodil Junior|eþ-stíll|125|mg|10|stk|1|pakki||N02BE01|01.11.1981||L|A|5|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||00|10|0|0,4167|Icepharma hf|GlaxoSmithKline CH A/S|Paracetamól|||||| 551408|N02CC0302|Zomig Rapimelt|munnltfl|2,5|mg|12|stk|1|þpakki||N02CC03|01.05.2001||R|A|3|0|0|E|0|AZA|0|0|0|100|SEK|11052|15996|lyfalmen|||00|12|0|12,0000|Vistor hf|AstraZeneca AB|Zolmítriptan||11052||11052|15996| 551572|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|1|hgl|dreifa|H02AB08|01.11.2003||R|A|3|0|0|B|0|MAB|0|0|1|100|SEK|1842|3397|lyfalmen|||03|1|0|2,6667|Vistor hf|Meda AB|Tríamcínólón||1842||1842|3397| 551606|M01AX0101|Relifex|töflur|500|mg|100|stk|1|þpakki||M01AX01|01.04.1995||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|4199|6621|lyfalmen|||00|100|0|50,0000|Vistor hf|Meda AB|Nabúmeton||4199||4199|6621| 551739|N02AA0102|Morfin|töflur|10|mg|20|stk|1|pakki||N02AA01|01.04.1999||R|S||1|0|E|0|LDR|0|0|0|100|IKR|738|1887|lyfalmen|||00|20|1|2,0000|Parlogis hf|Parlogis - óskráð lyf|Morfín||738||738|1887| 551846|A02BC0401|Pariet|sh-tfl|10|mg|28|stk|1|þpakki||A02BC04|01.05.2001||R|A|2|0|0|E|0|EIS|0|0|0|100|IKR|2157|2100|lyfalmen|||00|28|0|14,0000|Vistor hf|Eisai Ltd|Rabeprazól||894||894|2100| 551853|A02BC0401|Pariet|sh-tfl|10|mg|56|stk|1|þpakki||A02BC04|01.05.2001||R|A|2|0|0|E|0|EIS|0|0|0|100|IKR|3931|4200|lyfalmen|||00|56|0|28,0000|Vistor hf|Eisai Ltd|Rabeprazól||2429||2429|4200| 551879|A02BC0401|Pariet|sh-tfl|20|mg|14|stk|1|þpakki||A02BC04|01.11.2001||R|A|2|0|0|0|0|EIS|0|0|0|100|SEK|2739|4624|lyfalmen|||00|14|0|14,0000|Vistor hf|Eisai Ltd|Rabeprazól||2739||2739|4624| 551929|A02BC0401|Pariet|sh-tfl|20|mg|28|stk|1|þpakki||A02BC04|01.05.2001||R|A|2|0|0|E|0|EIS|0|0|0|100|IKR|4233|2100|lyfalmen|||00|28|0|28,0000|Vistor hf|Eisai Ltd|Rabeprazól||894||894|2100| 551937|A02BC0401|Pariet|sh-tfl|20|mg|56|stk|1|þpakki||A02BC04|01.05.2001||R|A|2|0|0|E|0|EIS|0|0|0|100|IKR|7916|4200|lyfalmen|||00|56|0|56,0000|Vistor hf|Eisai Ltd|Rabeprazól||2429||2429|4200| 552224|C08CA0501|Adalat|töflur|20|mg|100|stk|1|þpakki||C08CA05|01.04.1985||R|A|5|0|0|B|0|BAP|0|0|0|100|SEK|4330|6800|lyfalmen|||63|100|0|66,6667|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||4330||4330|6800| 552877|N05CF0105|Zopiklon Mylan|filmhtfl|7,5|mg|500|stk|1|plglas||N05CF01|01.07.2007||R|A|2|0|0|0|0|MYL|0|0|0|100|SEK|5068|7810|lyfalmen|||00|500|0|500,0000|Actavis Group PTC ehf|Mylan AB|Zópíklón||5068||5068|7810| 552901|N03AF0201|Trileptal|filmhtfl|150|mg|100|stk|1|þpakki||N03AF02|01.10.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|3501|5666|lyfalmen|||00|100|0|15,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||3501||3501|5666| 552919|N03AF0201|Trileptal|filmhtfl|300|mg|50|stk|1|glas||N03AF02|01.02.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|3475|5631|lyfalmen|||00|50|0|15,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||3475||3475|5631| 553206|N02CC0601|Relpax|filmhtfl|40|mg|18|stk|1|þpakki||N02CC06|01.08.2009||R|A||0|0|E|0|PER|0|0|0|100|DKK|12026|17372|lyfalmen|||00|18|0|18,0000|Icepharma hf|Pfizer ApS|Eletriptan||||12026|17372| 553313|N02CC0601|Relpax|filmhtfl|40|mg|3|stk|1|þpakki||N02CC06|01.10.2001||R|A|3|0|0|E|0|PER|0|0|0|100|DKK|2387|4143|lyfalmen|||00|3|0|3,0000|Icepharma hf|Pfizer ApS|Eletriptan||2387||2387|4143| 553339|N02CC0601|Relpax|filmhtfl|40|mg|6|stk|1|þpakki||N02CC06|01.10.2001||R|A|3|0|0|E|0|PER|0|0|0|100|DKK|4113|6504|lyfalmen|||00|6|0|6,0000|Icepharma hf|Pfizer ApS|Eletriptan||4113||4113|6504| 554154|QA12CE9902|Selevitan, vet.|stl|0| |100|ml|5|hgl||QA12CE99|01.05.1983||R|A|2|0|0|0|0|BID|0|0|0|100|DKK|7260|14113|vetalmen|||27|500|0|0,0000|Vistor hf|Boehringer Ingelheim Danmark|||7260||7260|14113| 556738|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|12|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|3802|5487|lyfsjukr|||00|6000|0|6,0000|Icepharma hf|Fresenius Kabi|Kolvetni||3802||3802|5487| 556936|N03AF0201|Trileptal|filmhtfl|300|mg|100|stk|1|þpakki||N03AF02|01.02.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|4885|7560|lyfalmen|||00|100|0|30,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||4885||4885|7560| 556944|N03AF0201|Trileptal|filmhtfl|600|mg|50|stk|1|glas||N03AF02|01.02.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|6740|10097|lyfalmen|||00|50|0|30,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||6740||6740|10097| 556951|N03AF0201|Trileptal|filmhtfl|600|mg|100|stk|1|þpakki||N03AF02|01.02.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|9524|13906|lyfalmen|||00|100|0|60,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||9524||9524|13906| 557546|D10AF0202|Zineryt|áburður|0| |30|ml|1|glas|+ leysir|D10AF02|01.07.1985||R|A|2|0|0|0|0|ASP|0|0|0|100|XEU|1601|3067|lyfalmen|||38|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Erýtrómýcín||1601||1601|3067| 558585|V08CA0101|Magnevist|stl|469|mg/ml|20|ml|10|hgl|röntgenskuggaefni|V08CA01|01.07.1992||R|A|5|0|0|0|1|SAG|0|0|0|100|SEK|183686|232408|lyfsjukr|||02|200|0|0,0000|Icepharma hf|Schering AG|Gadópentetat||183686||183686|232408| 559013|C08DA0103|Isoptin retard|forðatfl|120|mg|28|stk|1|þpakki||C08DA01|01.01.1995||R|A|4|0|0|B|0|ABS|0|0|0|100|DKK|981|2219|lyfalmen|||10|28|0|14,0000|Vistor hf|Abbott Scandinavia AB|Verapamíl||981||981|2219| 559021|C08DA0103|Isoptin retard|forðatfl|120|mg|98|stk|1|þpakki||C08DA01|01.01.1995||R|A|4|0|0|B|0|ABS|0|0|0|100|DKK|1947|3541|lyfalmen|||10|98|0|49,0000|Vistor hf|Abbott Scandinavia AB|Verapamíl||1947||1947|3541| 559070|N02AX0201|Nobligan|hylki|50|mg|20|stk|1|pakki||N02AX02|01.04.1994||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|588|1682|lyfalmen|V0730|1278|10|20|0|3,3333|Icepharma hf|Grunenthal|Tramadól||588||588|1682| 559104|N02AX0201|Nobligan|eþ-stíll|100|mg|20|stk|1|pakki||N02AX02|01.04.1994||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|1640|3121|lyfalmen|||04|20|0|6,6667|Icepharma hf|Grunenthal|Tramadól||1640||1640|3121| 559120|N02AX0201|Nobligan|stl|50|mg/ml|2|ml|5|lykjur||N02AX02|01.04.1994||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|943|2167|lyfalmen|V0732|2058|02|10|0|1,6667|Icepharma hf|Grunenthal|Tramadól||943||943|2167| 559286|C05BA0101|Hirudoid|krem|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|A|5|0|0|0|0|STD|0|0|0|100|IKR|||lyflausa|||00|100|0|100,0000|Icepharma hf|STADA Arzneimittel AG|Heparínóíð|||||| 559401|S01ED5104|Fotil|augndr|25|mg/ml|5|ml|1|glas|5+20 mg/ml|S01ED51|01.10.1995||R|K|3|0|0|*|0|SAO|0|0|0|100|XEU|2431|4203|lyfalmen|||06|5|0|0,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||2431||2431|4203| 559476|C05BA0101|Hirudoid|hlaup|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|A|5|0|0|0|0|STD|0|0|0|100|IKR|||lyflausa|||00|100|0|0,0000|Icepharma hf|STADA Arzneimittel AG|Heparínóíð|||||| 559948|G03CA0303|Estring|sk-hring|7,5|mcg/sólh|1|stk|1|pakki||G03CA03|01.07.1994||R|A|2|0|0|E|0|PER|0|0|0|100|DKK|5736|8724|lyfalmen|||23|1|0|90,0000|Icepharma hf|Pfizer ApS|Estradíól||5736||5736|8724| 559963|C01DA0201|Discotrine|forðapl|5|mg/sólh|30|stk|1|þpakki||C01DA02|01.01.1994||R|A|3|0|0|B|0|MEB|0|0|0|100|SEK|3186|5236|lyfalmen|||23|30|0|30,0000|Vistor hf|Meda AB (V)|Glýcerýltrínítrat||3186||3186|5236| 559971|C01DA0201|Discotrine|forðapl|10|mg/sólh|30|stk|1|þpakki||C01DA02|01.01.1994||R|A|3|0|0|B|0|MEB|0|0|0|100|SEK|3519|5691|lyfalmen|||23|30|0|60,0000|Vistor hf|Meda AB (V)|Glýcerýltrínítrat||3519||3519|5691| 559989|N01AB0701|Suprane|innönd.l|0| |240|ml|1|fl||N01AB07|01.01.1995||R|A|3|0|0|0|1|BAX|0|0|0|100|SEK|16591|22704|lyfsjukr|||00|240|0|0,0000|Icepharma hf|Baxter|Desflúran||16591||16591|22704| 560060|S01XA2004|Vidisic|augngel|2|mg/g|10|g|1|túpa||S01XA20|01.04.1993||L|A|3|0|0|E|0|GEM|0|0|0|100|XEU|||lyfalmen|||07|10|0|0,0000|Actavis Group hf|Gerhard Mann|Gervitár og aðrar óvirkar sam­setningar|||||1322| 560326|J05AB0102|Zovir|töflur|200|mg|25|stk|1|þpakki||J05AB01|01.07.1989||R|A|5|0|0|E|0|GSK|0|0|1|100|GBP|3006|4989|lyfalmen|||00|25|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||3006||3006|4989| 560367|D06BB0303|Zovir|krem|50|mg/g|2|g|1|túpa||D06BB03|01.07.1994||L|A|3|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||20|2|0|2,0000|Icepharma hf|GlaxoSmithKline CH A/S|Acíklóvír|||||| 560375|S01AD0301|Zovir|augnsm|30|mg/g|4,5|g|1|túpa||S01AD03|01.01.1988||R|A|5|0|0|E|0|GSK|0|0|1|100|GBP|1714|3222|lyfalmen|||07|4|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||1714||1714|3222| 560383|J05AB0102|Zovir|mixtúra|40|mg/ml|125|ml|1|glas||J05AB01|01.01.1995||R|A|3|0|0|E|0|GSK|0|0|1|100|GBP|5730|8716|lyfalmen|||00|125|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||5730||5730|8716| 560391|J05AB0102|Zovir|mixtúra|80|mg/ml|100|ml|1|glas||J05AB01|01.01.1995||R|A|3|0|0|E|0|GSK|0|0|1|100|GBP|6213|9376|lyfalmen|||00|100|0|2,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||6213||6213|9376| 560490|C01CX0801|Simdax|irþ|2,5|mg/ml|5|ml|1|lykja||C01CX08|01.09.2001||R|K|3|0|1|0|1|ORC|0|0|0|100|DKK|100422|127912|lyfsjukr|||00|5|0|1,1400|Vistor hf|Orion Corporation|Levosimendan||100422||100422|127912| 560557|C01CX0801|Simdax|irþ|2,5|mg/ml|5|ml|4|lykjur||C01CX08|01.09.2001||R|K|3|0|1|0|1|ORC|0|0|0|100|DKK|571687|541317|lyfsjukr|||00|20|0|4,5500|Vistor hf|Orion Corporation|Levosimendan||429828||429828|541317| 561159|S01ED5105|Fotil forte|augndr|45|mg/ml|5|ml|1|glas|5+40 mg/ml|S01ED51|01.10.1995||R|K|3|0|0|*|0|SAO|0|0|0|100|XEU|2437|4211|lyfalmen|||06|5|0|0,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||2437||2437|4211| 563346|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|3|spr|einnota sprauta|M09AX01|01.01.2001||R|A|3|0|0|E|0|NYG|0|0|0|100|DKK|24938|33576|lyfalmen|||02|6|0|17,1667|Gróco ehf|Nycomed Danmark A/S|Natríumhýalúrónat||24938||24938|33576| 563361|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|5|spr|einnota sprauta|M09AX01|01.01.2001||R|A|3|0|0|E|0|NYG|0|0|0|100|DKK|38390|50459|lyfalmen|||02|10|0|28,6111|Gróco ehf|Nycomed Danmark A/S|Natríumhýalúrónat||38390||38390|50459| 563379|D07AC1701|Cutivat|krem|0,5|mg/g|30|g|1|túpa||D07AC17|01.07.1995||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|669|1792|lyfalmen|||20|30|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||669||669|1792| 563395|D07AC1701|Cutivat|smyrsli|50|mcg/g|30|g|1|túpa||D07AC17|01.07.1995||R|A||0|0|B|0|GSK|0|0|1|100|GBP|669|1792|lyfalmen|||20|30|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||669||669|1792| 563502|N02AA0101|Contalgin|forðatfl|5|mg|100|stk|1|þpakki||N02AA01|01.10.1993||R|A|3|1|0|E|0|PER|0|0|0|100|DKK|1624|3099|lyfalmen|||10|100|0|5,0000|Icepharma hf|Pfizer ApS|Morfín||1624||1624|3099| 563528|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|30|spr|einnota sprauta|M09AX01|01.01.2001||R|A|3|0|0|E|0|NYG|0|0|0|100|DKK|206231|261099|lyfalmen|||02|60|0|171,6667|Gróco ehf|Nycomed Danmark A/S|Natríumhýalúrónat||206231||206231|261099| 563577|S01ED5104|Fotil|augndr|25|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|K|3|0|0|*|0|SAO|0|0|0|100|XEU|4758|7386|lyfalmen|||00|15|0|0,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||4758||4758|7386| 563593|S01ED5105|Fotil forte|augndr|45|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|K|3|0|0|*|0|SAO|0|0|0|100|XEU|5012|7733|lyfalmen|||00|15|0|0,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||5012||5012|7733| 564088|J05AB0401|Rebetol|hylki|200|mg|168|stk|1|þpakki|hart|J05AB04|01.02.2002||R|A|2|0|1|0|1|SCP|0|0|0|100|DKK|152085|192749|lyfsjukr|||00|168|0|33,6000|Vistor hf|Schering-Plough|Ribavirin||152085||152085|192749| 565275|C07AG0202|Dimitone|töflur|12,5|mg|100|stk|1|pakki||C07AG02|01.07.2001||R|A||0|0|B|0|LDR|0|0|0|100|DKK|5180|7963|lyfalmen|||00|100|1|33,3333|Parlogis hf|Parlogis - óskráð lyf|||5180||5180|7963| 565306|A02BX1302|Galieve Cool Mint|mixtúra|||300|ml|1|glerfl|dreifa|A02BX13|01.12.2010||L|A||0|0|0|0|RBS|0|0|0|100|IKR|||lyfalmen|||01|300|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||| 565325|C07AG0202|Dimitone|töflur|25|mg|100|stk|1|pakki||C07AG02|01.07.2001||R|A||0|0|B|0|LDR|0|0|0|100|DKK|7773|11510|lyfalmen|||00|100|1|66,6667|Parlogis hf|Parlogis - óskráð lyf|||7773||7773|11510| 565374|C07AG0202|Dimitone|töflur|6,25|mg|28|stk|1|pakki||C07AG02|01.07.2001||R|A||0|0|B|0|LDR|0|0|0|100|DKK|1374|2757|lyfalmen|||00|28|1|4,6667|Parlogis hf|Parlogis - óskráð lyf|||1374||1374|2757| 565457|A07EC0301|Dipentum|töflur|500|mg|100|stk|1|glas||A07EC03|01.10.1994||R|A|4|0|0|B|0|UCB|0|0|0|100|DKK|11572|16707|lyfalmen|||00|100|0|50,0000|Vistor hf|U.C.B|Olsalazín||11572||11572|16707| 566182|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|1|glas||S01EC04|01.01.2001||R|A|2|0|0|*|0|ALC|0|0|0|100|USD|1331|2698|lyfalmen|||06|5|0|25,0000|K.Pétursson hf|Alcon|Brinzólamíð||1331||1331|2698| 566661|L04AB0101|Enbrel|sts|25|mg|4|hgl|1|pakki|+ leysir|L04AB01|01.11.2000||R|K|3|0|1|0|1|WTE|0|0|0|100|DKK|73953|94694|lyfsjukr|||00|4|0|14,2900|Icepharma hf|Wyeth Europe|Etanercept||73953||73953|94694| 567016|R06AD0201|Phenergan|mixtúra|1|mg/ml|100|ml|1|glas||R06AD02|01.10.1995||R|A|2|0|0|E|0|SNO|0|0|1|100|NOK|2194|3879|lyfalmen|||00|100|0|4,0000|Vistor hf|Sanofi-aventis Norge AS|Prómetazín||2194||2194|3879| 567503|N05AX0801|Risperdal|töflur|1|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|6544|9829|lyfalmen|V0791|4103|00|60|0|12,0000|Vistor hf|Janssen-Cilag AB|Risperídón||6544||6544|9829| 567511|N05AX0801|Risperdal|töflur|2|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|15097|21226|lyfalmen|V0793|7294|00|60|0|24,0000|Vistor hf|Janssen-Cilag AB|Risperídón||15097||15097|21226| 567529|N05AX0801|Risperdal|töflur|3|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|25092|33770|lyfalmen|V0794|11833|00|60|0|36,0000|Vistor hf|Janssen-Cilag AB|Risperídón||25092||25092|33770| 567537|N05AX0801|Risperdal|töflur|4|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|33247|44004|lyfalmen|V0795|18555|00|60|0|48,0000|Vistor hf|Janssen-Cilag AB|Risperídón||33247||33247|44004| 567545|R01AC0201|Livostin|nefúði|0,5|mg/úðask|15|ml|1|glas||R01AC02|01.06.1998||L|A|3|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||24|15|0|12,5000|Vistor hf|McNeil Sweden AB|Levókabastín|||||| 567636|N05BA1205|Alprazolam Mylan|töflur|1|mg|20|stk|1|þpakki||N05BA12|01.07.2009|31.01.2011|R|A||0|0|0|0|MYL|0|0|1|100|SEK|612|1714|lyfalmen|||00|20|0|20,0000|Actavis Group PTC ehf|Mylan AB|Alprazólam||612||612|1714| 567946|A02BX1302|Galieve Cool Mint|mixtúra|||10|ml|24|skammt|dreifa|A02BX13|01.12.2010||L|A||0|0|0|0|RBS|0|0|0|100|IKR|||lyfalmen|||00|240|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||| 568238|A02BC0401|Pariet|sh-tfl|20|mg|120|stk|1|þpakki||A02BC04|01.05.2002||R|A|2|0|0|E|0|EIS|0|0|0|100|IKR|16169|9000|lyfalmen|||00|120|0|120,0000|Vistor hf|Eisai Ltd|Rabeprazól||5938||5938|9000| 568709|R01AX0601|Bactroban Nasal|nefsm|20|mg/g|3|g|1|túpa||R01AX06|01.07.1994||R|A|3|0|0|0|0|GSK|0|0|1|100|GBP|1075|2348|lyfalmen|||00|3|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Mupirocin||1075||1075|2348| 568790|N02AA5902|Parkodin forte|eþ-stíll|530|mg|10|stk|1|pakki|30+500 mg|N02AA59|01.07.1993||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|489|1546|lyfalmen|V0776|1396|04|10|0|3,3333|Actavis Group hf|Actavis hf|Kódein í blöndum nema með geðlyfjum||489||489|1546| 568840|C08CA0201|Feldil|forðatfl|5|mg|100|stk|1|glas||C08CA02|01.04.2003||R|A|5|0|0|B|0|ACA|0|0|0|100|IKR|1463|2879|lyfalmen|V0316|2879|10|100|0|100,0000|Actavis Group hf|Actavis hf|Felódipín||1463||1463|2879| 568865|C08CA0201|Feldil|forðatfl|10|mg|100|stk|1|glas||C08CA02|01.04.2003||R|A|5|0|0|B|0|ACA|0|0|0|100|IKR|2318|4048|lyfalmen|V0324|4048|10|100|0|200,0000|Actavis Group hf|Actavis hf|Felódipín||2318||2318|4048| 569467|M03BX0103|Lioresal|stl|2|mg/ml|5|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|A|3|0|0|0|1|NOH|0|0|0|100|DKK|15834|21754|lyfsjukr|||02|5|0|18,1800|Vistor hf|Novartis Healthcare A/S-|Baklófen||15834||15834|21754| 569483|M03BX0103|Lioresal|stl|0,5|mg/ml|20|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|A|5|0|0|0|1|NOH|0|0|0|100|DKK|17817|24243|lyfsjukr|||02|20|0|18,1800|Vistor hf|Novartis Healthcare A/S-|Baklófen||17817||17817|24243| 569897|J07AJ5204|DiTeKik|bóluefni|0| |0,5|ml|1|spr|án nálar|J07AJ52|01.11.1998||R|K|2|0|0|0|0|SSI|0|0|0|100|DKK|2302|4026|lyfalmen|||51|0|0|0,0000|Icepharma hf|Statens Serum Institut|Kíghósti, í blöndum með öðrum toxóíðum||2302||2302|4026| 571524|A02BX1303|Galieve Peppermint|tuggutfl|||24|stk|1|þpakki|dreifa|A02BX13|01.12.2010||L|A||0|0|0|0|RBS|0|0|0|100|IKR|||lyfalmen|||00|24|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||| 572768|B02BC1001|Tisseel Duo Quick|vefjalím|0| |0,5|ml|10|stk|samsett pk|B02BC10|01.03.2001||R|I|2|0|0|0|1|BAX|0|0|0|100|SEK|149988|190117|lyfsjukr|||00|5|0|0,0000|Icepharma hf|Baxter|Fíbrínógen manna||149988||149988|190117| 572776|B02BC1001|Tisseel Duo Quick|vefjalím|0| |1|ml|10|stk|samsett pk|B02BC10|01.03.2001||R|I|2|0|0|0|1|BAX|0|0|0|100|SEK|196326|248272|lyfsjukr|||00|10|0|0,0000|Icepharma hf|Baxter|Fíbrínógen manna||196326||196326|248272| 572784|B02BC1001|Tisseel Duo Quick|vefjalím|0| |2|ml|10|stk|samsett pk|B02BC10|01.03.2001||R|I|2|0|0|0|1|BAX|0|0|0|100|SEK|369338|465402|lyfsjukr|||00|20|0|0,0000|Icepharma hf|Baxter|Fíbrínógen manna||369338||369338|465402| 572798|A02BX1303|Galieve Peppermint|tuggutfl|||48|stk|1|þpakki|dreifa|A02BX13|01.12.2010||L|A||0|0|0|0|RBS|0|0|0|100|IKR|||lyfalmen|||00|48|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||| 573120|N03AX0903|Lamotrin|dreifit.|100|mg|98|stk|1|þpakki||N03AX09|01.12.2010||R|A||0|0|E|0|ACA|0|0|0|100|IKR|5300|8127|lyfalmen|V0705|8127|00|98|0|49,0000|Actavis Group hf|Actavis hf|Lamótrigín||5300||5300|8127| 573287|G03CA0306|Evorel|forðapl|25|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|4079|6457|lyfalmen|||23|26|0|45,5000|Vistor hf|Janssen-Cilag AB|Estradíól||4079||4079|6457| 573477|L01XC0301|Herceptin|sts|150|mg/hgl|1|hgl|1|pakki||L01XC03|01.01.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|96824|123397|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Roche|Trastuzumab||96824||96824|123397| 573634|J01DH0201|Meronem|sts/irs|500|mg/hgl|500|mg|10|hgl||J01DH02|01.10.1995||R|A|4|0|0|0|1|AZA|0|0|0|100|SEK|24095|32122|lyfsjukr|||00|5000|0|2,5000|Vistor hf|AstraZeneca AB|Meropenem||24095||24095|32122| 573642|J01DH0201|Meronem|sts/irs|1|g/hgl|1|g|10|hgl||J01DH02|01.10.1995||R|A|4|0|0|0|1|AZA|0|0|0|100|SEK|45718|59259|lyfsjukr|||00|10|0|5,0000|Vistor hf|AstraZeneca AB|Meropenem||45718||45718|59259| 573790|M01AB0506|Voltaren Rapid|töflur|50|mg|100|stk|1|þpakki||M01AB05|01.01.1996||R|A|3|0|0|0|0|NOH|0|0|1|100|IKR|2756|2557|lyfalmen|V0610|2501|67|100|0|50,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||1228||1228|2557| 575324|N06AB0601|Zoloft|töflur|50|mg|28|stk|1|þpakki||N06AB06|01.10.1995||R|A|5|0|0|B|0|PER|0|1|0|100|DKK|2972|2007|lyfalmen|V0931|1947|00|28|0|28,0000|Icepharma hf|Pfizer ApS|Sertralín||826||826|2007| 575340|N06AB0601|Zoloft|töflur|50|mg|98|stk|1|þpakki||N06AB06|01.10.1995||R|A|5|0|0|B|0|PER|0|1|0|100|DKK|7721|6847|lyfalmen|V0933|5003|00|98|0|98,0000|Icepharma hf|Pfizer ApS|Sertralín||4364||4364|6847| 575357|N06AB0601|Zoloft|töflur|100|mg|28|stk|1|þpakki||N06AB06|01.03.2001||R|A|5|0|0|B|0|PER|0|1|0|100|DKK|6180|2007|lyfalmen|V0935|1947|00|28|0|56,0000|Icepharma hf|Pfizer ApS|Sertralín||826||826|2007| 575365|N06AB0601|Zoloft|töflur|100|mg|98|stk|1|þpakki||N06AB06|01.03.2001||R|A|5|0|0|B|0|PER|0|1|0|100|DKK|13755|6847|lyfalmen|V0937|6575|00|98|0|196,0000|Icepharma hf|Pfizer ApS|Sertralín||4364||4364|6847| 575472|P03AX0301|Prioderm|hársápa|10|mg/ml|40|g|1|túpa||P03AX03|01.04.1994||L|K|2|0|0|0|0|NOP|0|0|0|100|IKR|||lyflausa|||23|40|0|0,0000|Icepharma hf|Norpharma |Malatíón|||||| 575506|C01EB1001|Adenocor|stl|3|mg/ml|2|ml|6|hgl||C01EB10|01.11.2007||R|A|3|0|0|0|1|SAA|0|0|0|100|NOK|15584|21440|lyfsjukr|||00|12|0|0,0000|Vistor hf|Sanofi - Aventis|Adenósín||15584||15584|21440| 575787|L04AB0201|Remicade|irs|100|mg|1|hgl|1|pakki||L04AB02|01.12.2000||R|K|3|0|1|0|1|CEO|0|0|0|100|DKK|88320|112724|lyfsjukr|||00|1|0|26,6700|Vistor hf|Centocor B.V.|Infliximab||88320||88320|112724| 576032|N03AX0903|Lamotrin|dreifit.|25|mg|42|stk|1|þpakki||N03AX09|01.12.2010||R|A||0|0|E|0|ACA|0|0|0|100|IKR|1150|2450|lyfalmen|V0704|2450|00|42|0|5,2500|Actavis Group hf|Actavis hf|Lamótrigín||1150||1150|2450| 579110|R03CC0301|Bricanyl|stl|0,5|mg/ml|1|ml|10|lykjur||R03CC03|01.12.1972||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|1320|2683|lyfalmen|||02|10|0|0,3300|Vistor hf|AstraZeneca A/S DK|Terbútalín||1320||1320|2683| 579854|L04AX0301|Methotrexate Wyeth Lederle|töflur|2,5|mg|30|stk|1|glas||L04AX03|01.01.1994||R|A|3|0|0|*|0|PER|0|0|0|100|DKK|707|1844|lyfalmen|||00|30|0|30,0000|Icepharma hf|Pfizer ApS|Metótrexat||707||707|1844| 581890|QN02AF0103|Torphasol vet.|stl|10|mg/ml|20|ml|1|hgl||QN02AF01|01.02.2011||R|A||0|0|0|0|ANI|1|0|0|100|XEU|14430|27880|vetalmen|||27|20|0||Dýraheilsa ehf|aniMedica GmbH|Bútorfanóltartrat||14430||14430|27880| 582080|H01AC0107|Humatrope 6 mg|sts|6|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|K|3|0|1|0|1|ELI|0|0|0|100|XEU|30777|40508|lyfsjukr|||02|1|0|9,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||30777||30777|40508| 582114|H01AC0108|Humatrope 12 mg|sts|12|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|K|3|0|1|0|1|ELI|0|0|0|100|XEU|61276|78784|lyfsjukr|||02|1|0|18,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||61276||61276|78784| 582130|H01AC0109|Humatrope 24 mg|sts|24|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|K|3|0|1|0|1|ELI|0|0|0|100|XEU|117434|149262|lyfsjukr|||02|1|0|36,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||117434||117434|149262| 582213|R01AA0503|Nezeril|nefúði|0,1|mg/ml|7,5|ml|1|glas|sk-úðari|R01AA05|01.10.1994||L|A|3|0|0|0|0|GCO|0|0|1|100|IKR|||lyflausa|||23|8|0|1,8750|Vistor hf|GlaxoSmithKline CH AB|Oxýmetazólín|||||| 582247|QP54AA0301|Dectomax vet.|stl|10|mg/ml|50|ml|1|hgl||QP54AA03|01.02.1999||R|A|2|0|0|0|0|PAL|1|0|0|100|DKK|4976|8680|vetorma|||16|50|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||4976||4976|8680| 582262|QP54AA0301|Dectomax vet.|stl|10|mg/ml|200|ml|1|hgl||QP54AA03|01.02.1999||R|A|2|0|0|0|0|PAL|1|0|0|100|DKK|18751|32710|vetorma|||16|200|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||18751||18751|32710| 582452|V08AB0201|Omnipaque|stl|300|mg J/ml|100|ml|10|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|57085|73524|lyfsjukr|||02|1000|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||57085||57085|73524| 582635|V08AB0201|Omnipaque|stl|300|mg J/ml|500|ml|6|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|98536|125545|lyfsjukr|||02|3000|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||98536||98536|125545| 582783|C07AB0205|Seloken|töflur|100|mg|28|stk|1|þpakki||C07AB02|01.12.2001||R|A|5|0|0|B|0|AZD|0|0|0|100|SEK|822|2002|lyfalmen|||00|28|0|18,6667|Vistor hf|AstraZeneca A/S DK|Metóprólól||822||822|2002| 582882|V08AB0901|Visipaque|stl|270|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|47745|61802|lyfsjukr|||02|1000|0|0,0000|Icepharma hf|GE Healthcare AS|Jódixanól||47745||47745|61802| 583401|V08AB0901|Visipaque|stl|270|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|94947|121041|lyfsjukr|||02|2000|0|0,0000|Icepharma hf|GE Healthcare AS|Jódixanól||94947||94947|121041| 583443|C07AA0705|Sotalol Mylan|töflur|80|mg|100|stk|1|þpakki||C07AA07|01.01.1994||R|A|4|0|0|B|0|MYL|0|0|0|100|SEK|1196|2513|lyfalmen|||00|100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Sótalól||1196||1196|2513| 583450|V08AB0901|Visipaque|stl|270|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|113327|144108|lyfsjukr|||02|3000|0|0,0000|Icepharma hf|GE Healthcare AS|Jódixanól||113327||113327|144108| 583518|V08AB0901|Visipaque|stl|320|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|51748|66826|lyfsjukr|||02|1000|0|0,0000|Icepharma hf|GE Healthcare AS|Jódixanól||51748||51748|66826| 583609|V08AB0901|Visipaque|stl|320|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|112522|143098|lyfsjukr|||02|2000|0|0,0000|Icepharma hf|GE Healthcare AS|Jódixanól||112522||112522|143098| 583708|V08AB0901|Visipaque|stl|320|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|116525|148121|lyfsjukr|||02|3000|0|0,0000|Icepharma hf|GE Healthcare AS|Jódixanól||116525||116525|148121| 583849|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|20|plpok|Excel umbúðir|B05BB01|01.11.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|3809|5497|lyfsjukr|||00|5000|0|5,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar||3809||3809|5497| 583930|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|1000|ml|9|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2919|4213|lyfsjukr|||00|9000|0|9,0000|Icepharma hf|Fresenius Kabi|Kolvetni||2919||2919|4213| 584029|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|1000|ml|9|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|3301|4764|lyfsjukr|||00|9000|0|9,0000|Icepharma hf|Fresenius Kabi|Kolvetni||3301||3301|4764| 584276|B05BB0115|Ringer-acetat Fresenius Kabi|irl|0| |1000|ml|9|plpok|Excel umbúðir|B05BB01|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2225|3211|lyfsjukr|||00|9000|0|9,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar||2225||2225|3211| 584292|N06AG0201|Aurorix|töflur|300|mg|30|stk|1|þpakki||N06AG02|01.07.1995||R|A|5|0|0|B|0|MAS|0|1|0|100|SEK|4118|6510|lyfalmen|||64|30|0|30,0000|Vistor hf|Meda AS|Móklóbemíð||4118||4118|6510| 585646|B01AB0101|Heparin Leo|stl|25000|ae/ml|2|ml|10|hgl||B01AB01|01.11.1981||R|A|3|0|0|0|1|LEP|0|0|0|100|DKK|9960|14375|lyfsjukr|||02|20|0|50,0000|Vistor hf|LEO Pharma A/S|Heparín||9960||9960|14375| 585679|B01AB0101|Heparin Leo|stl|5000|ae/ml|5|ml|5|hgl||B01AB01|01.12.1972||R|A|3|0|0|0|1|LEP|0|0|0|100|DKK|3628|5236|lyfsjukr|||02|25|0|12,5000|Vistor hf|LEO Pharma A/S|Heparín||3628||3628|5236| 585844|J01DH5101|Tienam|irs|500|mg|12|hgl|1|pakki|monovial|J01DH51|01.04.1988||R|A|2|0|0|0|1|MSD|0|0|0|100|XEU|35679|46660|lyfsjukr|||00|12|0|3,0000|Icepharma hf|M.S.D.|Imipenem og ensímhemill||35679||35679|46660| 585869|J07BC0201|Havrix|bóluefni|1440|ein/ml|1|ml|1|dæla|einnota dæla|J07BC02|01.07.1994||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|3568|5758|lyfalmen|||02|1|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||3568||3568|5758| 586107|L04AD0102|Sandimmun Neoral|mixtúra|100|mg/ml|50|ml|1|glas||L04AD01|01.07.1994||R|A|3|0|0|*|0|NOH|0|0|0|100|DKK|34545|45633|lyfalmen|||00|50|0|20,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||34545||34545|45633| 586206|D07AB0201|Locoid|smyrsli|1|mg/g|100|g|1|túpa||D07AB02|01.03.1977||R|A|5|0|0|B|0|ASP|0|0|1|100|XEU|2630|4475|lyfalmen|||20|100|0|100,0000|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||2630||2630|4475| 587667|B05BB0210|Rehydrex m. gl. 25 mg/ml Fresenius Kabi|irl|0| |1000|ml|9|plpok|Excel umbúðir|B05BB02|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|3092|4463|lyfsjukr|||00|9000|0|9,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með kol­vetnum||3092||3092|4463| 588152|S01GX0401|Tilavist|augndr|20|mg/ml|5|ml|1|glas||S01GX04|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|1531|2972|lyfalmen|||06|5|0|0,0000|Vistor hf|Sanofi-aventis Norge AS|Nedókrómíl||1531||1531|2972| 588574|J01FF0101|Dalacin|hylki|300|mg|20|stk|1|þpakki||J01FF01|01.10.1995||R|A|5|0|0|0|0|PER|0|0|1|100|DKK|2191|3874|lyfalmen|V0426|3813|43|20|0|5,0000|Icepharma hf|Pfizer ApS|Klindamýcín||2191||2191|3874| 588608|B01AC0501|Ticlid|töflur|250|mg|100|stk|1|þpakki||B01AC05|01.04.1995||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|13511|19235|lyfalmen|||00|100|0|50,0000|Vistor hf|Sanofi-aventis Norge AS|Tíklópídín||13511||13511|19235| 588772|H05BA0103|Miacalcic Nasal|nefúði|200|ae/sk|2|ml|1|úðagl|14 skammt|H05BA01|01.03.2002||R|K|3|0|0|E|0|NOH|0|0|0|100|DKK|8767|12870|lyfalmen|||23|2|0|14,0000|Vistor hf|Novartis Healthcare A/S-|Samtengt laxakalsítónín||8767||8767|12870| 589358|QP54AA0501|Stronghold vet.|bl.lausn|120|mg|1|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|6085|10615|vetorma|||16|3|0|0,0000|Icepharma hf|Pfizer Animal Health|||6085||6085|10615| 589366|QP54AA0501|Stronghold vet.|bl.lausn|15|mg|0,25|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|2358|4113|vetorma|||16|1|0|0,0000|Icepharma hf|Pfizer Animal Health|||2358||2358|4113| 589374|QP54AA0501|Stronghold vet.|bl.lausn|240|mg|2|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|5871|10242|vetorma|||16|6|0|0,0000|Icepharma hf|Pfizer Animal Health|||5871||5871|10242| 589382|QP54AA0501|Stronghold vet.|bl.lausn|30|mg|0,25|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|3171|5532|vetorma|||16|1|0|0,0000|Icepharma hf|Pfizer Animal Health|||3171||3171|5532| 589390|QP54AA0501|Stronghold vet.|bl.lausn|60|mg|0,5|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|3294|5746|vetorma|||16|2|0|0,0000|Icepharma hf|Pfizer Animal Health|||3294||3294|5746| 589408|QP54AA0501|Stronghold vet.|bl.lausn|45|mg|0,75|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|2551|4450|vetorma|||16|2|0|0,0000|Icepharma hf|Pfizer Animal Health|||2551||2551|4450| 589497|D11AF0102|Canthacur|lausn|0,7|%|7,5|ml|1|glas||D11AF01|01.01.1998||R|A||0|0|0|0|LDR|0|0|0|100|IKR|2566|4387|lyfalmen|||00|8|1|7,5000|Parlogis hf|Parlogis - óskráð lyf|||2566||2566|4387| 589500|D11AF0103|Canthacur-PS|lausn|36|%|7,5|ml|1|glas|1%+30%+5%|D11AF01|01.01.1998||R|A||0|0|0|0|LDR|0|0|0|100|IKR|5480|8374|lyfalmen|||00|8|1|7,5000|Parlogis hf|Parlogis - óskráð lyf|||5480||5480|8374| 589911|L01BB0501|Fludara|sts|50|mg/hgl|50|mg|5|hgl||L01BB05|01.01.1996||R|A|3|0|1|0|1|GZE|0|0|0|100|SEK|165632|209751|lyfsjukr|||00|250|0|0,0000|Vistor hf|Genzyme Europe B.V.|Flúdarabín||165632||165632|209751| 590315|J05AE0301|Norvir|hylki|100|mg|84|stk|4|glös|mjúk hylki|J05AE03|01.08.2003||R|K|2|0|1|0|1|ABL|0|0|0|100|DKK|85724|109466|lyfsjukr|||00|336|0|28,0000|Vistor hf|Abbott Laboratories A/S|Ritonavír||85724||85724|109466| 590497|D01AC0101|Canesten|krem|10|mg/g|20|g|1|túpa||D01AC01|01.12.1982||L|A|3|0|0|0|0|BAI|0|0|1|100|IKR|||lyflausa|||00|20|0|20,0000|Icepharma hf|Bayer A/S|Klótrímazól|||||| 590562|C01DA1403|Ismo|forðatfl|60|mg|98|stk|1|þpakki||C01DA14|01.10.1999||R|A|3|0|0|B|0|ACA|0|0|0|100|XEU|2030|3654|lyfalmen|V0139|3654|10|98|0|147,0000|Actavis Group hf|Actavis hf|Ísósorbíð mónónítrat||2030||2030|3654| 590752|N05AF0102|Fluanxol Depot|stl|100|mg/ml|1|ml|10|lykjur||N05AF01|01.03.1979||R|A|4|0|0|*|0|LBK|0|1|0|100|DKK|26474|35504|lyfalmen|||02|10|0|250,0000|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||26474||26474|35504| 590919|B01AD1101|Metalyse|sts/irs|10000|ein|1|stk|1|hgl|+ leysir áfyllt sprauta|B01AD11|01.07.2001||R|A|2|0|0|0|1|BOI|0|0|0|100|DKK|195232|246899|lyfsjukr|||00|1|0|1,2500|Vistor hf|Boehringer Ingelheim|Tenekteplasi||195232||195232|246899| 592097|N01AF0301|Pentothal Natrium|sts|500|mg|1|stk|12|hgl||N01AF03|01.07.1990||R|A|4|0|0|0|1|HOS|0|0|0|100|DKK|3248|4688|lyfsjukr|||02|12|0|0,0000|Icepharma hf|Hospira Enterprises B.V. (I)|Tíópentalnatríum||3248||3248|4688| 592378|D08AC0201|Hibiscrub|lyf.sápa|40|mg/ml|500|ml|1|glas||D08AC02|01.10.1976||L|A|3|0|0|0|0|REM|0|0|0|100|IKR|||lyflausa|||00|500|0|500,0000|Vistor hf|Regent Medical Overseas Limited|Klórhexidín|||||| 592469|N02BE0107|Paratabs|lausnart|160|mg|30|stk|1|þpakki||N02BE01|01.01.1995||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||09|30|0|1,6000|Actavis Group hf|Actavis hf|Paracetamól|||||| 593384|N03AE0101|Rivotril|töflur|0,5|mg|50|stk|1|glas||N03AE01|01.01.1978||R|A|5|0|0|E|0|ROC|0|0|0|100|DKK|516|1583|lyfalmen|||00|50|0|3,1250|Icepharma hf|Roche|Klónazepam||516||516|1583| 593392|N03AE0101|Rivotril|töflur|0,5|mg|150|stk|1|glas||N03AE01|01.01.1978||R|A|5|0|0|E|0|ROC|0|0|0|100|DKK|896|2103|lyfalmen|||00|150|0|9,3750|Icepharma hf|Roche|Klónazepam||896||896|2103| 593434|N03AE0101|Rivotril|töflur|2|mg|100|stk|1|glas||N03AE01|01.01.1978||R|A|5|0|0|E|0|ROC|0|0|0|100|DKK|1335|2703|lyfalmen|||00|100|0|25,0000|Icepharma hf|Roche|Klónazepam||1335||1335|2703| 594325|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|12|hgl|dreifa|H02AB08|01.12.2003||R|A|3|0|0|B|0|MAB|0|0|1|100|SEK|21588|29372|lyfalmen|||03|12|0|32,0000|Vistor hf|Meda AB|Tríamcínólón||21588||21588|29372| 594713|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|10|g|1|spr||QP52AF02|01.07.1995||L|A|5|0|0|0|0|PAL|0|0|0|100|DKK|338|590|vetorma|||16|10|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||||338|590| 594721|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|10|g|10|spr||QP52AF02|01.07.1995||L|A|5|0|0|0|0|PAL|0|0|0|100|DKK|2808|4898|vetorma|||16|100|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||||2808|4898| 594903|B05BB0209|Glucos 100 mg/ml med Na40 + K20 Fres|irl|0| |1000|ml|9|plpok|Exel umbúðir|B05BB02|01.04.2005||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|2850|4113|lyfsjukr|||02|9000|0|0,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með kol­vetnum||2850||2850|4113| 595066|H05BA0102|Miacalcic|stl|100|ae/ml|1|ml|5|lykjur||H05BA01|01.03.1979||R|K|5|0|0|0|1|NOH|0|0|0|100|DKK|8699|12555|lyfsjukr|||02|5|0|5,0000|Vistor hf|Novartis Healthcare A/S-|Samtengt laxakalsítónín||8699||8699|12555| 595991|J07BB0201|Fluarix|bóluefni|0| |0,5|ml|1|spr|einnotaspr|J07BB02|01.10.1994||R|K|1|0|0|0|0|GSK|0|0|0|100|GBP|608|1709|lyfalmen|||02|0|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Inflúensa, hreinsaðir mótefnavakar||608||608|1709| 596023|D08AC0201|Hibiscrub|lyf.sápa|40|mg/ml|250|ml|1|glas||D08AC02|01.06.1982||L|A|3|0|0|0|0|REM|0|0|0|100|IKR|||lyflausa|||00|250|0|250,0000|Vistor hf|Regent Medical Overseas Limited|Klórhexidín|||||| 596085|B03XA0201|Aranesp|stl|50|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|64837|83253|lyfsjukr|||00|2|0|44,4400|Vistor hf|Amgen|Darbepóetín alfa||||64837|83253| 597401|J01FF0101|Dalacin|hylki|150|mg|24|stk|1|þpakki||J01FF01|01.06.1979||R|A|5|0|0|0|0|PER|0|0|1|100|DKK|3881|6186|lyfalmen|||43|24|0|3,0000|Icepharma hf|Pfizer ApS|Klindamýcín||3881||3881|6186| 597567|D01AC0301|Pevaryl|krem|10|mg/g|30|g|1|túpa||D01AC03|01.05.1978||L|A|2|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||00|30|0|30,0000|Vistor hf|McNeil Sweden AB|Ekónazól|||||| 598094|R06AD0101|Vallergan|mixtúra|5|mg/ml|150|ml|1|glas||R06AD01|01.03.2004||R|A|5|0|0|0|0|SNO|0|0|1|100|NOK|1019|2271|lyfalmen|||00|150|0|25,0000|Vistor hf|Sanofi-aventis Norge AS|Alímemazín||1019||1019|2271| 801120|A11HA0503|Biotin Bayer|töflur|5|mg|20|stk|1|glas||A11HA05|01.12.2005||R|A||0|0|0|0|LDR|0|0|0|100|DKK|1330|2697|lyfalmen|||00|20|1|0,0000|Parlogis hf|Parlogis - óskráð lyf|||1330||1330|2697| 912792|N07CA0301|Sibelium|hylki|5|mg|50|stk|1|glas||N07CA03|01.01.1998||R|A||0|0|E|0|PCO|0|0|0|100|SEK|5101|7855|lyfalmen|||00|50|1|25,0000|Distica|Distica - óskráð lyf|Flunarizín||5101||5101|7855| 916827|A03FA0301|Motilium|töflur|10|mg|100|stk|1|glas||A03FA03|01.05.1998||R|A||0|0|0|0|PCO|0|0|1|100|SEK|2780|4680|lyfalmen|||00|100|1|33,3333|Distica|Distica - óskráð lyf|Dómíperídón||2780||2780|4680| 922866|N05BA0602|Ativan|stl|4|mg/ml|1|ml|10|lykjur||N05BA06|01.11.2005||R|A||0|0|0|1|PCO|0|0|0|100|DKK|2785|4019|lyfsjukr|||00|10|1|0,0000|Distica|Distica - óskráð lyf|Lórazepam||2785||2785|4019| 923351|S01XA2006|Lacri - Lube|augnsm|0| |3,5|g|1|túpa||S01XA20|01.01.1998||R|A||0|0|E|0|PCO|0|0|0|100|IKR|480|1534|lyfalmen|||00|4|1|0,0000|Distica|Distica - óskráð lyf|Gervitár og aðrar óvirkar sam­setningar||480||480|1534| 924698|G03DA0402|Gestone|stl|50|mg/ml|2|ml|10|lykjur||G03DA04|01.11.2005||R|A||0|1|E|0|PCO|0|0|0|100|IKR|12095|17458|lyfalmen|||00|20|1|200,0000|Distica|Distica - óskráð lyf|||12095||12095|17458| 938376|N07BC0201|Metadon|hylki|40|mg|100|stk|1|glas||N07BC02|01.07.2000||R|A||1|0|0|0|LDR|0|0|0|100|IKR|11317|16358|lyfalmen|||00|100|1|160,0000|Parlogis hf|Parlogis - óskráð lyf|||11317||11317|16358| 938483|M04AC0101|Colchicine|töflur|0,5|mg|100|stk|1|glas||M04AC01|01.01.1998||R|A||0|0|E|0|LDR|0|0|0|100|GBP|5114|7873|lyfalmen|||00|100|1|50,0000|Parlogis hf|Parlogis - óskráð lyf|Kolkisín||5114||5114|7873| 938649|C05BA0401|Elmiron|hylki|100|mg|100|stk|1|glas||C05BA04|01.05.1998||R|A||0|0|E|0|LDR|0|0|0|100|IKR|50663|65861|lyfalmen|||00|100|1|0,0000|Parlogis hf|Parlogis - óskráð lyf|Pentósan pólýsúlfat natríum||50663||50663|65861| 938665|A12CX0001|K-Phos Neutral|töflur|||100|stk|1|glas||A12CX00|01.03.2001||R|A||0|0|0|0|LDR|0|0|0|100|IKR|4071|6446|lyfalmen|||00|100|1|0,0000|Parlogis hf|Parlogis - óskráð lyf|Málmlyf ýmisleg||4071||4071|6446| 938780|C09AA0104|Captopril|hylki|1|mg|100|stk|1|glas||C09AA01|01.01.2000||R|A||0|0|0|0|LDR|0|0|0|100|GBP|9662|14094|lyfalmen|||00|100|1|2,0000|Parlogis hf|Parlogis - óskráð lyf|Kaptópríl||9662||9662|14094| 939366|G03DA0402|Gestone|stl|50|mg/ml|1|ml|10|lykjur||G03DA04|01.11.2005||R|A||0|1|E|0|PCO|0|0|0|100|GBP|10477|15209|lyfalmen|||00|10|1|100,0000|Distica|Distica - óskráð lyf|||10477||10477|15209| 940256|G03CA0313|Oestradiol|vefjatfl|25|mg|1|stk|1|pakki||G03CA03|01.04.1998||R|A||0|0|E|0|PCO|0|0|0|100|DKK|2715|4591|lyfalmen|||00|1|1|83,3300|Distica|Distica - óskráð lyf|Estradíól||2715||2715|4591| 940264|G03CA0313|Oestradiol|vefjatfl|50|mg|1|stk|1|pakki||G03CA03|01.04.1998||R|A||0|0|E|0|PCO|0|0|0|100|DKK|5415|8285|lyfalmen|||00|1|1|166,6700|Distica|Distica - óskráð lyf|Estradíól||5415||5415|8285| 940272|G03CA0313|Oestradiol|vefjatfl|100|mg|1|stk|1|pakki||G03CA03|01.04.1998||R|A||0|0|E|0|PCO|0|0|0|100|DKK|9392|13725|lyfalmen|||00|1|1|333,3300|Distica|Distica - óskráð lyf|Estradíól||9392||9392|13725| 940313|G03BA0302|Testosteron|vefjatfl|100|mg|1|stk|1|pakki||G03BA03|01.04.1998||R|A||0|0|E|0|PCO|0|0|0|100|GBP|2842|4765|lyfalmen|||00|1|1|1,3900|Distica|Distica - óskráð lyf|Testósterón||2842||2842|4765| 944505|H02AB1005|Cortisonacetat|töflur|5|mg|100|stk|1|glas||H02AB10|01.12.2002||R|A||0|0|E|0|PCO|0|0|1|100|DKK|5404|8270|lyfalmen|||00|100|1|13,3300|Distica|Distica - óskráð lyf|Kortisón||5404||5404|8270| 944852|A06AX0102|Glycerol infant|eþ-stíll|||12|stk|1|pakki||A06AX01|01.10.1998||R|S||0|0|0|0|LDR|0|0|0|100|IKR|342|1345|lyfalmen|||00|12|1|0,0000|Parlogis hf|Parlogis - óskráð lyf|||342||342|1345| 944886|H02AB0601|Prednisolon|töflur|1|mg|28|stk|1|pakki||H02AB06|01.10.1998||R|A||0|0|E|0|LDR|0|0|1|100|IKR|122|1044|lyfalmen|||00|28|1|2,8000|Parlogis hf|Parlogis - óskráð lyf|Prednisólón||122||122|1044| 944985|A06AX0103|Glycerol adult|eþ-stíll|||12|stk|1|pakki||A06AX01|01.10.1998||R|S||0|0|0|0|LDR|0|0|0|100|IKR|342|1345|lyfalmen|||00|12|1|0,0000|Parlogis hf|Parlogis - óskráð lyf|||342||342|1345| 945850|R06AD0202|Atosil|stl|25|mg/ml|2|ml|5|lykjur||R06AD02|01.03.2001||R|A||0|0|0|0|PCO|0|0|1|100|IKR|2293|4014|lyfalmen|||00|10|1|10,0000|Distica|Distica - óskráð lyf|Prómetazín||2293||2293|4014| 947715|H02AB1004|Cortisone Acetat|töflur|25|mg|100|stk|1|glas||H02AB10|01.01.1998||R|A||0|0|E|0|LDR|0|0|1|100|IKR|5033|7762|lyfalmen|||00|100|1|66,6667|Parlogis hf|Parlogis - óskráð lyf|||5033||5033|7762| 948242|H02AB0203|Dexamethason|töflur|0,5|mg|100|stk|1|pakki||H02AB02|01.04.2005||R|A||0|0|E|0|LDR|0|0|1|100|IKR|1800|3340|lyfalmen|||00|100|1|33,3300|Parlogis hf|Parlogis - óskráð lyf|Dexametasón||1800||1800|3340| 949620|G03DA0401|Utrogestan|hylki|100|mg|30|stk|1|pakki||G03DA04|01.01.1999||R|A||0|1|E|0|LDR|0|0|0|100|IKR|1995|3606|lyfalmen|||00|30|1|10,0000|Parlogis hf|Parlogis - óskráð lyf|Prógesterón||1995||1995|3606| 950742|H02AB0204|Dexa-Ratiopharm|stl|4|mg/ml|1|ml|10|hgl||H02AB02|01.01.2003||R|A||0|0|0|1|LDR|0|0|0|100|IKR|1182|1706|lyfsjukr|||55|10|1|0,0000|Parlogis hf|Parlogis - óskráð lyf|Dexametasón||1182||1182|1706| 951005|G03CA0102|Etinylestradiol|töflur|25|mcg|21|stk|1|pakki||G03CA01|01.09.2002||R|A||0|0|E|0|LDR|0|0|0|100|IKR|838|2024|lyfalmen|||00|21|1|21,0000|Parlogis hf|Parlogis - óskráð lyf|||838||838|2024| 951592|H02AB0907|Hydrocortison|töflur|1|mg|100|stk|1|glas||H02AB09|01.08.2009||R|A||0|0|E|0|PCO|0|0|1|100|DKK|5404|8270|lyfalmen|||00|100|1||Distica|Distica - óskráð lyf|Hýdrókortisón||5404||5404|8270| 954421|C03CA0109|Furosemid|mixtúra|10|mg/ml|60|ml|1|glas||C03CA01|01.08.2009||R|A||0|0|E|0|LDR|0|0|0|100|IKR|1870|3435|lyfalmen|||00|60|1||Parlogis hf|Parlogis - óskráð lyf|Fúrósemíð||||1870|3435| 954504|C07AA0510|Syprol|mixtúra|2|mg/ml|150|ml|1|fl||C07AA05|01.08.2009||R|A||0|0|0|0|LDR|0|0|0|100|IKR|5690|8661|lyfalmen|||00|150|1||Parlogis hf|Parlogis - óskráð lyf|Própranólól||||5690|8661| 958829|A06AD0002|Miralax|lausnduf|0| |238|g|1|stauk||A06AD00|01.05.2007||R|A||0|0|0|0|LDR|0|0|0|100|IKR|2093|3740|lyfalmen|||00|238|1|0,0000|Parlogis hf|Parlogis - óskráð lyf|||2093||2093|3740| 960999|L02AB0101|Megace|töflur|160|mg|30|stk|1|glas||L02AB01|01.01.2009||R|A||0|1|0|1|PCO|0|0|0|100|DKK|17163|23422|lyfsjukr|||00|30|1|112,0000|Distica|Distica - óskráð lyf|||17163||17163|23422| 961393|A04AD0501|Vogalene|hylki|15|mg|20|stk|1|glas||A04AD05|01.01.1998||R|A||0|0|E|0|LDR|0|0|1|100|IKR|1960|3558|lyfalmen|||00|20|1|20,0000|Parlogis hf|Parlogis - óskráð lyf|Metópímazín||1960||1960|3558| 961591|H02AB0906|Hydrocortisone|töflur|10|mg|20|stk|1|glas||H02AB09|01.08.2009||R|A||0|0|E|0|LDR|0|0|1|100|IKR|1850|3408|lyfalmen|||00|20|1||Parlogis hf|Parlogis - óskráð lyf|Hýdrókortisón||1850||1850|3408| 961658|H02AB0905|Hydrocortisone|töflur|20|mg|25|stk|1|glas||H02AB09|01.01.2009||R|A||0|0|E|0|LDR|0|0|1|100|IKR|4320|6787|lyfalmen|||00|25|1|16,7000|Parlogis hf|Parlogis - óskráð lyf|Hýdrókortisón||4320||4320|6787| 962466|H02AB0203|Dexamethason|töflur|4|mg|100|stk|1|glas||H02AB02|01.08.2009||R|A||0|0|E|0|LDR|0|0|1|100|IKR|3451|5598|lyfalmen|||00|100|1|266,6600|Parlogis hf|Parlogis - óskráð lyf|||||3451|5598| 962945|R06AB0201|Polaramin|töflur|2|mg|30|stk|1|þpakki||R06AB02|01.11.2009||R|A||0|0|E|0|LDR|0|0|0|100|IKR|2360|4106|lyfalmen|||00|30|1|10,0000|Parlogis hf|Parlogis - óskráð lyf|Dexklórfeníramín||2360||2360|4106| 963802|M01AB0107|Indometacin|eþ-stíll|100|mg|10|stk|1|pakki||M01AB01|01.10.2010||R|A||0|0|E|0|PCO|0|0|1|100|GBP|412|1441|lyfalmen|||04|10|1|10,0000|Distica|Distica - óskráð lyf|Indómetacín||412||412|1441| 964371|A03AA0702|Merbentyl|mixtúra|2|mg/ml|120|ml|1|glas|sykursaft|A03AA07|01.12.2010||R|A||0|1|E|0|LDR|0|0|0|100|IKR|657|1776|lyfalmen|||00|120|1|3,0000|Parlogis hf|Parlogis - óskráð lyf|Dícýklóverín||657||657|1776|